data_2ktu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ktu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.51 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.98 -41.17 91.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.376 0.607 . . . . 0.0 109.857 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.654 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 2.1 mp0 -80.29 -42.08 23.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.33 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -70.01 -39.99 75.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -58.41 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 18.0 tp -58.93 -55.94 28.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.891 0.377 . . . . 0.0 111.318 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 47.1 mt -60.99 -49.91 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.806 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.434 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.47 -38.78 58.56 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 20.6 ttt85 -60.03 -37.64 80.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 110.277 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.5 t80 -55.79 -47.46 77.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.938 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 34.8 m-85 -83.63 -38.73 21.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.9 t0 -60.33 -42.75 96.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.522 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.644 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.0 mt-10 -69.47 -43.3 73.48 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.4 HD13 ' CB ' ' A' ' 301' ' ' TYR . 89.9 mt -59.55 -23.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.85 -12.88 53.32 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.22 0.534 . . . . 0.0 109.911 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.438 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 69.5 mt-30 -103.72 -0.01 29.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.466 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.24 30.29 20.01 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 6.5 p -67.21 -14.15 62.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.022 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.0 48.9 83.63 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.783 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.52 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 7.0 ttpt -130.22 37.1 3.92 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 86.4 m-85 -161.09 161.48 31.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.42 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 160.25 42.53 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.453 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 52.5 p90 -135.52 130.63 34.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 406' ' ' PHE . . . 106.83 150.9 17.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.61 -60.8 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.33 . . . . 0.0 111.028 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.9 pt-20 -47.4 -54.69 10.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.388 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.55 -54.57 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 22.1 m -56.21 -37.92 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.098 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.414 ' CD1' HG13 ' A' ' 305' ' ' VAL . 2.8 mp -69.93 -41.57 74.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.323 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 20.3 mtmt -58.88 -49.91 75.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.442 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.36 -26.16 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.289 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.765 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.32 -25.96 58.26 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.52 -28.08 51.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 78.5 mmm -79.99 -7.33 58.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.403 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.29 20.68 44.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.138 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.68 7.69 44.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.598 -0.301 . . . . 0.0 111.457 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.0 m -107.27 107.2 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 121.038 0.446 . . . . 0.0 112.002 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.688 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 11.2 tp10 -59.95 -50.76 72.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 388' ' ' THR . 33.3 mm -135.74 125.75 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.653 0.263 . . . . 0.0 111.425 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 322' ' ' VAL . 38.2 tp -92.52 128.65 38.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.968 0.413 . . . . 0.0 111.219 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -115.1 107.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.089 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 7.6 t -123.51 163.19 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.935 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.651 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.1 m-85 -110.9 149.23 30.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.696 ' HG2' HG22 ' A' ' 391' ' ' ILE . 49.1 mm-40 -59.37 -50.06 75.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.2 53.22 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.381 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 31.4 tp -78.88 123.29 27.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -89.61 23.84 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.704 HG22 HG21 ' A' ' 305' ' ' VAL . 15.8 mm -127.43 134.59 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.687 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.554 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 53.5 mtt -140.36 161.73 36.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.605 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.9 ttt180 -89.23 121.06 31.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.049 0.452 . . . . 0.0 111.303 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 4.6 m-85 -121.43 157.11 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.965 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 49.9 tp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.368 0.604 . . . . 0.0 111.957 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.53 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -94.04 118.86 32.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.601 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.5 mm? -121.18 159.75 25.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 14.4 p -101.77 171.33 5.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.381 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.6 Cg_exo -47.38 -43.58 26.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.737 1.624 . . . . 0.0 111.89 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.88 -54.96 41.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.191 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 83.1 mt-30 -67.61 -46.29 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 94.5 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.49 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.7 p . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 19.2 tpp -115.46 128.81 25.64 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.623 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.554 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 36.5 Cg_exo -59.77 120.0 7.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.011 1.807 . . . . 0.0 111.108 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.3 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.749 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.442 HD12 ' CD1' ' A' ' 391' ' ' ILE . 63.1 tp -60.07 -51.96 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.4 mt-10 -60.02 -39.92 87.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.031 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -62.58 -40.02 95.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.503 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -71.07 -25.84 62.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.49 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.91 -9.99 49.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.761 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -108.75 -9.18 15.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.23 18.0 5.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.36 -18.72 65.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.665 0.269 . . . . 0.0 111.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -83.02 -42.23 17.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.758 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.85 -40.1 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.492 ' CD2' HD23 ' A' ' 312' ' ' LEU . 38.0 m-85 -82.75 -10.25 58.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.28 2.41 53.92 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.498 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 317' ' ' VAL . . . -85.48 162.49 18.92 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.505 ' HB ' HD11 ' A' ' 319' ' ' ILE . 98.3 m -106.64 100.56 10.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.98 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.33 101.95 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.51 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 19.7 mm-40 -111.36 118.17 35.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.696 HG22 ' HG2' ' A' ' 324' ' ' GLU . 20.5 mm -88.66 108.96 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.042 0.448 . . . . 0.0 111.889 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 323' ' ' TYR . 15.6 m -101.75 -170.68 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.25 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.575 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -154.53 151.59 29.07 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -70.73 12.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 0.3 OUTLIER -64.7 -39.99 94.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.633 0.254 . . . . 0.0 111.644 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.9 m -92.05 170.6 9.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.386 . . . . 0.0 111.78 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -60.02 -48.83 80.1 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 44.3 mp0 -63.95 -39.99 95.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.372 0.606 . . . . 0.0 109.517 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.1 -20.42 60.38 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.15 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.6 m -84.23 -22.24 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.631 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.505 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 79.6 mt-30 -73.87 -43.36 58.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.651 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.8 m-85 -60.01 -41.98 93.31 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.924 0.392 . . . . 0.0 110.357 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.745 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 54.6 t -60.0 -39.98 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -72.55 -42.8 64.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.953 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.62 98.74 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.374 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.492 ' CD1' ' HA2' ' A' ' 304' ' ' GLY . 59.9 t80 -148.79 -67.14 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 125.03 57.88 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 119.842 -1.171 . . . . 0.0 115.095 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.75 -35.41 2.0 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.399 -1.382 . . . . 0.0 115.277 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.457 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -136.13 134.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.883 0.841 . . . . 0.0 112.904 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -154.53 148.14 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.48 147.15 17.74 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.694 -1.241 . . . . 0.0 114.031 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 318' ' ' GLU . 46.6 mt -108.72 126.39 65.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.779 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 50.4 mt -86.42 151.69 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 112.303 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.688 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.4 mtm180 -67.5 -38.69 84.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 96.6 m-85 -160.57 170.02 21.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.518 ' O ' ' HD1' ' A' ' 432' ' ' PHE . 95.9 m-20 . . . . . 0 C--O 1.226 -0.182 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -59.99 -40.05 87.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 110.345 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 26.7 p90 -96.92 67.68 2.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.518 ' HD1' ' O ' ' A' ' 429' ' ' ASP . 37.1 p90 -90.03 110.47 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.69 -2.61 30.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.719 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.65 -18.65 4.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.857 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.96 -39.97 87.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 0.0 110.587 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.68 -23.83 60.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.704 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.9 -37.56 79.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.251 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.03 -45.36 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.889 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.011 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 75.5 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.884 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 120.77 0.319 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.63 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.3 OUTLIER -59.94 -39.54 85.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.555 -179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.566 ' HA ' HG11 ' A' ' 392' ' ' VAL . 16.8 pt-20 -84.67 -22.69 29.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.324 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -50.01 8.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.27 -58.33 3.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.493 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.72 -55.66 31.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.942 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.502 HG21 ' CE1' ' A' ' 402' ' ' PHE . 23.7 mt -59.48 -49.22 84.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.89 -37.03 75.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.084 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -59.93 -39.09 84.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.309 0.576 . . . . 0.0 110.049 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.9 t80 -57.56 -45.18 85.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.63 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -79.47 -39.94 31.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.07 -47.48 85.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.602 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.82 -43.29 99.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.039 0.447 . . . . 0.0 109.872 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -60.04 -24.54 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.664 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.16 0.505 . . . . 0.0 109.911 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -107.27 1.55 23.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.465 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 57.95 31.13 20.18 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.341 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.852 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.4 p -67.64 -11.97 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.845 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.6 78.09 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.535 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.12 36.3 4.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 93.5 m-85 -159.33 160.02 34.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.087 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.91 165.07 33.7 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.821 0.344 . . . . 0.0 111.231 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.47 164.82 28.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.18 167.82 34.28 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.234 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -72.88 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.214 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.25 -52.49 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.843 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.8 m-20 -65.73 -57.42 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.15 -36.42 68.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.951 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.67 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.601 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.43 -50.07 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -66.8 -28.28 68.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 111.037 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.738 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.51 -28.13 60.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.84 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -77.51 -26.99 51.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.21 -7.33 58.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.776 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.44 42.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.467 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.12 -2.24 58.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.287 0.235 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.0 m -100.98 107.1 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 412' ' ' ILE . 36.8 tt0 -59.86 -50.01 75.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.33 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 318' ' ' GLU . 39.8 mm -135.5 125.12 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.576 ' HG ' HG23 ' A' ' 322' ' ' VAL . 29.7 tp -90.8 128.25 36.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.275 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.493 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.76 105.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.742 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.576 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.64 162.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.371 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.594 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 94.2 m-85 -110.67 149.93 29.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.471 . . . . 0.0 111.674 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.6 pt-20 -66.92 -27.96 67.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.3 35.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 43.0 tp -70.31 122.32 19.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.53 23.35 5.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.236 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.689 HG21 HG11 ' A' ' 305' ' ' VAL . 14.8 mm -120.93 135.48 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.41 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.583 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.5 161.45 37.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.44 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.14 120.08 31.01 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.169 0.509 . . . . 0.0 111.468 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.14 155.22 29.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.734 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.99 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.162 0.506 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.421 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 3.5 p90 -100.96 120.05 39.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.651 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.569 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.3 mm? -124.43 156.33 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.8 168.11 9.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.368 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.85 -49.63 8.01 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.313 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.95 -55.56 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.392 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.533 ' HG2' ' CD1' ' A' ' 346' ' ' LEU . 4.7 tp60 -59.94 -53.17 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.5 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.827 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.519 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.415 ' HE1' ' CZ3' ' A' ' 377' ' ' TRP . 25.4 tpp -114.91 124.13 30.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.656 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.583 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.41 120.95 9.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.0 1.8 . . . . 0.0 110.982 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.603 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.3 mt -60.23 -42.3 94.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.595 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.7 tp -60.04 -51.39 69.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.665 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.91 -40.17 87.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.685 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.415 ' CZ3' ' HE1' ' A' ' 372' ' ' MET . 76.7 t-105 -62.01 -39.96 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.837 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.2 -29.4 60.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.125 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.39 47.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.598 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.11 -9.33 14.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.67 19.84 5.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.6 p90 -70.0 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.61 -38.35 21.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -59.93 -38.33 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.301 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.525 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -84.01 -10.43 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.62 1.28 52.7 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.654 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.76 165.12 17.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.428 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.422 ' HB ' HD12 ' A' ' 319' ' ' ILE . 97.9 m -106.72 100.27 9.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.3 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 2.4 tm? -71.92 102.2 2.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.854 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.63 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.8 mm-40 -107.86 128.01 54.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.873 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 22.5 mm -94.85 102.11 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 112.182 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 283' ' ' GLU . 4.1 m -100.47 -169.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.769 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.594 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.6 p -154.86 151.54 28.72 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.055 0.455 . . . . 0.0 111.506 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -71.04 1.43 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.303 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -59.94 -40.1 87.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 111.035 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.3 p -81.83 168.13 18.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.7 mt-30 -60.0 -54.81 41.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.84 -39.43 94.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.425 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -53.66 -59.74 9.3 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.6 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.58 12.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.1 mt-30 -69.97 -40.05 75.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 110.909 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.39 -44.9 93.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.764 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 88.4 t -59.99 -45.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.708 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.422 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.74 -38.19 56.96 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.68 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.7 -94.56 0.48 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 155.46 34.09 0.02 OUTLIER Glycine 0 CA--C 1.522 0.523 0 C-N-CA 119.642 -1.265 . . . . 0.0 114.853 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.51 -20.07 7.92 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.522 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.59 130.38 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 118.574 1.187 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.54 151.11 19.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.031 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.1 mt -109.4 127.47 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -88.22 153.32 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 112.286 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.4 mtt-85 -70.04 -36.81 75.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.565 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -160.91 170.54 20.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.852 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.963 0.411 . . . . 0.0 110.721 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.654 0.264 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.09 -39.92 87.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.356 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.43 91.18 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.191 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.4 -137.62 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.87 39.95 16.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.96 -0.28 57.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.391 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.07 -39.94 87.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 110.518 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -68.07 -35.19 77.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.418 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.96 -34.06 71.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.082 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.13 -42.43 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.01 -40.01 87.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.889 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 CA--C 1.524 -0.051 0 CA-C-O 120.824 0.345 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.687 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 2.0 tm0? -58.85 -39.97 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.831 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.515 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 50.4 mt-10 -78.96 -30.0 44.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -53.46 5.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -72.63 -58.38 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.67 ' HG ' HD13 ' A' ' 321' ' ' ILE . 46.7 tp -55.13 -60.86 2.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 111.55 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.621 HG21 ' HB3' ' A' ' 398' ' ' GLU . 67.7 mt -59.94 -50.05 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.26 -38.92 57.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.25 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.1 ttt-85 -60.05 -39.95 87.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.281 0.563 . . . . 0.0 110.272 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.597 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 10.2 t80 -57.12 -48.55 78.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.749 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -80.01 -38.49 31.96 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -60.63 -47.89 84.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.7 mt-10 -62.91 -44.49 95.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -24.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.463 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.47 -13.8 59.58 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.568 ' HB2' HG22 ' A' ' 298' ' ' THR . 58.4 mt-30 -103.37 -0.16 30.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.54 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.59 30.99 20.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.655 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.5 p -69.43 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.864 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.24 49.2 74.26 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.342 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 41.2 mttt -128.61 36.3 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.66 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 88.0 m-85 -159.75 160.74 34.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.309 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 19.3 m -140.5 160.03 40.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.14 0.495 . . . . 0.0 111.391 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.412 ' HB3' ' HH ' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -137.79 127.13 24.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.914 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 107.76 152.83 17.58 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -58.94 -55.48 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 0.0 111.174 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -49.35 -56.46 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.42 -52.37 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 18.5 m -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.09 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.462 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 2.7 mp -67.25 -43.79 81.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.701 0.286 . . . . 0.0 111.28 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 314' ' ' MET . 20.7 mtmt -60.01 -47.62 85.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.4 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -69.98 -27.81 65.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.431 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.675 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.7 -26.59 59.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.92 -28.9 49.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 94.3 mmm -80.84 -7.3 59.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.726 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.52 14.28 27.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.701 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.8 -9.76 59.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.617 0.246 . . . . 0.0 110.9 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 312' ' ' LEU . 27.5 m -92.27 105.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 412' ' ' ILE . 35.2 tt0 -60.01 -50.01 75.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.563 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.412 ' CG2' ' HB ' ' A' ' 388' ' ' THR . 42.6 mm -135.58 125.99 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.477 ' HB2' HD11 ' A' ' 312' ' ' LEU . 56.4 tp -90.96 126.14 35.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.67 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -113.13 105.95 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.814 179.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 23.3 t -124.29 151.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.4 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' A' ' 393' ' ' THR . 92.6 m-85 -95.57 145.01 25.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 14.5 pt-20 -63.53 -34.52 77.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -92.24 45.19 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 23.8 tp -75.85 125.81 29.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 347' ' ' THR . 83.0 m-20 -92.06 24.43 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.551 HG21 HG11 ' A' ' 305' ' ' VAL . 31.7 mm -125.87 136.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.939 0.399 . . . . 0.0 111.595 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.564 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.7 mtt -139.84 161.8 36.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.323 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.65 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.1 ttt85 -89.22 115.8 26.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 111.671 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.561 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 8.3 m-85 -116.53 156.91 26.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.145 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 110.942 179.634 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 49.4 tp . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.373 0.606 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.518 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 2.8 p90 -100.02 123.19 43.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.189 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 350' ' ' GLN . 1.6 mm? -124.84 157.88 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 69.8 p -101.16 170.28 6.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.672 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.6 Cg_exo -44.7 -48.38 10.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.837 1.691 . . . . 0.0 112.012 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -49.92 75.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.51 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 346' ' ' LEU . 4.5 tp60 -69.59 -47.87 62.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 92.6 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.586 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.561 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.269 0.557 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.4 tpt -117.04 131.46 23.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.8 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.1 Cg_exo -60.16 120.56 8.4 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.87 1.713 . . . . 0.0 110.782 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 12.8 mt -62.21 -40.45 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.773 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 60.8 tp -60.06 -51.68 68.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.7 mt-10 -60.23 -42.42 95.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.964 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.403 ' CD1' ' ND2' ' A' ' 381' ' ' ASN . 82.5 t90 -62.26 -39.93 94.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.421 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -70.0 -25.89 63.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.97 46.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.3 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.67 -12.75 15.8 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.5 20.34 5.67 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -68.76 -17.52 64.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.577 0.227 . . . . 0.0 111.446 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -77.14 -47.13 21.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.125 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -61.43 -44.43 97.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.322 0.582 . . . . 0.0 110.622 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.513 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.1 m-85 -69.95 -17.72 63.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.885 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.21 1.96 65.45 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.324 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.76 164.76 16.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.162 0.506 . . . . 0.0 110.796 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.412 ' HB ' ' CG2' ' A' ' 319' ' ' ILE . 66.6 m -107.14 100.27 9.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.049 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.439 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.7 tm? -71.74 102.34 2.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.97 0.414 . . . . 0.0 110.858 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.687 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -110.31 140.84 44.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.111 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.3 mm -106.48 103.66 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 287' ' ' ILE . 7.8 m -101.07 -175.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.487 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 3.0 p -157.95 152.29 24.58 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -76.85 76.15 3.46 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -117.57 -29.98 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.313 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 35.1 m -113.55 -174.93 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.771 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 401' ' ' GLN . 31.0 mt-30 -59.98 -47.75 84.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.01 0.434 . . . . 0.0 110.341 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.621 ' HB3' HG21 ' A' ' 287' ' ' ILE . 22.1 mp0 -61.62 -41.93 98.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.47 -22.45 67.67 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.546 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.4 m -83.08 -21.56 33.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.791 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 397' ' ' GLN . 9.5 mm100 -75.79 -46.67 29.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.013 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.522 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -59.96 -49.97 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.085 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.642 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 96.9 t -59.98 -39.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -68.58 -42.9 77.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.399 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.1 -22.92 74.54 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.256 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 28.8 t80 -176.45 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.642 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 91.68 101.1 1.32 Allowed Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.564 -0.827 . . . . 0.0 115.101 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 409' ' ' ILE . . . 130.42 -34.22 2.73 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.178 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -150.8 127.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 111.939 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -150.74 138.12 6.47 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.77 142.24 14.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.601 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 318' ' ' GLU . 23.5 mt -104.66 126.71 59.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 59.2 mt -90.78 157.14 17.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.643 0.735 . . . . 0.0 112.466 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -70.04 -39.99 75.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.358 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 53.9 p90 -167.07 178.7 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.508 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.6 mtm180 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.899 0.38 . . . . 0.0 110.7 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 93.7 m-20 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -59.91 -40.07 87.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.018 0.437 . . . . 0.0 110.12 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.67 100.11 7.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.325 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 429' ' ' ASP . 1.3 p90 -117.34 130.94 56.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -86.1 6.84 27.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.81 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.97 -4.25 23.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.905 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.96 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.698 0.285 . . . . 0.0 111.068 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.95 -33.24 75.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.473 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.49 -34.26 72.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.268 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.02 -43.7 95.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -70.05 140.08 52.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.881 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.89 0.376 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.663 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.59 -39.99 85.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.606 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.5 mt-10 -77.08 -29.97 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.269 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.65 -58.16 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 321' ' ' ILE . 16.2 tp -58.76 -54.66 44.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 398' ' ' GLU . 46.3 mt -60.03 -48.43 87.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.555 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.444 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.36 -37.88 67.19 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 44.0 ttt180 -60.0 -39.22 85.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.624 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.9 t80 -55.65 -45.73 77.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.755 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.4 -39.15 21.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.0 t0 -59.99 -43.2 95.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.402 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.18 -42.29 84.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 109.743 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.24 -23.81 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.6 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.04 -15.45 56.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.175 0.512 . . . . 0.0 110.006 178.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -104.84 2.08 29.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.622 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.25 29.72 18.43 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.966 0.413 . . . . 0.0 110.571 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 13.9 p -66.74 -12.98 60.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.915 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 49.12 73.39 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.443 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 17.5 mttp -126.38 36.84 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 95.3 m-85 -159.35 160.05 34.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.323 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -141.0 161.19 38.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.445 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.15 144.84 47.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.515 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.31 156.89 28.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.871 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -59.94 -55.89 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.195 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.4 pt-20 -47.27 -57.23 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 96.0 m-20 -61.13 -54.9 38.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.676 0.274 . . . . 0.0 111.386 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 28.1 m -56.51 -40.09 74.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.86 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.2 mp -66.88 -45.26 78.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.2 mtmt -56.63 -50.03 73.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.993 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.682 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.66 -34.5 74.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.914 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.52 -24.41 61.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.78 -7.96 59.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.098 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.1 10.96 36.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.123 -1.036 . . . . 0.0 111.544 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.02 -6.16 57.09 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.399 0.28 . . . . 0.0 110.766 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 312' ' ' LEU . 34.7 m -95.83 105.5 17.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.0 tt0 -59.59 -49.98 75.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.306 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.492 HD13 ' HB ' ' A' ' 388' ' ' THR . 28.0 mm -136.7 126.56 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.579 0.228 . . . . 0.0 111.375 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 312' ' ' LEU . 45.0 tp -89.73 126.49 35.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.94 0.4 . . . . 0.0 111.5 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.628 HD11 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -111.57 103.61 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.313 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 17.2 t -122.29 152.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -98.48 142.94 29.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 16.8 pt-20 -65.37 -24.0 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.833 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.32 33.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.762 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.6 tp -71.17 123.81 23.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -96.55 28.76 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 20.0 mm -126.61 133.19 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.042 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.549 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.1 mtt -140.6 162.47 35.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.22 29.76 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.092 0.472 . . . . 0.0 111.222 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 7.4 m-85 -124.81 160.76 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 111.411 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.923 0.392 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.553 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 0.3 OUTLIER -85.02 137.15 33.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.104 178.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.546 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.71 164.05 22.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.596 0.713 . . . . 0.0 112.525 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.7 p -101.5 172.08 4.78 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.31 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 72.9 Cg_exo -48.95 -47.47 21.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 121.789 1.659 . . . . 0.0 111.815 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.15 -58.52 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -59.98 -48.99 79.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 91.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.524 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.111 0.482 . . . . 0.0 110.469 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.401 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.61 121.97 32.37 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.761 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.549 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.63 120.91 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.77 1.647 . . . . 0.0 110.712 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.7 mt -60.03 -44.09 94.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.265 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 69.1 tp -60.01 -50.87 72.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.99 85.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.638 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.28 -43.77 95.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.641 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.527 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 8.8 m-85 -73.59 -30.7 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.2 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.38 -25.09 60.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.495 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.71 -6.62 14.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.27 20.18 5.79 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.95 -14.48 63.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.615 0.245 . . . . 0.0 111.374 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.36 -40.41 30.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.923 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.1 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.52 -4.21 59.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.401 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.74 2.96 31.99 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.532 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.603 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -89.64 166.28 13.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 111.103 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.492 ' HB ' HD13 ' A' ' 319' ' ' ILE . 57.0 m -109.15 100.54 9.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.936 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 3.2 tm? -69.32 102.39 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.663 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.8 130.02 55.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.757 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.5 mm -95.86 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.173 0.511 . . . . 0.0 112.094 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.51 -171.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.155 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.5 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.55 155.33 26.16 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.274 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.48 11.31 0.63 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.15 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.04 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 111.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -92.06 170.83 9.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.838 0.352 . . . . 0.0 111.406 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.9 mt-30 -60.02 -54.38 46.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.575 ' HB3' HG23 ' A' ' 287' ' ' ILE . 15.4 mp0 -60.02 -39.98 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 0.0 109.502 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -54.09 -57.64 15.85 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.805 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.87 -19.53 51.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.36 -40.04 77.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.609 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -59.99 -46.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.464 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.92 -34.06 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.014 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.25 -54.08 20.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.309 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.73 -20.62 70.41 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.938 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.515 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.4 t80 174.97 -75.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.33 167.95 28.99 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.67 -51.47 3.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.835 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.55 131.79 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.294 0.547 . . . . 0.0 112.227 -178.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -150.82 141.05 8.33 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.68 145.87 15.95 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.866 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.1 mt -109.11 128.55 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.8 mt -90.68 153.17 20.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.766 0.793 . . . . 0.0 112.815 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.01 -37.92 75.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.542 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 82.3 m-85 -158.25 -177.91 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.869 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.02 -41.04 91.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.43 99.1 5.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.397 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -116.68 117.07 28.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.84 -0.65 24.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.94 -19.4 1.0 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.939 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -59.7 -40.01 86.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -74.9 -24.29 58.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.541 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.96 -38.42 82.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.452 . . . . 0.0 110.007 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.01 -46.44 89.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.887 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.04 -39.91 87.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.133 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.913 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -55.64 -41.8 74.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.591 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 55.1 mt-10 -69.96 -33.43 72.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -57.2 3.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -70.0 -58.08 4.25 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 31.4 tp -57.51 -57.44 12.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.591 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 13.6 mt -61.48 -49.79 82.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.506 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.73 -34.36 81.85 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.415 -0.897 . . . . 0.0 112.651 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.407 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 4.8 ttt85 -59.95 -37.78 80.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 9.4 t80 -60.13 -41.29 92.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.754 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -84.66 -39.44 18.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.49 -50.05 75.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.667 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.1 OUTLIER -64.31 -40.95 96.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.524 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 290' ' ' TYR . 82.0 mt -60.04 -23.26 26.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -15.39 46.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.331 0.586 . . . . 0.0 109.685 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.468 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 68.3 mt-30 -100.7 1.92 40.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.649 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 56.09 29.85 15.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.106 0.479 . . . . 0.0 110.035 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.561 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 34.9 p -69.97 -10.34 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.773 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.79 50.69 59.68 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.091 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 18.6 mtpt -127.96 38.76 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.653 ' HB3' ' CE2' ' A' ' 290' ' ' TYR . 81.7 m-85 -161.99 163.37 28.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 290' ' ' TYR . 1.8 p -146.43 162.39 38.35 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.417 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.1 p90 -138.68 133.06 31.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.323 . . . . 0.0 110.33 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 103.58 147.76 18.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.955 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 374' ' ' LEU . 0.2 OUTLIER -52.82 -60.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -44.54 -58.09 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.345 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.93 -54.49 41.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 111.235 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 10.6 m -55.73 -40.01 71.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.027 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 305' ' ' VAL . 2.5 mp -70.01 -41.21 74.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.697 0.284 . . . . 0.0 111.211 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mtmm -58.55 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.156 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.458 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.95 -27.96 64.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.685 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.69 -28.6 63.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.744 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.2 -26.48 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 93.2 mmm -82.5 -9.1 59.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.648 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.42 42.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.324 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.92 59.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.386 0.274 . . . . 0.0 110.975 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 312' ' ' LEU . 27.6 m -93.54 104.83 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 34.1 tt0 -59.91 -49.88 75.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.434 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.484 ' HA ' ' H ' ' A' ' 388' ' ' THR . 23.4 mm -133.96 126.15 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.65 0.262 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 308' ' ' THR . 43.6 tp -91.55 127.33 36.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.942 0.401 . . . . 0.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.646 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 2.3 mt -112.71 106.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 29.8 t -122.61 155.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.488 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.572 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.9 m-85 -102.65 143.92 31.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.7 pt-20 -61.78 -35.68 78.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.68 48.31 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.053 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -78.19 125.43 29.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.804 0.335 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -92.94 26.39 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.57 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.502 ' CG2' HG23 ' A' ' 305' ' ' VAL . 23.2 mm -128.36 136.31 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.561 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.584 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 59.8 mtt -139.97 161.93 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.811 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.643 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 46.8 ttm-85 -89.17 115.48 26.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.803 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.517 ' CE2' ' HG2' ' A' ' 351' ' ' GLU . 3.2 m-85 -115.48 154.74 28.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 33.1 tp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.276 0.56 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.479 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -97.67 120.03 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.4 mm? -124.46 167.48 14.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.554 0.692 . . . . 0.0 112.596 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 11.3 p -101.59 169.25 7.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.778 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 75.2 Cg_exo -49.46 -42.56 41.3 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.843 1.696 . . . . 0.0 111.745 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.26 -51.57 69.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.101 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.43 -46.61 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.996 0.426 . . . . 0.0 110.722 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 97.2 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.852 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.454 ' CB ' ' CZ ' ' A' ' 331' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.188 0.518 . . . . 0.0 111.494 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.0 tpt -111.66 126.93 27.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.229 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.584 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.3 Cg_exo -57.56 118.67 5.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.877 1.718 . . . . 0.0 111.003 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.643 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 15.2 mt -60.89 -39.95 91.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.887 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.469 HD12 ' CD1' ' A' ' 391' ' ' ILE . 57.1 tp -59.5 -52.8 64.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.2 mt-10 -58.87 -40.01 83.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.059 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -67.35 -34.0 76.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.316 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 374' ' ' LEU . 11.3 m-85 -69.78 -31.51 69.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.433 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -9.24 50.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.655 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -101.08 -15.44 17.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.423 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.68 18.11 5.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.35 -20.94 64.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 0.0 111.019 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -79.84 -43.37 22.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.98 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 110.637 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.488 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.3 m-85 -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.64 71.25 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.127 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 317' ' ' VAL . . . -88.38 162.78 16.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.172 0.511 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.484 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 84.7 m -107.32 100.61 10.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.025 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.9 tm? -70.69 102.74 2.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.426 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -108.42 134.99 50.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.884 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 33.9 mm -99.93 102.09 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.447 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.7 m -101.6 -168.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.928 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.572 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -157.14 153.9 28.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.498 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -71.2 -1.86 14.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.532 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -41.36 92.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.534 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 283' ' ' GLU . 3.2 t -75.0 167.27 22.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 111.154 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 48.8 tp60 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.506 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 35.8 mp0 -67.72 -34.26 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 109.776 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.46 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -51.62 -57.9 11.27 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.921 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.7 m -62.74 -19.47 63.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 67.8 mt-30 -72.99 -40.08 65.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.996 0.427 . . . . 0.0 110.579 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.503 ' CE1' ' HA3' ' A' ' 410' ' ' GLY . 0.2 OUTLIER -65.86 -41.53 91.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.802 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.755 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 71.8 t -60.45 -37.91 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -62.38 -45.03 95.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 0.0 110.417 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -74.95 -20.66 79.34 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.05 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.462 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 12.5 t80 -174.98 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.755 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 94.3 96.69 1.6 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.264 -0.969 . . . . 0.0 114.853 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 409' ' ' ILE . . . 135.85 -31.68 2.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.764 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.0 OUTLIER -152.86 127.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 117.493 0.646 . . . . 0.0 111.895 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.07 136.04 5.65 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.42 134.69 11.33 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.139 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 318' ' ' GLU . 63.0 mt -99.13 129.99 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 47.0 mt -88.58 149.39 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.728 0.775 . . . . 0.0 113.005 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.58 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.6 mtt180 -71.24 -29.92 65.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.239 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 63.7 t80 -169.81 165.01 9.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.983 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.458 -0.03 0 CA-C-O 120.677 0.275 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.57 -39.94 88.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.569 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -109.12 62.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 40.4 p90 -79.94 99.82 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.314 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.21 13.42 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.051 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.46 -6.41 30.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.742 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -59.96 -40.03 87.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.769 0.318 . . . . 0.0 110.504 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.07 -32.35 71.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.91 -35.26 72.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.06 -44.64 94.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.874 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -60.06 -40.11 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.813 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 2.6 pt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.655 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -55.32 -36.85 66.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.7 pt-20 -69.93 -29.97 67.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -57.82 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.96 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -54.86 11.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 21.0 tp -58.55 -57.11 14.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 111.698 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.608 HD12 HG12 ' A' ' 392' ' ' VAL . 43.9 mt -59.95 -49.15 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.435 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -58.67 -38.17 91.09 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.217 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 8.3 ttt180 -60.02 -38.07 81.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 109.923 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.622 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 3.0 t80 -55.85 -48.62 75.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.93 -39.95 29.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.99 0.424 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 295' ' ' SER . 74.6 m-20 -60.01 -41.96 93.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.808 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.7 mt-10 -70.03 -41.15 74.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.424 HD12 ' CE1' ' A' ' 290' ' ' TYR . 79.4 mt -60.58 -22.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.04 -14.28 53.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 109.65 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -103.17 0.04 31.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.418 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 7.3 t70 56.34 33.4 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 109.977 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.774 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 31.4 p -73.46 -10.8 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.126 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 53.94 40.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.665 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.537 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 9.0 mtpt -130.24 36.23 4.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 86.6 m-85 -158.87 159.61 35.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.468 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 31.2 m -134.49 155.46 50.32 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.026 0.441 . . . . 0.0 111.378 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.486 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -134.87 118.32 16.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.82 155.41 10.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -56.22 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.824 0.345 . . . . 0.0 111.113 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 9.0 pt-20 -51.91 -51.23 58.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.733 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -63.13 -54.15 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.455 ' CG2' HD12 ' A' ' 320' ' ' LEU . 31.9 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.459 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.7 mp -65.61 -50.3 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 111.522 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -55.61 -52.38 63.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 -179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.42 -31.56 71.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.719 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.34 -27.42 61.5 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.839 0.352 . . . . 0.0 110.463 179.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -77.55 -27.6 51.62 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 30.9 mmt -80.86 -7.46 59.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.832 -1.531 . . . . 0.0 111.593 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.4 18.63 44.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.3 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.36 -2.97 58.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.601 -0.3 . . . . 0.0 111.377 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.719 HG22 ' HA ' ' A' ' 312' ' ' LEU . 29.9 m -99.43 104.47 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 412' ' ' ILE . 6.6 tp10 -57.12 -49.99 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.185 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.496 HG21 ' HB ' ' A' ' 388' ' ' THR . 42.5 mm -135.49 126.01 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.562 0.22 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 308' ' ' THR . 37.3 tp -90.91 123.41 34.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 111.699 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.468 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.3 OUTLIER -109.68 103.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 389' ' ' LEU . 36.3 t -111.38 155.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.241 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.475 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 7.6 m-85 -103.61 142.45 34.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.174 0.511 . . . . 0.0 112.278 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 393' ' ' THR . 36.4 tt0 -68.07 156.78 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.017 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 28.27 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.92 0.391 . . . . 0.0 110.296 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.1 tp -59.96 125.5 23.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.409 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.08 30.31 1.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.7 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.65 HG21 HG22 ' A' ' 305' ' ' VAL . 26.5 mm -130.35 133.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.511 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.692 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 33.3 mtt -140.6 163.01 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.622 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.4 OUTLIER -88.19 118.79 28.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.801 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 59.9 m-85 -126.9 124.71 40.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.536 -179.167 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 34.4 tp . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.399 0.619 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.504 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 2.5 p90 -100.93 125.7 47.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.629 ' HB2' ' HG2' ' A' ' 351' ' ' GLU . 2.7 mm? -122.3 157.71 31.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.544 0.688 . . . . 0.0 112.773 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.563 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.3 p -99.35 168.13 10.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.311 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.563 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 4.7 Cg_endo -46.43 -46.62 16.87 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.27 1.98 . . . . 0.0 112.297 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.65 -44.89 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -69.94 -46.64 64.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.801 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.373 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.514 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 121.182 0.515 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.518 ' HE3' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -121.31 137.27 26.62 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.186 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.692 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 28.1 Cg_endo -64.31 122.97 11.09 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.117 1.878 . . . . 0.0 110.626 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.622 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 19.6 mt -65.3 -41.06 94.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 38.4 tp -60.08 -53.66 55.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 48.0 mt-10 -59.98 -40.38 88.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.024 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -62.49 -40.03 95.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.083 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.523 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.6 m-85 -70.54 -28.25 64.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.276 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -10.48 48.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.828 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.07 -9.49 14.72 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.5 m120 -129.2 19.45 5.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.604 0.24 . . . . 0.0 111.61 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -68.57 -17.41 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.597 0.237 . . . . 0.0 111.347 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -79.85 -46.97 15.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.02 -44.19 94.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.318 0.58 . . . . 0.0 109.96 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.544 ' CD2' HD23 ' A' ' 312' ' ' LEU . 26.7 m-85 -73.49 -19.97 60.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.039 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . 0.466 ' HA3' HH22 ' A' ' 414' ' ' ARG . . . 74.87 2.14 64.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.454 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.22 165.37 18.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.073 0.463 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.496 ' HB ' HG21 ' A' ' 319' ' ' ILE . 24.2 m -107.68 100.67 10.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 322' ' ' VAL . 0.9 OUTLIER -73.54 107.34 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.628 -178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.655 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -115.39 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.593 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 324' ' ' GLU . 27.2 mm -98.5 102.34 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.114 0.483 . . . . 0.0 112.26 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.608 HG12 HD12 ' A' ' 287' ' ' ILE . 27.7 m -114.06 133.62 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.607 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 3.2 p -112.74 166.21 11.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -73.48 70.06 1.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.846 0.355 . . . . 0.0 111.352 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.401 ' HE2' ' OE2' ' A' ' 283' ' ' GLU . 4.9 ptmt -119.83 12.02 12.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 47.5 t -155.17 179.57 9.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -59.38 -53.32 59.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 50.9 mp0 -63.65 -39.98 95.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.404 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.87 -25.4 67.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.521 -0.847 . . . . 0.0 110.992 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.5 m -83.74 -23.38 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.554 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.78 -43.44 65.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.376 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.2 m-85 -65.3 -48.39 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.21 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.44 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 75.4 t -59.95 -40.08 81.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -48.17 33.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -73.22 -28.29 66.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 290' ' ' TYR . 0.1 OUTLIER -157.68 -84.72 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 100.09 151.73 26.04 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.461 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.99 -47.49 3.13 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.67 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -148.94 134.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 118.232 1.016 . . . . 0.0 112.985 -177.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.39 145.49 12.96 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.72 147.6 18.96 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.712 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 318' ' ' GLU . 18.0 mt -106.5 126.72 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.3 mt -87.85 156.15 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 0.0 112.195 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.466 HH22 ' HA3' ' A' ' 386' ' ' GLY . 16.3 mtt-85 -77.77 -33.07 52.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.685 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -156.39 170.01 23.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.753 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.833 0.349 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -59.94 -40.03 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.551 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.404 ' CZ ' ' OD2' ' A' ' 433' ' ' ASP . 64.8 t80 -120.56 102.35 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.297 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -130.97 80.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . 0.404 ' OD2' ' CZ ' ' A' ' 431' ' ' PHE . 96.6 m-20 -95.19 18.65 11.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.13 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.28 -15.42 47.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.86 -40.02 87.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -80.62 -20.22 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -59.97 -38.46 82.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.313 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.92 -49.18 78.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.951 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -67.84 139.97 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.914 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.693 0.283 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -57.48 -40.01 77.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.212 0.53 . . . . 0.0 110.019 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.585 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 1.9 mp0 -75.69 -51.34 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.407 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -40.05 87.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -84.55 -58.69 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.655 ' HG ' HD13 ' A' ' 321' ' ' ILE . 29.9 tp -60.01 -55.84 29.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.909 0.385 . . . . 0.0 111.834 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 398' ' ' GLU . 67.3 mt -59.95 -47.88 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.572 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.407 ' HA2' ' OE1' ' A' ' 398' ' ' GLU . . . -57.81 -37.79 85.69 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.444 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt180 -60.02 -42.41 94.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.513 ' CE1' ' CE1' ' A' ' 402' ' ' PHE . 5.5 t80 -59.99 -41.71 92.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.516 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.417 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.7 t80 -84.27 -40.98 17.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -60.57 -43.37 97.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.663 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.543 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 75.4 mt-10 -60.06 -40.03 88.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.947 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.544 HG12 ' CD1' ' A' ' 301' ' ' TYR . 64.1 mt -56.4 -30.26 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 t -53.03 -29.87 32.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 21.8 mt-30 -94.77 1.46 55.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.26 32.03 17.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.978 0.418 . . . . 0.0 110.085 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.603 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 1.5 p -64.26 -13.14 47.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.541 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.85 47.57 87.9 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.699 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 413' ' ' LEU . 36.3 mttp -129.48 48.05 2.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.544 ' CD1' HG12 ' A' ' 294' ' ' ILE . 0.1 OUTLIER -170.51 168.08 7.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 111.348 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.6 p -153.1 169.0 24.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.42 135.64 33.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.047 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 104.17 146.52 15.98 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.815 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.892 HG21 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.47 -57.82 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.909 0.385 . . . . 0.0 110.982 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -49.02 -53.48 19.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.397 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.77 -53.04 53.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.312 . . . . 0.0 111.29 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 7.4 m -57.88 -38.58 76.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.416 ' CD1' HG13 ' A' ' 305' ' ' VAL . 3.0 mp -69.07 -43.64 74.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.371 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 12.3 mtmm -57.37 -49.99 74.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.457 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -71.1 -26.08 62.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.389 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.667 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.07 -27.28 60.83 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.923 0.392 . . . . 0.0 110.586 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -77.51 -28.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.1 mmt -80.54 -7.01 59.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.979 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.91 14.48 23.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.677 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.29 -6.59 59.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.395 0.278 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.739 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 20.8 m -93.16 105.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 37.3 tt0 -59.98 -50.0 75.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 388' ' ' THR . 32.9 mm -135.22 126.34 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.529 0.204 . . . . 0.0 111.483 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.0 125.52 36.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.022 0.439 . . . . 0.0 110.914 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.655 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -112.41 106.95 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.975 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 18.9 t -124.24 158.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.282 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.598 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 90.3 m-85 -104.58 146.48 28.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.42 . . . . 0.0 111.345 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.479 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 15.9 pt-20 -64.97 -30.9 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -97.25 49.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 20.3 tp -80.19 126.16 30.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 347' ' ' THR . 35.8 p-10 -92.67 21.42 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.468 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.892 HG22 HG21 ' A' ' 305' ' ' VAL . 14.8 mm -124.7 136.78 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.535 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 40.2 mtt -140.52 161.6 37.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.868 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.476 ' HG2' HD23 ' A' ' 374' ' ' LEU . 11.1 mmt-85 -89.3 120.52 30.72 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.072 0.463 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.613 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.4 m-85 -118.08 152.34 35.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.739 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 332' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 48.7 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.308 0.575 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.624 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.21 119.01 36.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.773 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.493 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 0.9 OUTLIER -121.36 154.23 36.73 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.3 p -101.27 171.44 5.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.087 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.607 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.9 Cg_exo -44.02 -47.39 10.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.858 1.705 . . . . 0.0 112.106 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.0 pt-20 -59.98 -49.04 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 97.5 mt-30 -70.22 -46.52 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.613 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 90.2 mt-10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.303 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.3 p . . . . . 0 CA--C 1.523 -0.084 0 CA-C-O 121.132 0.491 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 20.3 tpp -112.9 128.22 25.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.669 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 34.1 Cg_exo -59.95 116.96 3.67 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 121.925 1.75 . . . . 0.0 110.618 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.476 HD23 ' HG2' ' A' ' 330' ' ' ARG . 6.5 mt -60.06 -39.47 86.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.851 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 59.4 tp -60.03 -50.69 72.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.7 mt-10 -60.02 -39.95 87.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -66.31 -36.66 83.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.618 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -26.38 65.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.76 -18.64 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.785 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -105.76 4.89 30.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 384' ' ' LYS . 39.4 t-20 -139.79 13.85 2.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -69.98 -17.58 63.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -77.16 -48.37 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . 0.444 ' HB2' ' OD1' ' A' ' 381' ' ' ASN . 34.1 mttt -60.11 -44.6 94.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.546 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.5 m-85 -69.89 -16.4 63.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.894 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.4 62.7 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.177 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.582 ' CB ' HG21 ' A' ' 317' ' ' VAL . . . -85.52 162.01 19.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 319' ' ' ILE . 72.8 m -105.71 100.05 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.823 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.421 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.1 tm? -74.47 103.13 4.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.2 mm-40 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.694 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 22.4 mm -96.08 104.34 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 14.7 m -100.87 -172.57 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.235 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.536 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -158.57 154.15 26.14 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.098 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.403 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.6 p-10 -67.91 5.6 0.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -59.96 -39.97 87.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.8 m -91.1 169.76 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.9 0.381 . . . . 0.0 111.525 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.94 -49.34 78.07 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.621 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.646 ' HB3' HG23 ' A' ' 287' ' ' ILE . 60.8 mm-40 -63.49 -35.94 82.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.642 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -24.02 66.28 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.004 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 59.8 m -83.94 -23.15 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.614 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.09 -41.59 63.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.602 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.598 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.3 OUTLIER -65.0 -44.0 90.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.797 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 92.3 t -58.77 -32.84 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.486 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.07 -54.23 14.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.225 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -55.65 -53.79 39.2 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.887 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.415 ' CE1' HD13 ' A' ' 409' ' ' ILE . 46.6 t80 -137.09 -66.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.797 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 102.7 81.13 1.52 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.517 -0.849 . . . . 0.0 115.163 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.02 -29.4 2.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.991 -1.1 . . . . 0.0 114.15 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.518 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.2 OUTLIER -149.98 130.64 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.689 0.744 . . . . 0.0 112.229 -178.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.99 135.12 5.13 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.95 142.15 14.37 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.461 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 318' ' ' GLU . 81.4 mt -109.96 130.0 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.8 mt -88.59 155.24 19.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.583 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 74.4 mtm180 -70.03 -39.96 75.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.581 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.553 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 54.4 p90 -158.42 169.92 23.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.7 mmm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.733 0.302 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.12 -40.01 90.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.163 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -101.4 49.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 36.5 p90 -65.38 89.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 111.201 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.07 13.59 14.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.462 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.79 -18.13 41.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.606 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.379 . . . . 0.0 110.313 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -79.48 -19.96 48.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.83 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.74 -38.61 82.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.91 -41.21 91.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.933 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.86 152.24 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.762 0.315 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.635 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.3 tm0? -55.28 -43.99 75.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 0.0 109.993 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.695 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 64.5 mt-10 -77.59 -41.53 38.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -70.76 -40.07 72.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -87.03 -58.83 2.44 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.597 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 21.5 tp -59.94 -56.43 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 30.6 mt -60.72 -48.71 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.333 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.13 -38.83 78.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.444 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.427 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 29.7 ttt180 -60.02 -39.61 86.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.328 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.573 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 5.7 t80 -55.59 -49.85 71.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.506 ' CE2' ' CB ' ' A' ' 401' ' ' GLN . 63.6 m-85 -79.41 -38.37 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.042 0.449 . . . . 0.0 111.006 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.93 -49.79 76.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.331 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.9 mt-10 -63.76 -45.43 89.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.877 0.37 . . . . 0.0 110.03 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.02 -23.6 21.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.42 -15.18 47.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.49 0.662 . . . . 0.0 109.549 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 34.9 mt-30 -103.25 2.38 34.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.09 31.57 18.41 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.177 0.513 . . . . 0.0 110.25 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 25.2 p -70.02 -9.99 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.766 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.52 48.03 73.0 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 119.926 -1.13 . . . . 0.0 113.655 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 33.5 mtmt -128.4 36.97 4.2 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.641 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 89.6 m-85 -160.0 160.04 32.84 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.35 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.13 159.42 43.32 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.747 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.8 p90 -131.9 125.35 31.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 114.94 169.13 15.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.765 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.554 HG23 ' CG2' ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.45 -56.81 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 13.2 pt-20 -48.78 -50.35 34.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.463 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.32 -53.6 28.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.754 0.311 . . . . 0.0 111.368 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.444 HG22 HG23 ' A' ' 409' ' ' ILE . 60.2 m -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.244 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.455 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 3.0 mp -65.81 -45.04 83.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.9 mttm -58.95 -48.08 82.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.439 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.457 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.01 -27.9 65.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.233 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.809 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.55 -27.87 61.56 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.804 0.335 . . . . 0.0 110.762 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -76.47 -26.82 55.77 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.2 mmt -81.82 -7.05 59.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.75 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.16 35.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.544 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.9 -2.11 58.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.289 0.236 . . . . 0.0 111.143 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 312' ' ' LEU . 27.7 m -99.54 104.79 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 412' ' ' ILE . 34.9 tt0 -56.8 -50.07 73.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.279 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 319' ' ' ILE . 39.8 mm -136.42 127.56 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.668 0.27 . . . . 0.0 111.466 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 312' ' ' LEU . 41.9 tp -95.34 128.62 42.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.026 0.441 . . . . 0.0 111.342 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.597 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -117.18 110.13 30.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 110.172 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 12.2 t -125.47 162.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.136 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.599 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 90.4 m-85 -107.29 145.39 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.476 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.6 pt-20 -63.61 -41.43 98.3 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -86.36 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 34.6 tp -89.24 120.6 30.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.604 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -90.06 26.64 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 305' ' ' VAL . 23.9 mm -123.45 136.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.135 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.715 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 73.7 mtp -140.05 162.36 35.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.236 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.682 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.9 ttt-85 -84.7 106.27 16.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.991 0.424 . . . . 0.0 111.897 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 7.6 m-85 -120.57 123.54 43.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.259 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 0.0 111.517 -179.584 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.1 tp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.579 0.704 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.538 ' HD2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.08 134.43 41.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.579 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.493 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -128.12 161.17 29.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.615 0.721 . . . . 0.0 112.87 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.2 p -101.56 168.76 8.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.372 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.5 Cg_endo -45.66 -47.42 13.59 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.283 1.989 . . . . 0.0 111.982 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.8 -50.07 74.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.743 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -69.05 -46.09 68.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.5 ' HG2' ' CE2' ' A' ' 331' ' ' TYR . 76.4 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.869 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 7.7 tpt -122.22 141.2 33.98 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.556 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.715 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.2 Cg_exo -62.96 124.4 13.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.232 1.955 . . . . 0.0 110.399 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.682 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.5 mt -68.42 -40.55 81.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.476 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.8 tp -59.95 -51.9 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 47.2 mt-10 -59.92 -39.96 87.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -62.21 -39.94 94.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.579 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.473 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.61 -27.09 61.95 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.477 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.81 -8.83 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.894 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.09 -9.93 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 18.94 5.9 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.71 -20.13 65.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.558 0.218 . . . . 0.0 111.202 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -79.13 -47.43 16.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -60.59 -45.24 94.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.477 ' CD2' HD23 ' A' ' 312' ' ' LEU . 25.9 m-85 -71.38 -19.13 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.635 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.03 73.91 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.044 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' A' ' 317' ' ' VAL . . . -84.6 160.99 20.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.124 0.488 . . . . 0.0 110.338 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.438 ' HB ' HD12 ' A' ' 319' ' ' ILE . 64.5 m -106.47 99.87 9.42 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.43 102.7 5.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.388 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.635 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.2 mm-40 -109.17 135.64 49.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.756 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 43.4 mm -99.98 104.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.0 m -101.38 -170.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.148 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.524 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -157.55 151.47 24.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.056 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -76.58 69.97 3.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -43.47 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.5 m -90.03 176.71 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.743 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 398' ' ' GLU . 4.7 pt20 -60.02 -44.29 94.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 287' ' ' ILE . 63.7 mm-40 -69.99 -41.51 74.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.727 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -19.23 60.84 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.545 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.0 m -83.9 -21.82 31.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.397 -0.401 . . . . 0.0 110.72 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.506 ' CB ' ' CE2' ' A' ' 291' ' ' PHE . 81.2 mt-30 -75.84 -41.37 52.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.784 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.599 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 7.3 m-30 -59.94 -44.99 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.889 0.376 . . . . 0.0 110.769 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.6 t -60.01 -40.09 82.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.07 -40.03 47.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.042 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -67.41 -38.42 91.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.924 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 2.2 p90 -142.56 -78.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.756 0.312 . . . . 0.0 110.334 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 135.65 47.93 0.08 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.832 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.63 -37.04 1.96 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.393 -1.384 . . . . 0.0 115.416 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.566 ' O ' ' CD2' ' A' ' 406' ' ' PHE . 1.1 mp -126.47 128.88 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.751 0.775 . . . . 0.0 112.977 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.64 136.76 6.38 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -121.49 140.15 13.66 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.744 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.496 ' CG2' ' CE2' ' A' ' 301' ' ' TYR . 18.7 mt -103.4 127.18 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.7 mt -91.55 158.58 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 112.732 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.55 -39.89 67.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.435 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.2 p90 -165.1 176.05 8.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.93 -40.02 87.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -117.13 101.19 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -133.27 121.72 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.253 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -79.48 0.05 31.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 109.7 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.95 -9.85 54.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -60.03 -40.3 88.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.795 0.331 . . . . 0.0 110.629 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.0 -29.78 66.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -60.05 -34.86 73.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.314 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.91 -49.99 75.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.253 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -107.01 121.63 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.926 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.993 0.425 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.714 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.449 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.489 ' HB2' HD11 ' A' ' 287' ' ' ILE . 17.6 pt-20 -77.61 -24.61 49.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.548 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -83.94 -51.47 7.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -75.37 -57.11 4.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.554 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 24.2 tp -59.1 -53.76 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.841 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.504 HD12 ' HB ' ' A' ' 392' ' ' VAL . 29.5 mt -58.93 -49.96 81.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.7 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.32 -37.02 71.59 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -60.01 -37.51 79.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.5 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.576 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.3 t80 -58.86 -45.51 89.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.612 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.91 -39.16 17.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.717 0.294 . . . . 0.0 111.444 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.6 t0 -62.29 -45.2 94.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 111.336 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.659 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 18.4 tp10 -67.64 -39.98 84.59 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 301' ' ' TYR . 80.4 mt -62.07 -26.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.43 -14.73 13.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.074 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.463 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 23.5 mt-30 -99.24 1.23 44.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.603 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.92 27.43 16.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.317 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.614 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 17.2 p -64.88 -13.38 56.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.941 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 58.38 45.06 94.81 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.23 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 4.7 ptpt -130.89 46.6 2.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.041 0.421 . . . . 0.0 110.782 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 98.6 m-85 -160.49 160.96 32.66 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.954 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 27.6 m -141.56 159.38 42.35 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.812 0.339 . . . . 0.0 111.234 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.435 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.2 p90 -135.4 124.68 24.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.621 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.513 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 107.68 156.09 19.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.311 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -59.97 -53.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 20.5 pt-20 -51.8 -51.93 52.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.47 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 87.5 m-20 -67.02 -53.17 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 0.0 111.095 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 42.0 m -58.05 -40.01 79.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.017 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.4 mp -67.81 -46.59 71.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 41.3 mtmt -54.45 -50.03 68.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.941 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.449 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -74.17 -24.82 59.44 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.321 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.776 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.63 -33.28 68.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.004 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -72.77 -25.52 61.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 4.3 mmt -82.46 -7.72 59.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.956 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.54 13.54 45.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.172 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.93 -6.99 59.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.549 0.34 . . . . 0.0 111.094 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 312' ' ' LEU . 35.6 m -99.79 106.68 19.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 37.4 tt0 -60.0 -52.7 64.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.696 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 388' ' ' THR . 26.7 mm -130.31 125.55 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.401 0.144 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.441 HD13 ' CG2' ' A' ' 308' ' ' THR . 44.2 tp -91.15 127.4 36.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.959 0.409 . . . . 0.0 111.081 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.554 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.0 OUTLIER -112.87 106.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.352 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 21.7 t -120.94 147.5 24.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.314 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.522 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.7 m-85 -90.17 143.19 26.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.0 112.252 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 12.2 tp10 -60.07 -43.06 95.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -91.6 53.57 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.4 tp -84.34 124.9 31.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -95.47 29.2 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.047 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 345' ' ' TYR . 18.8 mm -123.84 131.45 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.926 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.8 mtt -140.58 162.54 35.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.507 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.0 ttt-85 -90.91 120.19 31.72 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.109 0.481 . . . . 0.0 111.606 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.549 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 18.3 m-85 -130.91 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.013 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 111.359 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 26.1 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.019 0.438 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.555 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -90.41 135.49 33.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.315 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.531 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.3 mm? -126.85 158.46 36.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.693 0.759 . . . . 0.0 112.63 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.584 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.6 p -101.09 169.22 8.07 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.741 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.584 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 2.2 Cg_endo -44.64 -48.83 9.96 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.055 1.836 . . . . 0.0 111.92 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.559 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.97 -46.07 66.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.767 0.317 . . . . 0.0 111.647 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 57.1 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.651 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.549 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.0 128.46 25.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.621 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.5 Cg_exo -59.3 121.2 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.69 1.593 . . . . 0.0 110.5 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 18.0 mt -60.12 -39.9 87.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 391' ' ' ILE . 56.1 tp -59.98 -56.29 23.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.5 mt-10 -60.0 -40.05 87.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.008 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.78 -39.93 95.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.395 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.482 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -67.54 -25.17 65.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.014 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.65 -10.48 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -102.57 -14.7 16.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.8 19.88 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.19 -20.06 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.56 0.219 . . . . 0.0 111.265 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -80.37 -42.16 23.36 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.171 0.51 . . . . 0.0 110.493 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.492 ' CD2' HD23 ' A' ' 312' ' ' LEU . 20.9 m-85 -81.81 -10.01 59.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.35 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.79 54.52 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 319' ' ' ILE . 48.0 m -107.64 100.99 10.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.486 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.462 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.1 tm? -71.12 103.69 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.209 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.714 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.0 mm-40 -111.31 131.19 55.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.59 ' CD1' HD12 ' A' ' 375' ' ' LEU . 32.0 mm -95.24 100.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.567 HG11 HE22 ' A' ' 282' ' ' GLN . 17.6 m -112.73 139.34 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 395' ' ' LYS . 5.7 p -111.45 164.47 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.881 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.409 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.3 p-10 -69.5 15.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 393' ' ' THR . 38.8 tttp -59.95 -45.25 93.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 5.0 m -90.76 173.77 7.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.978 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.84 -50.39 73.98 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.785 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.412 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 74.1 mm-40 -62.94 -36.89 84.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.506 0.67 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.409 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.11 -26.37 67.45 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.436 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.2 m -83.34 -26.62 30.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.242 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.8 -43.7 68.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.797 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.522 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.0 m-85 -60.02 -48.22 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 72.8 t -57.59 -33.57 45.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 400' ' ' SER . 2.9 mmpt? -74.65 -52.16 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.524 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.75 -25.57 69.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.279 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.513 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 21.7 t80 179.35 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.71 167.11 30.82 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.498 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.39 -47.83 3.03 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.594 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.77 130.58 5.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 117.742 0.771 . . . . 0.0 112.159 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.49 134.63 5.11 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.97 138.88 14.29 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.577 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 26.6 mt -102.48 127.2 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 69.8 mt -87.91 152.54 21.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 112.345 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.3 mtt-85 -68.99 -35.55 76.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.94 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.439 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 97.0 m-85 -159.84 -171.83 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.56 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -61.04 -39.96 91.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.454 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 53.7 p90 -140.59 114.99 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.293 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -135.62 116.41 14.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.335 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.99 11.3 9.76 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.062 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.6 mt -70.05 -2.25 12.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.937 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.38 -39.3 69.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -60.01 -39.53 86.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.316 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.61 -32.18 62.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.741 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.94 -45.81 91.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 N--CA 1.46 0.043 0 CA-C-O 120.732 0.301 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.645 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.32 -41.01 88.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.287 0.565 . . . . 0.0 109.917 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.715 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 79.8 mt-10 -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.896 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -39.95 94.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -86.8 -59.16 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 22.0 tp -60.76 -55.22 35.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.838 0.352 . . . . 0.0 111.455 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 54.1 mt -59.91 -48.89 86.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.531 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -55.11 -38.34 66.32 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.532 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -59.97 -36.59 77.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 0.0 110.046 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.608 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 11.6 t80 -60.09 -47.77 84.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.635 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -81.87 -36.65 27.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.89 -52.11 61.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.769 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.537 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -60.85 -44.63 96.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.397 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 301' ' ' TYR . 97.5 mt -56.38 -24.95 19.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -15.25 33.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 121.471 0.653 . . . . 0.0 109.621 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.425 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 76.4 mt-30 -100.41 1.36 41.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.443 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.39 32.45 18.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.182 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.765 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -74.13 -5.65 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 45.51 75.21 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.948 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 37.0 mtmt -122.26 37.9 4.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 73.8 m-85 -162.31 164.26 27.58 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.1 p -149.43 163.55 37.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.2 p90 -137.43 131.13 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.448 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 112.39 149.69 10.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.898 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.24 -58.23 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.6 pt-20 -49.33 -55.62 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.0 -52.42 63.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.701 0.286 . . . . 0.0 111.535 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 409' ' ' ILE . 49.7 m -59.32 -39.96 84.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.091 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.495 ' HG ' ' CZ ' ' A' ' 378' ' ' PHE . 3.1 mp -66.26 -42.08 89.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 314' ' ' MET . 24.4 mtmt -59.95 -45.42 92.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.129 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.403 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.03 -28.61 65.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.899 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.596 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.27 -24.97 59.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.985 0.422 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -78.94 -28.91 43.82 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 14.3 mmt -81.2 -8.04 59.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.676 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.67 28.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.742 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.78 -11.22 58.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.835 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.596 HG22 ' HA ' ' A' ' 312' ' ' LEU . 30.9 m -90.44 105.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.1 tt0 -59.91 -49.42 77.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.418 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' A' ' 319' ' ' ILE . 36.3 mm -135.76 127.1 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.611 0.243 . . . . 0.0 111.434 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.571 ' HB2' HD12 ' A' ' 312' ' ' LEU . 55.4 tp -93.69 128.15 39.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.252 0.548 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.572 HG21 HG21 ' A' ' 392' ' ' VAL . 0.8 OUTLIER -115.43 107.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.975 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 389' ' ' LEU . 17.8 t -125.78 161.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.563 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.7 m-85 -112.25 132.59 54.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 111.396 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.575 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.3 pt-20 -56.23 -25.92 49.32 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.847 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -90.05 45.28 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.291 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 409' ' ' ILE . 25.3 tp -89.14 124.2 34.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 110.948 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.16 30.04 2.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.521 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 20.0 mm -124.52 135.18 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.129 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.632 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 60.5 mtp -140.11 162.32 35.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.623 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 15.6 ttt85 -88.08 117.12 26.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.029 0.442 . . . . 0.0 111.588 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 6.8 m-85 -125.42 123.39 39.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.347 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 111.436 -179.191 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 46.6 tp . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.277 0.561 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.615 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.5 p90 -100.07 119.48 38.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.554 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.546 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -124.33 163.58 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 112.534 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -101.32 170.79 6.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.669 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -49.36 -42.0 41.86 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.836 1.69 . . . . 0.0 111.862 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.2 -50.02 75.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.052 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 48.9 mt-30 -69.38 -50.12 49.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 84.2 mt-10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.485 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.999 0.428 . . . . 0.0 110.775 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.7 tpt -120.83 134.93 24.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.276 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.4 Cg_exo -61.01 130.36 32.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.926 1.75 . . . . 0.0 110.412 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.7 mt -69.63 -40.6 76.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.669 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 60.1 tp -60.19 -56.1 25.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.902 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.58 -40.05 78.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.69 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.97 -40.02 91.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.458 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.2 OUTLIER -70.56 -26.87 63.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.43 -8.84 52.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.397 . . . . 0.0 112.005 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -108.23 -9.5 15.51 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.26 18.03 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.35 -21.02 66.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.595 0.236 . . . . 0.0 111.317 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -77.19 -46.36 23.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -62.87 -41.71 99.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 0.0 110.679 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.464 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -74.07 -17.89 60.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.35 69.25 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.209 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.54 ' CB ' HG23 ' A' ' 317' ' ' VAL . . . -86.2 163.07 18.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.425 ' HB ' HD12 ' A' ' 319' ' ' ILE . 90.0 m -106.66 99.84 9.39 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.473 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.3 tm? -76.12 102.6 5.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.923 0.392 . . . . 0.0 111.235 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.645 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.4 mm-40 -111.92 132.09 54.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.157 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 37.8 mm -94.97 105.63 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 111.886 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.572 HG21 HG21 ' A' ' 321' ' ' ILE . 6.5 m -101.91 -169.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.813 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.563 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.8 p -158.03 154.04 27.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.331 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.47 0.96 3.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.202 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -59.8 -40.87 89.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.618 0.247 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 283' ' ' GLU . 53.5 p -85.51 168.59 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -60.05 -55.16 37.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 69.6 mm-40 -63.21 -36.07 82.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 109.852 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -52.72 -59.04 9.75 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.323 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 m -59.59 -19.7 50.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 32.7 mt-30 -69.69 -40.04 76.57 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.069 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.549 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.9 m-85 -62.04 -36.5 81.8 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.03 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.856 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.8 t -60.09 -38.8 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -71.36 -45.63 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.991 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -58.75 -44.83 95.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.99 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 303' ' ' PHE . 60.3 t80 -146.44 -66.26 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.856 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.71 57.26 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.808 -1.187 . . . . 0.0 115.165 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 139.78 -36.1 1.86 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.258 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.514 ' CD1' HG21 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -132.24 133.38 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 117.964 0.882 . . . . 0.0 112.815 -177.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.498 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -150.83 136.67 5.69 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.73 143.64 15.95 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.441 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 318' ' ' GLU . 30.9 mt -104.47 125.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.3 mt -94.98 163.16 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 0.0 112.799 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 74.6 mtt180 -78.48 -38.36 41.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.764 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 89.9 m-85 -158.48 -179.94 8.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 298' ' ' THR . 45.8 mtm180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.721 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.436 ' O ' ' CD1' ' A' ' 432' ' ' PHE . 41.5 tt0 -60.06 -49.4 77.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 432' ' ' PHE . 87.1 m-85 -76.28 -40.09 52.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 35.1 p90 45.14 69.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.221 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -77.92 6.1 8.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.931 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.28 -3.49 14.1 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.579 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.52 -40.07 81.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 110.47 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.91 -32.27 70.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.335 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.64 -35.8 75.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.02 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.01 -48.01 83.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.936 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--O 1.231 0.125 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.534 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.07 -39.96 83.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.262 0.553 . . . . 0.0 110.054 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.713 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.6 mt-10 -81.13 -44.0 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -67.44 -40.06 85.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -86.03 -58.65 2.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.632 ' HG ' HD13 ' A' ' 321' ' ' ILE . 22.0 tp -61.2 -56.59 18.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.634 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.713 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 58.1 mt -59.97 -45.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.69 -37.67 77.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.264 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 -59.96 -36.84 77.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.407 0.622 . . . . 0.0 110.056 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.637 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 8.9 t80 -59.96 -46.07 90.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.683 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -83.68 -37.33 22.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 295' ' ' SER . 53.4 t0 -62.02 -47.39 84.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.829 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.5 mp0 -66.71 -40.0 88.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.72 -22.35 26.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.17 -13.54 58.42 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.347 0.594 . . . . 0.0 109.528 178.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.611 ' HB2' HG23 ' A' ' 298' ' ' THR . 67.9 mt-30 -102.96 -0.71 30.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.541 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.19 30.66 20.47 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.657 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 11.3 p -69.73 -12.36 61.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.871 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.17 48.57 85.28 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.123 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 3.2 mtpm? -125.94 37.45 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 82.1 m-85 -160.61 161.54 32.55 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.142 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.7 159.71 41.67 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -135.91 124.84 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.481 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.82 153.06 13.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.27 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -57.33 -58.45 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.764 0.316 . . . . 0.0 110.794 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.8 pt-20 -50.41 -53.53 28.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.98 -55.2 27.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.428 ' CG2' HD13 ' A' ' 320' ' ' LEU . 21.4 m -57.01 -39.35 74.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.3 mp -67.54 -42.21 83.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 25.2 mtmt -60.0 -49.94 75.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.792 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.416 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -68.84 -29.27 67.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.63 0.252 . . . . 0.0 110.934 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.69 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -71.76 -26.84 62.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.919 0.39 . . . . 0.0 110.448 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.04 -27.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.2 mmt -80.28 -7.42 59.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.849 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.33 18.15 48.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.258 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.59 11.76 29.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.364 0.266 . . . . 0.0 111.04 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 17.0 m -111.33 105.53 18.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.697 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 59.9 tt0 -59.95 -49.99 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.451 ' HA ' ' H ' ' A' ' 388' ' ' THR . 43.5 mm -137.65 126.02 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.552 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.6 tp -90.95 128.79 36.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 111.314 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.632 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -113.5 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.766 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.552 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.9 t -122.68 150.56 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.332 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 393' ' ' THR . 96.7 m-85 -98.16 146.06 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 111.144 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.478 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.8 pt-20 -65.95 -33.28 75.45 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.074 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -90.06 41.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 29.3 tp -74.05 122.17 22.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 110.869 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -90.57 24.17 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 345' ' ' TYR . 18.5 mm -125.95 131.34 71.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.676 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 66.7 mtp -140.27 161.76 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.593 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.623 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.6 ttt180 -85.1 116.09 23.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.937 0.398 . . . . 0.0 111.555 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.722 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 15.0 m-85 -119.07 119.0 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.528 0.11 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.317 -179.714 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.0 tp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.329 0.585 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.538 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.91 121.21 40.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.923 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.8 mm? -121.09 161.39 21.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 4.4 p -101.66 169.14 8.06 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.115 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 86.5 Cg_exo -43.67 -53.02 4.75 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.812 1.675 . . . . 0.0 112.162 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.96 -58.8 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.79 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.13 -44.99 95.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.944 0.402 . . . . 0.0 111.36 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.626 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.8 mt-10 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.074 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.722 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 90.9 p . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -117.83 133.49 23.34 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.204 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.618 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 37.7 Cg_exo -58.39 114.29 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.824 1.682 . . . . 0.0 111.108 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 23.5 mt -60.01 -39.29 85.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.147 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.493 HD12 ' CD1' ' A' ' 391' ' ' ILE . 63.3 tp -60.01 -52.27 66.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.61 -39.94 90.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.205 0.526 . . . . 0.0 109.822 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -61.28 -40.02 92.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.569 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.587 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -73.54 -24.19 60.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -9.13 53.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.75 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -110.04 -10.02 14.71 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.29 14.02 6.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -64.4 -18.5 64.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.584 0.23 . . . . 0.0 111.394 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -75.38 -39.97 58.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -67.21 -40.88 86.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.556 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.1 m-85 -72.67 -16.36 61.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.52 70.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.894 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.445 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -88.96 164.45 15.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.271 0.558 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.451 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 57.7 m -107.19 100.59 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.11 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.475 ' CD2' HG23 ' A' ' 322' ' ' VAL . 2.3 tm? -71.99 102.87 3.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.384 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.534 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -111.02 138.88 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.877 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.7 mm -101.92 103.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.521 HG12 HD12 ' A' ' 287' ' ' ILE . 4.4 m -101.6 -171.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.225 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -156.24 153.75 29.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.468 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.5 p-10 -70.89 2.94 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -60.05 -40.0 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.567 0.222 . . . . 0.0 111.399 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.5 p -84.65 169.86 13.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.358 . . . . 0.0 111.416 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.04 -52.51 65.07 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 65.1 mm-40 -61.64 -38.08 86.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.468 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -63.22 -25.04 67.88 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.792 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 68.3 m -82.88 -25.7 32.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.529 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.14 -45.21 58.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.509 ' CE1' ' CD1' ' A' ' 290' ' ' TYR . 1.6 m-85 -56.29 -49.6 73.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.489 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 85.2 t -59.86 -35.21 59.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.762 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -69.9 -49.96 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.203 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.86 -23.84 75.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 11.1 t80 178.76 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 97.87 167.07 31.93 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.674 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.89 -49.2 2.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.025 -0.607 . . . . 0.0 114.191 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -145.15 132.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 117.492 0.646 . . . . 0.0 112.205 -177.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -152.5 143.33 10.22 Favored Glycine 0 CA--C 1.509 -0.301 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.9 142.07 13.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.57 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 318' ' ' GLU . 57.2 mt -104.66 128.65 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.5 mt -87.38 150.16 24.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.784 0.802 . . . . 0.0 112.821 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.697 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 72.7 mtt-85 -69.95 -36.19 75.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 96.2 m-85 -159.38 167.04 29.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.772 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mtm180 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.874 0.369 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.97 -40.64 89.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.61 104.68 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -124.6 103.84 8.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 11.71 19.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.055 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 64.1 mt -73.4 -3.92 30.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.646 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -40.02 87.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 110.632 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.84 -30.6 68.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.0 -33.72 72.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.432 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.97 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.09 124.31 47.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.948 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.729 0.3 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.593 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -59.92 -40.47 88.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.957 0.408 . . . . 0.0 110.382 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.6 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 24.8 pt-20 -85.62 -38.54 18.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.904 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -70.03 -39.92 75.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -86.22 -57.23 3.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.504 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 36.0 tp -58.26 -56.31 23.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.079 0.466 . . . . 0.0 111.719 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 52.4 mt -59.36 -49.97 81.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.98 -39.79 89.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.591 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -60.06 -36.49 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.471 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.573 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 4.9 t80 -59.08 -45.98 89.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -83.48 -42.32 17.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.864 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 295' ' ' SER . 45.1 t0 -60.72 -47.48 86.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.567 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.68 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 22.9 tp10 -63.06 -39.94 96.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.456 HG13 ' CD2' ' A' ' 301' ' ' TYR . 87.7 mt -62.75 -26.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.579 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -60.34 -12.53 9.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 109.957 178.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.439 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 83.7 mt-30 -98.97 0.04 43.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.466 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.99 29.65 19.25 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.346 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.566 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 19.0 p -73.35 -7.75 52.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.958 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.65 53.47 29.02 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.938 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 22.0 mttt -130.2 41.95 3.33 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 74.6 m-85 -161.78 163.02 29.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.775 0.321 . . . . 0.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.0 p -149.12 161.82 41.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.74 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.81 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 53.0 p90 -141.44 149.99 41.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 96.67 142.19 12.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.171 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -49.37 -64.12 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.765 0.317 . . . . 0.0 111.238 -179.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.1 pt-20 -47.15 -52.89 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.831 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.0 m-20 -64.35 -56.75 12.32 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 26.0 m -58.03 -37.38 74.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.9 mp -69.94 -44.0 70.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.603 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.9 mtmm -59.9 -46.44 89.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.585 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.021 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.711 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.81 -24.92 55.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.895 0.378 . . . . 0.0 110.618 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -77.96 -28.32 49.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 89.8 mmm -81.1 -7.37 59.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.731 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.55 16.34 36.38 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.358 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.51 -9.65 58.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.411 0.284 . . . . 0.0 111.207 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 312' ' ' LEU . 28.0 m -94.94 105.49 17.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 412' ' ' ILE . 43.0 tt0 -58.78 -50.9 72.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.275 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.452 HG22 HD13 ' A' ' 286' ' ' LEU . 33.0 mm -134.05 127.0 50.96 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.061 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.63 ' HG ' HG22 ' A' ' 322' ' ' VAL . 31.6 tp -92.38 125.6 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.81 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.509 ' HB ' ' CE2' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -106.67 103.85 16.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.244 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.63 HG22 ' HG ' ' A' ' 320' ' ' LEU . 11.6 t -124.23 162.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.596 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 75.9 m-85 -112.67 149.78 32.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 111.905 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.489 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 15.6 pt-20 -65.91 -40.41 91.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.149 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -89.77 56.49 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.752 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.442 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 26.5 tp -89.09 121.75 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -89.15 23.77 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.581 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 4.8 mm -121.62 131.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.575 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.3 mtt -139.48 162.97 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.5 ttt180 -88.85 116.04 26.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 112.012 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.568 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 9.1 m-85 -123.46 123.77 41.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.097 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 332' ' ' VAL . 16.2 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.144 0.497 . . . . 0.0 111.662 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 55.8 tp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.342 0.591 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.581 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 10.3 p90 -97.32 120.04 36.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -125.33 160.56 29.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.1 p -101.64 172.2 4.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.466 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.0 Cg_exo -46.6 -42.8 23.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.882 1.721 . . . . 0.0 111.92 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -59.22 5.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 88.9 mt-30 -60.37 -49.69 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 89.2 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.207 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.525 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.4 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.228 0.537 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.69 130.87 24.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.961 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.575 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.7 Cg_exo -60.72 120.15 7.71 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.03 1.82 . . . . 0.0 110.752 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.2 mt -61.89 -39.56 92.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.021 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.9 tp -59.99 -51.88 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.82 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.05 -40.15 88.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.718 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -63.0 -40.01 96.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.651 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.468 ' CZ ' ' HG ' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -70.01 -24.92 63.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.31 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.03 -7.62 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.072 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -105.47 -11.9 16.22 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.65 16.02 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -62.11 -20.49 64.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.93 -44.77 17.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -61.34 -40.57 94.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.704 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 23.5 m-85 -79.96 -12.7 59.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.15 55.44 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 317' ' ' VAL . . . -84.87 161.54 19.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.103 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 319' ' ' ILE . 47.2 m -105.64 99.66 9.25 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.435 HD23 HG21 ' A' ' 322' ' ' VAL . 2.5 tm? -74.6 103.55 4.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.115 0.483 . . . . 0.0 111.082 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.593 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.2 mm-40 -110.66 140.47 44.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 18.2 mm -105.43 104.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 287' ' ' ILE . 9.3 m -101.09 -170.06 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.879 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.596 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.5 p -154.59 152.51 30.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.408 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.4 p-10 -68.58 3.28 1.91 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.548 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -59.99 -40.1 88.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.645 0.259 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -89.17 167.72 12.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.8 0.334 . . . . 0.0 111.516 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.07 -49.89 75.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 45.6 mp0 -63.47 -39.98 95.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.37 0.605 . . . . 0.0 109.756 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.408 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -64.3 -19.16 63.89 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.664 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.1 m -83.89 -22.46 31.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.017 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -74.23 -39.99 62.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.028 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.548 ' CD2' ' HE2' ' A' ' 406' ' ' PHE . 2.7 m-85 -63.26 -49.62 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.0 -45.92 94.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -73.97 -43.98 56.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.742 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.405 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -66.37 -41.51 94.44 Favored Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.81 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -129.29 -86.91 0.54 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.793 -0.704 . . . . 0.0 109.582 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 160.77 40.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.35 -1.405 . . . . 0.0 115.117 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 102.9 7.36 44.5 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.035 -1.078 . . . . 0.0 115.424 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.547 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.4 OUTLIER -144.97 125.34 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.207 1.003 . . . . 0.0 110.449 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.31 145.32 12.63 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -126.35 140.46 12.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.548 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 56.6 mt -99.11 127.52 51.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 34.9 mt -92.08 165.66 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.476 0.655 . . . . 0.0 112.345 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -91.6 -27.19 18.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 64.7 t80 -164.49 162.96 22.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 298' ' ' THR . 6.0 mmm180 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.0 -49.95 75.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.556 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.03 -31.52 69.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -81.41 107.9 14.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -82.82 7.51 14.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.339 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.69 -9.76 39.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.775 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -39.97 87.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.01 -31.37 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.355 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.405 ' O ' ' CE1' ' A' ' 440' ' ' HIS . 64.1 t80 -59.91 -31.88 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.745 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.06 -49.91 75.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.266 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -109.09 130.17 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 437' ' ' TYR . 59.1 m80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 120.904 0.383 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.608 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 23.0 tm0? -59.45 -39.57 84.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.568 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 59.7 mt-10 -78.97 -30.27 44.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -52.17 6.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -70.01 -56.98 5.56 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.608 ' HG ' HD13 ' A' ' 321' ' ' ILE . 23.7 tp -57.83 -54.93 41.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.317 0.579 . . . . 0.0 110.804 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 11.0 mt -63.46 -45.34 98.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.248 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.61 ' N ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.31 -39.48 82.55 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.604 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -59.98 -37.77 80.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 21.7 t80 -60.05 -47.18 86.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.524 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -86.27 -35.92 19.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 295' ' ' SER . 26.2 t0 -66.22 -46.26 77.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 111.306 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.683 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 10.5 tp10 -65.7 -39.93 91.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.555 HG13 ' CD2' ' A' ' 301' ' ' TYR . 86.3 mt -62.22 -25.41 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.599 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.63 -14.72 14.82 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.28 0.562 . . . . 0.0 109.806 178.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.606 ' HB2' HG21 ' A' ' 298' ' ' THR . 51.4 mt-30 -98.2 -0.06 44.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.748 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.69 29.97 19.31 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.974 0.416 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 296' ' ' GLN . 32.0 p -70.66 -12.05 61.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.949 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.26 47.78 89.17 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.72 -1.229 . . . . 0.0 114.442 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.717 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 16.8 ptpt -130.46 45.04 2.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.13 0.465 . . . . 0.0 110.783 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.717 ' CE2' ' HG3' ' A' ' 300' ' ' LYS . 87.3 m-85 -160.94 161.09 31.54 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.911 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 p -144.61 160.62 40.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -134.51 124.16 25.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.849 0.357 . . . . 0.0 110.819 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.487 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 113.79 155.1 11.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -59.91 -56.76 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.843 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.506 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -49.57 -57.46 7.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.482 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -60.06 -52.2 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 111.308 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.466 ' CG2' HD13 ' A' ' 320' ' ' LEU . 33.5 m -59.99 -40.03 87.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.138 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.446 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 2.0 mp -66.01 -46.72 76.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -57.64 -50.46 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.027 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -65.18 -31.28 72.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.698 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.71 -24.29 59.9 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -79.73 -27.41 40.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.1 mmt -80.89 -8.83 59.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.313 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.55 15.16 38.61 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.518 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.52 -8.8 57.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.134 . . . . 0.0 111.322 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 312' ' ' LEU . 27.7 m -92.03 103.91 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.844 0.354 . . . . 0.0 111.708 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 412' ' ' ILE . 35.3 tt0 -58.68 -49.96 75.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.552 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.433 ' HA ' ' H ' ' A' ' 388' ' ' THR . 44.5 mm -133.75 126.6 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.545 0.212 . . . . 0.0 111.171 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.466 HD13 ' CG2' ' A' ' 308' ' ' THR . 47.5 tp -92.03 124.04 35.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.608 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -111.41 105.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.584 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 389' ' ' LEU . 23.4 t -116.51 159.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.833 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.589 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 70.2 m-85 -107.14 144.82 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -71.28 160.87 32.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.526 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.0 22.98 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.803 0.335 . . . . 0.0 110.445 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 24.4 tp -54.78 125.26 19.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.74 26.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.001 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 12.3 mm -130.76 130.57 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.537 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.611 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 9.9 mtt -139.68 162.66 34.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.582 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt180 -85.28 118.08 24.6 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 120.728 0.299 . . . . 0.0 111.662 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.795 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 43.8 m-85 -124.92 122.07 36.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.424 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 332' ' ' VAL . 23.7 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 0.0 111.161 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.183 0.516 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.529 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.62 116.95 29.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.54 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.456 0.645 . . . . 0.0 112.58 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.5 p -100.41 169.7 7.59 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.96 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.523 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.5 Cg_exo -47.71 -46.07 22.11 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 121.943 1.762 . . . . 0.0 112.953 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 350' ' ' GLN . 23.9 pm0 -64.4 -41.72 96.48 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 349' ' ' GLU . 40.3 mt-30 -84.62 -48.18 9.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.795 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 3.5 tm-20 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.946 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.567 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 1.4 m . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 121.187 0.518 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 3.1 tpt -113.6 129.11 24.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.608 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.2 Cg_exo -56.0 120.51 8.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.805 1.67 . . . . 0.0 110.981 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.589 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 32.6 mt -62.03 -40.06 94.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.956 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 391' ' ' ILE . 50.4 tp -60.8 -55.65 30.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.3 mt-10 -59.79 -40.05 86.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.874 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -60.93 -39.92 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.982 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.538 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.1 m-85 -72.82 -27.12 61.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.214 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 389' ' ' LEU . . . -88.54 -10.81 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.42 -9.75 15.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 20.69 5.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.567 0.222 . . . . 0.0 111.47 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -69.0 -17.65 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.09 -43.45 17.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.84 -41.47 99.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.466 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.523 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.6 m-85 -78.5 -15.84 58.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.805 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.34 2.21 66.97 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.52 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 317' ' ' VAL . . . -85.62 162.66 18.73 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.164 0.507 . . . . 0.0 110.601 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.433 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 71.5 m -107.13 100.57 10.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.371 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.0 OUTLIER -72.19 105.53 4.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.389 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.608 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 14.3 mm-40 -111.39 143.5 42.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.774 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 375' ' ' LEU . 18.6 mm -107.37 100.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.507 HG22 ' CZ ' ' A' ' 323' ' ' TYR . 18.6 m -100.54 -170.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.267 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.523 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.6 OUTLIER -160.35 157.1 27.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.945 0.403 . . . . 0.0 111.748 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.42 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.0 p-10 -71.5 -0.12 9.74 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.496 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.25 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 54.3 p -78.88 168.07 20.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.778 0.323 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.97 -51.0 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 110.725 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.61 ' HG2' ' N ' ' A' ' 288' ' ' GLY . 13.1 tp10 -70.07 -34.72 73.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.42 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -51.84 -57.21 13.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.8 m -60.7 -19.65 59.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.536 . . . . 0.0 112.073 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 36.6 mt-30 -70.3 -40.06 74.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.967 0.413 . . . . 0.0 110.467 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.589 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -59.6 -46.43 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.376 179.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 76.3 t -58.97 -33.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -69.14 -51.06 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.033 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -71.13 -22.1 78.47 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.637 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.487 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.0 t80 176.65 -77.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.48 168.33 31.33 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.52 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.32 -48.59 2.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.277 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.559 HD11 ' N ' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -144.22 132.33 17.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 117.495 0.648 . . . . 0.0 112.383 -177.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.59 137.51 6.29 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.55 139.39 12.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.392 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 56.2 mt -101.32 127.72 54.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 66.6 mt -91.6 168.77 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.719 . . . . 0.0 112.645 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -67.29 -40.05 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.742 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.632 ' O ' ' HB3' ' A' ' 300' ' ' LYS . 58.1 t80 -172.09 -60.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.724 0.297 . . . . 0.0 111.574 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 120.846 0.355 . . . . 0.0 110.643 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.798 0.333 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.85 -43.74 97.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.396 . . . . 0.0 110.918 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -128.43 106.25 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 24.8 p90 -122.5 98.55 5.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.371 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 9.4 27.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.395 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.97 -18.16 43.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.63 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -81.1 -20.07 42.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.656 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.98 -38.45 82.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.028 0.442 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.98 -46.86 88.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -72.2 146.75 47.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.78 0.324 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.545 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -58.5 -40.23 82.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.127 0.489 . . . . 0.0 110.491 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.0 tt0 -71.39 -38.28 71.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -78.98 -55.36 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -67.76 -58.58 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.142 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.639 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 17.6 tp -52.62 -57.6 9.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 111.371 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.589 HG21 ' CE1' ' A' ' 402' ' ' PHE . 25.7 mt -61.69 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.878 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.9 -38.67 60.51 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 36.6 ttt180 -60.08 -39.95 87.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.204 0.526 . . . . 0.0 110.286 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.589 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.7 t80 -55.82 -47.85 76.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.685 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 33.6 m-85 -83.59 -37.83 22.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -61.22 -42.23 98.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.429 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.679 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.2 mt-10 -69.89 -42.14 73.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.999 0.428 . . . . 0.0 109.882 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.16 -24.6 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -62.9 -15.95 57.14 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.244 0.545 . . . . 0.0 109.871 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.424 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 26.2 mt-30 -101.9 0.76 35.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.521 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.3 29.86 19.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 110.157 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.4 p -67.02 -10.15 46.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.997 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.55 49.57 60.46 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.841 -1.171 . . . . 0.0 113.374 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.7 mtmt -130.36 38.93 3.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.679 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 84.5 m-85 -160.88 161.42 31.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.252 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.66 163.25 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.6 p90 -137.65 130.88 30.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.69 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 406' ' ' PHE . . . 109.35 142.46 9.68 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.361 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -50.17 -60.31 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 111.208 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 9.9 pt-20 -47.31 -54.04 12.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.629 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.08 -53.93 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 111.521 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.449 ' CG2' HD13 ' A' ' 320' ' ' LEU . 40.6 m -58.36 -39.08 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.096 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.437 ' HG ' ' CZ ' ' A' ' 378' ' ' PHE . 2.5 mp -65.93 -42.79 89.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.0 mtmm -59.96 -49.99 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.442 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -66.38 -29.35 69.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.29 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.793 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.07 -24.81 58.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.77 0.319 . . . . 0.0 110.733 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -79.39 -27.96 41.87 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 34.1 mmt -80.51 -7.57 59.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.759 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.97 18.33 47.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.409 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.63 -1.3 57.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.388 0.275 . . . . 0.0 111.371 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 312' ' ' LEU . 30.3 m -100.3 104.3 15.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 412' ' ' ILE . 9.4 tp10 -57.71 -50.89 71.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.321 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 388' ' ' THR . 26.4 mm -135.4 126.85 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.643 0.259 . . . . 0.0 111.221 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 322' ' ' VAL . 48.6 tp -92.74 126.43 37.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 111.634 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.639 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -112.67 106.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.522 HG22 ' HG ' ' A' ' 320' ' ' LEU . 11.8 t -124.8 161.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.155 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.601 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -108.19 146.1 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.466 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 11.4 pt-20 -65.02 -34.11 77.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.9 47.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 31.1 tp -81.01 123.15 28.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.577 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -93.07 25.67 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.604 HG21 HG11 ' A' ' 305' ' ' VAL . 24.3 mm -123.18 132.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.656 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.5 mtm -140.35 162.09 36.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.57 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.4 ttt85 -89.7 119.99 30.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.105 0.479 . . . . 0.0 111.572 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 9.9 m-85 -127.11 123.09 36.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.485 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 332' ' ' VAL . 14.2 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.214 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.504 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.9 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.445 0.64 . . . . 0.0 112.153 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.567 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.8 p90 -99.97 121.15 40.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.047 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.549 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.6 mm? -127.42 160.61 30.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.2 p -101.5 172.49 4.39 Favored Pre-proline 0 N--CA 1.455 -0.177 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.588 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.6 Cg_exo -49.5 -43.22 39.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.035 1.823 . . . . 0.0 112.414 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -61.57 -49.27 77.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.535 ' HG2' ' CD1' ' A' ' 346' ' ' LEU . 10.9 tp60 -70.03 -48.1 59.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 75.3 mt-10 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.583 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.084 0.468 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 3.9 tpt -117.17 130.04 24.91 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.875 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.656 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.8 Cg_exo -60.02 125.17 16.9 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.832 1.688 . . . . 0.0 110.922 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 27.4 mt -66.49 -39.86 88.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.91 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 65.0 tp -60.05 -52.16 66.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.6 mt-10 -58.89 -39.99 83.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.887 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.84 -40.83 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.618 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -70.31 -27.76 64.64 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -10.01 47.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.177 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -104.18 -12.78 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.976 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 30.6 m120 -129.64 19.93 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -65.51 -19.71 66.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.568 0.223 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.77 -44.93 17.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.05 -39.93 91.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.655 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.467 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -79.92 -13.14 59.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.84 2.26 56.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.305 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.464 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.02 163.16 18.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 110.649 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 319' ' ' ILE . 48.5 m -107.82 100.41 9.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.401 ' CD2' HG21 ' A' ' 322' ' ' VAL . 2.3 tm? -75.35 102.3 5.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.111 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.545 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -108.43 139.46 43.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.827 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 40.0 mm -103.49 104.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.388 0.613 . . . . 0.0 112.432 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' A' ' 287' ' ' ILE . 6.0 m -101.65 -169.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.917 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.527 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -156.16 153.08 28.71 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.958 0.409 . . . . 0.0 111.511 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -72.87 17.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -70.03 -39.92 75.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.78 0.324 . . . . 0.0 111.235 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.5 t -89.26 170.04 10.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.678 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.0 -50.03 75.34 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.516 ' HB3' HG22 ' A' ' 287' ' ' ILE . 66.8 mm-40 -64.51 -40.38 95.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.163 0.506 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.31 -18.53 63.13 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.442 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.1 m -83.98 -21.74 31.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.848 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 84.4 mt-30 -75.14 -41.35 58.49 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.835 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.601 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 3.3 m-85 -59.73 -42.75 93.82 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.763 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 57.7 t -60.01 -39.99 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.665 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -40.04 64.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.78 96.87 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.117 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 304' ' ' GLY . 62.5 t80 -151.6 -68.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.14 58.29 0.18 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 119.965 -1.112 . . . . 0.0 114.916 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 140.78 -34.13 1.98 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 119.387 -1.387 . . . . 0.0 115.214 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.45 HD12 HG23 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -137.98 134.9 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.944 0.872 . . . . 0.0 112.997 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -151.86 142.92 9.85 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.72 145.95 15.97 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 119.781 -1.199 . . . . 0.0 113.887 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 27.5 mt -107.03 127.09 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 24.6 mt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.735 0.779 . . . . 0.0 112.753 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.414 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 64.8 mtm180 -70.15 -39.97 75.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.55 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.3 p90 -159.86 175.48 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 298' ' ' THR . 15.5 mtm180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.39 . . . . 0.0 111.197 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.458 -0.028 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.94 -44.4 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.646 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 20.7 p90 -106.38 83.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.769 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 434' ' ' LEU . 52.4 p90 -106.28 22.18 16.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.71 45.16 0.67 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.489 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 432' ' ' PHE . 26.8 mt -78.26 -3.81 44.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.467 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -39.95 87.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 110.434 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.0 -32.74 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.331 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.57 -33.6 71.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.363 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.97 -47.44 85.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.922 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -59.92 -40.04 87.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.957 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.444 ' HB ' ' HE2' ' A' ' 285' ' ' LYS . 41.9 pt . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -51.91 -45.89 64.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.706 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 58.9 mt-10 -73.82 -39.65 63.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.782 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -73.4 -43.85 59.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.444 ' HE2' ' HB ' ' A' ' 281' ' ' ILE . 38.1 mttm -87.07 -58.44 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 25.6 tp -57.41 -57.09 14.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.454 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 60.6 mt -60.12 -50.11 81.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.846 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.406 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.82 -36.13 78.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.716 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -60.08 -38.14 81.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.306 0.574 . . . . 0.0 110.291 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.628 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 5.6 t80 -59.93 -45.52 92.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.972 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -83.13 -35.14 25.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.3 t0 -65.39 -45.31 84.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -68.95 -40.08 79.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 301' ' ' TYR . 85.8 mt -60.63 -24.05 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.09 -13.69 49.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.321 0.582 . . . . 0.0 109.642 178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.457 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 31.0 mt-30 -102.63 -0.02 32.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.583 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 58.54 30.63 20.04 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.062 0.458 . . . . 0.0 110.229 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.55 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 14.1 p -70.04 -9.71 56.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.47 42.96 94.15 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.839 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.4 mtmt -121.25 38.03 4.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 83.3 m-85 -161.81 164.19 28.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.7 p -147.01 163.79 35.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -137.72 128.52 27.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.838 0.351 . . . . 0.0 110.816 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.76 151.69 12.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -58.91 -56.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.598 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.2 pt-20 -51.11 -53.74 31.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.18 -52.24 59.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.735 0.302 . . . . 0.0 111.307 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.417 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 33.6 m -59.42 -39.76 84.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.9 mp -67.51 -43.8 80.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.436 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 13.7 mttm -59.23 -49.36 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.778 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -69.94 -26.7 64.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.31 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.718 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.95 -26.32 59.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.783 0.325 . . . . 0.0 110.691 179.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -76.83 -28.1 55.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.4 mmt -81.43 -7.38 59.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.899 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.03 13.51 27.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.72 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.13 -4.77 57.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.486 0.184 . . . . 0.0 110.914 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.8 m -98.93 107.11 19.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 33.9 tt0 -59.9 -50.03 75.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.779 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 388' ' ' THR . 44.7 mm -135.8 127.28 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 111.53 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.51 ' HB2' HD11 ' A' ' 312' ' ' LEU . 49.6 tp -93.23 128.22 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.482 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.604 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.3 mt -114.07 107.87 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.501 HG11 HD13 ' A' ' 375' ' ' LEU . 19.0 t -125.3 149.15 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.327 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.583 ' HD1' ' HA ' ' A' ' 393' ' ' THR . 96.6 m-85 -99.89 132.61 45.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.579 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 13.6 pt-20 -53.58 -29.6 38.24 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.4 45.33 1.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 38.9 tp -83.71 121.54 27.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.376 . . . . 0.0 110.645 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -91.26 23.54 3.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.953 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.489 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 19.6 mm -119.97 136.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.563 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.5 mtt -139.05 161.94 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.59 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpm_? -90.05 114.27 26.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.874 ' CD2' ' HB2' ' A' ' 371' ' ' SER . 33.3 m-85 -109.29 145.63 35.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.311 0.577 . . . . 0.0 111.361 179.735 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.0 tp . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.489 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 2.2 p90 -103.78 119.78 39.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.076 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.512 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 1.8 mm? -123.29 158.24 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.5 p -101.86 173.34 3.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.601 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.4 Cg_exo -45.45 -46.7 14.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.997 1.798 . . . . 0.0 112.27 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.39 -58.55 8.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.365 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.93 -47.31 87.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.647 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 76.9 mt-10 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.443 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.874 ' HB2' ' CD2' ' A' ' 331' ' ' TYR . 17.5 t . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.428 ' HE2' ' HA ' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.87 128.82 25.67 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.152 179.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.688 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 71.7 Cg_exo -50.23 112.8 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.78 1.653 . . . . 0.0 111.153 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.5 mt -58.82 -40.04 82.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.388 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.579 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 65.6 tp -60.08 -52.49 65.11 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.305 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.4 mt-10 -60.94 -39.94 91.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 110.125 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -61.11 -40.01 92.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.596 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.5 OUTLIER -71.48 -23.45 61.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.571 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -8.77 53.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.994 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -108.34 -10.3 15.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.03 20.35 5.41 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -67.42 -20.16 65.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -79.88 -43.61 21.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -60.82 -40.03 91.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.447 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -80.15 -11.38 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.4 2.46 54.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.302 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.509 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.73 163.37 17.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.194 0.521 . . . . 0.0 110.62 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.461 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 66.0 m -107.8 100.37 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.0 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.486 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.1 tm? -73.76 102.63 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.478 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.9 mm-40 -108.84 139.44 43.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.408 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 16.4 mm -102.94 101.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.521 ' HB ' HD12 ' A' ' 287' ' ' ILE . 4.5 m -102.75 -172.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.587 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.583 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 14.6 p -156.99 152.41 26.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.337 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -78.91 76.96 5.39 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -119.22 -49.66 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.0 m -88.05 -176.78 5.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 11.7 mm-40 -59.43 -46.01 89.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.693 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 52.3 mp0 -64.5 -40.48 95.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -61.34 -27.69 68.11 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.405 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 72.9 m -83.87 -22.97 31.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.677 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 27.3 mt-30 -72.45 -40.62 66.88 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.501 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 287' ' ' ILE . 2.1 m-85 -67.38 -49.96 61.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.443 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.412 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.22 -38.14 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.467 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 400' ' ' SER . 8.6 mmpt? -69.96 -51.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.143 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.45 -26.2 69.35 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.543 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.53 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 17.0 t80 179.09 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 96.85 167.11 33.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.499 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.06 -48.69 2.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.031 -0.604 . . . . 0.0 114.28 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.535 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -147.44 131.43 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.383 0.592 . . . . 0.0 111.985 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.33 135.03 5.17 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.21 140.48 15.47 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.316 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 318' ' ' GLU . 44.5 mt -103.5 125.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.793 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.1 mt -87.58 151.37 23.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.484 0.659 . . . . 0.0 112.264 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.551 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 63.4 mtt-85 -71.62 -33.9 69.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.632 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.434 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 51.8 t80 -169.0 166.06 11.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 111.148 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.427 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.79 -41.14 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.708 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.438 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 51.3 p90 -144.32 114.74 7.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.357 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 19.0 p90 -133.59 85.7 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.273 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -90.08 15.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.459 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 53.5 mt -65.87 -9.46 29.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.804 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.481 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -78.41 -21.18 49.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -59.92 -38.33 82.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.04 0.448 . . . . 0.0 110.284 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.99 -44.99 94.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.954 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.06 -40.03 88.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.887 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 48.5 pt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.05 -39.58 56.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.815 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.611 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 mp0 -69.98 -46.73 64.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -49.16 78.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -74.55 -58.83 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.581 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 40.6 tp -61.32 -58.84 6.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.957 0.408 . . . . 0.0 112.079 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 41.3 mt -59.99 -41.24 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.154 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.451 ' CA ' ' HG3' ' A' ' 398' ' ' GLU . . . -57.1 -38.92 88.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.358 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.494 ' HG2' ' HH ' ' A' ' 301' ' ' TYR . 53.9 ttt-85 -60.02 -38.7 83.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.283 0.563 . . . . 0.0 109.767 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.625 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 8.3 t80 -60.01 -46.14 90.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -80.79 -35.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.3 t0 -60.01 -49.86 76.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.576 0.227 . . . . 0.0 111.572 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.1 mt-10 -61.75 -43.11 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.403 HD12 ' CE1' ' A' ' 290' ' ' TYR . 94.5 mt -57.76 -27.9 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.448 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -63.69 -14.61 53.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.283 0.563 . . . . 0.0 109.56 178.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.463 ' HB2' HG21 ' A' ' 298' ' ' THR . 56.8 mt-30 -105.96 -2.46 22.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.653 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.85 32.44 21.27 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.033 0.444 . . . . 0.0 110.405 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.629 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.9 p -69.82 -14.31 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.841 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.73 46.36 94.64 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 119.869 -1.157 . . . . 0.0 113.363 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.545 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 49.2 mttp -122.68 33.97 5.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 290' ' ' TYR . 93.4 m-85 -159.87 161.06 34.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.618 0.247 . . . . 0.0 111.544 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 55.7 m -140.99 159.94 41.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.09 0.472 . . . . 0.0 111.456 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.7 p90 -131.96 149.36 52.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.461 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 84.77 167.21 42.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.832 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.54 HG11 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -71.59 -55.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.0 111.065 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.7 pt-20 -47.31 -53.71 12.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.798 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 85.3 m-20 -64.27 -53.87 42.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.477 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 23.8 m -58.21 -40.03 80.57 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.668 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.493 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.9 mp -66.02 -47.52 74.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.834 0.35 . . . . 0.0 111.223 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 314' ' ' MET . 14.7 mttm -56.42 -49.98 72.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -67.42 -29.19 68.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.737 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.852 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.24 -27.64 63.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.57 -26.77 41.26 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.5 mmt -80.47 -9.06 59.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.771 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.23 45.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.458 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.61 -5.45 58.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.142 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 312' ' ' LEU . 17.5 m -92.74 102.48 13.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 412' ' ' ILE . 36.0 tt0 -59.4 -48.79 80.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.204 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.435 ' HA ' ' H ' ' A' ' 388' ' ' THR . 42.8 mm -136.43 125.06 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.51 0.195 . . . . 0.0 111.362 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 322' ' ' VAL . 23.6 tp -88.69 123.66 33.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.581 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -109.53 103.66 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.554 HG23 ' HG ' ' A' ' 320' ' ' LEU . 10.6 t -114.39 153.64 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 77.2 m-85 -99.94 142.18 31.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.474 . . . . 0.0 112.135 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 12.6 pt-20 -67.13 154.91 40.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.73 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.05 25.39 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 0.0 110.301 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.544 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 49.2 tp -52.41 128.89 27.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.719 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -91.02 22.23 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.481 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.544 ' H ' ' HG ' ' A' ' 326' ' ' LEU . 19.3 mm -124.41 135.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.62 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.622 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.02 161.97 36.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.625 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 47.3 ttt180 -91.5 118.78 30.88 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 110.892 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.545 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.1 m-85 -116.21 153.13 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.145 0.498 . . . . 0.0 111.556 179.818 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 50.5 tp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.29 0.566 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.453 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -95.38 116.53 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.258 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.3 mm? -118.83 152.0 37.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.409 0.623 . . . . 0.0 112.156 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.614 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 40.7 p -100.44 173.82 3.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.337 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -45.61 -45.07 16.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.786 1.657 . . . . 0.0 112.01 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -59.95 -57.33 13.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.26 -49.91 73.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 95.5 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.493 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.428 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 9.1 tpp -118.51 134.36 23.48 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.473 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.5 Cg_endo -59.84 123.02 12.38 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 110.846 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 12.2 mt -65.98 -44.08 85.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.401 HD12 ' CD1' ' A' ' 391' ' ' ILE . 56.3 tp -59.98 -50.0 75.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.563 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 47.3 mt-10 -60.57 -40.0 90.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.001 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.428 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 68.8 t-105 -67.51 -38.77 84.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.277 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.564 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.7 m-85 -73.47 -27.82 61.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.29 53.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.144 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -107.87 -16.61 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.819 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -129.82 21.4 5.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.5 p90 -61.83 -16.62 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.566 0.222 . . . . 0.0 111.572 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -83.46 -36.39 24.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.667 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -60.02 -39.92 87.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.43 ' CD2' HD23 ' A' ' 312' ' ' LEU . 42.9 m-85 -87.04 -5.95 58.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.179 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.73 2.71 46.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.188 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.27 18.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.435 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 76.0 m -107.11 100.91 10.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.29 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.459 ' CD2' HG23 ' A' ' 322' ' ' VAL . 1.9 tm? -66.85 102.33 0.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.596 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.71 134.2 52.26 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 30.9 mm -99.97 99.93 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 13.1 m -100.99 -171.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.776 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.643 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -160.04 156.44 26.98 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.008 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.44 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.4 p-10 -74.04 16.64 0.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -29.56 66.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.714 0.292 . . . . 0.0 111.411 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 17.2 m -97.3 169.66 9.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 111.385 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -59.93 -50.0 75.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.096 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.544 ' HB3' HG21 ' A' ' 287' ' ' ILE . 75.0 mm-40 -67.84 -40.43 83.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 110.121 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.44 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -64.99 -19.08 65.36 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.038 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.4 m -83.92 -23.47 31.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.754 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -70.53 -40.01 73.71 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.704 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.605 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.5 m-85 -60.03 -50.71 72.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.297 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.449 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 73.8 t -56.51 -35.57 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.088 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -70.62 -49.86 43.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 110.35 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -73.5 -18.58 79.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.041 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.461 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.4 t80 174.47 -78.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.22 169.61 30.6 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.306 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.5 -49.04 2.97 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.244 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -140.49 133.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 117.527 0.663 . . . . 0.0 112.624 -177.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -152.38 142.18 9.13 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.2 143.47 14.34 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.556 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.5 mt -104.26 128.87 57.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 30.0 mt -89.94 151.4 21.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.677 0.751 . . . . 0.0 112.494 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 415' ' ' TYR . 11.0 mtt180 -69.97 -38.47 76.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.866 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.464 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 97.8 m-85 -160.71 178.47 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.371 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.894 0.378 . . . . 0.0 110.282 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.729 0.299 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -66.45 -37.66 85.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.492 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -125.83 105.95 9.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -132.41 128.4 37.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -88.57 13.32 12.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.471 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.01 -3.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.043 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -58.84 -40.07 83.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.302 . . . . 0.0 110.555 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.43 -24.94 60.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.93 -35.56 75.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.511 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.91 -41.05 90.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.924 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -69.09 127.28 32.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.001 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 49.4 pt . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 120.875 0.369 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.662 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -48.15 -44.73 32.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.258 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 4.1 mp0 -71.66 -32.06 67.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.467 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -54.49 4.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -73.42 -57.99 3.62 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.507 ' HG ' HD13 ' A' ' 321' ' ' ILE . 15.9 tp -57.69 -54.88 41.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.767 0.318 . . . . 0.0 111.659 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.572 HD12 ' HB ' ' A' ' 392' ' ' VAL . 20.7 mt -59.96 -51.31 74.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.519 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.55 -36.23 88.64 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.012 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -59.98 -33.0 71.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.597 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.4 t80 -60.08 -45.58 92.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.63 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 32.3 m-85 -85.83 -36.85 19.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -60.04 -49.96 75.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.839 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.7 mp0 -66.29 -40.73 90.26 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.0 -22.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -18.77 52.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.493 0.663 . . . . 0.0 109.62 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 41.6 mt-30 -101.41 0.21 36.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.828 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 57.73 29.89 18.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.965 0.412 . . . . 0.0 110.333 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.568 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.0 p -67.43 -11.53 58.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.828 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.25 53.4 45.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.402 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.0 mttt -130.34 36.66 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 86.6 m-85 -160.86 162.39 32.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.695 0.284 . . . . 0.0 111.743 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.1 p -148.99 165.98 30.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.963 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.518 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.2 p90 -138.45 148.6 44.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.29 157.57 33.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.049 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.517 HG11 HG22 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.98 -58.68 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 110.662 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.2 pt-20 -47.0 -54.24 10.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.706 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 73.9 m-20 -63.67 -54.56 33.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.351 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 27.9 m -56.38 -37.91 70.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.897 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.459 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 2.2 mp -69.7 -43.97 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.1 mttm -56.2 -52.62 63.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.67 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.455 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -69.98 -26.2 63.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.79 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.757 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.18 -36.81 77.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 110.685 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -70.77 -25.36 62.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.6 mmt -82.58 -7.87 59.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.889 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.11 13.61 42.74 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.253 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.43 -7.13 59.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.941 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 312' ' ' LEU . 28.2 m -97.86 106.73 19.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.666 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 36.1 tt0 -59.93 -50.26 74.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.748 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.466 ' CG2' ' HB ' ' A' ' 388' ' ' THR . 26.5 mm -136.6 122.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.528 0.204 . . . . 0.0 110.776 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.446 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.9 tp -84.76 125.87 32.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.523 HG22 HG21 ' A' ' 392' ' ' VAL . 0.1 OUTLIER -109.65 103.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.284 179.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.446 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.5 t -111.45 158.45 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.903 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 9.8 m-85 -109.96 148.33 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.12 0.486 . . . . 0.0 112.196 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.452 ' CG ' ' CG2' ' A' ' 391' ' ' ILE . 90.1 mt-10 -67.48 158.92 30.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.183 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.39 29.42 13.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.8 tp -57.87 127.23 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 109.999 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 347' ' ' THR . 34.3 p-10 -90.02 26.94 1.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.517 HG22 HG11 ' A' ' 305' ' ' VAL . 29.8 mm -128.25 132.96 67.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.939 0.399 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.638 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 57.0 mtt -140.43 161.93 36.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.525 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.6 ttm180 -86.11 106.76 17.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.087 0.47 . . . . 0.0 110.757 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.533 ' CD2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -116.01 119.75 36.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 332' ' ' VAL . 17.0 m . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.032 0.444 . . . . 0.0 111.662 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 56.7 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.281 0.562 . . . . 0.0 111.738 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.449 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 2.4 p90 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.685 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.0 mm? -124.82 164.61 19.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.736 0.779 . . . . 0.0 113.009 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 p -101.83 171.26 5.5 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.803 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.1 Cg_exo -49.29 -42.39 40.52 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.98 1.787 . . . . 0.0 112.051 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.56 -50.22 72.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 21.6 mm100 -68.07 -48.81 64.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.591 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.533 ' HG2' ' CD2' ' A' ' 331' ' ' TYR . 94.2 mt-10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.301 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.863 0.363 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.415 ' HE1' ' HD2' ' A' ' 373' ' ' PRO . 2.7 tpt -115.17 120.09 37.42 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.783 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 7.5 Cg_endo -50.27 120.45 6.27 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.094 1.863 . . . . 0.0 111.107 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 18.4 mt -61.9 -41.42 97.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.669 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 391' ' ' ILE . 45.5 tp -60.0 -53.3 59.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 61.6 mt-10 -59.93 -40.01 87.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.039 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -66.92 -35.72 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.405 ' CG ' HD21 ' A' ' 320' ' ' LEU . 1.2 m-85 -69.5 -27.5 65.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.965 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -11.65 43.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.223 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.21 -9.74 15.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 14.7 m120 -130.0 18.24 5.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.7 p90 -67.89 -19.25 64.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 382' ' ' TYR . 33.1 mmtt -81.37 -40.93 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -61.49 -39.97 92.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.21 0.529 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.519 ' CD2' HD23 ' A' ' 312' ' ' LEU . 17.3 m-85 -81.55 -8.18 59.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.287 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.0 2.79 48.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.363 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 317' ' ' VAL . . . -88.23 164.55 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 111.15 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' A' ' 319' ' ' ILE . 84.6 m -107.56 102.7 11.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.15 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 0.9 OUTLIER -65.15 103.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.115 0.483 . . . . 0.0 111.124 -178.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.662 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.1 mm-40 -109.43 127.57 54.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.953 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.452 ' CG2' ' CG ' ' A' ' 324' ' ' GLU . 42.0 mm -99.91 100.01 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 112.03 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.572 ' HB ' HD12 ' A' ' 287' ' ' ILE . 21.9 m -113.71 141.36 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.44 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 13.1 p -121.09 164.44 16.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.832 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.411 ' HB2' HG22 ' A' ' 403' ' ' VAL . 57.4 t0 -68.65 80.66 0.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -112.87 -30.13 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.305 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 8.3 t -126.76 -172.95 2.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -59.97 -49.51 77.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 52.8 mp0 -59.96 -44.12 94.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.181 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.95 66.52 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 68.9 m -84.01 -23.47 30.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.44 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.418 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 73.4 mt-30 -70.99 -43.95 66.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.529 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.481 ' CD1' HG23 ' A' ' 287' ' ' ILE . 4.5 m-85 -62.89 -48.03 80.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 394' ' ' ASP . 55.1 t -60.09 -39.58 80.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.001 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -70.37 -52.83 19.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.77 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -62.39 -22.35 63.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.931 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 18.0 t80 176.77 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.11 168.47 31.86 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.156 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.55 -47.69 2.76 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.39 133.38 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 117.847 0.824 . . . . 0.0 112.609 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -156.97 149.8 20.7 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -133.72 149.19 19.65 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.677 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 318' ' ' GLU . 20.1 mt -110.25 127.75 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 78.3 mt -84.84 150.62 24.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.646 0.736 . . . . 0.0 112.76 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.666 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 20.7 mtm180 -70.01 -32.18 70.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.363 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.505 ' HA ' ' HE2' ' A' ' 300' ' ' LYS . 53.2 p90 -159.45 179.51 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 298' ' ' THR . 1.2 tmm_? . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.264 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.6 0.238 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.41 -39.98 92.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.604 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.65 99.04 6.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -118.29 109.61 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.044 0.45 . . . . 0.0 111.179 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.57 -5.38 36.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 434' ' ' LEU . 36.1 mt -53.63 -13.52 0.67 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.207 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -55.17 -40.02 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -70.01 -32.56 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.374 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -59.98 -32.22 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.514 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.101 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.849 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 N--CA 1.461 0.09 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.612 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -57.67 -40.74 80.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 -179.23 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.489 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 21.3 pt-20 -73.22 -29.9 63.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.303 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -84.69 -56.67 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.92 -57.81 4.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.778 ' HG ' HD13 ' A' ' 321' ' ' ILE . 28.9 tp -57.45 -57.31 13.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 31.2 mt -59.94 -48.71 86.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.42 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.25 60.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.083 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.5 ttt180 -59.94 -40.11 87.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.607 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 6.6 t80 -57.39 -45.93 83.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.72 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -83.36 -38.25 22.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 111.564 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.7 t0 -62.03 -46.16 90.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.462 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.653 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.3 mt-10 -64.2 -42.94 96.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.45 -21.43 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.643 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -66.17 -13.93 61.02 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.256 0.551 . . . . 0.0 109.665 178.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.428 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 27.9 mt-30 -103.47 -0.73 29.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.469 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.01 28.18 17.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.628 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.2 p -67.64 -11.48 58.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.38 51.48 55.94 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.423 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.5 mttt -126.13 35.65 4.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.653 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 83.3 m-85 -159.84 162.96 34.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.536 0.208 . . . . 0.0 111.267 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.5 164.69 30.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 53.0 p90 -138.02 149.03 45.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 90.1 155.56 31.17 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.083 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -63.55 -61.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -47.33 -52.31 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.43 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.3 m-20 -63.35 -55.77 21.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.398 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.43 HG21 HD12 ' A' ' 320' ' ' LEU . 35.7 m -57.82 -36.24 71.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.962 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.464 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.7 mp -68.63 -43.12 77.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 52.3 mtmt -60.01 -45.43 92.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.556 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.06 66.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.813 0.339 . . . . 0.0 110.643 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.713 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -72.09 -26.92 62.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.25 -27.84 47.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 92.8 mmm -80.9 -8.5 59.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.585 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.9 16.89 49.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.275 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.95 -8.44 55.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.342 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.713 HG22 ' HA ' ' A' ' 312' ' ' LEU . 27.5 m -92.74 104.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 412' ' ' ILE . 42.4 tt0 -59.64 -49.96 75.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.325 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.431 HG22 HD21 ' A' ' 286' ' ' LEU . 36.8 mm -136.7 124.05 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 308' ' ' THR . 46.2 tp -87.92 126.05 34.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.201 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.778 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -111.53 104.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 21.7 t -122.4 162.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.435 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.484 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.1 m-85 -106.88 144.34 33.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.505 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.51 -36.48 83.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.38 45.7 1.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 35.9 tp -79.11 122.58 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.47 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.2 m-20 -90.25 29.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 345' ' ' TYR . 26.1 mm -126.92 133.18 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 111.567 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.662 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.7 mtt -140.19 162.08 36.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.877 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.503 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 17.1 tpt180 -86.6 111.47 20.66 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.662 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 38.8 m-85 -123.77 123.76 41.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.688 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 29.3 tp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.604 0.716 . . . . 0.0 112.684 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.522 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.12 127.34 37.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.896 178.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.496 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -122.09 165.09 16.62 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.9 p -101.6 169.88 7.16 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.306 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 5.3 Cg_endo -47.13 -49.88 12.01 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.024 1.816 . . . . 0.0 111.749 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -54.96 -53.59 53.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.38 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -65.25 -46.09 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.64 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 87.7 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.124 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 3.9 tpt -119.07 130.26 24.94 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.672 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.639 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.6 Cg_exo -56.77 118.35 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.836 1.69 . . . . 0.0 110.835 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.503 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 32.4 mt -59.89 -41.23 91.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.935 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.475 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.2 tp -60.01 -54.37 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.749 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 48.7 mt-10 -59.62 -40.03 86.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 109.564 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.447 ' CZ3' HD23 ' A' ' 309' ' ' LEU . 46.0 t90 -60.24 -39.85 88.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.988 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.533 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -74.88 -27.37 60.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.588 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.61 -12.58 42.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.986 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -106.34 -13.7 15.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.8 m120 -129.96 20.06 5.46 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -63.09 -16.1 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.584 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -83.31 -38.05 22.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -60.95 -38.02 84.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.766 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 381' ' ' ASN . 48.7 m-85 -85.95 -9.15 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.52 60.81 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.444 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 317' ' ' VAL . . . -88.16 165.54 15.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 319' ' ' ILE . 53.4 m -108.92 101.75 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.434 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.414 HD21 HG22 ' A' ' 322' ' ' VAL . 2.3 tm? -70.78 102.6 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.612 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.8 mm-40 -111.38 131.98 54.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.834 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.505 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 38.0 mm -98.76 103.83 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 112.182 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 5.8 m -100.73 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.823 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 1.3 p -157.94 154.0 27.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.07 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.458 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.5 p-10 -73.22 20.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 393' ' ' THR . 15.8 mtpt -66.91 -40.03 87.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.635 0.255 . . . . 0.0 111.301 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 m -93.08 173.7 7.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.559 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.9 -50.11 75.08 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.417 ' C ' HG22 ' A' ' 287' ' ' ILE . 67.6 mm-40 -62.9 -40.44 97.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.322 0.582 . . . . 0.0 109.648 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.458 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -61.93 -23.01 63.08 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 53.6 m -83.7 -23.11 31.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.092 -0.554 . . . . 0.0 110.483 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.23 -41.44 49.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.495 ' CG ' ' CZ ' ' A' ' 406' ' ' PHE . 2.3 m-85 -60.0 -50.07 75.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.535 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 70.1 t -60.31 -39.96 82.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.563 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 400' ' ' SER . 1.4 mmpt? -71.14 -46.02 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.808 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -73.97 -31.02 60.41 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.595 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER -156.7 -83.36 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 99.39 148.63 23.31 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.995 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.67 -47.09 2.97 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.607 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.586 ' CD1' HG22 ' A' ' 305' ' ' VAL . 0.1 OUTLIER -148.36 134.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 118.336 1.068 . . . . 0.0 112.737 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -155.12 148.2 18.23 Favored Glycine 0 CA--C 1.511 -0.173 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.43 150.08 19.6 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.872 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 318' ' ' GLU . 27.1 mt -109.5 126.8 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 42.3 mt -90.83 157.42 17.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.675 0.75 . . . . 0.0 112.776 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 415' ' ' TYR . 63.0 mtm180 -74.36 -40.03 62.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.531 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.467 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 85.1 m-85 -160.79 172.97 16.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.682 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.535 0.207 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.97 -39.92 87.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.27 37.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.528 ' O ' ' HG ' ' A' ' 434' ' ' LEU . 19.5 p90 -59.62 -50.05 75.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 40.72 31.06 0.11 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.109 0.48 . . . . 0.0 111.38 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 432' ' ' PHE . 54.9 mt -99.53 -1.41 38.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.275 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.04 -41.24 91.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.0 110.71 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.97 -33.16 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.496 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.0 -31.8 70.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.618 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.02 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.002 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.71 130.03 49.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.898 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.414 ' HB ' ' HE3' ' A' ' 285' ' ' LYS . 44.4 pt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 110.221 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.611 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.8 pt-20 -85.24 -34.33 22.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -72.0 -39.97 68.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.414 ' HE3' ' HB ' ' A' ' 281' ' ' ILE . 21.2 mttt -86.6 -58.23 2.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 29.7 tp -57.69 -55.88 29.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 112.03 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 42.3 mt -58.0 -48.41 84.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.725 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.458 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.39 -37.54 82.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.716 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 23.4 ttt85 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.646 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.2 t80 -56.98 -46.76 81.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -79.12 -40.01 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.756 0.312 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.0 t0 -61.65 -45.48 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.671 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 6.7 mt-10 -64.53 -41.76 96.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -60.33 -21.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.474 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -66.76 -12.67 59.65 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.373 0.606 . . . . 0.0 109.458 178.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 298' ' ' THR . 39.4 mt-30 -103.5 0.06 30.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.577 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.53 20.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.635 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.7 p -68.03 -14.7 63.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.57 31.32 70.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.911 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.528 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 43.9 mtmt -110.38 37.07 2.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.452 0.168 . . . . 0.0 110.642 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 290' ' ' TYR . 89.8 m-85 -158.97 159.98 35.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.866 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.445 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -139.36 157.74 45.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 111.09 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.5 124.55 22.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 110.665 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 109.8 147.34 11.71 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.545 HG22 ' CD1' ' A' ' 409' ' ' ILE . 0.0 OUTLIER -54.75 -58.91 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 0.0 110.744 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.1 pt-20 -47.41 -54.72 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.34 -57.02 9.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 18.7 m -52.1 -33.29 38.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.045 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 378' ' ' PHE . 3.3 mp -75.66 -40.07 56.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.701 0.286 . . . . 0.0 111.517 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 10.4 mtmt -57.49 -50.02 74.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.412 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -71.52 -28.01 63.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.648 0.261 . . . . 0.0 110.922 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.825 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.39 -30.76 66.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.054 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.407 ' OE2' ' CZ ' ' A' ' 385' ' ' PHE . 78.3 mm-40 -73.75 -25.22 60.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.6 mmt -83.04 -7.61 59.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.43 17.03 46.02 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.265 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.77 6.08 43.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.825 HG23 ' HA ' ' A' ' 312' ' ' LEU . 30.1 m -107.46 106.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.1 tt0 -59.05 -49.97 75.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.629 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 286' ' ' LEU . 42.8 mm -136.78 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 38.7 tp -91.16 127.93 36.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.535 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.0 OUTLIER -112.23 105.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 389' ' ' LEU . 20.4 t -123.18 161.75 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.433 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.48 ' HD1' ' HA ' ' A' ' 393' ' ' THR . 93.2 m-85 -109.67 146.04 35.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.915 0.388 . . . . 0.0 111.307 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.539 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 16.9 pt-20 -64.97 -30.03 71.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.334 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.17 48.5 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.68 125.52 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.1 32.22 1.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 27.3 mm -129.5 137.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.0 162.08 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.373 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.543 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 22.1 ttt180 -94.12 124.62 38.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.09 0.471 . . . . 0.0 111.053 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 6.6 m-85 -121.08 158.12 28.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.43 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.542 -179.643 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.513 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -88.47 117.05 27.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.06 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.516 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -118.83 156.4 29.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 22.0 p -100.59 169.4 7.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.8 Cg_endo -44.1 -45.57 11.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.87 -52.98 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -65.18 -50.02 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.7 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.509 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.555 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 3.1 p . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 121.178 0.513 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.454 ' HA ' ' HE3' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.12 126.88 26.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.105 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 11.2 Cg_endo -55.49 125.81 20.37 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.064 1.842 . . . . 0.0 110.69 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 12.3 mt -65.43 -41.33 93.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 61.6 tp -60.06 -53.81 53.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.1 mt-10 -56.88 -40.01 75.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.893 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.24 -35.25 75.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.267 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 309' ' ' LEU . 6.6 m-85 -64.16 -32.14 73.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.696 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.67 -10.01 47.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.71 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -103.19 -0.09 30.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -138.97 16.14 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -67.45 -19.16 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.689 0.281 . . . . 0.0 111.112 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -78.58 -47.44 17.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.94 -45.9 91.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 110.702 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.551 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -73.73 -15.21 61.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.787 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.14 2.49 66.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.27 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.432 ' HB3' HG21 ' A' ' 317' ' ' VAL . . . -87.2 162.18 17.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.445 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 84.4 m -107.14 100.32 9.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.548 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 322' ' ' VAL . 1.9 tm? -70.8 102.77 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.652 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 67.2 mm-40 -110.45 128.95 55.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.845 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 33.2 mm -95.2 104.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.203 0.525 . . . . 0.0 112.146 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.522 HG12 HD11 ' A' ' 287' ' ' ILE . 15.0 m -101.2 -169.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.923 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.48 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.97 156.6 27.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 111.823 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.44 -7.34 9.58 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.209 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -53.21 -41.65 65.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.7 m -87.51 167.44 13.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.689 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 27.2 tt0 -60.03 -53.32 59.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.601 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 41.1 mp0 -60.07 -35.43 75.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.495 0.664 . . . . 0.0 109.316 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -56.24 -58.13 15.78 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.704 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 3.4 m -59.44 -22.0 60.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.815 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 84.5 mt-30 -68.93 -40.05 79.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.82 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.532 ' CE1' HG22 ' A' ' 287' ' ' ILE . 2.6 m-85 -65.9 -50.8 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.421 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 80.6 t -55.8 -35.11 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 400' ' ' SER . 6.0 mmtt -77.12 -50.6 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.468 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -75.45 -27.28 63.81 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.816 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -157.86 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 99.6 153.3 27.59 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.753 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 82.32 -50.63 4.36 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.934 -0.65 . . . . 0.0 114.699 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.607 HD11 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -149.06 133.23 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 117.837 0.819 . . . . 0.0 112.482 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -150.14 139.13 7.14 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -123.93 144.61 15.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.805 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 318' ' ' GLU . 26.4 mt -106.63 128.73 61.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.1 mt -89.55 152.8 21.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.751 0.786 . . . . 0.0 112.82 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.03 -34.96 73.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.729 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 88.3 m-85 -156.84 164.68 37.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.4 mtm180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.258 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.712 0.291 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.01 -40.06 95.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 110.452 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -111.61 98.78 7.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.539 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.56 124.97 44.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.467 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.12 6.61 11.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.16 -3.85 6.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.963 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.23 -39.88 84.14 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.721 0.296 . . . . 0.0 110.772 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.61 -33.91 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.01 -34.55 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.251 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.98 -46.62 88.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.966 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.07 -39.92 87.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.878 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 3.4 pt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.828 0.347 . . . . 0.0 111.806 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -57.59 -35.82 70.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 -179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 41.8 mt-10 -72.12 -31.43 66.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 398' ' ' GLU . 0.9 OUTLIER -83.79 -56.27 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.32 -179.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -57.66 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 319' ' ' ILE . 22.0 tp -55.23 -58.21 8.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 398' ' ' GLU . 82.5 mt -60.07 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.282 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.442 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.15 -39.02 57.37 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.269 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -60.05 -34.16 73.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.126 0.489 . . . . 0.0 110.279 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.584 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 19.0 t80 -59.92 -49.29 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.12 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -83.45 -38.31 22.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.53 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 295' ' ' SER . 43.3 t0 -64.18 -49.94 70.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.58 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.659 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 46.2 tp10 -61.26 -40.03 92.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.464 HG13 ' CD2' ' A' ' 301' ' ' TYR . 88.2 mt -62.58 -26.33 40.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.841 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.595 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.77 -13.7 16.79 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.279 0.561 . . . . 0.0 109.944 178.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.606 ' HB2' HG22 ' A' ' 298' ' ' THR . 26.2 mt-30 -100.07 0.89 41.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.389 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.6 30.04 19.31 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 10.0 p -69.84 -10.04 56.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.21 51.14 57.79 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.43 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.1 mttt -130.25 40.67 3.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.877 -0.19 . . . . 0.0 110.6 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 77.8 m-85 -161.69 163.57 29.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.38 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 p -145.15 160.38 41.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.43 126.76 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.649 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.531 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 109.38 153.25 14.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.331 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -55.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.861 0.362 . . . . 0.0 110.673 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.4 pt-20 -50.35 -51.03 49.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.19 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.38 -55.24 12.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.883 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 20.7 m -55.49 -37.56 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.225 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 3.2 mp -69.61 -44.47 70.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.326 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.0 mttm -56.14 -50.03 72.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.32 -28.24 65.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.936 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -70.72 -29.63 65.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.807 0.337 . . . . 0.0 110.616 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.54 -25.91 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 6.7 mmm -81.68 -8.6 59.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.853 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.12 11.57 32.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.343 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.47 59.77 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.4 0.28 . . . . 0.0 110.811 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 28.3 m -92.73 104.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 412' ' ' ILE . 6.2 tp10 -59.55 -49.13 78.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.518 HG22 HD21 ' A' ' 286' ' ' LEU . 31.3 mm -136.22 129.12 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 308' ' ' THR . 42.8 tp -94.08 127.85 40.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.222 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.475 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -114.48 108.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.09 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 389' ' ' LEU . 20.4 t -124.45 161.97 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.435 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.607 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 89.4 m-85 -108.18 146.22 33.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.835 0.35 . . . . 0.0 111.312 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.9 pt-20 -63.62 -31.96 73.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.129 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -95.98 52.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 45.6 tp -85.65 123.91 31.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.21 27.72 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.963 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.518 HG21 HG11 ' A' ' 305' ' ' VAL . 28.0 mm -127.15 134.83 65.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.104 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.587 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.8 mtm -139.99 161.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.669 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.0 OUTLIER -90.61 120.37 31.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.1 0.476 . . . . 0.0 111.218 -179.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -118.3 157.23 27.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.172 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 332' ' ' VAL . 11.0 m . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.269 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 57.3 tp . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.383 0.611 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.494 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 5.9 p90 -100.67 118.28 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -123.52 163.8 20.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 20.0 p -101.09 168.68 8.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.789 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.6 Cg_endo -45.55 -43.61 17.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.409 2.072 . . . . 0.0 111.949 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.02 -57.09 14.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 18.6 mm100 -62.95 -49.64 73.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.957 0.408 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 4.2 tpt -112.62 127.25 27.08 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.587 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 13.6 Cg_endo -57.73 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.071 1.847 . . . . 0.0 110.971 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 19.4 mt -64.38 -40.07 95.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.866 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 59.5 tp -59.84 -53.59 56.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -58.6 -39.93 81.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.873 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.409 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 74.0 t-105 -64.88 -39.74 94.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.425 ' CD1' ' CD2' ' A' ' 320' ' ' LEU . 6.4 m-85 -64.1 -30.75 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.22 -12.31 38.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.779 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -102.35 -13.83 17.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 69.0 m-80 -129.71 17.07 5.81 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -64.82 -19.59 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.243 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -79.0 -44.24 22.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.32 -43.45 96.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.179 0.514 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.54 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.8 m-85 -76.02 -12.27 60.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.17 2.41 58.73 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.17 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.475 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.71 161.49 18.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.174 0.511 . . . . 0.0 110.556 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 319' ' ' ILE . 73.5 m -106.59 100.72 10.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.261 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.9 tm? -71.81 104.75 3.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.373 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.457 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -113.78 129.92 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.738 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 34.2 mm -94.75 103.61 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.016 0.436 . . . . 0.0 111.968 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.459 HG21 HG23 ' A' ' 321' ' ' ILE . 26.5 m -100.86 -172.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.901 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.474 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -157.97 154.42 27.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.639 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.38 3.29 1.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.89 -40.01 87.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.589 0.233 . . . . 0.0 111.208 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -94.36 162.47 13.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.96 -55.26 28.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 60.0 mp0 -59.97 -40.0 87.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.27 -24.36 68.94 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -84.0 -25.45 29.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.543 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.36 -40.01 77.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.586 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.607 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.4 OUTLIER -59.59 -49.54 77.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.418 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 90.9 t -57.71 -37.76 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.409 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.3 OUTLIER -69.97 -54.13 14.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.223 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.5 66.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.565 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.531 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 27.4 t80 179.93 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.83 164.59 29.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.774 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 322' ' ' VAL . . . 78.56 -49.48 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.009 -0.615 . . . . 0.0 114.328 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.572 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.67 131.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 117.529 0.664 . . . . 0.0 111.924 -177.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.32 135.89 5.7 Favored Glycine 0 CA--C 1.51 -0.237 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -119.88 138.62 13.28 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.516 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 21.4 mt -100.87 129.0 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 31.4 mt -90.57 153.71 20.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.684 0.754 . . . . 0.0 112.527 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 65.3 mtt180 -70.02 -38.05 75.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.707 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 50.9 p90 -163.79 175.77 10.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.692 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.2 mtm105 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.576 0.227 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.07 -42.72 95.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 111.082 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -103.76 5.31 36.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.23 110.53 23.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 111.389 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -87.39 12.49 11.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.042 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 45.0 mt -70.82 -5.4 30.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.971 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -40.06 87.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -73.75 -23.88 59.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.99 -36.36 77.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.437 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.03 -47.87 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 281' ' ' ILE . 40.7 pt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.944 0.402 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.496 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -53.83 -42.09 68.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.8 pt-20 -86.09 -25.08 26.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.553 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -84.1 -43.19 15.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.02 -58.45 2.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.65 ' HG ' HD13 ' A' ' 321' ' ' ILE . 27.1 tp -56.82 -56.45 21.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.678 -178.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 63.9 mt -60.03 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.537 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.444 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.32 -38.87 57.97 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.041 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -60.05 -32.2 70.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.03 0.443 . . . . 0.0 110.268 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.589 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 14.9 t80 -59.86 -46.0 90.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.094 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 41.3 m-85 -87.38 -40.14 14.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 295' ' ' SER . 71.4 m-20 -60.0 -44.25 94.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.475 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.8 tp10 -69.95 -39.74 75.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.495 HG13 ' CD1' ' A' ' 301' ' ' TYR . 76.4 mt -63.82 -24.45 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.92 178.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -57.73 -17.52 15.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.096 0.474 . . . . 0.0 110.186 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -100.48 2.99 42.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 30.0 18.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.011 0.434 . . . . 0.0 110.362 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.615 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.8 p -66.84 -11.79 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.32 52.3 54.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.65 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 40.1 mttt -131.12 39.78 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.804 -0.233 . . . . 0.0 111.214 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.658 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 76.6 m-85 -161.12 162.85 31.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 0.0 111.726 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.47 164.51 33.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 49.3 p90 -134.99 150.01 50.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.51 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 87.06 154.71 26.63 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.327 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -60.58 -62.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.983 -179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -43.31 -52.13 5.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.619 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.6 m-20 -64.83 -54.8 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.498 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 36.3 m -57.58 -37.18 72.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.907 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.486 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.8 mp -68.1 -45.0 74.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mttm -58.12 -49.6 76.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.465 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -68.95 -28.65 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.474 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.821 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -70.77 -30.1 66.5 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.891 0.377 . . . . 0.0 110.267 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.8 -27.57 58.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 12.8 mmt -80.0 -7.24 58.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.82 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 18.69 47.41 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.06 -1.066 . . . . 0.0 110.942 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -91.27 0.0 57.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.481 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.821 HG23 ' HA ' ' A' ' 312' ' ' LEU . 30.8 m -100.39 105.68 18.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 412' ' ' ILE . 12.0 tp10 -59.6 -50.04 75.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.39 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 318' ' ' GLU . 24.4 mm -135.91 123.97 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.334 0.112 . . . . 0.0 111.214 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 21.4 tp -85.41 122.97 30.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 111.204 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.65 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -107.11 102.21 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.824 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 389' ' ' LEU . 25.4 t -114.08 162.01 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.326 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 37.9 m-85 -114.0 148.72 36.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.623 ' HG2' HG22 ' A' ' 391' ' ' ILE . 22.0 mm-40 -65.3 155.73 34.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.06 178.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 57.8 t30 56.95 28.94 15.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.265 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -57.16 126.63 28.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.469 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.3 m-20 -89.93 27.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.614 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 305' ' ' VAL . 31.0 mm -126.43 137.68 57.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.629 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -139.52 161.13 38.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.743 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.579 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 11.0 ttt-85 -86.94 105.66 17.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 5.9 m-85 -118.58 122.59 42.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 332' ' ' VAL . 19.4 m . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.095 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 39.4 tp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.319 0.581 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.525 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -94.41 128.35 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.986 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.474 HD21 ' HB2' ' A' ' 331' ' ' TYR . 2.2 mm? -119.07 148.16 43.34 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.574 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.7 p -100.86 173.74 3.45 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.868 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -48.29 -48.13 17.81 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 121.905 1.737 . . . . 0.0 113.16 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -71.75 -30.96 66.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -87.07 -49.3 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.068 0.461 . . . . 0.0 111.719 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.411 ' CD ' ' CZ ' ' A' ' 331' ' ' TYR . 1.3 tm-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.918 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 121.113 0.482 . . . . 0.0 111.624 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.461 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 6.1 tpt -117.82 132.08 23.82 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.627 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.621 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.4 Cg_exo -58.05 129.06 31.25 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.707 1.604 . . . . 0.0 110.133 178.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 18.0 mt -69.14 -44.04 73.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 322' ' ' VAL . 33.0 tp -59.98 -53.43 57.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 44.0 mt-10 -58.04 -40.09 80.05 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.064 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.461 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 73.5 t-105 -67.21 -36.38 81.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.611 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.593 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 10.3 m-85 -70.04 -33.49 72.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.279 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.09 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.751 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -110.23 -12.95 14.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 377' ' ' TRP . 68.5 m-80 -134.11 19.94 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 53.1 p90 -64.47 -14.54 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -83.5 -35.04 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.72 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -39.81 87.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.465 ' CG ' HD23 ' A' ' 312' ' ' LEU . 59.1 m-85 -82.37 -10.07 59.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.045 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.97 64.1 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.796 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.438 ' CB ' HG21 ' A' ' 317' ' ' VAL . . . -86.32 163.67 17.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.454 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 49.4 m -106.86 104.76 14.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.498 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 1.2 tm? -65.16 102.41 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.116 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.496 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.2 mm-40 -115.92 107.79 15.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.933 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.623 HG22 ' HG2' ' A' ' 324' ' ' GLU . 27.6 mm -84.14 104.59 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.209 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 321' ' ' ILE . 11.3 m -102.49 -172.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.078 -178.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.508 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -160.97 157.34 26.22 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.329 179.152 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . 0.418 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 11.3 p-10 -69.98 19.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 393' ' ' THR . 23.7 mtpp -68.12 -40.04 82.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.652 0.263 . . . . 0.0 111.126 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 93.6 p -94.51 170.06 9.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 111.556 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.04 -45.51 92.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.687 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.459 ' C ' HG23 ' A' ' 287' ' ' ILE . 33.6 mp0 -68.01 -40.54 82.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.382 0.61 . . . . 0.0 109.827 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.418 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.35 -19.67 60.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.293 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 404' ' ' LYS . 65.6 m -84.02 -23.16 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.752 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 30.8 mt-30 -70.88 -41.47 71.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.807 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.609 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.0 m-85 -60.32 -46.33 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.082 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.98 -37.84 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 400' ' ' SER . 22.1 mttm -66.94 -57.88 6.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.08 -52.56 42.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.834 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.51 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 50.4 t80 -151.91 -66.97 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.03 166.48 31.59 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.235 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.2 -49.2 2.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.041 -0.6 . . . . 0.0 114.404 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.541 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.1 OUTLIER -143.97 134.4 21.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 117.697 0.748 . . . . 0.0 112.632 -177.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 145.22 12.18 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.97 144.26 15.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.287 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 318' ' ' GLU . 34.8 mt -105.66 127.6 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 51.0 mt -87.85 153.49 21.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.64 0.733 . . . . 0.0 112.735 -177.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.408 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 58.8 mtp85 -69.83 -35.2 74.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.419 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 416' ' ' ARG . 50.9 p90 -171.3 179.63 2.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.683 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.447 ' CB ' ' HB2' ' A' ' 432' ' ' PHE . 90.6 m-20 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -59.98 -46.68 88.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.126 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -123.17 18.27 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.4 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.447 ' HB2' ' CB ' ' A' ' 429' ' ' ASP . 81.6 m-85 -98.84 119.69 38.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.69 -9.89 56.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.516 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.6 mt -53.49 -13.24 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.389 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 429' ' ' ASP . 81.0 m-20 -57.04 -40.04 75.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.837 0.351 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -68.56 -35.19 77.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.02 -31.66 70.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.14 -46.71 88.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -59.99 -39.96 87.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.994 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.902 179.991 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 120.788 0.327 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.629 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.3 OUTLIER -60.02 -39.48 85.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.512 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.565 ' HA ' HG11 ' A' ' 392' ' ' VAL . 16.8 pt-20 -84.69 -22.67 29.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.35 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -50.09 8.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.21 -58.33 3.35 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.74 -55.61 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.054 0.454 . . . . 0.0 111.975 -178.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.502 HG21 ' CE1' ' A' ' 402' ' ' PHE . 23.6 mt -59.55 -49.18 84.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.623 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.86 -37.0 75.49 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.9 ttt85 -60.01 -39.08 84.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.8 t80 -57.51 -45.19 85.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.669 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -79.45 -40.0 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.01 -47.44 85.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.697 -179.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.85 -43.3 99.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.067 0.46 . . . . 0.0 109.864 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -59.98 -24.6 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.648 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 178.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.27 1.59 23.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 57.95 31.13 20.19 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.998 0.428 . . . . 0.0 110.341 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.852 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -67.71 -11.93 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.858 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.08 48.56 78.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.511 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.1 36.3 4.33 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 93.5 m-85 -159.32 160.06 34.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.95 164.99 33.99 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.35 164.86 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 0.0 110.928 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.21 167.84 34.37 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.226 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -72.91 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.213 -179.583 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.26 -52.43 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.872 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.6 m-20 -65.78 -57.44 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.13 -36.39 68.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.591 0.234 . . . . 0.0 110.974 -179.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.69 64.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.64 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.44 -50.01 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.609 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -66.84 -28.32 68.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.68 0.276 . . . . 0.0 111.027 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.738 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.37 -28.24 61.03 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -77.51 -26.93 51.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.28 -7.3 58.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.789 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.42 42.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.519 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.14 -2.27 58.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.313 0.245 . . . . 0.0 111.073 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.2 m -100.95 107.11 20.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 412' ' ' ILE . 36.8 tt0 -59.84 -50.03 75.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.327 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 318' ' ' GLU . 39.7 mm -135.51 125.1 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.576 ' HG ' HG23 ' A' ' 322' ' ' VAL . 29.7 tp -90.82 128.23 36.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.903 0.382 . . . . 0.0 111.305 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.494 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.74 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.576 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.63 162.21 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.405 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.593 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 94.1 m-85 -110.63 149.86 29.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.043 0.449 . . . . 0.0 111.687 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.6 pt-20 -66.83 -27.98 67.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.31 34.98 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.681 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 43.0 tp -70.31 122.33 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.526 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.53 23.28 5.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.268 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.689 HG21 HG11 ' A' ' 305' ' ' VAL . 14.9 mm -120.89 135.5 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.401 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.54 161.47 36.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.336 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.19 120.04 31.03 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.488 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.11 155.26 29.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.723 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.04 0.448 . . . . 0.0 111.033 179.863 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.1 tp . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 121.177 0.513 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.421 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 3.4 p90 -101.0 120.1 39.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.645 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.569 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.3 mm? -124.48 156.37 37.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.83 168.12 9.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.34 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.89 -49.58 8.12 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.525 2.15 . . . . 0.0 112.303 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.0 -55.51 33.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.397 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . 0.533 ' HG2' ' CD1' ' A' ' 346' ' ' LEU . 4.7 tp60 -59.97 -53.19 60.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.376 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.6 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.85 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.52 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.945 0.403 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.416 ' HE1' ' CZ3' ' A' ' 377' ' ' TRP . 25.4 tpp -114.99 124.16 30.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.602 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.582 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.44 120.92 9.16 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.945 1.763 . . . . 0.0 110.984 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.603 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.4 mt -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.616 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.7 tp -60.06 -51.44 69.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.77 -40.22 87.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.704 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.416 ' CZ3' ' HE1' ' A' ' 372' ' ' MET . 76.7 t-105 -62.0 -40.03 94.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.809 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.544 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.1 -29.45 60.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.19 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.42 47.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.617 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -111.02 -9.31 14.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.74 19.84 5.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.5 p90 -69.99 -11.89 61.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.63 -38.3 21.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.99 -38.33 82.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.295 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.525 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -83.97 -10.43 57.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.63 1.26 52.7 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.644 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.75 165.15 17.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.422 ' HB ' HD12 ' A' ' 319' ' ' ILE . 97.9 m -106.74 100.23 9.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.338 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 2.4 tm? -71.93 102.22 2.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.629 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.7 mm-40 -107.82 128.01 54.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.928 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 22.6 mm -94.85 102.09 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 112.208 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 283' ' ' GLU . 4.1 m -100.43 -169.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.817 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.593 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.7 p -154.89 151.55 28.7 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.021 0.439 . . . . 0.0 111.557 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -71.08 1.43 5.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.319 -179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -60.03 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.283 . . . . 0.0 111.017 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.4 p -81.88 168.15 18.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.6 mt-30 -60.03 -54.79 41.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.8 -39.5 94.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.266 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . 0.425 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -53.63 -59.7 9.34 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.593 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.92 -19.55 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.0 mt-30 -69.96 -40.03 75.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.914 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.47 -44.81 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.767 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 88.2 t -59.99 -45.23 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.423 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.79 -38.19 56.79 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -178.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.681 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.75 -94.52 0.48 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.192 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 155.46 34.06 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.818 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.53 -20.04 7.91 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.562 -1.304 . . . . 0.0 115.504 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.498 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.6 130.32 66.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.562 1.181 . . . . 0.0 111.765 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.67 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.48 151.05 19.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.735 -1.221 . . . . 0.0 114.105 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.512 ' CG2' ' CE2' ' A' ' 301' ' ' TYR . 19.0 mt -109.35 127.48 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.6 mt -88.23 153.33 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.52 0.676 . . . . 0.0 112.302 -178.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.2 mtt-85 -70.06 -36.75 75.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.605 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -160.92 170.59 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.852 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.611 0.243 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.13 -39.92 87.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.926 0.394 . . . . 0.0 110.337 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.37 91.29 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.208 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.5 -137.68 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.88 40.02 16.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 109.194 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -89.03 -0.25 57.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.338 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.02 87.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -68.0 -35.17 77.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.478 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.93 -34.14 71.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.079 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.09 -42.4 94.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -60.06 -40.01 88.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.845 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 5.6 pt . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.796 0.332 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.556 ' NE2' HG11 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -57.17 -37.34 71.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.533 . . . . 0.0 110.085 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 93.3 mt-10 -77.77 -28.58 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.899 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -83.99 -57.52 3.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -70.0 -58.23 4.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' A' ' 321' ' ' ILE . 19.2 tp -57.26 -58.35 8.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.702 0.287 . . . . 0.0 111.509 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 30.4 mt -59.97 -49.65 83.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.152 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.418 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.28 -37.19 79.6 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.633 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -60.03 -35.79 75.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 110.282 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.569 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.6 t80 -60.0 -46.58 89.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.699 0.285 . . . . 0.0 111.614 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 295' ' ' SER . 38.0 t0 -63.67 -46.85 83.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.463 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.652 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 33.4 tp10 -64.74 -40.0 94.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 301' ' ' TYR . 81.8 mt -62.27 -26.1 39.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.29 -14.06 16.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.273 0.559 . . . . 0.0 109.865 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -98.36 -0.02 44.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.422 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.23 28.89 17.21 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.196 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.789 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.5 p -69.98 -10.03 57.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.067 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.29 52.62 46.2 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.525 178.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 11.8 mtpt -130.33 40.57 3.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.652 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 74.2 m-85 -162.54 165.25 26.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.106 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.7 164.31 35.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 52.7 p90 -136.98 151.89 49.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.082 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 88.3 155.45 29.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.445 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -61.55 -56.49 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.283 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.521 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -47.68 -56.9 6.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.591 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.2 m-20 -60.7 -54.98 38.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.667 0.27 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 18.9 m -58.68 -40.04 82.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 3.2 mp -67.69 -48.07 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -54.99 -56.53 18.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.144 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.23 -30.14 70.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.07 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.7 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.04 -28.44 62.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.796 179.39 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -76.93 -26.21 53.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 45.4 mmm -82.08 -8.53 59.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.851 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.75 14.22 42.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.263 -178.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.79 -5.96 59.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.394 0.278 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 312' ' ' LEU . 27.2 m -99.1 105.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 412' ' ' ILE . 42.3 tt0 -59.93 -49.97 75.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.451 ' CD1' ' HB ' ' A' ' 388' ' ' THR . 42.3 mm -133.78 126.34 50.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.563 0.221 . . . . 0.0 111.185 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 322' ' ' VAL . 40.9 tp -93.52 129.43 39.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 111.058 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.488 ' HB ' ' HE2' ' A' ' 402' ' ' PHE . 1.1 mt -116.14 109.32 27.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 110.142 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 14.8 t -125.43 161.84 29.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.525 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 31.5 m-85 -108.14 146.94 31.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 111.168 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.506 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.62 -32.76 74.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -94.1 51.53 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -83.9 125.87 32.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.7 23.03 4.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.598 HG21 HG11 ' A' ' 305' ' ' VAL . 14.8 mm -122.43 133.47 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.596 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.571 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.7 mtt -139.53 161.54 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 31.9 ttt180 -92.39 122.26 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 111.645 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.497 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 6.6 m-85 -120.7 159.02 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.22 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.362 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 32.4 tp . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.446 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.2 OUTLIER -92.09 116.67 29.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.629 179.461 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.483 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.4 mm? -120.59 153.64 36.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 112.711 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.6 p -101.0 168.98 8.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.542 178.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.9 Cg_endo -41.24 -46.14 5.54 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.062 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.05 -54.92 41.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.77 -48.35 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.1 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.535 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.7 p . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 121.137 0.494 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.8 tpt -114.22 129.86 24.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.571 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -59.1 118.35 5.22 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.204 1.936 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.4 mt -60.07 -39.46 86.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.674 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.9 tp -60.07 -54.08 50.24 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.958 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.523 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.0 mt-10 -58.12 -40.06 80.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.928 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -62.51 -39.89 94.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.376 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.571 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.66 -28.69 62.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.085 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.48 -9.74 48.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.33 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -104.86 -14.06 15.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.62 20.22 5.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -64.88 -18.94 65.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.739 0.304 . . . . 0.0 111.019 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -81.05 -39.96 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -64.77 -39.96 94.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.621 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.509 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.7 m-85 -80.02 -11.33 59.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.976 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.34 57.52 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.488 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.486 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -87.22 163.66 16.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.189 0.519 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.451 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 50.2 m -106.95 100.4 9.9 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.08 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.439 ' CD2' HG21 ' A' ' 322' ' ' VAL . 2.4 tm? -76.28 107.18 8.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.48 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 43.3 mm-40 -113.71 135.17 54.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 36.2 mm -98.97 105.2 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 0.0 112.146 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.556 HG11 ' NE2' ' A' ' 282' ' ' GLN . 5.8 m -102.1 -169.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.239 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.471 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -158.25 153.37 25.49 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.175 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -77.91 69.97 4.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.295 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -114.56 -34.94 5.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.937 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.5 m -102.93 179.36 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 25.3 mm100 -60.01 -40.65 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 34.4 mp0 -69.49 -40.66 76.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.46 -21.06 61.97 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.271 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 52.3 m -84.2 -21.43 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.027 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 85.5 mt-30 -77.48 -41.69 38.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.779 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 406' ' ' PHE . 3.3 m-85 -67.31 -49.62 63.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.555 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.03 -40.04 82.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.871 0.367 . . . . 0.0 110.517 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -79.86 -41.32 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.325 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.26 95.29 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.711 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -134.06 -84.74 0.43 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.018 -0.591 . . . . 0.0 109.713 178.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 148.32 41.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.563 -1.303 . . . . 0.0 115.138 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 126.61 -28.49 4.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 119.556 -1.307 . . . . 0.0 115.218 177.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.467 ' O ' ' CD2' ' A' ' 406' ' ' PHE . 0.8 OUTLIER -125.02 127.83 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.056 0.928 . . . . 0.0 111.913 -178.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.43 139.77 7.67 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.34 140.62 13.59 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.595 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 48.4 mt -101.9 127.29 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.164 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 53.9 mt -87.42 151.55 22.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 112.798 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 34.9 mtp-105 -78.77 -27.68 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.734 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.402 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 95.5 m-85 -151.99 170.06 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.958 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.789 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.99 -42.67 94.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.678 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 31.3 p90 -144.64 114.32 7.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 26.2 p90 -130.98 106.73 8.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 0.0 111.376 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.03 14.2 12.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.035 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.71 -3.86 27.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.774 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 110.641 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -69.8 -32.49 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -60.06 -33.2 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.03 -41.59 92.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.012 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.869 179.875 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.92 0.391 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.662 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.63 -39.99 86.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.592 -179.433 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.4 mt-10 -77.16 -29.91 54.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.228 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.7 -58.1 3.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 321' ' ' ILE . 16.2 tp -58.75 -54.7 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 398' ' ' GLU . 46.0 mt -59.98 -48.47 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.572 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.33 -37.88 66.9 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.041 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 43.8 ttt180 -60.0 -39.2 84.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.166 0.508 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.624 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.8 t80 -55.63 -45.77 77.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.772 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.32 -39.24 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.737 0.303 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.9 t0 -59.97 -43.25 95.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.381 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.17 -42.32 84.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.2 -23.88 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.57 178.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.02 -15.47 56.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.203 0.525 . . . . 0.0 110.048 178.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -104.86 2.12 29.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.596 178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.25 29.73 18.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.962 0.41 . . . . 0.0 110.57 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 13.8 p -66.75 -13.02 60.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.9 49.18 73.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.402 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 17.5 mttp -126.4 36.8 4.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 95.3 m-85 -159.35 159.99 34.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.337 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -140.95 161.2 38.4 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.11 144.85 47.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.517 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.29 157.0 29.1 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.908 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.06 -55.82 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 0.0 111.166 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -47.31 -57.24 5.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.943 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.12 -54.85 39.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.712 0.291 . . . . 0.0 111.452 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 28.0 m -56.56 -40.02 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.2 mp -66.86 -45.23 78.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.566 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.3 mtmt -56.66 -50.04 73.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.998 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . 0.489 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -73.85 -27.32 61.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.66 -34.53 74.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.886 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.56 -24.35 61.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.8 -7.96 59.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.092 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.07 10.94 36.02 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.561 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -79.96 -6.19 57.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.441 0.296 . . . . 0.0 110.79 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 312' ' ' LEU . 34.9 m -95.79 105.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.0 tt0 -59.64 -50.0 75.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 319' ' ' ILE . . . . . 0.493 HD13 ' HB ' ' A' ' 388' ' ' THR . 27.9 mm -136.64 126.5 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.534 0.206 . . . . 0.0 111.41 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 312' ' ' LEU . 44.9 tp -89.72 126.48 35.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.972 0.415 . . . . 0.0 111.467 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 321' ' ' ILE . . . . . 0.627 HD11 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -111.56 103.6 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.286 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 17.4 t -122.33 152.66 26.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.476 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.5 m-85 -98.42 142.95 29.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.411 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 324' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 16.8 pt-20 -65.36 -24.05 67.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.835 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.28 33.35 1.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 326' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -71.2 123.91 23.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.699 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -96.57 28.7 3.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.724 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 20.0 mm -126.58 133.19 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 329' ' ' MET . . . . . 0.55 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.3 mtt -140.62 162.53 35.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.161 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.17 29.72 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.244 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 331' ' ' TYR . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 7.4 m-85 -124.81 160.74 28.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.496 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.872 0.368 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 345' ' ' TYR . . . . . 0.553 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 0.3 OUTLIER -84.96 137.09 33.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.183 178.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.546 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.68 164.1 22.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.635 0.731 . . . . 0.0 112.475 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.7 p -101.56 172.05 4.79 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.283 178.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 348' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 74.0 Cg_exo -48.94 -47.52 21.2 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 121.755 1.637 . . . . 0.0 111.768 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.17 -58.46 8.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.04 -48.95 79.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 91.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 371' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.112 0.482 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 372' ' ' MET . . . . . 0.402 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.56 121.92 32.5 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.72 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.57 120.84 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.782 1.655 . . . . 0.0 110.784 178.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 374' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.9 mt -59.94 -44.16 94.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.259 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 68.9 tp -60.06 -50.79 72.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 376' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.97 85.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.673 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 377' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.26 -43.77 95.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.6 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.527 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 8.7 m-85 -73.68 -30.68 63.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.19 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.36 -25.09 60.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.539 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.69 -6.56 14.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.33 20.25 5.75 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.532 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.565 0.221 . . . . 0.0 111.349 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.35 -40.43 30.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.919 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.16 -36.37 77.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 385' ' ' PHE . . . . . 0.5 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.49 -4.18 59.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.399 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.71 3.06 32.3 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.519 -179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.604 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -89.72 166.31 13.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 388' ' ' THR . . . . . 0.493 ' HB ' HD13 ' A' ' 319' ' ' ILE . 58.1 m -109.13 100.57 9.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.003 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 3.2 tm? -69.35 102.36 1.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.662 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.77 130.03 55.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.4 mm -95.91 103.87 15.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.057 -178.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 392' ' ' VAL . . . . . 0.488 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.47 -171.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.173 -178.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.5 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.59 155.33 26.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.198 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.49 11.37 0.63 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.208 -179.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.02 94.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.676 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.4 m -92.06 170.91 9.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.844 0.354 . . . . 0.0 111.389 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.8 mt-30 -60.12 -54.35 46.93 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.545 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 398' ' ' GLU . . . . . 0.575 ' HB3' HG23 ' A' ' 287' ' ' ILE . 15.4 mp0 -59.99 -40.02 87.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.496 0.665 . . . . 0.0 109.467 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -54.11 -57.64 15.89 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.776 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.9 -19.44 51.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 401' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.42 -40.04 77.53 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.915 0.388 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 402' ' ' PHE . . . . . 0.609 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -59.97 -46.56 89.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.464 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.2 t -59.91 -34.08 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.017 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.24 -54.11 19.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.271 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.72 -20.56 70.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.939 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.517 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.2 t80 174.95 -75.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.41 167.86 28.88 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.705 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.73 -51.53 3.76 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.846 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.56 131.78 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.293 0.547 . . . . 0.0 112.234 -178.199 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -150.75 141.06 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.73 145.86 15.93 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.867 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.1 mt -109.16 128.5 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.9 mt -90.66 153.15 20.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.72 0.771 . . . . 0.0 112.807 -177.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.0 -37.91 75.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.597 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 415' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 82.3 m-85 -158.24 -177.89 6.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.77 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 416' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 110.846 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.0 -41.09 91.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.4 99.12 5.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -116.71 117.07 28.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.83 -0.69 24.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.9 mt -50.96 -19.38 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.927 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -59.69 -40.02 86.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.396 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -74.88 -24.2 58.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.61 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.07 -38.43 82.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.003 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.06 -46.35 89.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.919 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.02 -39.95 87.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.869 -179.895 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.781 0.324 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -65.75 -29.23 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.359 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.4 ' N ' HG11 ' A' ' 278' ' ' VAL . 21.2 mtpt -53.22 -40.56 64.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.521 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -62.71 -47.27 84.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.753 0.311 . . . . 0.0 111.19 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 42.7 pt -81.98 -23.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.533 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.51 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.98 -41.17 91.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.376 0.607 . . . . 0.0 109.857 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.654 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 2.1 mp0 -80.29 -42.08 23.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.33 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -70.01 -39.99 75.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -58.41 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 18.0 tp -58.93 -55.94 28.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.891 0.377 . . . . 0.0 111.318 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 47.1 mt -60.99 -49.91 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.806 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.434 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.47 -38.78 58.56 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 20.6 ttt85 -60.03 -37.64 80.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 110.277 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.5 t80 -55.79 -47.46 77.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.938 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 34.8 m-85 -83.63 -38.73 21.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.9 t0 -60.33 -42.75 96.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.522 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.644 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.0 mt-10 -69.47 -43.3 73.48 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.4 HD13 ' CB ' ' A' ' 301' ' ' TYR . 89.9 mt -59.55 -23.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.85 -12.88 53.32 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.22 0.534 . . . . 0.0 109.911 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.438 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 69.5 mt-30 -103.72 -0.01 29.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.466 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.24 30.29 20.01 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.546 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 6.5 p -67.21 -14.15 62.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.022 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.0 48.9 83.63 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.783 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.52 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 7.0 ttpt -130.22 37.1 3.92 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.644 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 86.4 m-85 -161.09 161.48 31.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.42 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 160.25 42.53 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.453 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 52.5 p90 -135.52 130.63 34.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 406' ' ' PHE . . . 106.83 150.9 17.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.61 -60.8 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.33 . . . . 0.0 111.028 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.9 pt-20 -47.4 -54.69 10.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.388 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.55 -54.57 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 22.1 m -56.21 -37.92 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.098 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.414 ' CD1' HG13 ' A' ' 305' ' ' VAL . 2.8 mp -69.93 -41.57 74.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.323 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 20.3 mtmt -58.88 -49.91 75.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.442 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.36 -26.16 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.289 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.765 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.32 -25.96 58.26 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.52 -28.08 51.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 78.5 mmm -79.99 -7.33 58.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.403 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.29 20.68 44.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.138 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.68 7.69 44.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.598 -0.301 . . . . 0.0 111.457 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.0 m -107.27 107.2 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 121.038 0.446 . . . . 0.0 112.002 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.688 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 11.2 tp10 -59.95 -50.76 72.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 388' ' ' THR . 33.3 mm -135.74 125.75 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.653 0.263 . . . . 0.0 111.425 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 322' ' ' VAL . 38.2 tp -92.52 128.65 38.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.968 0.413 . . . . 0.0 111.219 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -115.1 107.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.089 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 7.6 t -123.51 163.19 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.935 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.651 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.1 m-85 -110.9 149.23 30.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.696 ' HG2' HG22 ' A' ' 391' ' ' ILE . 49.1 mm-40 -59.37 -50.06 75.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.2 53.22 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.381 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 31.4 tp -78.88 123.29 27.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -89.61 23.84 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.704 HG22 HG21 ' A' ' 305' ' ' VAL . 15.8 mm -127.43 134.59 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.687 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.554 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 53.5 mtt -140.36 161.73 36.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.605 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.9 ttt180 -89.23 121.06 31.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.049 0.452 . . . . 0.0 111.303 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 4.6 m-85 -121.43 157.11 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.965 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.481 ' HA ' HD12 ' A' ' 343' ' ' ILE . 3.9 m -120.84 108.37 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.509 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 2.7 mm? -99.15 145.57 27.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 17.3 m170 -91.17 -177.04 4.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 9.1 t -113.55 160.74 18.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -60.1 -40.01 88.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.56 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.42 ' O ' ' OG1' ' A' ' 338' ' ' THR . . . -97.85 -5.05 57.68 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.734 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 337' ' ' GLY . 2.9 p 75.17 -171.13 0.1 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.62 0.368 . . . . 0.0 110.769 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 60.54 24.71 14.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.659 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -160.11 122.3 3.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.958 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.86 138.34 49.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -120.06 140.3 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 332' ' ' VAL . 6.7 mm -119.02 116.27 50.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.159 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 49.9 tp -131.88 156.56 45.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.368 0.604 . . . . 0.0 111.957 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.53 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -94.04 118.86 32.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.601 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.491 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 1.5 mm? -121.18 159.75 25.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 14.4 p -101.77 171.33 5.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.381 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.6 Cg_exo -47.38 -43.58 26.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.737 1.624 . . . . 0.0 111.89 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.88 -54.96 41.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.191 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 83.1 mt-30 -67.61 -46.29 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 94.5 mt-10 -61.21 -31.44 71.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -57.65 -34.82 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.286 0.565 . . . . 0.0 109.946 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.7 t0 -87.17 62.76 7.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.256 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 368' ' ' LEU . 28.8 tttt -68.78 -45.11 72.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 94.1 p -59.97 -53.56 56.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.719 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.486 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 84.4 m-70 -86.32 -48.63 8.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.627 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.509 ' CD2' ' CD1' ' A' ' 333' ' ' LEU . 0.4 OUTLIER 53.41 11.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.863 0.364 . . . . 0.0 110.336 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 364' ' ' GLN . 0.7 OUTLIER -106.68 -169.85 1.62 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.202 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.438 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 87.3 m-20 -130.66 133.2 45.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.96 -2.44 12.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.301 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -101.33 -28.26 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.438 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 2.4 t -117.46 -36.46 3.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.154 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 77.37 39.94 25.0 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.711 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.478 ' O ' HG23 ' A' ' 358' ' ' THR . 23.7 mt-30 -52.66 -169.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -131.07 83.48 2.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.817 0.341 . . . . 0.0 110.83 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -130.02 137.36 50.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.412 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 43.6 mt-10 -140.97 102.63 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.78 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 331' ' ' TYR . 51.9 tp -72.33 132.1 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.174 0.511 . . . . 0.0 112.146 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 367' ' ' GLU . 3.4 mm -113.5 -44.12 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.56 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 368' ' ' LEU . 36.8 tt0 -139.99 163.04 33.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.125 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.49 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.7 p -147.42 119.74 8.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.252 0.549 . . . . 0.0 111.536 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 19.2 tpp -115.46 128.81 25.64 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.623 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.554 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 36.5 Cg_exo -59.77 120.0 7.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.011 1.807 . . . . 0.0 111.108 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.3 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.749 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.442 HD12 ' CD1' ' A' ' 391' ' ' ILE . 63.1 tp -60.07 -51.96 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.4 mt-10 -60.02 -39.92 87.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.031 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -62.58 -40.02 95.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.503 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -71.07 -25.84 62.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.49 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.91 -9.99 49.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.761 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -108.75 -9.18 15.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.23 18.0 5.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.36 -18.72 65.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.665 0.269 . . . . 0.0 111.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -83.02 -42.23 17.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.758 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.85 -40.1 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.492 ' CD2' HD23 ' A' ' 312' ' ' LEU . 38.0 m-85 -82.75 -10.25 58.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.28 2.41 53.92 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.498 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 317' ' ' VAL . . . -85.48 162.49 18.92 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.505 ' HB ' HD11 ' A' ' 319' ' ' ILE . 98.3 m -106.64 100.56 10.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.98 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.33 101.95 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.51 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 19.7 mm-40 -111.36 118.17 35.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.696 HG22 ' HG2' ' A' ' 324' ' ' GLU . 20.5 mm -88.66 108.96 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.042 0.448 . . . . 0.0 111.889 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 323' ' ' TYR . 15.6 m -101.75 -170.68 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.25 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.575 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -154.53 151.59 29.07 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -70.73 12.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.44 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 0.3 OUTLIER -64.7 -39.99 94.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.633 0.254 . . . . 0.0 111.644 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.9 m -92.05 170.6 9.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.386 . . . . 0.0 111.78 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -60.02 -48.83 80.1 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 44.3 mp0 -63.95 -39.99 95.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.372 0.606 . . . . 0.0 109.517 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.1 -20.42 60.38 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.15 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.6 m -84.23 -22.24 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.631 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.505 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 79.6 mt-30 -73.87 -43.36 58.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.651 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.8 m-85 -60.01 -41.98 93.31 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.924 0.392 . . . . 0.0 110.357 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.745 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 54.6 t -60.0 -39.98 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -72.55 -42.8 64.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.953 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.62 98.74 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.374 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.492 ' CD1' ' HA2' ' A' ' 304' ' ' GLY . 59.9 t80 -148.79 -67.14 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 125.03 57.88 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 119.842 -1.171 . . . . 0.0 115.095 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.75 -35.41 2.0 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.399 -1.382 . . . . 0.0 115.277 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.457 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.6 OUTLIER -136.13 134.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.883 0.841 . . . . 0.0 112.904 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -154.53 148.14 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.48 147.15 17.74 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.694 -1.241 . . . . 0.0 114.031 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 318' ' ' GLU . 46.6 mt -108.72 126.39 65.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.779 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 50.4 mt -86.42 151.69 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 112.303 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.688 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.4 mtm180 -67.5 -38.69 84.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 96.6 m-85 -160.57 170.02 21.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -57.22 124.18 17.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 32.9 m -126.97 153.97 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.84 -0.37 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 58.91 170.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.684 0.278 . . . . 0.0 110.692 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -118.79 142.46 47.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.938 0.399 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.651 ' HA3' ' HG2' ' A' ' 425' ' ' GLN . . . 160.0 -139.13 5.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.611 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.55 ' N ' ' HB3' ' A' ' 425' ' ' GLN . 9.8 mmt -76.25 -168.62 0.98 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.775 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 424' ' ' TYR . 15.2 pt-20 -60.02 -49.21 78.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.522 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.428 ' N ' ' HG3' ' A' ' 423' ' ' GLU . 64.8 t80 -77.9 -35.0 51.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.437 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.651 ' HG2' ' HA3' ' A' ' 421' ' ' GLY . 11.9 tp60 -60.0 -39.94 87.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.589 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 150.19 -98.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.968 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 421' ' ' GLY . . . -75.15 -144.96 1.16 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 421' ' ' GLY . 95.3 m-20 -141.27 22.9 2.2 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.755 0.312 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.518 ' O ' ' HD1' ' A' ' 432' ' ' PHE . 95.9 m-20 -107.9 24.46 12.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.621 ' HB2' ' HA2' ' A' ' 421' ' ' GLY . 6.9 tm-20 -59.99 -40.05 87.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 110.345 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 26.7 p90 -96.92 67.68 2.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.518 ' HD1' ' O ' ' A' ' 429' ' ' ASP . 37.1 p90 -90.03 110.47 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.69 -2.61 30.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.719 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.65 -18.65 4.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.857 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.96 -39.97 87.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 0.0 110.587 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.68 -23.83 60.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.704 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.9 -37.56 79.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.251 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.03 -45.36 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.889 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.011 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 75.5 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.884 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -60.07 -29.94 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.3 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -51.54 -40.02 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.01 -50.04 75.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.667 0.27 . . . . 0.0 111.241 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt -82.91 -23.51 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.849 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.63 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.3 OUTLIER -59.94 -39.54 85.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.555 -179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.566 ' HA ' HG11 ' A' ' 392' ' ' VAL . 16.8 pt-20 -84.67 -22.69 29.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.324 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -50.01 8.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.27 -58.33 3.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.493 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.72 -55.66 31.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.942 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.502 HG21 ' CE1' ' A' ' 402' ' ' PHE . 23.7 mt -59.48 -49.22 84.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.89 -37.03 75.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.084 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -59.93 -39.09 84.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.309 0.576 . . . . 0.0 110.049 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.9 t80 -57.56 -45.18 85.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.63 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -79.47 -39.94 31.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.07 -47.48 85.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.602 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.82 -43.29 99.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.039 0.447 . . . . 0.0 109.872 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -60.04 -24.54 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.664 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.16 0.505 . . . . 0.0 109.911 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -107.27 1.55 23.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.465 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 57.95 31.13 20.18 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.341 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.852 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.4 p -67.64 -11.97 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.845 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.6 78.09 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.535 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.12 36.3 4.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 93.5 m-85 -159.33 160.02 34.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.087 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.91 165.07 33.7 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.821 0.344 . . . . 0.0 111.231 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.47 164.82 28.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.18 167.82 34.28 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.234 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -72.88 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.214 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.25 -52.49 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.843 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.8 m-20 -65.73 -57.42 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.15 -36.42 68.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.951 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.67 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.601 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.43 -50.07 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -66.8 -28.28 68.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 111.037 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.738 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.51 -28.13 60.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.84 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -77.51 -26.99 51.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.21 -7.33 58.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.776 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.44 42.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.467 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.12 -2.24 58.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.287 0.235 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.0 m -100.98 107.1 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 412' ' ' ILE . 36.8 tt0 -59.86 -50.01 75.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.33 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 318' ' ' GLU . 39.8 mm -135.5 125.12 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.576 ' HG ' HG23 ' A' ' 322' ' ' VAL . 29.7 tp -90.8 128.25 36.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.275 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.493 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.76 105.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.742 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.576 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.64 162.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.371 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.594 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 94.2 m-85 -110.67 149.93 29.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.471 . . . . 0.0 111.674 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.6 pt-20 -66.92 -27.96 67.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.3 35.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 43.0 tp -70.31 122.32 19.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.53 23.35 5.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.236 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.689 HG21 HG11 ' A' ' 305' ' ' VAL . 14.8 mm -120.93 135.48 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.41 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.583 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.5 161.45 37.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.44 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.14 120.08 31.01 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.169 0.509 . . . . 0.0 111.468 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.14 155.22 29.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.734 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.482 ' HA ' HD12 ' A' ' 343' ' ' ILE . 9.6 m -117.77 110.96 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.733 HD13 ' CD2' ' A' ' 357' ' ' PHE . 2.4 mp -97.52 142.33 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.927 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 369' ' ' ILE . 2.5 m170 -82.32 176.43 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.049 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 21.6 p -103.36 162.4 13.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.584 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -47.58 -28.94 2.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.037 0.446 . . . . 0.0 110.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.58 -119.62 4.54 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.743 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.56 22.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.827 0.313 . . . . 0.0 111.756 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.9 43.34 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 111.451 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -169.15 130.0 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.929 0.395 . . . . 0.0 110.274 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -115.4 140.42 49.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.168 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -121.54 145.48 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 332' ' ' VAL . 6.6 mm -123.17 119.66 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.9 tp -128.15 161.76 28.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.162 0.506 . . . . 0.0 111.744 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.421 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 3.5 p90 -100.96 120.05 39.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.651 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.569 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.3 mm? -124.43 156.33 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.8 168.11 9.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.368 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.85 -49.63 8.01 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.313 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.95 -55.56 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.392 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.533 ' HG2' ' CD1' ' A' ' 346' ' ' LEU . 4.7 tp60 -59.94 -53.17 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.5 mt-10 -49.67 -33.14 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.827 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.1 mmmm -59.98 -28.3 67.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.179 0.514 . . . . 0.0 110.486 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.428 ' HB2' ' NE2' ' A' ' 356' ' ' HIS . 0.0 OUTLIER -82.07 16.56 1.89 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.654 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.707 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 8.5 ptmm? -55.58 -23.29 26.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 85.6 p -59.96 -44.94 94.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.67 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.481 ' C ' ' H ' ' A' ' 358' ' ' THR . 6.3 p80 -107.79 -41.97 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.228 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.733 ' CD2' HD13 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.42 5.1 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.866 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 364' ' ' GLN . 3.6 m -86.89 178.09 7.08 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.99 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 358' ' ' THR . 93.2 m-20 -132.97 135.64 45.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -72.44 -0.16 11.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.073 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -104.35 -15.37 15.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.643 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 5.5 t -133.47 -37.76 0.94 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.767 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.55 7.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.77 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.518 ' N ' HG22 ' A' ' 358' ' ' THR . 13.0 pt20 -86.53 88.15 7.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.151 0.501 . . . . 0.0 110.624 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -64.27 129.91 41.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.635 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 60.7 m80 -143.85 167.55 22.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.205 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -145.33 113.93 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.323 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.433 HD22 ' CD2' ' A' ' 331' ' ' TYR . 58.5 tp -70.29 133.17 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 111.021 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.452 HD12 ' CD2' ' A' ' 334' ' ' HIS . 2.7 mp -106.53 -40.12 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 371' ' ' SER . 38.7 tt0 -152.12 166.16 32.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.568 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.519 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -145.35 117.04 8.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.845 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.415 ' HE1' ' CZ3' ' A' ' 377' ' ' TRP . 25.4 tpp -114.91 124.13 30.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.656 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.583 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.41 120.95 9.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.0 1.8 . . . . 0.0 110.982 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.603 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.3 mt -60.23 -42.3 94.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.595 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.7 tp -60.04 -51.39 69.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.665 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.91 -40.17 87.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.685 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.415 ' CZ3' ' HE1' ' A' ' 372' ' ' MET . 76.7 t-105 -62.01 -39.96 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.837 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.2 -29.4 60.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.125 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.39 47.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.598 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.11 -9.33 14.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.67 19.84 5.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.6 p90 -70.0 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.61 -38.35 21.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -59.93 -38.33 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.301 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.525 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -84.01 -10.43 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.62 1.28 52.7 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.654 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.76 165.12 17.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.428 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.422 ' HB ' HD12 ' A' ' 319' ' ' ILE . 97.9 m -106.72 100.27 9.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.3 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 2.4 tm? -71.92 102.2 2.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.854 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.63 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.8 mm-40 -107.86 128.01 54.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.873 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 22.5 mm -94.85 102.11 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 112.182 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 283' ' ' GLU . 4.1 m -100.47 -169.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.769 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.594 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.6 p -154.86 151.54 28.72 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.055 0.455 . . . . 0.0 111.506 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -71.04 1.43 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.303 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -59.94 -40.1 87.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 111.035 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.3 p -81.83 168.13 18.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.7 mt-30 -60.0 -54.81 41.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.84 -39.43 94.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.425 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -53.66 -59.74 9.3 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.6 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.58 12.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.1 mt-30 -69.97 -40.05 75.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 110.909 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.39 -44.9 93.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.764 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 88.4 t -59.99 -45.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.708 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.74 -38.19 56.96 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.68 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.7 -94.56 0.48 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 155.46 34.09 0.02 OUTLIER Glycine 0 CA--C 1.522 0.523 0 C-N-CA 119.642 -1.265 . . . . 0.0 114.853 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.51 -20.07 7.92 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.522 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.59 130.38 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 118.574 1.187 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.54 151.11 19.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.031 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.1 mt -109.4 127.47 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -88.22 153.32 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 112.286 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.4 mtt-85 -70.04 -36.81 75.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.565 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -160.91 170.54 20.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.852 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -58.01 127.99 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.963 0.411 . . . . 0.0 110.721 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 159.87 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.908 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -87.16 132.25 33.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.0 136.91 50.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -59.96 130.65 47.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -66.18 147.18 49.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.7 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -149.9 170.11 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.01 -40.98 91.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.96 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.807 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.65 140.01 58.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.97 0.48 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.524 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -141.55 130.16 4.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.391 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.37 -39.97 89.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.079 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -115.47 24.16 11.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.09 -39.92 87.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.356 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.43 91.18 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.191 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.4 -137.62 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.87 39.95 16.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.96 -0.28 57.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.391 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.07 -39.94 87.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 110.518 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -68.07 -35.19 77.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.418 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.96 -34.06 71.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.082 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.13 -42.43 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.01 -40.01 87.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.889 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.651 0.262 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.1 p -76.62 -29.98 18.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.153 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -48.19 -47.88 35.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.768 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.92 75.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.08 -20.75 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.92 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.687 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 2.0 tm0? -58.85 -39.97 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.831 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.515 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 50.4 mt-10 -78.96 -30.0 44.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -53.46 5.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -72.63 -58.38 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.67 ' HG ' HD13 ' A' ' 321' ' ' ILE . 46.7 tp -55.13 -60.86 2.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 111.55 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.621 HG21 ' HB3' ' A' ' 398' ' ' GLU . 67.7 mt -59.94 -50.05 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.26 -38.92 57.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.25 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.1 ttt-85 -60.05 -39.95 87.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.281 0.563 . . . . 0.0 110.272 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.597 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 10.2 t80 -57.12 -48.55 78.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.749 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -80.01 -38.49 31.96 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -60.63 -47.89 84.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.7 mt-10 -62.91 -44.49 95.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -24.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.463 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.47 -13.8 59.58 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.568 ' HB2' HG22 ' A' ' 298' ' ' THR . 58.4 mt-30 -103.37 -0.16 30.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.54 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.59 30.99 20.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.655 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.5 p -69.43 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.864 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.24 49.2 74.26 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.342 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 41.2 mttt -128.61 36.3 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.66 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 88.0 m-85 -159.75 160.74 34.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.309 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 19.3 m -140.5 160.03 40.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.14 0.495 . . . . 0.0 111.391 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.412 ' HB3' ' HH ' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -137.79 127.13 24.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.914 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 107.76 152.83 17.58 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -58.94 -55.48 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 0.0 111.174 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -49.35 -56.46 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.42 -52.37 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 18.5 m -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.09 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.462 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 2.7 mp -67.25 -43.79 81.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.701 0.286 . . . . 0.0 111.28 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 314' ' ' MET . 20.7 mtmt -60.01 -47.62 85.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.4 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -69.98 -27.81 65.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.431 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.675 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.7 -26.59 59.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.92 -28.9 49.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 94.3 mmm -80.84 -7.3 59.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.726 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.52 14.28 27.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.701 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.8 -9.76 59.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.617 0.246 . . . . 0.0 110.9 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 312' ' ' LEU . 27.5 m -92.27 105.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 412' ' ' ILE . 35.2 tt0 -60.01 -50.01 75.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.563 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.412 ' CG2' ' HB ' ' A' ' 388' ' ' THR . 42.6 mm -135.58 125.99 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.477 ' HB2' HD11 ' A' ' 312' ' ' LEU . 56.4 tp -90.96 126.14 35.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.67 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -113.13 105.95 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.814 179.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 23.3 t -124.29 151.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.4 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' A' ' 393' ' ' THR . 92.6 m-85 -95.57 145.01 25.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 14.5 pt-20 -63.53 -34.52 77.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -92.24 45.19 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 23.8 tp -75.85 125.81 29.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 347' ' ' THR . 83.0 m-20 -92.06 24.43 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.551 HG21 HG11 ' A' ' 305' ' ' VAL . 31.7 mm -125.87 136.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.939 0.399 . . . . 0.0 111.595 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.564 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.7 mtt -139.84 161.8 36.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.323 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.65 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.1 ttt85 -89.22 115.8 26.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 111.671 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.561 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 8.3 m-85 -116.53 156.91 26.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.145 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.469 ' HA ' HD13 ' A' ' 343' ' ' ILE . 4.0 m -121.27 110.56 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 110.942 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.567 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 1.2 mm? -106.07 149.81 26.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.49 ' CD2' HD13 ' A' ' 369' ' ' ILE . 41.0 m170 -80.63 170.69 16.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -114.84 161.92 17.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.606 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -46.83 -29.66 2.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.32 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 339' ' ' GLU . . . -113.5 96.04 0.78 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.14 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 337' ' ' GLY . 0.8 OUTLIER -20.34 -44.95 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.537 0.735 . . . . 0.0 112.979 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 337' ' ' GLY . 44.8 mt-10 -73.44 42.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 110.964 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 60.3 tt0 -166.17 134.06 2.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -122.3 144.61 48.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 332' ' ' VAL . 8.4 mm -120.0 122.16 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.289 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 49.4 tp -132.17 160.67 35.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.373 0.606 . . . . 0.0 112.424 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.518 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 2.8 p90 -100.02 123.19 43.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.189 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.543 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 1.6 mm? -124.84 157.88 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 69.8 p -101.16 170.28 6.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.672 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.6 Cg_exo -44.7 -48.38 10.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.837 1.691 . . . . 0.0 112.012 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -49.92 75.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.51 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 346' ' ' LEU . 4.5 tp60 -69.59 -47.87 62.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 92.6 mt-10 -59.74 -35.72 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.586 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -58.03 -28.33 64.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.125 0.488 . . . . 0.0 110.305 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -84.36 21.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.0 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' A' ' 357' ' ' PHE . 2.9 ptmm? -55.76 -11.35 0.94 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 94.2 p -61.12 -56.21 23.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.763 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.447 ' C ' ' H ' ' A' ' 358' ' ' THR . 75.8 m80 -108.03 -50.21 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.744 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER 63.27 0.86 0.84 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.877 -178.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.477 HG23 ' HA2' ' A' ' 363' ' ' GLY . 15.3 t -88.18 -164.36 1.1 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.515 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.46 151.42 22.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 111.076 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -74.03 0.37 13.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.565 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -84.86 -50.16 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.212 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 1.2 t -106.55 -36.19 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 0.0 110.313 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.477 ' HA2' HG23 ' A' ' 358' ' ' THR . . . 73.21 22.79 78.59 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.496 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.574 ' O ' ' HG3' ' A' ' 364' ' ' GLN . 14.7 pt20 -166.81 94.5 0.49 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 112.097 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.467 ' CG ' ' CD2' ' A' ' 366' ' ' HIS . 4.2 pt-20 -159.08 -42.25 0.06 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.17 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.467 ' CD2' ' CG ' ' A' ' 365' ' ' GLU . 97.4 m-70 -110.0 160.91 16.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -151.0 119.71 6.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 53.2 tp -70.01 137.22 51.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.49 HD13 ' CD2' ' A' ' 334' ' ' HIS . 2.1 mp -106.61 -41.03 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.801 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 371' ' ' SER . 42.2 tt0 -155.63 167.7 29.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.561 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p -147.93 117.0 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.448 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.4 tpt -117.04 131.46 23.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.8 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.564 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.1 Cg_exo -60.16 120.56 8.4 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.87 1.713 . . . . 0.0 110.782 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 12.8 mt -62.21 -40.45 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.773 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 60.8 tp -60.06 -51.68 68.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.7 mt-10 -60.23 -42.42 95.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.964 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.403 ' CD1' ' ND2' ' A' ' 381' ' ' ASN . 82.5 t90 -62.26 -39.93 94.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.421 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.524 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -70.0 -25.89 63.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.97 46.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.3 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.67 -12.75 15.8 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.5 20.34 5.67 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -68.76 -17.52 64.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.577 0.227 . . . . 0.0 111.446 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -77.14 -47.13 21.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.125 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -61.43 -44.43 97.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.322 0.582 . . . . 0.0 110.622 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.513 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.1 m-85 -69.95 -17.72 63.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.885 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.21 1.96 65.45 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.324 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.76 164.76 16.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.162 0.506 . . . . 0.0 110.796 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.412 ' HB ' ' CG2' ' A' ' 319' ' ' ILE . 66.6 m -107.14 100.27 9.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.049 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.439 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.7 tm? -71.74 102.34 2.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.97 0.414 . . . . 0.0 110.858 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.687 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -110.31 140.84 44.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.111 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.3 mm -106.48 103.66 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 287' ' ' ILE . 7.8 m -101.07 -175.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.487 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 3.0 p -157.95 152.29 24.58 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -76.85 76.15 3.46 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -117.57 -29.98 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.313 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 35.1 m -113.55 -174.93 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.771 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 401' ' ' GLN . 31.0 mt-30 -59.98 -47.75 84.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.01 0.434 . . . . 0.0 110.341 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.621 ' HB3' HG21 ' A' ' 287' ' ' ILE . 22.1 mp0 -61.62 -41.93 98.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.47 -22.45 67.67 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.546 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.4 m -83.08 -21.56 33.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.791 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 397' ' ' GLN . 9.5 mm100 -75.79 -46.67 29.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.013 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.522 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -59.96 -49.97 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.085 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.642 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 96.9 t -59.98 -39.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -68.58 -42.9 77.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.399 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.1 -22.92 74.54 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.256 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 28.8 t80 -176.45 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.642 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 91.68 101.1 1.32 Allowed Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.564 -0.827 . . . . 0.0 115.101 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 409' ' ' ILE . . . 130.42 -34.22 2.73 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.178 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -150.8 127.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 111.939 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.457 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -150.74 138.12 6.47 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.77 142.24 14.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.601 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 318' ' ' GLU . 23.5 mt -104.66 126.71 59.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 59.2 mt -90.78 157.14 17.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.643 0.735 . . . . 0.0 112.466 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -70.04 -39.99 75.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.358 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 53.9 p90 -167.07 178.7 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.508 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.6 mtm180 -56.47 124.29 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.899 0.38 . . . . 0.0 110.7 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.04 159.98 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.21 130.93 45.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.773 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -100.0 15.75 26.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 425' ' ' GLN . 63.8 mt-30 -67.97 140.09 56.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 92.73 83.8 1.52 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.987 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.6 ttt -148.49 163.56 36.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.764 0.316 . . . . 0.0 110.76 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -60.0 -39.96 87.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.07 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.26 17.28 23.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.518 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 4.6 tp60 -59.99 -47.94 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.053 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 51.16 57.18 11.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.847 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -125.26 141.57 13.14 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.86 -40.04 87.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 93.7 m-20 -105.84 36.83 2.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.518 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 49.8 tt0 -59.91 -40.07 87.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.018 0.437 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.67 100.11 7.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.325 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 429' ' ' ASP . 1.3 p90 -117.34 130.94 56.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -86.1 6.84 27.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.81 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.97 -4.25 23.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.905 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.96 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.698 0.285 . . . . 0.0 111.068 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.95 -33.24 75.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.473 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.49 -34.26 72.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.268 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.02 -43.7 95.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -70.05 140.08 52.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.881 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.81 0.338 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.5 p -66.11 -29.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.313 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 278' ' ' VAL . 7.4 ttmm -51.58 -40.56 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.98 -50.06 75.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt -82.75 -20.94 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.653 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.663 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.59 -39.99 85.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.606 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.5 mt-10 -77.08 -29.97 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.269 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.65 -58.16 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 321' ' ' ILE . 16.2 tp -58.76 -54.66 44.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 398' ' ' GLU . 46.3 mt -60.03 -48.43 87.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.555 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.444 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.36 -37.88 67.19 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 44.0 ttt180 -60.0 -39.22 85.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.624 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.9 t80 -55.65 -45.73 77.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.755 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.4 -39.15 21.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.0 t0 -59.99 -43.2 95.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.402 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.18 -42.29 84.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 109.743 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.24 -23.81 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.6 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.04 -15.45 56.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.175 0.512 . . . . 0.0 110.006 178.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -104.84 2.08 29.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.622 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.25 29.72 18.43 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.966 0.413 . . . . 0.0 110.571 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 13.9 p -66.74 -12.98 60.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.915 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 49.12 73.39 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.443 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 17.5 mttp -126.38 36.84 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 95.3 m-85 -159.35 160.05 34.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.323 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -141.0 161.19 38.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.445 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.15 144.84 47.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.515 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.31 156.89 28.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.871 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -59.94 -55.89 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.195 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.4 pt-20 -47.27 -57.23 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 96.0 m-20 -61.13 -54.9 38.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.676 0.274 . . . . 0.0 111.386 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 28.1 m -56.51 -40.09 74.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.86 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.2 mp -66.88 -45.26 78.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.2 mtmt -56.63 -50.03 73.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.993 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.682 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.66 -34.5 74.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.914 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.52 -24.41 61.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.78 -7.96 59.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.098 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.1 10.96 36.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.123 -1.036 . . . . 0.0 111.544 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.02 -6.16 57.09 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.399 0.28 . . . . 0.0 110.766 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 312' ' ' LEU . 34.7 m -95.83 105.5 17.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.0 tt0 -59.59 -49.98 75.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.306 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.492 HD13 ' HB ' ' A' ' 388' ' ' THR . 28.0 mm -136.7 126.56 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.579 0.228 . . . . 0.0 111.375 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 312' ' ' LEU . 45.0 tp -89.73 126.49 35.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.94 0.4 . . . . 0.0 111.5 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.628 HD11 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -111.57 103.61 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.313 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 17.2 t -122.29 152.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -98.48 142.94 29.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 16.8 pt-20 -65.37 -24.0 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.833 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.32 33.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.762 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.6 tp -71.17 123.81 23.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -96.55 28.76 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 20.0 mm -126.61 133.19 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.042 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.549 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.1 mtt -140.6 162.47 35.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.22 29.76 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.092 0.472 . . . . 0.0 111.222 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 7.4 m-85 -124.81 160.76 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.8 112.23 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 111.411 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.71 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 1.9 mm? -101.56 129.61 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.507 ' CG ' HD13 ' A' ' 369' ' ' ILE . 57.1 m170 -137.11 150.74 48.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -111.55 152.75 27.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.92 129.94 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.596 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.16 35.18 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.768 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.43 23.6 2.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.658 0.266 . . . . 0.0 111.656 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -102.22 10.25 39.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.174 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -159.96 119.97 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 17.5 mt-10 -136.63 130.0 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -136.03 121.22 19.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 2.4 mm -113.14 112.39 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.672 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp -144.03 156.52 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.446 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.553 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 0.3 OUTLIER -85.02 137.15 33.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.104 178.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.554 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.7 mm? -127.71 164.05 22.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.596 0.713 . . . . 0.0 112.525 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.7 p -101.5 172.08 4.78 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.31 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 72.9 Cg_exo -48.95 -47.47 21.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 121.789 1.659 . . . . 0.0 111.815 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.15 -58.52 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -59.98 -48.99 79.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 91.1 mt-10 -59.96 -35.71 75.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.02 -34.05 69.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 109.756 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.66 40.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.856 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.702 ' HB2' HD22 ' A' ' 368' ' ' LEU . 4.1 pttt -70.46 -19.04 62.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.551 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.5 t -66.8 -40.03 87.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.107 0.48 . . . . 0.0 110.111 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.413 ' C ' ' H ' ' A' ' 358' ' ' THR . 90.4 m-70 -98.08 -56.44 2.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.089 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.595 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER 60.06 4.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.086 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.509 HG22 ' H ' ' A' ' 359' ' ' ASP . 3.3 m -91.67 174.41 7.37 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.509 ' H ' HG22 ' A' ' 358' ' ' THR . 96.4 m-20 -130.06 138.59 50.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -72.96 -1.98 19.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.368 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -104.54 -13.73 15.91 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.481 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 6.7 t -131.88 -36.33 1.2 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.576 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.28 76.45 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.635 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 358' ' ' THR . 37.5 mt-30 -50.04 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.33 133.03 35.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.362 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.71 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 73.5 m80 -147.11 164.43 33.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.141 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.27 108.1 7.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.912 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 354' ' ' LYS . 45.6 tp -63.52 139.96 58.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.157 0.503 . . . . 0.0 111.482 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.507 HD13 ' CG ' ' A' ' 334' ' ' HIS . 2.2 mp -111.7 -45.56 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.511 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -143.12 156.26 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.524 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -143.87 116.19 8.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.469 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.401 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.61 121.97 32.37 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.761 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.549 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.63 120.91 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.77 1.647 . . . . 0.0 110.712 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.7 mt -60.03 -44.09 94.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.265 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 69.1 tp -60.01 -50.87 72.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.99 85.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.638 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.28 -43.77 95.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.641 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.527 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 8.8 m-85 -73.59 -30.7 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.2 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.38 -25.09 60.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.495 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.71 -6.62 14.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.27 20.18 5.79 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.95 -14.48 63.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.615 0.245 . . . . 0.0 111.374 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.36 -40.41 30.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.923 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.1 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.52 -4.21 59.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.401 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.74 2.96 31.99 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.532 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.603 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -89.64 166.28 13.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 111.103 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.492 ' HB ' HD13 ' A' ' 319' ' ' ILE . 57.0 m -109.15 100.54 9.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.936 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 3.2 tm? -69.32 102.39 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.663 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.8 130.02 55.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.757 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.5 mm -95.86 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.173 0.511 . . . . 0.0 112.094 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.51 -171.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.155 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.5 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.55 155.33 26.16 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.274 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.48 11.31 0.63 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.15 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.04 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 111.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -92.06 170.83 9.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.838 0.352 . . . . 0.0 111.406 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.9 mt-30 -60.02 -54.38 46.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.575 ' HB3' HG23 ' A' ' 287' ' ' ILE . 15.4 mp0 -60.02 -39.98 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 0.0 109.502 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -54.09 -57.64 15.85 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.805 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.87 -19.53 51.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.36 -40.04 77.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.609 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -59.99 -46.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.464 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.92 -34.06 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.014 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.25 -54.08 20.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.309 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.73 -20.62 70.41 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.938 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.515 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.4 t80 174.97 -75.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.33 167.95 28.99 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.67 -51.47 3.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.835 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.55 131.79 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.294 0.547 . . . . 0.0 112.227 -178.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -150.82 141.05 8.33 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.68 145.87 15.95 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.866 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.1 mt -109.11 128.55 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.651 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.8 mt -90.68 153.17 20.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.766 0.793 . . . . 0.0 112.815 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.01 -37.92 75.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.542 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 417' ' ' VAL . 82.3 m-85 -158.25 -177.91 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.0 99.97 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.869 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 415' ' ' TYR . 2.3 p -143.42 137.73 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.161 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -146.32 100.25 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.632 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.07 -49.4 77.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.252 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.13 126.63 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -154.46 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.8 mtp 57.16 23.14 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.675 0.274 . . . . 0.0 111.079 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 424' ' ' TYR . 12.3 pt-20 -151.61 -53.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.397 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 423' ' ' GLU . 98.0 m-85 -160.88 88.61 0.77 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.683 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 32.0 mm-40 -69.99 -40.04 75.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.857 0.361 . . . . 0.0 110.88 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 156.11 -24.16 0.53 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.738 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -154.29 33.21 0.71 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.73 34.36 24.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 111.057 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -118.42 37.53 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.683 ' HA ' ' HG3' ' A' ' 425' ' ' GLN . 1.7 tm-20 -60.02 -41.04 91.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.43 99.1 5.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.397 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -116.68 117.07 28.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.84 -0.65 24.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.8 mt -50.94 -19.4 1.0 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.939 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -59.7 -40.01 86.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -74.9 -24.29 58.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.541 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.96 -38.42 82.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.452 . . . . 0.0 110.007 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.01 -46.44 89.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.887 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.04 -39.91 87.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.133 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.913 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.583 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.7 p -66.87 -29.43 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -56.53 -44.83 81.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.57 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.17 -47.54 82.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.205 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 278' ' ' VAL . 46.8 pt -75.64 -29.91 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.445 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -55.64 -41.8 74.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.591 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 55.1 mt-10 -69.96 -33.43 72.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -57.2 3.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -70.0 -58.08 4.25 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 31.4 tp -57.51 -57.44 12.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.591 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 13.6 mt -61.48 -49.79 82.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.506 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.73 -34.36 81.85 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.415 -0.897 . . . . 0.0 112.651 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.407 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 4.8 ttt85 -59.95 -37.78 80.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 9.4 t80 -60.13 -41.29 92.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.754 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -84.66 -39.44 18.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.49 -50.05 75.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.667 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.1 OUTLIER -64.31 -40.95 96.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.524 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 290' ' ' TYR . 82.0 mt -60.04 -23.26 26.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -15.39 46.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.331 0.586 . . . . 0.0 109.685 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.468 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 68.3 mt-30 -100.7 1.92 40.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.649 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 56.09 29.85 15.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.106 0.479 . . . . 0.0 110.035 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.561 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 34.9 p -69.97 -10.34 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.773 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.79 50.69 59.68 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.091 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 18.6 mtpt -127.96 38.76 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.653 ' HB3' ' CE2' ' A' ' 290' ' ' TYR . 81.7 m-85 -161.99 163.37 28.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 290' ' ' TYR . 1.8 p -146.43 162.39 38.35 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.417 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.1 p90 -138.68 133.06 31.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.323 . . . . 0.0 110.33 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 103.58 147.76 18.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.955 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 374' ' ' LEU . 0.2 OUTLIER -52.82 -60.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -44.54 -58.09 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.345 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.93 -54.49 41.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 111.235 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 10.6 m -55.73 -40.01 71.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.027 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 305' ' ' VAL . 2.5 mp -70.01 -41.21 74.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.697 0.284 . . . . 0.0 111.211 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mtmm -58.55 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.156 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.458 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.95 -27.96 64.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.685 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.69 -28.6 63.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.744 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.2 -26.48 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 93.2 mmm -82.5 -9.1 59.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.648 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.42 42.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.324 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.92 59.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.386 0.274 . . . . 0.0 110.975 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 312' ' ' LEU . 27.6 m -93.54 104.83 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 34.1 tt0 -59.91 -49.88 75.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.434 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.484 ' HA ' ' H ' ' A' ' 388' ' ' THR . 23.4 mm -133.96 126.15 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.65 0.262 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 308' ' ' THR . 43.6 tp -91.55 127.33 36.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.942 0.401 . . . . 0.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.646 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 2.3 mt -112.71 106.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 29.8 t -122.61 155.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.488 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.572 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.9 m-85 -102.65 143.92 31.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.7 pt-20 -61.78 -35.68 78.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.68 48.31 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.053 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -78.19 125.43 29.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.804 0.335 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -92.94 26.39 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.57 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.502 ' CG2' HG23 ' A' ' 305' ' ' VAL . 23.2 mm -128.36 136.31 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.561 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.584 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 59.8 mtt -139.97 161.93 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.811 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.643 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 46.8 ttm-85 -89.17 115.48 26.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.803 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.517 ' CE2' ' HG2' ' A' ' 351' ' ' GLU . 3.2 m-85 -115.48 154.74 28.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.495 ' HA ' HD13 ' A' ' 343' ' ' ILE . 9.4 m -118.85 111.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 366' ' ' HIS . 0.7 OUTLIER -99.08 155.42 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.757 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.464 ' CD2' HD11 ' A' ' 369' ' ' ILE . 1.8 m170 -98.12 179.61 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.893 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 1.8 m -116.95 161.36 19.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -45.11 -30.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -95.03 -121.4 3.61 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.751 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -163.46 13.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.25 30.26 5.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 20.6 tp10 -155.01 121.05 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.259 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.408 ' OE1' ' CD2' ' A' ' 334' ' ' HIS . 2.6 mt-10 -116.05 141.16 48.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -115.36 143.15 45.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 332' ' ' VAL . 11.1 mm -119.69 119.99 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.043 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 33.1 tp -132.67 158.96 40.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 112.064 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.479 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -97.67 120.03 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.539 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.4 mm? -124.46 167.48 14.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.554 0.692 . . . . 0.0 112.596 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 11.3 p -101.59 169.25 7.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.778 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 75.2 Cg_exo -49.46 -42.56 41.3 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.843 1.696 . . . . 0.0 111.745 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.26 -51.57 69.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.101 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.43 -46.61 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.996 0.426 . . . . 0.0 110.722 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 97.2 mt-10 -63.1 -28.42 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.852 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -56.25 -30.2 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 0.0 109.754 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.0 t0 -90.12 63.07 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.998 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 25.8 mtmt -70.08 -41.34 74.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -63.79 -57.93 8.39 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.405 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.502 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 36.3 m170 -80.96 -46.02 15.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.809 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.561 ' CD2' HD13 ' A' ' 333' ' ' LEU . 0.7 OUTLIER 49.92 15.2 0.16 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.175 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.526 HG22 ' HB2' ' A' ' 364' ' ' GLN . 1.8 m -107.17 -178.56 3.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.661 ' HB2' HG22 ' A' ' 362' ' ' THR . 94.1 m-20 -128.79 134.67 48.46 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -69.44 -7.0 33.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.694 0.283 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -100.89 -29.51 12.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.851 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.661 HG22 ' HB2' ' A' ' 359' ' ' ASP . 0.1 OUTLIER -109.01 -39.06 5.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.15 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.11 40.84 19.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.061 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.526 ' HB2' HG22 ' A' ' 358' ' ' THR . 14.1 mm-40 -41.47 166.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.148 -0.526 . . . . 0.0 111.676 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.22 17.19 14.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.735 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.652 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 72.7 m80 -87.81 157.03 19.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.271 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -147.75 115.19 6.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.802 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.444 HD21 ' CD2' ' A' ' 331' ' ' TYR . 56.1 tp -76.35 142.79 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 111.564 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.464 HD11 ' CD2' ' A' ' 334' ' ' HIS . 1.7 mp -117.44 -41.13 2.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.247 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 371' ' ' SER . 59.5 tt0 -144.78 167.85 21.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.368 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.454 ' CB ' ' CZ ' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -149.66 116.81 6.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.188 0.518 . . . . 0.0 111.494 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.0 tpt -111.66 126.93 27.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.229 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.584 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.3 Cg_exo -57.56 118.67 5.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.877 1.718 . . . . 0.0 111.003 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.643 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 15.2 mt -60.89 -39.95 91.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.887 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.469 HD12 ' CD1' ' A' ' 391' ' ' ILE . 57.1 tp -59.5 -52.8 64.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.2 mt-10 -58.87 -40.01 83.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.059 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -67.35 -34.0 76.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.316 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.431 ' CE2' ' HB3' ' A' ' 374' ' ' LEU . 11.3 m-85 -69.78 -31.51 69.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.433 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -9.24 50.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.655 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -101.08 -15.44 17.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.423 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.68 18.11 5.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.35 -20.94 64.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 0.0 111.019 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -79.84 -43.37 22.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.98 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 110.637 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.488 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.3 m-85 -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.64 71.25 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.127 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 317' ' ' VAL . . . -88.38 162.78 16.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.172 0.511 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.484 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 84.7 m -107.32 100.61 10.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.025 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.9 tm? -70.69 102.74 2.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.426 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -108.42 134.99 50.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.884 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 33.9 mm -99.93 102.09 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.447 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.7 m -101.6 -168.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.928 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.572 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -157.14 153.9 28.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.498 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -71.2 -1.86 14.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.532 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -41.36 92.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.534 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 283' ' ' GLU . 3.2 t -75.0 167.27 22.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 111.154 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 48.8 tp60 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.506 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 35.8 mp0 -67.72 -34.26 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 109.776 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.46 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -51.62 -57.9 11.27 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.921 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.7 m -62.74 -19.47 63.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 67.8 mt-30 -72.99 -40.08 65.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.996 0.427 . . . . 0.0 110.579 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.503 ' CE1' ' HA3' ' A' ' 410' ' ' GLY . 0.2 OUTLIER -65.86 -41.53 91.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.802 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.755 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 71.8 t -60.45 -37.91 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -62.38 -45.03 95.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 0.0 110.417 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -74.95 -20.66 79.34 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.05 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.462 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 12.5 t80 -174.98 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.755 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 94.3 96.69 1.6 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.264 -0.969 . . . . 0.0 114.853 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 409' ' ' ILE . . . 135.85 -31.68 2.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.764 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.0 OUTLIER -152.86 127.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 117.493 0.646 . . . . 0.0 111.895 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.07 136.04 5.65 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.42 134.69 11.33 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.139 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 318' ' ' GLU . 63.0 mt -99.13 129.99 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 47.0 mt -88.58 149.39 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.728 0.775 . . . . 0.0 113.005 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.58 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.6 mtt180 -71.24 -29.92 65.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.239 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 63.7 t80 -169.81 165.01 9.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.983 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -49.98 121.05 4.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.292 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.45 ' CG2' HD12 ' A' ' 413' ' ' LEU . 32.8 m -130.02 159.99 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.718 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 138.39 57.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -76.91 145.33 38.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -119.36 140.01 51.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 430' ' ' GLU . . . 62.78 108.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.4 mmm -142.24 169.05 18.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.92 -28.63 67.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -70.1 -30.93 68.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.942 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 149.01 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -58.37 -79.52 0.1 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.743 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -178.85 -90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.06 -33.46 72.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.15 20.16 10.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.01 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.4 ' CG ' ' HA2' ' A' ' 421' ' ' GLY . 39.7 tt0 -66.57 -39.94 88.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.569 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -109.12 62.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 40.4 p90 -79.94 99.82 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.314 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.21 13.42 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.051 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.46 -6.41 30.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.742 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -59.96 -40.03 87.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.769 0.318 . . . . 0.0 110.504 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.07 -32.35 71.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.91 -35.26 72.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.06 -44.64 94.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.874 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -60.06 -40.11 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.813 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 282' ' ' GLN . 9.8 p -65.8 -28.46 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 282' ' ' GLN . 3.0 pttm -53.13 -38.15 62.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.382 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.443 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -62.69 -47.04 85.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.547 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 2.6 pt -83.44 -41.89 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.091 0.472 . . . . 0.0 111.838 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.655 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -55.32 -36.85 66.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.7 pt-20 -69.93 -29.97 67.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -57.82 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.96 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -54.86 11.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 21.0 tp -58.55 -57.11 14.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 111.698 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.608 HD12 HG12 ' A' ' 392' ' ' VAL . 43.9 mt -59.95 -49.15 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.435 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -58.67 -38.17 91.09 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.217 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 8.3 ttt180 -60.02 -38.07 81.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 109.923 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.622 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 3.0 t80 -55.85 -48.62 75.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.93 -39.95 29.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.99 0.424 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 295' ' ' SER . 74.6 m-20 -60.01 -41.96 93.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.808 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.7 mt-10 -70.03 -41.15 74.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.424 HD12 ' CE1' ' A' ' 290' ' ' TYR . 79.4 mt -60.58 -22.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.04 -14.28 53.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 109.65 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -103.17 0.04 31.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.418 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 7.3 t70 56.34 33.4 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 109.977 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.774 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 31.4 p -73.46 -10.8 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.126 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 53.94 40.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.665 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.537 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 9.0 mtpt -130.24 36.23 4.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 86.6 m-85 -158.87 159.61 35.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.468 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 31.2 m -134.49 155.46 50.32 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.026 0.441 . . . . 0.0 111.378 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.486 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -134.87 118.32 16.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.82 155.41 10.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -56.22 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.824 0.345 . . . . 0.0 111.113 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.477 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 9.0 pt-20 -51.91 -51.23 58.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.733 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -63.13 -54.15 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.455 ' CG2' HD12 ' A' ' 320' ' ' LEU . 31.9 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.459 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.7 mp -65.61 -50.3 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 111.522 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -55.61 -52.38 63.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 -179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.423 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.42 -31.56 71.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.719 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.34 -27.42 61.5 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.839 0.352 . . . . 0.0 110.463 179.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -77.55 -27.6 51.62 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 30.9 mmt -80.86 -7.46 59.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.832 -1.531 . . . . 0.0 111.593 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.4 18.63 44.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.3 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.36 -2.97 58.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.601 -0.3 . . . . 0.0 111.377 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.719 HG22 ' HA ' ' A' ' 312' ' ' LEU . 29.9 m -99.43 104.47 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 412' ' ' ILE . 6.6 tp10 -57.12 -49.99 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.185 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.496 HG21 ' HB ' ' A' ' 388' ' ' THR . 42.5 mm -135.49 126.01 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.562 0.22 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.455 HD12 ' CG2' ' A' ' 308' ' ' THR . 37.3 tp -90.91 123.41 34.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 111.699 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.468 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.3 OUTLIER -109.68 103.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 389' ' ' LEU . 36.3 t -111.38 155.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.241 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.475 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 7.6 m-85 -103.61 142.45 34.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.174 0.511 . . . . 0.0 112.278 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 393' ' ' THR . 36.4 tt0 -68.07 156.78 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.017 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 28.27 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.92 0.391 . . . . 0.0 110.296 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.411 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.1 tp -59.96 125.5 23.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.409 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.08 30.31 1.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.7 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.65 HG21 HG22 ' A' ' 305' ' ' VAL . 26.5 mm -130.35 133.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.511 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.692 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 33.3 mtt -140.6 163.01 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.622 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.4 OUTLIER -88.19 118.79 28.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.801 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 59.9 m-85 -126.9 124.71 40.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 370' ' ' GLU . 4.7 m -92.15 117.48 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.536 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.556 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.2 mm? -100.94 164.4 11.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.153 0.502 . . . . 0.0 111.38 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.437 ' CG ' HD12 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -108.5 -173.77 2.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.779 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 40.9 t -116.06 160.24 20.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.96 -39.98 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -89.11 -6.08 72.17 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.717 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.6 p 66.86 27.97 8.88 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.908 0.385 . . . . 0.0 111.075 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -125.04 25.2 7.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.674 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 21.7 tp10 -165.74 130.21 2.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.76 129.69 56.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 0.0 111.176 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.72 141.52 48.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.727 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.41 ' CD1' HG13 ' A' ' 332' ' ' VAL . 3.0 mm -113.97 127.08 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.185 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 34.4 tp -140.7 160.62 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.776 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.504 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 2.5 p90 -100.93 125.7 47.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.629 ' HB2' ' HG2' ' A' ' 351' ' ' GLU . 2.7 mm? -122.3 157.71 31.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.544 0.688 . . . . 0.0 112.773 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.563 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.3 p -99.35 168.13 10.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.311 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.563 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 4.7 Cg_endo -46.43 -46.62 16.87 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.27 1.98 . . . . 0.0 112.297 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.65 -44.89 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -69.94 -46.64 64.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.801 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -68.73 -24.2 64.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.373 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -58.13 -25.12 61.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.307 0.575 . . . . 0.0 109.765 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.92 19.0 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.817 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 30.4 tttt -48.18 -26.0 1.73 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.7 p -64.3 -39.95 94.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.446 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 358' ' ' THR . 94.6 m-70 -106.66 -53.6 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.297 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.659 ' HB3' ' HB2' ' A' ' 366' ' ' HIS . 0.1 OUTLIER 62.7 3.6 1.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.617 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 359' ' ' ASP . 1.4 m -89.04 178.43 6.39 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.611 ' H ' HG23 ' A' ' 358' ' ' THR . 76.1 m-20 -130.33 130.47 44.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -68.4 -4.15 13.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.448 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -101.97 -19.04 15.39 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 359' ' ' ASP . 4.4 t -131.86 -37.32 1.16 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.555 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 365' ' ' GLU . . . 91.09 5.25 68.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.917 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.452 ' HG2' HG21 ' A' ' 362' ' ' THR . 61.1 mm-40 -52.83 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 363' ' ' GLY . 72.5 mm-40 -65.7 128.65 36.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.476 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 96.5 m-70 -140.08 153.48 46.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.506 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -139.51 113.2 8.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.327 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.5 ' HB3' ' HG3' ' A' ' 354' ' ' LYS . 49.9 tp -75.58 138.29 41.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.045 0.45 . . . . 0.0 111.55 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.437 HD12 ' CG ' ' A' ' 334' ' ' HIS . 3.3 mp -113.68 -35.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.191 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 33.9 mt-10 -140.05 150.2 44.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.015 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.514 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 2.8 p -141.13 115.08 9.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.182 0.515 . . . . 0.0 111.575 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.518 ' HE3' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -121.31 137.27 26.62 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.186 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.692 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 28.1 Cg_endo -64.31 122.97 11.09 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.117 1.878 . . . . 0.0 110.626 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.622 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 19.6 mt -65.3 -41.06 94.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 38.4 tp -60.08 -53.66 55.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.628 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 48.0 mt-10 -59.98 -40.38 88.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.024 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -62.49 -40.03 95.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.083 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.523 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.6 m-85 -70.54 -28.25 64.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.276 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -10.48 48.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.828 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.07 -9.49 14.72 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.5 m120 -129.2 19.45 5.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.604 0.24 . . . . 0.0 111.61 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -68.57 -17.41 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.597 0.237 . . . . 0.0 111.347 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -79.85 -46.97 15.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.02 -44.19 94.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.318 0.58 . . . . 0.0 109.96 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.544 ' CD2' HD23 ' A' ' 312' ' ' LEU . 26.7 m-85 -73.49 -19.97 60.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.039 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . 0.466 ' HA3' HH22 ' A' ' 414' ' ' ARG . . . 74.87 2.14 64.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.454 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.22 165.37 18.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.073 0.463 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.496 ' HB ' HG21 ' A' ' 319' ' ' ILE . 24.2 m -107.68 100.67 10.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 322' ' ' VAL . 0.9 OUTLIER -73.54 107.34 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.628 -178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.655 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -115.39 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.593 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 324' ' ' GLU . 27.2 mm -98.5 102.34 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.114 0.483 . . . . 0.0 112.26 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.608 HG12 HD12 ' A' ' 287' ' ' ILE . 27.7 m -114.06 133.62 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.607 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 3.2 p -112.74 166.21 11.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -73.48 70.06 1.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.846 0.355 . . . . 0.0 111.352 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.401 ' HE2' ' OE2' ' A' ' 283' ' ' GLU . 4.9 ptmt -119.83 12.02 12.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 47.5 t -155.17 179.57 9.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -59.38 -53.32 59.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 50.9 mp0 -63.65 -39.98 95.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.404 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.87 -25.4 67.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.521 -0.847 . . . . 0.0 110.992 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.5 m -83.74 -23.38 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.554 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.78 -43.44 65.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.376 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' A' ' 407' ' ' GLY . 3.2 m-85 -65.3 -48.39 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.21 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.44 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 75.4 t -59.95 -40.08 81.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -48.17 33.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -73.22 -28.29 66.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 290' ' ' TYR . 0.1 OUTLIER -157.68 -84.72 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 100.09 151.73 26.04 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.461 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.99 -47.49 3.13 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.67 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -148.94 134.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 118.232 1.016 . . . . 0.0 112.985 -177.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.39 145.49 12.96 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.72 147.6 18.96 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.712 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 318' ' ' GLU . 18.0 mt -106.5 126.72 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.3 mt -87.85 156.15 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 0.0 112.195 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.466 HH22 ' HA3' ' A' ' 386' ' ' GLY . 16.3 mtt-85 -77.77 -33.07 52.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.685 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -156.39 170.01 23.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.753 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.774 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -64.21 120.78 12.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.41 ' CG2' HD12 ' A' ' 413' ' ' LEU . 17.0 m -130.04 159.95 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.997 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -80.36 170.03 16.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.798 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.65 137.74 37.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.98 -40.01 87.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.426 ' HA3' ' HG3' ' A' ' 430' ' ' GLU . . . 89.47 163.87 39.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 52.6 mtp -143.08 160.28 40.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.1 -39.94 87.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.032 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 424' ' ' TYR . 53.5 t80 -98.38 11.91 36.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 130.56 -51.82 0.85 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.619 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -59.46 126.88 43.43 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.527 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.05 -40.02 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -115.91 31.07 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HG3' ' HA3' ' A' ' 421' ' ' GLY . 8.2 tp10 -59.94 -40.03 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.551 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.404 ' CZ ' ' OD2' ' A' ' 433' ' ' ASP . 64.8 t80 -120.56 102.35 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.297 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -130.97 80.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . 0.404 ' OD2' ' CZ ' ' A' ' 431' ' ' PHE . 96.6 m-20 -95.19 18.65 11.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.13 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.28 -15.42 47.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.86 -40.02 87.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -80.62 -20.22 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -59.97 -38.46 82.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.313 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.92 -49.18 78.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.951 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -67.84 139.97 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.914 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.1 m120 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.733 0.302 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.6 p -58.88 -27.21 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.109 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -41.26 76.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.039 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.97 -47.77 84.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -80.01 -22.83 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.432 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -57.48 -40.01 77.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.212 0.53 . . . . 0.0 110.019 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.585 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 1.9 mp0 -75.69 -51.34 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.407 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -40.05 87.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -84.55 -58.69 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.655 ' HG ' HD13 ' A' ' 321' ' ' ILE . 29.9 tp -60.01 -55.84 29.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.909 0.385 . . . . 0.0 111.834 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 398' ' ' GLU . 67.3 mt -59.95 -47.88 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.572 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.407 ' HA2' ' OE1' ' A' ' 398' ' ' GLU . . . -57.81 -37.79 85.69 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.444 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt180 -60.02 -42.41 94.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.513 ' CE1' ' CE1' ' A' ' 402' ' ' PHE . 5.5 t80 -59.99 -41.71 92.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.516 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.417 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.7 t80 -84.27 -40.98 17.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -60.57 -43.37 97.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.663 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.543 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 75.4 mt-10 -60.06 -40.03 88.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.947 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.544 HG12 ' CD1' ' A' ' 301' ' ' TYR . 64.1 mt -56.4 -30.26 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 t -53.03 -29.87 32.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 21.8 mt-30 -94.77 1.46 55.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.26 32.03 17.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.978 0.418 . . . . 0.0 110.085 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.603 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 1.5 p -64.26 -13.14 47.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.541 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.85 47.57 87.9 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.699 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 413' ' ' LEU . 36.3 mttp -129.48 48.05 2.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.544 ' CD1' HG12 ' A' ' 294' ' ' ILE . 0.1 OUTLIER -170.51 168.08 7.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 111.348 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.6 p -153.1 169.0 24.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.42 135.64 33.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.047 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 104.17 146.52 15.98 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.815 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.892 HG21 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.47 -57.82 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.909 0.385 . . . . 0.0 110.982 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -49.02 -53.48 19.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.397 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.77 -53.04 53.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.312 . . . . 0.0 111.29 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 7.4 m -57.88 -38.58 76.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.416 ' CD1' HG13 ' A' ' 305' ' ' VAL . 3.0 mp -69.07 -43.64 74.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.371 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 12.3 mtmm -57.37 -49.99 74.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.457 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -71.1 -26.08 62.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.389 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.667 ' HG ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.07 -27.28 60.83 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.923 0.392 . . . . 0.0 110.586 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -77.51 -28.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.1 mmt -80.54 -7.01 59.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.979 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.91 14.48 23.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.677 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.29 -6.59 59.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.395 0.278 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.739 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 20.8 m -93.16 105.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 37.3 tt0 -59.98 -50.0 75.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 388' ' ' THR . 32.9 mm -135.22 126.34 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.529 0.204 . . . . 0.0 111.483 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 50.2 tp -92.0 125.52 36.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.022 0.439 . . . . 0.0 110.914 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.655 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -112.41 106.95 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.975 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 18.9 t -124.24 158.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.282 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.598 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 90.3 m-85 -104.58 146.48 28.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.42 . . . . 0.0 111.345 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.479 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 15.9 pt-20 -64.97 -30.9 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -97.25 49.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 20.3 tp -80.19 126.16 30.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 347' ' ' THR . 35.8 p-10 -92.67 21.42 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.468 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.892 HG22 HG21 ' A' ' 305' ' ' VAL . 14.8 mm -124.7 136.78 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.535 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 40.2 mtt -140.52 161.6 37.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.868 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.476 ' HG2' HD23 ' A' ' 374' ' ' LEU . 11.1 mmt-85 -89.3 120.52 30.72 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.072 0.463 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.613 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.4 m-85 -118.08 152.34 35.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.739 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.613 ' CG2' ' HB2' ' A' ' 370' ' ' GLU . 15.4 m -116.44 108.03 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 368' ' ' LEU . 1.6 mm? -96.36 150.02 21.04 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.506 ' CG ' HD13 ' A' ' 369' ' ' ILE . 3.7 m170 -91.58 179.75 5.57 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.962 0.411 . . . . 0.0 111.102 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.57 161.44 20.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.692 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -45.19 -30.06 1.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -92.75 -118.17 2.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.058 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -168.85 25.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.691 0.281 . . . . 0.0 111.722 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.49 38.37 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 110.047 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -157.04 120.04 4.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.16 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -114.18 139.16 49.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.113 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -117.57 142.57 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.477 HD11 ' HA ' ' A' ' 332' ' ' VAL . 8.3 mm -120.75 116.67 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.491 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 48.7 tp -128.49 157.85 39.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.308 0.575 . . . . 0.0 112.256 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.624 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.21 119.01 36.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.773 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.61 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 0.9 OUTLIER -121.36 154.23 36.73 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.3 p -101.27 171.44 5.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.087 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.607 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.9 Cg_exo -44.02 -47.39 10.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.858 1.705 . . . . 0.0 112.106 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.0 pt-20 -59.98 -49.04 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 97.5 mt-30 -70.22 -46.52 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.613 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 90.2 mt-10 -60.74 -33.59 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.303 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.95 -36.16 72.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 66.0 t0 -84.53 58.45 4.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.724 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.457 ' HG3' HD22 ' A' ' 368' ' ' LEU . 21.5 ttpt -67.1 -39.95 86.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 54.1 m -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.469 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 35.1 m80 -102.49 -55.87 2.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 0.0 111.08 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.61 ' CZ ' ' HG ' ' A' ' 346' ' ' LEU . 0.1 OUTLIER 60.56 3.22 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.206 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.589 HG23 ' N ' ' A' ' 365' ' ' GLU . 6.4 m -88.18 -174.56 4.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.958 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.52 ' H ' ' CG2' ' A' ' 358' ' ' THR . 95.9 m-20 -81.24 162.53 23.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.586 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -73.08 -3.96 29.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -82.15 -44.39 16.51 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.907 0.384 . . . . 0.0 111.035 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.92 -35.5 3.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.874 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.466 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 63.29 18.92 61.32 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.117 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -155.59 84.93 1.04 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 358' ' ' THR . 53.4 mm-40 -144.17 -39.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.364 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -128.23 171.37 12.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.735 0.302 . . . . 0.0 111.093 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -145.36 118.89 9.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.464 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.633 ' HA ' HD12 ' A' ' 333' ' ' LEU . 55.5 tp -70.02 134.31 48.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.506 HD13 ' CG ' ' A' ' 334' ' ' HIS . 4.0 mp -112.5 -45.1 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.187 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.613 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 54.0 mm-40 -137.64 162.98 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.3 p -148.86 117.35 6.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.132 0.491 . . . . 0.0 111.401 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 20.3 tpp -112.9 128.22 25.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.669 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.487 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 34.1 Cg_exo -59.95 116.96 3.67 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 121.925 1.75 . . . . 0.0 110.618 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.476 HD23 ' HG2' ' A' ' 330' ' ' ARG . 6.5 mt -60.06 -39.47 86.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.851 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.479 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 59.4 tp -60.03 -50.69 72.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.7 mt-10 -60.02 -39.95 87.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -66.31 -36.66 83.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.618 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -26.38 65.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.76 -18.64 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.785 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -105.76 4.89 30.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 384' ' ' LYS . 39.4 t-20 -139.79 13.85 2.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -69.98 -17.58 63.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -77.16 -48.37 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . 0.444 ' HB2' ' OD1' ' A' ' 381' ' ' ASN . 34.1 mttt -60.11 -44.6 94.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.546 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.5 m-85 -69.89 -16.4 63.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.894 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.4 62.7 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.177 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.582 ' CB ' HG21 ' A' ' 317' ' ' VAL . . . -85.52 162.01 19.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.442 ' HB ' HD11 ' A' ' 319' ' ' ILE . 72.8 m -105.71 100.05 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.823 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.421 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.1 tm? -74.47 103.13 4.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.531 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.2 mm-40 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.694 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 22.4 mm -96.08 104.34 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 14.7 m -100.87 -172.57 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.235 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.536 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -158.57 154.15 26.14 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.098 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.403 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.6 p-10 -67.91 5.6 0.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -59.96 -39.97 87.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.8 m -91.1 169.76 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.9 0.381 . . . . 0.0 111.525 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.94 -49.34 78.07 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.621 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.646 ' HB3' HG23 ' A' ' 287' ' ' ILE . 60.8 mm-40 -63.49 -35.94 82.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.642 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -24.02 66.28 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.004 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 59.8 m -83.94 -23.15 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.614 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.09 -41.59 63.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.602 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.598 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.3 OUTLIER -65.0 -44.0 90.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.797 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 92.3 t -58.77 -32.84 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.486 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.07 -54.23 14.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.225 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -55.65 -53.79 39.2 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.887 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.415 ' CE1' HD13 ' A' ' 409' ' ' ILE . 46.6 t80 -137.09 -66.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.797 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 102.7 81.13 1.52 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.517 -0.849 . . . . 0.0 115.163 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.02 -29.4 2.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.991 -1.1 . . . . 0.0 114.15 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.518 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.2 OUTLIER -149.98 130.64 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.689 0.744 . . . . 0.0 112.229 -178.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.503 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.99 135.12 5.13 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.95 142.15 14.37 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.461 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 318' ' ' GLU . 81.4 mt -109.96 130.0 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.8 mt -88.59 155.24 19.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.583 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 74.4 mtm180 -70.03 -39.96 75.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.581 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.553 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 54.4 p90 -158.42 169.92 23.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.7 mmm180 -56.15 128.2 34.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.0 159.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.042 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.67 127.39 40.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.19 134.21 47.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -133.64 156.4 47.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.711 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 72.58 96.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.394 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.3 mtt -146.19 161.81 39.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.755 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.99 -40.04 87.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.27 21.25 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.467 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 6.1 tp-100 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 146.25 -100.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.823 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.84 100.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.653 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.35 10.37 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.22 . . . . 0.0 111.379 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.5 23.05 14.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.733 0.302 . . . . 0.0 110.47 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.467 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 69.1 mt-10 -66.12 -40.01 90.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.163 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -101.4 49.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 36.5 p90 -65.38 89.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 111.201 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.07 13.59 14.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.462 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.79 -18.13 41.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.606 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.379 . . . . 0.0 110.313 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -79.48 -19.96 48.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.83 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.74 -38.61 82.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.91 -41.21 91.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.933 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.86 152.24 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 34.8 t30 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.67 0.271 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -60.03 -29.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.284 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.402 ' N ' HG12 ' A' ' 278' ' ' VAL . 8.6 mmtp -52.27 -47.28 65.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.609 0.242 . . . . 0.0 111.526 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -49.92 75.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 278' ' ' VAL . 45.7 pt -75.75 -26.73 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.799 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.635 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.3 tm0? -55.28 -43.99 75.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 0.0 109.993 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.695 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 64.5 mt-10 -77.59 -41.53 38.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -70.76 -40.07 72.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -87.03 -58.83 2.44 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.597 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 21.5 tp -59.94 -56.43 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 30.6 mt -60.72 -48.71 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.333 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.13 -38.83 78.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.444 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.427 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 29.7 ttt180 -60.02 -39.61 86.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.328 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.573 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 5.7 t80 -55.59 -49.85 71.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.506 ' CE2' ' CB ' ' A' ' 401' ' ' GLN . 63.6 m-85 -79.41 -38.37 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.042 0.449 . . . . 0.0 111.006 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.93 -49.79 76.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.331 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.641 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.9 mt-10 -63.76 -45.43 89.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.877 0.37 . . . . 0.0 110.03 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 93.6 mt -58.02 -23.6 21.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.42 -15.18 47.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.49 0.662 . . . . 0.0 109.549 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 34.9 mt-30 -103.25 2.38 34.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.09 31.57 18.41 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.177 0.513 . . . . 0.0 110.25 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 25.2 p -70.02 -9.99 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.766 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.52 48.03 73.0 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 119.926 -1.13 . . . . 0.0 113.655 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.516 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 33.5 mtmt -128.4 36.97 4.2 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.641 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 89.6 m-85 -160.0 160.04 32.84 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.35 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.13 159.42 43.32 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.747 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.8 p90 -131.9 125.35 31.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 114.94 169.13 15.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.765 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.554 HG23 ' CG2' ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.45 -56.81 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 13.2 pt-20 -48.78 -50.35 34.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.463 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.32 -53.6 28.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.754 0.311 . . . . 0.0 111.368 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.444 HG22 HG23 ' A' ' 409' ' ' ILE . 60.2 m -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.244 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.455 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 3.0 mp -65.81 -45.04 83.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.9 mttm -58.95 -48.08 82.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.439 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.457 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.01 -27.9 65.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.233 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.809 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.55 -27.87 61.56 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.804 0.335 . . . . 0.0 110.762 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -76.47 -26.82 55.77 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.2 mmt -81.82 -7.05 59.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.75 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.16 35.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.544 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.9 -2.11 58.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.289 0.236 . . . . 0.0 111.143 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.809 HG23 ' HA ' ' A' ' 312' ' ' LEU . 27.7 m -99.54 104.79 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 412' ' ' ILE . 34.9 tt0 -56.8 -50.07 73.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.279 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 319' ' ' ILE . 39.8 mm -136.42 127.56 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.668 0.27 . . . . 0.0 111.466 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 312' ' ' LEU . 41.9 tp -95.34 128.62 42.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.026 0.441 . . . . 0.0 111.342 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.597 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -117.18 110.13 30.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 110.172 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 12.2 t -125.47 162.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.136 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.599 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 90.4 m-85 -107.29 145.39 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.476 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.6 pt-20 -63.61 -41.43 98.3 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -86.36 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 34.6 tp -89.24 120.6 30.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.604 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -90.06 26.64 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.554 ' CG2' HG23 ' A' ' 305' ' ' VAL . 23.9 mm -123.45 136.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.135 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.715 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 73.7 mtp -140.05 162.36 35.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.236 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.682 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.9 ttt-85 -84.7 106.27 16.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.991 0.424 . . . . 0.0 111.897 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.566 ' CD2' HD13 ' A' ' 368' ' ' LEU . 7.6 m-85 -120.57 123.54 43.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.259 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.0 m -97.58 124.82 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 0.0 111.517 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 367' ' ' GLU . 2.1 mm? -117.35 139.98 50.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.687 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.535 ' CE1' HG13 ' A' ' 369' ' ' ILE . 48.8 m170 -117.75 136.21 53.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.04 0.447 . . . . 0.0 110.557 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 58.5 m -110.08 150.5 28.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.11 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 339' ' ' GLU . 89.1 mt-30 60.02 25.63 14.88 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.398 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 84.02 -39.09 2.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.593 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.87 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 336' ' ' GLN . 54.8 tt0 -59.98 -38.24 82.0 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.733 0.301 . . . . 0.0 111.062 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -143.92 119.08 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.8 mt-10 -120.04 128.94 53.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.767 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.56 150.95 50.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.585 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.432 ' N ' ' CD1' ' A' ' 343' ' ' ILE . 1.4 mm -109.29 136.34 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.1 tp -143.99 159.48 42.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 112.54 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.538 ' HD2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.08 134.43 41.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.579 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.545 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -128.12 161.17 29.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.615 0.721 . . . . 0.0 112.87 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.2 p -101.56 168.76 8.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.372 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.545 ' O ' ' HG2' ' A' ' 352' ' ' LYS . 3.5 Cg_endo -45.66 -47.42 13.59 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.283 1.989 . . . . 0.0 111.982 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.8 -50.07 74.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.743 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -69.05 -46.09 68.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.5 ' HG2' ' CE2' ' A' ' 331' ' ' TYR . 76.4 mt-10 -58.76 -33.43 70.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.869 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 49.4 mmtt -57.92 -32.93 68.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.349 0.595 . . . . 0.0 109.597 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -92.63 36.74 1.01 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.95 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.587 ' HB2' ' CD1' ' A' ' 368' ' ' LEU . 5.3 pttt -70.05 -28.62 65.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 87.1 p -59.97 -40.03 87.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.051 0.453 . . . . 0.0 110.436 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 358' ' ' THR . 95.1 m-70 -98.76 -51.63 3.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.244 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.545 ' CE1' ' HG ' ' A' ' 346' ' ' LEU . 0.2 OUTLIER 56.9 10.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.98 0.419 . . . . 0.0 110.25 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 364' ' ' GLN . 2.0 m -101.79 -179.96 4.16 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.678 ' HB2' HG23 ' A' ' 362' ' ' THR . 76.5 m-20 -129.08 130.96 47.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -67.16 -4.06 9.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.746 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -101.31 -22.02 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.678 HG23 ' HB2' ' A' ' 359' ' ' ASP . 10.3 t -119.44 -35.36 3.59 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.076 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.04 42.63 15.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.794 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.467 ' HB2' HG21 ' A' ' 358' ' ' THR . 58.5 mt-30 -52.05 -172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.447 . . . . 0.0 111.206 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -135.49 29.31 3.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -70.31 153.42 43.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.386 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.482 ' O ' HD12 ' A' ' 369' ' ' ILE . 43.5 mt-10 -151.85 123.09 7.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.587 ' CD1' ' HB2' ' A' ' 354' ' ' LYS . 6.9 tt -78.79 129.06 34.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.706 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.535 HG13 ' CE1' ' A' ' 334' ' ' HIS . 1.5 mm -102.47 -46.49 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.656 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.463 ' N ' HD23 ' A' ' 368' ' ' LEU . 33.9 tt0 -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.008 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.2 OUTLIER -144.93 115.85 7.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 7.7 tpt -122.22 141.2 33.98 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.556 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.715 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.2 Cg_exo -62.96 124.4 13.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.232 1.955 . . . . 0.0 110.399 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.682 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.5 mt -68.42 -40.55 81.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.476 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.8 tp -59.95 -51.9 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 47.2 mt-10 -59.92 -39.96 87.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -62.21 -39.94 94.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.579 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.473 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.61 -27.09 61.95 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.477 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.81 -8.83 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.894 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.09 -9.93 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 18.94 5.9 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.71 -20.13 65.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.558 0.218 . . . . 0.0 111.202 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -79.13 -47.43 16.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -60.59 -45.24 94.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.477 ' CD2' HD23 ' A' ' 312' ' ' LEU . 25.9 m-85 -71.38 -19.13 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.635 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.03 73.91 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.044 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.421 ' HB3' HG21 ' A' ' 317' ' ' VAL . . . -84.6 160.99 20.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.124 0.488 . . . . 0.0 110.338 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.438 ' HB ' HD12 ' A' ' 319' ' ' ILE . 64.5 m -106.47 99.87 9.42 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.43 102.7 5.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.388 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.635 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.2 mm-40 -109.17 135.64 49.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.756 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 43.4 mm -99.98 104.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.0 m -101.38 -170.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.148 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.524 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -157.55 151.47 24.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.056 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -76.58 69.97 3.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.851 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -43.47 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.5 m -90.03 176.71 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.743 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 398' ' ' GLU . 4.7 pt20 -60.02 -44.29 94.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.584 ' HB3' HG23 ' A' ' 287' ' ' ILE . 63.7 mm-40 -69.99 -41.51 74.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.727 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -19.23 60.84 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.545 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.0 m -83.9 -21.82 31.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.397 -0.401 . . . . 0.0 110.72 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.506 ' CB ' ' CE2' ' A' ' 291' ' ' PHE . 81.2 mt-30 -75.84 -41.37 52.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.784 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.599 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 7.3 m-30 -59.94 -44.99 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.889 0.376 . . . . 0.0 110.769 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.6 t -60.01 -40.09 82.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.07 -40.03 47.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.042 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -67.41 -38.42 91.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.924 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.747 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 2.2 p90 -142.56 -78.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.756 0.312 . . . . 0.0 110.334 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 135.65 47.93 0.08 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.832 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.63 -37.04 1.96 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.393 -1.384 . . . . 0.0 115.416 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.566 ' O ' ' CD2' ' A' ' 406' ' ' PHE . 1.1 mp -126.47 128.88 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.751 0.775 . . . . 0.0 112.977 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.64 136.76 6.38 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -121.49 140.15 13.66 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.744 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.496 ' CG2' ' CE2' ' A' ' 301' ' ' TYR . 18.7 mt -103.4 127.18 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.7 mt -91.55 158.58 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 112.732 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.55 -39.89 67.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.435 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.2 p90 -165.1 176.05 8.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -57.78 130.57 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.935 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.85 160.0 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.108 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -105.55 49.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.203 0.525 . . . . 0.0 111.231 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -49.99 75.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -139.81 139.07 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -65.87 120.02 15.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.475 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 61.4 mtt -130.9 162.26 30.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.888 0.375 . . . . 0.0 110.932 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -59.95 -40.0 87.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -82.05 5.67 18.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.52 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 5.1 tp-100 -59.97 -39.99 87.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.788 0.327 . . . . 0.0 111.043 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.01 -32.28 7.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -92.93 110.15 3.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -60.06 -39.95 87.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -100.91 33.05 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.682 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.52 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 16.1 tp10 -59.93 -40.02 87.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -117.13 101.19 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -133.27 121.72 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.253 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -79.48 0.05 31.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 109.7 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.95 -9.85 54.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -60.03 -40.3 88.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.795 0.331 . . . . 0.0 110.629 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.0 -29.78 66.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -60.05 -34.86 73.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.314 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.91 -49.99 75.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.253 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -107.01 121.63 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.926 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.676 0.274 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.81 -29.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -41.27 37.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.917 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -50.02 75.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.667 0.27 . . . . 0.0 111.544 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -82.95 -27.26 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 111.766 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.714 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.449 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.489 ' HB2' HD11 ' A' ' 287' ' ' ILE . 17.6 pt-20 -77.61 -24.61 49.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.548 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -83.94 -51.47 7.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -75.37 -57.11 4.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.554 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 24.2 tp -59.1 -53.76 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.841 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.504 HD12 ' HB ' ' A' ' 392' ' ' VAL . 29.5 mt -58.93 -49.96 81.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.7 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.32 -37.02 71.59 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -60.01 -37.51 79.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.5 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.576 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.3 t80 -58.86 -45.51 89.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.612 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.91 -39.16 17.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.717 0.294 . . . . 0.0 111.444 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.6 t0 -62.29 -45.2 94.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 111.336 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.659 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 18.4 tp10 -67.64 -39.98 84.59 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 301' ' ' TYR . 80.4 mt -62.07 -26.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.43 -14.73 13.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.074 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.463 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 23.5 mt-30 -99.24 1.23 44.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.603 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.92 27.43 16.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.317 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.614 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 17.2 p -64.88 -13.38 56.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.941 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 58.38 45.06 94.81 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.23 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 4.7 ptpt -130.89 46.6 2.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.041 0.421 . . . . 0.0 110.782 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 98.6 m-85 -160.49 160.96 32.66 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.954 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 27.6 m -141.56 159.38 42.35 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.812 0.339 . . . . 0.0 111.234 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.435 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.2 p90 -135.4 124.68 24.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.621 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.513 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 107.68 156.09 19.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.311 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -59.97 -53.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 20.5 pt-20 -51.8 -51.93 52.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.47 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 87.5 m-20 -67.02 -53.17 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 0.0 111.095 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 42.0 m -58.05 -40.01 79.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.017 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.4 mp -67.81 -46.59 71.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 41.3 mtmt -54.45 -50.03 68.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.941 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.449 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -74.17 -24.82 59.44 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.321 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.776 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.63 -33.28 68.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.004 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -72.77 -25.52 61.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 4.3 mmt -82.46 -7.72 59.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.956 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.54 13.54 45.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.172 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.93 -6.99 59.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.549 0.34 . . . . 0.0 111.094 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 312' ' ' LEU . 35.6 m -99.79 106.68 19.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 37.4 tt0 -60.0 -52.7 64.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.696 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 388' ' ' THR . 26.7 mm -130.31 125.55 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.401 0.144 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.441 HD13 ' CG2' ' A' ' 308' ' ' THR . 44.2 tp -91.15 127.4 36.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.959 0.409 . . . . 0.0 111.081 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.554 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.0 OUTLIER -112.87 106.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.352 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 21.7 t -120.94 147.5 24.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.314 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.522 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.7 m-85 -90.17 143.19 26.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.0 112.252 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 12.2 tp10 -60.07 -43.06 95.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -91.6 53.57 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.4 tp -84.34 124.9 31.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -95.47 29.2 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.047 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 345' ' ' TYR . 18.8 mm -123.84 131.45 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.926 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.8 mtt -140.58 162.54 35.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.507 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.0 ttt-85 -90.91 120.19 31.72 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.109 0.481 . . . . 0.0 111.606 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.549 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 18.3 m-85 -130.91 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.013 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.473 ' O ' HD11 ' A' ' 369' ' ' ILE . 2.4 m -98.31 119.18 45.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 111.359 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.499 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 1.3 mm? -104.57 119.94 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.514 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.483 ' CG ' ' CD1' ' A' ' 369' ' ' ILE . 47.7 m170 -129.44 152.63 48.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.225 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 18.2 m -103.27 160.95 14.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.607 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.06 130.03 44.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 89.59 12.92 62.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.91 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.6 p 48.84 39.93 15.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.711 0.291 . . . . 0.0 111.44 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -103.28 8.64 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.619 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 9.9 tp10 -163.84 122.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.803 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -129.78 128.17 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.525 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 24.4 tttp -140.36 121.33 14.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 1.9 mm -113.8 115.51 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 26.1 tp -143.07 160.95 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.019 0.438 . . . . 0.0 111.508 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.555 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -90.41 135.49 33.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.315 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.531 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.3 mm? -126.85 158.46 36.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.693 0.759 . . . . 0.0 112.63 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.584 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.6 p -101.09 169.22 8.07 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.741 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.584 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 2.2 Cg_endo -44.64 -48.83 9.96 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.055 1.836 . . . . 0.0 111.92 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.559 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.97 -46.07 66.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.767 0.317 . . . . 0.0 111.647 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 57.1 mt-10 -59.96 -38.44 82.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.651 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 13.9 mmtm -58.29 -32.68 68.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.134 0.492 . . . . 0.0 110.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.24 37.88 0.95 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.36 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.606 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -73.11 -12.72 61.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.979 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 70.0 m -59.99 -39.98 87.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' A' ' 358' ' ' THR . 58.8 m80 -104.0 -56.91 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.224 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER 60.66 -0.74 0.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 364' ' ' GLN . 1.3 m -86.85 -169.69 2.74 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.623 0.249 . . . . 0.0 111.182 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.434 ' H ' ' CG2' ' A' ' 358' ' ' THR . 93.6 m-20 -90.73 158.12 17.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.107 0.479 . . . . 0.0 111.266 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -75.17 -3.53 33.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.981 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.09 -49.29 14.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.301 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.457 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 1.3 t -110.17 -35.21 6.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.173 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 71.11 22.43 78.49 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.618 ' HB2' HG22 ' A' ' 358' ' ' THR . 75.7 mt-30 -49.32 178.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.748 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -119.92 106.09 11.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.631 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -81.29 171.99 14.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.62 103.94 7.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 25.4 tp -67.0 124.76 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.78 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.483 ' CD1' ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -84.65 -47.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.88 161.62 34.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.733 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.549 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.6 OUTLIER -141.33 115.81 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.617 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.0 128.46 25.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.621 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.5 Cg_exo -59.3 121.2 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.69 1.593 . . . . 0.0 110.5 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 18.0 mt -60.12 -39.9 87.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 391' ' ' ILE . 56.1 tp -59.98 -56.29 23.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.5 mt-10 -60.0 -40.05 87.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.008 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.78 -39.93 95.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.395 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.482 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -67.54 -25.17 65.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.014 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.65 -10.48 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -102.57 -14.7 16.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.8 19.88 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.19 -20.06 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.56 0.219 . . . . 0.0 111.265 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -80.37 -42.16 23.36 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.171 0.51 . . . . 0.0 110.493 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.492 ' CD2' HD23 ' A' ' 312' ' ' LEU . 20.9 m-85 -81.81 -10.01 59.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.35 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.79 54.52 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 319' ' ' ILE . 48.0 m -107.64 100.99 10.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.486 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.462 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.1 tm? -71.12 103.69 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.209 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.714 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.0 mm-40 -111.31 131.19 55.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.59 ' CD1' HD12 ' A' ' 375' ' ' LEU . 32.0 mm -95.24 100.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.567 HG11 HE22 ' A' ' 282' ' ' GLN . 17.6 m -112.73 139.34 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 395' ' ' LYS . 5.7 p -111.45 164.47 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.881 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.409 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.3 p-10 -69.5 15.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 393' ' ' THR . 38.8 tttp -59.95 -45.25 93.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 5.0 m -90.76 173.77 7.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.978 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.84 -50.39 73.98 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.785 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.412 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 74.1 mm-40 -62.94 -36.89 84.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.506 0.67 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.409 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.11 -26.37 67.45 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.436 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.2 m -83.34 -26.62 30.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.242 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.8 -43.7 68.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.797 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.522 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 2.0 m-85 -60.02 -48.22 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 72.8 t -57.59 -33.57 45.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 400' ' ' SER . 2.9 mmpt? -74.65 -52.16 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.524 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.75 -25.57 69.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.279 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.513 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 21.7 t80 179.35 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.71 167.11 30.82 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.498 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.39 -47.83 3.03 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.594 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.77 130.58 5.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 117.742 0.771 . . . . 0.0 112.159 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.49 134.63 5.11 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.97 138.88 14.29 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.577 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 26.6 mt -102.48 127.2 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 69.8 mt -87.91 152.54 21.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 112.345 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.3 mtt-85 -68.99 -35.55 76.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.94 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.439 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 97.0 m-85 -159.84 -171.83 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -66.69 99.3 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.56 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.462 HG12 HD12 ' A' ' 413' ' ' LEU . 1.5 p -136.57 139.43 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.147 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -104.77 160.95 14.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -69.97 149.86 47.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.993 0.425 . . . . 0.0 110.587 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -60.08 -39.97 87.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.985 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -133.89 -140.21 4.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.563 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.469 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 72.3 mtm -111.04 179.93 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.816 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.57 -39.99 95.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.83 61.06 0.6 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 422' ' ' MET . 27.6 mt-30 -60.05 -40.06 88.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.3 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.54 -93.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.615 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -121.11 -154.58 9.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.764 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.669 0.271 . . . . 0.0 111.462 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.38 60.19 3.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.929 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 425' ' ' GLN . 47.7 mp0 -61.04 -39.96 91.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.454 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 53.7 p90 -140.59 114.99 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.293 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -135.62 116.41 14.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.335 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.99 11.3 9.76 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.062 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.6 mt -70.05 -2.25 12.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.937 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.38 -39.3 69.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -60.01 -39.53 86.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.316 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.61 -32.18 62.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.741 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.94 -45.81 91.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.815 0.34 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.24 -30.04 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.417 ' N ' HG12 ' A' ' 278' ' ' VAL . 2.9 ttpm? -52.02 -44.83 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.645 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.98 -49.92 75.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 111.084 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -77.76 -26.93 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.697 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.645 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.32 -41.01 88.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.287 0.565 . . . . 0.0 109.917 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.715 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 79.8 mt-10 -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.896 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -39.95 94.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -86.8 -59.16 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 22.0 tp -60.76 -55.22 35.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.838 0.352 . . . . 0.0 111.455 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.715 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 54.1 mt -59.91 -48.89 86.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.531 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -55.11 -38.34 66.32 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.532 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -59.97 -36.59 77.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 0.0 110.046 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.608 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 11.6 t80 -60.09 -47.77 84.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.635 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -81.87 -36.65 27.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.89 -52.11 61.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.769 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.537 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -60.85 -44.63 96.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.397 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 301' ' ' TYR . 97.5 mt -56.38 -24.95 19.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -15.25 33.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 121.471 0.653 . . . . 0.0 109.621 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.425 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 76.4 mt-30 -100.41 1.36 41.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.443 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.39 32.45 18.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.182 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.765 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -74.13 -5.65 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 45.51 75.21 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.948 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 37.0 mtmt -122.26 37.9 4.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 73.8 m-85 -162.31 164.26 27.58 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.1 p -149.43 163.55 37.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.2 p90 -137.43 131.13 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.448 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 112.39 149.69 10.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.898 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.24 -58.23 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.6 pt-20 -49.33 -55.62 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.0 -52.42 63.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.701 0.286 . . . . 0.0 111.535 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 409' ' ' ILE . 49.7 m -59.32 -39.96 84.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.091 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.495 ' HG ' ' CZ ' ' A' ' 378' ' ' PHE . 3.1 mp -66.26 -42.08 89.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 314' ' ' MET . 24.4 mtmt -59.95 -45.42 92.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.129 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.403 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.03 -28.61 65.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.899 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.596 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.27 -24.97 59.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.985 0.422 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -78.94 -28.91 43.82 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 14.3 mmt -81.2 -8.04 59.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.676 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.67 28.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.742 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.78 -11.22 58.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.835 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.596 HG22 ' HA ' ' A' ' 312' ' ' LEU . 30.9 m -90.44 105.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.1 tt0 -59.91 -49.42 77.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.418 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' A' ' 319' ' ' ILE . 36.3 mm -135.76 127.1 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.611 0.243 . . . . 0.0 111.434 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.571 ' HB2' HD12 ' A' ' 312' ' ' LEU . 55.4 tp -93.69 128.15 39.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.252 0.548 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.572 HG21 HG21 ' A' ' 392' ' ' VAL . 0.8 OUTLIER -115.43 107.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.975 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 389' ' ' LEU . 17.8 t -125.78 161.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.563 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.7 m-85 -112.25 132.59 54.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 111.396 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.575 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.3 pt-20 -56.23 -25.92 49.32 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.847 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -90.05 45.28 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.291 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 409' ' ' ILE . 25.3 tp -89.14 124.2 34.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 110.948 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.16 30.04 2.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.521 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.615 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 20.0 mm -124.52 135.18 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.129 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.632 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 60.5 mtp -140.11 162.32 35.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.623 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 15.6 ttt85 -88.08 117.12 26.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.029 0.442 . . . . 0.0 111.588 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 6.8 m-85 -125.42 123.39 39.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.347 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.57 ' CG1' HG13 ' A' ' 343' ' ' ILE . 17.6 m -92.21 121.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 111.436 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.782 HD13 ' CD2' ' A' ' 357' ' ' PHE . 1.1 mp -109.26 148.09 31.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.504 ' CD2' HD13 ' A' ' 369' ' ' ILE . 11.2 m170 -81.35 179.6 7.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.396 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 340' ' ' GLU . 0.1 OUTLIER -142.08 105.63 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 111.208 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 52.27 33.36 12.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.6 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.15 88.14 0.99 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.184 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 339' ' ' GLU . 1.1 p 45.51 -169.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.631 0.253 . . . . 0.0 111.667 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 338' ' ' THR . 5.5 mm-40 77.08 -15.27 0.76 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.941 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 335' ' ' CYS . 6.0 tp10 -158.68 118.22 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.427 ' OE2' ' CD2' ' A' ' 334' ' ' HIS . 3.2 mm-40 -109.23 137.98 46.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.008 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 146.62 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.17 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.57 HG13 ' CG1' ' A' ' 332' ' ' VAL . 1.3 mp -117.91 126.94 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.6 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 46.6 tp -134.8 159.78 40.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.277 0.561 . . . . 0.0 111.279 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.615 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.5 p90 -100.07 119.48 38.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.554 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.546 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -124.33 163.58 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 112.534 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -101.32 170.79 6.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.669 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -49.36 -42.0 41.86 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.836 1.69 . . . . 0.0 111.862 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.2 -50.02 75.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.052 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 48.9 mt-30 -69.38 -50.12 49.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 84.2 mt-10 -59.96 -35.06 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -57.74 -33.18 68.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -95.37 36.22 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.635 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.644 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 5.6 ptpt -70.03 -23.65 63.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.239 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.4 m -60.48 -39.99 89.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.461 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.491 ' O ' ' HB2' ' A' ' 366' ' ' HIS . 99.3 m-70 -99.05 -50.59 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.782 ' CD2' HD13 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 53.2 7.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.713 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.54 HG23 ' HB2' ' A' ' 364' ' ' GLN . 0.2 OUTLIER -92.2 -176.87 4.49 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -82.19 156.89 24.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.978 0.418 . . . . 0.0 110.949 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -75.07 -0.83 20.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.968 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -83.0 -45.89 13.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.425 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 1.0 OUTLIER -113.83 -37.11 4.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.922 0.391 . . . . 0.0 110.454 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 364' ' ' GLN . . . 67.31 27.52 73.52 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.162 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' A' ' 358' ' ' THR . 85.7 mt-30 -46.18 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -113.88 107.04 15.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 356' ' ' HIS . 68.1 m-70 -91.73 -174.68 3.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -140.72 113.5 8.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.358 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 354' ' ' LYS . 6.2 tt -90.54 123.01 33.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' A' ' 332' ' ' VAL . 2.4 mp -76.05 -42.42 38.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.486 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -169.56 167.22 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.059 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.485 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -142.82 116.38 9.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.999 0.428 . . . . 0.0 110.775 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.7 tpt -120.83 134.93 24.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.276 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.4 Cg_exo -61.01 130.36 32.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.926 1.75 . . . . 0.0 110.412 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.7 mt -69.63 -40.6 76.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.669 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 60.1 tp -60.19 -56.1 25.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.902 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.58 -40.05 78.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.69 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.97 -40.02 91.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.458 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.522 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.2 OUTLIER -70.56 -26.87 63.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.43 -8.84 52.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.397 . . . . 0.0 112.005 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -108.23 -9.5 15.51 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.26 18.03 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.35 -21.02 66.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.595 0.236 . . . . 0.0 111.317 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -77.19 -46.36 23.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -62.87 -41.71 99.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 0.0 110.679 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.464 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -74.07 -17.89 60.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.35 69.25 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.209 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.54 ' CB ' HG23 ' A' ' 317' ' ' VAL . . . -86.2 163.07 18.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.425 ' HB ' HD12 ' A' ' 319' ' ' ILE . 90.0 m -106.66 99.84 9.39 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.473 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.3 tm? -76.12 102.6 5.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.923 0.392 . . . . 0.0 111.235 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.645 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.4 mm-40 -111.92 132.09 54.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.157 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 37.8 mm -94.97 105.63 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 111.886 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.572 HG21 HG21 ' A' ' 321' ' ' ILE . 6.5 m -101.91 -169.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.813 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.563 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.8 p -158.03 154.04 27.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.331 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.47 0.96 3.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.202 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -59.8 -40.87 89.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.618 0.247 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 283' ' ' GLU . 53.5 p -85.51 168.59 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -60.05 -55.16 37.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 69.6 mm-40 -63.21 -36.07 82.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 109.852 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -52.72 -59.04 9.75 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.323 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 m -59.59 -19.7 50.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 32.7 mt-30 -69.69 -40.04 76.57 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.069 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.549 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.9 m-85 -62.04 -36.5 81.8 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.03 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.856 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.8 t -60.09 -38.8 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -71.36 -45.63 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.991 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -58.75 -44.83 95.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.99 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 303' ' ' PHE . 60.3 t80 -146.44 -66.26 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.856 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.71 57.26 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.808 -1.187 . . . . 0.0 115.165 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 139.78 -36.1 1.86 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.258 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.514 ' CD1' HG21 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -132.24 133.38 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 117.964 0.882 . . . . 0.0 112.815 -177.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.498 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -150.83 136.67 5.69 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.73 143.64 15.95 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.441 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 318' ' ' GLU . 30.9 mt -104.47 125.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.3 mt -94.98 163.16 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 0.0 112.799 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 74.6 mtt180 -78.48 -38.36 41.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.764 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 89.9 m-85 -158.48 -179.94 8.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.765 ' HG2' ' O ' ' A' ' 298' ' ' THR . 45.8 mtm180 -61.99 124.16 20.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.721 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.406 ' CG2' HD12 ' A' ' 413' ' ' LEU . 33.2 m -130.03 159.98 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.201 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -74.24 129.98 38.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.95 -39.99 75.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 58.24 40.06 25.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.389 . . . . 0.0 110.763 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 134.14 140.15 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 20.9 ptp -159.15 179.91 8.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.749 0.309 . . . . 0.0 110.957 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.56 -33.09 67.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -107.04 107.16 18.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.498 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 2.1 tp-100 -162.59 160.36 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -54.14 -70.97 0.79 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.844 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 165.99 -96.95 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -36.13 76.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.992 0.425 . . . . 0.0 110.495 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.34 24.58 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.837 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 41.5 tt0 -60.06 -49.4 77.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 432' ' ' PHE . 87.1 m-85 -76.28 -40.09 52.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 35.1 p90 45.14 69.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.221 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -77.92 6.1 8.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.931 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.28 -3.49 14.1 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.579 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.52 -40.07 81.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 110.47 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.91 -32.27 70.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.335 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.64 -35.8 75.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.02 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.01 -48.01 83.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.936 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 33.8 m120 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.3 -30.05 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.182 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -52.19 -45.92 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.639 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.96 -49.7 76.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.23 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -77.09 -27.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.758 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.534 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.07 -39.96 83.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.262 0.553 . . . . 0.0 110.054 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.713 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.6 mt-10 -81.13 -44.0 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -67.44 -40.06 85.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -86.03 -58.65 2.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.632 ' HG ' HD13 ' A' ' 321' ' ' ILE . 22.0 tp -61.2 -56.59 18.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.634 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.713 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 58.1 mt -59.97 -45.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.69 -37.67 77.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.264 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 -59.96 -36.84 77.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.407 0.622 . . . . 0.0 110.056 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.637 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 8.9 t80 -59.96 -46.07 90.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.683 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -83.68 -37.33 22.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 295' ' ' SER . 53.4 t0 -62.02 -47.39 84.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.829 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.5 mp0 -66.71 -40.0 88.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 79.4 mt -60.72 -22.35 26.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.17 -13.54 58.42 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.347 0.594 . . . . 0.0 109.528 178.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.611 ' HB2' HG23 ' A' ' 298' ' ' THR . 67.9 mt-30 -102.96 -0.71 30.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.541 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.19 30.66 20.47 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.657 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 11.3 p -69.73 -12.36 61.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.871 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.17 48.57 85.28 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.123 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 3.2 mtpm? -125.94 37.45 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 82.1 m-85 -160.61 161.54 32.55 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.142 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.7 159.71 41.67 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -135.91 124.84 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.481 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.82 153.06 13.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.27 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -57.33 -58.45 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.764 0.316 . . . . 0.0 110.794 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.8 pt-20 -50.41 -53.53 28.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.98 -55.2 27.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.428 ' CG2' HD13 ' A' ' 320' ' ' LEU . 21.4 m -57.01 -39.35 74.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.3 mp -67.54 -42.21 83.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 25.2 mtmt -60.0 -49.94 75.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.792 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.416 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -68.84 -29.27 67.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.63 0.252 . . . . 0.0 110.934 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.69 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -71.76 -26.84 62.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.919 0.39 . . . . 0.0 110.448 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.04 -27.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.2 mmt -80.28 -7.42 59.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.849 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.33 18.15 48.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.258 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.59 11.76 29.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.364 0.266 . . . . 0.0 111.04 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 17.0 m -111.33 105.53 18.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.697 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 59.9 tt0 -59.95 -49.99 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.451 ' HA ' ' H ' ' A' ' 388' ' ' THR . 43.5 mm -137.65 126.02 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.552 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.6 tp -90.95 128.79 36.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 111.314 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.632 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -113.5 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.766 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.552 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.9 t -122.68 150.56 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.332 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 393' ' ' THR . 96.7 m-85 -98.16 146.06 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 111.144 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.478 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.8 pt-20 -65.95 -33.28 75.45 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.074 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -90.06 41.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 29.3 tp -74.05 122.17 22.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 110.869 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -90.57 24.17 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 345' ' ' TYR . 18.5 mm -125.95 131.34 71.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.676 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.714 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 66.7 mtp -140.27 161.76 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.593 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.623 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.6 ttt180 -85.1 116.09 23.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.937 0.398 . . . . 0.0 111.555 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.722 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 15.0 m-85 -119.07 119.0 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.462 ' HA ' HD12 ' A' ' 343' ' ' ILE . 6.2 m -91.05 112.1 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.317 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.553 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 0.6 OUTLIER -91.99 174.83 7.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.672 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.457 ' CD2' HD13 ' A' ' 369' ' ' ILE . 1.7 m170 -120.38 -179.67 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 34.5 t -126.13 160.99 28.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.719 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -59.47 -39.9 85.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.909 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.11 -16.16 79.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.699 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.7 m 72.59 3.61 4.74 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -111.08 30.59 6.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.43 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -161.08 124.04 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -111.43 135.44 52.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -117.87 140.47 49.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.257 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 332' ' ' VAL . 7.3 mm -118.12 117.52 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.97 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.0 tp -131.18 157.68 42.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 112.139 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.538 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.91 121.21 40.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.923 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.524 HD23 ' HE2' ' A' ' 357' ' ' PHE . 1.8 mm? -121.09 161.39 21.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 4.4 p -101.66 169.14 8.06 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.115 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 352' ' ' LYS . 86.5 Cg_exo -43.67 -53.02 4.75 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.812 1.675 . . . . 0.0 112.162 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.96 -58.8 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.79 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.13 -44.99 95.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.944 0.402 . . . . 0.0 111.36 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.626 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.8 mt-10 -60.03 -29.93 68.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.074 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -57.6 -38.67 75.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.382 0.61 . . . . 0.0 109.755 179.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.505 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 61.3 t0 -78.3 61.98 2.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.211 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.595 ' HG3' HD22 ' A' ' 368' ' ' LEU . 18.2 ttpt -65.3 -50.25 66.39 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.3 m -55.87 -58.24 8.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.505 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 90.9 m-70 -80.48 -49.76 10.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.553 ' CD2' ' CD1' ' A' ' 333' ' ' LEU . 0.6 OUTLIER 53.13 10.35 0.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -178.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 365' ' ' GLU . 0.4 OUTLIER -98.32 -169.02 1.74 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.08 0.467 . . . . 0.0 111.706 -179.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 358' ' ' THR . 95.9 m-20 -81.09 162.58 23.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.573 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -74.92 0.89 14.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -85.5 -47.3 10.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.692 0.282 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 362' ' ' THR . 1.6 t -115.68 -37.27 3.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.805 0.336 . . . . 0.0 110.517 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 57.4 24.66 52.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.773 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.7 36.03 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.533 ' HB2' ' CG2' ' A' ' 358' ' ' THR . 70.9 mm-40 -125.58 13.05 8.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -145.96 160.0 42.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.831 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -152.24 123.42 7.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.595 HD22 ' HG3' ' A' ' 354' ' ' LYS . 42.4 tp -95.16 133.56 38.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.058 0.456 . . . . 0.0 111.606 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 334' ' ' HIS . 1.8 mt -95.72 -57.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.615 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -160.47 140.22 11.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.722 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 90.9 p -116.19 139.05 50.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.49 0.662 . . . . 0.0 112.041 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -117.83 133.49 23.34 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.204 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.618 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 37.7 Cg_exo -58.39 114.29 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.824 1.682 . . . . 0.0 111.108 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 23.5 mt -60.01 -39.29 85.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.147 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.493 HD12 ' CD1' ' A' ' 391' ' ' ILE . 63.3 tp -60.01 -52.27 66.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.61 -39.94 90.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.205 0.526 . . . . 0.0 109.822 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -61.28 -40.02 92.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.569 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.587 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -73.54 -24.19 60.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -9.13 53.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.75 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -110.04 -10.02 14.71 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.29 14.02 6.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -64.4 -18.5 64.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.584 0.23 . . . . 0.0 111.394 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -75.38 -39.97 58.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -67.21 -40.88 86.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.556 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.1 m-85 -72.67 -16.36 61.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.52 70.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.894 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.445 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -88.96 164.45 15.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.271 0.558 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.451 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 57.7 m -107.19 100.59 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.11 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.475 ' CD2' HG23 ' A' ' 322' ' ' VAL . 2.3 tm? -71.99 102.87 3.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.384 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.534 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -111.02 138.88 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.877 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 36.7 mm -101.92 103.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.521 HG12 HD12 ' A' ' 287' ' ' ILE . 4.4 m -101.6 -171.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.225 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -156.24 153.75 29.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.468 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.5 p-10 -70.89 2.94 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -60.05 -40.0 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.567 0.222 . . . . 0.0 111.399 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.5 p -84.65 169.86 13.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.358 . . . . 0.0 111.416 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.04 -52.51 65.07 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 65.1 mm-40 -61.64 -38.08 86.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.468 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -63.22 -25.04 67.88 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.792 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 68.3 m -82.88 -25.7 32.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.529 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.14 -45.21 58.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.509 ' CE1' ' CD1' ' A' ' 290' ' ' TYR . 1.6 m-85 -56.29 -49.6 73.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.489 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 85.2 t -59.86 -35.21 59.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.762 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -69.9 -49.96 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.203 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.86 -23.84 75.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.481 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 11.1 t80 178.76 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 97.87 167.07 31.93 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.674 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.89 -49.2 2.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.025 -0.607 . . . . 0.0 114.191 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -145.15 132.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 117.492 0.646 . . . . 0.0 112.205 -177.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -152.5 143.33 10.22 Favored Glycine 0 CA--C 1.509 -0.301 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.9 142.07 13.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.57 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 318' ' ' GLU . 57.2 mt -104.66 128.65 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.5 mt -87.38 150.16 24.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.784 0.802 . . . . 0.0 112.821 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.697 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 72.7 mtt-85 -69.95 -36.19 75.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 96.2 m-85 -159.38 167.04 29.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.772 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.657 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mtm180 -55.12 121.91 9.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 413' ' ' LEU . 27.6 m -130.04 158.23 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -110.36 13.94 22.76 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.328 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 60.06 31.42 20.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -70.01 156.12 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.076 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 431' ' ' PHE . . . 87.65 121.21 1.55 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.062 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.1 mmt 60.02 29.04 18.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 111.535 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.432 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 59.0 tt0 -152.2 103.84 2.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 61.89 30.1 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.476 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.439 ' NE2' ' H ' ' A' ' 421' ' ' GLY . 2.6 mp0 -98.99 139.98 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.78 -29.98 49.82 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -83.27 123.25 6.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -110.76 38.23 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.704 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.97 -40.64 89.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 421' ' ' GLY . 24.9 m-85 -126.61 104.68 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -124.6 103.84 8.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 11.71 19.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.055 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 64.1 mt -73.4 -3.92 30.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.646 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -40.02 87.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 110.632 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.84 -30.6 68.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.0 -33.72 72.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.432 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.97 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.09 124.31 47.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.948 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 34.5 m120 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.771 0.319 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 282' ' ' GLN . 10.6 p -67.61 -27.44 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.307 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -54.65 -39.97 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.575 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -68.67 -42.33 78.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.904 0.383 . . . . 0.0 111.534 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 278' ' ' VAL . 27.8 pt -82.72 -21.36 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.689 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.593 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -59.92 -40.47 88.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.957 0.408 . . . . 0.0 110.382 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.6 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 24.8 pt-20 -85.62 -38.54 18.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.904 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -70.03 -39.92 75.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -86.22 -57.23 3.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.504 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 36.0 tp -58.26 -56.31 23.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.079 0.466 . . . . 0.0 111.719 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 52.4 mt -59.36 -49.97 81.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.98 -39.79 89.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.591 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -60.06 -36.49 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.471 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.573 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 4.9 t80 -59.08 -45.98 89.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -83.48 -42.32 17.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.864 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 295' ' ' SER . 45.1 t0 -60.72 -47.48 86.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.567 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.68 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 22.9 tp10 -63.06 -39.94 96.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.456 HG13 ' CD2' ' A' ' 301' ' ' TYR . 87.7 mt -62.75 -26.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.579 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -60.34 -12.53 9.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 109.957 178.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.439 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 83.7 mt-30 -98.97 0.04 43.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.466 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.99 29.65 19.25 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.346 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.566 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 19.0 p -73.35 -7.75 52.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.958 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.65 53.47 29.02 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.938 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 22.0 mttt -130.2 41.95 3.33 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 74.6 m-85 -161.78 163.02 29.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.775 0.321 . . . . 0.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.0 p -149.12 161.82 41.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.74 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.81 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 53.0 p90 -141.44 149.99 41.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 96.67 142.19 12.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.171 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -49.37 -64.12 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.765 0.317 . . . . 0.0 111.238 -179.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.1 pt-20 -47.15 -52.89 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.831 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.0 m-20 -64.35 -56.75 12.32 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 26.0 m -58.03 -37.38 74.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.9 mp -69.94 -44.0 70.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.603 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.9 mtmm -59.9 -46.44 89.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.585 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.021 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.711 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.81 -24.92 55.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.895 0.378 . . . . 0.0 110.618 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -77.96 -28.32 49.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 89.8 mmm -81.1 -7.37 59.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.731 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.55 16.34 36.38 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.358 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.51 -9.65 58.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.411 0.284 . . . . 0.0 111.207 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 312' ' ' LEU . 28.0 m -94.94 105.49 17.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 412' ' ' ILE . 43.0 tt0 -58.78 -50.9 72.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.275 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.452 HG22 HD13 ' A' ' 286' ' ' LEU . 33.0 mm -134.05 127.0 50.96 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.061 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.63 ' HG ' HG22 ' A' ' 322' ' ' VAL . 31.6 tp -92.38 125.6 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.81 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.509 ' HB ' ' CE2' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -106.67 103.85 16.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.244 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.63 HG22 ' HG ' ' A' ' 320' ' ' LEU . 11.6 t -124.23 162.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.596 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 75.9 m-85 -112.67 149.78 32.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 111.905 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.489 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 15.6 pt-20 -65.91 -40.41 91.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.149 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -89.77 56.49 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.752 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.442 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 26.5 tp -89.09 121.75 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -89.15 23.77 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.581 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 4.8 mm -121.62 131.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.575 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 8.3 mtt -139.48 162.97 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.5 ttt180 -88.85 116.04 26.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 112.012 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.568 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 9.1 m-85 -123.46 123.77 41.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.097 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.546 ' CG1' HG13 ' A' ' 343' ' ' ILE . 16.2 m -91.43 117.57 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.144 0.497 . . . . 0.0 111.662 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.705 HD13 ' CD2' ' A' ' 357' ' ' PHE . 5.3 mp -102.76 154.88 18.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.465 ' CD2' HD12 ' A' ' 369' ' ' ILE . 9.8 m170 -90.66 176.05 6.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.145 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 7.9 t -112.77 161.85 16.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -44.0 -39.32 4.03 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.847 0.356 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -85.51 -118.43 0.93 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.983 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.84 19.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.1 40.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.497 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.42 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 7.4 tp10 -156.9 119.97 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.93 141.51 46.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -128.54 146.88 50.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.394 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.546 HG13 ' CG1' ' A' ' 332' ' ' VAL . 1.7 mp -123.14 122.89 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 55.8 tp -130.69 161.65 31.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.342 0.591 . . . . 0.0 111.704 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.581 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 10.3 p90 -97.32 120.04 36.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.618 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -125.33 160.56 29.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.1 p -101.64 172.2 4.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.466 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.0 Cg_exo -46.6 -42.8 23.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.882 1.721 . . . . 0.0 111.92 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -59.22 5.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 88.9 mt-30 -60.37 -49.69 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 89.2 mt-10 -59.97 -31.5 69.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.207 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.55 -39.9 77.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.352 0.596 . . . . 0.0 109.414 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 63.2 t0 -82.76 60.77 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.129 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 9.0 pttp -69.95 -38.77 76.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.12 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 41.3 t -59.48 -58.06 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.616 0.246 . . . . 0.0 111.336 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.47 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 55.6 m80 -80.23 -56.98 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.704 0.288 . . . . 0.0 110.769 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.705 ' CD2' HD13 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.58 5.45 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.627 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 365' ' ' GLU . 4.4 m -91.32 -173.22 3.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.504 ' H ' ' CG2' ' A' ' 358' ' ' THR . 96.0 m-20 -78.69 162.27 26.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.774 0.321 . . . . 0.0 110.451 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -71.93 -3.87 25.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -84.56 -46.39 11.61 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.43 ' H ' HG21 ' A' ' 362' ' ' THR . 1.3 t -113.35 -37.33 4.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.976 0.417 . . . . 0.0 110.355 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.497 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 62.74 22.46 64.23 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.85 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -156.6 83.65 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.59 ' N ' HG22 ' A' ' 358' ' ' THR . 81.7 mt-10 -151.03 -28.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -123.05 163.09 21.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 46.5 mt-10 -145.08 116.77 8.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 357' ' ' PHE . 56.6 tp -71.42 139.0 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.465 HD12 ' CD2' ' A' ' 334' ' ' HIS . 2.9 mp -109.44 -49.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.505 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.03 166.82 23.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.373 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.525 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.4 p -145.15 116.58 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.0 111.611 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.69 130.87 24.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.961 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.575 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.7 Cg_exo -60.72 120.15 7.71 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.03 1.82 . . . . 0.0 110.752 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.2 mt -61.89 -39.56 92.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.021 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.9 tp -59.99 -51.88 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.82 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.05 -40.15 88.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.718 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -63.0 -40.01 96.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.651 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.468 ' CZ ' ' HG ' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -70.01 -24.92 63.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.31 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.03 -7.62 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.072 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -105.47 -11.9 16.22 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.65 16.02 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -62.11 -20.49 64.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.93 -44.77 17.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -61.34 -40.57 94.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.704 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 23.5 m-85 -79.96 -12.7 59.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.15 55.44 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 317' ' ' VAL . . . -84.87 161.54 19.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.103 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.422 ' HB ' ' CG2' ' A' ' 319' ' ' ILE . 47.2 m -105.64 99.66 9.25 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.435 HD23 HG21 ' A' ' 322' ' ' VAL . 2.5 tm? -74.6 103.55 4.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.115 0.483 . . . . 0.0 111.082 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.593 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.2 mm-40 -110.66 140.47 44.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 18.2 mm -105.43 104.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 287' ' ' ILE . 9.3 m -101.09 -170.06 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.879 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.596 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.5 p -154.59 152.51 30.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.408 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.4 p-10 -68.58 3.28 1.91 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.548 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -59.99 -40.1 88.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.645 0.259 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -89.17 167.72 12.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.8 0.334 . . . . 0.0 111.516 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.07 -49.89 75.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 45.6 mp0 -63.47 -39.98 95.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.37 0.605 . . . . 0.0 109.756 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.408 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -64.3 -19.16 63.89 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.664 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.1 m -83.89 -22.46 31.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.017 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -74.23 -39.99 62.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.028 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.548 ' CD2' ' HE2' ' A' ' 406' ' ' PHE . 2.7 m-85 -63.26 -49.62 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.0 -45.92 94.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -73.97 -43.98 56.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.742 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.405 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -66.37 -41.51 94.44 Favored Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.81 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -129.29 -86.91 0.54 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.793 -0.704 . . . . 0.0 109.582 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 160.77 40.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.35 -1.405 . . . . 0.0 115.117 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 102.9 7.36 44.5 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.035 -1.078 . . . . 0.0 115.424 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.547 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.4 OUTLIER -144.97 125.34 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.207 1.003 . . . . 0.0 110.449 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.31 145.32 12.63 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -126.35 140.46 12.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.548 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 56.6 mt -99.11 127.52 51.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 34.9 mt -92.08 165.66 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.476 0.655 . . . . 0.0 112.345 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -91.6 -27.19 18.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 64.7 t80 -164.49 162.96 22.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 298' ' ' THR . 6.0 mmm180 -56.8 120.36 7.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.0 159.94 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.501 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -63.67 130.01 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.982 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -70.64 -52.49 20.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.416 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 28.1 pt20 -159.92 163.71 34.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -51.06 123.46 17.48 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.845 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 39.9 mtt -128.43 168.08 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.8 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.11 -39.97 88.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.655 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -92.86 -4.29 53.15 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 420' ' ' GLN . 1.7 tp-100 -59.99 -41.36 91.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.307 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 70.99 79.09 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.564 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -167.46 105.09 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.44 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.97 -39.98 87.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.353 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.65 16.42 24.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.188 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.0 -49.95 75.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.556 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.03 -31.52 69.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -81.41 107.9 14.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -82.82 7.51 14.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.339 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.69 -9.76 39.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.775 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -39.97 87.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.01 -31.37 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.355 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.405 ' O ' ' CE1' ' A' ' 440' ' ' HIS . 64.1 t80 -59.91 -31.88 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.745 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.06 -49.91 75.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.266 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -109.09 130.17 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 437' ' ' TYR . 59.1 m80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.764 0.316 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 282' ' ' GLN . 7.1 p -67.09 -30.24 48.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -48.9 -44.29 40.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.97 -49.94 75.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.332 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.8 pt -83.06 -20.99 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.687 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.608 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 23.0 tm0? -59.45 -39.57 84.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.568 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 59.7 mt-10 -78.97 -30.27 44.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -52.17 6.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -70.01 -56.98 5.56 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.608 ' HG ' HD13 ' A' ' 321' ' ' ILE . 23.7 tp -57.83 -54.93 41.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.317 0.579 . . . . 0.0 110.804 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 11.0 mt -63.46 -45.34 98.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.248 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.61 ' N ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.31 -39.48 82.55 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.604 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -59.98 -37.77 80.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 21.7 t80 -60.05 -47.18 86.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.524 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -86.27 -35.92 19.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 295' ' ' SER . 26.2 t0 -66.22 -46.26 77.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 111.306 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.683 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 10.5 tp10 -65.7 -39.93 91.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.555 HG13 ' CD2' ' A' ' 301' ' ' TYR . 86.3 mt -62.22 -25.41 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.599 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.63 -14.72 14.82 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.28 0.562 . . . . 0.0 109.806 178.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.606 ' HB2' HG21 ' A' ' 298' ' ' THR . 51.4 mt-30 -98.2 -0.06 44.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.748 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.69 29.97 19.31 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.974 0.416 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 296' ' ' GLN . 32.0 p -70.66 -12.05 61.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.949 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.26 47.78 89.17 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.72 -1.229 . . . . 0.0 114.442 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.717 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 16.8 ptpt -130.46 45.04 2.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.13 0.465 . . . . 0.0 110.783 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.717 ' CE2' ' HG3' ' A' ' 300' ' ' LYS . 87.3 m-85 -160.94 161.09 31.54 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.911 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 p -144.61 160.62 40.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -134.51 124.16 25.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.849 0.357 . . . . 0.0 110.819 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.487 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 113.79 155.1 11.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -59.91 -56.76 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.843 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.506 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -49.57 -57.46 7.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.482 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -60.06 -52.2 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 111.308 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.466 ' CG2' HD13 ' A' ' 320' ' ' LEU . 33.5 m -59.99 -40.03 87.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.138 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.446 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 2.0 mp -66.01 -46.72 76.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -57.64 -50.46 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.027 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -65.18 -31.28 72.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.698 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.71 -24.29 59.9 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -79.73 -27.41 40.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.1 mmt -80.89 -8.83 59.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.313 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.55 15.16 38.61 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.518 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.647 ' CB ' HG13 ' A' ' 417' ' ' VAL . . . -86.52 -8.8 57.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.134 . . . . 0.0 111.322 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 312' ' ' LEU . 27.7 m -92.03 103.91 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.844 0.354 . . . . 0.0 111.708 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 412' ' ' ILE . 35.3 tt0 -58.68 -49.96 75.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.552 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.433 ' HA ' ' H ' ' A' ' 388' ' ' THR . 44.5 mm -133.75 126.6 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.545 0.212 . . . . 0.0 111.171 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.466 HD13 ' CG2' ' A' ' 308' ' ' THR . 47.5 tp -92.03 124.04 35.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.608 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -111.41 105.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.584 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 389' ' ' LEU . 23.4 t -116.51 159.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.833 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.589 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 70.2 m-85 -107.14 144.82 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -71.28 160.87 32.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.526 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.0 22.98 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.803 0.335 . . . . 0.0 110.445 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 24.4 tp -54.78 125.26 19.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.74 26.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.001 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 12.3 mm -130.76 130.57 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.537 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.611 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 9.9 mtt -139.68 162.66 34.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.582 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt180 -85.28 118.08 24.6 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 120.728 0.299 . . . . 0.0 111.662 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.795 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 43.8 m-85 -124.92 122.07 36.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.424 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.509 ' CG1' HG13 ' A' ' 343' ' ' ILE . 23.7 m -93.0 117.54 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 0.0 111.161 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.603 HD13 ' CD2' ' A' ' 357' ' ' PHE . 2.2 mm? -100.27 149.61 23.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.062 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.44 ' CG ' HD11 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -88.85 -176.0 5.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 28.9 t -126.39 158.91 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -60.0 -39.94 87.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.43 -19.41 60.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.953 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 78.33 179.29 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 61.82 35.77 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 0.0 110.426 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -163.69 121.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.949 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -112.19 138.11 49.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 0.0 111.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 332' ' ' VAL . 17.4 tttp -124.79 146.71 49.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.483 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.509 HG13 ' CG1' ' A' ' 332' ' ' VAL . 1.1 mp -119.46 120.03 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 59.9 tp -130.91 151.17 51.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.626 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.529 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.62 116.95 29.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.54 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.556 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 1.9 mm? -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.456 0.645 . . . . 0.0 112.58 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.5 p -100.41 169.7 7.59 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.96 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.523 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.5 Cg_exo -47.71 -46.07 22.11 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 121.943 1.762 . . . . 0.0 112.953 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 350' ' ' GLN . 23.9 pm0 -64.4 -41.72 96.48 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 349' ' ' GLU . 40.3 mt-30 -84.62 -48.18 9.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.795 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 3.5 tm-20 -60.96 -27.8 68.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 348' ' ' PRO . 1.3 ttmp? -56.46 -30.02 62.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 109.807 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.547 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 58.6 t0 -88.34 63.52 7.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.1 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.565 ' HA ' ' HD1' ' A' ' 357' ' ' PHE . 20.2 mtmt -69.97 -40.48 75.35 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.8 t -60.2 -57.96 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.051 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.547 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 80.1 m80 -82.16 -45.27 15.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.387 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 366' ' ' HIS . 0.2 OUTLIER 52.59 12.56 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.23 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 356' ' ' HIS . 1.4 m -104.77 -175.35 2.77 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.339 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.608 ' HB2' HG23 ' A' ' 362' ' ' THR . 82.0 m-20 -130.05 138.76 50.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -72.84 -3.48 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.28 -26.41 13.32 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.608 HG23 ' HB2' ' A' ' 359' ' ' ASP . 7.2 t -120.4 -36.9 3.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.469 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.22 39.73 22.2 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.752 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.458 ' HG2' HG22 ' A' ' 362' ' ' THR . 60.2 mm-40 -54.48 -167.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 0.0 111.111 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 52.1 mt-10 -138.74 116.52 11.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.724 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 93.5 m-70 -159.3 147.09 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 333' ' ' LEU . 68.3 mt-10 -141.94 105.36 4.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.288 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 2.9 tt -64.66 119.84 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.804 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.44 HD11 ' CG ' ' A' ' 334' ' ' HIS . 2.5 mt -108.37 -50.02 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.491 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 39.1 mt-10 -137.97 155.4 48.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.333 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.567 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 1.4 m -148.26 116.66 6.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.187 0.518 . . . . 0.0 111.767 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 3.1 tpt -113.6 129.11 24.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.608 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.2 Cg_exo -56.0 120.51 8.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.805 1.67 . . . . 0.0 110.981 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.589 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 32.6 mt -62.03 -40.06 94.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.956 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 391' ' ' ILE . 50.4 tp -60.8 -55.65 30.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.3 mt-10 -59.79 -40.05 86.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.874 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -60.93 -39.92 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.982 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.538 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.1 m-85 -72.82 -27.12 61.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.214 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 389' ' ' LEU . . . -88.54 -10.81 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.42 -9.75 15.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 20.69 5.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.567 0.222 . . . . 0.0 111.47 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -69.0 -17.65 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.09 -43.45 17.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.84 -41.47 99.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.466 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.523 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.6 m-85 -78.5 -15.84 58.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.805 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.34 2.21 66.97 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.52 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 317' ' ' VAL . . . -85.62 162.66 18.73 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.164 0.507 . . . . 0.0 110.601 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.433 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 71.5 m -107.13 100.57 10.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.371 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.0 OUTLIER -72.19 105.53 4.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.389 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.608 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 14.3 mm-40 -111.39 143.5 42.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.774 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 375' ' ' LEU . 18.6 mm -107.37 100.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.507 HG22 ' CZ ' ' A' ' 323' ' ' TYR . 18.6 m -100.54 -170.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.267 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.523 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.6 OUTLIER -160.35 157.1 27.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.945 0.403 . . . . 0.0 111.748 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.42 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.0 p-10 -71.5 -0.12 9.74 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.496 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.25 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 54.3 p -78.88 168.07 20.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.778 0.323 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.97 -51.0 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 110.725 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.61 ' HG2' ' N ' ' A' ' 288' ' ' GLY . 13.1 tp10 -70.07 -34.72 73.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.42 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -51.84 -57.21 13.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.8 m -60.7 -19.65 59.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.536 . . . . 0.0 112.073 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 36.6 mt-30 -70.3 -40.06 74.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.967 0.413 . . . . 0.0 110.467 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.589 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -59.6 -46.43 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.376 179.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.519 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 76.3 t -58.97 -33.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -69.14 -51.06 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.033 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -71.13 -22.1 78.47 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.637 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.487 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.0 t80 176.65 -77.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.48 168.33 31.33 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.52 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.32 -48.59 2.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.277 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.559 HD11 ' N ' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -144.22 132.33 17.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 117.495 0.648 . . . . 0.0 112.383 -177.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.59 137.51 6.29 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.55 139.39 12.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.392 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 56.2 mt -101.32 127.72 54.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 66.6 mt -91.6 168.77 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.719 . . . . 0.0 112.645 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -67.29 -40.05 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.742 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.632 ' O ' ' HB3' ' A' ' 300' ' ' LYS . 58.1 t80 -172.09 -60.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.724 0.297 . . . . 0.0 111.574 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -164.81 128.2 2.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.846 0.355 . . . . 0.0 110.643 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.647 HG13 ' CB ' ' A' ' 316' ' ' ALA . 33.1 m -130.03 159.99 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.538 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.49 134.65 57.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.32 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 419' ' ' PHE . 58.1 t80 -80.78 -5.76 57.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.385 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 65.9 29.63 10.26 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.844 0.354 . . . . 0.0 111.257 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 430' ' ' GLU . . . 69.26 -176.86 30.07 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.509 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.9 mtt -135.12 169.15 17.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.039 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.01 -40.04 87.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.311 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -99.15 7.52 45.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -59.98 -39.98 87.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.747 0.308 . . . . 0.0 111.263 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 155.95 -77.68 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.609 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 430' ' ' GLU . . . -141.42 -161.04 8.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.539 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.63 54.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 427' ' ' GLY . 2.4 mt-10 -62.85 -43.74 97.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.396 . . . . 0.0 110.918 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -128.43 106.25 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 24.8 p90 -122.5 98.55 5.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.371 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 9.4 27.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.395 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.97 -18.16 43.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.63 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -81.1 -20.07 42.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.656 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.98 -38.45 82.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.028 0.442 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.98 -46.86 88.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -72.2 146.75 47.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 50.7 t30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.803 0.335 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 11.3 p -69.95 -30.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -42.48 -30.01 0.31 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.94 -60.0 2.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.747 0.308 . . . . 0.0 111.473 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -82.31 -21.13 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.767 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.545 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -58.5 -40.23 82.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.127 0.489 . . . . 0.0 110.491 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.0 tt0 -71.39 -38.28 71.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -78.98 -55.36 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -67.76 -58.58 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.142 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.639 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 17.6 tp -52.62 -57.6 9.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 111.371 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.589 HG21 ' CE1' ' A' ' 402' ' ' PHE . 25.7 mt -61.69 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.878 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.9 -38.67 60.51 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 36.6 ttt180 -60.08 -39.95 87.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.204 0.526 . . . . 0.0 110.286 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.589 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.7 t80 -55.82 -47.85 76.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.685 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 33.6 m-85 -83.59 -37.83 22.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -61.22 -42.23 98.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.429 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.679 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.2 mt-10 -69.89 -42.14 73.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.999 0.428 . . . . 0.0 109.882 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.16 -24.6 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -62.9 -15.95 57.14 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.244 0.545 . . . . 0.0 109.871 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.424 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 26.2 mt-30 -101.9 0.76 35.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.521 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.3 29.86 19.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 110.157 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.4 p -67.02 -10.15 46.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.997 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.55 49.57 60.46 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.841 -1.171 . . . . 0.0 113.374 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.7 mtmt -130.36 38.93 3.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.679 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 84.5 m-85 -160.88 161.42 31.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.252 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.66 163.25 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.6 p90 -137.65 130.88 30.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.69 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 406' ' ' PHE . . . 109.35 142.46 9.68 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.361 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -50.17 -60.31 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 111.208 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 9.9 pt-20 -47.31 -54.04 12.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.629 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.08 -53.93 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 111.521 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.449 ' CG2' HD13 ' A' ' 320' ' ' LEU . 40.6 m -58.36 -39.08 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.096 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.437 ' HG ' ' CZ ' ' A' ' 378' ' ' PHE . 2.5 mp -65.93 -42.79 89.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.0 mtmm -59.96 -49.99 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.442 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -66.38 -29.35 69.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.29 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.793 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.07 -24.81 58.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.77 0.319 . . . . 0.0 110.733 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -79.39 -27.96 41.87 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 34.1 mmt -80.51 -7.57 59.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.759 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.97 18.33 47.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.409 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.63 -1.3 57.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.388 0.275 . . . . 0.0 111.371 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.793 HG21 ' HA ' ' A' ' 312' ' ' LEU . 30.3 m -100.3 104.3 15.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 412' ' ' ILE . 9.4 tp10 -57.71 -50.89 71.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.321 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 388' ' ' THR . 26.4 mm -135.4 126.85 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.643 0.259 . . . . 0.0 111.221 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 322' ' ' VAL . 48.6 tp -92.74 126.43 37.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 111.634 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.639 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -112.67 106.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.522 HG22 ' HG ' ' A' ' 320' ' ' LEU . 11.8 t -124.8 161.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.155 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.601 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -108.19 146.1 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.466 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 11.4 pt-20 -65.02 -34.11 77.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.9 47.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 31.1 tp -81.01 123.15 28.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.577 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -93.07 25.67 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.604 HG21 HG11 ' A' ' 305' ' ' VAL . 24.3 mm -123.18 132.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.656 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.5 mtm -140.35 162.09 36.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.57 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.4 ttt85 -89.7 119.99 30.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.105 0.479 . . . . 0.0 111.572 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 9.9 m-85 -127.11 123.09 36.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.485 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 332' ' ' VAL . 14.2 m -92.8 114.29 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.214 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.529 HD11 ' CZ ' ' A' ' 357' ' ' PHE . 1.7 mm? -93.58 160.5 14.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 111.654 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.457 ' CD2' HD11 ' A' ' 369' ' ' ILE . 0.1 OUTLIER -108.69 -170.34 1.65 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.942 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 48.8 t -121.48 160.77 23.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.714 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -87.05 -11.93 69.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.631 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.9 m 74.1 30.0 1.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -129.01 25.56 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.004 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 6.9 tp10 -160.87 125.37 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.139 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -118.72 140.78 49.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.01 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.788 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.406 HD12 ' CG1' ' A' ' 332' ' ' VAL . 2.8 mm -120.05 119.31 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.525 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.504 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.9 tp -131.19 161.83 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.445 0.64 . . . . 0.0 112.153 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.567 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.8 p90 -99.97 121.15 40.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.047 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.549 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.6 mm? -127.42 160.61 30.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.2 p -101.5 172.49 4.39 Favored Pre-proline 0 N--CA 1.455 -0.177 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.588 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.6 Cg_exo -49.5 -43.22 39.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.035 1.823 . . . . 0.0 112.414 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -61.57 -49.27 77.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.535 ' HG2' ' CD1' ' A' ' 346' ' ' LEU . 10.9 tp60 -70.03 -48.1 59.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 75.3 mt-10 -57.52 -33.6 68.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.583 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.78 -39.44 84.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.889 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -79.72 67.68 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.217 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -70.05 -37.43 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.71 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 93.2 p -56.23 -52.09 65.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.916 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.507 ' C ' ' H ' ' A' ' 358' ' ' THR . 79.1 m80 -88.29 -58.04 2.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.309 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.529 ' CZ ' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 57.51 -3.28 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 364' ' ' GLN . 13.4 t -88.34 -162.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 0.0 111.472 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 363' ' ' GLY . 55.2 m-20 -95.63 161.57 13.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.453 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -75.78 -6.42 50.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.991 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -73.41 -41.76 62.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.667 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 2.4 t -116.61 -34.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 359' ' ' ASP . . . 63.45 21.67 64.83 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.767 -0.652 . . . . 0.0 113.122 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.667 ' HG3' ' OG1' ' A' ' 362' ' ' THR . 84.3 mt-30 -54.99 -172.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.04 0.448 . . . . 0.0 111.717 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -117.28 134.86 54.31 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.437 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.516 ' CD2' ' HB ' ' A' ' 358' ' ' THR . 82.9 m-70 -127.0 176.85 7.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -137.21 109.8 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 34.1 tp -72.93 132.79 43.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 111.103 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.457 HD11 ' CD2' ' A' ' 334' ' ' HIS . 3.1 mp -89.03 -53.77 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.159 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -147.51 166.54 26.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.505 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.2 p -143.62 116.99 9.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.084 0.468 . . . . 0.0 110.97 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 3.9 tpt -117.17 130.04 24.91 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.875 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.656 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.8 Cg_exo -60.02 125.17 16.9 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.832 1.688 . . . . 0.0 110.922 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 27.4 mt -66.49 -39.86 88.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.91 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 65.0 tp -60.05 -52.16 66.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.6 mt-10 -58.89 -39.99 83.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.887 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.84 -40.83 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.618 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -70.31 -27.76 64.64 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -10.01 47.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.177 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -104.18 -12.78 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.976 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 30.6 m120 -129.64 19.93 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -65.51 -19.71 66.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.568 0.223 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.77 -44.93 17.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.05 -39.93 91.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.655 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.467 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -79.92 -13.14 59.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.84 2.26 56.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.305 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.464 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.02 163.16 18.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 110.649 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 319' ' ' ILE . 48.5 m -107.82 100.41 9.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.401 ' CD2' HG21 ' A' ' 322' ' ' VAL . 2.3 tm? -75.35 102.3 5.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.111 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.545 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -108.43 139.46 43.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.827 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 40.0 mm -103.49 104.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.388 0.613 . . . . 0.0 112.432 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' A' ' 287' ' ' ILE . 6.0 m -101.65 -169.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.917 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.527 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -156.16 153.08 28.71 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.958 0.409 . . . . 0.0 111.511 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -72.87 17.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -70.03 -39.92 75.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.78 0.324 . . . . 0.0 111.235 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.5 t -89.26 170.04 10.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.678 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.0 -50.03 75.34 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.516 ' HB3' HG22 ' A' ' 287' ' ' ILE . 66.8 mm-40 -64.51 -40.38 95.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.163 0.506 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.31 -18.53 63.13 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.442 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.1 m -83.98 -21.74 31.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.848 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 84.4 mt-30 -75.14 -41.35 58.49 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.835 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.601 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 3.3 m-85 -59.73 -42.75 93.82 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.763 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 57.7 t -60.01 -39.99 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.665 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -40.04 64.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.78 96.87 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.117 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 304' ' ' GLY . 62.5 t80 -151.6 -68.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.763 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.14 58.29 0.18 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 119.965 -1.112 . . . . 0.0 114.916 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 140.78 -34.13 1.98 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 119.387 -1.387 . . . . 0.0 115.214 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.45 HD12 HG23 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -137.98 134.9 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.944 0.872 . . . . 0.0 112.997 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.515 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -151.86 142.92 9.85 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.72 145.95 15.97 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 119.781 -1.199 . . . . 0.0 113.887 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 27.5 mt -107.03 127.09 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 24.6 mt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.735 0.779 . . . . 0.0 112.753 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.414 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 64.8 mtm180 -70.15 -39.97 75.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.55 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.3 p90 -159.86 175.48 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 298' ' ' THR . 15.5 mtm180 -57.66 123.89 17.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.39 . . . . 0.0 111.197 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.446 ' CG2' HD12 ' A' ' 413' ' ' LEU . 33.2 m -130.05 160.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 128.5 36.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.592 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.13 149.82 30.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -80.01 159.93 26.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -60.7 134.74 49.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' A' ' 430' ' ' GLU . 45.8 mtt -118.89 169.65 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.672 0.272 . . . . 0.0 110.684 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.01 -42.58 94.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 0.0 111.076 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -69.89 -34.79 74.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.008 0.432 . . . . 0.0 110.567 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.421 ' HB3' ' H ' ' A' ' 422' ' ' MET . 48.6 tt0 -65.64 128.77 37.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.982 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 45.88 -105.17 0.08 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 155.08 -100.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.53 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -38.94 84.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.18 23.93 13.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 422' ' ' MET . 1.2 tt0 -59.94 -44.4 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 20.7 p90 -106.38 83.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.769 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 434' ' ' LEU . 52.4 p90 -106.28 22.18 16.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.71 45.16 0.67 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.489 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 432' ' ' PHE . 26.8 mt -78.26 -3.81 44.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.467 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -39.95 87.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 110.434 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.0 -32.74 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.331 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.57 -33.6 71.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.363 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.97 -47.44 85.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.922 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -59.92 -40.04 87.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.957 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.847 0.356 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.0 p -67.46 -26.81 36.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -40.23 74.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.664 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -50.07 75.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.444 ' HB ' ' HE2' ' A' ' 285' ' ' LYS . 41.9 pt -78.33 -27.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -51.91 -45.89 64.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.706 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 58.9 mt-10 -73.82 -39.65 63.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.782 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -73.4 -43.85 59.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.444 ' HE2' ' HB ' ' A' ' 281' ' ' ILE . 38.1 mttm -87.07 -58.44 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 25.6 tp -57.41 -57.09 14.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.454 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 60.6 mt -60.12 -50.11 81.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.846 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.406 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.82 -36.13 78.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.716 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -60.08 -38.14 81.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.306 0.574 . . . . 0.0 110.291 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.628 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 5.6 t80 -59.93 -45.52 92.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.972 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -83.13 -35.14 25.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.3 t0 -65.39 -45.31 84.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -68.95 -40.08 79.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 301' ' ' TYR . 85.8 mt -60.63 -24.05 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.09 -13.69 49.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.321 0.582 . . . . 0.0 109.642 178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.457 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 31.0 mt-30 -102.63 -0.02 32.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.583 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 58.54 30.63 20.04 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.062 0.458 . . . . 0.0 110.229 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.55 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 14.1 p -70.04 -9.71 56.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.47 42.96 94.15 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.839 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.4 mtmt -121.25 38.03 4.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 83.3 m-85 -161.81 164.19 28.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.7 p -147.01 163.79 35.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -137.72 128.52 27.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.838 0.351 . . . . 0.0 110.816 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.53 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.76 151.69 12.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -58.91 -56.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.598 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.2 pt-20 -51.11 -53.74 31.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.18 -52.24 59.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.735 0.302 . . . . 0.0 111.307 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.417 ' CG2' ' CD1' ' A' ' 320' ' ' LEU . 33.6 m -59.42 -39.76 84.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.9 mp -67.51 -43.8 80.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.436 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 13.7 mttm -59.23 -49.36 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.778 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -69.94 -26.7 64.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.31 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.718 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.95 -26.32 59.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.783 0.325 . . . . 0.0 110.691 179.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -76.83 -28.1 55.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.4 mmt -81.43 -7.38 59.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.899 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.03 13.51 27.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.72 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.13 -4.77 57.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.486 0.184 . . . . 0.0 110.914 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.793 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.8 m -98.93 107.11 19.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 33.9 tt0 -59.9 -50.03 75.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.779 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 388' ' ' THR . 44.7 mm -135.8 127.28 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 111.53 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.51 ' HB2' HD11 ' A' ' 312' ' ' LEU . 49.6 tp -93.23 128.22 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.482 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.604 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.3 mt -114.07 107.87 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.501 HG11 HD13 ' A' ' 375' ' ' LEU . 19.0 t -125.3 149.15 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.327 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.583 ' HD1' ' HA ' ' A' ' 393' ' ' THR . 96.6 m-85 -99.89 132.61 45.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.579 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 13.6 pt-20 -53.58 -29.6 38.24 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.4 45.33 1.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 38.9 tp -83.71 121.54 27.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.376 . . . . 0.0 110.645 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -91.26 23.54 3.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.953 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.489 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 19.6 mm -119.97 136.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.563 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.5 mtt -139.05 161.94 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.59 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpm_? -90.05 114.27 26.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.874 ' CD2' ' HB2' ' A' ' 371' ' ' SER . 33.3 m-85 -109.29 145.63 35.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.5 ' HA ' HD12 ' A' ' 343' ' ' ILE . 2.7 m -109.7 109.34 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.311 0.577 . . . . 0.0 111.361 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.595 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 0.5 OUTLIER -97.14 175.07 6.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.411 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.496 ' CD2' HD11 ' A' ' 369' ' ' ILE . 32.6 m170 -113.27 170.01 8.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 49.4 t -105.65 160.55 15.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.56 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.14 -38.77 40.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.349 . . . . 0.0 110.883 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.47 -108.35 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.234 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.54 36.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -156.37 46.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -170.84 113.64 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.699 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.13 139.06 35.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.058 0.456 . . . . 0.0 111.005 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.02 141.43 48.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.984 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 332' ' ' VAL . 8.8 mm -120.72 121.46 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.02 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.0 tp -130.09 161.02 31.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 0.0 112.13 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.489 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 2.2 p90 -103.78 119.78 39.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.076 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.513 HD23 ' CE2' ' A' ' 357' ' ' PHE . 1.8 mm? -123.29 158.24 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.5 p -101.86 173.34 3.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.601 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.4 Cg_exo -45.45 -46.7 14.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.997 1.798 . . . . 0.0 112.27 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.39 -58.55 8.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.365 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -60.93 -47.31 87.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.647 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 76.9 mt-10 -59.76 -34.98 73.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.443 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -57.46 -29.77 64.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -92.31 40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.956 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.648 ' HA ' ' CD1' ' A' ' 357' ' ' PHE . 15.9 pttt -64.13 -28.66 69.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 55.1 m -60.04 -39.99 87.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.748 0.309 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 358' ' ' THR . 95.5 m-70 -106.81 -54.31 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.668 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 354' ' ' LYS . 0.1 OUTLIER 61.19 5.12 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.701 -178.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 365' ' ' GLU . 13.5 m -87.59 -178.9 6.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.458 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.496 ' H ' ' CG2' ' A' ' 358' ' ' THR . 96.0 m-20 -79.07 161.83 26.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.825 0.345 . . . . 0.0 110.315 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -74.64 -2.07 24.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.572 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -84.16 -46.07 12.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.09 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.82 -36.3 4.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.91 0.386 . . . . 0.0 110.844 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.437 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 62.78 21.7 63.43 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.881 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -156.07 83.14 1.0 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.821 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 358' ' ' THR . 61.7 mm-40 -151.51 -47.59 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -101.73 169.92 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.59 119.33 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.347 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 333' ' ' LEU . 2.4 tm? -83.82 127.88 34.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.213 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.496 HD11 ' CD2' ' A' ' 334' ' ' HIS . 3.5 mt -93.2 -49.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.547 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.426 ' H ' HG23 ' A' ' 332' ' ' VAL . 22.5 tt0 -179.36 153.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.028 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.874 ' HB2' ' CD2' ' A' ' 331' ' ' TYR . 17.5 t -125.42 148.09 48.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.428 ' HE2' ' HA ' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.87 128.82 25.67 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.152 179.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.688 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 71.7 Cg_exo -50.23 112.8 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.78 1.653 . . . . 0.0 111.153 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.5 mt -58.82 -40.04 82.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.388 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.579 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 65.6 tp -60.08 -52.49 65.11 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.305 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.4 mt-10 -60.94 -39.94 91.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 110.125 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -61.11 -40.01 92.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.596 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.459 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.5 OUTLIER -71.48 -23.45 61.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.571 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -8.77 53.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.994 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -108.34 -10.3 15.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.03 20.35 5.41 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -67.42 -20.16 65.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -79.88 -43.61 21.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -60.82 -40.03 91.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.447 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -80.15 -11.38 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.4 2.46 54.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.302 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.509 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.73 163.37 17.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.194 0.521 . . . . 0.0 110.62 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.461 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 66.0 m -107.8 100.37 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.0 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.486 ' CD2' HG22 ' A' ' 322' ' ' VAL . 2.1 tm? -73.76 102.63 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.478 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.9 mm-40 -108.84 139.44 43.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.408 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 16.4 mm -102.94 101.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.521 ' HB ' HD12 ' A' ' 287' ' ' ILE . 4.5 m -102.75 -172.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.587 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.583 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 14.6 p -156.99 152.41 26.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.337 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -78.91 76.96 5.39 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -119.22 -49.66 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.0 m -88.05 -176.78 5.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 11.7 mm-40 -59.43 -46.01 89.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.693 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 52.3 mp0 -64.5 -40.48 95.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -61.34 -27.69 68.11 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.405 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 72.9 m -83.87 -22.97 31.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.677 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 27.3 mt-30 -72.45 -40.62 66.88 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.501 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 287' ' ' ILE . 2.1 m-85 -67.38 -49.96 61.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.443 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.412 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.22 -38.14 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.467 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 400' ' ' SER . 8.6 mmpt? -69.96 -51.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.143 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.45 -26.2 69.35 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.543 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.53 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 17.0 t80 179.09 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 96.85 167.11 33.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.499 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.06 -48.69 2.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.031 -0.604 . . . . 0.0 114.28 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.535 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -147.44 131.43 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.383 0.592 . . . . 0.0 111.985 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.33 135.03 5.17 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.21 140.48 15.47 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.316 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 318' ' ' GLU . 44.5 mt -103.5 125.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.793 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.1 mt -87.58 151.37 23.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.484 0.659 . . . . 0.0 112.264 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.551 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 63.4 mtt-85 -71.62 -33.9 69.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.632 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.434 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 51.8 t80 -169.0 166.06 11.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -53.42 132.73 40.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 111.148 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.02 160.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -78.67 127.81 32.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.324 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -69.95 -40.02 75.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.074 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -104.2 142.8 33.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -81.8 -42.13 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.473 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 ptp -150.04 162.86 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.21 -32.45 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -113.62 82.39 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.65 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.45 ' CB ' ' HG2' ' A' ' 430' ' ' GLU . 82.4 mt-30 -70.01 -39.99 75.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.416 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.84 68.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.781 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.08 -175.48 17.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.905 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.06 -40.1 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.427 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 -76.13 60.63 1.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.512 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.45 ' HG2' ' CB ' ' A' ' 425' ' ' GLN . 48.4 mt-10 -59.79 -41.14 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.708 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.438 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 51.3 p90 -144.32 114.74 7.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.357 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 19.0 p90 -133.59 85.7 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.273 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -90.08 15.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.459 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 53.5 mt -65.87 -9.46 29.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.804 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.481 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -78.41 -21.18 49.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -59.92 -38.33 82.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.04 0.448 . . . . 0.0 110.284 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.99 -44.99 94.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.954 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.06 -40.03 88.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.887 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 32.4 m120 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -66.29 -27.58 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.67 -46.87 74.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.568 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.419 ' CD2' ' HE3' ' A' ' 395' ' ' LYS . 51.8 t80 -60.03 -49.09 79.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 278' ' ' VAL . 48.5 pt -76.45 -21.47 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.0 OUTLIER -51.05 -39.58 56.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.815 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.611 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 mp0 -69.98 -46.73 64.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -49.16 78.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -74.55 -58.83 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.581 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 40.6 tp -61.32 -58.84 6.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.957 0.408 . . . . 0.0 112.079 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 41.3 mt -59.99 -41.24 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.154 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.451 ' CA ' ' HG3' ' A' ' 398' ' ' GLU . . . -57.1 -38.92 88.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.358 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.494 ' HG2' ' HH ' ' A' ' 301' ' ' TYR . 53.9 ttt-85 -60.02 -38.7 83.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.283 0.563 . . . . 0.0 109.767 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.625 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 8.3 t80 -60.01 -46.14 90.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -80.79 -35.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.3 t0 -60.01 -49.86 76.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.576 0.227 . . . . 0.0 111.572 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.1 mt-10 -61.75 -43.11 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.403 HD12 ' CE1' ' A' ' 290' ' ' TYR . 94.5 mt -57.76 -27.9 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.448 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -63.69 -14.61 53.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.283 0.563 . . . . 0.0 109.56 178.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.463 ' HB2' HG21 ' A' ' 298' ' ' THR . 56.8 mt-30 -105.96 -2.46 22.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.653 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.85 32.44 21.27 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.033 0.444 . . . . 0.0 110.405 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.629 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.9 p -69.82 -14.31 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.841 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.73 46.36 94.64 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 119.869 -1.157 . . . . 0.0 113.363 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.545 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 49.2 mttp -122.68 33.97 5.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.625 ' CE2' ' HA ' ' A' ' 290' ' ' TYR . 93.4 m-85 -159.87 161.06 34.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.618 0.247 . . . . 0.0 111.544 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 55.7 m -140.99 159.94 41.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.09 0.472 . . . . 0.0 111.456 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.7 p90 -131.96 149.36 52.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.461 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 84.77 167.21 42.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.832 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.54 HG11 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -71.59 -55.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.0 111.065 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.7 pt-20 -47.31 -53.71 12.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.798 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 85.3 m-20 -64.27 -53.87 42.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.477 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 23.8 m -58.21 -40.03 80.57 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.668 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.493 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.9 mp -66.02 -47.52 74.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.834 0.35 . . . . 0.0 111.223 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 314' ' ' MET . 14.7 mttm -56.42 -49.98 72.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.429 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -67.42 -29.19 68.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.737 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.852 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -71.24 -27.64 63.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.57 -26.77 41.26 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.5 mmt -80.47 -9.06 59.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.771 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.23 45.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.458 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.61 -5.45 58.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.142 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 312' ' ' LEU . 17.5 m -92.74 102.48 13.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 412' ' ' ILE . 36.0 tt0 -59.4 -48.79 80.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.204 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.435 ' HA ' ' H ' ' A' ' 388' ' ' THR . 42.8 mm -136.43 125.06 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.51 0.195 . . . . 0.0 111.362 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 322' ' ' VAL . 23.6 tp -88.69 123.66 33.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.581 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -109.53 103.66 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.554 HG23 ' HG ' ' A' ' 320' ' ' LEU . 10.6 t -114.39 153.64 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.643 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 77.2 m-85 -99.94 142.18 31.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.474 . . . . 0.0 112.135 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 12.6 pt-20 -67.13 154.91 40.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.73 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.05 25.39 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 0.0 110.301 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.544 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 49.2 tp -52.41 128.89 27.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.719 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -91.02 22.23 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.481 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.544 ' H ' ' HG ' ' A' ' 326' ' ' LEU . 19.3 mm -124.41 135.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.62 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.622 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.02 161.97 36.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.625 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 47.3 ttt180 -91.5 118.78 30.88 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 110.892 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.545 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.1 m-85 -116.21 153.13 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.617 ' CG2' ' HB2' ' A' ' 370' ' ' GLU . 16.1 m -114.59 114.04 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.145 0.498 . . . . 0.0 111.556 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.588 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 2.6 mm? -108.06 160.88 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.577 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.47 ' CD2' ' CD1' ' A' ' 369' ' ' ILE . 33.0 m170 -89.55 171.17 9.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 12.8 t -101.49 160.91 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.813 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . 0.411 ' HG2' ' HG3' ' A' ' 365' ' ' GLU . 78.6 mt-30 -44.83 -31.43 1.23 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -106.56 -116.09 4.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.799 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.74 172.43 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.664 0.269 . . . . 0.0 110.549 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 59.89 45.71 12.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.261 0.553 . . . . 0.0 110.107 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -172.23 128.5 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.175 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.16 139.01 52.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -111.58 148.71 32.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.571 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 332' ' ' VAL . 9.3 mm -119.0 123.86 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.611 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 50.5 tp -132.38 154.14 50.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.29 0.566 . . . . 0.0 111.998 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.453 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -95.38 116.53 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.258 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 1.3 mm? -118.83 152.0 37.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.409 0.623 . . . . 0.0 112.156 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.614 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 40.7 p -100.44 173.82 3.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.337 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -45.61 -45.07 16.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.786 1.657 . . . . 0.0 112.01 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -59.95 -57.33 13.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.26 -49.91 73.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 95.5 mt-10 -60.04 -32.75 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.39 -29.68 64.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 66.2 t0 -89.79 60.41 5.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.859 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 7.6 mtmp? -69.97 -39.04 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.848 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 74.1 m -57.88 -40.01 79.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.802 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.467 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 71.6 m80 -105.61 -53.12 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.588 ' CD2' ' CD1' ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.42 4.29 0.68 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -178.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 364' ' ' GLN . 0.2 OUTLIER -96.96 -166.24 1.37 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.463 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 85.8 m-20 -130.37 123.77 30.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -65.8 -2.39 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -101.23 -23.69 14.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.457 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.463 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -126.1 -36.28 2.36 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.441 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 364' ' ' GLN . . . 79.62 42.91 10.75 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.734 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.446 ' HB2' HG23 ' A' ' 358' ' ' THR . 13.5 mm-40 -47.02 -177.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 336' ' ' GLN . 76.0 mm-40 -119.34 28.97 7.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -88.2 139.99 29.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -140.26 112.51 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.019 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.485 ' HA ' HD12 ' A' ' 333' ' ' LEU . 14.1 tp -65.08 127.31 31.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.252 0.549 . . . . 0.0 112.127 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.47 ' CD1' ' CD2' ' A' ' 334' ' ' HIS . 1.4 mt -115.48 -41.73 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.063 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.617 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 37.2 mt-10 -141.36 160.19 40.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.554 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.493 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p -147.02 116.49 7.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.352 0.596 . . . . 0.0 111.125 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.428 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 9.1 tpp -118.51 134.36 23.48 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.473 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.5 Cg_endo -59.84 123.02 12.38 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 110.846 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 12.2 mt -65.98 -44.08 85.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.401 HD12 ' CD1' ' A' ' 391' ' ' ILE . 56.3 tp -59.98 -50.0 75.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.563 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 47.3 mt-10 -60.57 -40.0 90.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.001 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.428 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 68.8 t-105 -67.51 -38.77 84.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.277 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.564 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.7 m-85 -73.47 -27.82 61.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.29 53.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.144 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -107.87 -16.61 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.819 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -129.82 21.4 5.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.5 p90 -61.83 -16.62 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.566 0.222 . . . . 0.0 111.572 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -83.46 -36.39 24.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.667 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -60.02 -39.92 87.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.43 ' CD2' HD23 ' A' ' 312' ' ' LEU . 42.9 m-85 -87.04 -5.95 58.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.179 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.73 2.71 46.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.188 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.27 18.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.435 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 76.0 m -107.11 100.91 10.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.29 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.459 ' CD2' HG23 ' A' ' 322' ' ' VAL . 1.9 tm? -66.85 102.33 0.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.596 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.71 134.2 52.26 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 30.9 mm -99.97 99.93 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 13.1 m -100.99 -171.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.776 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.643 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -160.04 156.44 26.98 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.008 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.44 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.4 p-10 -74.04 16.64 0.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 280' ' ' PHE . 1.0 OUTLIER -70.01 -29.56 66.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.714 0.292 . . . . 0.0 111.411 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 17.2 m -97.3 169.66 9.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 111.385 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -59.93 -50.0 75.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.096 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.544 ' HB3' HG21 ' A' ' 287' ' ' ILE . 75.0 mm-40 -67.84 -40.43 83.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 110.121 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.44 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -64.99 -19.08 65.36 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.038 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.4 m -83.92 -23.47 31.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.754 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -70.53 -40.01 73.71 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.704 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.605 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.5 m-85 -60.03 -50.71 72.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.297 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.449 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 73.8 t -56.51 -35.57 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.088 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -70.62 -49.86 43.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 110.35 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -73.5 -18.58 79.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.041 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.461 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.4 t80 174.47 -78.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.22 169.61 30.6 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.306 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.5 -49.04 2.97 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.244 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -140.49 133.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 117.527 0.663 . . . . 0.0 112.624 -177.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -152.38 142.18 9.13 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.2 143.47 14.34 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.556 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.5 mt -104.26 128.87 57.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.602 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 30.0 mt -89.94 151.4 21.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.677 0.751 . . . . 0.0 112.494 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 415' ' ' TYR . 11.0 mtt180 -69.97 -38.47 76.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.866 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.464 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 97.8 m-85 -160.71 178.47 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.371 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.13 136.76 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.894 0.378 . . . . 0.0 110.282 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.98 160.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -85.97 97.85 10.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -59.93 -50.11 75.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -103.21 -118.32 4.45 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.491 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.488 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 83.1 mtp -114.03 160.04 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.641 0.258 . . . . 0.0 110.649 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 416' ' ' ARG . 36.9 tt0 -65.58 -43.5 89.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -59.98 -46.28 89.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.158 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 422' ' ' MET . 83.8 mt-30 57.41 51.77 9.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -63.15 100.37 0.34 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.619 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.47 -145.74 20.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.0 19.98 18.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.015 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.9 52.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.475 ' CG ' ' HG2' ' A' ' 425' ' ' GLN . 51.1 mp0 -66.45 -37.66 85.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.492 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -125.83 105.95 9.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -132.41 128.4 37.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -88.57 13.32 12.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.471 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.01 -3.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.043 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -58.84 -40.07 83.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.302 . . . . 0.0 110.555 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.43 -24.94 60.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.93 -35.56 75.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.511 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.91 -41.05 90.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.924 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -69.09 127.28 32.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.001 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.73 0.3 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.7 p -65.49 -29.96 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.333 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -50.12 -50.32 48.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.789 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.53 -50.03 74.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.571 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' A' ' 278' ' ' VAL . 49.4 pt -75.4 -21.06 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.717 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.662 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -48.15 -44.73 32.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.258 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 4.1 mp0 -71.66 -32.06 67.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.467 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -54.49 4.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -73.42 -57.99 3.62 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.507 ' HG ' HD13 ' A' ' 321' ' ' ILE . 15.9 tp -57.69 -54.88 41.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.767 0.318 . . . . 0.0 111.659 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.572 HD12 ' HB ' ' A' ' 392' ' ' VAL . 20.7 mt -59.96 -51.31 74.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.519 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.55 -36.23 88.64 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.012 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -59.98 -33.0 71.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.597 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.4 t80 -60.08 -45.58 92.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.63 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 32.3 m-85 -85.83 -36.85 19.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -60.04 -49.96 75.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.839 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.7 mp0 -66.29 -40.73 90.26 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 83.5 mt -60.0 -22.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -18.77 52.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.493 0.663 . . . . 0.0 109.62 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 41.6 mt-30 -101.41 0.21 36.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.828 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 57.73 29.89 18.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.965 0.412 . . . . 0.0 110.333 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.568 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.0 p -67.43 -11.53 58.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.828 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.25 53.4 45.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.402 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.0 mttt -130.34 36.66 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 290' ' ' TYR . 86.6 m-85 -160.86 162.39 32.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.695 0.284 . . . . 0.0 111.743 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.1 p -148.99 165.98 30.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.963 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.518 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.2 p90 -138.45 148.6 44.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.29 157.57 33.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.049 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.517 HG11 HG22 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.98 -58.68 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 110.662 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.2 pt-20 -47.0 -54.24 10.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.706 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 73.9 m-20 -63.67 -54.56 33.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.351 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 27.9 m -56.38 -37.91 70.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.897 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.459 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 2.2 mp -69.7 -43.97 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.1 mttm -56.2 -52.62 63.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.67 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.455 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -69.98 -26.2 63.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.79 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.757 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.18 -36.81 77.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 110.685 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -70.77 -25.36 62.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.6 mmt -82.58 -7.87 59.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.889 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.11 13.61 42.74 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.253 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.43 -7.13 59.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.941 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 312' ' ' LEU . 28.2 m -97.86 106.73 19.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.666 ' HB2' ' HA ' ' A' ' 414' ' ' ARG . 36.1 tt0 -59.93 -50.26 74.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.748 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.466 ' CG2' ' HB ' ' A' ' 388' ' ' THR . 26.5 mm -136.6 122.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.528 0.204 . . . . 0.0 110.776 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.446 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.9 tp -84.76 125.87 32.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.523 HG22 HG21 ' A' ' 392' ' ' VAL . 0.1 OUTLIER -109.65 103.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.284 179.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.446 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.5 t -111.45 158.45 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.903 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.47 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 9.8 m-85 -109.96 148.33 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.12 0.486 . . . . 0.0 112.196 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.452 ' CG ' ' CG2' ' A' ' 391' ' ' ILE . 90.1 mt-10 -67.48 158.92 30.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.183 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.39 29.42 13.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.8 tp -57.87 127.23 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 109.999 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 347' ' ' THR . 34.3 p-10 -90.02 26.94 1.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.517 HG22 HG11 ' A' ' 305' ' ' VAL . 29.8 mm -128.25 132.96 67.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.939 0.399 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.638 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 57.0 mtt -140.43 161.93 36.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.525 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.6 ttm180 -86.11 106.76 17.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.087 0.47 . . . . 0.0 110.757 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.533 ' CD2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -116.01 119.75 36.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 332' ' ' VAL . 17.0 m -92.44 117.94 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.032 0.444 . . . . 0.0 111.662 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.525 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 1.6 mm? -105.25 153.39 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.91 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 0.6 OUTLIER -89.96 -177.87 5.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.731 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.432 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 44.7 t -104.06 157.66 16.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.997 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 365' ' ' GLU . 86.3 mt-30 -60.0 -40.02 87.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.39 10.29 57.88 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.112 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.09 -178.57 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 60.04 28.49 18.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 47.4 tp10 -165.65 126.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.878 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -117.26 136.02 53.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.413 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -117.4 144.64 44.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.405 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.4 mm -118.63 122.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.545 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 56.7 tp -136.2 161.02 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.281 0.562 . . . . 0.0 111.738 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.449 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 2.4 p90 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.685 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.0 mm? -124.82 164.61 19.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.736 0.779 . . . . 0.0 113.009 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 p -101.83 171.26 5.5 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.803 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.1 Cg_exo -49.29 -42.39 40.52 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.98 1.787 . . . . 0.0 112.051 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.56 -50.22 72.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 21.6 mm100 -68.07 -48.81 64.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.591 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.533 ' HG2' ' CD2' ' A' ' 331' ' ' TYR . 94.2 mt-10 -60.01 -31.76 70.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.301 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -57.44 -32.31 66.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 0.0 110.156 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 64.6 t0 -89.62 58.18 4.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.441 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 7.6 mtmp? -66.51 -40.02 88.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.6 t -62.47 -58.23 8.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 111.585 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 91.4 m-70 -81.5 -51.83 7.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.369 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.808 ' HB3' ' HB2' ' A' ' 366' ' ' HIS . 0.5 OUTLIER 52.21 12.16 0.2 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.409 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.463 ' CG2' ' H ' ' A' ' 359' ' ' ASP . 6.3 m -97.43 -177.84 3.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.463 ' H ' ' CG2' ' A' ' 358' ' ' THR . 90.1 m-20 -132.62 135.55 45.94 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -72.84 1.38 8.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.673 0.273 . . . . 0.0 111.421 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -104.06 -22.38 13.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.45 HG21 ' HB2' ' A' ' 359' ' ' ASP . 5.7 t -122.92 -37.82 2.69 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.576 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 82.95 41.61 8.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.738 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.461 ' N ' HG22 ' A' ' 358' ' ' THR . 15.0 mm100 -92.86 98.33 11.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 336' ' ' GLN . 17.3 mm-40 -69.34 132.87 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 111.181 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 64.2 m80 -139.56 159.99 40.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 70.4 mt-10 -142.99 115.16 8.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.93 0.395 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 14.1 tp -79.29 123.3 27.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.602 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 334' ' ' HIS . 3.7 mp -93.8 -35.87 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.523 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -158.12 165.4 35.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.564 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.2 115.84 6.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.571 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.415 ' HE1' ' HD2' ' A' ' 373' ' ' PRO . 2.7 tpt -115.17 120.09 37.42 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.783 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 7.5 Cg_endo -50.27 120.45 6.27 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.094 1.863 . . . . 0.0 111.107 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 18.4 mt -61.9 -41.42 97.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.669 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 391' ' ' ILE . 45.5 tp -60.0 -53.3 59.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 61.6 mt-10 -59.93 -40.01 87.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.039 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -66.92 -35.72 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.405 ' CG ' HD21 ' A' ' 320' ' ' LEU . 1.2 m-85 -69.5 -27.5 65.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.965 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -11.65 43.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.223 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.21 -9.74 15.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 14.7 m120 -130.0 18.24 5.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.7 p90 -67.89 -19.25 64.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 382' ' ' TYR . 33.1 mmtt -81.37 -40.93 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -61.49 -39.97 92.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.21 0.529 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.519 ' CD2' HD23 ' A' ' 312' ' ' LEU . 17.3 m-85 -81.55 -8.18 59.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.287 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.0 2.79 48.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.363 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 317' ' ' VAL . . . -88.23 164.55 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 111.15 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' A' ' 319' ' ' ILE . 84.6 m -107.56 102.7 11.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.15 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 0.9 OUTLIER -65.15 103.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.115 0.483 . . . . 0.0 111.124 -178.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.662 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.1 mm-40 -109.43 127.57 54.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.953 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.452 ' CG2' ' CG ' ' A' ' 324' ' ' GLU . 42.0 mm -99.91 100.01 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 112.03 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.572 ' HB ' HD12 ' A' ' 287' ' ' ILE . 21.9 m -113.71 141.36 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.44 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 13.1 p -121.09 164.44 16.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.832 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.411 ' HB2' HG22 ' A' ' 403' ' ' VAL . 57.4 t0 -68.65 80.66 0.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -112.87 -30.13 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.305 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 8.3 t -126.76 -172.95 2.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -59.97 -49.51 77.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 52.8 mp0 -59.96 -44.12 94.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.181 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.95 66.52 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 68.9 m -84.01 -23.47 30.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.44 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.418 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 73.4 mt-30 -70.99 -43.95 66.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.529 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.481 ' CD1' HG23 ' A' ' 287' ' ' ILE . 4.5 m-85 -62.89 -48.03 80.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 394' ' ' ASP . 55.1 t -60.09 -39.58 80.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.001 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -70.37 -52.83 19.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.77 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -62.39 -22.35 63.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.931 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 18.0 t80 176.77 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.11 168.47 31.86 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.156 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.55 -47.69 2.76 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.39 133.38 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 117.847 0.824 . . . . 0.0 112.609 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -156.97 149.8 20.7 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -133.72 149.19 19.65 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.677 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 318' ' ' GLU . 20.1 mt -110.25 127.75 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 78.3 mt -84.84 150.62 24.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.646 0.736 . . . . 0.0 112.76 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.666 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 20.7 mtm180 -70.01 -32.18 70.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.363 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.505 ' HA ' ' HE2' ' A' ' 300' ' ' LYS . 53.2 p90 -159.45 179.51 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 298' ' ' THR . 1.2 tmm_? -61.96 94.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.264 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 415' ' ' TYR . 1.3 p -130.05 130.02 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.176 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -112.71 159.78 18.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.599 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -69.47 -29.93 67.71 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.641 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -63.11 140.06 58.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -75.05 -84.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.811 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 93.6 mtp -92.36 176.81 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -59.96 -41.05 91.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.451 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.99 139.95 51.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.422 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.415 ' NE2' ' CG ' ' A' ' 430' ' ' GLU . 57.6 mt-30 -131.64 150.06 52.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 170.79 37.24 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.188 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.84 165.92 25.24 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.616 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -59.96 -40.06 87.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 111.132 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -88.7 39.55 0.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.623 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.415 ' CG ' ' NE2' ' A' ' 425' ' ' GLN . 41.8 tt0 -61.41 -39.98 92.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.604 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.65 99.04 6.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -118.29 109.61 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.044 0.45 . . . . 0.0 111.179 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.57 -5.38 36.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 434' ' ' LEU . 36.1 mt -53.63 -13.52 0.67 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.207 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -55.17 -40.02 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -70.01 -32.56 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.374 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -59.98 -32.22 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.514 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.101 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.849 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.802 0.334 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.7 p -65.84 -29.73 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.403 ' N ' HG13 ' A' ' 278' ' ' VAL . 10.5 mtmt -51.32 -43.71 61.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.402 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -66.76 -43.62 83.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 111.519 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 278' ' ' VAL . 45.6 pt -82.77 -21.04 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.612 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -57.67 -40.74 80.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 -179.23 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.489 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 21.3 pt-20 -73.22 -29.9 63.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.303 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -84.69 -56.67 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.92 -57.81 4.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.778 ' HG ' HD13 ' A' ' 321' ' ' ILE . 28.9 tp -57.45 -57.31 13.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 31.2 mt -59.94 -48.71 86.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.42 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.25 60.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.083 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.5 ttt180 -59.94 -40.11 87.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.607 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 6.6 t80 -57.39 -45.93 83.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.72 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -83.36 -38.25 22.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 111.564 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.7 t0 -62.03 -46.16 90.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.462 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.653 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.3 mt-10 -64.2 -42.94 96.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 91.7 mt -60.45 -21.43 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.643 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -66.17 -13.93 61.02 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.256 0.551 . . . . 0.0 109.665 178.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.428 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 27.9 mt-30 -103.47 -0.73 29.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.469 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.01 28.18 17.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.628 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.2 p -67.64 -11.48 58.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.38 51.48 55.94 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.423 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.5 mttt -126.13 35.65 4.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.653 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 83.3 m-85 -159.84 162.96 34.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.536 0.208 . . . . 0.0 111.267 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.5 164.69 30.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 53.0 p90 -138.02 149.03 45.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 90.1 155.56 31.17 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.083 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -63.55 -61.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -47.33 -52.31 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.43 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.3 m-20 -63.35 -55.77 21.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.398 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.43 HG21 HD12 ' A' ' 320' ' ' LEU . 35.7 m -57.82 -36.24 71.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.962 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.464 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.7 mp -68.63 -43.12 77.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 52.3 mtmt -60.01 -45.43 92.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.556 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.06 66.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.813 0.339 . . . . 0.0 110.643 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.713 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -72.09 -26.92 62.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.25 -27.84 47.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 92.8 mmm -80.9 -8.5 59.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.585 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.9 16.89 49.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.275 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.95 -8.44 55.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.342 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.713 HG22 ' HA ' ' A' ' 312' ' ' LEU . 27.5 m -92.74 104.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 412' ' ' ILE . 42.4 tt0 -59.64 -49.96 75.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.325 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.431 HG22 HD21 ' A' ' 286' ' ' LEU . 36.8 mm -136.7 124.05 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 308' ' ' THR . 46.2 tp -87.92 126.05 34.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.201 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.778 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -111.53 104.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 21.7 t -122.4 162.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.435 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.484 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.1 m-85 -106.88 144.34 33.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.505 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.51 -36.48 83.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.38 45.7 1.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 35.9 tp -79.11 122.58 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.47 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.638 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.2 m-20 -90.25 29.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 345' ' ' TYR . 26.1 mm -126.92 133.18 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 111.567 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.662 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.7 mtt -140.19 162.08 36.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.877 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.503 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 17.1 tpt180 -86.6 111.47 20.66 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.662 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 38.8 m-85 -123.77 123.76 41.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.85 120.2 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.688 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 0.9 OUTLIER -107.95 133.74 51.86 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.52 ' HB2' HD12 ' A' ' 369' ' ' ILE . 36.2 m170 -140.01 158.5 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.75 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 8.5 t -105.29 160.03 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.053 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.02 130.04 44.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.652 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 89.72 9.96 65.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.781 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 50.95 37.43 17.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.902 0.351 . . . . 0.0 111.295 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.01 6.69 43.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.303 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -167.14 111.62 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.759 0.314 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 12.0 mt-10 -122.8 129.05 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.253 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -137.54 123.68 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.939 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 2.1 mm -110.22 118.67 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.891 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 29.3 tp -143.37 156.81 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 112.684 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.522 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.12 127.34 37.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.896 178.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.536 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -122.09 165.09 16.62 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.9 p -101.6 169.88 7.16 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.306 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 5.3 Cg_endo -47.13 -49.88 12.01 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.024 1.816 . . . . 0.0 111.749 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -54.96 -53.59 53.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.38 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -65.25 -46.09 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.64 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 87.7 mt-10 -60.01 -34.77 73.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.124 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 38.6 mmtt -57.58 -29.63 64.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.349 0.595 . . . . 0.0 109.653 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -96.49 31.63 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.092 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.722 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 5.0 pttt -71.08 -21.89 62.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.442 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.194 0.521 . . . . 0.0 109.945 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' A' ' 358' ' ' THR . 97.8 m-70 -101.15 -49.77 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.282 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.722 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 0.3 OUTLIER 57.11 8.87 0.58 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 110.349 -178.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 364' ' ' GLN . 6.3 m -105.28 178.64 4.5 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.082 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' A' ' 362' ' ' THR . 73.7 m-20 -130.72 132.9 45.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -69.41 -2.57 11.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.687 0.279 . . . . 0.0 111.734 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -102.63 -20.26 14.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 359' ' ' ASP . 14.2 t -116.08 -38.71 3.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.919 0.39 . . . . 0.0 110.531 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 79.78 40.27 15.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.82 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.479 ' HB2' HG21 ' A' ' 358' ' ' THR . 12.9 mt-30 -52.85 -172.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.988 0.423 . . . . 0.0 111.033 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -145.93 87.55 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 96.4 m-70 -144.86 148.08 33.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.017 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 334' ' ' HIS . 5.8 mm-40 -140.89 114.47 8.83 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.404 HD22 ' HD2' ' A' ' 331' ' ' TYR . 16.7 tp -62.71 138.42 58.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.539 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.52 HD12 ' HB2' ' A' ' 334' ' ' HIS . 3.3 mp -117.28 -40.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.002 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -143.99 149.81 37.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.497 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER -146.51 116.07 7.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.805 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 3.9 tpt -119.07 130.26 24.94 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.672 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.639 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.6 Cg_exo -56.77 118.35 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.836 1.69 . . . . 0.0 110.835 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.503 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 32.4 mt -59.89 -41.23 91.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.935 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.475 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.2 tp -60.01 -54.37 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.749 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 48.7 mt-10 -59.62 -40.03 86.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 109.564 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.447 ' CZ3' HD23 ' A' ' 309' ' ' LEU . 46.0 t90 -60.24 -39.85 88.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.988 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.533 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -74.88 -27.37 60.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.588 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.61 -12.58 42.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.986 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -106.34 -13.7 15.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.8 m120 -129.96 20.06 5.46 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -63.09 -16.1 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.584 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -83.31 -38.05 22.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -60.95 -38.02 84.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.766 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 381' ' ' ASN . 48.7 m-85 -85.95 -9.15 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.52 60.81 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.444 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 317' ' ' VAL . . . -88.16 165.54 15.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 319' ' ' ILE . 53.4 m -108.92 101.75 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.434 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.414 HD21 HG22 ' A' ' 322' ' ' VAL . 2.3 tm? -70.78 102.6 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.612 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.8 mm-40 -111.38 131.98 54.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.834 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.505 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 38.0 mm -98.76 103.83 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 112.182 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . . . . . . . . . 5.8 m -100.73 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.823 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 1.3 p -157.94 154.0 27.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.07 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.458 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.5 p-10 -73.22 20.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 393' ' ' THR . 15.8 mtpt -66.91 -40.03 87.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.635 0.255 . . . . 0.0 111.301 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 m -93.08 173.7 7.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.559 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.9 -50.11 75.08 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.417 ' C ' HG22 ' A' ' 287' ' ' ILE . 67.6 mm-40 -62.9 -40.44 97.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.322 0.582 . . . . 0.0 109.648 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.458 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -61.93 -23.01 63.08 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 53.6 m -83.7 -23.11 31.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.092 -0.554 . . . . 0.0 110.483 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.23 -41.44 49.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.495 ' CG ' ' CZ ' ' A' ' 406' ' ' PHE . 2.3 m-85 -60.0 -50.07 75.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.535 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 70.1 t -60.31 -39.96 82.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.563 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 400' ' ' SER . 1.4 mmpt? -71.14 -46.02 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.808 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -73.97 -31.02 60.41 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.595 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER -156.7 -83.36 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.535 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 99.39 148.63 23.31 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.995 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.67 -47.09 2.97 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.607 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.586 ' CD1' HG22 ' A' ' 305' ' ' VAL . 0.1 OUTLIER -148.36 134.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 118.336 1.068 . . . . 0.0 112.737 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -155.12 148.2 18.23 Favored Glycine 0 CA--C 1.511 -0.173 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.43 150.08 19.6 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.872 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 318' ' ' GLU . 27.1 mt -109.5 126.8 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 42.3 mt -90.83 157.42 17.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.675 0.75 . . . . 0.0 112.776 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 415' ' ' TYR . 63.0 mtm180 -74.36 -40.03 62.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.531 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.467 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 85.1 m-85 -160.79 172.97 16.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -56.88 124.42 18.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.682 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.99 160.02 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.396 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.61 136.44 45.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.0 -40.0 75.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.852 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -139.61 139.97 36.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -107.71 109.46 2.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.403 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 30.9 mtt -139.99 169.91 16.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.03 -40.02 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -72.97 -16.11 61.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.363 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 137.54 37.93 0.15 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 152.94 123.21 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.588 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.95 -33.05 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.67 22.2 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.507 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.97 -39.92 87.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.27 37.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.528 ' O ' ' HG ' ' A' ' 434' ' ' LEU . 19.5 p90 -59.62 -50.05 75.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 40.72 31.06 0.11 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.109 0.48 . . . . 0.0 111.38 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 432' ' ' PHE . 54.9 mt -99.53 -1.41 38.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.275 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.04 -41.24 91.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.0 110.71 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.97 -33.16 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.496 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.0 -31.8 70.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.618 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.02 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.002 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.71 130.03 49.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.898 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.754 0.312 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -68.76 -28.25 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.29 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.408 ' N ' HG11 ' A' ' 278' ' ' VAL . 18.9 mttm -53.33 -40.03 64.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.642 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.03 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.414 ' HB ' ' HE3' ' A' ' 285' ' ' LYS . 44.4 pt -82.7 -23.06 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.777 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 110.221 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.611 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.8 pt-20 -85.24 -34.33 22.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -72.0 -39.97 68.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.414 ' HE3' ' HB ' ' A' ' 281' ' ' ILE . 21.2 mttt -86.6 -58.23 2.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 29.7 tp -57.69 -55.88 29.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 112.03 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 42.3 mt -58.0 -48.41 84.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.725 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.458 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.39 -37.54 82.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.716 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 23.4 ttt85 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.646 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.2 t80 -56.98 -46.76 81.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -79.12 -40.01 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.756 0.312 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.0 t0 -61.65 -45.48 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.671 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 6.7 mt-10 -64.53 -41.76 96.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -60.33 -21.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.474 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -66.76 -12.67 59.65 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.373 0.606 . . . . 0.0 109.458 178.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 298' ' ' THR . 39.4 mt-30 -103.5 0.06 30.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.577 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.53 20.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.635 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.7 p -68.03 -14.7 63.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.57 31.32 70.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.911 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.528 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 43.9 mtmt -110.38 37.07 2.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.452 0.168 . . . . 0.0 110.642 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 290' ' ' TYR . 89.8 m-85 -158.97 159.98 35.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.866 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.445 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -139.36 157.74 45.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 111.09 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.5 124.55 22.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 110.665 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 109.8 147.34 11.71 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.545 HG22 ' CD1' ' A' ' 409' ' ' ILE . 0.0 OUTLIER -54.75 -58.91 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 0.0 110.744 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.1 pt-20 -47.41 -54.72 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.34 -57.02 9.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 18.7 m -52.1 -33.29 38.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.045 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 378' ' ' PHE . 3.3 mp -75.66 -40.07 56.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.701 0.286 . . . . 0.0 111.517 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 10.4 mtmt -57.49 -50.02 74.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.412 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -71.52 -28.01 63.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.648 0.261 . . . . 0.0 110.922 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.825 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.39 -30.76 66.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.054 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.407 ' OE2' ' CZ ' ' A' ' 385' ' ' PHE . 78.3 mm-40 -73.75 -25.22 60.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 420' ' ' GLN . 29.6 mmt -83.04 -7.61 59.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.43 17.03 46.02 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.265 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.77 6.08 43.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.825 HG23 ' HA ' ' A' ' 312' ' ' LEU . 30.1 m -107.46 106.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.1 tt0 -59.05 -49.97 75.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.629 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 286' ' ' LEU . 42.8 mm -136.78 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 38.7 tp -91.16 127.93 36.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.535 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 1.0 OUTLIER -112.23 105.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 389' ' ' LEU . 20.4 t -123.18 161.75 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.433 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.48 ' HD1' ' HA ' ' A' ' 393' ' ' THR . 93.2 m-85 -109.67 146.04 35.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.915 0.388 . . . . 0.0 111.307 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.539 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 16.9 pt-20 -64.97 -30.03 71.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.334 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.17 48.5 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 28.3 tp -83.68 125.52 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.1 32.22 1.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 27.3 mm -129.5 137.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.0 162.08 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.373 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.543 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 22.1 ttt180 -94.12 124.62 38.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.09 0.471 . . . . 0.0 111.053 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 6.6 m-85 -121.08 158.12 28.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.43 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.579 HG12 HD12 ' A' ' 343' ' ' ILE . 10.0 m -122.27 113.52 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.626 HD13 ' CD2' ' A' ' 357' ' ' PHE . 0.5 OUTLIER -104.76 156.75 17.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.261 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.14 161.74 30.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -141.92 110.99 6.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 49.94 37.12 13.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.348 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.77 -86.75 0.31 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 119.892 -1.147 . . . . 0.0 114.003 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 340' ' ' GLU . 0.8 OUTLIER -170.51 -29.02 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.92 14.9 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.255 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 338' ' ' THR . 20.6 tp10 -166.39 137.36 3.47 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -130.32 140.12 50.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.009 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -94.42 144.38 25.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.266 179.498 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.579 HD12 HG12 ' A' ' 332' ' ' VAL . 20.6 mm -117.11 119.39 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.939 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 55.9 tp -135.07 149.0 50.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.241 0.543 . . . . 0.0 112.063 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.513 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -88.47 117.05 27.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.06 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.516 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -118.83 156.4 29.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 22.0 p -100.59 169.4 7.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.8 Cg_endo -44.1 -45.57 11.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.87 -52.98 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -65.18 -50.02 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.7 mt-10 -59.97 -33.9 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.509 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -57.39 -29.93 64.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.338 0.59 . . . . 0.0 109.488 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.38 24.75 7.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.048 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 5.1 ptpt -62.45 -24.9 67.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.046 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 35.8 t -57.31 -40.03 77.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 110.007 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.463 ' C ' ' H ' ' A' ' 358' ' ' THR . 78.5 m80 -102.52 -42.4 5.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.626 ' CD2' HD13 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 55.38 6.92 0.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.999 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.463 ' H ' ' C ' ' A' ' 356' ' ' HIS . 1.3 m -107.29 -170.75 1.75 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.478 ' HB2' ' CG2' ' A' ' 362' ' ' THR . 88.4 m-20 -131.14 134.55 46.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -71.14 -1.33 12.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 111.441 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.01 -18.08 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.478 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 13.3 t -117.31 -37.86 3.45 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 74.31 27.95 64.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.892 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.438 ' HG3' HG21 ' A' ' 362' ' ' THR . 54.4 mt-30 -58.32 -153.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.626 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 56.3 mm-40 -139.84 122.81 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.702 0.287 . . . . 0.0 110.808 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 357' ' ' PHE . 91.4 m-70 -158.82 139.64 12.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.23 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 119.93 7.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.461 ' HA ' HD12 ' A' ' 333' ' ' LEU . 54.7 tp -80.66 143.61 32.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.754 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 1.9 mm -112.33 -36.75 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.848 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 371' ' ' SER . 42.2 tt0 -158.2 166.65 31.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.555 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 3.1 p -145.88 118.5 8.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.178 0.513 . . . . 0.0 111.381 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.454 ' HA ' ' HE3' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.12 126.88 26.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.105 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 11.2 Cg_endo -55.49 125.81 20.37 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.064 1.842 . . . . 0.0 110.69 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 12.3 mt -65.43 -41.33 93.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 61.6 tp -60.06 -53.81 53.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.1 mt-10 -56.88 -40.01 75.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.893 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.24 -35.25 75.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.267 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 309' ' ' LEU . 6.6 m-85 -64.16 -32.14 73.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.696 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.67 -10.01 47.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.71 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -103.19 -0.09 30.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -138.97 16.14 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -67.45 -19.16 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.689 0.281 . . . . 0.0 111.112 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -78.58 -47.44 17.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.94 -45.9 91.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 110.702 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.551 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -73.73 -15.21 61.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.787 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.14 2.49 66.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.27 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.432 ' HB3' HG21 ' A' ' 317' ' ' VAL . . . -87.2 162.18 17.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.445 ' H ' ' HA ' ' A' ' 319' ' ' ILE . 84.4 m -107.14 100.32 9.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.548 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.457 HD23 HG22 ' A' ' 322' ' ' VAL . 1.9 tm? -70.8 102.77 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.652 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 67.2 mm-40 -110.45 128.95 55.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.845 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.456 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 33.2 mm -95.2 104.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.203 0.525 . . . . 0.0 112.146 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.522 HG12 HD11 ' A' ' 287' ' ' ILE . 15.0 m -101.2 -169.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.923 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.48 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.97 156.6 27.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 111.823 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.44 -7.34 9.58 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.209 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -53.21 -41.65 65.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.7 m -87.51 167.44 13.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.689 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 27.2 tt0 -60.03 -53.32 59.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.601 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 41.1 mp0 -60.07 -35.43 75.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.495 0.664 . . . . 0.0 109.316 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -56.24 -58.13 15.78 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.704 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 3.4 m -59.44 -22.0 60.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.815 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 84.5 mt-30 -68.93 -40.05 79.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.82 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.532 ' CE1' HG22 ' A' ' 287' ' ' ILE . 2.6 m-85 -65.9 -50.8 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.421 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 80.6 t -55.8 -35.11 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 400' ' ' SER . 6.0 mmtt -77.12 -50.6 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.468 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -75.45 -27.28 63.81 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.816 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -157.86 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 99.6 153.3 27.59 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.753 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 82.32 -50.63 4.36 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.934 -0.65 . . . . 0.0 114.699 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.607 HD11 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -149.06 133.23 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 117.837 0.819 . . . . 0.0 112.482 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -150.14 139.13 7.14 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -123.93 144.61 15.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.805 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 318' ' ' GLU . 26.4 mt -106.63 128.73 61.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.1 mt -89.55 152.8 21.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.751 0.786 . . . . 0.0 112.82 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.03 -34.96 73.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.729 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 88.3 m-85 -156.84 164.68 37.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.4 mtm180 -59.15 122.83 14.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.258 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 8.4 m -123.87 142.86 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.409 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.31 -39.96 77.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -145.5 161.63 39.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 314' ' ' MET . 2.6 mp0 -50.31 -63.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.771 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -46.4 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.151 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.7 ttt -137.13 160.68 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.03 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -59.97 -41.03 91.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.25 122.61 46.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.734 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -120.96 148.06 44.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.99 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -116.28 -5.36 17.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 116.02 -105.24 1.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.224 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.697 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.92 39.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.337 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.01 -40.06 95.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 110.452 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -111.61 98.78 7.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.539 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.56 124.97 44.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.467 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.12 6.61 11.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.16 -3.85 6.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.963 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.23 -39.88 84.14 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.721 0.296 . . . . 0.0 110.772 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.61 -33.91 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.01 -34.55 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.251 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.98 -46.62 88.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.966 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.07 -39.92 87.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.878 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 33.2 m120 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.764 0.316 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 282' ' ' GLN . 8.6 p -69.48 -27.63 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.202 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.407 ' N ' HG13 ' A' ' 278' ' ' VAL . 11.4 mttm -54.34 -39.97 67.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.75 -50.03 75.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.208 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 3.4 pt -79.04 -43.48 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.806 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.759 ' HB3' HG23 ' A' ' 278' ' ' VAL . 0.1 OUTLIER -57.59 -35.82 70.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 -179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 41.8 mt-10 -72.12 -31.43 66.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 398' ' ' GLU . 0.9 OUTLIER -83.79 -56.27 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.32 -179.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -57.66 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 319' ' ' ILE . 22.0 tp -55.23 -58.21 8.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 398' ' ' GLU . 82.5 mt -60.07 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.282 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.442 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.15 -39.02 57.37 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.269 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -60.05 -34.16 73.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.126 0.489 . . . . 0.0 110.279 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.584 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 19.0 t80 -59.92 -49.29 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.12 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -83.45 -38.31 22.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.53 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 295' ' ' SER . 43.3 t0 -64.18 -49.94 70.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.58 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.659 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 46.2 tp10 -61.26 -40.03 92.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.464 HG13 ' CD2' ' A' ' 301' ' ' TYR . 88.2 mt -62.58 -26.33 40.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.841 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.595 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.77 -13.7 16.79 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.279 0.561 . . . . 0.0 109.944 178.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.606 ' HB2' HG22 ' A' ' 298' ' ' THR . 26.2 mt-30 -100.07 0.89 41.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.389 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.6 30.04 19.31 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.699 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 10.0 p -69.84 -10.04 56.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.21 51.14 57.79 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.43 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.1 mttt -130.25 40.67 3.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.877 -0.19 . . . . 0.0 110.6 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 77.8 m-85 -161.69 163.57 29.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.38 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 p -145.15 160.38 41.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.43 126.76 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.649 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.531 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 109.38 153.25 14.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.331 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -55.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.861 0.362 . . . . 0.0 110.673 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.4 pt-20 -50.35 -51.03 49.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.19 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.38 -55.24 12.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.883 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 20.7 m -55.49 -37.56 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.225 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 3.2 mp -69.61 -44.47 70.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.326 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.0 mttm -56.14 -50.03 72.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -70.32 -28.24 65.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.936 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.545 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -70.72 -29.63 65.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.807 0.337 . . . . 0.0 110.616 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.54 -25.91 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 6.7 mmm -81.68 -8.6 59.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.853 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.12 11.57 32.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.343 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.47 59.77 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.4 0.28 . . . . 0.0 110.811 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 28.3 m -92.73 104.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 412' ' ' ILE . 6.2 tp10 -59.55 -49.13 78.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.518 HG22 HD21 ' A' ' 286' ' ' LEU . 31.3 mm -136.22 129.12 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 308' ' ' THR . 42.8 tp -94.08 127.85 40.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.222 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.475 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -114.48 108.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.09 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 389' ' ' LEU . 20.4 t -124.45 161.97 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.435 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.607 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 89.4 m-85 -108.18 146.22 33.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.835 0.35 . . . . 0.0 111.312 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.9 pt-20 -63.62 -31.96 73.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.129 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -95.98 52.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 45.6 tp -85.65 123.91 31.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.21 27.72 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.963 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.518 HG21 HG11 ' A' ' 305' ' ' VAL . 28.0 mm -127.15 134.83 65.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.104 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.587 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.8 mtm -139.99 161.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.669 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.0 OUTLIER -90.61 120.37 31.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.1 0.476 . . . . 0.0 111.218 -179.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -118.3 157.23 27.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.172 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.47 ' HA ' HD12 ' A' ' 343' ' ' ILE . 11.0 m -120.01 110.72 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.269 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.552 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 1.7 mm? -102.15 150.38 23.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.476 ' CD2' HD12 ' A' ' 369' ' ' ILE . 9.1 m170 -86.66 177.69 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.114 0.483 . . . . 0.0 111.425 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 3.4 m -115.14 161.67 18.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.686 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -45.92 -39.08 8.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -87.85 -119.57 1.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.907 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.86 17.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -130.76 33.25 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 110.5 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 16.0 tp10 -158.29 122.97 4.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.996 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -113.1 136.7 52.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.981 0.419 . . . . 0.0 111.175 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -111.01 139.67 46.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.736 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 332' ' ' VAL . 10.6 mm -121.03 120.77 63.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.416 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 57.3 tp -135.32 163.05 30.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.383 0.611 . . . . 0.0 112.147 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.494 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 5.9 p90 -100.67 118.28 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.575 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 2.1 mm? -123.52 163.8 20.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.608 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 20.0 p -101.09 168.68 8.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.789 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.608 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.6 Cg_endo -45.55 -43.61 17.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.409 2.072 . . . . 0.0 111.949 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.02 -57.09 14.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 18.6 mm100 -62.95 -49.64 73.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.539 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.9 mt-10 -60.09 -31.29 69.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.404 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -39.59 77.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.418 0.628 . . . . 0.0 109.418 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.528 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 64.2 t0 -85.75 53.74 2.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.423 ' HA ' ' HD1' ' A' ' 357' ' ' PHE . 14.1 pttm -69.98 -34.68 73.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.4 m -63.13 -51.49 66.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.003 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.528 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 90.5 m-70 -88.71 -52.2 5.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.255 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.604 ' HB3' ' CB ' ' A' ' 366' ' ' HIS . 0.1 OUTLIER 54.6 12.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 364' ' ' GLN . 1.5 m -109.1 -170.61 1.69 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.062 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.459 ' HB2' HG21 ' A' ' 362' ' ' THR . 88.7 m-20 -132.27 139.33 48.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -74.25 0.39 14.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.617 0.246 . . . . 0.0 111.638 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -103.9 -20.91 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.585 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.558 HG23 ' HG2' ' A' ' 364' ' ' GLN . 6.5 t -117.88 -38.35 3.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.259 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 76.36 30.3 56.99 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.057 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.558 ' HG2' HG23 ' A' ' 362' ' ' THR . 11.8 mm100 -56.78 -156.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.621 -0.289 . . . . 0.0 110.913 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 49.0 mt-10 -144.86 121.79 11.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.86 0.362 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.604 ' CB ' ' HB3' ' A' ' 357' ' ' PHE . 77.2 m80 -160.09 142.09 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.33 116.29 7.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 331' ' ' TYR . 39.4 tp -83.02 138.72 33.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.47 . . . . 0.0 111.878 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.476 HD12 ' CD2' ' A' ' 334' ' ' HIS . 3.0 mp -110.74 -43.52 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.838 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -145.26 167.12 23.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.177 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -148.33 117.62 6.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.957 0.408 . . . . 0.0 110.98 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 4.2 tpt -112.62 127.25 27.08 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.587 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 13.6 Cg_endo -57.73 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.071 1.847 . . . . 0.0 110.971 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 19.4 mt -64.38 -40.07 95.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.866 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 59.5 tp -59.84 -53.59 56.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -58.6 -39.93 81.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.873 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.409 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 74.0 t-105 -64.88 -39.74 94.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.425 ' CD1' ' CD2' ' A' ' 320' ' ' LEU . 6.4 m-85 -64.1 -30.75 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.22 -12.31 38.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.779 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -102.35 -13.83 17.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 69.0 m-80 -129.71 17.07 5.81 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -64.82 -19.59 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.243 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -79.0 -44.24 22.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.32 -43.45 96.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.179 0.514 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.54 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.8 m-85 -76.02 -12.27 60.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.17 2.41 58.73 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.17 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.475 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -86.71 161.49 18.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.174 0.511 . . . . 0.0 110.556 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 319' ' ' ILE . 73.5 m -106.59 100.72 10.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.261 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 322' ' ' VAL . 1.9 tm? -71.81 104.75 3.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.373 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.457 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -113.78 129.92 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.738 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 34.2 mm -94.75 103.61 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.016 0.436 . . . . 0.0 111.968 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.459 HG21 HG23 ' A' ' 321' ' ' ILE . 26.5 m -100.86 -172.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.901 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.474 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -157.97 154.42 27.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.639 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.38 3.29 1.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.89 -40.01 87.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.589 0.233 . . . . 0.0 111.208 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -94.36 162.47 13.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.96 -55.26 28.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 60.0 mp0 -59.97 -40.0 87.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.27 -24.36 68.94 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -84.0 -25.45 29.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.543 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.36 -40.01 77.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.586 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.607 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.4 OUTLIER -59.59 -49.54 77.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.418 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 90.9 t -57.71 -37.76 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.409 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.3 OUTLIER -69.97 -54.13 14.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.223 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.5 66.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.565 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.531 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 27.4 t80 179.93 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.83 164.59 29.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.774 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 322' ' ' VAL . . . 78.56 -49.48 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.009 -0.615 . . . . 0.0 114.328 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.572 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.67 131.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 117.529 0.664 . . . . 0.0 111.924 -177.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.32 135.89 5.7 Favored Glycine 0 CA--C 1.51 -0.237 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -119.88 138.62 13.28 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.516 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 21.4 mt -100.87 129.0 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 31.4 mt -90.57 153.71 20.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.684 0.754 . . . . 0.0 112.527 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.409 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 65.3 mtt180 -70.02 -38.05 75.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.707 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 50.9 p90 -163.79 175.77 10.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.692 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.2 mtm105 -57.96 126.58 28.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.068 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.34 128.86 34.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -85.06 -43.14 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.243 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.403 ' HB3' ' NE2' ' A' ' 425' ' ' GLN . 55.9 tt0 -162.05 133.5 5.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.073 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.48 ' HA3' ' HG3' ' A' ' 430' ' ' GLU . . . 43.24 -157.27 0.11 Allowed Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.401 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.465 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 5.3 ttm -118.79 -179.75 3.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -42.61 149.97 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 62.75 46.11 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.615 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 40.1 mt-30 -59.98 -46.78 88.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.024 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.79 -2.53 54.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.98 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 163.28 -156.23 27.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.45 24.0 13.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.603 0.24 . . . . 0.0 111.341 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -112.74 30.58 7.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.45 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.615 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 14.0 mm-40 -60.07 -42.72 95.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -103.76 5.31 36.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.23 110.53 23.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 111.389 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -87.39 12.49 11.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.042 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 45.0 mt -70.82 -5.4 30.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.971 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -40.06 87.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -73.75 -23.88 59.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.99 -36.36 77.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.437 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.03 -47.87 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.665 0.269 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 281' ' ' ILE . 12.5 p -67.2 -29.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.453 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -48.46 79.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.253 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.82 -48.7 79.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 278' ' ' VAL . 40.7 pt -72.03 -23.9 22.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.31 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.496 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -53.83 -42.09 68.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.8 pt-20 -86.09 -25.08 26.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.553 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -84.1 -43.19 15.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.02 -58.45 2.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.65 ' HG ' HD13 ' A' ' 321' ' ' ILE . 27.1 tp -56.82 -56.45 21.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.678 -178.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 63.9 mt -60.03 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.537 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.444 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.32 -38.87 57.97 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.041 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -60.05 -32.2 70.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.03 0.443 . . . . 0.0 110.268 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.589 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 14.9 t80 -59.86 -46.0 90.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.094 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 41.3 m-85 -87.38 -40.14 14.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 295' ' ' SER . 71.4 m-20 -60.0 -44.25 94.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.475 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.8 tp10 -69.95 -39.74 75.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.495 HG13 ' CD1' ' A' ' 301' ' ' TYR . 76.4 mt -63.82 -24.45 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.92 178.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -57.73 -17.52 15.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.096 0.474 . . . . 0.0 110.186 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -100.48 2.99 42.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 30.0 18.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.011 0.434 . . . . 0.0 110.362 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.615 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.8 p -66.84 -11.79 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.32 52.3 54.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.65 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 40.1 mttt -131.12 39.78 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.804 -0.233 . . . . 0.0 111.214 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.658 ' CE1' ' HB3' ' A' ' 293' ' ' GLU . 76.6 m-85 -161.12 162.85 31.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 0.0 111.726 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.47 164.51 33.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 49.3 p90 -134.99 150.01 50.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.51 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 87.06 154.71 26.63 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.327 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -60.58 -62.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.983 -179.788 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -43.31 -52.13 5.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.619 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.6 m-20 -64.83 -54.8 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.498 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 36.3 m -57.58 -37.18 72.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.907 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.486 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 1.8 mp -68.1 -45.0 74.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mttm -58.12 -49.6 76.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.465 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -68.95 -28.65 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.474 179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.821 ' HA ' HG23 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -70.77 -30.1 66.5 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.891 0.377 . . . . 0.0 110.267 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.8 -27.57 58.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 12.8 mmt -80.0 -7.24 58.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.82 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 18.69 47.41 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.06 -1.066 . . . . 0.0 110.942 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -91.27 0.0 57.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.481 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.821 HG23 ' HA ' ' A' ' 312' ' ' LEU . 30.8 m -100.39 105.68 18.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 412' ' ' ILE . 12.0 tp10 -59.6 -50.04 75.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.39 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 318' ' ' GLU . 24.4 mm -135.91 123.97 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.334 0.112 . . . . 0.0 111.214 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 21.4 tp -85.41 122.97 30.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 111.204 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.65 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -107.11 102.21 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.824 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.487 HG22 ' CD2' ' A' ' 389' ' ' LEU . 25.4 t -114.08 162.01 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.326 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 37.9 m-85 -114.0 148.72 36.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.623 ' HG2' HG22 ' A' ' 391' ' ' ILE . 22.0 mm-40 -65.3 155.73 34.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.06 178.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 57.8 t30 56.95 28.94 15.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.265 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -57.16 126.63 28.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.469 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.3 m-20 -89.93 27.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.614 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 305' ' ' VAL . 31.0 mm -126.43 137.68 57.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.629 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -139.52 161.13 38.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.743 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.579 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 11.0 ttt-85 -86.94 105.66 17.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 5.9 m-85 -118.58 122.59 42.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.476 HG13 ' CD1' ' A' ' 343' ' ' ILE . 19.4 m -92.3 122.9 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.095 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.8 mm? -116.59 159.16 22.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.081 0.467 . . . . 0.0 111.009 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.48 ' CD2' ' CD1' ' A' ' 369' ' ' ILE . 34.6 m170 -83.54 172.45 12.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.13 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -109.37 162.12 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.503 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -41.91 -32.04 0.39 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.087 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -93.93 -138.09 8.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.854 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.45 12.6 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.832 0.316 . . . . 0.0 111.543 179.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -131.24 39.77 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.029 0.442 . . . . 0.0 110.307 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 9.8 tp10 -164.26 132.45 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -115.94 139.23 50.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.068 0.461 . . . . 0.0 111.193 -178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 18.6 tttp -122.8 138.16 54.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.112 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.476 ' CD1' HG13 ' A' ' 332' ' ' VAL . 2.1 mm -106.67 128.2 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.213 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 39.4 tp -137.04 148.09 46.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.319 0.581 . . . . 0.0 111.982 -179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.525 ' HB2' HG22 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -94.41 128.35 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.986 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.506 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -119.07 148.16 43.34 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.574 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.7 p -100.86 173.74 3.45 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.868 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.574 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -48.29 -48.13 17.81 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 121.905 1.737 . . . . 0.0 113.16 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 352' ' ' LYS . 25.1 pm0 -71.75 -30.96 66.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -87.07 -49.3 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.068 0.461 . . . . 0.0 111.719 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.411 ' CD ' ' CZ ' ' A' ' 331' ' ' TYR . 1.3 tm-20 -62.28 -32.94 73.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.918 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 349' ' ' GLU . 18.4 pttp -57.03 -24.32 52.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.082 0.468 . . . . 0.0 110.285 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -90.02 43.44 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.025 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.526 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 0.0 OUTLIER -69.97 -28.66 65.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.238 -179.028 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.3 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 110.681 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.451 ' C ' ' H ' ' A' ' 358' ' ' THR . 96.9 m-70 -101.73 -53.32 2.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.713 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.617 ' HB3' ' HB2' ' A' ' 366' ' ' HIS . 0.1 OUTLIER 60.79 2.17 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 -179.366 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.481 ' CG2' ' H ' ' A' ' 359' ' ' ASP . 6.1 m -92.7 -174.76 3.73 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.481 ' H ' ' CG2' ' A' ' 358' ' ' THR . 81.8 m-20 -136.56 130.59 32.62 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -70.04 -2.01 11.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.856 0.36 . . . . 0.0 110.795 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.36 -21.5 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.09 -37.83 1.25 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.476 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.01 -3.51 80.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.709 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.418 ' O ' HG21 ' A' ' 358' ' ' THR . 11.9 pt20 -48.3 98.75 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.907 0.384 . . . . 0.0 110.787 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -64.67 132.67 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.258 0.551 . . . . 0.0 111.327 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 46.8 m80 -135.46 150.22 49.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.259 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.89 118.27 12.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.468 ' HB3' ' HE3' ' A' ' 354' ' ' LYS . 2.5 tm? -77.5 96.25 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.462 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.48 ' CD1' ' CD2' ' A' ' 334' ' ' HIS . 4.2 mp -72.28 -40.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -149.75 157.09 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.263 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.4 OUTLIER -148.7 116.49 6.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.624 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.461 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 6.1 tpt -117.82 132.08 23.82 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.627 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.621 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.4 Cg_exo -58.05 129.06 31.25 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.707 1.604 . . . . 0.0 110.133 178.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 18.0 mt -69.14 -44.04 73.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.418 HD13 HG11 ' A' ' 322' ' ' VAL . 33.0 tp -59.98 -53.43 57.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 44.0 mt-10 -58.04 -40.09 80.05 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.064 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.461 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 73.5 t-105 -67.21 -36.38 81.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.611 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.593 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 10.3 m-85 -70.04 -33.49 72.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.279 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.09 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.751 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -110.23 -12.95 14.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 377' ' ' TRP . 68.5 m-80 -134.11 19.94 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 53.1 p90 -64.47 -14.54 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -83.5 -35.04 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.72 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -39.81 87.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.465 ' CG ' HD23 ' A' ' 312' ' ' LEU . 59.1 m-85 -82.37 -10.07 59.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.045 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.97 64.1 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.796 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.438 ' CB ' HG21 ' A' ' 317' ' ' VAL . . . -86.32 163.67 17.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.454 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 49.4 m -106.86 104.76 14.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.498 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 1.2 tm? -65.16 102.41 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.116 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.496 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.2 mm-40 -115.92 107.79 15.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.933 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.623 HG22 ' HG2' ' A' ' 324' ' ' GLU . 27.6 mm -84.14 104.59 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.209 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 321' ' ' ILE . 11.3 m -102.49 -172.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.078 -178.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.508 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -160.97 157.34 26.22 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.329 179.152 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . 0.418 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 11.3 p-10 -69.98 19.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 393' ' ' THR . 23.7 mtpp -68.12 -40.04 82.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.652 0.263 . . . . 0.0 111.126 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 93.6 p -94.51 170.06 9.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 111.556 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.04 -45.51 92.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.687 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.459 ' C ' HG23 ' A' ' 287' ' ' ILE . 33.6 mp0 -68.01 -40.54 82.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.382 0.61 . . . . 0.0 109.827 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.418 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.35 -19.67 60.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.293 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 404' ' ' LYS . 65.6 m -84.02 -23.16 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.752 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 30.8 mt-30 -70.88 -41.47 71.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.807 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.609 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 4.0 m-85 -60.32 -46.33 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.082 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.98 -37.84 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 400' ' ' SER . 22.1 mttm -66.94 -57.88 6.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.08 -52.56 42.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.834 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.51 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 50.4 t80 -151.91 -66.97 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.03 166.48 31.59 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.235 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.2 -49.2 2.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.041 -0.6 . . . . 0.0 114.404 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.541 ' CD1' HG23 ' A' ' 305' ' ' VAL . 0.1 OUTLIER -143.97 134.4 21.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 117.697 0.748 . . . . 0.0 112.632 -177.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 145.22 12.18 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.97 144.26 15.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.287 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 318' ' ' GLU . 34.8 mt -105.66 127.6 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 51.0 mt -87.85 153.49 21.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.64 0.733 . . . . 0.0 112.735 -177.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.408 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 58.8 mtp85 -69.83 -35.2 74.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.419 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 416' ' ' ARG . 50.9 p90 -171.3 179.63 2.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.683 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER -57.11 128.23 35.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 110.954 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.93 160.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.235 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.49 139.64 58.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.94 129.39 55.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.175 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -60.28 -39.94 88.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.483 ' HA2' ' HG2' ' A' ' 425' ' ' GLN . . . 134.32 90.79 0.38 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mtt -150.16 162.55 40.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 60.15 70.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.633 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 57.28 31.0 19.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.078 179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.483 ' HG2' ' HA2' ' A' ' 421' ' ' GLY . 17.7 tp60 -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.957 0.408 . . . . 0.0 110.657 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.4 -23.73 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.566 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 116.12 -154.62 16.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.169 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -36.75 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.033 0.444 . . . . 0.0 110.519 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.447 ' CB ' ' HB2' ' A' ' 432' ' ' PHE . 90.6 m-20 -103.43 68.34 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.751 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -59.98 -46.68 88.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.126 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -123.17 18.27 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.4 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.447 ' HB2' ' CB ' ' A' ' 429' ' ' ASP . 81.6 m-85 -98.84 119.69 38.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.69 -9.89 56.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.516 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.6 mt -53.49 -13.24 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.389 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 429' ' ' ASP . 81.0 m-20 -57.04 -40.04 75.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.837 0.351 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -68.56 -35.19 77.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.02 -31.66 70.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.14 -46.71 88.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -59.99 -39.96 87.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.994 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.902 179.991 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.719 0.295 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -60.04 -30.02 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -51.58 -39.93 58.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.771 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.06 -50.0 75.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.24 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -82.96 -23.47 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.864 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.629 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.3 OUTLIER -60.02 -39.48 85.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.512 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.565 ' HA ' HG11 ' A' ' 392' ' ' VAL . 16.8 pt-20 -84.69 -22.67 29.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.35 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -50.09 8.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.21 -58.33 3.35 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.74 -55.61 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.054 0.454 . . . . 0.0 111.975 -178.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.502 HG21 ' CE1' ' A' ' 402' ' ' PHE . 23.6 mt -59.55 -49.18 84.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.623 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.86 -37.0 75.49 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.9 ttt85 -60.01 -39.08 84.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.8 t80 -57.51 -45.19 85.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.669 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -79.45 -40.0 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.01 -47.44 85.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.697 -179.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.85 -43.3 99.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.067 0.46 . . . . 0.0 109.864 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -59.98 -24.6 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.648 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 178.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.27 1.59 23.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.443 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 57.95 31.13 20.19 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.998 0.428 . . . . 0.0 110.341 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.852 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -67.71 -11.93 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.858 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.08 48.56 78.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.511 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.1 36.3 4.33 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 93.5 m-85 -159.32 160.06 34.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.95 164.99 33.99 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.35 164.86 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 0.0 110.928 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.21 167.84 34.37 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.226 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -72.91 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.213 -179.583 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.26 -52.43 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.872 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.6 m-20 -65.78 -57.44 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.13 -36.39 68.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.591 0.234 . . . . 0.0 110.974 -179.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.69 64.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.64 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.44 -50.01 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.609 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.422 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -66.84 -28.32 68.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.68 0.276 . . . . 0.0 111.027 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.738 ' HA ' HG22 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.37 -28.24 61.03 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -77.51 -26.93 51.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.28 -7.3 58.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.789 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.42 42.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.519 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.14 -2.27 58.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.313 0.245 . . . . 0.0 111.073 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.759 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 31.2 m -100.95 107.11 20.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 412' ' ' ILE . 36.8 tt0 -59.84 -50.03 75.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.327 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 318' ' ' GLU . 39.7 mm -135.51 125.1 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.576 ' HG ' HG23 ' A' ' 322' ' ' VAL . 29.7 tp -90.82 128.23 36.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.903 0.382 . . . . 0.0 111.305 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.494 ' CD1' ' HG ' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -111.74 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.576 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.63 162.21 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.405 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.593 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 94.1 m-85 -110.63 149.86 29.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.043 0.449 . . . . 0.0 111.687 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 12.6 pt-20 -66.83 -27.98 67.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.31 34.98 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.681 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 43.0 tp -70.31 122.33 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.526 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.53 23.28 5.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.268 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.689 HG21 HG11 ' A' ' 305' ' ' VAL . 14.9 mm -120.89 135.5 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.401 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.582 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.54 161.47 36.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.336 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.19 120.04 31.03 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.488 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.11 155.26 29.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.723 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.482 ' HA ' HD12 ' A' ' 343' ' ' ILE . 9.6 m -117.8 110.97 32.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.04 0.448 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.734 HD13 ' CD2' ' A' ' 357' ' ' PHE . 2.4 mp -97.49 142.28 29.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.941 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 369' ' ' ILE . 2.5 m170 -82.28 176.47 9.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 21.5 p -103.36 162.39 13.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.613 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -47.65 -28.86 2.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.958 0.409 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.63 -119.6 4.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.726 179.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.54 22.26 0.28 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.788 0.294 . . . . 0.0 111.74 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.91 43.37 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.433 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -169.15 130.01 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 110.214 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -115.49 140.41 49.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.099 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -121.48 145.48 47.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.862 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 332' ' ' VAL . 6.6 mm -123.18 119.65 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.052 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.1 tp -128.14 161.85 28.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.177 0.513 . . . . 0.0 111.731 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.421 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 3.4 p90 -101.0 120.1 39.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.645 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.569 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.3 mm? -124.48 156.37 37.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.83 168.12 9.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.34 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.89 -49.58 8.12 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.525 2.15 . . . . 0.0 112.303 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.0 -55.51 33.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.397 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . 0.533 ' HG2' ' CD1' ' A' ' 346' ' ' LEU . 4.7 tp60 -59.97 -53.19 60.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.376 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.6 mt-10 -49.55 -33.22 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.85 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.1 mmmm -60.08 -28.28 67.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.153 0.501 . . . . 0.0 110.425 179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.428 ' HB2' ' NE2' ' A' ' 356' ' ' HIS . 0.0 OUTLIER -81.94 16.48 1.87 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.75 179.291 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.706 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 8.5 ptmm? -55.56 -23.26 25.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 85.8 p -60.05 -44.85 94.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.664 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 358' ' ' THR . 6.3 p80 -107.84 -41.85 4.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.234 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.734 ' CD2' HD13 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.35 5.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.517 HG22 ' N ' ' A' ' 364' ' ' GLN . 3.6 m -86.87 178.11 7.08 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.026 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.5 ' H ' HG22 ' A' ' 358' ' ' THR . 93.1 m-20 -133.0 135.64 45.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -72.43 -0.19 11.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.096 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -104.37 -15.33 15.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.602 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 5.5 t -133.52 -37.76 0.94 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.718 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 84.87 41.52 7.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.716 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.517 ' N ' HG22 ' A' ' 358' ' ' THR . 13.0 pt20 -86.46 88.15 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.151 0.5 . . . . 0.0 110.686 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.29 129.91 41.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.174 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.635 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 61.1 m80 -143.86 167.49 22.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -145.33 113.93 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.303 179.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 331' ' ' TYR . 58.6 tp -70.23 133.13 46.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.019 0.438 . . . . 0.0 111.055 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.452 HD12 ' CD2' ' A' ' 334' ' ' HIS . 2.7 mp -106.56 -40.02 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 371' ' ' SER . 38.8 tt0 -152.17 166.12 32.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.535 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.52 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -145.34 117.14 8.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 179.515 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.416 ' HE1' ' CZ3' ' A' ' 377' ' ' TRP . 25.4 tpp -114.99 124.16 30.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.602 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.582 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.44 120.92 9.16 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.945 1.763 . . . . 0.0 110.984 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.603 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.4 mt -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.616 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.7 tp -60.06 -51.44 69.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.77 -40.22 87.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.704 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.416 ' CZ3' ' HE1' ' A' ' 372' ' ' MET . 76.7 t-105 -62.0 -40.03 94.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.809 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.544 ' CE1' HD21 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.1 -29.45 60.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.19 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.42 47.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.617 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -111.02 -9.31 14.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.74 19.84 5.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.5 p90 -69.99 -11.89 61.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.63 -38.3 21.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.99 -38.33 82.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.295 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.525 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -83.97 -10.43 57.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.63 1.26 52.7 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.644 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.75 165.15 17.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.422 ' HB ' HD12 ' A' ' 319' ' ' ILE . 97.9 m -106.74 100.23 9.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.338 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 2.4 tm? -71.93 102.22 2.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.629 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.7 mm-40 -107.82 128.01 54.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.928 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 22.6 mm -94.85 102.09 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 112.208 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 283' ' ' GLU . 4.1 m -100.43 -169.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.817 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.593 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.7 p -154.89 151.55 28.7 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.021 0.439 . . . . 0.0 111.557 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -71.08 1.43 5.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.319 -179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -60.03 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.283 . . . . 0.0 111.017 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.4 p -81.88 168.15 18.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.6 mt-30 -60.03 -54.79 41.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.8 -39.5 94.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.266 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . 0.425 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -53.63 -59.7 9.34 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.593 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.92 -19.55 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.0 mt-30 -69.96 -40.03 75.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.914 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.47 -44.81 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.767 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 88.2 t -59.99 -45.23 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.423 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.79 -38.19 56.79 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -178.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.681 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.75 -94.52 0.48 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.192 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 155.46 34.06 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.818 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.53 -20.04 7.91 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.562 -1.304 . . . . 0.0 115.504 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.498 ' CD1' HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.6 130.32 66.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.562 1.181 . . . . 0.0 111.765 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.67 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.48 151.05 19.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.735 -1.221 . . . . 0.0 114.105 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.512 ' CG2' ' CE2' ' A' ' 301' ' ' TYR . 19.0 mt -109.35 127.48 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.6 mt -88.23 153.33 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.52 0.676 . . . . 0.0 112.302 -178.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.2 mtt-85 -70.06 -36.75 75.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.605 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -160.92 170.59 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.852 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -58.09 128.03 35.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.693 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.98 159.91 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.886 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -87.16 132.24 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -70.04 136.89 50.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.0 130.7 48.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.767 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -66.15 147.23 49.94 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.704 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -150.02 170.1 19.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.464 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.01 -40.94 90.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.982 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.79 -40.03 91.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.794 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.64 140.03 58.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.125 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.94 0.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.539 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -141.57 130.09 4.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.395 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.28 -40.04 88.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.106 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -115.44 24.15 11.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.13 -39.92 87.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.926 0.394 . . . . 0.0 110.337 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.37 91.29 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.208 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.5 -137.68 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.88 40.02 16.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 109.194 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -89.03 -0.25 57.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.338 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.02 87.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -68.0 -35.17 77.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.478 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.93 -34.14 71.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.079 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.09 -42.4 94.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -60.06 -40.01 88.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.845 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.851 0.358 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 282' ' ' GLN . 11.9 p -66.21 -29.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.257 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -52.28 -40.38 61.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.694 0.283 . . . . 0.0 111.434 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.55 -44.2 78.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.615 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 5.6 pt -81.47 -45.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.332 . . . . 0.0 111.802 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.662 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -57.17 -37.34 71.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.533 . . . . 0.0 110.085 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.55 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 93.3 mt-10 -77.77 -28.58 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.899 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -83.99 -57.52 3.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -70.0 -58.23 4.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' A' ' 321' ' ' ILE . 19.2 tp -57.26 -58.35 8.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.702 0.287 . . . . 0.0 111.509 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 30.4 mt -59.97 -49.65 83.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.152 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.418 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.28 -37.19 79.6 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.633 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -60.03 -35.79 75.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 110.282 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.569 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.6 t80 -60.0 -46.58 89.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.699 0.285 . . . . 0.0 111.614 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 295' ' ' SER . 38.0 t0 -63.67 -46.85 83.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.463 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.652 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 33.4 tp10 -64.74 -40.0 94.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 301' ' ' TYR . 81.8 mt -62.27 -26.1 39.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.29 -14.06 16.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.273 0.559 . . . . 0.0 109.865 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -98.36 -0.02 44.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.422 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.23 28.89 17.21 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.196 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.789 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.5 p -69.98 -10.03 57.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.067 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.29 52.62 46.2 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.525 178.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 11.8 mtpt -130.33 40.57 3.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.652 ' CE2' ' HB3' ' A' ' 293' ' ' GLU . 74.2 m-85 -162.54 165.25 26.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.106 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -149.7 164.31 35.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.966 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 52.7 p90 -136.98 151.89 49.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.082 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 88.3 155.45 29.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.445 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -61.55 -56.49 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.283 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.521 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -47.68 -56.9 6.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.591 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.2 m-20 -60.7 -54.98 38.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.667 0.27 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 18.9 m -58.68 -40.04 82.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 305' ' ' VAL . 3.2 mp -67.69 -48.07 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -54.99 -56.53 18.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.144 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -61.23 -30.14 70.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.07 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.7 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.04 -28.44 62.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.796 179.39 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -76.93 -26.21 53.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 45.4 mmm -82.08 -8.53 59.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.851 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.75 14.22 42.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.263 -178.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.79 -5.96 59.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.394 0.278 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 312' ' ' LEU . 27.2 m -99.1 105.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 412' ' ' ILE . 42.3 tt0 -59.93 -49.97 75.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.451 ' CD1' ' HB ' ' A' ' 388' ' ' THR . 42.3 mm -133.78 126.34 50.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.563 0.221 . . . . 0.0 111.185 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 322' ' ' VAL . 40.9 tp -93.52 129.43 39.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 111.058 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.488 ' HB ' ' HE2' ' A' ' 402' ' ' PHE . 1.1 mt -116.14 109.32 27.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 110.142 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 14.8 t -125.43 161.84 29.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.525 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 31.5 m-85 -108.14 146.94 31.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 111.168 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.506 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.62 -32.76 74.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -94.1 51.53 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -83.9 125.87 32.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.7 23.03 4.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.598 HG21 HG11 ' A' ' 305' ' ' VAL . 14.8 mm -122.43 133.47 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.596 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.571 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.7 mtt -139.53 161.54 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 31.9 ttt180 -92.39 122.26 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 111.645 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.497 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 6.6 m-85 -120.7 159.02 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.22 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.464 ' HA ' HD12 ' A' ' 343' ' ' ILE . 5.3 m -121.87 111.87 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.362 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' A' ' 357' ' ' PHE . 2.0 mm? -103.13 149.39 24.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.72 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 29.2 m170 -88.38 -179.3 6.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . 0.443 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 17.9 t -110.57 161.25 15.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -45.7 -38.02 6.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.08 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.96 -113.22 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.391 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -169.49 29.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.476 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 42.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.001 0.429 . . . . 0.0 110.753 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . 0.443 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 7.5 tp10 -164.37 124.62 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.98 142.37 45.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.977 0.418 . . . . 0.0 111.298 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -121.24 141.52 50.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.798 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 332' ' ' VAL . 5.5 mm -121.44 118.63 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.258 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 32.4 tp -132.55 157.8 43.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.446 ' O ' ' CD1' ' A' ' 345' ' ' TYR . 0.2 OUTLIER -92.09 116.67 29.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.629 179.461 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.511 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 1.4 mm? -120.59 153.64 36.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 112.711 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.6 p -101.0 168.98 8.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.542 178.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.9 Cg_endo -41.24 -46.14 5.54 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.062 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.05 -54.92 41.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -66.77 -48.35 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.1 mt-10 -60.07 -32.42 70.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.535 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -57.28 -32.26 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.158 0.504 . . . . 0.0 110.174 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.0 t0 -91.46 61.46 4.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.612 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 24.3 mttt -70.01 -41.45 74.3 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.8 m -59.83 -55.39 34.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.425 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.487 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 36.7 m170 -85.47 -49.44 8.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.319 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.558 ' CD2' ' CD1' ' A' ' 333' ' ' LEU . 0.2 OUTLIER 54.23 10.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.925 0.393 . . . . 0.0 110.403 -178.183 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 364' ' ' GLN . 1.4 m -108.65 -165.6 1.04 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.49 ' HB2' HG23 ' A' ' 362' ' ' THR . 74.3 m-20 -132.0 134.54 45.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -72.14 1.33 7.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.659 0.266 . . . . 0.0 111.587 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.86 -23.18 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 359' ' ' ASP . 2.2 t -118.63 -36.42 3.49 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.405 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 76.91 33.87 44.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.462 ' O ' HG22 ' A' ' 358' ' ' THR . 74.5 mm-40 -57.37 -157.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.544 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 0.4 OUTLIER -140.28 126.02 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.291 -179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.474 ' CB ' ' HB3' ' A' ' 357' ' ' PHE . 95.6 m-70 -161.51 142.82 11.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 57.0 mt-10 -145.91 105.26 3.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.421 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 354' ' ' LYS . 62.0 tp -75.22 137.38 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.024 0.44 . . . . 0.0 111.951 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.454 HD12 ' CD2' ' A' ' 334' ' ' HIS . 2.6 mp -116.54 -45.42 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.59 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -140.94 165.36 27.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.204 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.7 p -147.42 118.59 7.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.868 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.8 tpt -114.22 129.86 24.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.571 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -59.1 118.35 5.22 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.204 1.936 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 14.4 mt -60.07 -39.46 86.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.674 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 63.9 tp -60.07 -54.08 50.24 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.958 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.523 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.0 mt-10 -58.12 -40.06 80.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.928 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -62.51 -39.89 94.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.376 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.571 ' CE1' HD21 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.66 -28.69 62.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.085 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.48 -9.74 48.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.33 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -104.86 -14.06 15.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.62 20.22 5.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -64.88 -18.94 65.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.739 0.304 . . . . 0.0 111.019 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -81.05 -39.96 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -64.77 -39.96 94.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.621 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.509 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.7 m-85 -80.02 -11.33 59.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.976 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.34 57.52 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.488 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.486 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -87.22 163.66 16.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.189 0.519 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.451 ' HB ' ' CD1' ' A' ' 319' ' ' ILE . 50.2 m -106.95 100.4 9.9 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.08 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.439 ' CD2' HG21 ' A' ' 322' ' ' VAL . 2.4 tm? -76.28 107.18 8.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.48 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 43.3 mm-40 -113.71 135.17 54.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 36.2 mm -98.97 105.2 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 0.0 112.146 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.556 HG11 ' NE2' ' A' ' 282' ' ' GLN . 5.8 m -102.1 -169.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.239 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.471 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -158.25 153.37 25.49 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.175 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -77.91 69.97 4.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.295 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -114.56 -34.94 5.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.937 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.5 m -102.93 179.36 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 25.3 mm100 -60.01 -40.65 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 34.4 mp0 -69.49 -40.66 76.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.46 -21.06 61.97 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.271 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 52.3 m -84.2 -21.43 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.027 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 85.5 mt-30 -77.48 -41.69 38.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.779 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 406' ' ' PHE . 3.3 m-85 -67.31 -49.62 63.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.555 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.03 -40.04 82.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.871 0.367 . . . . 0.0 110.517 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -79.86 -41.32 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.325 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.26 95.29 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.711 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -134.06 -84.74 0.43 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.018 -0.591 . . . . 0.0 109.713 178.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 148.32 41.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.563 -1.303 . . . . 0.0 115.138 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 126.61 -28.49 4.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 119.556 -1.307 . . . . 0.0 115.218 177.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.467 ' O ' ' CD2' ' A' ' 406' ' ' PHE . 0.8 OUTLIER -125.02 127.83 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.056 0.928 . . . . 0.0 111.913 -178.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.43 139.77 7.67 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.34 140.62 13.59 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.595 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 317' ' ' VAL . 48.4 mt -101.9 127.29 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.164 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 53.9 mt -87.42 151.55 22.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 112.798 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 34.9 mtp-105 -78.77 -27.68 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.734 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.402 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 95.5 m-85 -151.99 170.06 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.958 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.789 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -71.2 123.78 22.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.861 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.436 ' CG2' HD12 ' A' ' 413' ' ' LEU . 24.3 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . 0.409 ' O ' ' CD2' ' A' ' 419' ' ' PHE . 96.4 m-20 -89.92 -79.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.704 0.288 . . . . 0.0 111.052 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 418' ' ' ASP . 54.0 m-85 -159.15 159.94 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.969 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 420' ' ' GLN . 10.0 mm-40 -60.78 -39.96 90.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -167.7 120.26 0.89 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.767 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 73.4 mtm -78.85 174.09 11.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.661 0.267 . . . . 0.0 110.647 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.97 -50.01 75.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -69.97 -39.99 75.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 110.245 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.01 -40.08 88.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.638 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -54.57 122.81 26.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.575 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.33 -140.63 5.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.33 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.91 -39.95 96.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 111.195 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 -133.79 63.69 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.99 -42.67 94.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.678 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 31.3 p90 -144.64 114.32 7.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 26.2 p90 -130.98 106.73 8.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 0.0 111.376 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.03 14.2 12.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.035 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.71 -3.86 27.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.774 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 110.641 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -69.8 -32.49 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -60.06 -33.2 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.03 -41.59 92.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.012 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.869 179.875 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.5 p -66.05 -29.95 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 278' ' ' VAL . 7.4 ttmm -51.65 -40.54 60.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.841 -179.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -50.05 75.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.0 111.056 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -82.76 -20.91 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.697 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.662 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.63 -39.99 86.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.592 -179.433 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.509 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.4 mt-10 -77.16 -29.91 54.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.228 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.7 -58.1 3.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 321' ' ' ILE . 16.2 tp -58.75 -54.7 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 398' ' ' GLU . 46.0 mt -59.98 -48.47 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.572 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.33 -37.88 66.9 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.041 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 43.8 ttt180 -60.0 -39.2 84.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.166 0.508 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.624 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.8 t80 -55.63 -45.77 77.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.772 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.32 -39.24 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.737 0.303 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.9 t0 -59.97 -43.25 95.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.381 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.17 -42.32 84.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.2 -23.88 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.57 178.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.02 -15.47 56.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.203 0.525 . . . . 0.0 110.048 178.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -104.86 2.12 29.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.596 178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.25 29.73 18.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.962 0.41 . . . . 0.0 110.57 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.523 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 13.8 p -66.75 -13.02 60.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.9 49.18 73.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.402 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 17.5 mttp -126.4 36.8 4.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' A' ' 293' ' ' GLU . 95.3 m-85 -159.35 159.99 34.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.337 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -140.95 161.2 38.4 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.11 144.85 47.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.517 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.29 157.0 29.1 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.908 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.06 -55.82 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 0.0 111.166 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -47.31 -57.24 5.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.943 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.12 -54.85 39.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.712 0.291 . . . . 0.0 111.452 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 28.0 m -56.56 -40.02 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 305' ' ' VAL . 2.2 mp -66.86 -45.23 78.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.566 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.3 mtmt -56.66 -50.04 73.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.998 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . 0.489 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . . . -73.85 -27.32 61.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -69.66 -34.53 74.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.886 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.56 -24.35 61.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.8 -7.96 59.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.092 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.07 10.94 36.02 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.561 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -79.96 -6.19 57.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.441 0.296 . . . . 0.0 110.79 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 312' ' ' LEU . 34.9 m -95.79 105.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 412' ' ' ILE . 37.0 tt0 -59.64 -50.0 75.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.493 HD13 ' HB ' ' A' ' 388' ' ' THR . 27.9 mm -136.64 126.5 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.534 0.206 . . . . 0.0 111.41 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 312' ' ' LEU . 44.9 tp -89.72 126.48 35.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.972 0.415 . . . . 0.0 111.467 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 321' ' ' ILE . . . . . 0.627 HD11 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -111.56 103.6 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.286 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 391' ' ' ILE . 17.4 t -122.33 152.66 26.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.476 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.5 m-85 -98.42 142.95 29.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.411 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 324' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 16.8 pt-20 -65.36 -24.05 67.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.835 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.28 33.35 1.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -71.2 123.91 23.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.699 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -96.57 28.7 3.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.724 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 345' ' ' TYR . 20.0 mm -126.58 133.19 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 329' ' ' MET . . . . . 0.55 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.3 mtt -140.62 162.53 35.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.161 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.17 29.72 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.244 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 331' ' ' TYR . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 7.4 m-85 -124.81 160.74 28.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.496 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.79 112.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 366' ' ' HIS . 1.9 mm? -101.54 129.6 47.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.24 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 334' ' ' HIS . . . . . 0.506 ' CG ' HD13 ' A' ' 369' ' ' ILE . 57.2 m170 -137.05 150.81 48.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.179 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -111.56 152.74 27.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.92 129.92 44.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.755 0.312 . . . . 0.0 110.588 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.21 -1.2 35.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.701 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.48 23.55 2.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.775 0.287 . . . . 0.0 111.626 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.21 10.31 39.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.223 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -159.97 119.99 2.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.33 . . . . 0.0 111.155 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 17.5 mt-10 -136.6 129.97 31.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.165 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -136.0 121.22 19.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.935 0.398 . . . . 0.0 111.435 -179.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 2.4 mm -113.18 112.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.662 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp -144.08 156.5 44.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.414 -178.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 345' ' ' TYR . . . . . 0.553 ' N ' ' HG ' ' A' ' 344' ' ' LEU . 0.3 OUTLIER -84.96 137.09 33.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.183 178.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.553 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.7 mm? -127.68 164.1 22.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.635 0.731 . . . . 0.0 112.475 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.7 p -101.56 172.05 4.79 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.283 178.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 348' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 74.0 Cg_exo -48.94 -47.52 21.2 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 121.755 1.637 . . . . 0.0 111.768 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.17 -58.46 8.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.04 -48.95 79.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 91.1 mt-10 -59.96 -35.69 75.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -57.97 -34.06 69.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.094 0.473 . . . . 0.0 109.807 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.68 40.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 354' ' ' LYS . . . . . 0.702 ' HB2' HD22 ' A' ' 368' ' ' LEU . 4.1 pttt -70.43 -19.09 63.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.55 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.6 t -66.83 -40.02 87.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 358' ' ' THR . 90.5 m-70 -98.03 -56.46 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.142 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 354' ' ' LYS . 0.2 OUTLIER 60.04 4.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.087 -179.108 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 359' ' ' ASP . 3.3 m -91.74 174.44 7.34 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.508 ' H ' HG22 ' A' ' 358' ' ' THR . 96.4 m-20 -130.09 138.54 50.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -72.89 -2.02 19.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.362 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -104.48 -13.83 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 362' ' ' THR . . . . . 0.481 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 6.6 t -131.85 -36.32 1.21 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.565 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 89.57 2.18 76.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.634 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 364' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 358' ' ' THR . 37.5 mt-30 -50.01 94.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -82.37 133.0 35.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.371 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 366' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 73.4 m80 -147.1 164.41 33.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.159 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.25 108.1 7.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.93 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 354' ' ' LYS . 45.6 tp -63.46 140.02 58.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.114 0.483 . . . . 0.0 111.483 -179.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.506 HD13 ' CG ' ' A' ' 334' ' ' HIS . 2.2 mp -111.74 -45.62 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -143.12 156.25 44.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.177 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 371' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -143.87 116.16 8.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.403 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 372' ' ' MET . . . . . 0.402 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.56 121.92 32.5 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.72 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.57 120.84 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.782 1.655 . . . . 0.0 110.784 178.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 374' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 330' ' ' ARG . 20.9 mt -59.94 -44.16 94.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.259 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . 0.505 ' CD2' ' HA ' ' A' ' 324' ' ' GLU . 68.9 tp -60.06 -50.79 72.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.97 85.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.673 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 377' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.26 -43.77 95.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.6 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.527 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 8.7 m-85 -73.68 -30.68 63.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.19 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.36 -25.09 60.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.539 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.69 -6.56 14.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.33 20.25 5.75 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.532 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.565 0.221 . . . . 0.0 111.349 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.429 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.35 -40.43 30.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.919 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.16 -36.37 77.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.5 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.49 -4.18 59.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.399 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.71 3.06 32.3 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.519 -179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.604 ' CB ' HG22 ' A' ' 317' ' ' VAL . . . -89.72 166.31 13.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 388' ' ' THR . . . . . 0.493 ' HB ' HD13 ' A' ' 319' ' ' ILE . 58.1 m -109.13 100.57 9.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.003 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 382' ' ' TYR . 3.2 tm? -69.35 102.36 1.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.662 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.77 130.03 55.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 32.4 mm -95.91 103.87 15.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.057 -178.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 392' ' ' VAL . . . . . 0.488 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.47 -171.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.173 -178.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.5 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.59 155.33 26.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.198 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.49 11.37 0.63 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.208 -179.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.02 94.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.676 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.4 m -92.06 170.91 9.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.844 0.354 . . . . 0.0 111.389 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.8 mt-30 -60.12 -54.35 46.93 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.545 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 398' ' ' GLU . . . . . 0.575 ' HB3' HG23 ' A' ' 287' ' ' ILE . 15.4 mp0 -59.99 -40.02 87.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.496 0.665 . . . . 0.0 109.467 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -54.11 -57.64 15.89 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.776 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.9 -19.44 51.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 401' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.42 -40.04 77.53 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.915 0.388 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 402' ' ' PHE . . . . . 0.609 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -59.97 -46.56 89.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.464 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.2 t -59.91 -34.08 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.017 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.24 -54.11 19.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.271 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.72 -20.56 70.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.939 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.517 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.2 t80 174.95 -75.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.41 167.86 28.88 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.705 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.73 -51.53 3.76 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.846 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.474 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.56 131.78 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.293 0.547 . . . . 0.0 112.234 -178.199 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -150.75 141.06 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.73 145.86 15.93 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.867 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 318' ' ' GLU . 19.1 mt -109.16 128.5 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.9 mt -90.66 153.15 20.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.72 0.771 . . . . 0.0 112.807 -177.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.0 -37.91 75.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.597 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 415' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 417' ' ' VAL . 82.3 m-85 -158.24 -177.89 6.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.77 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 416' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.01 100.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 110.846 -179.712 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 415' ' ' TYR . 2.3 p -143.43 137.74 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.073 -179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -146.27 100.24 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.09 -49.36 77.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.275 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.2 126.66 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.281 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -154.47 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.541 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.8 mtp 57.16 23.15 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.675 0.274 . . . . 0.0 111.056 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 424' ' ' TYR . 12.3 pt-20 -151.55 -53.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.385 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 424' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 423' ' ' GLU . 98.0 m-85 -160.85 88.66 0.77 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.705 0.288 . . . . 0.0 111.332 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 425' ' ' GLN . . . . . 0.683 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 32.0 mm-40 -70.05 -40.09 75.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.817 0.342 . . . . 0.0 110.803 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 156.12 -24.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.712 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -154.26 33.16 0.71 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.771 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.83 34.27 24.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 0.0 111.026 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -118.39 37.52 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.683 ' HA ' ' HG3' ' A' ' 425' ' ' GLN . 1.7 tm-20 -60.0 -41.09 91.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.4 99.12 5.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -116.71 117.07 28.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.83 -0.69 24.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.9 mt -50.96 -19.38 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.927 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -59.69 -40.02 86.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.396 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -74.88 -24.2 58.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.61 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.07 -38.43 82.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.003 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.06 -46.35 89.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.919 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.02 -39.95 87.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.869 -179.895 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.98 -41.17 91.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.376 0.607 . . . . 0.0 109.857 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.678 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 2.1 mp0 -80.29 -42.08 23.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.33 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -70.01 -39.99 75.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -58.41 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 18.0 tp -58.93 -55.94 28.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.891 0.377 . . . . 0.0 111.318 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 47.1 mt -60.99 -49.91 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.806 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.47 -38.78 58.56 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 20.6 ttt85 -60.03 -37.64 80.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 110.277 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.5 t80 -55.79 -47.46 77.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.938 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 34.8 m-85 -83.63 -38.73 21.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.9 t0 -60.33 -42.75 96.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.522 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.674 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.0 mt-10 -69.47 -43.3 73.48 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 301' ' ' TYR . 89.9 mt -59.55 -23.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.85 -12.88 53.32 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.22 0.534 . . . . 0.0 109.911 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 69.5 mt-30 -103.72 -0.01 29.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.466 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.24 30.29 20.01 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.6 HG23 ' HB2' ' A' ' 296' ' ' GLN . 6.5 p -67.21 -14.15 62.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.022 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.0 48.9 83.63 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.783 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.52 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 7.0 ttpt -130.22 37.1 3.92 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.4 m-85 -161.09 161.48 31.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.42 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 160.25 42.53 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.459 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 52.5 p90 -135.52 130.63 34.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 406' ' ' PHE . . . 106.83 150.9 17.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.982 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -54.61 -60.8 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.33 . . . . 0.0 111.028 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.9 pt-20 -47.4 -54.69 10.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.388 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.55 -54.57 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.518 HG21 HG22 ' A' ' 409' ' ' ILE . 22.1 m -56.21 -37.92 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.098 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.851 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.8 mp -69.93 -41.57 74.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.323 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 20.3 mtmt -58.88 -49.91 75.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.36 -26.16 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.289 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.883 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.32 -25.96 58.26 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 77.3 mm-40 -77.52 -28.08 51.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 78.5 mmm -79.99 -7.33 58.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.403 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.29 20.68 44.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.138 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.68 7.69 44.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.598 -0.301 . . . . 0.0 111.457 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 387' ' ' ALA . 31.0 m -107.27 107.2 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 121.038 0.446 . . . . 0.0 112.002 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.84 ' O ' HD13 ' A' ' 319' ' ' ILE . 11.2 tp10 -59.95 -50.76 72.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.3 mm -135.74 125.75 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.653 0.263 . . . . 0.0 111.425 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.2 tp -92.52 128.65 38.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.968 0.413 . . . . 0.0 111.219 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -115.1 107.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.089 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.603 HG23 ' HG ' ' A' ' 320' ' ' LEU . 7.6 t -123.51 163.19 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.935 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.908 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -110.9 149.23 30.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.764 ' CD ' HG21 ' A' ' 391' ' ' ILE . 49.1 mm-40 -59.37 -50.06 75.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.2 53.22 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.381 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 409' ' ' ILE . 31.4 tp -78.88 123.29 27.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -89.61 23.84 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 305' ' ' VAL . 15.8 mm -127.43 134.59 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.687 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.583 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 53.5 mtt -140.36 161.73 36.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.9 ttt180 -89.23 121.06 31.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.049 0.452 . . . . 0.0 111.303 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 4.6 m-85 -121.43 157.11 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.965 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.607 HD23 HD11 ' A' ' 346' ' ' LEU . 49.9 tp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.368 0.604 . . . . 0.0 111.957 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.557 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -94.04 118.86 32.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.601 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 344' ' ' LEU . 1.5 mm? -121.18 159.75 25.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 14.4 p -101.77 171.33 5.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.381 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.6 Cg_exo -47.38 -43.58 26.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.737 1.624 . . . . 0.0 111.89 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.88 -54.96 41.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.191 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 83.1 mt-30 -67.61 -46.29 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 94.5 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.515 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.7 p . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 19.2 tpp -115.46 128.81 25.64 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.623 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.583 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 36.5 Cg_exo -59.77 120.0 7.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.011 1.807 . . . . 0.0 111.108 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.982 HD13 HG11 ' A' ' 305' ' ' VAL . 14.3 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.749 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 391' ' ' ILE . 63.1 tp -60.07 -51.96 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.4 mt-10 -60.02 -39.92 87.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.031 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -62.58 -40.02 95.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -71.07 -25.84 62.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.49 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.91 -9.99 49.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.761 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -108.75 -9.18 15.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.23 18.0 5.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.36 -18.72 65.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.665 0.269 . . . . 0.0 111.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -83.02 -42.23 17.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.758 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.85 -40.1 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 312' ' ' LEU . 38.0 m-85 -82.75 -10.25 58.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.28 2.41 53.92 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.498 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.48 162.49 18.92 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 319' ' ' ILE . 98.3 m -106.64 100.56 10.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.98 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.971 HD11 HD11 ' A' ' 391' ' ' ILE . 2.0 tm? -72.33 101.95 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.577 ' HG2' HG22 ' A' ' 388' ' ' THR . 19.7 mm-40 -111.36 118.17 35.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 375' ' ' LEU . 20.5 mm -88.66 108.96 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.042 0.448 . . . . 0.0 111.889 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.908 HG23 ' CE2' ' A' ' 323' ' ' TYR . 15.6 m -101.75 -170.68 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.25 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -154.53 151.59 29.07 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -70.73 12.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 395' ' ' LYS . 0.3 OUTLIER -64.7 -39.99 94.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.633 0.254 . . . . 0.0 111.644 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.9 m -92.05 170.6 9.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.386 . . . . 0.0 111.78 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -60.02 -48.83 80.1 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 44.3 mp0 -63.95 -39.99 95.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.372 0.606 . . . . 0.0 109.517 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.42 60.38 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.15 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.6 m -84.23 -22.24 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.631 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.533 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 79.6 mt-30 -73.87 -43.36 58.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.8 m-85 -60.01 -41.98 93.31 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.924 0.392 . . . . 0.0 110.357 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.77 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 54.6 t -60.0 -39.98 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -72.55 -42.8 64.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.953 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.62 98.74 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.374 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CD1' ' HA2' ' A' ' 304' ' ' GLY . 59.9 t80 -148.79 -67.14 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 125.03 57.88 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 119.842 -1.171 . . . . 0.0 115.095 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.75 -35.41 2.0 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.399 -1.382 . . . . 0.0 115.277 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.758 HD11 HD11 ' A' ' 326' ' ' LEU . 0.6 OUTLIER -136.13 134.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.883 0.841 . . . . 0.0 112.904 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -154.53 148.14 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.48 147.15 17.74 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.694 -1.241 . . . . 0.0 114.031 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 46.6 mt -108.72 126.39 65.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 50.4 mt -86.42 151.69 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 112.303 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.4 mtm180 -67.5 -38.69 84.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 96.6 m-85 -160.57 170.02 21.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.522 ' O ' ' HD1' ' A' ' 432' ' ' PHE . 95.9 m-20 . . . . . 0 C--O 1.226 -0.182 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -59.99 -40.05 87.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 110.345 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 26.7 p90 -96.92 67.68 2.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.522 ' HD1' ' O ' ' A' ' 429' ' ' ASP . 37.1 p90 -90.03 110.47 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.69 -2.61 30.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.719 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.65 -18.65 4.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.857 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.96 -39.97 87.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 0.0 110.587 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.68 -23.83 60.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.704 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.9 -37.56 79.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.251 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.03 -45.36 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.889 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.011 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 75.5 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.884 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 120.77 0.319 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.677 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -59.94 -39.54 85.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.555 -179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.67 -22.69 29.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.324 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -50.01 8.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.27 -58.33 3.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.501 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.72 -55.66 31.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.942 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.7 mt -59.48 -49.22 84.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.436 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.89 -37.03 75.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.084 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.8 ttt85 -59.93 -39.09 84.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.309 0.576 . . . . 0.0 110.049 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.607 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.9 t80 -57.56 -45.18 85.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.63 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -79.47 -39.94 31.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.07 -47.48 85.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.602 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.82 -43.29 99.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.039 0.447 . . . . 0.0 109.872 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -60.04 -24.54 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.664 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.16 0.505 . . . . 0.0 109.911 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.5 mt-30 -107.27 1.55 23.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.465 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 57.95 31.13 20.18 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.341 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.4 p -67.64 -11.97 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.845 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.6 78.09 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.535 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.12 36.3 4.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.33 160.02 34.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.087 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.91 165.07 33.7 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.821 0.344 . . . . 0.0 111.231 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.47 164.82 28.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.18 167.82 34.28 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.234 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.88 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.214 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.25 -52.49 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.843 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.8 m-20 -65.73 -57.42 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.15 -36.42 68.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.951 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.67 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.601 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.43 -50.07 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.8 -28.28 68.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 111.037 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.51 -28.13 60.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.84 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -77.51 -26.99 51.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.21 -7.33 58.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.776 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.44 42.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.467 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.12 -2.24 58.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.287 0.235 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.0 m -100.98 107.1 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.86 -50.01 75.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.33 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -135.5 125.12 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.77 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.8 128.25 36.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.275 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.76 105.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.742 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.635 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.64 162.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.371 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.857 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.2 m-85 -110.67 149.93 29.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.471 . . . . 0.0 111.674 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.92 -27.96 67.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.3 35.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.32 19.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.53 23.35 5.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.236 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.978 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -120.93 135.48 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.41 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.5 161.45 37.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.44 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.618 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.14 120.08 31.01 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.169 0.509 . . . . 0.0 111.468 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.14 155.22 29.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.734 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.99 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.162 0.506 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.5 p90 -100.96 120.05 39.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.651 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 1.077 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.43 156.33 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.8 168.11 9.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.368 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.85 -49.63 8.01 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.313 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.95 -55.56 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.392 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 1.077 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.94 -53.17 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.5 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.827 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.91 124.13 30.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.656 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.41 120.95 9.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.0 1.8 . . . . 0.0 110.982 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.978 HD12 HG22 ' A' ' 328' ' ' ILE . 14.3 mt -60.23 -42.3 94.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.595 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.04 -51.39 69.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.665 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.91 -40.17 87.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.685 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.01 -39.96 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.837 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.2 -29.4 60.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.125 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.39 47.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.598 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.11 -9.33 14.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.67 19.84 5.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -70.0 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.61 -38.35 21.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -59.93 -38.33 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.301 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.555 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -84.01 -10.43 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.62 1.28 52.7 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.654 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.76 165.12 17.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.428 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.72 100.27 9.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.3 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.92 102.2 2.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.854 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.649 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.8 mm-40 -107.86 128.01 54.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.873 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.5 mm -94.85 102.11 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 112.182 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.857 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.47 -169.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.769 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.6 p -154.86 151.54 28.72 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.055 0.455 . . . . 0.0 111.506 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.1 p-10 -71.04 1.43 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.303 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -59.94 -40.1 87.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 111.035 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.3 p -81.83 168.13 18.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.7 mt-30 -60.0 -54.81 41.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.84 -39.43 94.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.66 -59.74 9.3 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.6 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.58 12.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.1 mt-30 -69.97 -40.05 75.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 110.909 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.39 -44.9 93.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.764 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.4 t -59.99 -45.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.708 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.422 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.74 -38.19 56.96 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.707 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.7 -94.56 0.48 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.09 0.02 OUTLIER Glycine 0 CA--C 1.522 0.523 0 C-N-CA 119.642 -1.265 . . . . 0.0 114.853 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.51 -20.07 7.92 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.522 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.636 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.59 130.38 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 118.574 1.187 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.69 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.54 151.11 19.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.031 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.4 127.47 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -88.22 153.32 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 112.286 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.4 mtt-85 -70.04 -36.81 75.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.565 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -160.91 170.54 20.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.963 0.411 . . . . 0.0 110.721 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.654 0.264 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.09 -39.92 87.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.356 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.43 91.18 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.191 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.4 -137.62 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.87 39.95 16.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.96 -0.28 57.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.391 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.07 -39.94 87.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 110.518 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -68.07 -35.19 77.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.418 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.96 -34.06 71.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.082 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.13 -42.43 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.01 -40.01 87.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.889 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 CA--C 1.524 -0.051 0 CA-C-O 120.824 0.345 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.707 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 2.0 tm0? -58.85 -39.97 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.831 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 50.4 mt-10 -78.96 -30.0 44.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -53.46 5.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -72.63 -58.38 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.885 ' HG ' HD13 ' A' ' 321' ' ' ILE . 46.7 tp -55.13 -60.86 2.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 111.55 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.824 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.7 mt -59.94 -50.05 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.26 -38.92 57.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.25 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.1 ttt-85 -60.05 -39.95 87.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.281 0.563 . . . . 0.0 110.272 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.602 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 10.2 t80 -57.12 -48.55 78.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.749 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -80.01 -38.49 31.96 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -60.63 -47.89 84.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.7 mt-10 -62.91 -44.49 95.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 301' ' ' TYR . 96.5 mt -59.62 -24.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.463 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.47 -13.8 59.58 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.648 ' HB2' HG23 ' A' ' 298' ' ' THR . 58.4 mt-30 -103.37 -0.16 30.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.54 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.59 30.99 20.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.5 p -69.43 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.864 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.24 49.2 74.26 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.342 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 41.2 mttt -128.61 36.3 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 88.0 m-85 -159.75 160.74 34.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.309 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 19.3 m -140.5 160.03 40.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.14 0.495 . . . . 0.0 111.391 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.411 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -137.79 127.13 24.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.914 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 107.76 152.83 17.58 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.022 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -58.94 -55.48 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 0.0 111.174 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -49.35 -56.46 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.42 -52.37 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 409' ' ' ILE . 18.5 m -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.09 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.988 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.7 mp -67.25 -43.79 81.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.701 0.286 . . . . 0.0 111.28 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 314' ' ' MET . 20.7 mtmt -60.01 -47.62 85.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.4 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -27.81 65.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.431 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.77 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.7 -26.59 59.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 78.3 mm-40 -77.92 -28.9 49.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 94.3 mmm -80.84 -7.3 59.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.726 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.52 14.28 27.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.701 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.8 -9.76 59.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.617 0.246 . . . . 0.0 110.9 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.27 105.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.665 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.2 tt0 -60.01 -50.01 75.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.563 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.6 mm -135.58 125.99 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.746 ' HG ' HG23 ' A' ' 322' ' ' VAL . 56.4 tp -90.96 126.14 35.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.885 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -113.13 105.95 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.814 179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.746 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.3 t -124.29 151.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.4 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 392' ' ' VAL . 92.6 m-85 -95.57 145.01 25.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.53 -34.52 77.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -92.24 45.19 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.575 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 23.8 tp -75.85 125.81 29.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.678 ' O ' ' HA ' ' A' ' 347' ' ' THR . 83.0 m-20 -92.06 24.43 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.032 HG22 HD12 ' A' ' 374' ' ' LEU . 31.7 mm -125.87 136.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.939 0.399 . . . . 0.0 111.595 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.7 mtt -139.84 161.8 36.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.323 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.664 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.1 ttt85 -89.22 115.8 26.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 111.671 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 8.3 m-85 -116.53 156.91 26.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.145 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 110.942 179.634 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 346' ' ' LEU . 49.4 tp . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.373 0.606 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.732 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.8 p90 -100.02 123.19 43.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.189 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 1.048 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -124.84 157.88 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 69.8 p -101.16 170.28 6.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.672 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.6 Cg_exo -44.7 -48.38 10.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.837 1.691 . . . . 0.0 112.012 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -49.92 75.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.51 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 1.048 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.5 tp60 -69.59 -47.87 62.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 92.6 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.586 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.59 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.269 0.557 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.4 tpt -117.04 131.46 23.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.8 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.588 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.1 Cg_exo -60.16 120.56 8.4 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.87 1.713 . . . . 0.0 110.782 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 328' ' ' ILE . 12.8 mt -62.21 -40.45 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.773 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 391' ' ' ILE . 60.8 tp -60.06 -51.68 68.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.7 mt-10 -60.23 -42.42 95.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.964 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.403 ' CD1' ' ND2' ' A' ' 381' ' ' ASN . 82.5 t90 -62.26 -39.93 94.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.421 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.65 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -70.0 -25.89 63.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.97 46.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.3 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.67 -12.75 15.8 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.5 20.34 5.67 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -68.76 -17.52 64.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.577 0.227 . . . . 0.0 111.446 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -77.14 -47.13 21.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.125 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -61.43 -44.43 97.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.322 0.582 . . . . 0.0 110.622 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.1 m-85 -69.95 -17.72 63.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.885 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.21 1.96 65.45 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.324 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.76 164.76 16.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.162 0.506 . . . . 0.0 110.796 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.842 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.6 m -107.14 100.27 9.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.049 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.55 HD23 HD23 ' A' ' 320' ' ' LEU . 1.7 tm? -71.74 102.34 2.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.97 0.414 . . . . 0.0 110.858 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -110.31 140.84 44.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.111 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 375' ' ' LEU . 36.3 mm -106.48 103.66 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.644 HG12 ' OE1' ' A' ' 282' ' ' GLN . 7.8 m -101.07 -175.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 3.0 p -157.95 152.29 24.58 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.686 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.3 t0 -76.85 76.15 3.46 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -117.57 -29.98 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.313 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 35.1 m -113.55 -174.93 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.771 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 401' ' ' GLN . 31.0 mt-30 -59.98 -47.75 84.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.01 0.434 . . . . 0.0 110.341 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 22.1 mp0 -61.62 -41.93 98.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.47 -22.45 67.67 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.546 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.4 m -83.08 -21.56 33.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.791 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 397' ' ' GLN . 9.5 mm100 -75.79 -46.67 29.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.013 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.824 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -59.96 -49.97 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.085 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 394' ' ' ASP . 96.9 t -59.98 -39.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -68.58 -42.9 77.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.399 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.1 -22.92 74.54 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.256 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.447 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 28.8 t80 -176.45 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.657 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 91.68 101.1 1.32 Allowed Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.564 -0.827 . . . . 0.0 115.101 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 130.42 -34.22 2.73 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.178 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -150.8 127.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 111.939 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -150.74 138.12 6.47 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.77 142.24 14.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.601 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.5 mt -104.66 126.71 59.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 59.2 mt -90.78 157.14 17.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.643 0.735 . . . . 0.0 112.466 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -70.04 -39.99 75.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.358 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 53.9 p90 -167.07 178.7 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.508 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.6 mtm180 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.899 0.38 . . . . 0.0 110.7 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 93.7 m-20 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -59.91 -40.07 87.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.018 0.437 . . . . 0.0 110.12 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.67 100.11 7.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.325 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 429' ' ' ASP . 1.3 p90 -117.34 130.94 56.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -86.1 6.84 27.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.81 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.97 -4.25 23.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.905 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.96 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.698 0.285 . . . . 0.0 111.068 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.95 -33.24 75.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.473 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.49 -34.26 72.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.268 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' LEU . . . . . 0.565 ' C ' HD13 ' A' ' 438' ' ' LEU . 3.0 tm? -60.02 -43.7 95.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -70.05 140.08 52.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.7 m80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.881 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.89 0.376 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.68 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.59 -39.99 85.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.606 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.5 mt-10 -77.08 -29.97 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.269 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.65 -58.16 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.76 -54.66 44.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.3 mt -60.03 -48.43 87.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.555 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.36 -37.88 67.19 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 44.0 ttt180 -60.0 -39.22 85.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.9 t80 -55.65 -45.73 77.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.755 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.4 -39.15 21.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.0 t0 -59.99 -43.2 95.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.402 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.18 -42.29 84.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 109.743 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.24 -23.81 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.6 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.04 -15.45 56.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.175 0.512 . . . . 0.0 110.006 178.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.84 2.08 29.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.622 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.25 29.72 18.43 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.966 0.413 . . . . 0.0 110.571 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.9 p -66.74 -12.98 60.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.915 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 49.12 73.39 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.443 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.38 36.84 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.947 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 160.05 34.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.323 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -141.0 161.19 38.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.445 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.15 144.84 47.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.31 156.89 28.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.871 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -59.94 -55.89 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.195 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.4 pt-20 -47.27 -57.23 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 96.0 m-20 -61.13 -54.9 38.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.676 0.274 . . . . 0.0 111.386 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.1 m -56.51 -40.09 74.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.86 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.88 -45.26 78.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.2 mtmt -56.63 -50.03 73.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.993 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.682 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.827 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.5 74.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.914 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.52 -24.41 61.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.78 -7.96 59.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.098 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.1 10.96 36.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.123 -1.036 . . . . 0.0 111.544 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.02 -6.16 57.09 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.399 0.28 . . . . 0.0 110.766 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.856 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.7 m -95.83 105.5 17.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.59 -49.98 75.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.306 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -136.7 126.56 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.579 0.228 . . . . 0.0 111.375 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 45.0 tp -89.73 126.49 35.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.94 0.4 . . . . 0.0 111.5 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.57 103.61 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.313 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.2 t -122.29 152.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -98.48 142.94 29.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.37 -24.0 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.833 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.32 33.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.762 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.6 tp -71.17 123.81 23.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -96.55 28.76 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.61 133.19 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.042 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.1 mtt -140.6 162.47 35.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.22 29.76 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.092 0.472 . . . . 0.0 111.222 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.76 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 111.411 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.923 0.392 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.9 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -85.02 137.15 33.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.104 178.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.71 164.05 22.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.596 0.713 . . . . 0.0 112.525 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.5 172.08 4.78 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.31 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 72.9 Cg_exo -48.95 -47.47 21.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 121.789 1.659 . . . . 0.0 111.815 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.15 -58.52 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -59.98 -48.99 79.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.111 0.482 . . . . 0.0 110.469 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.61 121.97 32.37 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.761 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.63 120.91 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.77 1.647 . . . . 0.0 110.712 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.007 HD12 HG22 ' A' ' 328' ' ' ILE . 20.7 mt -60.03 -44.09 94.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.265 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 69.1 tp -60.01 -50.87 72.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.99 85.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.638 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.28 -43.77 95.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.641 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.827 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.8 m-85 -73.59 -30.7 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.2 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.38 -25.09 60.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.495 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.71 -6.62 14.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.27 20.18 5.79 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.95 -14.48 63.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.615 0.245 . . . . 0.0 111.374 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.36 -40.41 30.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.923 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.1 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.52 -4.21 59.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.401 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.74 2.96 31.99 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.532 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.856 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.64 166.28 13.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 111.103 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.802 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.0 m -109.15 100.54 9.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.936 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.757 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.32 102.39 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.68 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.8 130.02 55.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.757 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.5 mm -95.86 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.173 0.511 . . . . 0.0 112.094 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.616 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.51 -171.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.155 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.52 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.55 155.33 26.16 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.274 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.48 11.31 0.63 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.15 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.04 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 111.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -92.06 170.83 9.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.838 0.352 . . . . 0.0 111.406 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.9 mt-30 -60.02 -54.38 46.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -60.02 -39.98 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 0.0 109.502 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.09 -57.64 15.85 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.805 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.87 -19.53 51.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.36 -40.04 77.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.751 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.99 -46.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.92 -34.06 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.014 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.25 -54.08 20.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.309 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.73 -20.62 70.41 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.938 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.4 t80 174.97 -75.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.33 167.95 28.99 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -51.47 3.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.835 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.55 131.79 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.294 0.547 . . . . 0.0 112.227 -178.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 141.05 8.33 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.68 145.87 15.95 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.866 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.947 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.11 128.55 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.71 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.8 mt -90.68 153.17 20.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.766 0.793 . . . . 0.0 112.815 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.01 -37.92 75.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.542 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 82.3 m-85 -158.25 -177.91 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.869 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.02 -41.04 91.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.43 99.1 5.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.397 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -116.68 117.07 28.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.84 -0.65 24.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.8 mt -50.94 -19.4 1.0 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.939 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -59.7 -40.01 86.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -74.9 -24.29 58.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.541 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.96 -38.42 82.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.452 . . . . 0.0 110.007 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.01 -46.44 89.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.887 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.04 -39.91 87.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.133 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.913 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -55.64 -41.8 74.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.614 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 55.1 mt-10 -69.96 -33.43 72.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -57.2 3.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -70.0 -58.08 4.25 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.893 ' HG ' HD13 ' A' ' 321' ' ' ILE . 31.4 tp -57.51 -57.44 12.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 13.6 mt -61.48 -49.79 82.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.535 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.73 -34.36 81.85 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.415 -0.897 . . . . 0.0 112.651 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 4.8 ttt85 -59.95 -37.78 80.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 9.4 t80 -60.13 -41.29 92.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.754 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -84.66 -39.44 18.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.49 -50.05 75.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.667 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.1 OUTLIER -64.31 -40.95 96.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.524 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.0 mt -60.04 -23.26 26.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -15.39 46.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.331 0.586 . . . . 0.0 109.685 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.866 ' HB2' HG23 ' A' ' 298' ' ' THR . 68.3 mt-30 -100.7 1.92 40.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.649 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 56.09 29.85 15.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.106 0.479 . . . . 0.0 110.035 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.866 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.9 p -69.97 -10.34 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.773 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.79 50.69 59.68 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.091 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 18.6 mtpt -127.96 38.76 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.874 ' CE1' HG23 ' A' ' 412' ' ' ILE . 81.7 m-85 -161.99 163.37 28.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.417 ' O ' ' HE2' ' A' ' 290' ' ' TYR . 1.8 p -146.43 162.39 38.35 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.424 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.1 p90 -138.68 133.06 31.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.323 . . . . 0.0 110.33 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 103.58 147.76 18.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.955 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.981 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -52.82 -60.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -44.54 -58.09 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.345 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.93 -54.49 41.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 111.235 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.597 HG21 HG22 ' A' ' 409' ' ' ILE . 10.6 m -55.73 -40.01 71.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.027 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.981 HD13 HG12 ' A' ' 305' ' ' VAL . 2.5 mp -70.01 -41.21 74.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.697 0.284 . . . . 0.0 111.211 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mtmm -58.55 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.156 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.96 64.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.69 -28.6 63.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.744 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.2 -26.48 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 93.2 mmm -82.5 -9.1 59.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.648 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.42 42.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.324 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.92 59.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.386 0.274 . . . . 0.0 110.975 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.6 m -93.54 104.83 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.914 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.1 tt0 -59.91 -49.88 75.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.434 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 318' ' ' GLU . 23.4 mm -133.96 126.15 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.65 0.262 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.693 ' HG ' HG23 ' A' ' 322' ' ' VAL . 43.6 tp -91.55 127.33 36.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.942 0.401 . . . . 0.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.893 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.3 mt -112.71 106.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.693 HG23 ' HG ' ' A' ' 320' ' ' LEU . 29.8 t -122.61 155.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.488 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.591 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.9 m-85 -102.65 143.92 31.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.518 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.7 pt-20 -61.78 -35.68 78.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.68 48.31 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.053 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -78.19 125.43 29.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.804 0.335 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -92.94 26.39 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.57 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.003 HG22 HD12 ' A' ' 374' ' ' LEU . 23.2 mm -128.36 136.31 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.561 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 59.8 mtt -139.97 161.93 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.811 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.659 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 46.8 ttm-85 -89.17 115.48 26.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.803 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.51 ' CE2' ' HG2' ' A' ' 351' ' ' GLU . 3.2 m-85 -115.48 154.74 28.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 33.1 tp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.276 0.56 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.506 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.2 OUTLIER -97.67 120.03 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.4 mm? -124.46 167.48 14.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.554 0.692 . . . . 0.0 112.596 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.3 p -101.59 169.25 7.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.778 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 75.2 Cg_exo -49.46 -42.56 41.3 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.843 1.696 . . . . 0.0 111.745 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.26 -51.57 69.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.101 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 76.8 mt-30 -70.43 -46.61 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.996 0.426 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 97.2 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.852 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.188 0.518 . . . . 0.0 111.494 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.0 tpt -111.66 126.93 27.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.229 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.3 Cg_exo -57.56 118.67 5.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.877 1.718 . . . . 0.0 111.003 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.003 HD12 HG22 ' A' ' 328' ' ' ILE . 15.2 mt -60.89 -39.95 91.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.887 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.769 HD11 HD12 ' A' ' 391' ' ' ILE . 57.1 tp -59.5 -52.8 64.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.2 mt-10 -58.87 -40.01 83.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.059 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -67.35 -34.0 76.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.316 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 11.3 m-85 -69.78 -31.51 69.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.433 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -9.24 50.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.655 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -101.08 -15.44 17.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.423 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.68 18.11 5.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.35 -20.94 64.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 0.0 111.019 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -79.84 -43.37 22.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.98 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 110.637 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.635 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.3 m-85 -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.64 71.25 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.127 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.38 162.78 16.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.172 0.511 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.866 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.7 m -107.32 100.61 10.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.025 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.746 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.69 102.74 2.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.568 ' HB3' HE22 ' A' ' 282' ' ' GLN . 5.8 mm-40 -108.42 134.99 50.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.884 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.769 HD12 HD11 ' A' ' 375' ' ' LEU . 33.9 mm -99.93 102.09 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 5.7 m -101.6 -168.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.928 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -157.14 153.9 28.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.498 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 403' ' ' VAL . 35.4 p-10 -71.2 -1.86 14.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.532 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -41.36 92.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.534 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 283' ' ' GLU . 3.2 t -75.0 167.27 22.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 111.154 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 48.8 tp60 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 35.8 mp0 -67.72 -34.26 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 109.776 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -51.62 -57.9 11.27 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.921 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.7 m -62.74 -19.47 63.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 38.6 mt-30 -72.99 -40.08 65.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.996 0.427 . . . . 0.0 110.579 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 410' ' ' GLY . 0.2 OUTLIER -65.86 -41.53 91.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.802 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.774 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 71.8 t -60.45 -37.91 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -62.38 -45.03 95.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 0.0 110.417 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -74.95 -20.66 79.34 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.05 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 12.5 t80 -174.98 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.774 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 94.3 96.69 1.6 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.264 -0.969 . . . . 0.0 114.853 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.537 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 135.85 -31.68 2.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.764 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER -152.86 127.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 117.493 0.646 . . . . 0.0 111.895 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.07 136.04 5.65 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.42 134.69 11.33 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.139 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.874 HG23 ' CE1' ' A' ' 301' ' ' TYR . 63.0 mt -99.13 129.99 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 47.0 mt -88.58 149.39 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.728 0.775 . . . . 0.0 113.005 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.6 mtt180 -71.24 -29.92 65.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.239 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 63.7 t80 -169.81 165.01 9.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.983 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.458 -0.03 0 CA-C-O 120.677 0.275 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.57 -39.94 88.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.569 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -109.12 62.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 40.4 p90 -79.94 99.82 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.314 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.21 13.42 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.051 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.46 -6.41 30.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.742 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -59.96 -40.03 87.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.769 0.318 . . . . 0.0 110.504 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.07 -32.35 71.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.91 -35.26 72.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.06 -44.64 94.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.874 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -60.06 -40.11 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.813 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 2.6 pt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.598 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -55.32 -36.85 66.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.7 pt-20 -69.93 -29.97 67.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -57.82 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.96 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -54.86 11.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 21.0 tp -58.55 -57.11 14.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 111.698 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.682 HG23 ' CE1' ' A' ' 402' ' ' PHE . 43.9 mt -59.95 -49.15 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -58.67 -38.17 91.09 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.217 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 8.3 ttt180 -60.02 -38.07 81.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 109.923 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.635 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 3.0 t80 -55.85 -48.62 75.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.93 -39.95 29.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.99 0.424 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 295' ' ' SER . 74.6 m-20 -60.01 -41.96 93.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.808 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.7 mt-10 -70.03 -41.15 74.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.58 -22.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.04 -14.28 53.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 109.65 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.769 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.2 mt-30 -103.17 0.04 31.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.418 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 7.3 t70 56.34 33.4 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 109.977 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.797 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 31.4 p -73.46 -10.8 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.126 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.41 ' HA3' ' HE ' ' A' ' 416' ' ' ARG . . . 56.89 53.94 40.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.665 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.537 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 9.0 mtpt -130.24 36.23 4.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.934 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -158.87 159.61 35.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.468 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 31.2 m -134.49 155.46 50.32 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.026 0.441 . . . . 0.0 111.378 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -134.87 118.32 16.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.82 155.41 10.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.978 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -60.03 -56.22 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.824 0.345 . . . . 0.0 111.113 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 9.0 pt-20 -51.91 -51.23 58.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.733 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -63.13 -54.15 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.443 HG21 HG22 ' A' ' 409' ' ' ILE . 31.9 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.978 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -65.61 -50.3 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 111.522 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -55.61 -52.38 63.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 -179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.56 71.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.27 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.962 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.34 -27.42 61.5 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.839 0.352 . . . . 0.0 110.463 179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -77.55 -27.6 51.62 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 30.9 mmt -80.86 -7.46 59.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.832 -1.531 . . . . 0.0 111.593 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.4 18.63 44.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.3 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.36 -2.97 58.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.601 -0.3 . . . . 0.0 111.377 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 312' ' ' LEU . 29.9 m -99.43 104.47 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.6 tp10 -57.12 -49.99 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.185 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.5 mm -135.49 126.01 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.562 0.22 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.66 ' HG ' HG23 ' A' ' 322' ' ' VAL . 37.3 tp -90.91 123.41 34.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 111.699 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -109.68 103.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.66 HG23 ' HG ' ' A' ' 320' ' ' LEU . 36.3 t -111.38 155.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.241 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 7.6 m-85 -103.61 142.45 34.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.174 0.511 . . . . 0.0 112.278 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 393' ' ' THR . 36.4 tt0 -68.07 156.78 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.017 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 28.27 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.92 0.391 . . . . 0.0 110.296 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.499 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.1 tp -59.96 125.5 23.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.409 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.08 30.31 1.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.7 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.957 HG22 HD12 ' A' ' 374' ' ' LEU . 26.5 mm -130.35 133.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.511 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.709 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 33.3 mtt -140.6 163.01 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.636 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.4 OUTLIER -88.19 118.79 28.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.832 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 59.9 m-85 -126.9 124.71 40.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.536 -179.167 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 34.4 tp . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.399 0.619 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.798 ' HD2' HD12 ' A' ' 328' ' ' ILE . 2.5 p90 -100.93 125.7 47.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.658 ' HB2' ' HG2' ' A' ' 351' ' ' GLU . 2.7 mm? -122.3 157.71 31.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.544 0.688 . . . . 0.0 112.773 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.626 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.3 p -99.35 168.13 10.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.311 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 4.7 Cg_endo -46.43 -46.62 16.87 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.27 1.98 . . . . 0.0 112.297 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -72.65 -44.89 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 349' ' ' GLU . 33.3 mt-30 -69.94 -46.64 64.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.832 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.373 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.546 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 121.182 0.515 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.66 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -121.31 137.27 26.62 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.186 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.709 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 28.1 Cg_endo -64.31 122.97 11.09 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.117 1.878 . . . . 0.0 110.626 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.957 HD12 HG22 ' A' ' 328' ' ' ILE . 19.6 mt -65.3 -41.06 94.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 38.4 tp -60.08 -53.66 55.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.644 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 48.0 mt-10 -59.98 -40.38 88.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.024 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -62.49 -40.03 95.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.083 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.578 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -70.54 -28.25 64.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.276 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -10.48 48.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.828 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.07 -9.49 14.72 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.5 m120 -129.2 19.45 5.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.604 0.24 . . . . 0.0 111.61 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -68.57 -17.41 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.597 0.237 . . . . 0.0 111.347 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -79.85 -46.97 15.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.02 -44.19 94.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.318 0.58 . . . . 0.0 109.96 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.553 ' CD2' HD23 ' A' ' 312' ' ' LEU . 26.7 m-85 -73.49 -19.97 60.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.039 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLY . . . . . 0.49 ' HA3' HH22 ' A' ' 414' ' ' ARG . . . 74.87 2.14 64.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.22 165.37 18.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.073 0.463 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.851 ' HB ' HG23 ' A' ' 319' ' ' ILE . 24.2 m -107.68 100.67 10.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 389' ' ' LEU . 0.9 OUTLIER -73.54 107.34 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.628 -178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.527 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 5.8 mm-40 -115.39 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.593 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 27.2 mm -98.5 102.34 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.114 0.483 . . . . 0.0 112.26 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.7 m -114.06 133.62 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.607 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 3.2 p -112.74 166.21 11.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.657 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.4 t0 -73.48 70.06 1.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.846 0.355 . . . . 0.0 111.352 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' A' ' 283' ' ' GLU . 4.9 ptmt -119.83 12.02 12.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 47.5 t -155.17 179.57 9.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -59.38 -53.32 59.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 50.9 mp0 -63.65 -39.98 95.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.411 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.87 -25.4 67.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.521 -0.847 . . . . 0.0 110.992 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.5 m -83.74 -23.38 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.554 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.78 -43.44 65.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.376 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.682 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.2 m-85 -65.3 -48.39 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.21 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.657 HG21 ' HB2' ' A' ' 394' ' ' ASP . 75.4 t -59.95 -40.08 81.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -48.17 33.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -73.22 -28.29 66.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -157.68 -84.72 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 100.09 151.73 26.04 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.461 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.99 -47.49 3.13 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.67 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -148.94 134.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 118.232 1.016 . . . . 0.0 112.985 -177.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.39 145.49 12.96 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.72 147.6 18.96 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.712 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.934 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.0 mt -106.5 126.72 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.3 mt -87.85 156.15 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 0.0 112.195 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.49 HH22 ' HA3' ' A' ' 386' ' ' GLY . 16.3 mtt-85 -77.77 -33.07 52.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.685 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.428 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 93.5 m-85 -156.39 170.01 23.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.753 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.833 0.349 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -59.94 -40.03 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.551 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.404 ' CZ ' ' OD2' ' A' ' 433' ' ' ASP . 64.8 t80 -120.56 102.35 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.297 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -130.97 80.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ASP . . . . . 0.404 ' OD2' ' CZ ' ' A' ' 431' ' ' PHE . 96.6 m-20 -95.19 18.65 11.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.13 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.28 -15.42 47.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.86 -40.02 87.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -80.62 -20.22 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -59.97 -38.46 82.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.313 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.92 -49.18 78.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.951 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -67.84 139.97 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.914 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.693 0.283 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.55 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -57.48 -40.01 77.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.212 0.53 . . . . 0.0 110.019 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.603 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 1.9 mp0 -75.69 -51.34 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.407 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -40.05 87.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -84.55 -58.69 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.843 ' HG ' HD13 ' A' ' 321' ' ' ILE . 29.9 tp -60.01 -55.84 29.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.909 0.385 . . . . 0.0 111.834 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.878 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.3 mt -59.95 -47.88 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.572 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.425 ' HA2' ' OE1' ' A' ' 398' ' ' GLU . . . -57.81 -37.79 85.69 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.444 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt180 -60.02 -42.41 94.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.513 ' CE1' ' CE1' ' A' ' 402' ' ' PHE . 5.5 t80 -59.99 -41.71 92.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.516 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.688 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.7 t80 -84.27 -40.98 17.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -60.57 -43.37 97.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.663 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 75.4 mt-10 -60.06 -40.03 88.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.947 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 291' ' ' PHE . 64.1 mt -56.4 -30.26 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 t -53.03 -29.87 32.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.552 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 21.8 mt-30 -94.77 1.46 55.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.26 32.03 17.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.978 0.418 . . . . 0.0 110.085 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 1.5 p -64.26 -13.14 47.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.541 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.85 47.57 87.9 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.699 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 413' ' ' LEU . 36.3 mttp -129.48 48.05 2.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.585 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -170.51 168.08 7.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 111.348 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.6 p -153.1 169.0 24.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.42 135.64 33.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.047 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 104.17 146.52 15.98 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.815 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.47 -57.82 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.909 0.385 . . . . 0.0 110.982 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -49.02 -53.48 19.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.397 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.77 -53.04 53.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.312 . . . . 0.0 111.29 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.595 HG21 HG22 ' A' ' 409' ' ' ILE . 7.4 m -57.88 -38.58 76.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.871 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -69.07 -43.64 74.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.371 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.3 mtmm -57.37 -49.99 74.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.1 -26.08 62.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.389 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.797 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.07 -27.28 60.83 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.923 0.392 . . . . 0.0 110.586 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -77.51 -28.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.1 mmt -80.54 -7.01 59.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.979 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.91 14.48 23.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.677 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.29 -6.59 59.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.395 0.278 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.821 HG23 ' HB2' ' A' ' 387' ' ' ALA . 20.8 m -93.16 105.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.798 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.3 tt0 -59.98 -50.0 75.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 32.9 mm -135.22 126.34 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.529 0.204 . . . . 0.0 111.483 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.683 ' HG ' HG23 ' A' ' 322' ' ' VAL . 50.2 tp -92.0 125.52 36.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.022 0.439 . . . . 0.0 110.914 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.843 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -112.41 106.95 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.975 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.683 HG23 ' HG ' ' A' ' 320' ' ' LEU . 18.9 t -124.24 158.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.282 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.724 ' CE1' HG23 ' A' ' 392' ' ' VAL . 90.3 m-85 -104.58 146.48 28.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.42 . . . . 0.0 111.345 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.555 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.9 pt-20 -64.97 -30.9 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -97.25 49.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 20.3 tp -80.19 126.16 30.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 347' ' ' THR . 35.8 p-10 -92.67 21.42 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.468 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 305' ' ' VAL . 14.8 mm -124.7 136.78 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.569 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 40.2 mtt -140.52 161.6 37.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.868 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.571 HH21 HD22 ' A' ' 309' ' ' LEU . 11.1 mmt-85 -89.3 120.52 30.72 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.072 0.463 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.4 m-85 -118.08 152.34 35.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.739 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 332' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 346' ' ' LEU . 48.7 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.308 0.575 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.641 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.21 119.01 36.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.773 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.777 HD11 HD23 ' A' ' 344' ' ' LEU . 0.9 OUTLIER -121.36 154.23 36.73 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.679 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.3 p -101.27 171.44 5.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.087 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.679 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.9 Cg_exo -44.02 -47.39 10.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.858 1.705 . . . . 0.0 112.106 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.0 pt-20 -59.98 -49.04 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 97.5 mt-30 -70.22 -46.52 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 90.2 mt-10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.303 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.598 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.3 p . . . . . 0 CA--C 1.523 -0.084 0 CA-C-O 121.132 0.491 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 20.3 tpp -112.9 128.22 25.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.669 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.508 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 34.1 Cg_exo -59.95 116.96 3.67 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 121.925 1.75 . . . . 0.0 110.618 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.789 HD13 HG11 ' A' ' 305' ' ' VAL . 6.5 mt -60.06 -39.47 86.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.851 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.897 HD11 HD12 ' A' ' 391' ' ' ILE . 59.4 tp -60.03 -50.69 72.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.7 mt-10 -60.02 -39.95 87.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -66.31 -36.66 83.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.618 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.425 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -68.64 -26.38 65.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.76 -18.64 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.785 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -105.76 4.89 30.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 384' ' ' LYS . 39.4 t-20 -139.79 13.85 2.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -69.98 -17.58 63.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -77.16 -48.37 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' LYS . . . . . 0.445 ' HB2' ' OD1' ' A' ' 381' ' ' ASN . 34.1 mttt -60.11 -44.6 94.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.5 m-85 -69.89 -16.4 63.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.894 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.4 62.7 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.177 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.821 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.52 162.01 19.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 72.8 m -105.71 100.05 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.823 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.1 tm? -74.47 103.13 4.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.2 mm-40 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.694 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.897 HD12 HD11 ' A' ' 375' ' ' LEU . 22.4 mm -96.08 104.34 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.814 ' HB ' HD11 ' A' ' 287' ' ' ILE . 14.7 m -100.87 -172.57 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.235 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.556 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -158.57 154.15 26.14 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.098 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.448 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.6 p-10 -67.91 5.6 0.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -59.96 -39.97 87.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.8 m -91.1 169.76 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.9 0.381 . . . . 0.0 111.525 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.94 -49.34 78.07 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.621 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.653 ' O ' HG21 ' A' ' 287' ' ' ILE . 60.8 mm-40 -63.49 -35.94 82.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.642 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.675 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -24.02 66.28 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.004 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 59.8 m -83.94 -23.15 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.614 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.09 -41.59 63.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.602 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.878 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -65.0 -44.0 90.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.837 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 92.3 t -58.77 -32.84 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.486 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.07 -54.23 14.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.225 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -55.65 -53.79 39.2 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.887 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -137.09 -66.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 102.7 81.13 1.52 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.517 -0.849 . . . . 0.0 115.163 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.464 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 138.02 -29.4 2.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.991 -1.1 . . . . 0.0 114.15 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.98 130.64 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.689 0.744 . . . . 0.0 112.229 -178.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.99 135.12 5.13 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.95 142.15 14.37 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.461 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 318' ' ' GLU . 81.4 mt -109.96 130.0 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.8 mt -88.59 155.24 19.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 74.4 mtm180 -70.03 -39.96 75.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.581 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.572 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 54.4 p90 -158.42 169.92 23.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.7 mmm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.733 0.302 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.12 -40.01 90.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.163 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -101.4 49.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 36.5 p90 -65.38 89.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 111.201 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.07 13.59 14.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.462 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.79 -18.13 41.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.606 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.379 . . . . 0.0 110.313 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -79.48 -19.96 48.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.83 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.74 -38.61 82.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.91 -41.21 91.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.933 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.86 152.24 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.762 0.315 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.56 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 0.0 OUTLIER -55.28 -43.99 75.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 0.0 109.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.714 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 64.5 mt-10 -77.59 -41.53 38.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -70.76 -40.07 72.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -87.03 -58.83 2.44 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 21.5 tp -59.94 -56.43 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 402' ' ' PHE . 30.6 mt -60.72 -48.71 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.333 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.13 -38.83 78.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.444 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.472 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 29.7 ttt180 -60.02 -39.61 86.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.328 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 5.7 t80 -55.59 -49.85 71.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.56 ' CD2' ' NE2' ' A' ' 401' ' ' GLN . 63.6 m-85 -79.41 -38.37 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.042 0.449 . . . . 0.0 111.006 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.93 -49.79 76.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.331 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.9 mt-10 -63.76 -45.43 89.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.877 0.37 . . . . 0.0 110.03 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 301' ' ' TYR . 93.6 mt -58.02 -23.6 21.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.42 -15.18 47.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.49 0.662 . . . . 0.0 109.549 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.799 ' HB2' HG23 ' A' ' 298' ' ' THR . 34.9 mt-30 -103.25 2.38 34.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.09 31.57 18.41 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.177 0.513 . . . . 0.0 110.25 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 296' ' ' GLN . 25.2 p -70.02 -9.99 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.766 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.52 48.03 73.0 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 119.926 -1.13 . . . . 0.0 113.655 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 33.5 mtmt -128.4 36.97 4.2 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.925 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.6 m-85 -160.0 160.04 32.84 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.35 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.13 159.42 43.32 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.748 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.8 p90 -131.9 125.35 31.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 114.94 169.13 15.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.765 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.45 -56.81 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 13.2 pt-20 -48.78 -50.35 34.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.463 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.32 -53.6 28.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.754 0.311 . . . . 0.0 111.368 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 409' ' ' ILE . 60.2 m -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.244 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.971 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -65.81 -45.04 83.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.9 mttm -58.95 -48.08 82.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.439 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.9 65.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.233 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.55 -27.87 61.56 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.804 0.335 . . . . 0.0 110.762 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 75.4 mm-40 -76.47 -26.82 55.77 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.2 mmt -81.82 -7.05 59.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.75 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.16 35.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.544 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.9 -2.11 58.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.289 0.236 . . . . 0.0 111.143 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.948 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.7 m -99.54 104.79 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.9 tt0 -56.8 -50.07 73.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.279 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.873 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -136.42 127.56 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.668 0.27 . . . . 0.0 111.466 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 312' ' ' LEU . 41.9 tp -95.34 128.62 42.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.026 0.441 . . . . 0.0 111.342 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 412' ' ' ILE . 0.9 OUTLIER -117.18 110.13 30.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 110.172 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.589 HG23 ' HG ' ' A' ' 320' ' ' LEU . 12.2 t -125.47 162.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.136 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 392' ' ' VAL . 90.4 m-85 -107.29 145.39 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -63.61 -41.43 98.3 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -86.36 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 409' ' ' ILE . 34.6 tp -89.24 120.6 30.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.604 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -90.06 26.64 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.017 HG21 HG21 ' A' ' 305' ' ' VAL . 23.9 mm -123.45 136.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.135 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 73.7 mtp -140.05 162.36 35.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.236 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.7 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.9 ttt-85 -84.7 106.27 16.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.991 0.424 . . . . 0.0 111.897 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.534 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 7.6 m-85 -120.57 123.54 43.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.259 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 0.0 111.517 -179.584 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.1 tp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.579 0.704 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.747 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.08 134.43 41.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.579 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.2 mm? -128.12 161.17 29.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.615 0.721 . . . . 0.0 112.87 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.2 p -101.56 168.76 8.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.372 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.5 Cg_endo -45.66 -47.42 13.59 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.283 1.989 . . . . 0.0 111.982 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.8 -50.07 74.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.743 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.484 ' OE1' HD12 ' A' ' 346' ' ' LEU . 61.1 mt-30 -69.05 -46.09 68.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 76.4 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.869 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 7.7 tpt -122.22 141.2 33.98 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.556 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.729 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.2 Cg_exo -62.96 124.4 13.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.232 1.955 . . . . 0.0 110.399 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.989 HD12 HG22 ' A' ' 328' ' ' ILE . 20.5 mt -68.42 -40.55 81.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.859 HD11 HD12 ' A' ' 391' ' ' ILE . 63.8 tp -59.95 -51.9 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 47.2 mt-10 -59.92 -39.96 87.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -62.21 -39.94 94.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.579 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.548 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.61 -27.09 61.95 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.477 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.81 -8.83 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.894 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.09 -9.93 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 18.94 5.9 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.71 -20.13 65.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.558 0.218 . . . . 0.0 111.202 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -79.13 -47.43 16.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -60.59 -45.24 94.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 312' ' ' LEU . 25.9 m-85 -71.38 -19.13 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.635 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.03 73.91 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.044 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.948 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.6 160.99 20.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.124 0.488 . . . . 0.0 110.338 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.873 ' HB ' HG23 ' A' ' 319' ' ' ILE . 64.5 m -106.47 99.87 9.42 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.7 tm? -75.43 102.7 5.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.388 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.521 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -109.17 135.64 49.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.756 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.859 HD12 HD11 ' A' ' 375' ' ' LEU . 43.4 mm -99.98 104.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.673 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.0 m -101.38 -170.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.148 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -157.55 151.47 24.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.056 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.548 ' HB2' HG21 ' A' ' 403' ' ' VAL . 60.1 t0 -76.58 69.97 3.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.851 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -43.47 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.5 m -90.03 176.71 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.743 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 398' ' ' GLU . 4.7 pt20 -60.02 -44.29 94.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 63.7 mm-40 -69.99 -41.51 74.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.727 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -19.23 60.84 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.545 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.0 m -83.9 -21.82 31.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.397 -0.401 . . . . 0.0 110.72 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.56 ' NE2' ' CD2' ' A' ' 291' ' ' PHE . 25.2 mt-30 -75.84 -41.37 52.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.784 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.834 ' CE2' HG23 ' A' ' 287' ' ' ILE . 7.3 m-30 -59.94 -44.99 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.889 0.376 . . . . 0.0 110.769 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 394' ' ' ASP . 55.6 t -60.01 -40.09 82.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.07 -40.03 47.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.042 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -67.41 -38.42 91.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.924 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 2.2 p90 -142.56 -78.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.756 0.312 . . . . 0.0 110.334 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 135.65 47.93 0.08 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.832 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.63 -37.04 1.96 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.393 -1.384 . . . . 0.0 115.416 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.781 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -126.47 128.88 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.751 0.775 . . . . 0.0 112.977 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.64 136.76 6.38 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.49 140.15 13.66 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.744 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.925 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.7 mt -103.4 127.18 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.7 mt -91.55 158.58 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 112.732 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.55 -39.89 67.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.435 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.2 p90 -165.1 176.05 8.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.93 -40.02 87.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -117.13 101.19 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -133.27 121.72 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.253 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -79.48 0.05 31.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 109.7 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.95 -9.85 54.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -60.03 -40.3 88.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.795 0.331 . . . . 0.0 110.629 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.0 -29.78 66.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -60.05 -34.86 73.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.314 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.91 -49.99 75.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.253 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -107.01 121.63 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.926 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.993 0.425 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.6 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 0.3 OUTLIER -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.449 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.6 pt-20 -77.61 -24.61 49.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.548 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -83.94 -51.47 7.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -75.37 -57.11 4.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 24.2 tp -59.1 -53.76 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.841 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.793 HD11 ' HB ' ' A' ' 392' ' ' VAL . 29.5 mt -58.93 -49.96 81.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.7 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.32 -37.02 71.59 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -60.01 -37.51 79.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.5 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.3 t80 -58.86 -45.51 89.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.612 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.91 -39.16 17.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.717 0.294 . . . . 0.0 111.444 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.6 t0 -62.29 -45.2 94.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 111.336 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.772 ' OE2' HG21 ' A' ' 298' ' ' THR . 18.4 tp10 -67.64 -39.98 84.59 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 301' ' ' TYR . 80.4 mt -62.07 -26.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.43 -14.73 13.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.074 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.751 ' HB2' HG23 ' A' ' 298' ' ' THR . 23.5 mt-30 -99.24 1.23 44.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.603 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.92 27.43 16.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.317 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.772 HG21 ' OE2' ' A' ' 293' ' ' GLU . 17.2 p -64.88 -13.38 56.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.941 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 58.38 45.06 94.81 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.23 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.629 ' HA ' HD12 ' A' ' 413' ' ' LEU . 4.7 ptpt -130.89 46.6 2.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.041 0.421 . . . . 0.0 110.782 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.891 ' CE1' HG23 ' A' ' 412' ' ' ILE . 98.6 m-85 -160.49 160.96 32.66 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.954 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 27.6 m -141.56 159.38 42.35 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.812 0.339 . . . . 0.0 111.234 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.447 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.2 p90 -135.4 124.68 24.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.621 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.534 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 107.68 156.09 19.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.311 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.954 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -59.97 -53.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 20.5 pt-20 -51.8 -51.93 52.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.47 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 87.5 m-20 -67.02 -53.17 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 0.0 111.095 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 42.0 m -58.05 -40.01 79.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.017 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.954 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.4 mp -67.81 -46.59 71.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 41.3 mtmt -54.45 -50.03 68.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.941 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.82 59.44 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.321 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.878 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.63 -33.28 68.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.004 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -72.77 -25.52 61.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 4.3 mmt -82.46 -7.72 59.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.956 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.54 13.54 45.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.172 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.93 -6.99 59.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.549 0.34 . . . . 0.0 111.094 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 387' ' ' ALA . 35.6 m -99.79 106.68 19.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.649 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.4 tt0 -60.0 -52.7 64.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.696 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.7 mm -130.31 125.55 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.401 0.144 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.2 tp -91.15 127.4 36.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.959 0.409 . . . . 0.0 111.081 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.87 106.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.352 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.653 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -120.94 147.5 24.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.314 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.7 m-85 -90.17 143.19 26.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.0 112.252 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 12.2 tp10 -60.07 -43.06 95.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -91.6 53.57 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.541 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.4 tp -84.34 124.9 31.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -95.47 29.2 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.047 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.05 HG22 HD12 ' A' ' 374' ' ' LEU . 18.8 mm -123.84 131.45 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.926 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.635 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.8 mtt -140.58 162.54 35.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.516 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.0 ttt-85 -90.91 120.19 31.72 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.109 0.481 . . . . 0.0 111.606 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 18.3 m-85 -130.91 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.013 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 111.359 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 26.1 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.019 0.438 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -90.41 135.49 33.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.315 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.3 mm? -126.85 158.46 36.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.693 0.759 . . . . 0.0 112.63 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.6 p -101.09 169.22 8.07 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.741 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 2.2 Cg_endo -44.64 -48.83 9.96 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.055 1.836 . . . . 0.0 111.92 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.559 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.97 -46.07 66.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.767 0.317 . . . . 0.0 111.647 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 57.1 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.651 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.0 128.46 25.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.635 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.5 Cg_exo -59.3 121.2 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.69 1.593 . . . . 0.0 110.5 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.05 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -60.12 -39.9 87.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.811 HD11 HD12 ' A' ' 391' ' ' ILE . 56.1 tp -59.98 -56.29 23.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.5 mt-10 -60.0 -40.05 87.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.008 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.78 -39.93 95.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.395 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.613 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -67.54 -25.17 65.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.014 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.65 -10.48 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -102.57 -14.7 16.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.8 19.88 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.19 -20.06 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.56 0.219 . . . . 0.0 111.265 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -80.37 -42.16 23.36 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.171 0.51 . . . . 0.0 110.493 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.68 ' CD2' HD23 ' A' ' 312' ' ' LEU . 20.9 m-85 -81.81 -10.01 59.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.35 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.79 54.52 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.0 m -107.64 100.99 10.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.486 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 391' ' ' ILE . 2.1 tm? -71.12 103.69 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.209 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.604 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.0 mm-40 -111.31 131.19 55.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 375' ' ' LEU . 32.0 mm -95.24 100.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.793 ' HB ' HD11 ' A' ' 287' ' ' ILE . 17.6 m -112.73 139.34 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 395' ' ' LYS . 5.7 p -111.45 164.47 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.881 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.411 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.3 p-10 -69.5 15.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 393' ' ' THR . 38.8 tttp -59.95 -45.25 93.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 5.0 m -90.76 173.77 7.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.978 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.84 -50.39 73.98 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.785 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 74.1 mm-40 -62.94 -36.89 84.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.506 0.67 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.411 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.11 -26.37 67.45 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.436 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.2 m -83.34 -26.62 30.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.242 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.8 -43.7 68.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.797 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.589 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.0 m-85 -60.02 -48.22 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 72.8 t -57.59 -33.57 45.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 400' ' ' SER . 2.9 mmpt? -74.65 -52.16 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.524 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.75 -25.57 69.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.279 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.534 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 21.7 t80 179.35 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.71 167.11 30.82 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.498 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.494 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.39 -47.83 3.03 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.594 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.77 130.58 5.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 117.742 0.771 . . . . 0.0 112.159 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.49 134.63 5.11 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.97 138.88 14.29 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.577 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.891 HG23 ' CE1' ' A' ' 301' ' ' TYR . 26.6 mt -102.48 127.2 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 69.8 mt -87.91 152.54 21.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 112.345 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.3 mtt-85 -68.99 -35.55 76.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.94 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.439 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 97.0 m-85 -159.84 -171.83 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.56 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -61.04 -39.96 91.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.454 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 53.7 p90 -140.59 114.99 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.293 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -135.62 116.41 14.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.335 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.99 11.3 9.76 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.062 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.6 mt -70.05 -2.25 12.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.937 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.38 -39.3 69.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -60.01 -39.53 86.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.316 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.61 -32.18 62.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.741 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.94 -45.81 91.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 N--CA 1.46 0.043 0 CA-C-O 120.732 0.301 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.591 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 0.1 OUTLIER -59.32 -41.01 88.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.287 0.565 . . . . 0.0 109.917 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.74 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 79.8 mt-10 -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.896 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -39.95 94.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -86.8 -59.16 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -60.76 -55.22 35.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.838 0.352 . . . . 0.0 111.455 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 54.1 mt -59.91 -48.89 86.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.531 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -55.11 -38.34 66.32 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.532 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.421 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 43.3 ttt-85 -59.97 -36.59 77.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 0.0 110.046 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.621 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 11.6 t80 -60.09 -47.77 84.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.635 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -81.87 -36.65 27.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.89 -52.11 61.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.769 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -60.85 -44.63 96.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.397 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 301' ' ' TYR . 97.5 mt -56.38 -24.95 19.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -15.25 33.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 121.471 0.653 . . . . 0.0 109.621 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.817 ' HB2' HG23 ' A' ' 298' ' ' THR . 76.4 mt-30 -100.41 1.36 41.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.443 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.39 32.45 18.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.182 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 296' ' ' GLN . 24.3 p -74.13 -5.65 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 45.51 75.21 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.948 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 37.0 mtmt -122.26 37.9 4.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.883 ' CE1' HG23 ' A' ' 412' ' ' ILE . 73.8 m-85 -162.31 164.26 27.58 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.1 p -149.43 163.55 37.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.2 p90 -137.43 131.13 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 112.39 149.69 10.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.898 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.24 -58.23 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.6 pt-20 -49.33 -55.62 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.0 -52.42 63.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.701 0.286 . . . . 0.0 111.535 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 49.7 m -59.32 -39.96 84.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.091 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.823 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.1 mp -66.26 -42.08 89.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 314' ' ' MET . 24.4 mtmt -59.95 -45.42 92.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.129 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -70.03 -28.61 65.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.899 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.27 -24.97 59.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.985 0.422 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -78.94 -28.91 43.82 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 14.3 mmt -81.2 -8.04 59.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.676 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.67 28.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.742 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.78 -11.22 58.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.835 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.819 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.9 m -90.44 105.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.91 -49.42 77.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.418 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.887 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.3 mm -135.76 127.1 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.611 0.243 . . . . 0.0 111.434 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.674 ' HG ' HG23 ' A' ' 322' ' ' VAL . 55.4 tp -93.69 128.15 39.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.252 0.548 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -115.43 107.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.975 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.674 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.8 t -125.78 161.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.902 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -112.25 132.59 54.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 111.396 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.732 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.3 pt-20 -56.23 -25.92 49.32 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.847 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -90.05 45.28 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.291 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 25.3 tp -89.14 124.2 34.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 110.948 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.16 30.04 2.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.521 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.031 HG22 HD12 ' A' ' 374' ' ' LEU . 20.0 mm -124.52 135.18 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.129 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.645 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 60.5 mtp -140.11 162.32 35.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.623 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.615 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 15.6 ttt85 -88.08 117.12 26.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.029 0.442 . . . . 0.0 111.588 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 6.8 m-85 -125.42 123.39 39.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.347 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 111.436 -179.191 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 46.6 tp . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.277 0.561 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.633 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.5 p90 -100.07 119.48 38.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.554 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.592 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -124.33 163.58 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 112.534 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -101.32 170.79 6.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.669 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -49.36 -42.0 41.86 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.836 1.69 . . . . 0.0 111.862 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.2 -50.02 75.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.052 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 48.9 mt-30 -69.38 -50.12 49.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 84.2 mt-10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.999 0.428 . . . . 0.0 110.775 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.7 tpt -120.83 134.93 24.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.276 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.4 Cg_exo -61.01 130.36 32.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.926 1.75 . . . . 0.0 110.412 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.031 HD12 HG22 ' A' ' 328' ' ' ILE . 14.7 mt -69.63 -40.6 76.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.669 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 391' ' ' ILE . 60.1 tp -60.19 -56.1 25.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.902 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.0 mt-10 -57.58 -40.05 78.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.69 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.97 -40.02 91.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.458 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.2 OUTLIER -70.56 -26.87 63.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.43 -8.84 52.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.397 . . . . 0.0 112.005 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -108.23 -9.5 15.51 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 28.0 m120 -129.26 18.03 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.35 -21.02 66.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.595 0.236 . . . . 0.0 111.317 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -77.19 -46.36 23.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -62.87 -41.71 99.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 0.0 110.679 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -74.07 -17.89 60.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.35 69.25 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.209 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.819 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.2 163.07 18.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.887 ' HB ' HG23 ' A' ' 319' ' ' ILE . 90.0 m -106.66 99.84 9.39 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.3 tm? -76.12 102.6 5.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.923 0.392 . . . . 0.0 111.235 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.582 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.4 mm-40 -111.92 132.09 54.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.157 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.732 HG21 ' HB3' ' A' ' 324' ' ' GLU . 37.8 mm -94.97 105.63 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 111.886 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.902 HG23 ' CE2' ' A' ' 323' ' ' TYR . 6.5 m -101.91 -169.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.813 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.582 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.8 p -158.03 154.04 27.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.331 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.47 0.96 3.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.202 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -59.8 -40.87 89.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.618 0.247 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 283' ' ' GLU . 53.5 p -85.51 168.59 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.05 -55.16 37.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 69.6 mm-40 -63.21 -36.07 82.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 109.852 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.527 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -52.72 -59.04 9.75 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.323 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 m -59.59 -19.7 50.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 32.7 mt-30 -69.69 -40.04 76.57 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.069 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.561 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.9 m-85 -62.04 -36.5 81.8 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.03 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.883 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.8 t -60.09 -38.8 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -71.36 -45.63 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.991 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -58.75 -44.83 95.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.99 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 303' ' ' PHE . 60.3 t80 -146.44 -66.26 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.71 57.26 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.808 -1.187 . . . . 0.0 115.165 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 139.78 -36.1 1.86 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.258 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.656 HG12 HG13 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -132.24 133.38 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 117.964 0.882 . . . . 0.0 112.815 -177.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -150.83 136.67 5.69 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.73 143.64 15.95 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.441 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.883 HG23 ' CE1' ' A' ' 301' ' ' TYR . 30.9 mt -104.47 125.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.3 mt -94.98 163.16 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 0.0 112.799 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 74.6 mtt180 -78.48 -38.36 41.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.764 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 89.9 m-85 -158.48 -179.94 8.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.793 ' HG2' ' O ' ' A' ' 298' ' ' THR . 45.8 mtm180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.721 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.436 ' O ' ' CD1' ' A' ' 432' ' ' PHE . 41.5 tt0 -60.06 -49.4 77.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 432' ' ' PHE . 87.1 m-85 -76.28 -40.09 52.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 35.1 p90 45.14 69.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.221 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -77.92 6.1 8.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.931 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.28 -3.49 14.1 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.579 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.52 -40.07 81.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 110.47 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.91 -32.27 70.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.335 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.64 -35.8 75.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.02 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.01 -48.01 83.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.936 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--O 1.231 0.125 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.608 HE22 HG13 ' A' ' 392' ' ' VAL . 0.4 OUTLIER -59.07 -39.96 83.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.262 0.553 . . . . 0.0 110.054 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.736 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.6 mt-10 -81.13 -44.0 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -67.44 -40.06 85.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -86.03 -58.65 2.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -61.2 -56.59 18.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.634 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 58.1 mt -59.97 -45.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.69 -37.67 77.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.264 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 -59.96 -36.84 77.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.407 0.622 . . . . 0.0 110.056 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.647 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 8.9 t80 -59.96 -46.07 90.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.683 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -83.68 -37.33 22.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 295' ' ' SER . 53.4 t0 -62.02 -47.39 84.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.829 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.5 mp0 -66.71 -40.0 88.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.72 -22.35 26.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.17 -13.54 58.42 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.347 0.594 . . . . 0.0 109.528 178.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.66 ' HB2' HG23 ' A' ' 298' ' ' THR . 67.9 mt-30 -102.96 -0.71 30.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.541 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.19 30.66 20.47 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 11.3 p -69.73 -12.36 61.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.871 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.17 48.57 85.28 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.123 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.577 ' HA ' HD12 ' A' ' 413' ' ' LEU . 3.2 mtpm? -125.94 37.45 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.89 ' CE1' HG23 ' A' ' 412' ' ' ILE . 82.1 m-85 -160.61 161.54 32.55 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.142 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.7 159.71 41.67 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -135.91 124.84 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.82 153.06 13.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.27 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -57.33 -58.45 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.764 0.316 . . . . 0.0 110.794 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.8 pt-20 -50.41 -53.53 28.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.98 -55.2 27.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 409' ' ' ILE . 21.4 m -57.01 -39.35 74.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.931 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.3 mp -67.54 -42.21 83.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 25.2 mtmt -60.0 -49.94 75.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.792 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.84 -29.27 67.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.63 0.252 . . . . 0.0 110.934 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.752 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -71.76 -26.84 62.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.919 0.39 . . . . 0.0 110.448 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 33.6 mm-40 -79.04 -27.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.2 mmt -80.28 -7.42 59.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.849 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.33 18.15 48.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.258 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.59 11.76 29.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.364 0.266 . . . . 0.0 111.04 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.83 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.0 m -111.33 105.53 18.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 319' ' ' ILE . 59.9 tt0 -59.95 -49.99 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.85 HG23 ' HB ' ' A' ' 388' ' ' THR . 43.5 mm -137.65 126.02 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.618 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.6 tp -90.95 128.79 36.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 111.314 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.775 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -113.5 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.766 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.618 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.9 t -122.68 150.56 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.332 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -98.16 146.06 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 111.144 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.549 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.8 pt-20 -65.95 -33.28 75.45 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.074 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -90.06 41.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 29.3 tp -74.05 122.17 22.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 110.869 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -90.57 24.17 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.074 HG21 HG21 ' A' ' 305' ' ' VAL . 18.5 mm -125.95 131.34 71.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.676 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.743 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 66.7 mtp -140.27 161.76 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.593 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.639 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.6 ttt180 -85.1 116.09 23.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.937 0.398 . . . . 0.0 111.555 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 15.0 m-85 -119.07 119.0 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.528 0.11 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.317 -179.714 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 346' ' ' LEU . 47.0 tp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.329 0.585 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.91 121.21 40.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.923 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -121.09 161.39 21.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 4.4 p -101.66 169.14 8.06 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.115 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 86.5 Cg_exo -43.67 -53.02 4.75 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.812 1.675 . . . . 0.0 112.162 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.96 -58.8 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.79 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.13 -44.99 95.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.944 0.402 . . . . 0.0 111.36 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.8 mt-10 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.074 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 90.9 p . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -117.83 133.49 23.34 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.204 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 37.7 Cg_exo -58.39 114.29 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.824 1.682 . . . . 0.0 111.108 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.042 HD12 HG22 ' A' ' 328' ' ' ILE . 23.5 mt -60.01 -39.29 85.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.147 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 391' ' ' ILE . 63.3 tp -60.01 -52.27 66.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.61 -39.94 90.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.205 0.526 . . . . 0.0 109.822 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -61.28 -40.02 92.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.569 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -73.54 -24.19 60.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -9.13 53.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.75 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -110.04 -10.02 14.71 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 28.1 m120 -129.29 14.02 6.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -64.4 -18.5 64.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.584 0.23 . . . . 0.0 111.394 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -75.38 -39.97 58.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -67.21 -40.88 86.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.1 m-85 -72.67 -16.36 61.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.52 70.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.894 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.83 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.96 164.45 15.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.271 0.558 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.85 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.7 m -107.19 100.59 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.11 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -71.99 102.87 3.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.384 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.555 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -111.02 138.88 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.877 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 375' ' ' LEU . 36.7 mm -101.92 103.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.623 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.4 m -101.6 -171.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.225 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -156.24 153.75 29.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.473 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.5 p-10 -70.89 2.94 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -60.05 -40.0 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.567 0.222 . . . . 0.0 111.399 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.5 p -84.65 169.86 13.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.358 . . . . 0.0 111.416 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.04 -52.51 65.07 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 65.1 mm-40 -61.64 -38.08 86.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.473 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -63.22 -25.04 67.88 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.792 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.3 m -82.88 -25.7 32.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.529 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.14 -45.21 58.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 287' ' ' ILE . 1.6 m-85 -56.29 -49.6 73.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.522 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 85.2 t -59.86 -35.21 59.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.762 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 400' ' ' SER . 24.3 mmtt -69.9 -49.96 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.203 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.86 -23.84 75.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 11.1 t80 178.76 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 97.87 167.07 31.93 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.674 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.89 -49.2 2.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.025 -0.607 . . . . 0.0 114.191 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -145.15 132.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 117.492 0.646 . . . . 0.0 112.205 -177.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.572 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -152.5 143.33 10.22 Favored Glycine 0 CA--C 1.509 -0.301 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.9 142.07 13.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.57 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.89 HG23 ' CE1' ' A' ' 301' ' ' TYR . 57.2 mt -104.66 128.65 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.805 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.5 mt -87.38 150.16 24.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.784 0.802 . . . . 0.0 112.821 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.715 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 72.7 mtt-85 -69.95 -36.19 75.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 96.2 m-85 -159.38 167.04 29.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.772 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mtm180 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.874 0.369 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.97 -40.64 89.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.61 104.68 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -124.6 103.84 8.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 11.71 19.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.055 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 64.1 mt -73.4 -3.92 30.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.646 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -40.02 87.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 110.632 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.84 -30.6 68.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.0 -33.72 72.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.432 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.97 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.09 124.31 47.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.948 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.729 0.3 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.612 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -59.92 -40.47 88.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.957 0.408 . . . . 0.0 110.382 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.623 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 24.8 pt-20 -85.62 -38.54 18.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.904 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -70.03 -39.92 75.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -86.22 -57.23 3.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.917 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.0 tp -58.26 -56.31 23.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.079 0.466 . . . . 0.0 111.719 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 392' ' ' VAL . 52.4 mt -59.36 -49.97 81.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.466 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.98 -39.79 89.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.591 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -60.06 -36.49 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.471 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 4.9 t80 -59.08 -45.98 89.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -83.48 -42.32 17.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.864 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 295' ' ' SER . 45.1 t0 -60.72 -47.48 86.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.567 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.685 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 22.9 tp10 -63.06 -39.94 96.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 301' ' ' TYR . 87.7 mt -62.75 -26.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.599 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -60.34 -12.53 9.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 109.957 178.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.805 ' HB2' HG23 ' A' ' 298' ' ' THR . 83.7 mt-30 -98.97 0.04 43.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.466 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.99 29.65 19.25 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.346 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.805 HG23 ' HB2' ' A' ' 296' ' ' GLN . 19.0 p -73.35 -7.75 52.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.958 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.65 53.47 29.02 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.938 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 22.0 mttt -130.2 41.95 3.33 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.6 m-85 -161.78 163.02 29.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.775 0.321 . . . . 0.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.0 p -149.12 161.82 41.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.74 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.837 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 53.0 p90 -141.44 149.99 41.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 96.67 142.19 12.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.171 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.742 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -49.37 -64.12 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.765 0.317 . . . . 0.0 111.238 -179.161 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.1 pt-20 -47.15 -52.89 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.831 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.0 m-20 -64.35 -56.75 12.32 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 26.0 m -58.03 -37.38 74.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.742 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -69.94 -44.0 70.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.603 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.9 mtmm -59.9 -46.44 89.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.585 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.021 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.978 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.81 -24.92 55.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.895 0.378 . . . . 0.0 110.618 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -77.96 -28.32 49.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 89.8 mmm -81.1 -7.37 59.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.731 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.55 16.34 36.38 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.358 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.51 -9.65 58.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.411 0.284 . . . . 0.0 111.207 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.978 HG21 ' CD1' ' A' ' 312' ' ' LEU . 28.0 m -94.94 105.49 17.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.679 ' O ' HD13 ' A' ' 319' ' ' ILE . 43.0 tt0 -58.78 -50.9 72.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.275 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.88 HG23 ' HB ' ' A' ' 388' ' ' THR . 33.0 mm -134.05 127.0 50.96 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.061 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.737 ' HG ' HG23 ' A' ' 322' ' ' VAL . 31.6 tp -92.38 125.6 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.81 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.917 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -106.67 103.85 16.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.244 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.737 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.6 t -124.23 162.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 392' ' ' VAL . 75.9 m-85 -112.67 149.78 32.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 111.905 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.632 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.6 pt-20 -65.91 -40.41 91.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.149 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -89.77 56.49 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.752 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 26.5 tp -89.09 121.75 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -89.15 23.77 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.769 HG22 HD12 ' A' ' 374' ' ' LEU . 4.8 mm -121.62 131.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.6 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.3 mtt -139.48 162.97 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.622 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.5 ttt180 -88.85 116.04 26.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 112.012 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.6 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 9.1 m-85 -123.46 123.77 41.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.097 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.144 0.497 . . . . 0.0 111.662 -178.905 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.483 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 55.8 tp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.342 0.591 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.596 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 10.3 p90 -97.32 120.04 36.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.625 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.2 mm? -125.33 160.56 29.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.1 p -101.64 172.2 4.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.466 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.0 Cg_exo -46.6 -42.8 23.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.882 1.721 . . . . 0.0 111.92 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -59.22 5.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 88.9 mt-30 -60.37 -49.69 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 89.2 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.207 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.4 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.228 0.537 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.477 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -115.69 130.87 24.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.961 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.579 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.7 Cg_exo -60.72 120.15 7.71 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.03 1.82 . . . . 0.0 110.752 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 328' ' ' ILE . 20.2 mt -61.89 -39.56 92.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.021 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -59.99 -51.88 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.82 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.05 -40.15 88.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.718 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.495 ' O ' ' ND2' ' A' ' 381' ' ' ASN . 85.0 t90 -63.0 -40.01 96.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.651 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.484 ' CZ ' ' HG ' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -70.01 -24.92 63.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.31 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.03 -7.62 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.072 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -105.47 -11.9 16.22 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 377' ' ' TRP . 5.8 p30 -129.65 16.02 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -62.11 -20.49 64.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.93 -44.77 17.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -61.34 -40.57 94.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.704 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.661 ' CD2' HD23 ' A' ' 312' ' ' LEU . 23.5 m-85 -79.96 -12.7 59.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.15 55.44 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.873 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.87 161.54 19.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.103 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.88 ' HB ' HG23 ' A' ' 319' ' ' ILE . 47.2 m -105.64 99.66 9.25 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.5 tm? -74.6 103.55 4.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.115 0.483 . . . . 0.0 111.082 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.612 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.2 mm-40 -110.66 140.47 44.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.911 HD12 HD11 ' A' ' 375' ' ' LEU . 18.2 mm -105.43 104.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.834 HG23 ' CE2' ' A' ' 323' ' ' TYR . 9.3 m -101.09 -170.06 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.879 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.618 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.5 p -154.59 152.51 30.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.42 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.4 p-10 -68.58 3.28 1.91 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.548 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -59.99 -40.1 88.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.645 0.259 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -89.17 167.72 12.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.8 0.334 . . . . 0.0 111.516 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.07 -49.89 75.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 45.6 mp0 -63.47 -39.98 95.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.37 0.605 . . . . 0.0 109.756 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.3 -19.16 63.89 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.664 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.1 m -83.89 -22.46 31.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.017 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -74.23 -39.99 62.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.028 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.558 ' CD2' ' HE2' ' A' ' 406' ' ' PHE . 2.7 m-85 -63.26 -49.62 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.0 -45.92 94.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -73.97 -43.98 56.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.742 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.405 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -66.37 -41.51 94.44 Favored Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.837 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -129.29 -86.91 0.54 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.793 -0.704 . . . . 0.0 109.582 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 160.77 40.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.35 -1.405 . . . . 0.0 115.117 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.573 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 102.9 7.36 44.5 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.035 -1.078 . . . . 0.0 115.424 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.568 ' CD1' HG22 ' A' ' 305' ' ' VAL . 0.4 OUTLIER -144.97 125.34 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.207 1.003 . . . . 0.0 110.449 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.432 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -153.31 145.32 12.63 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -126.35 140.46 12.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.548 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.809 HG23 ' CE1' ' A' ' 301' ' ' TYR . 56.6 mt -99.11 127.52 51.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 34.9 mt -92.08 165.66 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.476 0.655 . . . . 0.0 112.345 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -91.6 -27.19 18.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 64.7 t80 -164.49 162.96 22.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 298' ' ' THR . 6.0 mmm180 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.0 -49.95 75.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.556 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.03 -31.52 69.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -81.41 107.9 14.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -82.82 7.51 14.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.339 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.69 -9.76 39.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.775 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -39.97 87.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.01 -31.37 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.355 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -59.91 -31.88 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.745 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.06 -49.91 75.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.266 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -109.09 130.17 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 285' ' ' LYS . 46.8 pt . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 120.904 0.383 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.6 OUTLIER -59.45 -39.57 84.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 -179.13 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.587 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 59.7 mt-10 -78.97 -30.27 44.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -52.17 6.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 281' ' ' ILE . 15.0 mtpt -70.01 -56.98 5.56 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 321' ' ' ILE . 23.7 tp -57.83 -54.93 41.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.317 0.579 . . . . 0.0 110.804 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 398' ' ' GLU . 11.0 mt -63.46 -45.34 98.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.248 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.31 -39.48 82.55 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.604 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -59.98 -37.77 80.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 21.7 t80 -60.05 -47.18 86.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.524 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -86.27 -35.92 19.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 295' ' ' SER . 26.2 t0 -66.22 -46.26 77.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 111.306 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.692 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 10.5 tp10 -65.7 -39.93 91.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 301' ' ' TYR . 86.3 mt -62.22 -25.41 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.63 -14.72 14.82 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.28 0.562 . . . . 0.0 109.806 178.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.649 ' HB2' HG23 ' A' ' 298' ' ' THR . 51.4 mt-30 -98.2 -0.06 44.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.748 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.69 29.97 19.31 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.974 0.416 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 296' ' ' GLN . 32.0 p -70.66 -12.05 61.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.949 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.26 47.78 89.17 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.72 -1.229 . . . . 0.0 114.442 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.751 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 16.8 ptpt -130.46 45.04 2.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.13 0.465 . . . . 0.0 110.783 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.841 ' CE1' HG23 ' A' ' 412' ' ' ILE . 87.3 m-85 -160.94 161.09 31.54 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.911 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 3.6 p -144.61 160.62 40.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.405 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 48.7 p90 -134.51 124.16 25.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.849 0.357 . . . . 0.0 110.819 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.509 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 113.79 155.1 11.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -59.91 -56.76 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.843 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.503 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -49.57 -57.46 7.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.482 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 88.0 m-20 -60.06 -52.2 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 33.5 m -59.99 -40.03 87.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.138 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.976 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.0 mp -66.01 -46.72 76.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -57.64 -50.46 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.027 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -65.18 -31.28 72.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.354 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.932 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.71 -24.29 59.9 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -79.73 -27.41 40.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.1 mmt -80.89 -8.83 59.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.313 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.55 15.16 38.61 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.518 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.52 -8.8 57.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.134 . . . . 0.0 111.322 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.7 m -92.03 103.91 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.844 0.354 . . . . 0.0 111.708 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.672 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.3 tt0 -58.68 -49.96 75.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.552 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.5 mm -133.75 126.6 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.545 0.212 . . . . 0.0 111.171 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.68 ' HG ' HG23 ' A' ' 322' ' ' VAL . 47.5 tp -92.03 124.04 35.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 1.031 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -111.41 105.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.584 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.68 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.4 t -116.51 159.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.833 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 70.2 m-85 -107.14 144.82 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -71.28 160.87 32.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.526 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.0 22.98 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.803 0.335 . . . . 0.0 110.445 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 24.4 tp -54.78 125.26 19.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.74 26.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.001 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.982 HG21 HG21 ' A' ' 305' ' ' VAL . 12.3 mm -130.76 130.57 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.537 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.633 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 9.9 mtt -139.68 162.66 34.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.582 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt180 -85.28 118.08 24.6 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 120.728 0.299 . . . . 0.0 111.662 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.816 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 43.8 m-85 -124.92 122.07 36.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.424 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 332' ' ' VAL . 23.7 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 0.0 111.161 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.183 0.516 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.546 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.62 116.95 29.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.54 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.9 mm? -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.456 0.645 . . . . 0.0 112.58 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.5 p -100.41 169.7 7.59 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.96 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.5 Cg_exo -47.71 -46.07 22.11 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 121.943 1.762 . . . . 0.0 112.953 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 350' ' ' GLN . 23.9 pm0 -64.4 -41.72 96.48 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 349' ' ' GLU . 40.3 mt-30 -84.62 -48.18 9.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.816 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 3.5 tm-20 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.946 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.566 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 1.4 m . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 121.187 0.518 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.1 tpt -113.6 129.11 24.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.2 Cg_exo -56.0 120.51 8.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.805 1.67 . . . . 0.0 110.981 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 305' ' ' VAL . 32.6 mt -62.03 -40.06 94.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.956 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 391' ' ' ILE . 50.4 tp -60.8 -55.65 30.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.3 mt-10 -59.79 -40.05 86.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.874 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -60.93 -39.92 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.982 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.559 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.1 m-85 -72.82 -27.12 61.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.214 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.54 -10.81 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.42 -9.75 15.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 20.69 5.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.567 0.222 . . . . 0.0 111.47 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -69.0 -17.65 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.09 -43.45 17.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.84 -41.47 99.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.466 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.6 m-85 -78.5 -15.84 58.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.805 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.34 2.21 66.97 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.52 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.62 162.66 18.73 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.164 0.507 . . . . 0.0 110.601 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 71.5 m -107.13 100.57 10.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.371 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.0 OUTLIER -72.19 105.53 4.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.389 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.476 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 14.3 mm-40 -111.39 143.5 42.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.774 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 375' ' ' LEU . 18.6 mm -107.37 100.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 287' ' ' ILE . 18.6 m -100.54 -170.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.267 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.553 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.6 OUTLIER -160.35 157.1 27.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.945 0.403 . . . . 0.0 111.748 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.43 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.0 p-10 -71.5 -0.12 9.74 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.496 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.25 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 54.3 p -78.88 168.07 20.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.778 0.323 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.97 -51.0 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 110.725 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.794 ' HG3' HG22 ' A' ' 287' ' ' ILE . 13.1 tp10 -70.07 -34.72 73.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -51.84 -57.21 13.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.8 m -60.7 -19.65 59.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.536 . . . . 0.0 112.073 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 36.6 mt-30 -70.3 -40.06 74.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.967 0.413 . . . . 0.0 110.467 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.608 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -59.6 -46.43 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.376 179.23 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.546 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 76.3 t -58.97 -33.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -69.14 -51.06 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.033 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -71.13 -22.1 78.47 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.637 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.509 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.0 t80 176.65 -77.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.48 168.33 31.33 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.52 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.32 -48.59 2.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.277 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.61 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -144.22 132.33 17.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 117.495 0.648 . . . . 0.0 112.383 -177.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.59 137.51 6.29 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.55 139.39 12.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.392 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 321' ' ' ILE . 56.2 mt -101.32 127.72 54.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 66.6 mt -91.6 168.77 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.719 . . . . 0.0 112.645 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -67.29 -40.05 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.742 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.652 ' O ' ' HB3' ' A' ' 300' ' ' LYS . 58.1 t80 -172.09 -60.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.724 0.297 . . . . 0.0 111.574 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 120.846 0.355 . . . . 0.0 110.643 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.798 0.333 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.85 -43.74 97.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.396 . . . . 0.0 110.918 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -128.43 106.25 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 24.8 p90 -122.5 98.55 5.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.371 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 9.4 27.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.395 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.97 -18.16 43.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.63 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -81.1 -20.07 42.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.656 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.98 -38.45 82.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.028 0.442 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.98 -46.86 88.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -72.2 146.75 47.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.78 0.324 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -58.5 -40.23 82.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.127 0.489 . . . . 0.0 110.491 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.429 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.0 tt0 -71.39 -38.28 71.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -78.98 -55.36 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -67.76 -58.58 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.142 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.931 ' HG ' HD13 ' A' ' 321' ' ' ILE . 17.6 tp -52.62 -57.6 9.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 111.371 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.564 HG23 ' CD1' ' A' ' 402' ' ' PHE . 25.7 mt -61.69 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.878 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.9 -38.67 60.51 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 36.6 ttt180 -60.08 -39.95 87.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.204 0.526 . . . . 0.0 110.286 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.598 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.7 t80 -55.82 -47.85 76.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.685 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 33.6 m-85 -83.59 -37.83 22.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -61.22 -42.23 98.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.429 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.709 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.2 mt-10 -69.89 -42.14 73.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.999 0.428 . . . . 0.0 109.882 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.4 mt -60.16 -24.6 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -62.9 -15.95 57.14 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.244 0.545 . . . . 0.0 109.871 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.678 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -101.9 0.76 35.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.521 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.3 29.86 19.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 110.157 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.751 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.4 p -67.02 -10.15 46.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.997 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.55 49.57 60.46 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.841 -1.171 . . . . 0.0 113.374 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.7 mtmt -130.36 38.93 3.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.916 ' CE2' HG23 ' A' ' 412' ' ' ILE . 84.5 m-85 -160.88 161.42 31.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.252 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.66 163.25 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.6 p90 -137.65 130.88 30.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.69 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.463 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 109.35 142.46 9.68 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.361 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -50.17 -60.31 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 111.208 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 9.9 pt-20 -47.31 -54.04 12.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.629 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.08 -53.93 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 111.521 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 409' ' ' ILE . 40.6 m -58.36 -39.08 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.096 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.891 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.5 mp -65.93 -42.79 89.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.0 mtmm -59.96 -49.99 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.38 -29.35 69.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.29 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.958 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.07 -24.81 58.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.77 0.319 . . . . 0.0 110.733 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 76.8 mm-40 -79.39 -27.96 41.87 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 34.1 mmt -80.51 -7.57 59.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.759 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.97 18.33 47.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.409 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.63 -1.3 57.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.388 0.275 . . . . 0.0 111.371 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.958 HG21 ' CD1' ' A' ' 312' ' ' LEU . 30.3 m -100.3 104.3 15.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 319' ' ' ILE . 9.4 tp10 -57.71 -50.89 71.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.321 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.4 mm -135.4 126.85 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.643 0.259 . . . . 0.0 111.221 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.662 ' HG ' HG23 ' A' ' 322' ' ' VAL . 48.6 tp -92.74 126.43 37.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 111.634 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.931 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -112.67 106.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.662 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.8 t -124.8 161.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.155 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.4 m-85 -108.19 146.1 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 11.4 pt-20 -65.02 -34.11 77.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.9 47.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.585 HD11 HD11 ' A' ' 409' ' ' ILE . 31.1 tp -81.01 123.15 28.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.577 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -93.07 25.67 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 24.3 mm -123.18 132.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.666 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.5 mtm -140.35 162.09 36.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.4 ttt85 -89.7 119.99 30.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.105 0.479 . . . . 0.0 111.572 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 9.9 m-85 -127.11 123.09 36.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.485 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 332' ' ' VAL . 14.2 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.214 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.745 HD23 HD11 ' A' ' 346' ' ' LEU . 54.9 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.445 0.64 . . . . 0.0 112.153 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.739 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.8 p90 -99.97 121.15 40.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.047 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.921 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -127.42 160.61 30.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.625 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.2 p -101.5 172.49 4.39 Favored Pre-proline 0 N--CA 1.455 -0.177 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.588 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.6 Cg_exo -49.5 -43.22 39.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.035 1.823 . . . . 0.0 112.414 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -61.57 -49.27 77.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.921 ' HG2' HD12 ' A' ' 346' ' ' LEU . 10.9 tp60 -70.03 -48.1 59.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 75.3 mt-10 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.583 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.084 0.468 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.402 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.9 tpt -117.17 130.04 24.91 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.875 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.8 Cg_exo -60.02 125.17 16.9 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.832 1.688 . . . . 0.0 110.922 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.028 HD12 HG22 ' A' ' 328' ' ' ILE . 27.4 mt -66.49 -39.86 88.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.91 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 391' ' ' ILE . 65.0 tp -60.05 -52.16 66.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.6 mt-10 -58.89 -39.99 83.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.887 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.468 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 76.6 t-105 -62.84 -40.83 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.618 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.55 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -70.31 -27.76 64.64 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -10.01 47.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.177 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -104.18 -12.78 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.976 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.468 ' ND2' ' CE2' ' A' ' 377' ' ' TRP . 79.1 m-20 -129.64 19.93 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -65.51 -19.71 66.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.568 0.223 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.77 -44.93 17.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.05 -39.93 91.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.655 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -79.92 -13.14 59.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.84 2.26 56.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.305 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.918 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.02 163.16 18.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 110.649 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.884 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.5 m -107.82 100.41 9.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.3 tm? -75.35 102.3 5.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.111 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -108.43 139.46 43.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.827 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 375' ' ' LEU . 40.0 mm -103.49 104.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.388 0.613 . . . . 0.0 112.432 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CE1' ' A' ' 323' ' ' TYR . 6.0 m -101.65 -169.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.917 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.55 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -156.16 153.08 28.71 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.958 0.409 . . . . 0.0 111.511 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 403' ' ' VAL . 11.8 p-10 -72.87 17.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -70.03 -39.92 75.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.78 0.324 . . . . 0.0 111.235 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.5 t -89.26 170.04 10.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.678 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.0 -50.03 75.34 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.478 ' C ' HG21 ' A' ' 287' ' ' ILE . 66.8 mm-40 -64.51 -40.38 95.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.163 0.506 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.541 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.31 -18.53 63.13 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.442 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.1 m -83.98 -21.74 31.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.848 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.52 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 84.4 mt-30 -75.14 -41.35 58.49 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.835 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.617 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 3.3 m-85 -59.73 -42.75 93.82 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.792 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 57.7 t -60.01 -39.99 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.665 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -40.04 64.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.78 96.87 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.117 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.463 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 62.5 t80 -151.6 -68.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.792 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.14 58.29 0.18 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 119.965 -1.112 . . . . 0.0 114.916 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 140.78 -34.13 1.98 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 119.387 -1.387 . . . . 0.0 115.214 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -137.98 134.9 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.944 0.872 . . . . 0.0 112.997 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -151.86 142.92 9.85 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -125.72 145.95 15.97 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 119.781 -1.199 . . . . 0.0 113.887 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.916 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.5 mt -107.03 127.09 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 24.6 mt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.735 0.779 . . . . 0.0 112.753 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.428 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 64.8 mtm180 -70.15 -39.97 75.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.55 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.3 p90 -159.86 175.48 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 298' ' ' THR . 15.5 mtm180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.39 . . . . 0.0 111.197 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.458 -0.028 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.94 -44.4 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.646 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 20.7 p90 -106.38 83.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.769 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -106.28 22.18 16.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.71 45.16 0.67 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.489 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.8 mt -78.26 -3.81 44.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.467 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -39.95 87.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 110.434 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.0 -32.74 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.331 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.57 -33.6 71.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.363 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.97 -47.44 85.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.922 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -59.92 -40.04 87.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.957 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.468 ' HB ' ' HE2' ' A' ' 285' ' ' LYS . 41.9 pt . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -51.91 -45.89 64.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.725 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 58.9 mt-10 -73.82 -39.65 63.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.782 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -73.4 -43.85 59.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.468 ' HE2' ' HB ' ' A' ' 281' ' ' ILE . 38.1 mttm -87.07 -58.44 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 319' ' ' ILE . 25.6 tp -57.41 -57.09 14.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.454 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 60.6 mt -60.12 -50.11 81.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.846 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.433 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.82 -36.13 78.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.716 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.402 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 10.2 ttt180 -60.08 -38.14 81.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.306 0.574 . . . . 0.0 110.291 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 5.6 t80 -59.93 -45.52 92.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.972 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -83.13 -35.14 25.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.3 t0 -65.39 -45.31 84.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -68.95 -40.08 79.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 85.8 mt -60.63 -24.05 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.09 -13.69 49.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.321 0.582 . . . . 0.0 109.642 178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -102.63 -0.02 32.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.583 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 58.54 30.63 20.04 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.062 0.458 . . . . 0.0 110.229 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 296' ' ' GLN . 14.1 p -70.04 -9.71 56.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.47 42.96 94.15 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.839 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.4 mtmt -121.25 38.03 4.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.92 ' CE1' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -161.81 164.19 28.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.7 p -147.01 163.79 35.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.403 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 47.6 p90 -137.72 128.52 27.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.838 0.351 . . . . 0.0 110.816 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.553 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.76 151.69 12.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -58.91 -56.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.598 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.2 pt-20 -51.11 -53.74 31.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.18 -52.24 59.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.735 0.302 . . . . 0.0 111.307 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 409' ' ' ILE . 33.6 m -59.42 -39.76 84.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.91 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -67.51 -43.8 80.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.436 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -59.23 -49.36 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.778 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.7 64.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.31 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.801 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.95 -26.32 59.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.783 0.325 . . . . 0.0 110.691 179.213 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 73.9 mm-40 -76.83 -28.1 55.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.4 mmt -81.43 -7.38 59.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.899 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.03 13.51 27.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.72 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.13 -4.77 57.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.486 0.184 . . . . 0.0 110.914 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.8 m -98.93 107.11 19.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.668 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.9 tt0 -59.9 -50.03 75.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.779 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.857 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.7 mm -135.8 127.28 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 111.53 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.678 ' HG ' HG23 ' A' ' 322' ' ' VAL . 49.6 tp -93.23 128.22 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.482 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.774 HD11 HD11 ' A' ' 412' ' ' ILE . 1.3 mt -114.07 107.87 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.678 HG23 ' HG ' ' A' ' 320' ' ' LEU . 19.0 t -125.3 149.15 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.327 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.625 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.6 m-85 -99.89 132.61 45.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.596 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 13.6 pt-20 -53.58 -29.6 38.24 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.4 45.33 1.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 38.9 tp -83.71 121.54 27.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.376 . . . . 0.0 110.645 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -91.26 23.54 3.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.953 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 19.6 mm -119.97 136.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.563 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.723 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.5 mtt -139.05 161.94 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpm_? -90.05 114.27 26.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 371' ' ' SER . 33.3 m-85 -109.29 145.63 35.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.311 0.577 . . . . 0.0 111.361 179.735 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 346' ' ' LEU . 53.0 tp . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.565 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.2 p90 -103.78 119.78 39.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.076 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -123.29 158.24 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.5 p -101.86 173.34 3.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.4 Cg_exo -45.45 -46.7 14.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.997 1.798 . . . . 0.0 112.27 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.39 -58.55 8.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.365 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 46.3 mt-30 -60.93 -47.31 87.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.644 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 76.9 mt-10 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.443 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.91 ' HB2' ' CD2' ' A' ' 331' ' ' TYR . 17.5 t . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.449 ' HA ' ' HE3' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.87 128.82 25.67 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.152 179.286 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.723 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 71.7 Cg_exo -50.23 112.8 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.78 1.653 . . . . 0.0 111.153 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.984 HD13 HG11 ' A' ' 305' ' ' VAL . 14.5 mt -58.82 -40.04 82.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.388 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.625 HD11 HD12 ' A' ' 391' ' ' ILE . 65.6 tp -60.08 -52.49 65.11 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.305 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.4 mt-10 -60.94 -39.94 91.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 110.125 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -61.11 -40.01 92.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.596 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.5 OUTLIER -71.48 -23.45 61.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.571 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -8.77 53.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.994 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -108.34 -10.3 15.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.03 20.35 5.41 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -67.42 -20.16 65.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -79.88 -43.61 21.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -60.82 -40.03 91.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.675 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -80.15 -11.38 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.4 2.46 54.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.302 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.836 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.73 163.37 17.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.194 0.521 . . . . 0.0 110.62 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.857 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.0 m -107.8 100.37 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.0 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.1 tm? -73.76 102.63 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.552 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.9 mm-40 -108.84 139.44 43.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.408 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.625 HD12 HD11 ' A' ' 375' ' ' LEU . 16.4 mm -102.94 101.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.625 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.5 m -102.75 -172.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.587 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.607 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 14.6 p -156.99 152.41 26.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.337 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.9 t0 -78.91 76.96 5.39 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -119.22 -49.66 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.0 m -88.05 -176.78 5.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 15.2 mm100 -59.43 -46.01 89.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.693 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.518 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 52.3 mp0 -64.5 -40.48 95.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -61.34 -27.69 68.11 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 72.9 m -83.87 -22.97 31.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.677 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 77.8 mt-30 -72.45 -40.62 66.88 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.501 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.637 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.1 m-85 -67.38 -49.96 61.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.443 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 394' ' ' ASP . 69.7 t -59.22 -38.14 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.467 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 400' ' ' SER . 8.6 mmpt? -69.96 -51.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.143 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.45 -26.2 69.35 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.543 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.553 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 17.0 t80 179.09 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 96.85 167.11 33.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.499 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.427 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.06 -48.69 2.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.031 -0.604 . . . . 0.0 114.28 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -147.44 131.43 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.383 0.592 . . . . 0.0 111.985 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.33 135.03 5.17 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.21 140.48 15.47 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.316 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.92 HG23 ' CE1' ' A' ' 301' ' ' TYR . 44.5 mt -103.5 125.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.849 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.1 mt -87.58 151.37 23.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.484 0.659 . . . . 0.0 112.264 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.571 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 63.4 mtt-85 -71.62 -33.9 69.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.632 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.434 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 51.8 t80 -169.0 166.06 11.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 111.148 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.79 -41.14 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.708 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.438 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 51.3 p90 -144.32 114.74 7.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.357 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 19.0 p90 -133.59 85.7 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.273 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -90.08 15.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.459 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 53.5 mt -65.87 -9.46 29.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.804 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.481 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -78.41 -21.18 49.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -59.92 -38.33 82.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.04 0.448 . . . . 0.0 110.284 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.99 -44.99 94.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.954 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.06 -40.03 88.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.887 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 48.5 pt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.418 HE22 HG13 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -51.05 -39.58 56.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.815 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 mp0 -69.98 -46.73 64.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -49.16 78.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -74.55 -58.83 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.737 ' HG ' HD13 ' A' ' 321' ' ' ILE . 40.6 tp -61.32 -58.84 6.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.957 0.408 . . . . 0.0 112.079 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.638 HD13 ' HA2' ' A' ' 399' ' ' GLY . 41.3 mt -59.99 -41.24 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.154 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 398' ' ' GLU . . . -57.1 -38.92 88.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.358 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 53.9 ttt-85 -60.02 -38.7 83.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.283 0.563 . . . . 0.0 109.767 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.637 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 8.3 t80 -60.01 -46.14 90.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -80.79 -35.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.3 t0 -60.01 -49.86 76.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.576 0.227 . . . . 0.0 111.572 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.623 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.1 mt-10 -61.75 -43.11 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 94.5 mt -57.76 -27.9 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.448 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -63.69 -14.61 53.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.283 0.563 . . . . 0.0 109.56 178.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.623 ' HB2' HG23 ' A' ' 298' ' ' THR . 56.8 mt-30 -105.96 -2.46 22.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.653 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.85 32.44 21.27 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.033 0.444 . . . . 0.0 110.405 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.9 p -69.82 -14.31 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.841 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.73 46.36 94.64 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 119.869 -1.157 . . . . 0.0 113.363 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.545 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 49.2 mttp -122.68 33.97 5.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.4 m-85 -159.87 161.06 34.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.618 0.247 . . . . 0.0 111.544 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 55.7 m -140.99 159.94 41.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.09 0.472 . . . . 0.0 111.456 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.7 p90 -131.96 149.36 52.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 84.77 167.21 42.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.832 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.034 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -71.59 -55.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.0 111.065 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.7 pt-20 -47.31 -53.71 12.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.798 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 85.3 m-20 -64.27 -53.87 42.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.477 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.481 HG22 HD13 ' A' ' 312' ' ' LEU . 23.8 m -58.21 -40.03 80.57 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.668 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 1.034 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.9 mp -66.02 -47.52 74.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.834 0.35 . . . . 0.0 111.223 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 314' ' ' MET . 14.7 mttm -56.42 -49.98 72.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.19 68.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.737 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.2 OUTLIER -71.24 -27.64 63.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.57 -26.77 41.26 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.5 mmt -80.47 -9.06 59.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.771 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.23 45.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.458 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.61 -5.45 58.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.142 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.5 m -92.74 102.48 13.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.74 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.0 tt0 -59.4 -48.79 80.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.204 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.43 125.06 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.51 0.195 . . . . 0.0 111.362 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.606 ' HG ' HG23 ' A' ' 322' ' ' VAL . 23.6 tp -88.69 123.66 33.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -109.53 103.66 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.606 HG23 ' HG ' ' A' ' 320' ' ' LEU . 10.6 t -114.39 153.64 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.663 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 77.2 m-85 -99.94 142.18 31.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.474 . . . . 0.0 112.135 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.411 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 12.6 pt-20 -67.13 154.91 40.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.73 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.05 25.39 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 0.0 110.301 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 49.2 tp -52.41 128.89 27.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.719 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -91.02 22.23 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.481 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 374' ' ' LEU . 19.3 mm -124.41 135.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.62 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.02 161.97 36.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.642 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 47.3 ttt180 -91.5 118.78 30.88 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 110.892 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.1 m-85 -116.21 153.13 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 332' ' ' VAL . 16.1 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.145 0.498 . . . . 0.0 111.556 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.67 HD23 HD11 ' A' ' 346' ' ' LEU . 50.5 tp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.29 0.566 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -95.38 116.53 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.258 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.67 HD11 HD23 ' A' ' 344' ' ' LEU . 1.3 mm? -118.83 152.0 37.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.409 0.623 . . . . 0.0 112.156 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 40.7 p -100.44 173.82 3.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.337 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -45.61 -45.07 16.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.786 1.657 . . . . 0.0 112.01 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -59.95 -57.33 13.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -62.26 -49.91 73.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.5 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.43 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 9.1 tpp -118.51 134.36 23.48 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.473 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.5 Cg_endo -59.84 123.02 12.38 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 110.846 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.044 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -65.98 -44.08 85.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.845 HD11 ' CD1' ' A' ' 391' ' ' ILE . 56.3 tp -59.98 -50.0 75.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 47.3 mt-10 -60.57 -40.0 90.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.001 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.43 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 68.8 t-105 -67.51 -38.77 84.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.277 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.717 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.7 m-85 -73.47 -27.82 61.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.29 53.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.144 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -107.87 -16.61 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.819 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -129.82 21.4 5.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.5 p90 -61.83 -16.62 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.566 0.222 . . . . 0.0 111.572 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -83.46 -36.39 24.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.667 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -60.02 -39.92 87.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.633 ' CD2' HD23 ' A' ' 312' ' ' LEU . 42.9 m-85 -87.04 -5.95 58.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.179 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.73 2.71 46.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.188 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.66 162.27 18.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.871 ' HB ' HG23 ' A' ' 319' ' ' ILE . 76.0 m -107.11 100.91 10.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.29 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -66.85 102.33 0.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.596 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.71 134.2 52.26 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.845 ' CD1' HD11 ' A' ' 375' ' ' LEU . 30.9 mm -99.97 99.93 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 13.1 m -100.99 -171.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.776 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.663 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -160.04 156.44 26.98 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.008 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.491 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.4 p-10 -74.04 16.64 0.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -29.56 66.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.714 0.292 . . . . 0.0 111.411 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 17.2 m -97.3 169.66 9.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 111.385 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -59.93 -50.0 75.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.096 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.445 ' HG3' ' CA ' ' A' ' 288' ' ' GLY . 75.0 mm-40 -67.84 -40.43 83.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 110.121 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.99 -19.08 65.36 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.038 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.4 m -83.92 -23.47 31.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.754 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -70.53 -40.01 73.71 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.704 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.618 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.5 m-85 -60.03 -50.71 72.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.297 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 394' ' ' ASP . 73.8 t -56.51 -35.57 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.088 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -70.62 -49.86 43.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 110.35 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -73.5 -18.58 79.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.041 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.483 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.4 t80 174.47 -78.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.22 169.61 30.6 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.306 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.473 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.5 -49.04 2.97 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.244 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.4 OUTLIER -140.49 133.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 117.527 0.663 . . . . 0.0 112.624 -177.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -152.38 142.18 9.13 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.2 143.47 14.34 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.556 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.5 mt -104.26 128.87 57.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 30.0 mt -89.94 151.4 21.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.677 0.751 . . . . 0.0 112.494 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 415' ' ' TYR . 11.0 mtt180 -69.97 -38.47 76.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.866 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 97.8 m-85 -160.71 178.47 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.371 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.894 0.378 . . . . 0.0 110.282 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.729 0.299 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -66.45 -37.66 85.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.492 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -125.83 105.95 9.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -132.41 128.4 37.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -88.57 13.32 12.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.471 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.01 -3.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.043 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -58.84 -40.07 83.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.302 . . . . 0.0 110.555 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.43 -24.94 60.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.93 -35.56 75.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.511 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.91 -41.05 90.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.924 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -69.09 127.28 32.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.001 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.737 HD12 ' HD2' ' A' ' 285' ' ' LYS . 49.4 pt . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 120.875 0.369 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.524 ' OE1' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -48.15 -44.73 32.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.258 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.504 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 4.1 mp0 -71.66 -32.06 67.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.467 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -54.49 4.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.737 ' HD2' HD12 ' A' ' 281' ' ' ILE . 57.7 mttt -73.42 -57.99 3.62 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -54.88 41.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.767 0.318 . . . . 0.0 111.659 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' A' ' 402' ' ' PHE . 20.7 mt -59.96 -51.31 74.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.519 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.55 -36.23 88.64 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.012 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -59.98 -33.0 71.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.604 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.4 t80 -60.08 -45.58 92.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.63 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 32.3 m-85 -85.83 -36.85 19.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -60.04 -49.96 75.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.839 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.7 mp0 -66.29 -40.73 90.26 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.697 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.5 mt -60.0 -22.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -18.77 52.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.493 0.663 . . . . 0.0 109.62 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.6 mt-30 -101.41 0.21 36.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.828 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 57.73 29.89 18.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.965 0.412 . . . . 0.0 110.333 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.0 p -67.43 -11.53 58.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.828 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.25 53.4 45.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.402 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.0 mttt -130.34 36.66 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.878 ' CE1' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -160.86 162.39 32.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.695 0.284 . . . . 0.0 111.743 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.1 p -148.99 165.98 30.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.963 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.2 p90 -138.45 148.6 44.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.29 157.57 33.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.049 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.98 -58.68 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 110.662 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.0 -54.24 10.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.706 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 73.9 m-20 -63.67 -54.56 33.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.351 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.537 HG22 HD13 ' A' ' 312' ' ' LEU . 27.9 m -56.38 -37.91 70.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.897 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.972 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -69.7 -43.97 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.1 mttm -56.2 -52.62 63.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.67 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -26.2 63.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.79 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -69.18 -36.81 77.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 110.685 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -70.77 -25.36 62.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.6 mmt -82.58 -7.87 59.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.889 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.11 13.61 42.74 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.253 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.43 -7.13 59.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.941 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.866 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.2 m -97.86 106.73 19.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.857 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.1 tt0 -59.93 -50.26 74.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.748 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.5 mm -136.6 122.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.528 0.204 . . . . 0.0 110.776 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.9 tp -84.76 125.87 32.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.67 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -109.65 103.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.284 179.354 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.5 t -111.45 158.45 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.903 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 392' ' ' VAL . 9.8 m-85 -109.96 148.33 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.12 0.486 . . . . 0.0 112.196 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 391' ' ' ILE . 90.1 mt-10 -67.48 158.92 30.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.183 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.39 29.42 13.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.8 tp -57.87 127.23 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 109.999 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 347' ' ' THR . 34.3 p-10 -90.02 26.94 1.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 305' ' ' VAL . 29.8 mm -128.25 132.96 67.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.939 0.399 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 57.0 mtt -140.43 161.93 36.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.6 ttm180 -86.11 106.76 17.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.087 0.47 . . . . 0.0 110.757 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.537 ' CD2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -116.01 119.75 36.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.032 0.444 . . . . 0.0 111.662 -179.099 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 56.7 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.281 0.562 . . . . 0.0 111.738 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.576 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.4 p90 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.685 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.0 mm? -124.82 164.61 19.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.736 0.779 . . . . 0.0 113.009 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 p -101.83 171.26 5.5 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.803 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.1 Cg_exo -49.29 -42.39 40.52 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.98 1.787 . . . . 0.0 112.051 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.56 -50.22 72.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 21.6 mm100 -68.07 -48.81 64.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.591 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 94.2 mt-10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.301 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.863 0.363 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -115.17 120.09 37.42 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.783 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.662 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 7.5 Cg_endo -50.27 120.45 6.27 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.094 1.863 . . . . 0.0 111.107 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 328' ' ' ILE . 18.4 mt -61.9 -41.42 97.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.669 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.826 HD11 HD12 ' A' ' 391' ' ' ILE . 45.5 tp -60.0 -53.3 59.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 61.6 mt-10 -59.93 -40.01 87.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.039 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -66.92 -35.72 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.462 ' HE1' HD22 ' A' ' 312' ' ' LEU . 1.2 m-85 -69.5 -27.5 65.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.965 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -11.65 43.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.223 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.21 -9.74 15.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 14.7 m120 -130.0 18.24 5.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.7 p90 -67.89 -19.25 64.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 382' ' ' TYR . 33.1 mmtt -81.37 -40.93 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -61.49 -39.97 92.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.21 0.529 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 312' ' ' LEU . 17.3 m-85 -81.55 -8.18 59.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.287 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.0 2.79 48.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.363 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.866 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.23 164.55 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 111.15 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.882 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.6 m -107.56 102.7 11.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.15 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 391' ' ' ILE . 0.9 OUTLIER -65.15 103.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.115 0.483 . . . . 0.0 111.124 -178.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.524 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 6.1 mm-40 -109.43 127.57 54.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.953 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.826 HD12 HD11 ' A' ' 375' ' ' LEU . 42.0 mm -99.91 100.01 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 112.03 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 321' ' ' ILE . 21.9 m -113.71 141.36 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.447 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 13.1 p -121.09 164.44 16.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.832 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.65 80.66 0.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -112.87 -30.13 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.305 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 8.3 t -126.76 -172.95 2.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 67.9 mt-30 -59.97 -49.51 77.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 52.8 mp0 -59.96 -44.12 94.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.181 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.95 66.52 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 404' ' ' LYS . 68.9 m -84.01 -23.47 30.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.44 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 34.7 mt-30 -70.99 -43.95 66.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.529 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.578 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.5 m-85 -62.89 -48.03 80.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.09 -39.58 80.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.001 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 400' ' ' SER . 25.4 mtmt -70.37 -52.83 19.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.77 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -62.39 -22.35 63.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.931 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 18.0 t80 176.77 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.11 168.47 31.86 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.156 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.488 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.55 -47.69 2.76 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.39 133.38 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 117.847 0.824 . . . . 0.0 112.609 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.476 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -156.97 149.8 20.7 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -133.72 149.19 19.65 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.677 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 301' ' ' TYR . 20.1 mt -110.25 127.75 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 78.3 mt -84.84 150.62 24.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.646 0.736 . . . . 0.0 112.76 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.684 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 20.7 mtm180 -70.01 -32.18 70.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.363 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.543 ' HA ' ' HE2' ' A' ' 300' ' ' LYS . 53.2 p90 -159.45 179.51 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 298' ' ' THR . 1.2 tmm_? . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.264 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.6 0.238 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.41 -39.98 92.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.604 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.65 99.04 6.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -118.29 109.61 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.044 0.45 . . . . 0.0 111.179 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.57 -5.38 36.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.63 -13.52 0.67 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.207 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -55.17 -40.02 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -70.01 -32.56 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.374 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -59.98 -32.22 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.514 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.101 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.849 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 N--CA 1.461 0.09 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.629 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -57.67 -40.74 80.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 -179.23 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 21.3 pt-20 -73.22 -29.9 63.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.303 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -84.69 -56.67 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.92 -57.81 4.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.58 HD23 ' OE1' ' A' ' 282' ' ' GLN . 28.9 tp -57.45 -57.31 13.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.781 HG23 ' CE1' ' A' ' 402' ' ' PHE . 31.2 mt -59.94 -48.71 86.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.42 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.25 60.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.083 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.5 ttt180 -59.94 -40.11 87.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.614 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 6.6 t80 -57.39 -45.93 83.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.72 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -83.36 -38.25 22.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 111.564 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.7 t0 -62.03 -46.16 90.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.462 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.679 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.3 mt-10 -64.2 -42.94 96.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 301' ' ' TYR . 91.7 mt -60.45 -21.43 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.643 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -66.17 -13.93 61.02 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.256 0.551 . . . . 0.0 109.665 178.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.73 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.9 mt-30 -103.47 -0.73 29.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.469 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.01 28.18 17.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.2 p -67.64 -11.48 58.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.38 51.48 55.94 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.423 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.5 mttt -126.13 35.65 4.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.933 ' CE2' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -159.84 162.96 34.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.536 0.208 . . . . 0.0 111.267 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.5 164.69 30.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 53.0 p90 -138.02 149.03 45.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 90.1 155.56 31.17 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.083 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.55 -61.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -47.33 -52.31 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.43 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.3 m-20 -63.35 -55.77 21.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.398 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 35.7 m -57.82 -36.24 71.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.962 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.966 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.63 -43.12 77.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 52.3 mtmt -60.01 -45.43 92.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.556 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.06 66.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.813 0.339 . . . . 0.0 110.643 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.835 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -72.09 -26.92 62.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.25 -27.84 47.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 92.8 mmm -80.9 -8.5 59.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.585 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.9 16.89 49.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.275 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.95 -8.44 55.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.342 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.74 104.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.774 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.4 tt0 -59.64 -49.96 75.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.325 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.8 mm -136.7 124.05 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 322' ' ' VAL . 46.2 tp -87.92 126.05 34.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.201 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -111.53 104.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -122.4 162.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.435 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.627 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -106.88 144.34 33.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.729 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.51 -36.48 83.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.38 45.7 1.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.555 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 35.9 tp -79.11 122.58 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.47 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.652 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.2 m-20 -90.25 29.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.071 HG22 HD12 ' A' ' 374' ' ' LEU . 26.1 mm -126.92 133.18 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 111.567 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.701 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.7 mtt -140.19 162.08 36.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.877 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.512 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 17.1 tpt180 -86.6 111.47 20.66 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 38.8 m-85 -123.77 123.76 41.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.688 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 29.3 tp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.604 0.716 . . . . 0.0 112.684 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.12 127.34 37.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.896 178.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.538 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -122.09 165.09 16.62 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.9 p -101.6 169.88 7.16 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.306 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 5.3 Cg_endo -47.13 -49.88 12.01 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.024 1.816 . . . . 0.0 111.749 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -54.96 -53.59 53.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.38 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 26.6 mm100 -65.25 -46.09 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.64 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 87.7 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.124 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 3.9 tpt -119.07 130.26 24.94 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.672 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.6 Cg_exo -56.77 118.35 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.836 1.69 . . . . 0.0 110.835 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.071 HD12 HG22 ' A' ' 328' ' ' ILE . 32.4 mt -59.89 -41.23 91.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.935 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 391' ' ' ILE . 63.2 tp -60.01 -54.37 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.749 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 48.7 mt-10 -59.62 -40.03 86.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 109.564 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -60.24 -39.85 88.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.988 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -74.88 -27.37 60.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.588 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.61 -12.58 42.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.986 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -106.34 -13.7 15.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 76.4 m-20 -129.96 20.06 5.46 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.7 p90 -63.09 -16.1 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.584 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -83.31 -38.05 22.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -60.95 -38.02 84.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.766 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 381' ' ' ASN . 48.7 m-85 -85.95 -9.15 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.52 60.81 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.444 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.842 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.16 165.54 15.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.885 ' HB ' HG23 ' A' ' 319' ' ' ILE . 53.4 m -108.92 101.75 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.434 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -70.78 102.6 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.629 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.8 mm-40 -111.38 131.98 54.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.834 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 375' ' ' LEU . 38.0 mm -98.76 103.83 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 112.182 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.627 HG23 ' CE1' ' A' ' 323' ' ' TYR . 5.8 m -100.73 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.823 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 392' ' ' VAL . 1.3 p -157.94 154.0 27.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.07 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.462 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.5 p-10 -73.22 20.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -66.91 -40.03 87.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.635 0.255 . . . . 0.0 111.301 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 m -93.08 173.7 7.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.559 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.9 -50.11 75.08 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.9 -40.44 97.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.322 0.582 . . . . 0.0 109.648 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.462 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -61.93 -23.01 63.08 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 53.6 m -83.7 -23.11 31.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.092 -0.554 . . . . 0.0 110.483 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.23 -41.44 49.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.781 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.3 m-85 -60.0 -50.07 75.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.548 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 70.1 t -60.31 -39.96 82.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.563 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 400' ' ' SER . 1.4 mmpt? -71.14 -46.02 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.808 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -73.97 -31.02 60.41 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.595 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER -156.7 -83.36 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 99.39 148.63 23.31 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.995 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.527 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -47.09 2.97 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.607 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.36 134.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 118.336 1.068 . . . . 0.0 112.737 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.12 148.2 18.23 Favored Glycine 0 CA--C 1.511 -0.173 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.43 150.08 19.6 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.872 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.1 mt -109.5 126.8 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 42.3 mt -90.83 157.42 17.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.675 0.75 . . . . 0.0 112.776 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 415' ' ' TYR . 63.0 mtm180 -74.36 -40.03 62.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.531 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.481 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 85.1 m-85 -160.79 172.97 16.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.682 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.535 0.207 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.97 -39.92 87.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.27 37.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.547 ' O ' ' HG ' ' A' ' 434' ' ' LEU . 19.5 p90 -59.62 -50.05 75.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 40.72 31.06 0.11 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.109 0.48 . . . . 0.0 111.38 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 432' ' ' PHE . 54.9 mt -99.53 -1.41 38.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.275 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.04 -41.24 91.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.0 110.71 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.97 -33.16 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.496 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.0 -31.8 70.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.618 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.02 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.002 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.71 130.03 49.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.898 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.455 ' HB ' ' HE3' ' A' ' 285' ' ' LYS . 44.4 pt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.675 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 110.221 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.8 pt-20 -85.24 -34.33 22.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -72.0 -39.97 68.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.455 ' HE3' ' HB ' ' A' ' 281' ' ' ILE . 21.2 mttt -86.6 -58.23 2.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.548 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 29.7 tp -57.69 -55.88 29.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 112.03 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.71 HG23 ' CE1' ' A' ' 402' ' ' PHE . 42.3 mt -58.0 -48.41 84.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.725 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.488 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.39 -37.54 82.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.716 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 23.4 ttt85 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.657 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.2 t80 -56.98 -46.76 81.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -79.12 -40.01 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.756 0.312 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.0 t0 -61.65 -45.48 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.671 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 6.7 mt-10 -64.53 -41.76 96.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -60.33 -21.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.474 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -66.76 -12.67 59.65 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.373 0.606 . . . . 0.0 109.458 178.672 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.533 ' HB2' HG23 ' A' ' 298' ' ' THR . 39.4 mt-30 -103.5 0.06 30.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.577 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.53 20.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.628 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.7 p -68.03 -14.7 63.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.57 31.32 70.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.911 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.528 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 43.9 mtmt -110.38 37.07 2.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.452 0.168 . . . . 0.0 110.642 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.949 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.8 m-85 -158.97 159.98 35.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.866 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.445 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -139.36 157.74 45.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 111.09 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.409 ' HD1' ' H ' ' A' ' 303' ' ' PHE . 0.2 OUTLIER -136.5 124.55 22.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 110.665 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 109.8 147.34 11.71 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.75 -58.91 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 0.0 110.744 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.1 pt-20 -47.41 -54.72 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.34 -57.02 9.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.63 HG21 HG22 ' A' ' 409' ' ' ILE . 18.7 m -52.1 -33.29 38.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.045 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.759 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.3 mp -75.66 -40.07 56.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.701 0.286 . . . . 0.0 111.517 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 10.4 mtmt -57.49 -50.02 74.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.52 -28.01 63.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.648 0.261 . . . . 0.0 110.922 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.39 -30.76 66.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.054 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.407 ' OE2' ' CZ ' ' A' ' 385' ' ' PHE . 78.3 mm-40 -73.75 -25.22 60.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.6 mmt -83.04 -7.61 59.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.43 17.03 46.02 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.265 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.77 6.08 43.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.904 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.1 m -107.46 106.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.781 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.05 -49.97 75.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.629 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.78 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.7 tp -91.16 127.93 36.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.23 105.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.649 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -123.18 161.75 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.433 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.885 ' CE1' HG23 ' A' ' 392' ' ' VAL . 93.2 m-85 -109.67 146.04 35.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.915 0.388 . . . . 0.0 111.307 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.9 pt-20 -64.97 -30.03 71.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.334 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.17 48.5 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.456 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.3 tp -83.68 125.52 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.1 32.22 1.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.054 HG22 HD12 ' A' ' 374' ' ' LEU . 27.3 mm -129.5 137.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.0 162.08 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.373 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.555 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 22.1 ttt180 -94.12 124.62 38.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.09 0.471 . . . . 0.0 111.053 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 6.6 m-85 -121.08 158.12 28.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.43 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.542 -179.643 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.404 ' O ' HD22 ' A' ' 346' ' ' LEU . 55.9 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 112.063 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.527 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -88.47 117.05 27.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.06 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.536 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -118.83 156.4 29.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 22.0 p -100.59 169.4 7.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.8 Cg_endo -44.1 -45.57 11.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.87 -52.98 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -65.18 -50.02 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.7 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.509 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.585 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 3.1 p . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 121.178 0.513 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.712 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -119.12 126.88 26.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.105 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.712 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 11.2 Cg_endo -55.49 125.81 20.37 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.064 1.842 . . . . 0.0 110.69 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -65.43 -41.33 93.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 391' ' ' ILE . 61.6 tp -60.06 -53.81 53.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.1 mt-10 -56.88 -40.01 75.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.893 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.24 -35.25 75.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.267 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 6.6 m-85 -64.16 -32.14 73.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.696 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.67 -10.01 47.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.71 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -103.19 -0.09 30.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -138.97 16.14 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -67.45 -19.16 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.689 0.281 . . . . 0.0 111.112 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -78.58 -47.44 17.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.94 -45.9 91.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 110.702 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -73.73 -15.21 61.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.787 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.14 2.49 66.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.27 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.904 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.2 162.18 17.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.811 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.4 m -107.14 100.32 9.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.548 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.8 102.77 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.675 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 67.2 mm-40 -110.45 128.95 55.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.845 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.967 HD12 HD11 ' A' ' 375' ' ' LEU . 33.2 mm -95.2 104.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.203 0.525 . . . . 0.0 112.146 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.885 HG23 ' CE1' ' A' ' 323' ' ' TYR . 15.0 m -101.2 -169.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.923 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.502 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.97 156.6 27.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 111.823 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 400' ' ' SER . 9.7 t70 -64.44 -7.34 9.58 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.209 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -53.21 -41.65 65.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.7 m -87.51 167.44 13.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.689 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 27.2 tt0 -60.03 -53.32 59.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.601 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 41.1 mp0 -60.07 -35.43 75.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.495 0.664 . . . . 0.0 109.316 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -56.24 -58.13 15.78 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.704 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 3.4 m -59.44 -22.0 60.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.815 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 84.5 mt-30 -68.93 -40.05 79.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.82 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.6 m-85 -65.9 -50.8 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.461 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 80.6 t -55.8 -35.11 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 400' ' ' SER . 6.0 mmtt -77.12 -50.6 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.468 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -75.45 -27.28 63.81 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.816 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -157.86 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 99.6 153.3 27.59 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.753 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 82.32 -50.63 4.36 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.934 -0.65 . . . . 0.0 114.699 178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -149.06 133.23 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 117.837 0.819 . . . . 0.0 112.482 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 139.13 7.14 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -123.93 144.61 15.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.805 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.949 HG23 ' CE2' ' A' ' 301' ' ' TYR . 26.4 mt -106.63 128.73 61.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.1 mt -89.55 152.8 21.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.751 0.786 . . . . 0.0 112.82 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.03 -34.96 73.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.729 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 88.3 m-85 -156.84 164.68 37.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.4 mtm180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.258 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.712 0.291 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.01 -40.06 95.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 110.452 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -111.61 98.78 7.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.539 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.56 124.97 44.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.467 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.12 6.61 11.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.16 -3.85 6.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.963 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.23 -39.88 84.14 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.721 0.296 . . . . 0.0 110.772 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.61 -33.91 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.01 -34.55 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.251 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.98 -46.62 88.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.966 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.07 -39.92 87.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.878 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 3.4 pt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.828 0.347 . . . . 0.0 111.806 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -57.59 -35.82 70.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 -179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.525 ' O ' HD12 ' A' ' 287' ' ' ILE . 41.8 mt-10 -72.12 -31.43 66.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 398' ' ' GLU . 0.9 OUTLIER -83.79 -56.27 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.32 -179.262 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -57.66 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 22.0 tp -55.23 -58.21 8.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.784 HG23 ' CD2' ' A' ' 402' ' ' PHE . 82.5 mt -60.07 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.282 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.467 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.15 -39.02 57.37 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.269 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -60.05 -34.16 73.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.126 0.489 . . . . 0.0 110.279 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 19.0 t80 -59.92 -49.29 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.12 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -83.45 -38.31 22.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.53 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 295' ' ' SER . 43.3 t0 -64.18 -49.94 70.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.58 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 46.2 tp10 -61.26 -40.03 92.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 301' ' ' TYR . 88.2 mt -62.58 -26.33 40.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.841 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.77 -13.7 16.79 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.279 0.561 . . . . 0.0 109.944 178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -100.07 0.89 41.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.389 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.6 30.04 19.31 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 10.0 p -69.84 -10.04 56.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.21 51.14 57.79 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.43 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.1 mttt -130.25 40.67 3.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.877 -0.19 . . . . 0.0 110.6 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.854 ' CE1' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -161.69 163.57 29.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.38 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 p -145.15 160.38 41.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.43 126.76 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.649 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.554 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 109.38 153.25 14.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.331 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -55.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.861 0.362 . . . . 0.0 110.673 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.4 pt-20 -50.35 -51.03 49.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.19 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.38 -55.24 12.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.883 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.558 HG21 HG22 ' A' ' 409' ' ' ILE . 20.7 m -55.49 -37.56 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.225 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.95 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -69.61 -44.47 70.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.326 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.0 mttm -56.14 -50.03 72.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.24 65.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.936 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -70.72 -29.63 65.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.807 0.337 . . . . 0.0 110.616 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.54 -25.91 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 6.7 mmm -81.68 -8.6 59.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.853 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.12 11.57 32.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.343 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.47 59.77 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.4 0.28 . . . . 0.0 110.811 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.3 m -92.73 104.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.898 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.2 tp10 -59.55 -49.13 78.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 318' ' ' GLU . 31.3 mm -136.22 129.12 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' HG23 ' A' ' 322' ' ' VAL . 42.8 tp -94.08 127.85 40.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.222 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.571 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -114.48 108.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.09 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.646 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -124.45 161.97 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.435 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.81 ' CE1' HG23 ' A' ' 392' ' ' VAL . 89.4 m-85 -108.18 146.22 33.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.835 0.35 . . . . 0.0 111.312 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.9 pt-20 -63.62 -31.96 73.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.129 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -95.98 52.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.541 HD13 ' CA ' ' A' ' 408' ' ' GLY . 45.6 tp -85.65 123.91 31.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.21 27.72 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.963 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 374' ' ' LEU . 28.0 mm -127.15 134.83 65.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.104 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.8 mtm -139.99 161.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.669 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.0 OUTLIER -90.61 120.37 31.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.1 0.476 . . . . 0.0 111.218 -179.171 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 371' ' ' SER . 3.9 m-85 -118.3 157.23 27.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.172 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 332' ' ' VAL . 11.0 m . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.269 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 57.3 tp . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.383 0.611 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.514 ' HD2' HD12 ' A' ' 328' ' ' ILE . 5.9 p90 -100.67 118.28 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -123.52 163.8 20.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 20.0 p -101.09 168.68 8.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.789 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.6 Cg_endo -45.55 -43.61 17.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.409 2.072 . . . . 0.0 111.949 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.02 -57.09 14.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 18.6 mm100 -62.95 -49.64 73.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.957 0.408 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 4.2 tpt -112.62 127.25 27.08 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 13.6 Cg_endo -57.73 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.071 1.847 . . . . 0.0 110.971 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.057 HD12 HG22 ' A' ' 328' ' ' ILE . 19.4 mt -64.38 -40.07 95.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.866 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 59.5 tp -59.84 -53.59 56.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -58.6 -39.93 81.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.873 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.409 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 74.0 t-105 -64.88 -39.74 94.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.57 ' CD1' HD21 ' A' ' 320' ' ' LEU . 6.4 m-85 -64.1 -30.75 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.22 -12.31 38.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.779 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -102.35 -13.83 17.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 69.0 m-80 -129.71 17.07 5.81 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -64.82 -19.59 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.243 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -79.0 -44.24 22.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.32 -43.45 96.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.179 0.514 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.716 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.8 m-85 -76.02 -12.27 60.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.17 2.41 58.73 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.17 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.785 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.71 161.49 18.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.174 0.511 . . . . 0.0 110.556 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.858 ' HB ' HG23 ' A' ' 319' ' ' ILE . 73.5 m -106.59 100.72 10.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.261 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.9 tm? -71.81 104.75 3.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.373 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -113.78 129.92 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.738 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 34.2 mm -94.75 103.61 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.016 0.436 . . . . 0.0 111.968 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.81 HG23 ' CE1' ' A' ' 323' ' ' TYR . 26.5 m -100.86 -172.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.901 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -157.97 154.42 27.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.639 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.38 3.29 1.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.89 -40.01 87.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.589 0.233 . . . . 0.0 111.208 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -94.36 162.47 13.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.96 -55.26 28.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 60.0 mp0 -59.97 -40.0 87.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.27 -24.36 68.94 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -84.0 -25.45 29.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.543 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.36 -40.01 77.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.586 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.784 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -59.59 -49.54 77.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.449 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 90.9 t -57.71 -37.76 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.3 OUTLIER -69.97 -54.13 14.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.223 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.5 66.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.565 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.554 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 27.4 t80 179.93 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.83 164.59 29.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.774 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.541 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.56 -49.48 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.009 -0.615 . . . . 0.0 114.328 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.67 131.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 117.529 0.664 . . . . 0.0 111.924 -177.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.32 135.89 5.7 Favored Glycine 0 CA--C 1.51 -0.237 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -119.88 138.62 13.28 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.516 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.854 HG23 ' CE1' ' A' ' 301' ' ' TYR . 21.4 mt -100.87 129.0 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 31.4 mt -90.57 153.71 20.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.684 0.754 . . . . 0.0 112.527 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 65.3 mtt180 -70.02 -38.05 75.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.707 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 50.9 p90 -163.79 175.77 10.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.692 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.2 mtm105 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.576 0.227 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.07 -42.72 95.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 111.082 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -103.76 5.31 36.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.23 110.53 23.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 111.389 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -87.39 12.49 11.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.042 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 45.0 mt -70.82 -5.4 30.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.971 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -40.06 87.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -73.75 -23.88 59.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.99 -36.36 77.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.437 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.03 -47.87 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 40.7 pt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.944 0.402 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -53.83 -42.09 68.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.8 pt-20 -86.09 -25.08 26.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.553 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -84.1 -43.19 15.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.02 -58.45 2.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 27.1 tp -56.82 -56.45 21.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.678 -178.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.852 HG23 ' CE1' ' A' ' 402' ' ' PHE . 63.9 mt -60.03 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.537 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.469 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.32 -38.87 57.97 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.041 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -60.05 -32.2 70.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.03 0.443 . . . . 0.0 110.268 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 14.9 t80 -59.86 -46.0 90.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.094 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 291' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 41.3 m-85 -87.38 -40.14 14.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 71.4 m-20 -60.0 -44.25 94.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.475 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.667 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.8 tp10 -69.95 -39.74 75.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 301' ' ' TYR . 76.4 mt -63.82 -24.45 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.92 178.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -57.73 -17.52 15.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.096 0.474 . . . . 0.0 110.186 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.622 ' HB2' HG23 ' A' ' 298' ' ' THR . 11.2 mt-30 -100.48 2.99 42.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.737 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 30.0 18.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.011 0.434 . . . . 0.0 110.362 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.8 p -66.84 -11.79 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.32 52.3 54.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.65 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 40.1 mttt -131.12 39.78 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.804 -0.233 . . . . 0.0 111.214 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.852 ' CE2' HG23 ' A' ' 412' ' ' ILE . 76.6 m-85 -161.12 162.85 31.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 0.0 111.726 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.47 164.51 33.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 49.3 p90 -134.99 150.01 50.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.531 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 87.06 154.71 26.63 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.327 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.019 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -60.58 -62.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.983 -179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -43.31 -52.13 5.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.619 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.6 m-20 -64.83 -54.8 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.498 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.582 HG22 HD13 ' A' ' 312' ' ' LEU . 36.3 m -57.58 -37.18 72.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.907 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 1.019 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.1 -45.0 74.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mttm -58.12 -49.6 76.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.65 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.474 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.747 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -70.77 -30.1 66.5 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.891 0.377 . . . . 0.0 110.267 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.8 -27.57 58.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 12.8 mmt -80.0 -7.24 58.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.82 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 18.69 47.41 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.06 -1.066 . . . . 0.0 110.942 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -91.27 0.0 57.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.481 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.939 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.8 m -100.39 105.68 18.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 412' ' ' ILE . 12.0 tp10 -59.6 -50.04 75.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.39 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 388' ' ' THR . 24.4 mm -135.91 123.97 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.334 0.112 . . . . 0.0 111.214 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.4 tp -85.41 122.97 30.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 111.204 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -107.11 102.21 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.824 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 320' ' ' LEU . 25.4 t -114.08 162.01 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.326 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.632 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 37.9 m-85 -114.0 148.72 36.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.927 ' OE2' HG21 ' A' ' 391' ' ' ILE . 22.0 mm-40 -65.3 155.73 34.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.06 178.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 57.8 t30 56.95 28.94 15.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.265 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -57.16 126.63 28.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.3 m-20 -89.93 27.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.614 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.062 HG22 HD12 ' A' ' 374' ' ' LEU . 31.0 mm -126.43 137.68 57.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.629 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -139.52 161.13 38.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.743 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 11.0 ttt-85 -86.94 105.66 17.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 346' ' ' LEU . 5.9 m-85 -118.58 122.59 42.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.095 -179.372 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 39.4 tp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.319 0.581 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.632 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -94.41 128.35 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.986 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.2 mm? -119.07 148.16 43.34 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.7 p -100.86 173.74 3.45 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.868 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -48.29 -48.13 17.81 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 121.905 1.737 . . . . 0.0 113.16 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -71.75 -30.96 66.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -87.07 -49.3 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.068 0.461 . . . . 0.0 111.719 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.411 ' CD ' ' CZ ' ' A' ' 331' ' ' TYR . 1.3 tm-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.918 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.516 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 121.113 0.482 . . . . 0.0 111.624 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.468 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 6.1 tpt -117.82 132.08 23.82 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.627 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.631 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.4 Cg_exo -58.05 129.06 31.25 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.707 1.604 . . . . 0.0 110.133 178.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.062 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -69.14 -44.04 73.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 391' ' ' ILE . 33.0 tp -59.98 -53.43 57.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 44.0 mt-10 -58.04 -40.09 80.05 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.064 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.468 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 73.5 t-105 -67.21 -36.38 81.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.611 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.602 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 10.3 m-85 -70.04 -33.49 72.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.279 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.09 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.751 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.23 -12.95 14.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 377' ' ' TRP . 68.5 m-80 -134.11 19.94 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.602 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 53.1 p90 -64.47 -14.54 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -83.5 -35.04 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.72 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -39.81 87.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 312' ' ' LEU . 59.1 m-85 -82.37 -10.07 59.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.045 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.97 64.1 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.796 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.939 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.32 163.67 17.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.776 ' HB ' HG23 ' A' ' 319' ' ' ILE . 49.4 m -106.86 104.76 14.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.498 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 391' ' ' ILE . 1.2 tm? -65.16 102.41 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.116 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -115.92 107.79 15.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.933 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.927 HG21 ' OE2' ' A' ' 324' ' ' GLU . 27.6 mm -84.14 104.59 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.209 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.65 ' CB ' HD11 ' A' ' 287' ' ' ILE . 11.3 m -102.49 -172.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.078 -178.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 392' ' ' VAL . 0.7 OUTLIER -160.97 157.34 26.22 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.329 179.152 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 11.3 p-10 -69.98 19.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 393' ' ' THR . 23.7 mtpp -68.12 -40.04 82.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.652 0.263 . . . . 0.0 111.126 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 93.6 p -94.51 170.06 9.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 111.556 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.04 -45.51 92.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.687 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.469 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 33.6 mp0 -68.01 -40.54 82.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.382 0.61 . . . . 0.0 109.827 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.528 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.35 -19.67 60.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.293 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 400' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' A' ' 404' ' ' LYS . 65.6 m -84.02 -23.16 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.752 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 94.6 mt-30 -70.88 -41.47 71.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.807 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.0 m-85 -60.32 -46.33 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.082 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 394' ' ' ASP . 54.0 t -59.98 -37.84 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 400' ' ' SER . 22.1 mttm -66.94 -57.88 6.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.08 -52.56 42.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.834 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.531 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 50.4 t80 -151.91 -66.97 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.03 166.48 31.59 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.235 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.2 -49.2 2.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.041 -0.6 . . . . 0.0 114.404 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -143.97 134.4 21.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 117.697 0.748 . . . . 0.0 112.632 -177.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 145.22 12.18 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.97 144.26 15.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.287 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.8 mt -105.66 127.6 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 51.0 mt -87.85 153.49 21.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.64 0.733 . . . . 0.0 112.735 -177.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 58.8 mtp85 -69.83 -35.2 74.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.419 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 416' ' ' ARG . 50.9 p90 -171.3 179.63 2.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.683 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 432' ' ' PHE . 90.6 m-20 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -59.98 -46.68 88.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.126 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -123.17 18.27 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.4 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.467 ' HB2' ' CB ' ' A' ' 429' ' ' ASP . 81.6 m-85 -98.84 119.69 38.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.69 -9.89 56.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.516 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.6 mt -53.49 -13.24 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.389 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 429' ' ' ASP . 81.0 m-20 -57.04 -40.04 75.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.837 0.351 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -68.56 -35.19 77.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.02 -31.66 70.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.14 -46.71 88.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -59.99 -39.96 87.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.994 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.902 179.991 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 120.788 0.327 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.679 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -60.02 -39.48 85.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.512 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.501 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.69 -22.67 29.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.35 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -50.09 8.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.21 -58.33 3.35 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.502 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.74 -55.61 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.054 0.454 . . . . 0.0 111.975 -178.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.77 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.6 mt -59.55 -49.18 84.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.623 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.86 -37.0 75.49 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.9 ttt85 -60.01 -39.08 84.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.606 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.8 t80 -57.51 -45.19 85.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.669 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -79.45 -40.0 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.01 -47.44 85.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.697 -179.025 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.85 -43.3 99.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.067 0.46 . . . . 0.0 109.864 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -59.98 -24.6 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.648 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 178.798 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.599 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.4 mt-30 -107.27 1.59 23.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.443 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 57.95 31.13 20.19 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.998 0.428 . . . . 0.0 110.341 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -67.71 -11.93 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.858 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.08 48.56 78.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.511 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.1 36.3 4.33 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.32 160.06 34.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.95 164.99 33.99 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.35 164.86 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 0.0 110.928 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.21 167.84 34.37 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.226 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.792 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.91 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.213 -179.583 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.26 -52.43 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.872 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.6 m-20 -65.78 -57.44 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.13 -36.39 68.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.591 0.234 . . . . 0.0 110.974 -179.222 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.69 64.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.64 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.44 -50.01 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.609 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.84 -28.32 68.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.68 0.276 . . . . 0.0 111.027 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.37 -28.24 61.03 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -77.51 -26.93 51.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.28 -7.3 58.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.789 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.42 42.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.519 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.14 -2.27 58.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.313 0.245 . . . . 0.0 111.073 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.2 m -100.95 107.11 20.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.84 -50.03 75.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.327 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.7 mm -135.51 125.1 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.82 128.23 36.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.903 0.382 . . . . 0.0 111.305 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.74 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.636 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.63 162.21 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.405 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.859 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.1 m-85 -110.63 149.86 29.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.043 0.449 . . . . 0.0 111.687 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.53 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.83 -27.98 67.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.31 34.98 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.681 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.33 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.526 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.53 23.28 5.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.268 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.977 HG22 HD12 ' A' ' 374' ' ' LEU . 14.9 mm -120.89 135.5 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.401 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.54 161.47 36.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.336 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.19 120.04 31.03 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.488 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.11 155.26 29.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.723 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.04 0.448 . . . . 0.0 111.033 179.863 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.1 tp . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 121.177 0.513 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.4 p90 -101.0 120.1 39.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.645 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 1.079 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.48 156.37 37.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.83 168.12 9.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.34 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.89 -49.58 8.12 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.525 2.15 . . . . 0.0 112.303 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.0 -55.51 33.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.397 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 1.079 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.97 -53.19 60.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.376 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.619 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.6 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.85 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.945 0.403 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.99 124.16 30.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.44 120.92 9.16 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.945 1.763 . . . . 0.0 110.984 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 0.977 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.616 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.06 -51.44 69.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.77 -40.22 87.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.704 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.0 -40.03 94.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.809 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.1 -29.45 60.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.19 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.42 47.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.617 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -111.02 -9.31 14.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.74 19.84 5.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.5 p90 -69.99 -11.89 61.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.63 -38.3 21.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.99 -38.33 82.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.295 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.556 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -83.97 -10.43 57.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.63 1.26 52.7 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.644 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.75 165.15 17.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.74 100.23 9.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.338 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.93 102.22 2.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.648 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.7 mm-40 -107.82 128.01 54.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.928 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.6 mm -94.85 102.09 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 112.208 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.859 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.43 -169.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.817 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.7 p -154.89 151.55 28.7 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.021 0.439 . . . . 0.0 111.557 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.0 p-10 -71.08 1.43 5.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.319 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -60.03 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.283 . . . . 0.0 111.017 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.4 p -81.88 168.15 18.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.6 mt-30 -60.03 -54.79 41.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.8 -39.5 94.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.266 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.63 -59.7 9.34 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.593 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.92 -19.55 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.0 mt-30 -69.96 -40.03 75.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.914 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.47 -44.81 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.767 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.2 t -59.99 -45.23 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.423 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.79 -38.19 56.79 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -178.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.709 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.75 -94.52 0.48 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.192 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.06 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.818 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.53 -20.04 7.91 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.562 -1.304 . . . . 0.0 115.504 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.637 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.6 130.32 66.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.562 1.181 . . . . 0.0 111.765 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.67 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.48 151.05 19.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.735 -1.221 . . . . 0.0 114.105 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.0 mt -109.35 127.48 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.6 mt -88.23 153.33 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.52 0.676 . . . . 0.0 112.302 -178.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.528 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.2 mtt-85 -70.06 -36.75 75.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.605 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -160.92 170.59 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.611 0.243 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.13 -39.92 87.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.926 0.394 . . . . 0.0 110.337 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.37 91.29 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.208 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.5 -137.68 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.88 40.02 16.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 109.194 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -89.03 -0.25 57.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.338 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.02 87.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -68.0 -35.17 77.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.478 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.93 -34.14 71.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.079 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.09 -42.4 94.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -60.06 -40.01 88.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.845 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 5.6 pt . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.796 0.332 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.561 ' NE2' HG13 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -57.17 -37.34 71.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.533 . . . . 0.0 110.085 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.576 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 93.3 mt-10 -77.77 -28.58 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.899 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -83.99 -57.52 3.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -70.0 -58.23 4.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 319' ' ' ILE . 19.2 tp -57.26 -58.35 8.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.702 0.287 . . . . 0.0 111.509 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.716 HG23 ' CE1' ' A' ' 402' ' ' PHE . 30.4 mt -59.97 -49.65 83.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.152 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.28 -37.19 79.6 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.633 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -60.03 -35.79 75.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 110.282 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.578 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.6 t80 -60.0 -46.58 89.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.699 0.285 . . . . 0.0 111.614 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 295' ' ' SER . 38.0 t0 -63.67 -46.85 83.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.463 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 33.4 tp10 -64.74 -40.0 94.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 301' ' ' TYR . 81.8 mt -62.27 -26.1 39.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.29 -14.06 16.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.273 0.559 . . . . 0.0 109.865 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.807 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.2 mt-30 -98.36 -0.02 44.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.422 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.23 28.89 17.21 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.196 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.5 p -69.98 -10.03 57.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.067 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.29 52.62 46.2 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.525 178.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 11.8 mtpt -130.33 40.57 3.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.864 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.2 m-85 -162.54 165.25 26.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.106 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 2.0 p -149.7 164.31 35.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.716 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 52.7 p90 -136.98 151.89 49.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.082 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 88.3 155.45 29.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.445 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.949 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -61.55 -56.49 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.283 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -47.68 -56.9 6.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.591 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.2 m-20 -60.7 -54.98 38.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.667 0.27 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 409' ' ' ILE . 18.9 m -58.68 -40.04 82.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.932 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -67.69 -48.07 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -54.99 -56.53 18.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.144 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.23 -30.14 70.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.07 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.865 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.04 -28.44 62.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.796 179.39 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -76.93 -26.21 53.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 45.4 mmm -82.08 -8.53 59.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.851 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.75 14.22 42.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.263 -178.307 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.79 -5.96 59.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.394 0.278 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.2 m -99.1 105.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.611 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.3 tt0 -59.93 -49.97 75.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.3 mm -133.78 126.34 50.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.563 0.221 . . . . 0.0 111.185 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.9 tp -93.52 129.43 39.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 111.058 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 412' ' ' ILE . 1.1 mt -116.14 109.32 27.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 110.142 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.61 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.8 t -125.43 161.84 29.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 31.5 m-85 -108.14 146.94 31.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 111.168 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.644 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.62 -32.76 74.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -94.1 51.53 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -83.9 125.87 32.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.7 23.03 4.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.036 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -122.43 133.47 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.596 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.599 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.7 mtt -139.53 161.54 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 31.9 ttt180 -92.39 122.26 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 111.645 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.53 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 6.6 m-85 -120.7 159.02 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.22 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.362 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.693 HD23 HD11 ' A' ' 346' ' ' LEU . 32.4 tp . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.609 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -92.09 116.67 29.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.629 179.461 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.693 HD11 HD23 ' A' ' 344' ' ' LEU . 1.4 mm? -120.59 153.64 36.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 112.711 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.6 p -101.0 168.98 8.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.542 178.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.9 Cg_endo -41.24 -46.14 5.54 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.062 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.05 -54.92 41.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 350' ' ' GLN . . . . . 0.547 ' OE1' HD12 ' A' ' 346' ' ' LEU . 62.8 mt-30 -66.77 -48.35 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.523 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.1 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.535 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.7 p . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 121.137 0.494 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.8 tpt -114.22 129.86 24.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.599 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -59.1 118.35 5.22 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.204 1.936 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.07 -39.46 86.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.674 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -60.07 -54.08 50.24 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.958 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.537 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.0 mt-10 -58.12 -40.06 80.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.928 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -62.51 -39.89 94.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.376 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.684 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.66 -28.69 62.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.085 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.48 -9.74 48.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.33 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -104.86 -14.06 15.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.62 20.22 5.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -64.88 -18.94 65.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.739 0.304 . . . . 0.0 111.019 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -81.05 -39.96 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -64.77 -39.96 94.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.621 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.581 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.7 m-85 -80.02 -11.33 59.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.976 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.34 57.52 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.488 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.22 163.66 16.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.189 0.519 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 50.2 m -106.95 100.4 9.9 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.08 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.744 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -76.28 107.18 8.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.504 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 43.3 mm-40 -113.71 135.17 54.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.909 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -98.97 105.2 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 0.0 112.146 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.561 HG13 ' NE2' ' A' ' 282' ' ' GLN . 5.8 m -102.1 -169.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.239 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -158.25 153.37 25.49 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.175 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 394' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.0 t0 -77.91 69.97 4.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.295 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -114.56 -34.94 5.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.937 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.5 m -102.93 179.36 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 25.3 mm100 -60.01 -40.65 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 34.4 mp0 -69.49 -40.66 76.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.46 -21.06 61.97 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.271 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 52.3 m -84.2 -21.43 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.027 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 85.5 mt-30 -77.48 -41.69 38.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.779 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.716 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -67.31 -49.62 63.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.555 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 394' ' ' ASP . 72.3 t -60.03 -40.04 82.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.871 0.367 . . . . 0.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -79.86 -41.32 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.325 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.26 95.29 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -134.06 -84.74 0.43 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.018 -0.591 . . . . 0.0 109.713 178.928 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 148.32 41.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.563 -1.303 . . . . 0.0 115.138 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 126.61 -28.49 4.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 119.556 -1.307 . . . . 0.0 115.218 177.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.563 HG22 HG21 ' A' ' 308' ' ' THR . 0.8 OUTLIER -125.02 127.83 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.056 0.928 . . . . 0.0 111.913 -178.51 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.43 139.77 7.67 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.34 140.62 13.59 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.595 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.864 HG23 ' CE1' ' A' ' 301' ' ' TYR . 48.4 mt -101.9 127.29 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.164 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 53.9 mt -87.42 151.55 22.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 112.798 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 34.9 mtp-105 -78.77 -27.68 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.734 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.413 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 95.5 m-85 -151.99 170.06 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.958 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 429' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.99 -42.67 94.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.678 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 431' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 31.3 p90 -144.64 114.32 7.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 432' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 26.2 p90 -130.98 106.73 8.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 0.0 111.376 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.03 14.2 12.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.035 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.71 -3.86 27.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.774 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 110.641 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -69.8 -32.49 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -60.06 -33.2 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.03 -41.59 92.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.012 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.869 179.875 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.92 0.391 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.679 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.63 -39.99 86.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.592 -179.433 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.4 mt-10 -77.16 -29.91 54.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.228 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.7 -58.1 3.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.75 -54.7 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.0 mt -59.98 -48.47 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.572 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.474 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.33 -37.88 66.9 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.041 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 43.8 ttt180 -60.0 -39.2 84.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.166 0.508 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.8 t80 -55.63 -45.77 77.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.772 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.32 -39.24 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.737 0.303 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.9 t0 -59.97 -43.25 95.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.381 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 293' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.17 -42.32 84.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.2 -23.88 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.57 178.642 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.02 -15.47 56.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.203 0.525 . . . . 0.0 110.048 178.847 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.86 2.12 29.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.596 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.25 29.73 18.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.962 0.41 . . . . 0.0 110.57 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.8 p -66.75 -13.02 60.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.9 49.18 73.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.402 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.635 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.4 36.8 4.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 159.99 34.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.337 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -140.95 161.2 38.4 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.11 144.85 47.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.29 157.0 29.1 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.908 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.06 -55.82 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 0.0 111.166 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -47.31 -57.24 5.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.943 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.12 -54.85 39.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.712 0.291 . . . . 0.0 111.452 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.0 m -56.56 -40.02 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.832 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.86 -45.23 78.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.566 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.3 mtmt -56.66 -50.04 73.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.998 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.85 -27.32 61.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.53 74.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.886 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.56 -24.35 61.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.8 -7.96 59.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.092 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.07 10.94 36.02 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.561 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -79.96 -6.19 57.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.441 0.296 . . . . 0.0 110.79 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.9 m -95.79 105.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.64 -50.0 75.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.9 mm -136.64 126.5 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.534 0.206 . . . . 0.0 111.41 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.9 tp -89.72 126.48 35.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.972 0.415 . . . . 0.0 111.467 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 321' ' ' ILE . . . . . 0.777 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.56 103.6 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.286 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.4 t -122.33 152.66 26.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.476 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.5 m-85 -98.42 142.95 29.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.411 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 324' ' ' GLU . . . . . 0.642 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.36 -24.05 67.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.835 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.28 33.35 1.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 326' ' ' LEU . . . . . 0.492 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -71.2 123.91 23.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.699 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -96.57 28.7 3.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.724 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.58 133.19 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 329' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.3 mtt -140.62 162.53 35.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.161 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.58 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.17 29.72 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.244 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.74 28.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.496 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.872 0.368 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 345' ' ' TYR . . . . . 0.901 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -84.96 137.09 33.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.183 178.861 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.68 164.1 22.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.635 0.731 . . . . 0.0 112.475 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.56 172.05 4.79 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.283 178.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 74.0 Cg_exo -48.94 -47.52 21.2 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 121.755 1.637 . . . . 0.0 111.768 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.17 -58.46 8.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.04 -48.95 79.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.112 0.482 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.56 121.92 32.5 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.72 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.57 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.57 120.84 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.782 1.655 . . . . 0.0 110.784 178.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 374' ' ' LEU . . . . . 1.008 HD12 HG22 ' A' ' 328' ' ' ILE . 20.9 mt -59.94 -44.16 94.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.259 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 68.9 tp -60.06 -50.79 72.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.97 85.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.673 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 377' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.26 -43.77 95.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.6 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.7 m-85 -73.68 -30.68 63.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.19 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.36 -25.09 60.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.539 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.69 -6.56 14.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.33 20.25 5.75 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.565 0.221 . . . . 0.0 111.349 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.35 -40.43 30.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.919 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.16 -36.37 77.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.49 -4.18 59.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.399 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.71 3.06 32.3 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.519 -179.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.72 166.31 13.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 388' ' ' THR . . . . . 0.801 ' HB ' HG23 ' A' ' 319' ' ' ILE . 58.1 m -109.13 100.57 9.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.003 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.756 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.35 102.36 1.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.679 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.77 130.03 55.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.4 mm -95.91 103.87 15.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.057 -178.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 392' ' ' VAL . . . . . 0.615 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.47 -171.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.173 -178.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.519 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.59 155.33 26.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.198 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.49 11.37 0.63 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.208 -179.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.02 94.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.676 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.4 m -92.06 170.91 9.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.844 0.354 . . . . 0.0 111.389 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.8 mt-30 -60.12 -54.35 46.93 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.545 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 398' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -59.99 -40.02 87.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.496 0.665 . . . . 0.0 109.467 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.11 -57.64 15.89 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.776 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.9 -19.44 51.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 401' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.42 -40.04 77.53 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.915 0.388 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 402' ' ' PHE . . . . . 0.749 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.97 -46.56 89.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.497 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.2 t -59.91 -34.08 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.017 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.24 -54.11 19.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.271 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.72 -20.56 70.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.939 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.2 t80 174.95 -75.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.41 167.86 28.88 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.705 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.73 -51.53 3.76 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.846 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.56 131.78 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.293 0.547 . . . . 0.0 112.234 -178.199 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 410' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.75 141.06 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.514 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.73 145.86 15.93 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.867 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.16 128.5 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.9 mt -90.66 153.15 20.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.72 0.771 . . . . 0.0 112.807 -177.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.0 -37.91 75.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.597 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 415' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 82.3 m-85 -158.24 -177.89 6.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.77 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 110.846 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.0 -41.09 91.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.4 99.12 5.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -116.71 117.07 28.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.83 -0.69 24.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.9 mt -50.96 -19.38 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.927 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -59.69 -40.02 86.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.396 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -74.88 -24.2 58.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.61 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.07 -38.43 82.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.003 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.06 -46.35 89.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.919 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.02 -39.95 87.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.869 -179.895 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.618 HD21 ' N ' ' A' ' 277' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.781 0.324 . . . . 0.0 111.273 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -65.75 -29.23 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.359 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -53.22 -40.56 64.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.521 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -62.71 -47.27 84.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.753 0.311 . . . . 0.0 111.19 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 42.7 pt -81.98 -23.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.533 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.98 -41.17 91.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.376 0.607 . . . . 0.0 109.857 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.678 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 2.1 mp0 -80.29 -42.08 23.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.33 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -70.01 -39.99 75.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -58.41 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 18.0 tp -58.93 -55.94 28.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.891 0.377 . . . . 0.0 111.318 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 47.1 mt -60.99 -49.91 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.806 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.47 -38.78 58.56 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 20.6 ttt85 -60.03 -37.64 80.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 110.277 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.5 t80 -55.79 -47.46 77.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.938 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 34.8 m-85 -83.63 -38.73 21.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.9 t0 -60.33 -42.75 96.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.522 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.674 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.0 mt-10 -69.47 -43.3 73.48 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 301' ' ' TYR . 89.9 mt -59.55 -23.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.85 -12.88 53.32 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.22 0.534 . . . . 0.0 109.911 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 69.5 mt-30 -103.72 -0.01 29.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.466 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.24 30.29 20.01 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.6 HG23 ' HB2' ' A' ' 296' ' ' GLN . 6.5 p -67.21 -14.15 62.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.022 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.0 48.9 83.63 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.783 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.52 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 7.0 ttpt -130.22 37.1 3.92 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.4 m-85 -161.09 161.48 31.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.42 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 160.25 42.53 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.459 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 52.5 p90 -135.52 130.63 34.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 406' ' ' PHE . . . 106.83 150.9 17.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.982 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -54.61 -60.8 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.33 . . . . 0.0 111.028 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.9 pt-20 -47.4 -54.69 10.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.388 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.55 -54.57 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.518 HG21 HG22 ' A' ' 409' ' ' ILE . 22.1 m -56.21 -37.92 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.098 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.851 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.8 mp -69.93 -41.57 74.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.323 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 20.3 mtmt -58.88 -49.91 75.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.36 -26.16 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.289 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.883 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.32 -25.96 58.26 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 77.3 mm-40 -77.52 -28.08 51.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 78.5 mmm -79.99 -7.33 58.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.403 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.29 20.68 44.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.138 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.68 7.69 44.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.598 -0.301 . . . . 0.0 111.457 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 387' ' ' ALA . 31.0 m -107.27 107.2 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 121.038 0.446 . . . . 0.0 112.002 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.84 ' O ' HD13 ' A' ' 319' ' ' ILE . 11.2 tp10 -59.95 -50.76 72.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.3 mm -135.74 125.75 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.653 0.263 . . . . 0.0 111.425 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.2 tp -92.52 128.65 38.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.968 0.413 . . . . 0.0 111.219 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -115.1 107.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.089 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.603 HG23 ' HG ' ' A' ' 320' ' ' LEU . 7.6 t -123.51 163.19 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.935 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.908 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -110.9 149.23 30.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.764 ' CD ' HG21 ' A' ' 391' ' ' ILE . 49.1 mm-40 -59.37 -50.06 75.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.2 53.22 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.381 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 409' ' ' ILE . 31.4 tp -78.88 123.29 27.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -89.61 23.84 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 305' ' ' VAL . 15.8 mm -127.43 134.59 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.687 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.583 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 53.5 mtt -140.36 161.73 36.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.9 ttt180 -89.23 121.06 31.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.049 0.452 . . . . 0.0 111.303 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 4.6 m-85 -121.43 157.11 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.965 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.988 HG12 HD12 ' A' ' 343' ' ' ILE . 3.9 m -120.84 108.37 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.744 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.7 mm? -99.15 145.57 27.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 17.3 m170 -91.17 -177.04 4.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 9.1 t -113.55 160.74 18.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -60.1 -40.01 88.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.56 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -97.85 -5.05 57.68 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.734 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.9 p 75.17 -171.13 0.1 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.62 0.368 . . . . 0.0 110.769 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 60.54 24.71 14.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.659 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -160.11 122.3 3.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.958 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.86 138.34 49.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.644 ' C ' HD13 ' A' ' 343' ' ' ILE . 4.9 tmtm? -120.06 140.3 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.988 HD12 HG12 ' A' ' 332' ' ' VAL . 6.7 mm -119.02 116.27 50.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.159 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.607 HD23 HD11 ' A' ' 346' ' ' LEU . 49.9 tp -131.88 156.56 45.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.368 0.604 . . . . 0.0 111.957 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.557 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -94.04 118.86 32.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.601 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 344' ' ' LEU . 1.5 mm? -121.18 159.75 25.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 14.4 p -101.77 171.33 5.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.381 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.6 Cg_exo -47.38 -43.58 26.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.737 1.624 . . . . 0.0 111.89 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.88 -54.96 41.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.191 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 83.1 mt-30 -67.61 -46.29 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 94.5 mt-10 -61.21 -31.44 71.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -57.65 -34.82 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.286 0.565 . . . . 0.0 109.946 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.7 t0 -87.17 62.76 7.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.256 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.547 ' HG3' HD23 ' A' ' 368' ' ' LEU . 28.8 tttt -68.78 -45.11 72.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 94.1 p -59.97 -53.56 56.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.719 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 56.9 m80 -86.32 -48.63 8.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.627 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.744 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.4 OUTLIER 53.41 11.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.863 0.364 . . . . 0.0 110.336 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.642 HG22 ' H ' ' A' ' 359' ' ' ASP . 0.7 OUTLIER -106.68 -169.85 1.62 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.202 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.642 ' H ' HG22 ' A' ' 358' ' ' THR . 87.3 m-20 -130.66 133.2 45.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.96 -2.44 12.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.301 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -101.33 -28.26 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.4 t -117.46 -36.46 3.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.154 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 77.37 39.94 25.0 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.711 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.42 ' C ' HG23 ' A' ' 358' ' ' THR . 23.7 mt-30 -52.66 -169.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -131.07 83.48 2.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.817 0.341 . . . . 0.0 110.83 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -130.02 137.36 50.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.412 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 43.6 mt-10 -140.97 102.63 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.78 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.74 HD11 ' O ' ' A' ' 370' ' ' GLU . 51.9 tp -72.33 132.1 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.174 0.511 . . . . 0.0 112.146 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.682 HD13 ' C ' ' A' ' 368' ' ' LEU . 3.4 mm -113.5 -44.12 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.56 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.74 ' O ' HD11 ' A' ' 368' ' ' LEU . 36.8 tt0 -139.99 163.04 33.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.125 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.515 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.7 p -147.42 119.74 8.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.252 0.549 . . . . 0.0 111.536 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 19.2 tpp -115.46 128.81 25.64 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.623 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.583 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 36.5 Cg_exo -59.77 120.0 7.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.011 1.807 . . . . 0.0 111.108 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.982 HD13 HG11 ' A' ' 305' ' ' VAL . 14.3 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.749 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 391' ' ' ILE . 63.1 tp -60.07 -51.96 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.4 mt-10 -60.02 -39.92 87.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.031 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -62.58 -40.02 95.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -71.07 -25.84 62.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.49 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.91 -9.99 49.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.761 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -108.75 -9.18 15.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.23 18.0 5.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.36 -18.72 65.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.665 0.269 . . . . 0.0 111.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -83.02 -42.23 17.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.758 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.85 -40.1 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 312' ' ' LEU . 38.0 m-85 -82.75 -10.25 58.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.28 2.41 53.92 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.498 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.48 162.49 18.92 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 319' ' ' ILE . 98.3 m -106.64 100.56 10.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.98 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.971 HD11 HD11 ' A' ' 391' ' ' ILE . 2.0 tm? -72.33 101.95 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.577 ' HG2' HG22 ' A' ' 388' ' ' THR . 19.7 mm-40 -111.36 118.17 35.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 375' ' ' LEU . 20.5 mm -88.66 108.96 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.042 0.448 . . . . 0.0 111.889 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.908 HG23 ' CE2' ' A' ' 323' ' ' TYR . 15.6 m -101.75 -170.68 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.25 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -154.53 151.59 29.07 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -70.73 12.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 0.3 OUTLIER -64.7 -39.99 94.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.633 0.254 . . . . 0.0 111.644 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.9 m -92.05 170.6 9.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.386 . . . . 0.0 111.78 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -60.02 -48.83 80.1 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 44.3 mp0 -63.95 -39.99 95.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.372 0.606 . . . . 0.0 109.517 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.42 60.38 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.15 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.6 m -84.23 -22.24 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.631 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.533 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 79.6 mt-30 -73.87 -43.36 58.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.8 m-85 -60.01 -41.98 93.31 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.924 0.392 . . . . 0.0 110.357 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.77 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 54.6 t -60.0 -39.98 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -72.55 -42.8 64.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.953 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.62 98.74 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.374 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CD1' ' HA2' ' A' ' 304' ' ' GLY . 59.9 t80 -148.79 -67.14 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 125.03 57.88 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 119.842 -1.171 . . . . 0.0 115.095 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.75 -35.41 2.0 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.399 -1.382 . . . . 0.0 115.277 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.758 HD11 HD11 ' A' ' 326' ' ' LEU . 0.6 OUTLIER -136.13 134.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.883 0.841 . . . . 0.0 112.904 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -154.53 148.14 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.48 147.15 17.74 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.694 -1.241 . . . . 0.0 114.031 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 46.6 mt -108.72 126.39 65.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 50.4 mt -86.42 151.69 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 112.303 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.4 mtm180 -67.5 -38.69 84.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 417' ' ' VAL . 96.6 m-85 -160.57 170.02 21.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -57.22 124.18 17.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 415' ' ' TYR . 32.9 m -126.97 153.97 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.84 -0.37 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 58.91 170.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.684 0.278 . . . . 0.0 110.692 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.449 ' HA ' ' H ' ' A' ' 427' ' ' GLY . 30.2 mt-30 -118.79 142.46 47.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.938 0.399 . . . . 0.0 111.139 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.682 ' HA3' ' HG2' ' A' ' 425' ' ' GLN . . . 160.0 -139.13 5.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.611 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' HB3' ' A' ' 425' ' ' GLN . 9.8 mmt -76.25 -168.62 0.98 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.775 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 424' ' ' TYR . 15.2 pt-20 -60.02 -49.21 78.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.522 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.444 ' N ' ' HG3' ' A' ' 423' ' ' GLU . 64.8 t80 -77.9 -35.0 51.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.437 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.682 ' HG2' ' HA3' ' A' ' 421' ' ' GLY . 11.9 tp60 -60.0 -39.94 87.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.589 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 150.19 -98.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.968 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 421' ' ' GLY . . . -75.15 -144.96 1.16 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 421' ' ' GLY . 95.3 m-20 -141.27 22.9 2.2 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.755 0.312 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.522 ' O ' ' HD1' ' A' ' 432' ' ' PHE . 95.9 m-20 -107.9 24.46 12.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.625 ' HB2' ' HA2' ' A' ' 421' ' ' GLY . 6.9 tm-20 -59.99 -40.05 87.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 110.345 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 26.7 p90 -96.92 67.68 2.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.522 ' HD1' ' O ' ' A' ' 429' ' ' ASP . 37.1 p90 -90.03 110.47 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.69 -2.61 30.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.719 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.65 -18.65 4.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.857 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.96 -39.97 87.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 0.0 110.587 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.68 -23.83 60.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.704 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.9 -37.56 79.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.251 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.03 -45.36 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.889 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.011 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 75.5 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.884 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -60.07 -29.94 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.3 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -51.54 -40.02 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.01 -50.04 75.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.667 0.27 . . . . 0.0 111.241 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt -82.91 -23.51 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.849 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.677 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -59.94 -39.54 85.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.555 -179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.67 -22.69 29.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.324 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -50.01 8.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.27 -58.33 3.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.501 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.72 -55.66 31.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.942 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.7 mt -59.48 -49.22 84.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.436 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.89 -37.03 75.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.084 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.8 ttt85 -59.93 -39.09 84.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.309 0.576 . . . . 0.0 110.049 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.607 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.9 t80 -57.56 -45.18 85.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.63 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -79.47 -39.94 31.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.07 -47.48 85.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.602 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.82 -43.29 99.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.039 0.447 . . . . 0.0 109.872 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -60.04 -24.54 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.664 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.16 0.505 . . . . 0.0 109.911 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.5 mt-30 -107.27 1.55 23.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.465 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 57.95 31.13 20.18 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.341 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.4 p -67.64 -11.97 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.845 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.6 78.09 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.535 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.12 36.3 4.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.33 160.02 34.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.087 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.91 165.07 33.7 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.821 0.344 . . . . 0.0 111.231 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.47 164.82 28.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.18 167.82 34.28 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.234 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.88 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.214 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.25 -52.49 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.843 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.8 m-20 -65.73 -57.42 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.15 -36.42 68.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.951 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.67 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.601 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.43 -50.07 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.8 -28.28 68.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 111.037 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.51 -28.13 60.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.84 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -77.51 -26.99 51.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.21 -7.33 58.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.776 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.44 42.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.467 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.12 -2.24 58.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.287 0.235 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.0 m -100.98 107.1 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.86 -50.01 75.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.33 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -135.5 125.12 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.77 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.8 128.25 36.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.275 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.76 105.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.742 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.635 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.64 162.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.371 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.857 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.2 m-85 -110.67 149.93 29.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.471 . . . . 0.0 111.674 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.92 -27.96 67.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.3 35.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.32 19.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.53 23.35 5.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.236 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.978 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -120.93 135.48 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.41 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.5 161.45 37.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.44 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.618 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.14 120.08 31.01 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.169 0.509 . . . . 0.0 111.468 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.14 155.22 29.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.734 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.049 HG12 HD12 ' A' ' 343' ' ' ILE . 9.6 m -117.77 110.96 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.766 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.4 mp -97.52 142.33 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.927 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.575 ' CE1' HG12 ' A' ' 369' ' ' ILE . 1.0 OUTLIER -82.32 176.43 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.049 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 340' ' ' GLU . 21.6 p -103.36 162.4 13.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -47.58 -28.94 2.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.037 0.446 . . . . 0.0 110.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.58 -119.62 4.54 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.743 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.56 22.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.827 0.313 . . . . 0.0 111.756 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.9 43.34 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 111.451 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.405 ' HB3' ' SG ' ' A' ' 335' ' ' CYS . 14.2 tt0 -169.15 130.0 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.929 0.395 . . . . 0.0 110.274 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -115.4 140.42 49.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.168 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 343' ' ' ILE . 8.4 ttpt -121.54 145.48 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.049 HD12 HG12 ' A' ' 332' ' ' VAL . 6.6 mm -123.17 119.66 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.9 tp -128.15 161.76 28.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.162 0.506 . . . . 0.0 111.744 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.5 p90 -100.96 120.05 39.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.651 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 1.077 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.43 156.33 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.8 168.11 9.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.368 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.85 -49.63 8.01 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.313 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.95 -55.56 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.392 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 1.077 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.94 -53.17 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.5 mt-10 -49.67 -33.14 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.827 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.1 mmmm -59.98 -28.3 67.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.179 0.514 . . . . 0.0 110.486 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.628 ' HB2' ' CE1' ' A' ' 356' ' ' HIS . 0.0 OUTLIER -82.07 16.56 1.89 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.654 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.719 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 8.5 ptmm? -55.58 -23.29 26.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 85.6 p -59.96 -44.94 94.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.67 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.628 ' CE1' ' HB2' ' A' ' 353' ' ' ASP . 23.9 p-80 -107.79 -41.97 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.228 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.766 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.42 5.1 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.866 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.806 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.6 m -86.89 178.09 7.08 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.99 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.656 ' HB2' HG22 ' A' ' 362' ' ' THR . 93.2 m-20 -132.97 135.64 45.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -72.44 -0.16 11.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.073 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -104.35 -15.37 15.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.643 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.5 t -133.47 -37.76 0.94 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.767 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.55 7.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.77 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.806 ' C ' HG23 ' A' ' 358' ' ' THR . 14.0 pt20 -86.53 88.15 7.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.151 0.501 . . . . 0.0 110.624 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -64.27 129.91 41.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.664 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 86.5 m-70 -143.85 167.55 22.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.205 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -145.33 113.93 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.323 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.664 HD11 ' O ' ' A' ' 370' ' ' GLU . 58.5 tp -70.29 133.17 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 111.021 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.7 mp -106.53 -40.12 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.664 ' O ' HD11 ' A' ' 368' ' ' LEU . 38.7 tt0 -152.12 166.16 32.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.568 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -145.35 117.04 8.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.845 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.91 124.13 30.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.656 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.41 120.95 9.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.0 1.8 . . . . 0.0 110.982 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.978 HD12 HG22 ' A' ' 328' ' ' ILE . 14.3 mt -60.23 -42.3 94.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.595 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.04 -51.39 69.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.665 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.91 -40.17 87.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.685 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.01 -39.96 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.837 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.2 -29.4 60.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.125 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.39 47.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.598 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.11 -9.33 14.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.67 19.84 5.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -70.0 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.61 -38.35 21.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -59.93 -38.33 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.301 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.555 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -84.01 -10.43 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.62 1.28 52.7 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.654 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.76 165.12 17.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.428 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.72 100.27 9.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.3 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.92 102.2 2.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.854 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.649 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.8 mm-40 -107.86 128.01 54.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.873 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.5 mm -94.85 102.11 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 112.182 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.857 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.47 -169.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.769 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.6 p -154.86 151.54 28.72 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.055 0.455 . . . . 0.0 111.506 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.1 p-10 -71.04 1.43 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.303 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -59.94 -40.1 87.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 111.035 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.3 p -81.83 168.13 18.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.7 mt-30 -60.0 -54.81 41.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.84 -39.43 94.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.66 -59.74 9.3 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.6 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.58 12.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.1 mt-30 -69.97 -40.05 75.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 110.909 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.39 -44.9 93.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.764 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.4 t -59.99 -45.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.708 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.74 -38.19 56.96 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.707 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.7 -94.56 0.48 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.09 0.02 OUTLIER Glycine 0 CA--C 1.522 0.523 0 C-N-CA 119.642 -1.265 . . . . 0.0 114.853 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.51 -20.07 7.92 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.522 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.636 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.59 130.38 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 118.574 1.187 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.69 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.54 151.11 19.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.031 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.4 127.47 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -88.22 153.32 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 112.286 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.4 mtt-85 -70.04 -36.81 75.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.565 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.431 ' O ' HG13 ' A' ' 417' ' ' VAL . 8.7 m-85 -160.91 170.54 20.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -58.01 127.99 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.963 0.411 . . . . 0.0 110.721 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.97 159.87 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.908 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -87.16 132.25 33.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.0 136.91 50.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -59.96 130.65 47.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -66.18 147.18 49.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.7 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -149.9 170.11 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.01 -40.98 91.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.96 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.807 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.65 140.01 58.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.97 0.48 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.524 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -141.55 130.16 4.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.391 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.37 -39.97 89.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.079 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -115.47 24.16 11.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.09 -39.92 87.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.356 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.43 91.18 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.191 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.4 -137.62 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.87 39.95 16.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.96 -0.28 57.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.391 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.07 -39.94 87.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 110.518 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -68.07 -35.19 77.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.418 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.96 -34.06 71.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.082 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.13 -42.43 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.01 -40.01 87.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.889 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.651 0.262 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.1 p -76.62 -29.98 18.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.153 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -48.19 -47.88 35.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.768 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.92 75.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.08 -20.75 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.92 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.707 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 2.0 tm0? -58.85 -39.97 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.831 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 50.4 mt-10 -78.96 -30.0 44.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -53.46 5.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -72.63 -58.38 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.885 ' HG ' HD13 ' A' ' 321' ' ' ILE . 46.7 tp -55.13 -60.86 2.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 111.55 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.824 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.7 mt -59.94 -50.05 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.26 -38.92 57.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.25 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.1 ttt-85 -60.05 -39.95 87.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.281 0.563 . . . . 0.0 110.272 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.602 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 10.2 t80 -57.12 -48.55 78.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.749 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -80.01 -38.49 31.96 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -60.63 -47.89 84.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.7 mt-10 -62.91 -44.49 95.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 301' ' ' TYR . 96.5 mt -59.62 -24.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.463 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.47 -13.8 59.58 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.648 ' HB2' HG23 ' A' ' 298' ' ' THR . 58.4 mt-30 -103.37 -0.16 30.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.54 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.59 30.99 20.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.5 p -69.43 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.864 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.24 49.2 74.26 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.342 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 41.2 mttt -128.61 36.3 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 88.0 m-85 -159.75 160.74 34.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.309 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 19.3 m -140.5 160.03 40.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.14 0.495 . . . . 0.0 111.391 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.411 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -137.79 127.13 24.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.914 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 107.76 152.83 17.58 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.022 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -58.94 -55.48 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 0.0 111.174 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -49.35 -56.46 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.42 -52.37 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 409' ' ' ILE . 18.5 m -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.09 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.988 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.7 mp -67.25 -43.79 81.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.701 0.286 . . . . 0.0 111.28 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 314' ' ' MET . 20.7 mtmt -60.01 -47.62 85.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.4 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -27.81 65.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.431 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.77 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.7 -26.59 59.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 78.3 mm-40 -77.92 -28.9 49.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 94.3 mmm -80.84 -7.3 59.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.726 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.52 14.28 27.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.701 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.8 -9.76 59.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.617 0.246 . . . . 0.0 110.9 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.27 105.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.665 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.2 tt0 -60.01 -50.01 75.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.563 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.6 mm -135.58 125.99 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.746 ' HG ' HG23 ' A' ' 322' ' ' VAL . 56.4 tp -90.96 126.14 35.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.885 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -113.13 105.95 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.814 179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.746 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.3 t -124.29 151.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.4 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 392' ' ' VAL . 92.6 m-85 -95.57 145.01 25.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.53 -34.52 77.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -92.24 45.19 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.575 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 23.8 tp -75.85 125.81 29.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.678 ' O ' ' HA ' ' A' ' 347' ' ' THR . 83.0 m-20 -92.06 24.43 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.032 HG22 HD12 ' A' ' 374' ' ' LEU . 31.7 mm -125.87 136.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.939 0.399 . . . . 0.0 111.595 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.7 mtt -139.84 161.8 36.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.323 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.664 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.1 ttt85 -89.22 115.8 26.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 111.671 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 8.3 m-85 -116.53 156.91 26.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.145 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.065 HG12 HD12 ' A' ' 343' ' ' ILE . 4.0 m -121.27 110.56 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 110.942 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.7 HD22 ' N ' ' A' ' 333' ' ' LEU . 1.2 mm? -106.07 149.81 26.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.8 ' CD2' HD11 ' A' ' 369' ' ' ILE . 41.0 m170 -80.63 170.69 16.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -114.84 161.92 17.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.606 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -46.83 -29.66 2.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.32 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 339' ' ' GLU . . . -113.5 96.04 0.78 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.14 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 337' ' ' GLY . 0.8 OUTLIER -20.34 -44.95 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.537 0.735 . . . . 0.0 112.979 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 337' ' ' GLY . 44.8 mt-10 -73.44 42.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 110.964 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 60.3 tt0 -166.17 134.06 2.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.618 ' O ' HD13 ' A' ' 343' ' ' ILE . 33.5 tttp -122.3 144.61 48.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.065 HD12 HG12 ' A' ' 332' ' ' VAL . 8.4 mm -120.0 122.16 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.289 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 346' ' ' LEU . 49.4 tp -132.17 160.67 35.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.373 0.606 . . . . 0.0 112.424 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.732 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.8 p90 -100.02 123.19 43.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.189 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 1.048 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -124.84 157.88 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 69.8 p -101.16 170.28 6.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.672 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.6 Cg_exo -44.7 -48.38 10.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.837 1.691 . . . . 0.0 112.012 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -49.92 75.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.51 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 1.048 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.5 tp60 -69.59 -47.87 62.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 92.6 mt-10 -59.74 -35.72 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.586 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -58.03 -28.33 64.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.125 0.488 . . . . 0.0 110.305 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -84.36 21.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.0 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 357' ' ' PHE . 2.9 ptmm? -55.76 -11.35 0.94 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 94.2 p -61.12 -56.21 23.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.763 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.757 ' HB3' HG22 ' A' ' 358' ' ' THR . 75.8 m80 -108.03 -50.21 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.744 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 63.27 0.86 0.84 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.877 -178.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.757 HG22 ' HB3' ' A' ' 356' ' ' HIS . 15.3 t -88.18 -164.36 1.1 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.515 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.46 151.42 22.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 111.076 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -74.03 0.37 13.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.565 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -84.86 -50.16 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.212 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 1.2 t -106.55 -36.19 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 0.0 110.313 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.699 ' C ' HG21 ' A' ' 358' ' ' THR . . . 73.21 22.79 78.59 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.496 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.638 ' N ' HG21 ' A' ' 358' ' ' THR . 14.7 pt20 -166.81 94.5 0.49 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 112.097 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.467 ' CG ' ' CD2' ' A' ' 366' ' ' HIS . 4.2 pt-20 -159.08 -42.25 0.06 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.17 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.467 ' CD2' ' CG ' ' A' ' 365' ' ' GLU . 97.4 m-70 -110.0 160.91 16.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -151.0 119.71 6.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 354' ' ' LYS . 53.2 tp -70.01 137.22 51.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 334' ' ' HIS . 2.1 mp -106.61 -41.03 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.801 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 371' ' ' SER . 42.2 tt0 -155.63 167.7 29.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.59 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p -147.93 117.0 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.448 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.4 tpt -117.04 131.46 23.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.8 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.588 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.1 Cg_exo -60.16 120.56 8.4 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.87 1.713 . . . . 0.0 110.782 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 328' ' ' ILE . 12.8 mt -62.21 -40.45 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.773 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 391' ' ' ILE . 60.8 tp -60.06 -51.68 68.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.7 mt-10 -60.23 -42.42 95.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.964 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.403 ' CD1' ' ND2' ' A' ' 381' ' ' ASN . 82.5 t90 -62.26 -39.93 94.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.421 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.65 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -70.0 -25.89 63.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.97 46.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.3 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.67 -12.75 15.8 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.5 20.34 5.67 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -68.76 -17.52 64.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.577 0.227 . . . . 0.0 111.446 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -77.14 -47.13 21.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.125 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -61.43 -44.43 97.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.322 0.582 . . . . 0.0 110.622 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.1 m-85 -69.95 -17.72 63.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.885 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.21 1.96 65.45 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.324 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.76 164.76 16.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.162 0.506 . . . . 0.0 110.796 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.842 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.6 m -107.14 100.27 9.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.049 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.55 HD23 HD23 ' A' ' 320' ' ' LEU . 1.7 tm? -71.74 102.34 2.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.97 0.414 . . . . 0.0 110.858 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -110.31 140.84 44.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.111 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 375' ' ' LEU . 36.3 mm -106.48 103.66 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.644 HG12 ' OE1' ' A' ' 282' ' ' GLN . 7.8 m -101.07 -175.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 3.0 p -157.95 152.29 24.58 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.686 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.3 t0 -76.85 76.15 3.46 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -117.57 -29.98 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.313 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 35.1 m -113.55 -174.93 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.771 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 401' ' ' GLN . 31.0 mt-30 -59.98 -47.75 84.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.01 0.434 . . . . 0.0 110.341 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 22.1 mp0 -61.62 -41.93 98.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.47 -22.45 67.67 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.546 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.4 m -83.08 -21.56 33.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.791 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 397' ' ' GLN . 9.5 mm100 -75.79 -46.67 29.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.013 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.824 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -59.96 -49.97 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.085 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 394' ' ' ASP . 96.9 t -59.98 -39.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -68.58 -42.9 77.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.399 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.1 -22.92 74.54 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.256 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.447 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 28.8 t80 -176.45 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.657 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 91.68 101.1 1.32 Allowed Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.564 -0.827 . . . . 0.0 115.101 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 130.42 -34.22 2.73 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.178 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -150.8 127.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 111.939 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -150.74 138.12 6.47 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.77 142.24 14.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.601 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.5 mt -104.66 126.71 59.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 59.2 mt -90.78 157.14 17.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.643 0.735 . . . . 0.0 112.466 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -70.04 -39.99 75.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.358 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 417' ' ' VAL . 53.9 p90 -167.07 178.7 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.508 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.6 mtm180 -56.47 124.29 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.899 0.38 . . . . 0.0 110.7 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.04 159.98 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.21 130.93 45.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.773 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -100.0 15.75 26.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.42 ' HA ' ' NE2' ' A' ' 425' ' ' GLN . 63.8 mt-30 -67.97 140.09 56.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 92.73 83.8 1.52 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.987 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.6 ttt -148.49 163.56 36.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.764 0.316 . . . . 0.0 110.76 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -60.0 -39.96 87.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.07 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.26 17.28 23.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.541 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 4.6 tp60 -59.99 -47.94 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.053 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 51.16 57.18 11.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.847 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -125.26 141.57 13.14 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.86 -40.04 87.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 93.7 m-20 -105.84 36.83 2.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.541 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 49.8 tt0 -59.91 -40.07 87.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.018 0.437 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.67 100.11 7.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.325 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 429' ' ' ASP . 1.3 p90 -117.34 130.94 56.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -86.1 6.84 27.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.81 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.97 -4.25 23.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.905 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.96 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.698 0.285 . . . . 0.0 111.068 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.95 -33.24 75.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.473 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.49 -34.26 72.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.268 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' LEU . . . . . 0.565 ' C ' HD13 ' A' ' 438' ' ' LEU . 3.0 tm? -60.02 -43.7 95.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -70.05 140.08 52.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.7 m80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.881 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.81 0.338 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.5 p -66.11 -29.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.313 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -51.58 -40.56 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.98 -50.06 75.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt -82.75 -20.94 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.653 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.68 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.59 -39.99 85.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.606 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.5 mt-10 -77.08 -29.97 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.269 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.65 -58.16 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.76 -54.66 44.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.3 mt -60.03 -48.43 87.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.555 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.36 -37.88 67.19 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 44.0 ttt180 -60.0 -39.22 85.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.9 t80 -55.65 -45.73 77.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.755 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.4 -39.15 21.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.0 t0 -59.99 -43.2 95.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.402 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.18 -42.29 84.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 109.743 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.24 -23.81 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.6 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.04 -15.45 56.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.175 0.512 . . . . 0.0 110.006 178.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.84 2.08 29.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.622 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.25 29.72 18.43 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.966 0.413 . . . . 0.0 110.571 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.9 p -66.74 -12.98 60.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.915 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 49.12 73.39 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.443 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.38 36.84 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.947 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 160.05 34.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.323 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -141.0 161.19 38.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.445 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.15 144.84 47.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.31 156.89 28.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.871 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -59.94 -55.89 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.195 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.4 pt-20 -47.27 -57.23 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 96.0 m-20 -61.13 -54.9 38.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.676 0.274 . . . . 0.0 111.386 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.1 m -56.51 -40.09 74.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.86 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.88 -45.26 78.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.2 mtmt -56.63 -50.03 73.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.993 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.682 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.827 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.5 74.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.914 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.52 -24.41 61.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.78 -7.96 59.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.098 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.1 10.96 36.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.123 -1.036 . . . . 0.0 111.544 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 1.012 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -80.02 -6.16 57.09 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.399 0.28 . . . . 0.0 110.766 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.856 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.7 m -95.83 105.5 17.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.59 -49.98 75.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.306 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -136.7 126.56 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.579 0.228 . . . . 0.0 111.375 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 45.0 tp -89.73 126.49 35.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.94 0.4 . . . . 0.0 111.5 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.57 103.61 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.313 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.2 t -122.29 152.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -98.48 142.94 29.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.37 -24.0 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.833 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.32 33.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.762 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.6 tp -71.17 123.81 23.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -96.55 28.76 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.61 133.19 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.042 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.1 mtt -140.6 162.47 35.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.22 29.76 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.092 0.472 . . . . 0.0 111.222 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.76 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -131.8 112.23 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 111.411 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.9 mm? -101.56 129.61 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.571 ' HB2' HD11 ' A' ' 369' ' ' ILE . 5.6 m-70 -137.11 150.74 48.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -111.55 152.75 27.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.92 129.94 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.596 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.16 35.18 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.768 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.43 23.6 2.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.658 0.266 . . . . 0.0 111.656 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -102.22 10.25 39.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.174 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -159.96 119.97 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -136.63 130.0 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.154 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.771 ' C ' HD13 ' A' ' 343' ' ' ILE . 6.2 tttp -136.03 121.22 19.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.771 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.4 mm -113.14 112.39 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.672 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp -144.03 156.52 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.446 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.9 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -85.02 137.15 33.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.104 178.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.71 164.05 22.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.596 0.713 . . . . 0.0 112.525 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.5 172.08 4.78 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.31 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 72.9 Cg_exo -48.95 -47.47 21.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 121.789 1.659 . . . . 0.0 111.815 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.15 -58.52 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -59.98 -48.99 79.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 -59.96 -35.71 75.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.02 -34.05 69.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 109.756 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.66 40.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.856 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.605 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 4.1 pttt -70.46 -19.04 62.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.551 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.5 t -66.8 -40.03 87.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.107 0.48 . . . . 0.0 110.111 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 358' ' ' THR . 90.4 m-70 -98.08 -56.44 2.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.089 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.787 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.06 4.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.086 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.3 m -91.67 174.41 7.37 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.749 ' HB2' HG22 ' A' ' 362' ' ' THR . 96.4 m-20 -130.06 138.59 50.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -72.96 -1.98 19.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.368 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -104.54 -13.73 15.91 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.7 t -131.88 -36.33 1.2 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.576 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.28 76.45 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.635 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.808 ' C ' HG23 ' A' ' 358' ' ' THR . 37.5 mt-30 -50.04 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.33 133.03 35.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.362 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 90.5 m-70 -147.11 164.43 33.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.141 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.27 108.1 7.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.912 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 370' ' ' GLU . 45.6 tp -63.52 139.96 58.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.157 0.503 . . . . 0.0 111.482 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 334' ' ' HIS . 2.2 mp -111.7 -45.56 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.511 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.568 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.7 tt0 -143.12 156.26 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -143.87 116.19 8.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.469 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.61 121.97 32.37 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.761 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.63 120.91 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.77 1.647 . . . . 0.0 110.712 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.007 HD12 HG22 ' A' ' 328' ' ' ILE . 20.7 mt -60.03 -44.09 94.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.265 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 69.1 tp -60.01 -50.87 72.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.99 85.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.638 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.28 -43.77 95.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.641 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.827 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.8 m-85 -73.59 -30.7 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.2 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.38 -25.09 60.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.495 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.71 -6.62 14.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.27 20.18 5.79 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.95 -14.48 63.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.615 0.245 . . . . 0.0 111.374 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.36 -40.41 30.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.923 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.1 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.52 -4.21 59.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.401 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.74 2.96 31.99 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.532 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.856 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.64 166.28 13.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 111.103 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.802 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.0 m -109.15 100.54 9.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.936 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.757 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.32 102.39 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.68 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.8 130.02 55.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.757 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.5 mm -95.86 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.173 0.511 . . . . 0.0 112.094 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.616 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.51 -171.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.155 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.52 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.55 155.33 26.16 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.274 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.48 11.31 0.63 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.15 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.04 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 111.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -92.06 170.83 9.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.838 0.352 . . . . 0.0 111.406 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.9 mt-30 -60.02 -54.38 46.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -60.02 -39.98 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 0.0 109.502 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.09 -57.64 15.85 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.805 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.87 -19.53 51.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.36 -40.04 77.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.751 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.99 -46.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.92 -34.06 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.014 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.25 -54.08 20.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.309 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.73 -20.62 70.41 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.938 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.4 t80 174.97 -75.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.33 167.95 28.99 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -51.47 3.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.835 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.55 131.79 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.294 0.547 . . . . 0.0 112.227 -178.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 141.05 8.33 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.68 145.87 15.95 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.866 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.947 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.11 128.55 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.025 HD13 HG13 ' A' ' 417' ' ' VAL . 38.8 mt -90.68 153.17 20.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.766 0.793 . . . . 0.0 112.815 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.01 -37.92 75.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.542 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.691 ' O ' HG12 ' A' ' 417' ' ' VAL . 82.3 m-85 -158.25 -177.91 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.0 99.97 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.869 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.025 HG13 HD13 ' A' ' 413' ' ' LEU . 2.3 p -143.42 137.73 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.161 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -146.32 100.25 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.632 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.07 -49.4 77.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.252 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.13 126.63 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -154.46 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.8 mtp 57.16 23.14 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.675 0.274 . . . . 0.0 111.079 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 424' ' ' TYR . 12.3 pt-20 -151.61 -53.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.397 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 423' ' ' GLU . 98.0 m-85 -160.88 88.61 0.77 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.69 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 32.0 mm-40 -69.99 -40.04 75.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.857 0.361 . . . . 0.0 110.88 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 156.11 -24.16 0.53 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.738 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -154.29 33.21 0.71 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.73 34.36 24.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 111.057 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -118.42 37.53 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.69 ' HA ' ' HG3' ' A' ' 425' ' ' GLN . 1.7 tm-20 -60.02 -41.04 91.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.43 99.1 5.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.397 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -116.68 117.07 28.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.84 -0.65 24.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.8 mt -50.94 -19.4 1.0 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.939 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -59.7 -40.01 86.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -74.9 -24.29 58.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.541 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.96 -38.42 82.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.452 . . . . 0.0 110.007 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.01 -46.44 89.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.887 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.04 -39.91 87.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.133 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.913 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.7 p -66.87 -29.43 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -56.53 -44.83 81.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.57 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.17 -47.54 82.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.205 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 278' ' ' VAL . 46.8 pt -75.64 -29.91 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.445 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -55.64 -41.8 74.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.614 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 55.1 mt-10 -69.96 -33.43 72.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -57.2 3.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -70.0 -58.08 4.25 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.893 ' HG ' HD13 ' A' ' 321' ' ' ILE . 31.4 tp -57.51 -57.44 12.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 13.6 mt -61.48 -49.79 82.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.535 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.73 -34.36 81.85 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.415 -0.897 . . . . 0.0 112.651 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 4.8 ttt85 -59.95 -37.78 80.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 9.4 t80 -60.13 -41.29 92.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.754 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -84.66 -39.44 18.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.49 -50.05 75.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.667 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.1 OUTLIER -64.31 -40.95 96.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.524 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.0 mt -60.04 -23.26 26.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -15.39 46.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.331 0.586 . . . . 0.0 109.685 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.866 ' HB2' HG23 ' A' ' 298' ' ' THR . 68.3 mt-30 -100.7 1.92 40.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.649 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 56.09 29.85 15.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.106 0.479 . . . . 0.0 110.035 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.866 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.9 p -69.97 -10.34 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.773 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.79 50.69 59.68 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.091 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 18.6 mtpt -127.96 38.76 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.874 ' CE1' HG23 ' A' ' 412' ' ' ILE . 81.7 m-85 -161.99 163.37 28.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.417 ' O ' ' HE2' ' A' ' 290' ' ' TYR . 1.8 p -146.43 162.39 38.35 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.424 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.1 p90 -138.68 133.06 31.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.323 . . . . 0.0 110.33 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 103.58 147.76 18.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.955 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.981 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -52.82 -60.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -44.54 -58.09 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.345 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.93 -54.49 41.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 111.235 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.597 HG21 HG22 ' A' ' 409' ' ' ILE . 10.6 m -55.73 -40.01 71.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.027 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.981 HD13 HG12 ' A' ' 305' ' ' VAL . 2.5 mp -70.01 -41.21 74.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.697 0.284 . . . . 0.0 111.211 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mtmm -58.55 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.156 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.96 64.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.69 -28.6 63.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.744 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.2 -26.48 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 93.2 mmm -82.5 -9.1 59.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.648 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.42 42.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.324 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.92 59.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.386 0.274 . . . . 0.0 110.975 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.6 m -93.54 104.83 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.914 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.1 tt0 -59.91 -49.88 75.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.434 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 318' ' ' GLU . 23.4 mm -133.96 126.15 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.65 0.262 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.693 ' HG ' HG23 ' A' ' 322' ' ' VAL . 43.6 tp -91.55 127.33 36.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.942 0.401 . . . . 0.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.893 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.3 mt -112.71 106.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.693 HG23 ' HG ' ' A' ' 320' ' ' LEU . 29.8 t -122.61 155.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.488 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.591 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.9 m-85 -102.65 143.92 31.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.518 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.7 pt-20 -61.78 -35.68 78.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.68 48.31 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.053 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -78.19 125.43 29.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.804 0.335 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -92.94 26.39 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.57 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.003 HG22 HD12 ' A' ' 374' ' ' LEU . 23.2 mm -128.36 136.31 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.561 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 59.8 mtt -139.97 161.93 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.811 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.659 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 46.8 ttm-85 -89.17 115.48 26.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.803 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.618 ' HB3' HD13 ' A' ' 368' ' ' LEU . 3.2 m-85 -115.48 154.74 28.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.023 HG12 HD12 ' A' ' 343' ' ' ILE . 9.4 m -118.85 111.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.7 OUTLIER -99.08 155.42 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.757 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.12 179.61 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.893 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 1.8 m -116.95 161.36 19.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -45.11 -30.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 338' ' ' THR . . . -95.03 -121.4 3.61 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.751 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.6 OUTLIER -163.46 13.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.25 30.26 5.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 20.6 tp10 -155.01 121.05 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.259 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.05 141.16 48.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.031 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.6 ' O ' HD13 ' A' ' 343' ' ' ILE . 6.0 tttp -115.36 143.15 45.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.023 HD12 HG12 ' A' ' 332' ' ' VAL . 11.1 mm -119.69 119.99 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.043 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 33.1 tp -132.67 158.96 40.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 112.064 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.506 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.2 OUTLIER -97.67 120.03 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.4 mm? -124.46 167.48 14.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.554 0.692 . . . . 0.0 112.596 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.3 p -101.59 169.25 7.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.778 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 75.2 Cg_exo -49.46 -42.56 41.3 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.843 1.696 . . . . 0.0 111.745 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.26 -51.57 69.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.101 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 76.8 mt-30 -70.43 -46.61 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.996 0.426 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 97.2 mt-10 -63.1 -28.42 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.852 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -56.25 -30.2 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 0.0 109.754 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.0 t0 -90.12 63.07 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.998 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 25.8 mtmt -70.08 -41.34 74.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -63.79 -57.93 8.39 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.405 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.509 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 36.3 m170 -80.96 -46.02 15.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.809 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.966 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.7 OUTLIER 49.92 15.2 0.16 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.175 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.8 m -107.17 -178.56 3.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.729 ' HB2' HG23 ' A' ' 362' ' ' THR . 94.1 m-20 -128.79 134.67 48.46 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -69.44 -7.0 33.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.694 0.283 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -100.89 -29.51 12.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.851 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.729 HG23 ' HB2' ' A' ' 359' ' ' ASP . 0.1 OUTLIER -109.01 -39.06 5.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.15 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.11 40.84 19.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.061 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.469 ' HB2' HG23 ' A' ' 358' ' ' THR . 14.1 mm-40 -41.47 166.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.148 -0.526 . . . . 0.0 111.676 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.22 17.19 14.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.735 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.638 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 72.7 m80 -87.81 157.03 19.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.271 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 333' ' ' LEU . 54.5 mt-10 -147.75 115.19 6.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.802 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.797 HD11 ' O ' ' A' ' 370' ' ' GLU . 56.1 tp -76.35 142.79 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 111.564 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.713 HD12 ' O ' ' A' ' 332' ' ' VAL . 1.7 mp -117.44 -41.13 2.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.247 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.797 ' O ' HD11 ' A' ' 368' ' ' LEU . 59.5 tt0 -144.78 167.85 21.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.368 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -149.66 116.81 6.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.188 0.518 . . . . 0.0 111.494 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.0 tpt -111.66 126.93 27.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.229 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.3 Cg_exo -57.56 118.67 5.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.877 1.718 . . . . 0.0 111.003 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.003 HD12 HG22 ' A' ' 328' ' ' ILE . 15.2 mt -60.89 -39.95 91.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.887 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.769 HD11 HD12 ' A' ' 391' ' ' ILE . 57.1 tp -59.5 -52.8 64.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.2 mt-10 -58.87 -40.01 83.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.059 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -67.35 -34.0 76.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.316 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 11.3 m-85 -69.78 -31.51 69.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.433 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -9.24 50.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.655 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -101.08 -15.44 17.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.423 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.68 18.11 5.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.35 -20.94 64.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 0.0 111.019 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -79.84 -43.37 22.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.98 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 110.637 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.635 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.3 m-85 -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.64 71.25 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.127 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.38 162.78 16.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.172 0.511 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.866 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.7 m -107.32 100.61 10.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.025 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.746 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.69 102.74 2.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.568 ' HB3' HE22 ' A' ' 282' ' ' GLN . 5.8 mm-40 -108.42 134.99 50.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.884 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.769 HD12 HD11 ' A' ' 375' ' ' LEU . 33.9 mm -99.93 102.09 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 5.7 m -101.6 -168.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.928 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -157.14 153.9 28.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.498 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 403' ' ' VAL . 35.4 p-10 -71.2 -1.86 14.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.532 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -41.36 92.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.534 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 283' ' ' GLU . 3.2 t -75.0 167.27 22.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 111.154 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 48.8 tp60 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 35.8 mp0 -67.72 -34.26 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 109.776 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -51.62 -57.9 11.27 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.921 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.7 m -62.74 -19.47 63.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 38.6 mt-30 -72.99 -40.08 65.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.996 0.427 . . . . 0.0 110.579 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 410' ' ' GLY . 0.2 OUTLIER -65.86 -41.53 91.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.802 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.774 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 71.8 t -60.45 -37.91 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -62.38 -45.03 95.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 0.0 110.417 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -74.95 -20.66 79.34 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.05 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 12.5 t80 -174.98 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.774 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 94.3 96.69 1.6 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.264 -0.969 . . . . 0.0 114.853 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.537 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 135.85 -31.68 2.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.764 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER -152.86 127.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 117.493 0.646 . . . . 0.0 111.895 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.07 136.04 5.65 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.42 134.69 11.33 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.139 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.874 HG23 ' CE1' ' A' ' 301' ' ' TYR . 63.0 mt -99.13 129.99 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 47.0 mt -88.58 149.39 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.728 0.775 . . . . 0.0 113.005 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.6 mtt180 -71.24 -29.92 65.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.239 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.635 ' O ' HG13 ' A' ' 417' ' ' VAL . 63.7 t80 -169.81 165.01 9.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.983 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -49.98 121.05 4.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.292 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 415' ' ' TYR . 32.8 m -130.02 159.99 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.718 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 138.39 57.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -76.91 145.33 38.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -119.36 140.01 51.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.418 ' HA2' ' CG ' ' A' ' 430' ' ' GLU . . . 62.78 108.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.4 mmm -142.24 169.05 18.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.92 -28.63 67.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -70.1 -30.93 68.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.942 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 149.01 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -58.37 -79.52 0.1 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.743 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -178.85 -90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.06 -33.46 72.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.15 20.16 10.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.01 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.418 ' CG ' ' HA2' ' A' ' 421' ' ' GLY . 39.7 tt0 -66.57 -39.94 88.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.569 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -109.12 62.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 40.4 p90 -79.94 99.82 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.314 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.21 13.42 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.051 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.46 -6.41 30.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.742 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -59.96 -40.03 87.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.769 0.318 . . . . 0.0 110.504 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.07 -32.35 71.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.91 -35.26 72.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.06 -44.64 94.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.874 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -60.06 -40.11 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.813 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 282' ' ' GLN . 9.8 p -65.8 -28.46 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' A' ' 282' ' ' GLN . 3.0 pttm -53.13 -38.15 62.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.382 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -62.69 -47.04 85.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.547 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 2.6 pt -83.44 -41.89 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.091 0.472 . . . . 0.0 111.838 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.789 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -55.32 -36.85 66.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.7 pt-20 -69.93 -29.97 67.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -57.82 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.96 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -54.86 11.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 21.0 tp -58.55 -57.11 14.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 111.698 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.682 HG23 ' CE1' ' A' ' 402' ' ' PHE . 43.9 mt -59.95 -49.15 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -58.67 -38.17 91.09 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.217 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 8.3 ttt180 -60.02 -38.07 81.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 109.923 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.635 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 3.0 t80 -55.85 -48.62 75.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.93 -39.95 29.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.99 0.424 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 295' ' ' SER . 74.6 m-20 -60.01 -41.96 93.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.808 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.7 mt-10 -70.03 -41.15 74.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.58 -22.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.04 -14.28 53.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 109.65 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.769 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.2 mt-30 -103.17 0.04 31.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.418 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 7.3 t70 56.34 33.4 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 109.977 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.797 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 31.4 p -73.46 -10.8 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.126 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.41 ' HA3' ' HE ' ' A' ' 416' ' ' ARG . . . 56.89 53.94 40.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.665 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.537 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 9.0 mtpt -130.24 36.23 4.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.934 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -158.87 159.61 35.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.468 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 31.2 m -134.49 155.46 50.32 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.026 0.441 . . . . 0.0 111.378 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -134.87 118.32 16.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.82 155.41 10.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.978 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -60.03 -56.22 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.824 0.345 . . . . 0.0 111.113 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 9.0 pt-20 -51.91 -51.23 58.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.733 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -63.13 -54.15 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.443 HG21 HG22 ' A' ' 409' ' ' ILE . 31.9 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.978 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -65.61 -50.3 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 111.522 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -55.61 -52.38 63.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 -179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.56 71.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.27 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.962 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.34 -27.42 61.5 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.839 0.352 . . . . 0.0 110.463 179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -77.55 -27.6 51.62 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 30.9 mmt -80.86 -7.46 59.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.832 -1.531 . . . . 0.0 111.593 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.4 18.63 44.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.3 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.36 -2.97 58.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.601 -0.3 . . . . 0.0 111.377 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 312' ' ' LEU . 29.9 m -99.43 104.47 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.6 tp10 -57.12 -49.99 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.185 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.5 mm -135.49 126.01 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.562 0.22 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.66 ' HG ' HG23 ' A' ' 322' ' ' VAL . 37.3 tp -90.91 123.41 34.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 111.699 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -109.68 103.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.66 HG23 ' HG ' ' A' ' 320' ' ' LEU . 36.3 t -111.38 155.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.241 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 7.6 m-85 -103.61 142.45 34.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.174 0.511 . . . . 0.0 112.278 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 393' ' ' THR . 36.4 tt0 -68.07 156.78 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.017 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 28.27 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.92 0.391 . . . . 0.0 110.296 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.499 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.1 tp -59.96 125.5 23.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.409 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.08 30.31 1.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.7 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.957 HG22 HD12 ' A' ' 374' ' ' LEU . 26.5 mm -130.35 133.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.511 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.709 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 33.3 mtt -140.6 163.01 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.636 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.4 OUTLIER -88.19 118.79 28.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.832 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 59.9 m-85 -126.9 124.71 40.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.025 HG12 HD12 ' A' ' 343' ' ' ILE . 4.7 m -92.15 117.48 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.536 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.835 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.2 mm? -100.94 164.4 11.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.153 0.502 . . . . 0.0 111.38 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.45 ' CG ' HD11 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -108.5 -173.77 2.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.779 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 40.9 t -116.06 160.24 20.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.96 -39.98 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -89.11 -6.08 72.17 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.717 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.6 p 66.86 27.97 8.88 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.908 0.385 . . . . 0.0 111.075 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -125.04 25.2 7.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.674 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 21.7 tp10 -165.74 130.21 2.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.76 129.69 56.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 0.0 111.176 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.652 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -117.72 141.52 48.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.727 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.025 HD12 HG12 ' A' ' 332' ' ' VAL . 3.0 mm -113.97 127.08 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.185 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 34.4 tp -140.7 160.62 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.776 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.798 ' HD2' HD12 ' A' ' 328' ' ' ILE . 2.5 p90 -100.93 125.7 47.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.658 ' HB2' ' HG2' ' A' ' 351' ' ' GLU . 2.7 mm? -122.3 157.71 31.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.544 0.688 . . . . 0.0 112.773 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.626 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.3 p -99.35 168.13 10.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.311 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 4.7 Cg_endo -46.43 -46.62 16.87 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.27 1.98 . . . . 0.0 112.297 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -72.65 -44.89 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 349' ' ' GLU . 33.3 mt-30 -69.94 -46.64 64.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.832 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -68.73 -24.2 64.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.373 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 348' ' ' PRO . 32.9 ttpt -58.13 -25.12 61.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.307 0.575 . . . . 0.0 109.765 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.92 19.0 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.817 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.894 ' HD2' HD23 ' A' ' 368' ' ' LEU . 30.4 tttt -48.18 -26.0 1.73 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.7 p -64.3 -39.95 94.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.446 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.41 ' C ' ' H ' ' A' ' 358' ' ' THR . 94.6 m-70 -106.66 -53.6 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.297 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.835 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 62.7 3.6 1.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.617 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.4 m -89.04 178.43 6.39 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.522 ' H ' HG22 ' A' ' 358' ' ' THR . 76.1 m-20 -130.33 130.47 44.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -68.4 -4.15 13.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.448 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -101.97 -19.04 15.39 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 364' ' ' GLN . 4.4 t -131.86 -37.32 1.16 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.555 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 365' ' ' GLU . . . 91.09 5.25 68.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.917 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.601 ' H ' HG23 ' A' ' 362' ' ' THR . 61.1 mm-40 -52.83 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.487 ' OE2' HG21 ' A' ' 358' ' ' THR . 72.5 mm-40 -65.7 128.65 36.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.476 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 96.5 m-70 -140.08 153.48 46.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.506 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 53.7 mt-10 -139.51 113.2 8.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.894 HD23 ' HD2' ' A' ' 354' ' ' LYS . 49.9 tp -75.58 138.29 41.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.045 0.45 . . . . 0.0 111.55 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.45 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.3 mp -113.68 -35.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.191 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.853 ' O ' HD11 ' A' ' 368' ' ' LEU . 33.9 mt-10 -140.05 150.2 44.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.015 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.546 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 2.8 p -141.13 115.08 9.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.182 0.515 . . . . 0.0 111.575 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.66 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -121.31 137.27 26.62 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.186 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.709 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 28.1 Cg_endo -64.31 122.97 11.09 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.117 1.878 . . . . 0.0 110.626 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.957 HD12 HG22 ' A' ' 328' ' ' ILE . 19.6 mt -65.3 -41.06 94.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 38.4 tp -60.08 -53.66 55.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.644 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 48.0 mt-10 -59.98 -40.38 88.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.024 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -62.49 -40.03 95.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.083 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.578 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -70.54 -28.25 64.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.276 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -10.48 48.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.828 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.07 -9.49 14.72 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.5 m120 -129.2 19.45 5.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.604 0.24 . . . . 0.0 111.61 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -68.57 -17.41 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.597 0.237 . . . . 0.0 111.347 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -79.85 -46.97 15.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.02 -44.19 94.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.318 0.58 . . . . 0.0 109.96 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.553 ' CD2' HD23 ' A' ' 312' ' ' LEU . 26.7 m-85 -73.49 -19.97 60.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.039 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . 0.49 ' HA3' HH22 ' A' ' 414' ' ' ARG . . . 74.87 2.14 64.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.22 165.37 18.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.073 0.463 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.851 ' HB ' HG23 ' A' ' 319' ' ' ILE . 24.2 m -107.68 100.67 10.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 389' ' ' LEU . 0.9 OUTLIER -73.54 107.34 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.628 -178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.527 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 5.8 mm-40 -115.39 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.593 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 27.2 mm -98.5 102.34 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.114 0.483 . . . . 0.0 112.26 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.7 m -114.06 133.62 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.607 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 3.2 p -112.74 166.21 11.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.657 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.4 t0 -73.48 70.06 1.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.846 0.355 . . . . 0.0 111.352 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' A' ' 283' ' ' GLU . 4.9 ptmt -119.83 12.02 12.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 47.5 t -155.17 179.57 9.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -59.38 -53.32 59.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 50.9 mp0 -63.65 -39.98 95.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.411 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.87 -25.4 67.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.521 -0.847 . . . . 0.0 110.992 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.5 m -83.74 -23.38 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.554 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.78 -43.44 65.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.376 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.682 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.2 m-85 -65.3 -48.39 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.21 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.657 HG21 ' HB2' ' A' ' 394' ' ' ASP . 75.4 t -59.95 -40.08 81.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -48.17 33.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -73.22 -28.29 66.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -157.68 -84.72 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 100.09 151.73 26.04 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.461 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.99 -47.49 3.13 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.67 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -148.94 134.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 118.232 1.016 . . . . 0.0 112.985 -177.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.39 145.49 12.96 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.72 147.6 18.96 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.712 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.934 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.0 mt -106.5 126.72 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.3 mt -87.85 156.15 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 0.0 112.195 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.49 HH22 ' HA3' ' A' ' 386' ' ' GLY . 16.3 mtt-85 -77.77 -33.07 52.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.685 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.428 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 93.5 m-85 -156.39 170.01 23.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.753 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -64.21 120.78 12.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 413' ' ' LEU . 17.0 m -130.04 159.95 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.997 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -80.36 170.03 16.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.798 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.65 137.74 37.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.98 -40.01 87.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.468 ' HA3' ' HG3' ' A' ' 430' ' ' GLU . . . 89.47 163.87 39.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 52.6 mtp -143.08 160.28 40.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.1 -39.94 87.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.032 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.436 ' O ' ' CD2' ' A' ' 424' ' ' TYR . 53.5 t80 -98.38 11.91 36.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 130.56 -51.82 0.85 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.619 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -59.46 126.88 43.43 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.527 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.05 -40.02 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -115.91 31.07 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.468 ' HG3' ' HA3' ' A' ' 421' ' ' GLY . 8.2 tp10 -59.94 -40.03 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.551 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.404 ' CZ ' ' OD2' ' A' ' 433' ' ' ASP . 64.8 t80 -120.56 102.35 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.297 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -130.97 80.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ASP . . . . . 0.404 ' OD2' ' CZ ' ' A' ' 431' ' ' PHE . 96.6 m-20 -95.19 18.65 11.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.13 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.28 -15.42 47.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.86 -40.02 87.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -80.62 -20.22 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -59.97 -38.46 82.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.313 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.92 -49.18 78.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.951 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -67.84 139.97 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.914 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.1 m120 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.733 0.302 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.6 p -58.88 -27.21 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.109 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -41.26 76.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.039 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.97 -47.77 84.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -80.01 -22.83 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.432 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.55 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -57.48 -40.01 77.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.212 0.53 . . . . 0.0 110.019 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.603 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 1.9 mp0 -75.69 -51.34 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.407 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -40.05 87.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -84.55 -58.69 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.843 ' HG ' HD13 ' A' ' 321' ' ' ILE . 29.9 tp -60.01 -55.84 29.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.909 0.385 . . . . 0.0 111.834 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.878 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.3 mt -59.95 -47.88 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.572 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.425 ' HA2' ' OE1' ' A' ' 398' ' ' GLU . . . -57.81 -37.79 85.69 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.444 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt180 -60.02 -42.41 94.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.513 ' CE1' ' CE1' ' A' ' 402' ' ' PHE . 5.5 t80 -59.99 -41.71 92.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.516 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.688 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.7 t80 -84.27 -40.98 17.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -60.57 -43.37 97.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.663 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 75.4 mt-10 -60.06 -40.03 88.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.947 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 291' ' ' PHE . 64.1 mt -56.4 -30.26 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 t -53.03 -29.87 32.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.552 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 21.8 mt-30 -94.77 1.46 55.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.26 32.03 17.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.978 0.418 . . . . 0.0 110.085 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 1.5 p -64.26 -13.14 47.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.541 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.85 47.57 87.9 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.699 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 413' ' ' LEU . 36.3 mttp -129.48 48.05 2.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.585 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -170.51 168.08 7.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 111.348 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.6 p -153.1 169.0 24.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.42 135.64 33.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.047 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 104.17 146.52 15.98 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.815 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.47 -57.82 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.909 0.385 . . . . 0.0 110.982 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -49.02 -53.48 19.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.397 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.77 -53.04 53.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.312 . . . . 0.0 111.29 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.595 HG21 HG22 ' A' ' 409' ' ' ILE . 7.4 m -57.88 -38.58 76.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.871 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -69.07 -43.64 74.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.371 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.3 mtmm -57.37 -49.99 74.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.1 -26.08 62.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.389 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.797 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.07 -27.28 60.83 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.923 0.392 . . . . 0.0 110.586 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -77.51 -28.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.1 mmt -80.54 -7.01 59.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.979 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.91 14.48 23.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.677 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.29 -6.59 59.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.395 0.278 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.821 HG23 ' HB2' ' A' ' 387' ' ' ALA . 20.8 m -93.16 105.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.798 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.3 tt0 -59.98 -50.0 75.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 32.9 mm -135.22 126.34 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.529 0.204 . . . . 0.0 111.483 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.683 ' HG ' HG23 ' A' ' 322' ' ' VAL . 50.2 tp -92.0 125.52 36.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.022 0.439 . . . . 0.0 110.914 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.843 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -112.41 106.95 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.975 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.683 HG23 ' HG ' ' A' ' 320' ' ' LEU . 18.9 t -124.24 158.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.282 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.724 ' CE1' HG23 ' A' ' 392' ' ' VAL . 90.3 m-85 -104.58 146.48 28.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.42 . . . . 0.0 111.345 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.555 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.9 pt-20 -64.97 -30.9 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -97.25 49.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 20.3 tp -80.19 126.16 30.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 347' ' ' THR . 35.8 p-10 -92.67 21.42 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.468 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 305' ' ' VAL . 14.8 mm -124.7 136.78 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.569 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 40.2 mtt -140.52 161.6 37.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.868 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.571 HH21 HD22 ' A' ' 309' ' ' LEU . 11.1 mmt-85 -89.3 120.52 30.72 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.072 0.463 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.4 m-85 -118.08 152.34 35.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.739 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.008 HG12 HD12 ' A' ' 343' ' ' ILE . 15.4 m -116.44 108.03 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.976 HD11 ' CD2' ' A' ' 357' ' ' PHE . 1.6 mm? -96.36 150.02 21.04 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.416 ' CG ' HD11 ' A' ' 369' ' ' ILE . 1.3 m-70 -91.58 179.75 5.57 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.962 0.411 . . . . 0.0 111.102 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.57 161.44 20.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.692 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -45.19 -30.06 1.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 338' ' ' THR . . . -92.75 -118.17 2.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.058 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.5 OUTLIER -168.85 25.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.691 0.281 . . . . 0.0 111.722 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.49 38.37 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 110.047 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -157.04 120.04 4.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.16 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -114.18 139.16 49.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.113 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.679 ' O ' HD13 ' A' ' 343' ' ' ILE . 1.7 ttpt -117.57 142.57 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.008 HD12 HG12 ' A' ' 332' ' ' VAL . 8.3 mm -120.75 116.67 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.491 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 346' ' ' LEU . 48.7 tp -128.49 157.85 39.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.308 0.575 . . . . 0.0 112.256 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.641 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.21 119.01 36.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.773 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.777 HD11 HD23 ' A' ' 344' ' ' LEU . 0.9 OUTLIER -121.36 154.23 36.73 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.679 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.3 p -101.27 171.44 5.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.087 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.679 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.9 Cg_exo -44.02 -47.39 10.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.858 1.705 . . . . 0.0 112.106 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.0 pt-20 -59.98 -49.04 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 97.5 mt-30 -70.22 -46.52 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 90.2 mt-10 -60.74 -33.59 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.303 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.95 -36.16 72.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 66.0 t0 -84.53 58.45 4.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.724 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.512 ' HG3' HD23 ' A' ' 368' ' ' LEU . 21.5 ttpt -67.1 -39.95 86.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 54.1 m -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.469 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 35.1 m80 -102.49 -55.87 2.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 0.0 111.08 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.976 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 60.56 3.22 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.206 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.835 HG22 ' H ' ' A' ' 359' ' ' ASP . 6.4 m -88.18 -174.56 4.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.958 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.835 ' H ' HG22 ' A' ' 358' ' ' THR . 95.9 m-20 -81.24 162.53 23.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.586 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -73.08 -3.96 29.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -82.15 -44.39 16.51 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.907 0.384 . . . . 0.0 111.035 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.92 -35.5 3.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.874 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 63.29 18.92 61.32 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.117 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.531 ' N ' HG21 ' A' ' 358' ' ' THR . 60.3 mt-30 -155.59 84.93 1.04 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.72 ' HB2' HG23 ' A' ' 358' ' ' THR . 53.4 mm-40 -144.17 -39.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.364 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -128.23 171.37 12.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.735 0.302 . . . . 0.0 111.093 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -145.36 118.89 9.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.464 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.747 HD11 ' O ' ' A' ' 370' ' ' GLU . 55.5 tp -70.02 134.31 48.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 332' ' ' VAL . 4.0 mp -112.5 -45.1 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.187 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.747 ' O ' HD11 ' A' ' 368' ' ' LEU . 54.0 mm-40 -137.64 162.98 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.598 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.3 p -148.86 117.35 6.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.132 0.491 . . . . 0.0 111.401 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 20.3 tpp -112.9 128.22 25.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.669 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.508 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 34.1 Cg_exo -59.95 116.96 3.67 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 121.925 1.75 . . . . 0.0 110.618 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.789 HD13 HG11 ' A' ' 305' ' ' VAL . 6.5 mt -60.06 -39.47 86.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.851 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.897 HD11 HD12 ' A' ' 391' ' ' ILE . 59.4 tp -60.03 -50.69 72.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.7 mt-10 -60.02 -39.95 87.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -66.31 -36.66 83.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.618 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.425 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -68.64 -26.38 65.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.76 -18.64 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.785 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -105.76 4.89 30.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 384' ' ' LYS . 39.4 t-20 -139.79 13.85 2.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -69.98 -17.58 63.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -77.16 -48.37 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' LYS . . . . . 0.445 ' HB2' ' OD1' ' A' ' 381' ' ' ASN . 34.1 mttt -60.11 -44.6 94.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.5 m-85 -69.89 -16.4 63.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.894 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.4 62.7 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.177 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.821 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.52 162.01 19.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 72.8 m -105.71 100.05 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.823 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.1 tm? -74.47 103.13 4.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.2 mm-40 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.694 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.897 HD12 HD11 ' A' ' 375' ' ' LEU . 22.4 mm -96.08 104.34 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.814 ' HB ' HD11 ' A' ' 287' ' ' ILE . 14.7 m -100.87 -172.57 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.235 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.556 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -158.57 154.15 26.14 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.098 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.448 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.6 p-10 -67.91 5.6 0.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -59.96 -39.97 87.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.8 m -91.1 169.76 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.9 0.381 . . . . 0.0 111.525 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.94 -49.34 78.07 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.621 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.653 ' O ' HG21 ' A' ' 287' ' ' ILE . 60.8 mm-40 -63.49 -35.94 82.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.642 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.675 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -24.02 66.28 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.004 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 59.8 m -83.94 -23.15 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.614 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.09 -41.59 63.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.602 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.878 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -65.0 -44.0 90.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.837 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 92.3 t -58.77 -32.84 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.486 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.07 -54.23 14.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.225 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -55.65 -53.79 39.2 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.887 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -137.09 -66.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 102.7 81.13 1.52 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.517 -0.849 . . . . 0.0 115.163 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.464 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 138.02 -29.4 2.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.991 -1.1 . . . . 0.0 114.15 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.98 130.64 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.689 0.744 . . . . 0.0 112.229 -178.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.99 135.12 5.13 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.95 142.15 14.37 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.461 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 318' ' ' GLU . 81.4 mt -109.96 130.0 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.8 mt -88.59 155.24 19.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 74.4 mtm180 -70.03 -39.96 75.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.581 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.572 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 54.4 p90 -158.42 169.92 23.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.7 mmm180 -56.15 128.2 34.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.0 159.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.042 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.67 127.39 40.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.19 134.21 47.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -133.64 156.4 47.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.711 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 72.58 96.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.394 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.3 mtt -146.19 161.81 39.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.755 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.99 -40.04 87.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.27 21.25 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.495 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 6.1 tp-100 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 146.25 -100.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.823 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.84 100.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.653 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.35 10.37 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.22 . . . . 0.0 111.379 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.5 23.05 14.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.733 0.302 . . . . 0.0 110.47 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 69.1 mt-10 -66.12 -40.01 90.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.163 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -101.4 49.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 36.5 p90 -65.38 89.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 111.201 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.07 13.59 14.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.462 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.79 -18.13 41.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.606 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.379 . . . . 0.0 110.313 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -79.48 -19.96 48.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.83 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.74 -38.61 82.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.91 -41.21 91.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.933 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.86 152.24 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 34.8 t30 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.67 0.271 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -60.03 -29.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.284 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -52.27 -47.28 65.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.609 0.242 . . . . 0.0 111.526 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -49.92 75.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 278' ' ' VAL . 45.7 pt -75.75 -26.73 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.799 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.56 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 0.0 OUTLIER -55.28 -43.99 75.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 0.0 109.993 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.714 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 64.5 mt-10 -77.59 -41.53 38.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -70.76 -40.07 72.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -87.03 -58.83 2.44 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 21.5 tp -59.94 -56.43 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 402' ' ' PHE . 30.6 mt -60.72 -48.71 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.333 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.13 -38.83 78.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.444 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.472 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 29.7 ttt180 -60.02 -39.61 86.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.328 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 5.7 t80 -55.59 -49.85 71.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.56 ' CD2' ' NE2' ' A' ' 401' ' ' GLN . 63.6 m-85 -79.41 -38.37 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.042 0.449 . . . . 0.0 111.006 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.93 -49.79 76.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.331 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.9 mt-10 -63.76 -45.43 89.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.877 0.37 . . . . 0.0 110.03 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 301' ' ' TYR . 93.6 mt -58.02 -23.6 21.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.42 -15.18 47.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.49 0.662 . . . . 0.0 109.549 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.799 ' HB2' HG23 ' A' ' 298' ' ' THR . 34.9 mt-30 -103.25 2.38 34.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.09 31.57 18.41 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.177 0.513 . . . . 0.0 110.25 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 296' ' ' GLN . 25.2 p -70.02 -9.99 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.766 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.52 48.03 73.0 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 119.926 -1.13 . . . . 0.0 113.655 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 33.5 mtmt -128.4 36.97 4.2 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.925 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.6 m-85 -160.0 160.04 32.84 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.35 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.13 159.42 43.32 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.748 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.8 p90 -131.9 125.35 31.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 114.94 169.13 15.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.765 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.45 -56.81 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 13.2 pt-20 -48.78 -50.35 34.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.463 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.32 -53.6 28.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.754 0.311 . . . . 0.0 111.368 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 409' ' ' ILE . 60.2 m -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.244 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.971 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -65.81 -45.04 83.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.9 mttm -58.95 -48.08 82.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.439 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.9 65.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.233 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.55 -27.87 61.56 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.804 0.335 . . . . 0.0 110.762 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 75.4 mm-40 -76.47 -26.82 55.77 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.2 mmt -81.82 -7.05 59.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.75 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.16 35.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.544 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.9 -2.11 58.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.289 0.236 . . . . 0.0 111.143 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.948 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.7 m -99.54 104.79 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.9 tt0 -56.8 -50.07 73.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.279 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.873 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -136.42 127.56 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.668 0.27 . . . . 0.0 111.466 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 312' ' ' LEU . 41.9 tp -95.34 128.62 42.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.026 0.441 . . . . 0.0 111.342 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 412' ' ' ILE . 0.9 OUTLIER -117.18 110.13 30.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 110.172 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.589 HG23 ' HG ' ' A' ' 320' ' ' LEU . 12.2 t -125.47 162.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.136 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 392' ' ' VAL . 90.4 m-85 -107.29 145.39 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -63.61 -41.43 98.3 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -86.36 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 409' ' ' ILE . 34.6 tp -89.24 120.6 30.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.604 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -90.06 26.64 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.017 HG21 HG21 ' A' ' 305' ' ' VAL . 23.9 mm -123.45 136.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.135 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 73.7 mtp -140.05 162.36 35.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.236 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.7 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.9 ttt-85 -84.7 106.27 16.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.991 0.424 . . . . 0.0 111.897 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.534 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 7.6 m-85 -120.57 123.54 43.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.259 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.608 HG12 HD12 ' A' ' 343' ' ' ILE . 3.0 m -97.58 124.82 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 0.0 111.517 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.775 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.1 mm? -117.35 139.98 50.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.687 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.557 ' CD2' ' OE2' ' A' ' 341' ' ' GLU . 2.5 m-70 -117.75 136.21 53.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.04 0.447 . . . . 0.0 110.557 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.409 ' CB ' ' HG2' ' A' ' 365' ' ' GLU . 58.5 m -110.08 150.5 28.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.11 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 339' ' ' GLU . 89.1 mt-30 60.02 25.63 14.88 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.398 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 338' ' ' THR . . . 84.02 -39.09 2.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.593 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.1 OUTLIER 177.87 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 336' ' ' GLN . 54.8 tt0 -59.98 -38.24 82.0 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.733 0.301 . . . . 0.0 111.062 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -143.92 119.08 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.557 ' OE2' ' CD2' ' A' ' 334' ' ' HIS . 3.8 mt-10 -120.04 128.94 53.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.767 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.787 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -129.56 150.95 50.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.585 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.787 HD13 ' C ' ' A' ' 342' ' ' LYS . 1.4 mm -109.29 136.34 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.1 tp -143.99 159.48 42.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 112.54 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.747 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.08 134.43 41.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.579 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.2 mm? -128.12 161.17 29.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.615 0.721 . . . . 0.0 112.87 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.2 p -101.56 168.76 8.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.372 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.57 ' O ' ' HG2' ' A' ' 352' ' ' LYS . 3.5 Cg_endo -45.66 -47.42 13.59 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.283 1.989 . . . . 0.0 111.982 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.8 -50.07 74.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.743 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.484 ' OE1' HD12 ' A' ' 346' ' ' LEU . 61.1 mt-30 -69.05 -46.09 68.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 76.4 mt-10 -58.76 -33.43 70.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.869 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 49.4 mmtt -57.92 -32.93 68.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.349 0.595 . . . . 0.0 109.597 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -92.63 36.74 1.01 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.95 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.743 ' HB2' HD13 ' A' ' 368' ' ' LEU . 5.3 pttt -70.05 -28.62 65.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 87.1 p -59.97 -40.03 87.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.051 0.453 . . . . 0.0 110.436 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -98.76 -51.63 3.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.244 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.775 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 56.9 10.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.98 0.419 . . . . 0.0 110.25 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 359' ' ' ASP . 2.0 m -101.79 -179.96 4.16 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 362' ' ' THR . 76.5 m-20 -129.08 130.96 47.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -67.16 -4.06 9.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.746 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -101.31 -22.02 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 359' ' ' ASP . 10.3 t -119.44 -35.36 3.59 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.076 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.04 42.63 15.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.794 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.432 ' C ' HG23 ' A' ' 358' ' ' THR . 58.5 mt-30 -52.05 -172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.447 . . . . 0.0 111.206 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 335' ' ' CYS . 1.7 pm0 -135.49 29.31 3.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -70.31 153.42 43.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.386 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 333' ' ' LEU . 43.5 mt-10 -151.85 123.09 7.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 354' ' ' LYS . 6.9 tt -78.79 129.06 34.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.706 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.648 ' N ' HD13 ' A' ' 369' ' ' ILE . 1.5 mm -102.47 -46.49 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.656 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.008 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.2 OUTLIER -144.93 115.85 7.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 7.7 tpt -122.22 141.2 33.98 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.556 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.729 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.2 Cg_exo -62.96 124.4 13.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.232 1.955 . . . . 0.0 110.399 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.989 HD12 HG22 ' A' ' 328' ' ' ILE . 20.5 mt -68.42 -40.55 81.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.859 HD11 HD12 ' A' ' 391' ' ' ILE . 63.8 tp -59.95 -51.9 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 47.2 mt-10 -59.92 -39.96 87.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -62.21 -39.94 94.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.579 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.548 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.61 -27.09 61.95 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.477 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.81 -8.83 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.894 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.09 -9.93 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 18.94 5.9 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.71 -20.13 65.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.558 0.218 . . . . 0.0 111.202 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -79.13 -47.43 16.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -60.59 -45.24 94.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 312' ' ' LEU . 25.9 m-85 -71.38 -19.13 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.635 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.03 73.91 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.044 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.948 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.6 160.99 20.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.124 0.488 . . . . 0.0 110.338 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.873 ' HB ' HG23 ' A' ' 319' ' ' ILE . 64.5 m -106.47 99.87 9.42 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.7 tm? -75.43 102.7 5.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.388 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.521 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -109.17 135.64 49.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.756 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.859 HD12 HD11 ' A' ' 375' ' ' LEU . 43.4 mm -99.98 104.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.673 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.0 m -101.38 -170.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.148 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -157.55 151.47 24.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.056 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.548 ' HB2' HG21 ' A' ' 403' ' ' VAL . 60.1 t0 -76.58 69.97 3.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.851 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -43.47 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.5 m -90.03 176.71 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.743 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 398' ' ' GLU . 4.7 pt20 -60.02 -44.29 94.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 63.7 mm-40 -69.99 -41.51 74.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.727 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -19.23 60.84 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.545 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.0 m -83.9 -21.82 31.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.397 -0.401 . . . . 0.0 110.72 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.56 ' NE2' ' CD2' ' A' ' 291' ' ' PHE . 25.2 mt-30 -75.84 -41.37 52.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.784 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.834 ' CE2' HG23 ' A' ' 287' ' ' ILE . 7.3 m-30 -59.94 -44.99 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.889 0.376 . . . . 0.0 110.769 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 394' ' ' ASP . 55.6 t -60.01 -40.09 82.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.07 -40.03 47.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.042 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -67.41 -38.42 91.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.924 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 2.2 p90 -142.56 -78.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.756 0.312 . . . . 0.0 110.334 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 135.65 47.93 0.08 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.832 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.63 -37.04 1.96 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.393 -1.384 . . . . 0.0 115.416 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.781 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -126.47 128.88 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.751 0.775 . . . . 0.0 112.977 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.64 136.76 6.38 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.49 140.15 13.66 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.744 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.925 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.7 mt -103.4 127.18 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.7 mt -91.55 158.58 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 112.732 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.55 -39.89 67.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.435 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.2 p90 -165.1 176.05 8.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -57.78 130.57 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.935 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.85 160.0 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.108 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -105.55 49.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.203 0.525 . . . . 0.0 111.231 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -49.99 75.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -139.81 139.07 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -65.87 120.02 15.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.475 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.401 ' H ' ' HB2' ' A' ' 425' ' ' GLN . 61.4 mtt -130.9 162.26 30.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.888 0.375 . . . . 0.0 110.932 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -59.95 -40.0 87.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -82.05 5.67 18.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.535 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 5.1 tp-100 -59.97 -39.99 87.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.788 0.327 . . . . 0.0 111.043 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.01 -32.28 7.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -92.93 110.15 3.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -60.06 -39.95 87.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -100.91 33.05 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.682 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 16.1 tp10 -59.93 -40.02 87.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -117.13 101.19 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -133.27 121.72 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.253 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -79.48 0.05 31.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 109.7 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.95 -9.85 54.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -60.03 -40.3 88.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.795 0.331 . . . . 0.0 110.629 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.0 -29.78 66.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -60.05 -34.86 73.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.314 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.91 -49.99 75.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.253 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -107.01 121.63 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.926 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.676 0.274 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.81 -29.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -41.27 37.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.917 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -50.02 75.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.667 0.27 . . . . 0.0 111.544 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -82.95 -27.26 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 111.766 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.6 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 0.3 OUTLIER -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.449 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.6 pt-20 -77.61 -24.61 49.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.548 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -83.94 -51.47 7.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -75.37 -57.11 4.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 24.2 tp -59.1 -53.76 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.841 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.793 HD11 ' HB ' ' A' ' 392' ' ' VAL . 29.5 mt -58.93 -49.96 81.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.7 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.32 -37.02 71.59 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -60.01 -37.51 79.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.5 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.3 t80 -58.86 -45.51 89.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.612 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.91 -39.16 17.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.717 0.294 . . . . 0.0 111.444 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.6 t0 -62.29 -45.2 94.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 111.336 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.772 ' OE2' HG21 ' A' ' 298' ' ' THR . 18.4 tp10 -67.64 -39.98 84.59 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 301' ' ' TYR . 80.4 mt -62.07 -26.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.43 -14.73 13.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.074 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.751 ' HB2' HG23 ' A' ' 298' ' ' THR . 23.5 mt-30 -99.24 1.23 44.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.603 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.92 27.43 16.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.317 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.772 HG21 ' OE2' ' A' ' 293' ' ' GLU . 17.2 p -64.88 -13.38 56.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.941 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 58.38 45.06 94.81 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.23 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.629 ' HA ' HD12 ' A' ' 413' ' ' LEU . 4.7 ptpt -130.89 46.6 2.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.041 0.421 . . . . 0.0 110.782 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.891 ' CE1' HG23 ' A' ' 412' ' ' ILE . 98.6 m-85 -160.49 160.96 32.66 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.954 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 27.6 m -141.56 159.38 42.35 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.812 0.339 . . . . 0.0 111.234 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.447 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.2 p90 -135.4 124.68 24.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.621 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.534 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 107.68 156.09 19.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.311 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.954 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -59.97 -53.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 20.5 pt-20 -51.8 -51.93 52.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.47 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 87.5 m-20 -67.02 -53.17 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 0.0 111.095 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 42.0 m -58.05 -40.01 79.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.017 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.954 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.4 mp -67.81 -46.59 71.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 41.3 mtmt -54.45 -50.03 68.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.941 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.82 59.44 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.321 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.878 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.63 -33.28 68.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.004 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -72.77 -25.52 61.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 4.3 mmt -82.46 -7.72 59.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.956 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.54 13.54 45.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.172 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.853 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -80.93 -6.99 59.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.549 0.34 . . . . 0.0 111.094 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 387' ' ' ALA . 35.6 m -99.79 106.68 19.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.649 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.4 tt0 -60.0 -52.7 64.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.696 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.7 mm -130.31 125.55 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.401 0.144 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.2 tp -91.15 127.4 36.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.959 0.409 . . . . 0.0 111.081 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.87 106.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.352 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.653 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -120.94 147.5 24.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.314 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.7 m-85 -90.17 143.19 26.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.0 112.252 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 12.2 tp10 -60.07 -43.06 95.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -91.6 53.57 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.541 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.4 tp -84.34 124.9 31.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -95.47 29.2 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.047 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.05 HG22 HD12 ' A' ' 374' ' ' LEU . 18.8 mm -123.84 131.45 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.926 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.635 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.8 mtt -140.58 162.54 35.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.516 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.0 ttt-85 -90.91 120.19 31.72 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.109 0.481 . . . . 0.0 111.606 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 18.3 m-85 -130.91 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.013 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.745 HG12 HD12 ' A' ' 343' ' ' ILE . 2.4 m -98.31 119.18 45.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 111.359 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.685 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.3 mm? -104.57 119.94 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.514 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.934 ' CG ' HD11 ' A' ' 369' ' ' ILE . 47.7 m170 -129.44 152.63 48.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.225 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 18.2 m -103.27 160.95 14.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.607 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.06 130.03 44.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 89.59 12.92 62.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.91 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.6 p 48.84 39.93 15.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.711 0.291 . . . . 0.0 111.44 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -103.28 8.64 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 9.9 tp10 -163.84 122.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.803 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -129.78 128.17 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.525 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.811 ' C ' HD13 ' A' ' 343' ' ' ILE . 24.4 tttp -140.36 121.33 14.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.811 HD13 ' C ' ' A' ' 342' ' ' LYS . 1.9 mm -113.8 115.51 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 26.1 tp -143.07 160.95 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.019 0.438 . . . . 0.0 111.508 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -90.41 135.49 33.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.315 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.3 mm? -126.85 158.46 36.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.693 0.759 . . . . 0.0 112.63 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.6 p -101.09 169.22 8.07 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.741 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 2.2 Cg_endo -44.64 -48.83 9.96 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.055 1.836 . . . . 0.0 111.92 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.559 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.97 -46.07 66.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.767 0.317 . . . . 0.0 111.647 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 57.1 mt-10 -59.96 -38.44 82.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.651 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 13.9 mmtm -58.29 -32.68 68.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.134 0.492 . . . . 0.0 110.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.24 37.88 0.95 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.36 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.62 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -73.11 -12.72 61.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.979 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 70.0 m -59.99 -39.98 87.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 358' ' ' THR . 53.9 m-70 -104.0 -56.91 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.224 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.66 -0.74 0.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 364' ' ' GLN . 1.3 m -86.85 -169.69 2.74 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.623 0.249 . . . . 0.0 111.182 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.761 ' H ' HG22 ' A' ' 358' ' ' THR . 93.6 m-20 -90.73 158.12 17.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.107 0.479 . . . . 0.0 111.266 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -75.17 -3.53 33.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.981 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.09 -49.29 14.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.301 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.482 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 1.3 t -110.17 -35.21 6.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.173 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 71.11 22.43 78.49 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.854 ' HB2' HG21 ' A' ' 358' ' ' THR . 30.6 mt-30 -49.32 178.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.748 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -119.92 106.09 11.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.631 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -81.29 171.99 14.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.62 103.94 7.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 332' ' ' VAL . 25.4 tp -67.0 124.76 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.78 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.934 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -84.65 -47.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.88 161.62 34.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.733 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.6 OUTLIER -141.33 115.81 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.617 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.0 128.46 25.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.635 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.5 Cg_exo -59.3 121.2 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.69 1.593 . . . . 0.0 110.5 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.05 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -60.12 -39.9 87.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.811 HD11 HD12 ' A' ' 391' ' ' ILE . 56.1 tp -59.98 -56.29 23.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.5 mt-10 -60.0 -40.05 87.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.008 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.78 -39.93 95.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.395 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.613 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -67.54 -25.17 65.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.014 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.65 -10.48 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -102.57 -14.7 16.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.8 19.88 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.19 -20.06 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.56 0.219 . . . . 0.0 111.265 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -80.37 -42.16 23.36 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.171 0.51 . . . . 0.0 110.493 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.68 ' CD2' HD23 ' A' ' 312' ' ' LEU . 20.9 m-85 -81.81 -10.01 59.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.35 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.79 54.52 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.0 m -107.64 100.99 10.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.486 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 391' ' ' ILE . 2.1 tm? -71.12 103.69 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.209 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.604 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.0 mm-40 -111.31 131.19 55.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 375' ' ' LEU . 32.0 mm -95.24 100.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.793 ' HB ' HD11 ' A' ' 287' ' ' ILE . 17.6 m -112.73 139.34 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 395' ' ' LYS . 5.7 p -111.45 164.47 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.881 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.411 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.3 p-10 -69.5 15.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 393' ' ' THR . 38.8 tttp -59.95 -45.25 93.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 5.0 m -90.76 173.77 7.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.978 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.84 -50.39 73.98 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.785 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 74.1 mm-40 -62.94 -36.89 84.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.506 0.67 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.411 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.11 -26.37 67.45 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.436 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.2 m -83.34 -26.62 30.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.242 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.8 -43.7 68.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.797 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.589 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.0 m-85 -60.02 -48.22 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 72.8 t -57.59 -33.57 45.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 400' ' ' SER . 2.9 mmpt? -74.65 -52.16 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.524 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.75 -25.57 69.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.279 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.534 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 21.7 t80 179.35 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.71 167.11 30.82 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.498 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.494 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.39 -47.83 3.03 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.594 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.77 130.58 5.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 117.742 0.771 . . . . 0.0 112.159 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.49 134.63 5.11 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.97 138.88 14.29 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.577 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.891 HG23 ' CE1' ' A' ' 301' ' ' TYR . 26.6 mt -102.48 127.2 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 417' ' ' VAL . 69.8 mt -87.91 152.54 21.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 112.345 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.3 mtt-85 -68.99 -35.55 76.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.94 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 417' ' ' VAL . 97.0 m-85 -159.84 -171.83 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -66.69 99.3 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.56 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 413' ' ' LEU . 1.5 p -136.57 139.43 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.147 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -104.77 160.95 14.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -69.97 149.86 47.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.993 0.425 . . . . 0.0 110.587 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -60.08 -39.97 87.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.985 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -133.89 -140.21 4.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.563 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 72.3 mtm -111.04 179.93 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.816 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.57 -39.99 95.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.83 61.06 0.6 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.498 ' HB3' ' HG3' ' A' ' 430' ' ' GLU . 47.0 mt-30 -60.05 -40.06 88.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.3 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.54 -93.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.615 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -121.11 -154.58 9.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.764 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.669 0.271 . . . . 0.0 111.462 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.38 60.19 3.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.929 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 425' ' ' GLN . 47.7 mp0 -61.04 -39.96 91.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.454 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 53.7 p90 -140.59 114.99 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.293 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -135.62 116.41 14.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.335 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.99 11.3 9.76 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.062 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.6 mt -70.05 -2.25 12.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.937 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.38 -39.3 69.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -60.01 -39.53 86.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.316 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.61 -32.18 62.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.741 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.94 -45.81 91.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.815 0.34 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.24 -30.04 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -52.02 -44.83 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.645 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.98 -49.92 75.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 111.084 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -77.76 -26.93 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.697 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.591 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 0.1 OUTLIER -59.32 -41.01 88.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.287 0.565 . . . . 0.0 109.917 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.74 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 79.8 mt-10 -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.896 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -39.95 94.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -86.8 -59.16 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -60.76 -55.22 35.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.838 0.352 . . . . 0.0 111.455 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 54.1 mt -59.91 -48.89 86.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.531 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -55.11 -38.34 66.32 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.532 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.421 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 43.3 ttt-85 -59.97 -36.59 77.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 0.0 110.046 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.621 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 11.6 t80 -60.09 -47.77 84.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.635 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -81.87 -36.65 27.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.89 -52.11 61.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.769 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -60.85 -44.63 96.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.397 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 301' ' ' TYR . 97.5 mt -56.38 -24.95 19.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -15.25 33.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 121.471 0.653 . . . . 0.0 109.621 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.817 ' HB2' HG23 ' A' ' 298' ' ' THR . 76.4 mt-30 -100.41 1.36 41.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.443 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.39 32.45 18.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.182 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 296' ' ' GLN . 24.3 p -74.13 -5.65 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 45.51 75.21 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.948 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 37.0 mtmt -122.26 37.9 4.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.883 ' CE1' HG23 ' A' ' 412' ' ' ILE . 73.8 m-85 -162.31 164.26 27.58 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.1 p -149.43 163.55 37.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.2 p90 -137.43 131.13 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 112.39 149.69 10.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.898 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.24 -58.23 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.6 pt-20 -49.33 -55.62 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.0 -52.42 63.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.701 0.286 . . . . 0.0 111.535 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 49.7 m -59.32 -39.96 84.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.091 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.823 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.1 mp -66.26 -42.08 89.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 314' ' ' MET . 24.4 mtmt -59.95 -45.42 92.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.129 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -70.03 -28.61 65.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.899 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.27 -24.97 59.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.985 0.422 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -78.94 -28.91 43.82 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 14.3 mmt -81.2 -8.04 59.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.676 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.67 28.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.742 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.78 -11.22 58.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.835 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.819 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.9 m -90.44 105.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.91 -49.42 77.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.418 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.887 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.3 mm -135.76 127.1 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.611 0.243 . . . . 0.0 111.434 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.674 ' HG ' HG23 ' A' ' 322' ' ' VAL . 55.4 tp -93.69 128.15 39.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.252 0.548 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -115.43 107.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.975 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.674 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.8 t -125.78 161.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.902 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -112.25 132.59 54.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 111.396 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.732 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.3 pt-20 -56.23 -25.92 49.32 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.847 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -90.05 45.28 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.291 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 25.3 tp -89.14 124.2 34.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 110.948 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.16 30.04 2.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.521 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.031 HG22 HD12 ' A' ' 374' ' ' LEU . 20.0 mm -124.52 135.18 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.129 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.645 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 60.5 mtp -140.11 162.32 35.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.623 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.692 ' CZ ' HG21 ' A' ' 343' ' ' ILE . 15.6 ttt85 -88.08 117.12 26.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.029 0.442 . . . . 0.0 111.588 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 6.8 m-85 -125.42 123.39 39.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.347 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.981 HG12 HG13 ' A' ' 343' ' ' ILE . 17.6 m -92.21 121.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 111.436 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.845 HD11 ' CD2' ' A' ' 357' ' ' PHE . 1.1 mp -109.26 148.09 31.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.544 ' CD2' HD11 ' A' ' 369' ' ' ILE . 11.2 m170 -81.35 179.6 7.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.396 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 340' ' ' GLU . 0.1 OUTLIER -142.08 105.63 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 111.208 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 52.27 33.36 12.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.6 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.15 88.14 0.99 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.184 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 339' ' ' GLU . 1.1 p 45.51 -169.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.631 0.253 . . . . 0.0 111.667 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 338' ' ' THR . 5.5 mm-40 77.08 -15.27 0.76 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.941 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 335' ' ' CYS . 6.0 tp10 -158.68 118.22 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.427 ' OE2' ' CD2' ' A' ' 334' ' ' HIS . 3.2 mm-40 -109.23 137.98 46.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.008 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.775 ' C ' HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -128.27 146.62 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.17 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.981 HG13 HG12 ' A' ' 332' ' ' VAL . 1.3 mp -117.91 126.94 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.6 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 46.6 tp -134.8 159.78 40.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.277 0.561 . . . . 0.0 111.279 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.633 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.5 p90 -100.07 119.48 38.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.554 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.592 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -124.33 163.58 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 112.534 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -101.32 170.79 6.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.669 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -49.36 -42.0 41.86 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.836 1.69 . . . . 0.0 111.862 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.2 -50.02 75.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.052 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 48.9 mt-30 -69.38 -50.12 49.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 84.2 mt-10 -59.96 -35.06 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -57.74 -33.18 68.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -95.37 36.22 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.635 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.69 ' HB2' HD13 ' A' ' 368' ' ' LEU . 5.6 ptpt -70.03 -23.65 63.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.239 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.4 m -60.48 -39.99 89.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.461 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 366' ' ' HIS . 99.3 m-70 -99.05 -50.59 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.845 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 53.2 7.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.713 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.807 HG21 ' HB2' ' A' ' 364' ' ' GLN . 0.2 OUTLIER -92.2 -176.87 4.49 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.572 ' H ' HG22 ' A' ' 358' ' ' THR . 96.0 m-20 -82.19 156.89 24.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.978 0.418 . . . . 0.0 110.949 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -75.07 -0.83 20.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.968 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -83.0 -45.89 13.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.452 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 1.0 OUTLIER -113.83 -37.11 4.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.922 0.391 . . . . 0.0 110.454 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 364' ' ' GLN . . . 67.31 27.52 73.52 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.162 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.807 ' HB2' HG21 ' A' ' 358' ' ' THR . 85.7 mt-30 -46.18 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -113.88 107.04 15.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.608 ' CE1' HG23 ' A' ' 358' ' ' THR . 25.2 m80 -91.73 -174.68 3.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -140.72 113.5 8.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.358 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 354' ' ' LYS . 6.2 tt -90.54 123.01 33.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.564 ' HB ' ' CG2' ' A' ' 332' ' ' VAL . 2.4 mp -76.05 -42.42 38.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.486 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -169.56 167.22 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.059 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -142.82 116.38 9.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.999 0.428 . . . . 0.0 110.775 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.7 tpt -120.83 134.93 24.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.276 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.4 Cg_exo -61.01 130.36 32.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.926 1.75 . . . . 0.0 110.412 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.031 HD12 HG22 ' A' ' 328' ' ' ILE . 14.7 mt -69.63 -40.6 76.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.669 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 391' ' ' ILE . 60.1 tp -60.19 -56.1 25.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.902 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.0 mt-10 -57.58 -40.05 78.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.69 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.97 -40.02 91.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.458 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.2 OUTLIER -70.56 -26.87 63.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.43 -8.84 52.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.397 . . . . 0.0 112.005 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -108.23 -9.5 15.51 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 28.0 m120 -129.26 18.03 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.35 -21.02 66.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.595 0.236 . . . . 0.0 111.317 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -77.19 -46.36 23.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -62.87 -41.71 99.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 0.0 110.679 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -74.07 -17.89 60.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.35 69.25 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.209 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.819 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.2 163.07 18.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.887 ' HB ' HG23 ' A' ' 319' ' ' ILE . 90.0 m -106.66 99.84 9.39 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' HD13 ' A' ' 389' ' ' LEU . 2.3 tm? -76.12 102.6 5.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.923 0.392 . . . . 0.0 111.235 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.582 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.4 mm-40 -111.92 132.09 54.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.157 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.732 HG21 ' HB3' ' A' ' 324' ' ' GLU . 37.8 mm -94.97 105.63 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 111.886 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.902 HG23 ' CE2' ' A' ' 323' ' ' TYR . 6.5 m -101.91 -169.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.813 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.582 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.8 p -158.03 154.04 27.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.331 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.47 0.96 3.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.202 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -59.8 -40.87 89.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.618 0.247 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 283' ' ' GLU . 53.5 p -85.51 168.59 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.05 -55.16 37.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 69.6 mm-40 -63.21 -36.07 82.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 109.852 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.527 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -52.72 -59.04 9.75 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.323 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 m -59.59 -19.7 50.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 32.7 mt-30 -69.69 -40.04 76.57 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.069 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.561 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.9 m-85 -62.04 -36.5 81.8 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.03 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.883 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.8 t -60.09 -38.8 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -71.36 -45.63 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.991 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -58.75 -44.83 95.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.99 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 303' ' ' PHE . 60.3 t80 -146.44 -66.26 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.71 57.26 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.808 -1.187 . . . . 0.0 115.165 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 139.78 -36.1 1.86 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.258 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.656 HG12 HG13 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -132.24 133.38 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 117.964 0.882 . . . . 0.0 112.815 -177.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -150.83 136.67 5.69 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.73 143.64 15.95 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.441 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.883 HG23 ' CE1' ' A' ' 301' ' ' TYR . 30.9 mt -104.47 125.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.3 mt -94.98 163.16 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 0.0 112.799 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 74.6 mtt180 -78.48 -38.36 41.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.764 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 89.9 m-85 -158.48 -179.94 8.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.793 ' HG2' ' O ' ' A' ' 298' ' ' THR . 45.8 mtm180 -61.99 124.16 20.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.721 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.422 ' CG2' HD13 ' A' ' 413' ' ' LEU . 33.2 m -130.03 159.98 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.201 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -74.24 129.98 38.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.95 -39.99 75.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 58.24 40.06 25.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.389 . . . . 0.0 110.763 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 134.14 140.15 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 20.9 ptp -159.15 179.91 8.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.749 0.309 . . . . 0.0 110.957 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.56 -33.09 67.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -107.04 107.16 18.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.516 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 2.1 tp-100 -162.59 160.36 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -54.14 -70.97 0.79 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.844 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 165.99 -96.95 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -36.13 76.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.992 0.425 . . . . 0.0 110.495 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.34 24.58 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.837 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.516 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 41.5 tt0 -60.06 -49.4 77.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 432' ' ' PHE . 87.1 m-85 -76.28 -40.09 52.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.443 ' CD2' ' O ' ' A' ' 432' ' ' PHE . 35.1 p90 45.14 69.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.221 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -77.92 6.1 8.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.931 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.28 -3.49 14.1 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.579 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.52 -40.07 81.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 110.47 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.91 -32.27 70.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.335 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.64 -35.8 75.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.02 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.01 -48.01 83.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.936 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 33.8 m120 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.546 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.3 -30.05 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.182 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -52.19 -45.92 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.639 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.96 -49.7 76.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.23 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -77.09 -27.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.758 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.608 HE22 HG13 ' A' ' 392' ' ' VAL . 0.4 OUTLIER -59.07 -39.96 83.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.262 0.553 . . . . 0.0 110.054 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.736 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.6 mt-10 -81.13 -44.0 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -67.44 -40.06 85.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -86.03 -58.65 2.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -61.2 -56.59 18.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.634 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 58.1 mt -59.97 -45.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.69 -37.67 77.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.264 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 -59.96 -36.84 77.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.407 0.622 . . . . 0.0 110.056 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.647 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 8.9 t80 -59.96 -46.07 90.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.683 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -83.68 -37.33 22.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 295' ' ' SER . 53.4 t0 -62.02 -47.39 84.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.829 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.5 mp0 -66.71 -40.0 88.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.72 -22.35 26.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.17 -13.54 58.42 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.347 0.594 . . . . 0.0 109.528 178.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.66 ' HB2' HG23 ' A' ' 298' ' ' THR . 67.9 mt-30 -102.96 -0.71 30.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.541 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.19 30.66 20.47 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 11.3 p -69.73 -12.36 61.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.871 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.17 48.57 85.28 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.123 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.577 ' HA ' HD12 ' A' ' 413' ' ' LEU . 3.2 mtpm? -125.94 37.45 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.89 ' CE1' HG23 ' A' ' 412' ' ' ILE . 82.1 m-85 -160.61 161.54 32.55 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.142 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.7 159.71 41.67 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -135.91 124.84 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.82 153.06 13.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.27 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -57.33 -58.45 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.764 0.316 . . . . 0.0 110.794 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.8 pt-20 -50.41 -53.53 28.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.98 -55.2 27.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 409' ' ' ILE . 21.4 m -57.01 -39.35 74.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.931 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.3 mp -67.54 -42.21 83.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 25.2 mtmt -60.0 -49.94 75.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.792 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.84 -29.27 67.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.63 0.252 . . . . 0.0 110.934 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.752 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -71.76 -26.84 62.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.919 0.39 . . . . 0.0 110.448 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 33.6 mm-40 -79.04 -27.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.2 mmt -80.28 -7.42 59.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.849 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.33 18.15 48.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.258 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.59 11.76 29.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.364 0.266 . . . . 0.0 111.04 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.83 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.0 m -111.33 105.53 18.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 319' ' ' ILE . 59.9 tt0 -59.95 -49.99 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.85 HG23 ' HB ' ' A' ' 388' ' ' THR . 43.5 mm -137.65 126.02 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.618 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.6 tp -90.95 128.79 36.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 111.314 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.775 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -113.5 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.766 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.618 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.9 t -122.68 150.56 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.332 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -98.16 146.06 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 111.144 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.549 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.8 pt-20 -65.95 -33.28 75.45 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.074 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -90.06 41.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 29.3 tp -74.05 122.17 22.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 110.869 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -90.57 24.17 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.074 HG21 HG21 ' A' ' 305' ' ' VAL . 18.5 mm -125.95 131.34 71.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.676 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.743 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 66.7 mtp -140.27 161.76 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.593 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.639 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.6 ttt180 -85.1 116.09 23.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.937 0.398 . . . . 0.0 111.555 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 15.0 m-85 -119.07 119.0 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.042 HG12 HD12 ' A' ' 343' ' ' ILE . 6.2 m -91.05 112.1 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.317 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.874 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.6 OUTLIER -91.99 174.83 7.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.672 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 334' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.38 -179.67 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 34.5 t -126.13 160.99 28.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.719 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -59.47 -39.9 85.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.909 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.11 -16.16 79.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.699 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.7 m 72.59 3.61 4.74 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -111.08 30.59 6.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.43 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -161.08 124.04 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -111.43 135.44 52.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.603 ' C ' HD13 ' A' ' 343' ' ' ILE . 22.2 ttpt -117.87 140.47 49.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.257 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.042 HD12 HG12 ' A' ' 332' ' ' VAL . 7.3 mm -118.12 117.52 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.97 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 346' ' ' LEU . 47.0 tp -131.18 157.68 42.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 112.139 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.91 121.21 40.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.923 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -121.09 161.39 21.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 4.4 p -101.66 169.14 8.06 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.115 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 86.5 Cg_exo -43.67 -53.02 4.75 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.812 1.675 . . . . 0.0 112.162 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.96 -58.8 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.79 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.13 -44.99 95.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.944 0.402 . . . . 0.0 111.36 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.8 mt-10 -60.03 -29.93 68.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.074 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -57.6 -38.67 75.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.382 0.61 . . . . 0.0 109.755 179.619 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 61.3 t0 -78.3 61.98 2.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.211 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.728 ' HG3' HD23 ' A' ' 368' ' ' LEU . 18.2 ttpt -65.3 -50.25 66.39 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.3 m -55.87 -58.24 8.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.513 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 90.9 m-70 -80.48 -49.76 10.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.874 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.6 OUTLIER 53.13 10.35 0.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -178.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.809 HG21 ' H ' ' A' ' 365' ' ' GLU . 0.4 OUTLIER -98.32 -169.02 1.74 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.08 0.467 . . . . 0.0 111.706 -179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 358' ' ' THR . 95.9 m-20 -81.09 162.58 23.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.573 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -74.92 0.89 14.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -85.5 -47.3 10.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.692 0.282 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.459 HG21 ' CG ' ' A' ' 365' ' ' GLU . 1.6 t -115.68 -37.27 3.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.805 0.336 . . . . 0.0 110.517 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 57.4 24.66 52.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.773 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.7 36.03 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.809 ' H ' HG21 ' A' ' 358' ' ' THR . 70.9 mm-40 -125.58 13.05 8.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.456 ' ND1' HG23 ' A' ' 358' ' ' THR . 40.7 m80 -145.96 160.0 42.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.831 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -152.24 123.42 7.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.728 HD23 ' HG3' ' A' ' 354' ' ' LYS . 42.4 tp -95.16 133.56 38.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.058 0.456 . . . . 0.0 111.606 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.932 HD12 ' O ' ' A' ' 332' ' ' VAL . 1.8 mt -95.72 -57.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.615 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.553 ' O ' HG22 ' A' ' 332' ' ' VAL . 9.2 tt0 -160.47 140.22 11.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.085 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 90.9 p -116.19 139.05 50.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.49 0.662 . . . . 0.0 112.041 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -117.83 133.49 23.34 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.204 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 37.7 Cg_exo -58.39 114.29 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.824 1.682 . . . . 0.0 111.108 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.042 HD12 HG22 ' A' ' 328' ' ' ILE . 23.5 mt -60.01 -39.29 85.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.147 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 391' ' ' ILE . 63.3 tp -60.01 -52.27 66.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.61 -39.94 90.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.205 0.526 . . . . 0.0 109.822 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -61.28 -40.02 92.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.569 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -73.54 -24.19 60.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -9.13 53.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.75 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -110.04 -10.02 14.71 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 28.1 m120 -129.29 14.02 6.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -64.4 -18.5 64.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.584 0.23 . . . . 0.0 111.394 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -75.38 -39.97 58.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -67.21 -40.88 86.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.1 m-85 -72.67 -16.36 61.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.52 70.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.894 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.83 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.96 164.45 15.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.271 0.558 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.85 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.7 m -107.19 100.59 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.11 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -71.99 102.87 3.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.384 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.555 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -111.02 138.88 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.877 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 375' ' ' LEU . 36.7 mm -101.92 103.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.623 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.4 m -101.6 -171.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.225 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -156.24 153.75 29.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.473 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.5 p-10 -70.89 2.94 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -60.05 -40.0 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.567 0.222 . . . . 0.0 111.399 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.5 p -84.65 169.86 13.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.358 . . . . 0.0 111.416 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.04 -52.51 65.07 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 65.1 mm-40 -61.64 -38.08 86.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.473 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -63.22 -25.04 67.88 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.792 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.3 m -82.88 -25.7 32.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.529 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.14 -45.21 58.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 287' ' ' ILE . 1.6 m-85 -56.29 -49.6 73.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.522 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 85.2 t -59.86 -35.21 59.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.762 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 400' ' ' SER . 24.3 mmtt -69.9 -49.96 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.203 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.86 -23.84 75.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 11.1 t80 178.76 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 97.87 167.07 31.93 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.674 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.89 -49.2 2.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.025 -0.607 . . . . 0.0 114.191 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -145.15 132.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 117.492 0.646 . . . . 0.0 112.205 -177.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.572 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -152.5 143.33 10.22 Favored Glycine 0 CA--C 1.509 -0.301 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.9 142.07 13.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.57 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.89 HG23 ' CE1' ' A' ' 301' ' ' TYR . 57.2 mt -104.66 128.65 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.805 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.5 mt -87.38 150.16 24.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.784 0.802 . . . . 0.0 112.821 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.715 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 72.7 mtt-85 -69.95 -36.19 75.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.573 ' O ' HG13 ' A' ' 417' ' ' VAL . 96.2 m-85 -159.38 167.04 29.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.772 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mtm180 -55.12 121.91 9.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 415' ' ' TYR . 27.6 m -130.04 158.23 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -110.36 13.94 22.76 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.328 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 60.06 31.42 20.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -70.01 156.12 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.076 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 431' ' ' PHE . . . 87.65 121.21 1.55 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.062 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.1 mmt 60.02 29.04 18.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 111.535 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -152.2 103.84 2.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 61.89 30.1 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.476 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -98.99 139.98 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.78 -29.98 49.82 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -83.27 123.25 6.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -110.76 38.23 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.704 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.97 -40.64 89.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.503 ' CD1' ' HA2' ' A' ' 421' ' ' GLY . 24.9 m-85 -126.61 104.68 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -124.6 103.84 8.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 11.71 19.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.055 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 64.1 mt -73.4 -3.92 30.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.646 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -40.02 87.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 110.632 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.84 -30.6 68.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.0 -33.72 72.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.432 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.97 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.09 124.31 47.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.948 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 34.5 m120 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.771 0.319 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 10.6 p -67.61 -27.44 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.307 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -54.65 -39.97 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.575 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -68.67 -42.33 78.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.904 0.383 . . . . 0.0 111.534 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 278' ' ' VAL . 27.8 pt -82.72 -21.36 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.689 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.612 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -59.92 -40.47 88.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.957 0.408 . . . . 0.0 110.382 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.623 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 24.8 pt-20 -85.62 -38.54 18.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.904 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -70.03 -39.92 75.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -86.22 -57.23 3.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.917 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.0 tp -58.26 -56.31 23.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.079 0.466 . . . . 0.0 111.719 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 392' ' ' VAL . 52.4 mt -59.36 -49.97 81.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.466 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.98 -39.79 89.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.591 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -60.06 -36.49 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.471 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 4.9 t80 -59.08 -45.98 89.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -83.48 -42.32 17.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.864 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 295' ' ' SER . 45.1 t0 -60.72 -47.48 86.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.567 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.685 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 22.9 tp10 -63.06 -39.94 96.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 301' ' ' TYR . 87.7 mt -62.75 -26.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.599 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -60.34 -12.53 9.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 109.957 178.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.805 ' HB2' HG23 ' A' ' 298' ' ' THR . 83.7 mt-30 -98.97 0.04 43.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.466 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.99 29.65 19.25 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.346 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.805 HG23 ' HB2' ' A' ' 296' ' ' GLN . 19.0 p -73.35 -7.75 52.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.958 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.65 53.47 29.02 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.938 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 22.0 mttt -130.2 41.95 3.33 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.6 m-85 -161.78 163.02 29.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.775 0.321 . . . . 0.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.0 p -149.12 161.82 41.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.74 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.837 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 53.0 p90 -141.44 149.99 41.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 96.67 142.19 12.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.171 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.742 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -49.37 -64.12 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.765 0.317 . . . . 0.0 111.238 -179.161 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.1 pt-20 -47.15 -52.89 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.831 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.0 m-20 -64.35 -56.75 12.32 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 26.0 m -58.03 -37.38 74.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.742 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -69.94 -44.0 70.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.603 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.9 mtmm -59.9 -46.44 89.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.585 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.021 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.978 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.81 -24.92 55.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.895 0.378 . . . . 0.0 110.618 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -77.96 -28.32 49.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 89.8 mmm -81.1 -7.37 59.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.731 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.55 16.34 36.38 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.358 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.51 -9.65 58.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.411 0.284 . . . . 0.0 111.207 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.978 HG21 ' CD1' ' A' ' 312' ' ' LEU . 28.0 m -94.94 105.49 17.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.679 ' O ' HD13 ' A' ' 319' ' ' ILE . 43.0 tt0 -58.78 -50.9 72.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.275 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.88 HG23 ' HB ' ' A' ' 388' ' ' THR . 33.0 mm -134.05 127.0 50.96 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.061 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.737 ' HG ' HG23 ' A' ' 322' ' ' VAL . 31.6 tp -92.38 125.6 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.81 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.917 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -106.67 103.85 16.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.244 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.737 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.6 t -124.23 162.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 392' ' ' VAL . 75.9 m-85 -112.67 149.78 32.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 111.905 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.632 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.6 pt-20 -65.91 -40.41 91.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.149 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -89.77 56.49 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.752 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 26.5 tp -89.09 121.75 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -89.15 23.77 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.769 HG22 HD12 ' A' ' 374' ' ' LEU . 4.8 mm -121.62 131.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.6 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.3 mtt -139.48 162.97 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.622 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.5 ttt180 -88.85 116.04 26.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 112.012 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.6 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 9.1 m-85 -123.46 123.77 41.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.097 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.996 HG12 HG13 ' A' ' 343' ' ' ILE . 16.2 m -91.43 117.57 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.144 0.497 . . . . 0.0 111.662 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.924 HD21 ' CD1' ' A' ' 357' ' ' PHE . 5.3 mp -102.76 154.88 18.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.54 ' CE1' HG12 ' A' ' 369' ' ' ILE . 2.0 m-70 -90.66 176.05 6.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.145 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.423 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 7.9 t -112.77 161.85 16.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -44.0 -39.32 4.03 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.847 0.356 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 338' ' ' THR . . . -85.51 -118.43 0.93 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.983 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.2 OUTLIER -164.84 19.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.1 40.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.497 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.423 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 7.4 tp10 -156.9 119.97 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.93 141.51 46.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.791 ' C ' HD12 ' A' ' 343' ' ' ILE . 5.5 tmmm? -128.54 146.88 50.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.394 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.996 HG13 HG12 ' A' ' 332' ' ' VAL . 1.7 mp -123.14 122.89 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.483 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 55.8 tp -130.69 161.65 31.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.342 0.591 . . . . 0.0 111.704 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.596 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 10.3 p90 -97.32 120.04 36.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.627 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -125.33 160.56 29.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.1 p -101.64 172.2 4.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.466 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.0 Cg_exo -46.6 -42.8 23.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.882 1.721 . . . . 0.0 111.92 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -59.22 5.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 88.9 mt-30 -60.37 -49.69 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 89.2 mt-10 -59.97 -31.5 69.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.207 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.55 -39.9 77.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.352 0.596 . . . . 0.0 109.414 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 63.2 t0 -82.76 60.77 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.129 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.641 ' HB2' HD23 ' A' ' 368' ' ' LEU . 9.0 pttp -69.95 -38.77 76.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.12 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 41.3 t -59.48 -58.06 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.616 0.246 . . . . 0.0 111.336 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 55.6 m80 -80.23 -56.98 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.704 0.288 . . . . 0.0 110.769 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.924 ' CD1' HD21 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.58 5.45 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.627 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.817 HG22 ' H ' ' A' ' 359' ' ' ASP . 4.4 m -91.32 -173.22 3.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.817 ' H ' HG22 ' A' ' 358' ' ' THR . 96.0 m-20 -78.69 162.27 26.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.774 0.321 . . . . 0.0 110.451 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -71.93 -3.87 25.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -84.56 -46.39 11.61 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.47 HG21 ' CD ' ' A' ' 365' ' ' GLU . 1.3 t -113.35 -37.33 4.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.976 0.417 . . . . 0.0 110.355 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.515 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 62.74 22.46 64.23 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.85 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.43 ' H ' HG21 ' A' ' 358' ' ' THR . 29.2 mt-30 -156.6 83.65 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.817 ' HB2' HG23 ' A' ' 358' ' ' THR . 81.7 mt-10 -151.03 -28.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.494 ' CB ' HD23 ' A' ' 333' ' ' LEU . 42.7 m170 -123.05 163.09 21.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 46.5 mt-10 -145.08 116.77 8.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 354' ' ' LYS . 56.6 tp -71.42 139.0 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.821 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.9 mp -109.44 -49.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.505 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.628 ' O ' HD11 ' A' ' 368' ' ' LEU . 9.1 tp10 -143.03 166.82 23.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.373 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.4 p -145.15 116.58 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.0 111.611 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.477 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -115.69 130.87 24.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.961 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.579 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.7 Cg_exo -60.72 120.15 7.71 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.03 1.82 . . . . 0.0 110.752 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 328' ' ' ILE . 20.2 mt -61.89 -39.56 92.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.021 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -59.99 -51.88 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.82 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.05 -40.15 88.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.718 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.495 ' O ' ' ND2' ' A' ' 381' ' ' ASN . 85.0 t90 -63.0 -40.01 96.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.651 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.484 ' CZ ' ' HG ' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -70.01 -24.92 63.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.31 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.03 -7.62 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.072 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -105.47 -11.9 16.22 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 377' ' ' TRP . 5.8 p30 -129.65 16.02 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -62.11 -20.49 64.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.93 -44.77 17.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -61.34 -40.57 94.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.704 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.661 ' CD2' HD23 ' A' ' 312' ' ' LEU . 23.5 m-85 -79.96 -12.7 59.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.15 55.44 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.873 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.87 161.54 19.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.103 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.88 ' HB ' HG23 ' A' ' 319' ' ' ILE . 47.2 m -105.64 99.66 9.25 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.5 tm? -74.6 103.55 4.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.115 0.483 . . . . 0.0 111.082 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.612 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.2 mm-40 -110.66 140.47 44.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.911 HD12 HD11 ' A' ' 375' ' ' LEU . 18.2 mm -105.43 104.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.834 HG23 ' CE2' ' A' ' 323' ' ' TYR . 9.3 m -101.09 -170.06 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.879 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.618 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.5 p -154.59 152.51 30.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.42 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.4 p-10 -68.58 3.28 1.91 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.548 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -59.99 -40.1 88.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.645 0.259 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -89.17 167.72 12.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.8 0.334 . . . . 0.0 111.516 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.07 -49.89 75.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 45.6 mp0 -63.47 -39.98 95.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.37 0.605 . . . . 0.0 109.756 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.3 -19.16 63.89 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.664 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.1 m -83.89 -22.46 31.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.017 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -74.23 -39.99 62.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.028 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.558 ' CD2' ' HE2' ' A' ' 406' ' ' PHE . 2.7 m-85 -63.26 -49.62 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.0 -45.92 94.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -73.97 -43.98 56.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.742 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.405 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -66.37 -41.51 94.44 Favored Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.837 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -129.29 -86.91 0.54 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.793 -0.704 . . . . 0.0 109.582 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 160.77 40.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.35 -1.405 . . . . 0.0 115.117 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.573 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 102.9 7.36 44.5 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.035 -1.078 . . . . 0.0 115.424 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.568 ' CD1' HG22 ' A' ' 305' ' ' VAL . 0.4 OUTLIER -144.97 125.34 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.207 1.003 . . . . 0.0 110.449 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.432 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -153.31 145.32 12.63 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -126.35 140.46 12.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.548 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.809 HG23 ' CE1' ' A' ' 301' ' ' TYR . 56.6 mt -99.11 127.52 51.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 34.9 mt -92.08 165.66 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.476 0.655 . . . . 0.0 112.345 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -91.6 -27.19 18.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.522 ' O ' HG13 ' A' ' 417' ' ' VAL . 64.7 t80 -164.49 162.96 22.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 298' ' ' THR . 6.0 mmm180 -56.8 120.36 7.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.0 159.94 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.501 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -63.67 130.01 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.982 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -70.64 -52.49 20.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.416 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 28.1 pt20 -159.92 163.71 34.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -51.06 123.46 17.48 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.845 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 39.9 mtt -128.43 168.08 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.8 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.11 -39.97 88.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.655 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -92.86 -4.29 53.15 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 420' ' ' GLN . 1.7 tp-100 -59.99 -41.36 91.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.307 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 70.99 79.09 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.564 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -167.46 105.09 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.44 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.97 -39.98 87.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.353 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.65 16.42 24.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.188 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.0 -49.95 75.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.556 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.03 -31.52 69.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -81.41 107.9 14.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -82.82 7.51 14.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.339 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.69 -9.76 39.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.775 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -39.97 87.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.01 -31.37 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.355 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -59.91 -31.88 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.745 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.06 -49.91 75.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.266 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -109.09 130.17 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.764 0.316 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 282' ' ' GLN . 7.1 p -67.09 -30.24 48.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -48.9 -44.29 40.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.97 -49.94 75.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.332 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 285' ' ' LYS . 46.8 pt -83.06 -20.99 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.687 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.591 ' N ' ' O ' ' A' ' 278' ' ' VAL . 0.6 OUTLIER -59.45 -39.57 84.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 -179.13 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.587 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 59.7 mt-10 -78.97 -30.27 44.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -52.17 6.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 281' ' ' ILE . 15.0 mtpt -70.01 -56.98 5.56 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 321' ' ' ILE . 23.7 tp -57.83 -54.93 41.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.317 0.579 . . . . 0.0 110.804 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 398' ' ' GLU . 11.0 mt -63.46 -45.34 98.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.248 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.31 -39.48 82.55 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.604 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -59.98 -37.77 80.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 21.7 t80 -60.05 -47.18 86.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.524 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -86.27 -35.92 19.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 295' ' ' SER . 26.2 t0 -66.22 -46.26 77.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 111.306 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.692 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 10.5 tp10 -65.7 -39.93 91.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 301' ' ' TYR . 86.3 mt -62.22 -25.41 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.63 -14.72 14.82 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.28 0.562 . . . . 0.0 109.806 178.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.649 ' HB2' HG23 ' A' ' 298' ' ' THR . 51.4 mt-30 -98.2 -0.06 44.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.748 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.69 29.97 19.31 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.974 0.416 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 296' ' ' GLN . 32.0 p -70.66 -12.05 61.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.949 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.26 47.78 89.17 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.72 -1.229 . . . . 0.0 114.442 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.751 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 16.8 ptpt -130.46 45.04 2.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.13 0.465 . . . . 0.0 110.783 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.841 ' CE1' HG23 ' A' ' 412' ' ' ILE . 87.3 m-85 -160.94 161.09 31.54 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.911 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 3.6 p -144.61 160.62 40.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.405 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 48.7 p90 -134.51 124.16 25.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.849 0.357 . . . . 0.0 110.819 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.509 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 113.79 155.1 11.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -59.91 -56.76 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.843 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.503 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -49.57 -57.46 7.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.482 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 88.0 m-20 -60.06 -52.2 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 33.5 m -59.99 -40.03 87.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.138 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.976 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.0 mp -66.01 -46.72 76.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -57.64 -50.46 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.027 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -65.18 -31.28 72.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.354 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.932 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.71 -24.29 59.9 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -79.73 -27.41 40.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.1 mmt -80.89 -8.83 59.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.313 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.55 15.16 38.61 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.518 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.723 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -86.52 -8.8 57.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.134 . . . . 0.0 111.322 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.7 m -92.03 103.91 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.844 0.354 . . . . 0.0 111.708 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.672 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.3 tt0 -58.68 -49.96 75.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.552 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.5 mm -133.75 126.6 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.545 0.212 . . . . 0.0 111.171 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.68 ' HG ' HG23 ' A' ' 322' ' ' VAL . 47.5 tp -92.03 124.04 35.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 1.031 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -111.41 105.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.584 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.68 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.4 t -116.51 159.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.833 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 70.2 m-85 -107.14 144.82 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -71.28 160.87 32.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.526 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.0 22.98 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.803 0.335 . . . . 0.0 110.445 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 24.4 tp -54.78 125.26 19.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.74 26.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.001 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.982 HG21 HG21 ' A' ' 305' ' ' VAL . 12.3 mm -130.76 130.57 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.537 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.633 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 9.9 mtt -139.68 162.66 34.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.582 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt180 -85.28 118.08 24.6 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 120.728 0.299 . . . . 0.0 111.662 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.816 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 43.8 m-85 -124.92 122.07 36.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.424 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.907 HG12 HG13 ' A' ' 343' ' ' ILE . 23.7 m -93.0 117.54 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 0.0 111.161 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.2 mm? -100.27 149.61 23.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.062 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.563 ' CG ' HD11 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -88.85 -176.0 5.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 28.9 t -126.39 158.91 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -60.0 -39.94 87.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.43 -19.41 60.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.953 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 339' ' ' GLU . 0.3 OUTLIER 78.33 179.29 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.535 ' H ' HG22 ' A' ' 338' ' ' THR . 65.1 mt-10 61.82 35.77 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 0.0 110.426 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -163.69 121.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.949 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -112.19 138.11 49.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 0.0 111.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.803 ' C ' HD12 ' A' ' 343' ' ' ILE . 17.4 tttp -124.79 146.71 49.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.483 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.907 HG13 HG12 ' A' ' 332' ' ' VAL . 1.1 mp -119.46 120.03 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 59.9 tp -130.91 151.17 51.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.626 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.546 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.62 116.95 29.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.54 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 1.9 mm? -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.456 0.645 . . . . 0.0 112.58 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.5 p -100.41 169.7 7.59 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.96 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.5 Cg_exo -47.71 -46.07 22.11 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 121.943 1.762 . . . . 0.0 112.953 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 350' ' ' GLN . 23.9 pm0 -64.4 -41.72 96.48 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 349' ' ' GLU . 40.3 mt-30 -84.62 -48.18 9.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.816 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 3.5 tm-20 -60.96 -27.8 68.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 348' ' ' PRO . 1.3 ttmp? -56.46 -30.02 62.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 109.807 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.559 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 58.6 t0 -88.34 63.52 7.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.1 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.641 ' HG2' HD13 ' A' ' 368' ' ' LEU . 20.2 mtmt -69.97 -40.48 75.35 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.8 t -60.2 -57.96 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.051 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.559 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 80.1 m80 -82.16 -45.27 15.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.387 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 52.59 12.56 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.23 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.4 m -104.77 -175.35 2.77 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.339 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.647 ' H ' HG22 ' A' ' 358' ' ' THR . 82.0 m-20 -130.05 138.76 50.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -72.84 -3.48 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.28 -26.41 13.32 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.604 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.2 t -120.4 -36.9 3.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.469 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.22 39.73 22.2 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.752 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.582 ' O ' HG23 ' A' ' 358' ' ' THR . 60.2 mm-40 -54.48 -167.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 0.0 111.111 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 52.1 mt-10 -138.74 116.52 11.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 73.4 m80 -159.3 147.09 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 68.3 mt-10 -141.94 105.36 4.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.288 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 331' ' ' TYR . 2.9 tt -64.66 119.84 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.804 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.563 HD11 ' CG ' ' A' ' 334' ' ' HIS . 2.5 mt -108.37 -50.02 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.491 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 39.1 mt-10 -137.97 155.4 48.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.333 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.566 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 1.4 m -148.26 116.66 6.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.187 0.518 . . . . 0.0 111.767 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.1 tpt -113.6 129.11 24.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.2 Cg_exo -56.0 120.51 8.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.805 1.67 . . . . 0.0 110.981 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 305' ' ' VAL . 32.6 mt -62.03 -40.06 94.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.956 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 391' ' ' ILE . 50.4 tp -60.8 -55.65 30.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.3 mt-10 -59.79 -40.05 86.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.874 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -60.93 -39.92 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.982 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.559 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.1 m-85 -72.82 -27.12 61.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.214 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.54 -10.81 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.42 -9.75 15.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 20.69 5.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.567 0.222 . . . . 0.0 111.47 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -69.0 -17.65 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.09 -43.45 17.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.84 -41.47 99.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.466 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.6 m-85 -78.5 -15.84 58.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.805 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.34 2.21 66.97 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.52 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.62 162.66 18.73 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.164 0.507 . . . . 0.0 110.601 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 71.5 m -107.13 100.57 10.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.371 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.0 OUTLIER -72.19 105.53 4.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.389 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.476 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 14.3 mm-40 -111.39 143.5 42.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.774 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 375' ' ' LEU . 18.6 mm -107.37 100.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 287' ' ' ILE . 18.6 m -100.54 -170.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.267 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.553 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.6 OUTLIER -160.35 157.1 27.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.945 0.403 . . . . 0.0 111.748 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.43 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.0 p-10 -71.5 -0.12 9.74 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.496 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.25 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 54.3 p -78.88 168.07 20.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.778 0.323 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.97 -51.0 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 110.725 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.794 ' HG3' HG22 ' A' ' 287' ' ' ILE . 13.1 tp10 -70.07 -34.72 73.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -51.84 -57.21 13.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.8 m -60.7 -19.65 59.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.536 . . . . 0.0 112.073 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 36.6 mt-30 -70.3 -40.06 74.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.967 0.413 . . . . 0.0 110.467 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.608 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -59.6 -46.43 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.376 179.23 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.546 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 76.3 t -58.97 -33.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -69.14 -51.06 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.033 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -71.13 -22.1 78.47 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.637 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.509 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.0 t80 176.65 -77.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.48 168.33 31.33 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.52 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.32 -48.59 2.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.277 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.61 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -144.22 132.33 17.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 117.495 0.648 . . . . 0.0 112.383 -177.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.59 137.51 6.29 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.55 139.39 12.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.392 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 321' ' ' ILE . 56.2 mt -101.32 127.72 54.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 66.6 mt -91.6 168.77 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.719 . . . . 0.0 112.645 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -67.29 -40.05 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.742 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.652 ' O ' ' HB3' ' A' ' 300' ' ' LYS . 58.1 t80 -172.09 -60.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.724 0.297 . . . . 0.0 111.574 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -164.81 128.2 2.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.846 0.355 . . . . 0.0 110.643 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.723 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -130.03 159.99 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.538 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.49 134.65 57.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.32 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 419' ' ' PHE . 58.1 t80 -80.78 -5.76 57.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.385 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 65.9 29.63 10.26 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.844 0.354 . . . . 0.0 111.257 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 430' ' ' GLU . . . 69.26 -176.86 30.07 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.509 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.42 ' H ' ' HB2' ' A' ' 425' ' ' GLN . 27.9 mtt -135.12 169.15 17.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.039 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.01 -40.04 87.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.311 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -99.15 7.52 45.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.42 ' HB2' ' H ' ' A' ' 422' ' ' MET . 7.1 tp-100 -59.98 -39.98 87.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.747 0.308 . . . . 0.0 111.263 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 155.95 -77.68 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.609 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 430' ' ' GLU . . . -141.42 -161.04 8.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.539 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.63 54.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 427' ' ' GLY . 2.4 mt-10 -62.85 -43.74 97.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.396 . . . . 0.0 110.918 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -128.43 106.25 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 24.8 p90 -122.5 98.55 5.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.371 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 9.4 27.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.395 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.97 -18.16 43.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.63 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -81.1 -20.07 42.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.656 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.98 -38.45 82.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.028 0.442 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.98 -46.86 88.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -72.2 146.75 47.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 50.7 t30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.803 0.335 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.932 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.3 p -69.95 -30.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.533 ' HE2' HE21 ' A' ' 282' ' ' GLN . 6.0 mmtt -42.48 -30.01 0.31 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.94 -60.0 2.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.747 0.308 . . . . 0.0 111.473 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -82.31 -21.13 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.767 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.932 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -58.5 -40.23 82.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.127 0.489 . . . . 0.0 110.491 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.429 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.0 tt0 -71.39 -38.28 71.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -78.98 -55.36 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -67.76 -58.58 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.142 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.931 ' HG ' HD13 ' A' ' 321' ' ' ILE . 17.6 tp -52.62 -57.6 9.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 111.371 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.564 HG23 ' CD1' ' A' ' 402' ' ' PHE . 25.7 mt -61.69 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.878 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.9 -38.67 60.51 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 36.6 ttt180 -60.08 -39.95 87.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.204 0.526 . . . . 0.0 110.286 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.598 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.7 t80 -55.82 -47.85 76.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.685 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 33.6 m-85 -83.59 -37.83 22.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -61.22 -42.23 98.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.429 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.709 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.2 mt-10 -69.89 -42.14 73.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.999 0.428 . . . . 0.0 109.882 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.4 mt -60.16 -24.6 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -62.9 -15.95 57.14 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.244 0.545 . . . . 0.0 109.871 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.678 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -101.9 0.76 35.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.521 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.3 29.86 19.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 110.157 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.751 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.4 p -67.02 -10.15 46.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.997 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.55 49.57 60.46 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.841 -1.171 . . . . 0.0 113.374 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.7 mtmt -130.36 38.93 3.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.916 ' CE2' HG23 ' A' ' 412' ' ' ILE . 84.5 m-85 -160.88 161.42 31.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.252 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.66 163.25 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.6 p90 -137.65 130.88 30.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.69 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.463 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 109.35 142.46 9.68 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.361 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -50.17 -60.31 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 111.208 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 9.9 pt-20 -47.31 -54.04 12.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.629 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.08 -53.93 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 111.521 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 409' ' ' ILE . 40.6 m -58.36 -39.08 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.096 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.891 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.5 mp -65.93 -42.79 89.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.0 mtmm -59.96 -49.99 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.38 -29.35 69.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.29 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.958 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.07 -24.81 58.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.77 0.319 . . . . 0.0 110.733 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 76.8 mm-40 -79.39 -27.96 41.87 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 34.1 mmt -80.51 -7.57 59.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.759 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.97 18.33 47.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.409 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.63 -1.3 57.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.388 0.275 . . . . 0.0 111.371 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.958 HG21 ' CD1' ' A' ' 312' ' ' LEU . 30.3 m -100.3 104.3 15.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 319' ' ' ILE . 9.4 tp10 -57.71 -50.89 71.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.321 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.4 mm -135.4 126.85 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.643 0.259 . . . . 0.0 111.221 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.662 ' HG ' HG23 ' A' ' 322' ' ' VAL . 48.6 tp -92.74 126.43 37.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 111.634 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.931 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -112.67 106.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.662 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.8 t -124.8 161.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.155 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.4 m-85 -108.19 146.1 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 11.4 pt-20 -65.02 -34.11 77.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.9 47.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.585 HD11 HD11 ' A' ' 409' ' ' ILE . 31.1 tp -81.01 123.15 28.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.577 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -93.07 25.67 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 24.3 mm -123.18 132.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.666 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.5 mtm -140.35 162.09 36.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.4 ttt85 -89.7 119.99 30.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.105 0.479 . . . . 0.0 111.572 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 9.9 m-85 -127.11 123.09 36.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.485 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.998 HG12 HD12 ' A' ' 343' ' ' ILE . 14.2 m -92.8 114.29 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.214 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 333' ' ' LEU . 1.7 mm? -93.58 160.5 14.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 111.654 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.534 ' CD2' HD11 ' A' ' 369' ' ' ILE . 0.1 OUTLIER -108.69 -170.34 1.65 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.942 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 48.8 t -121.48 160.77 23.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.714 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -87.05 -11.93 69.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.631 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.9 m 74.1 30.0 1.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -129.01 25.56 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.004 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 6.9 tp10 -160.87 125.37 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.139 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -118.72 140.78 49.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.01 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.837 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.0 pttt -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.788 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.998 HD12 HG12 ' A' ' 332' ' ' VAL . 2.8 mm -120.05 119.31 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.525 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.745 HD23 HD11 ' A' ' 346' ' ' LEU . 54.9 tp -131.19 161.83 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.445 0.64 . . . . 0.0 112.153 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.739 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.8 p90 -99.97 121.15 40.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.047 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.921 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -127.42 160.61 30.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.625 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.2 p -101.5 172.49 4.39 Favored Pre-proline 0 N--CA 1.455 -0.177 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.588 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.6 Cg_exo -49.5 -43.22 39.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.035 1.823 . . . . 0.0 112.414 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -61.57 -49.27 77.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.921 ' HG2' HD12 ' A' ' 346' ' ' LEU . 10.9 tp60 -70.03 -48.1 59.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 75.3 mt-10 -57.52 -33.6 68.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.583 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.78 -39.44 84.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.889 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -79.72 67.68 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.217 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.622 ' HE2' HD23 ' A' ' 368' ' ' LEU . 1.7 mtpm? -70.05 -37.43 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.71 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 93.2 p -56.23 -52.09 65.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.916 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.471 ' C ' ' H ' ' A' ' 358' ' ' THR . 79.1 m80 -88.29 -58.04 2.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.309 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.57 ' CE1' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 57.51 -3.28 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.84 HG21 ' N ' ' A' ' 364' ' ' GLN . 13.4 t -88.34 -162.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 0.0 111.472 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 363' ' ' GLY . 55.2 m-20 -95.63 161.57 13.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.453 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -75.78 -6.42 50.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.991 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -73.41 -41.76 62.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.681 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 2.4 t -116.61 -34.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 358' ' ' THR . . . 63.45 21.67 64.83 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.767 -0.652 . . . . 0.0 113.122 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.84 ' N ' HG21 ' A' ' 358' ' ' THR . 84.3 mt-30 -54.99 -172.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.04 0.448 . . . . 0.0 111.717 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -117.28 134.86 54.31 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.437 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -127.0 176.85 7.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -137.21 109.8 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.622 HD23 ' HE2' ' A' ' 354' ' ' LYS . 34.1 tp -72.93 132.79 43.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 111.103 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.831 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.1 mp -89.03 -53.77 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.159 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 371' ' ' SER . 33.7 tt0 -147.51 166.54 26.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.711 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.2 p -143.62 116.99 9.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.084 0.468 . . . . 0.0 110.97 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.402 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.9 tpt -117.17 130.04 24.91 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.875 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.8 Cg_exo -60.02 125.17 16.9 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.832 1.688 . . . . 0.0 110.922 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.028 HD12 HG22 ' A' ' 328' ' ' ILE . 27.4 mt -66.49 -39.86 88.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.91 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 391' ' ' ILE . 65.0 tp -60.05 -52.16 66.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.6 mt-10 -58.89 -39.99 83.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.887 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.468 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 76.6 t-105 -62.84 -40.83 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.618 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.55 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -70.31 -27.76 64.64 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -10.01 47.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.177 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -104.18 -12.78 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.976 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.468 ' ND2' ' CE2' ' A' ' 377' ' ' TRP . 79.1 m-20 -129.64 19.93 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -65.51 -19.71 66.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.568 0.223 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.77 -44.93 17.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.05 -39.93 91.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.655 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -79.92 -13.14 59.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.84 2.26 56.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.305 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.918 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.02 163.16 18.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 110.649 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.884 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.5 m -107.82 100.41 9.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.3 tm? -75.35 102.3 5.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.111 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -108.43 139.46 43.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.827 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 375' ' ' LEU . 40.0 mm -103.49 104.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.388 0.613 . . . . 0.0 112.432 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CE1' ' A' ' 323' ' ' TYR . 6.0 m -101.65 -169.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.917 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.55 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -156.16 153.08 28.71 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.958 0.409 . . . . 0.0 111.511 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 403' ' ' VAL . 11.8 p-10 -72.87 17.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -70.03 -39.92 75.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.78 0.324 . . . . 0.0 111.235 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.5 t -89.26 170.04 10.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.678 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.0 -50.03 75.34 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.478 ' C ' HG21 ' A' ' 287' ' ' ILE . 66.8 mm-40 -64.51 -40.38 95.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.163 0.506 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.541 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.31 -18.53 63.13 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.442 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.1 m -83.98 -21.74 31.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.848 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.52 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 84.4 mt-30 -75.14 -41.35 58.49 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.835 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.617 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 3.3 m-85 -59.73 -42.75 93.82 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.792 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 57.7 t -60.01 -39.99 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.665 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -40.04 64.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.78 96.87 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.117 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.463 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 62.5 t80 -151.6 -68.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.792 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.14 58.29 0.18 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 119.965 -1.112 . . . . 0.0 114.916 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 140.78 -34.13 1.98 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 119.387 -1.387 . . . . 0.0 115.214 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -137.98 134.9 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.944 0.872 . . . . 0.0 112.997 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -151.86 142.92 9.85 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -125.72 145.95 15.97 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 119.781 -1.199 . . . . 0.0 113.887 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.916 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.5 mt -107.03 127.09 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 24.6 mt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.735 0.779 . . . . 0.0 112.753 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.428 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 64.8 mtm180 -70.15 -39.97 75.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.55 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.3 p90 -159.86 175.48 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 298' ' ' THR . 15.5 mtm180 -57.66 123.89 17.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.39 . . . . 0.0 111.197 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.471 ' CG2' HD13 ' A' ' 413' ' ' LEU . 33.2 m -130.05 160.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 128.5 36.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.592 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.13 149.82 30.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -80.01 159.93 26.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -60.7 134.74 49.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.499 ' H ' ' HB3' ' A' ' 425' ' ' GLN . 45.8 mtt -118.89 169.65 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.672 0.272 . . . . 0.0 110.684 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.01 -42.58 94.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 0.0 111.076 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -69.89 -34.79 74.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.008 0.432 . . . . 0.0 110.567 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.499 ' HB3' ' H ' ' A' ' 422' ' ' MET . 48.6 tt0 -65.64 128.77 37.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.982 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 45.88 -105.17 0.08 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 155.08 -100.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.53 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -38.94 84.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.18 23.93 13.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 422' ' ' MET . 1.2 tt0 -59.94 -44.4 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 20.7 p90 -106.38 83.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.769 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -106.28 22.18 16.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.71 45.16 0.67 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.489 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.8 mt -78.26 -3.81 44.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.467 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -39.95 87.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 110.434 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.0 -32.74 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.331 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.57 -33.6 71.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.363 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.97 -47.44 85.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.922 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -59.92 -40.04 87.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.957 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.847 0.356 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.0 p -67.46 -26.81 36.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -40.23 74.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.664 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -50.07 75.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.468 ' HB ' ' HE2' ' A' ' 285' ' ' LYS . 41.9 pt -78.33 -27.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.547 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -51.91 -45.89 64.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.725 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 58.9 mt-10 -73.82 -39.65 63.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.782 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -73.4 -43.85 59.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.468 ' HE2' ' HB ' ' A' ' 281' ' ' ILE . 38.1 mttm -87.07 -58.44 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 319' ' ' ILE . 25.6 tp -57.41 -57.09 14.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.454 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 60.6 mt -60.12 -50.11 81.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.846 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.433 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.82 -36.13 78.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.716 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.402 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 10.2 ttt180 -60.08 -38.14 81.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.306 0.574 . . . . 0.0 110.291 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 5.6 t80 -59.93 -45.52 92.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.972 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -83.13 -35.14 25.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.3 t0 -65.39 -45.31 84.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -68.95 -40.08 79.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 85.8 mt -60.63 -24.05 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.09 -13.69 49.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.321 0.582 . . . . 0.0 109.642 178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -102.63 -0.02 32.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.583 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 58.54 30.63 20.04 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.062 0.458 . . . . 0.0 110.229 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 296' ' ' GLN . 14.1 p -70.04 -9.71 56.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.47 42.96 94.15 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.839 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.4 mtmt -121.25 38.03 4.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.92 ' CE1' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -161.81 164.19 28.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.7 p -147.01 163.79 35.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.403 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 47.6 p90 -137.72 128.52 27.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.838 0.351 . . . . 0.0 110.816 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.553 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.76 151.69 12.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -58.91 -56.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.598 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.2 pt-20 -51.11 -53.74 31.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.18 -52.24 59.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.735 0.302 . . . . 0.0 111.307 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 409' ' ' ILE . 33.6 m -59.42 -39.76 84.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.91 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -67.51 -43.8 80.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.436 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -59.23 -49.36 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.778 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.7 64.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.31 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.801 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.95 -26.32 59.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.783 0.325 . . . . 0.0 110.691 179.213 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 73.9 mm-40 -76.83 -28.1 55.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.4 mmt -81.43 -7.38 59.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.899 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.03 13.51 27.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.72 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.13 -4.77 57.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.486 0.184 . . . . 0.0 110.914 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.8 m -98.93 107.11 19.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.668 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.9 tt0 -59.9 -50.03 75.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.779 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.857 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.7 mm -135.8 127.28 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 111.53 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.678 ' HG ' HG23 ' A' ' 322' ' ' VAL . 49.6 tp -93.23 128.22 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.482 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.774 HD11 HD11 ' A' ' 412' ' ' ILE . 1.3 mt -114.07 107.87 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.678 HG23 ' HG ' ' A' ' 320' ' ' LEU . 19.0 t -125.3 149.15 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.327 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.625 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.6 m-85 -99.89 132.61 45.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.596 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 13.6 pt-20 -53.58 -29.6 38.24 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.4 45.33 1.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 38.9 tp -83.71 121.54 27.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.376 . . . . 0.0 110.645 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -91.26 23.54 3.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.953 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 19.6 mm -119.97 136.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.563 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.723 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.5 mtt -139.05 161.94 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpm_? -90.05 114.27 26.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 371' ' ' SER . 33.3 m-85 -109.29 145.63 35.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.88 HG12 HD12 ' A' ' 343' ' ' ILE . 2.7 m -109.7 109.34 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.311 0.577 . . . . 0.0 111.361 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.932 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.5 OUTLIER -97.14 175.07 6.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.411 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.83 ' CD2' HD11 ' A' ' 369' ' ' ILE . 32.6 m170 -113.27 170.01 8.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 49.4 t -105.65 160.55 15.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.56 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.14 -38.77 40.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.349 . . . . 0.0 110.883 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 338' ' ' THR . . . -82.47 -108.35 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.234 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.2 OUTLIER -178.54 36.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -156.37 46.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 4.4 tp10 -170.84 113.64 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.699 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.13 139.06 35.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.058 0.456 . . . . 0.0 111.005 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.649 ' O ' HD13 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -115.02 141.43 48.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.984 -179.38 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.88 HD12 HG12 ' A' ' 332' ' ' VAL . 8.8 mm -120.72 121.46 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.02 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 346' ' ' LEU . 53.0 tp -130.09 161.02 31.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 0.0 112.13 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.565 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.2 p90 -103.78 119.78 39.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.076 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -123.29 158.24 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.5 p -101.86 173.34 3.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.4 Cg_exo -45.45 -46.7 14.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.997 1.798 . . . . 0.0 112.27 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.39 -58.55 8.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.365 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 46.3 mt-30 -60.93 -47.31 87.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.644 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 76.9 mt-10 -59.76 -34.98 73.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.443 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -57.46 -29.77 64.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -92.31 40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.956 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.665 ' HA ' ' CD1' ' A' ' 357' ' ' PHE . 15.9 pttt -64.13 -28.66 69.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 55.1 m -60.04 -39.99 87.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.748 0.309 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -106.81 -54.31 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.668 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.932 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 61.19 5.12 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.701 -178.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.724 HG21 ' N ' ' A' ' 364' ' ' GLN . 13.5 m -87.59 -178.9 6.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.458 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.718 ' H ' HG22 ' A' ' 358' ' ' THR . 96.0 m-20 -79.07 161.83 26.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.825 0.345 . . . . 0.0 110.315 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -74.64 -2.07 24.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.572 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -84.16 -46.07 12.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.09 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.82 -36.3 4.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.91 0.386 . . . . 0.0 110.844 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 62.78 21.7 63.43 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.881 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.724 ' N ' HG21 ' A' ' 358' ' ' THR . 23.0 mt-30 -156.07 83.14 1.0 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.821 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.638 ' HB2' HG23 ' A' ' 358' ' ' THR . 61.7 mm-40 -151.51 -47.59 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -101.73 169.92 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.59 119.33 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.347 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.727 ' HA ' HD12 ' A' ' 333' ' ' LEU . 2.4 tm? -83.82 127.88 34.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.213 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.83 HD11 ' CD2' ' A' ' 334' ' ' HIS . 3.5 mt -93.2 -49.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.547 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.795 ' O ' HG22 ' A' ' 332' ' ' VAL . 22.5 tt0 -179.36 153.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.028 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.91 ' HB2' ' CD2' ' A' ' 331' ' ' TYR . 17.5 t -125.42 148.09 48.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.449 ' HE3' ' HA ' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.87 128.82 25.67 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.152 179.286 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.723 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 71.7 Cg_exo -50.23 112.8 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.78 1.653 . . . . 0.0 111.153 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.984 HD13 HG11 ' A' ' 305' ' ' VAL . 14.5 mt -58.82 -40.04 82.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.388 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.625 HD11 HD12 ' A' ' 391' ' ' ILE . 65.6 tp -60.08 -52.49 65.11 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.305 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.4 mt-10 -60.94 -39.94 91.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 110.125 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -61.11 -40.01 92.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.596 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.5 OUTLIER -71.48 -23.45 61.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.571 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -8.77 53.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.994 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -108.34 -10.3 15.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.03 20.35 5.41 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -67.42 -20.16 65.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -79.88 -43.61 21.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -60.82 -40.03 91.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.675 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -80.15 -11.38 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.4 2.46 54.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.302 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.836 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.73 163.37 17.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.194 0.521 . . . . 0.0 110.62 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.857 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.0 m -107.8 100.37 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.0 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 389' ' ' LEU . 2.1 tm? -73.76 102.63 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.552 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.9 mm-40 -108.84 139.44 43.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.408 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.625 HD12 HD11 ' A' ' 375' ' ' LEU . 16.4 mm -102.94 101.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.625 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.5 m -102.75 -172.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.587 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.607 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 14.6 p -156.99 152.41 26.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.337 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.9 t0 -78.91 76.96 5.39 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -119.22 -49.66 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.0 m -88.05 -176.78 5.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 15.2 mm100 -59.43 -46.01 89.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.693 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.518 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 52.3 mp0 -64.5 -40.48 95.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -61.34 -27.69 68.11 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 72.9 m -83.87 -22.97 31.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.677 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 77.8 mt-30 -72.45 -40.62 66.88 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.501 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.637 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.1 m-85 -67.38 -49.96 61.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.443 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 394' ' ' ASP . 69.7 t -59.22 -38.14 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.467 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 400' ' ' SER . 8.6 mmpt? -69.96 -51.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.143 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.45 -26.2 69.35 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.543 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.553 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 17.0 t80 179.09 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 96.85 167.11 33.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.499 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.427 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.06 -48.69 2.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.031 -0.604 . . . . 0.0 114.28 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -147.44 131.43 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.383 0.592 . . . . 0.0 111.985 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.33 135.03 5.17 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.21 140.48 15.47 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.316 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.92 HG23 ' CE1' ' A' ' 301' ' ' TYR . 44.5 mt -103.5 125.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.849 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.1 mt -87.58 151.37 23.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.484 0.659 . . . . 0.0 112.264 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.571 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 63.4 mtt-85 -71.62 -33.9 69.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.632 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 417' ' ' VAL . 51.8 t80 -169.0 166.06 11.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -53.42 132.73 40.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 111.148 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.3 m -130.02 160.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -78.67 127.81 32.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.324 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -69.95 -40.02 75.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.074 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -104.2 142.8 33.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -81.8 -42.13 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.473 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 ptp -150.04 162.86 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.21 -32.45 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -113.62 82.39 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.65 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.463 ' CB ' ' HG2' ' A' ' 430' ' ' GLU . 20.5 mt-30 -70.01 -39.99 75.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.416 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.84 68.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.781 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.08 -175.48 17.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.905 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.06 -40.1 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 -76.13 60.63 1.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.512 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 425' ' ' GLN . 48.4 mt-10 -59.79 -41.14 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.708 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.438 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 51.3 p90 -144.32 114.74 7.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.357 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 19.0 p90 -133.59 85.7 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.273 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -90.08 15.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.459 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 53.5 mt -65.87 -9.46 29.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.804 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.481 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -78.41 -21.18 49.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -59.92 -38.33 82.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.04 0.448 . . . . 0.0 110.284 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.99 -44.99 94.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.954 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.06 -40.03 88.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.887 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 32.4 m120 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -66.29 -27.58 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.67 -46.87 74.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.568 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.443 ' CD2' ' HE3' ' A' ' 395' ' ' LYS . 51.8 t80 -60.03 -49.09 79.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 278' ' ' VAL . 48.5 pt -76.45 -21.47 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.0 OUTLIER -51.05 -39.58 56.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.815 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 mp0 -69.98 -46.73 64.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -49.16 78.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -74.55 -58.83 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.737 ' HG ' HD13 ' A' ' 321' ' ' ILE . 40.6 tp -61.32 -58.84 6.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.957 0.408 . . . . 0.0 112.079 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.638 HD13 ' HA2' ' A' ' 399' ' ' GLY . 41.3 mt -59.99 -41.24 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.154 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 398' ' ' GLU . . . -57.1 -38.92 88.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.358 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 53.9 ttt-85 -60.02 -38.7 83.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.283 0.563 . . . . 0.0 109.767 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.637 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 8.3 t80 -60.01 -46.14 90.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -80.79 -35.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.3 t0 -60.01 -49.86 76.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.576 0.227 . . . . 0.0 111.572 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.623 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.1 mt-10 -61.75 -43.11 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 94.5 mt -57.76 -27.9 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.448 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -63.69 -14.61 53.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.283 0.563 . . . . 0.0 109.56 178.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.623 ' HB2' HG23 ' A' ' 298' ' ' THR . 56.8 mt-30 -105.96 -2.46 22.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.653 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.85 32.44 21.27 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.033 0.444 . . . . 0.0 110.405 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.9 p -69.82 -14.31 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.841 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.73 46.36 94.64 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 119.869 -1.157 . . . . 0.0 113.363 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.545 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 49.2 mttp -122.68 33.97 5.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.4 m-85 -159.87 161.06 34.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.618 0.247 . . . . 0.0 111.544 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 55.7 m -140.99 159.94 41.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.09 0.472 . . . . 0.0 111.456 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.7 p90 -131.96 149.36 52.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 84.77 167.21 42.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.832 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.034 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -71.59 -55.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.0 111.065 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.7 pt-20 -47.31 -53.71 12.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.798 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 85.3 m-20 -64.27 -53.87 42.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.477 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.481 HG22 HD13 ' A' ' 312' ' ' LEU . 23.8 m -58.21 -40.03 80.57 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.668 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 1.034 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.9 mp -66.02 -47.52 74.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.834 0.35 . . . . 0.0 111.223 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 314' ' ' MET . 14.7 mttm -56.42 -49.98 72.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.19 68.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.737 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.2 OUTLIER -71.24 -27.64 63.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.57 -26.77 41.26 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.5 mmt -80.47 -9.06 59.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.771 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.23 45.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.458 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.61 -5.45 58.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.142 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.5 m -92.74 102.48 13.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.74 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.0 tt0 -59.4 -48.79 80.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.204 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.43 125.06 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.51 0.195 . . . . 0.0 111.362 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.606 ' HG ' HG23 ' A' ' 322' ' ' VAL . 23.6 tp -88.69 123.66 33.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -109.53 103.66 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.606 HG23 ' HG ' ' A' ' 320' ' ' LEU . 10.6 t -114.39 153.64 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.663 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 77.2 m-85 -99.94 142.18 31.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.474 . . . . 0.0 112.135 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.411 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 12.6 pt-20 -67.13 154.91 40.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.73 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.05 25.39 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 0.0 110.301 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 49.2 tp -52.41 128.89 27.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.719 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -91.02 22.23 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.481 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 374' ' ' LEU . 19.3 mm -124.41 135.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.62 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.02 161.97 36.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.642 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 47.3 ttt180 -91.5 118.78 30.88 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 110.892 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.1 m-85 -116.21 153.13 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.894 HG12 ' CD1' ' A' ' 343' ' ' ILE . 16.1 m -114.59 114.04 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.145 0.498 . . . . 0.0 111.556 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.96 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.6 mm? -108.06 160.88 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.577 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.527 ' ND1' HD11 ' A' ' 369' ' ' ILE . 5.5 m-70 -89.55 171.17 9.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 12.8 t -101.49 160.91 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.813 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLN . . . . . 0.42 ' HG2' ' HG3' ' A' ' 365' ' ' GLU . 78.6 mt-30 -44.83 -31.43 1.23 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -106.56 -116.09 4.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.799 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.74 172.43 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.664 0.269 . . . . 0.0 110.549 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 59.89 45.71 12.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.261 0.553 . . . . 0.0 110.107 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -172.23 128.5 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.175 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.16 139.01 52.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 343' ' ' ILE . 39.9 tttp -111.58 148.71 32.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.571 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.894 ' CD1' HG12 ' A' ' 332' ' ' VAL . 9.3 mm -119.0 123.86 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.611 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.67 HD23 HD11 ' A' ' 346' ' ' LEU . 50.5 tp -132.38 154.14 50.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.29 0.566 . . . . 0.0 111.998 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -95.38 116.53 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.258 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.67 HD11 HD23 ' A' ' 344' ' ' LEU . 1.3 mm? -118.83 152.0 37.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.409 0.623 . . . . 0.0 112.156 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 40.7 p -100.44 173.82 3.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.337 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -45.61 -45.07 16.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.786 1.657 . . . . 0.0 112.01 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -59.95 -57.33 13.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -62.26 -49.91 73.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.5 mt-10 -60.04 -32.75 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.39 -29.68 64.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 66.2 t0 -89.79 60.41 5.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.859 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 7.6 mtmp? -69.97 -39.04 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.848 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 74.1 m -57.88 -40.01 79.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.802 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 71.6 m80 -105.61 -53.12 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.96 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.42 4.29 0.68 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -178.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 359' ' ' ASP . 0.2 OUTLIER -96.96 -166.24 1.37 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.57 ' H ' HG22 ' A' ' 358' ' ' THR . 85.8 m-20 -130.37 123.77 30.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -65.8 -2.39 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -101.23 -23.69 14.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.457 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -126.1 -36.28 2.36 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.441 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 364' ' ' GLN . . . 79.62 42.91 10.75 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.734 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.506 ' N ' HG22 ' A' ' 358' ' ' THR . 14.5 mm100 -47.02 -177.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 336' ' ' GLN . 76.0 mm-40 -119.34 28.97 7.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -88.2 139.99 29.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -140.26 112.51 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.019 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 333' ' ' LEU . 14.1 tp -65.08 127.31 31.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.252 0.549 . . . . 0.0 112.127 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 368' ' ' LEU . 1.4 mt -115.48 -41.73 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.063 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.63 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 37.2 mt-10 -141.36 160.19 40.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.554 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p -147.02 116.49 7.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.352 0.596 . . . . 0.0 111.125 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.43 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 9.1 tpp -118.51 134.36 23.48 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.473 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.5 Cg_endo -59.84 123.02 12.38 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 110.846 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.044 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -65.98 -44.08 85.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.845 HD11 ' CD1' ' A' ' 391' ' ' ILE . 56.3 tp -59.98 -50.0 75.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 47.3 mt-10 -60.57 -40.0 90.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.001 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.43 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 68.8 t-105 -67.51 -38.77 84.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.277 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.717 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.7 m-85 -73.47 -27.82 61.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.29 53.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.144 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -107.87 -16.61 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.819 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -129.82 21.4 5.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.5 p90 -61.83 -16.62 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.566 0.222 . . . . 0.0 111.572 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -83.46 -36.39 24.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.667 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -60.02 -39.92 87.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.633 ' CD2' HD23 ' A' ' 312' ' ' LEU . 42.9 m-85 -87.04 -5.95 58.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.179 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.73 2.71 46.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.188 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.66 162.27 18.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.871 ' HB ' HG23 ' A' ' 319' ' ' ILE . 76.0 m -107.11 100.91 10.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.29 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -66.85 102.33 0.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.596 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.71 134.2 52.26 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.845 ' CD1' HD11 ' A' ' 375' ' ' LEU . 30.9 mm -99.97 99.93 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 13.1 m -100.99 -171.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.776 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.663 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -160.04 156.44 26.98 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.008 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.491 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.4 p-10 -74.04 16.64 0.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.443 ' HE3' ' CD2' ' A' ' 280' ' ' PHE . 1.0 OUTLIER -70.01 -29.56 66.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.714 0.292 . . . . 0.0 111.411 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 17.2 m -97.3 169.66 9.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 111.385 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -59.93 -50.0 75.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.096 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.445 ' HG3' ' CA ' ' A' ' 288' ' ' GLY . 75.0 mm-40 -67.84 -40.43 83.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 110.121 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.99 -19.08 65.36 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.038 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.4 m -83.92 -23.47 31.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.754 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -70.53 -40.01 73.71 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.704 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.618 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.5 m-85 -60.03 -50.71 72.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.297 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 394' ' ' ASP . 73.8 t -56.51 -35.57 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.088 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -70.62 -49.86 43.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 110.35 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -73.5 -18.58 79.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.041 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.483 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.4 t80 174.47 -78.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.22 169.61 30.6 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.306 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.473 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.5 -49.04 2.97 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.244 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.4 OUTLIER -140.49 133.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 117.527 0.663 . . . . 0.0 112.624 -177.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -152.38 142.18 9.13 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.2 143.47 14.34 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.556 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.5 mt -104.26 128.87 57.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 30.0 mt -89.94 151.4 21.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.677 0.751 . . . . 0.0 112.494 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 415' ' ' TYR . 11.0 mtt180 -69.97 -38.47 76.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.866 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 97.8 m-85 -160.71 178.47 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.371 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.13 136.76 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.894 0.378 . . . . 0.0 110.282 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.578 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -129.98 160.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -85.97 97.85 10.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -59.93 -50.11 75.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -103.21 -118.32 4.45 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.491 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 83.1 mtp -114.03 160.04 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.641 0.258 . . . . 0.0 110.649 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 416' ' ' ARG . 36.9 tt0 -65.58 -43.5 89.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -59.98 -46.28 89.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.158 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 422' ' ' MET . 83.8 mt-30 57.41 51.77 9.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -63.15 100.37 0.34 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.619 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.47 -145.74 20.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.0 19.98 18.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.015 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.9 52.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.47 ' CG ' ' HG2' ' A' ' 425' ' ' GLN . 51.1 mp0 -66.45 -37.66 85.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.492 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -125.83 105.95 9.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -132.41 128.4 37.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -88.57 13.32 12.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.471 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.01 -3.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.043 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -58.84 -40.07 83.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.302 . . . . 0.0 110.555 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.43 -24.94 60.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.93 -35.56 75.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.511 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.91 -41.05 90.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.924 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -69.09 127.28 32.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.001 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.73 0.3 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.7 p -65.49 -29.96 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.333 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -50.12 -50.32 48.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.789 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.53 -50.03 74.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.571 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.737 HD12 ' HD2' ' A' ' 285' ' ' LYS . 49.4 pt -75.4 -21.06 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.717 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 278' ' ' VAL . 0.7 OUTLIER -48.15 -44.73 32.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.258 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.504 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 4.1 mp0 -71.66 -32.06 67.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.467 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -54.49 4.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.737 ' HD2' HD12 ' A' ' 281' ' ' ILE . 57.7 mttt -73.42 -57.99 3.62 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -54.88 41.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.767 0.318 . . . . 0.0 111.659 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' A' ' 402' ' ' PHE . 20.7 mt -59.96 -51.31 74.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.519 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.55 -36.23 88.64 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.012 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -59.98 -33.0 71.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.604 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.4 t80 -60.08 -45.58 92.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.63 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 32.3 m-85 -85.83 -36.85 19.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -60.04 -49.96 75.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.839 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.7 mp0 -66.29 -40.73 90.26 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.697 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.5 mt -60.0 -22.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -18.77 52.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.493 0.663 . . . . 0.0 109.62 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.6 mt-30 -101.41 0.21 36.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.828 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 57.73 29.89 18.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.965 0.412 . . . . 0.0 110.333 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.0 p -67.43 -11.53 58.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.828 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.25 53.4 45.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.402 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.0 mttt -130.34 36.66 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.878 ' CE1' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -160.86 162.39 32.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.695 0.284 . . . . 0.0 111.743 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.1 p -148.99 165.98 30.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.963 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.2 p90 -138.45 148.6 44.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.29 157.57 33.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.049 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.98 -58.68 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 110.662 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.0 -54.24 10.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.706 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 73.9 m-20 -63.67 -54.56 33.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.351 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.537 HG22 HD13 ' A' ' 312' ' ' LEU . 27.9 m -56.38 -37.91 70.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.897 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.972 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -69.7 -43.97 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.1 mttm -56.2 -52.62 63.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.67 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -26.2 63.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.79 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -69.18 -36.81 77.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 110.685 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -70.77 -25.36 62.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.6 mmt -82.58 -7.87 59.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.889 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.11 13.61 42.74 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.253 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.971 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -81.43 -7.13 59.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.941 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.866 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.2 m -97.86 106.73 19.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.857 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.1 tt0 -59.93 -50.26 74.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.748 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.5 mm -136.6 122.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.528 0.204 . . . . 0.0 110.776 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.9 tp -84.76 125.87 32.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.67 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -109.65 103.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.284 179.354 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.5 t -111.45 158.45 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.903 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 392' ' ' VAL . 9.8 m-85 -109.96 148.33 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.12 0.486 . . . . 0.0 112.196 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 391' ' ' ILE . 90.1 mt-10 -67.48 158.92 30.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.183 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.39 29.42 13.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.8 tp -57.87 127.23 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 109.999 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 347' ' ' THR . 34.3 p-10 -90.02 26.94 1.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 305' ' ' VAL . 29.8 mm -128.25 132.96 67.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.939 0.399 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 57.0 mtt -140.43 161.93 36.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.6 ttm180 -86.11 106.76 17.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.087 0.47 . . . . 0.0 110.757 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.537 ' CD2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -116.01 119.75 36.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.99 HG12 HD12 ' A' ' 343' ' ' ILE . 17.0 m -92.44 117.94 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.032 0.444 . . . . 0.0 111.662 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.688 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.6 mm? -105.25 153.39 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.91 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.68 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 0.2 OUTLIER -89.96 -177.87 5.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.731 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.432 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 44.7 t -104.06 157.66 16.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.997 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLN . . . . . 0.524 ' HG2' ' HB2' ' A' ' 365' ' ' GLU . 86.3 mt-30 -60.0 -40.02 87.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.39 10.29 57.88 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.112 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 339' ' ' GLU . 0.2 OUTLIER 67.09 -178.57 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.49 ' H ' HG22 ' A' ' 338' ' ' THR . 76.2 mm-40 60.04 28.49 18.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 47.4 tp10 -165.65 126.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.878 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -117.26 136.02 53.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.413 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.703 ' C ' HD13 ' A' ' 343' ' ' ILE . 5.7 ttpt -117.4 144.64 44.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.405 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.99 HD12 HG12 ' A' ' 332' ' ' VAL . 5.4 mm -118.63 122.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.545 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 56.7 tp -136.2 161.02 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.281 0.562 . . . . 0.0 111.738 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.576 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.4 p90 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.685 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.0 mm? -124.82 164.61 19.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.736 0.779 . . . . 0.0 113.009 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 p -101.83 171.26 5.5 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.803 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.1 Cg_exo -49.29 -42.39 40.52 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.98 1.787 . . . . 0.0 112.051 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.56 -50.22 72.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 21.6 mm100 -68.07 -48.81 64.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.591 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 94.2 mt-10 -60.01 -31.76 70.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.301 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -57.44 -32.31 66.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 0.0 110.156 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 64.6 t0 -89.62 58.18 4.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.441 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 7.6 mtmp? -66.51 -40.02 88.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.6 t -62.47 -58.23 8.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 111.585 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 91.4 m-70 -81.5 -51.83 7.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.369 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.86 ' HB3' ' HB2' ' A' ' 366' ' ' HIS . 0.5 OUTLIER 52.21 12.16 0.2 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.409 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.812 HG23 ' C ' ' A' ' 364' ' ' GLN . 6.3 m -97.43 -177.84 3.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.751 ' H ' HG22 ' A' ' 358' ' ' THR . 90.1 m-20 -132.62 135.55 45.94 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -72.84 1.38 8.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.673 0.273 . . . . 0.0 111.421 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -104.06 -22.38 13.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.642 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.7 t -122.92 -37.82 2.69 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.576 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 82.95 41.61 8.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.738 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.812 ' C ' HG23 ' A' ' 358' ' ' THR . 15.0 mm100 -92.86 98.33 11.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 336' ' ' GLN . 17.3 mm-40 -69.34 132.87 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 111.181 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.86 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 64.2 m80 -139.56 159.99 40.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 70.4 mt-10 -142.99 115.16 8.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.93 0.395 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 14.1 tp -79.29 123.3 27.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.602 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.7 mp -93.8 -35.87 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.523 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 371' ' ' SER . 38.6 tt0 -158.12 165.4 35.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.406 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 0.1 OUTLIER -147.2 115.84 6.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.571 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -115.17 120.09 37.42 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.783 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.662 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 7.5 Cg_endo -50.27 120.45 6.27 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.094 1.863 . . . . 0.0 111.107 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 328' ' ' ILE . 18.4 mt -61.9 -41.42 97.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.669 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.826 HD11 HD12 ' A' ' 391' ' ' ILE . 45.5 tp -60.0 -53.3 59.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 61.6 mt-10 -59.93 -40.01 87.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.039 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -66.92 -35.72 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.462 ' HE1' HD22 ' A' ' 312' ' ' LEU . 1.2 m-85 -69.5 -27.5 65.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.965 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -11.65 43.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.223 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.21 -9.74 15.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 14.7 m120 -130.0 18.24 5.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.7 p90 -67.89 -19.25 64.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 382' ' ' TYR . 33.1 mmtt -81.37 -40.93 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -61.49 -39.97 92.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.21 0.529 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 312' ' ' LEU . 17.3 m-85 -81.55 -8.18 59.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.287 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.0 2.79 48.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.363 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.866 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.23 164.55 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 111.15 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.882 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.6 m -107.56 102.7 11.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.15 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 391' ' ' ILE . 0.9 OUTLIER -65.15 103.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.115 0.483 . . . . 0.0 111.124 -178.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.524 ' HB3' ' OE1' ' A' ' 282' ' ' GLN . 6.1 mm-40 -109.43 127.57 54.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.953 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.826 HD12 HD11 ' A' ' 375' ' ' LEU . 42.0 mm -99.91 100.01 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 112.03 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 321' ' ' ILE . 21.9 m -113.71 141.36 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.447 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 13.1 p -121.09 164.44 16.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.832 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.65 80.66 0.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -112.87 -30.13 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.305 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 8.3 t -126.76 -172.95 2.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 67.9 mt-30 -59.97 -49.51 77.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 52.8 mp0 -59.96 -44.12 94.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.181 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.95 66.52 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 404' ' ' LYS . 68.9 m -84.01 -23.47 30.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.44 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 34.7 mt-30 -70.99 -43.95 66.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.529 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.578 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.5 m-85 -62.89 -48.03 80.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.09 -39.58 80.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.001 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 400' ' ' SER . 25.4 mtmt -70.37 -52.83 19.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.77 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -62.39 -22.35 63.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.931 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 18.0 t80 176.77 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.11 168.47 31.86 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.156 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.488 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.55 -47.69 2.76 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.39 133.38 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 117.847 0.824 . . . . 0.0 112.609 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.476 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -156.97 149.8 20.7 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -133.72 149.19 19.65 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.677 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 301' ' ' TYR . 20.1 mt -110.25 127.75 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.125 HD13 HG13 ' A' ' 417' ' ' VAL . 78.3 mt -84.84 150.62 24.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.646 0.736 . . . . 0.0 112.76 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.684 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 20.7 mtm180 -70.01 -32.18 70.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.363 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.697 ' O ' HG12 ' A' ' 417' ' ' VAL . 53.2 p90 -159.45 179.51 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 298' ' ' THR . 1.2 tmm_? -61.96 94.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.264 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.125 HG13 HD13 ' A' ' 413' ' ' LEU . 1.3 p -130.05 130.02 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.176 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -112.71 159.78 18.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.599 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -69.47 -29.93 67.71 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.641 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -63.11 140.06 58.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -75.05 -84.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.811 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 93.6 mtp -92.36 176.81 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -59.96 -41.05 91.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.451 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.99 139.95 51.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.422 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.415 ' NE2' ' CG ' ' A' ' 430' ' ' GLU . 57.6 mt-30 -131.64 150.06 52.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 170.79 37.24 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.188 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.84 165.92 25.24 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.616 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -59.96 -40.06 87.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 111.132 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -88.7 39.55 0.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.623 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.415 ' CG ' ' NE2' ' A' ' 425' ' ' GLN . 41.8 tt0 -61.41 -39.98 92.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.604 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.65 99.04 6.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -118.29 109.61 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.044 0.45 . . . . 0.0 111.179 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.57 -5.38 36.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.63 -13.52 0.67 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.207 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -55.17 -40.02 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -70.01 -32.56 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.374 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -59.98 -32.22 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.514 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.101 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.849 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ASN . . . . . 0.585 HD21 ' N ' ' A' ' 277' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.802 0.334 . . . . 0.0 111.239 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.7 p -65.84 -29.73 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -51.32 -43.71 61.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.419 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -66.76 -43.62 83.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 111.519 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 278' ' ' VAL . 45.6 pt -82.77 -21.04 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.629 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -57.67 -40.74 80.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 -179.23 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 21.3 pt-20 -73.22 -29.9 63.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.303 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -84.69 -56.67 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.92 -57.81 4.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.58 HD23 ' OE1' ' A' ' 282' ' ' GLN . 28.9 tp -57.45 -57.31 13.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.781 HG23 ' CE1' ' A' ' 402' ' ' PHE . 31.2 mt -59.94 -48.71 86.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.42 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.25 60.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.083 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.5 ttt180 -59.94 -40.11 87.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.614 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 6.6 t80 -57.39 -45.93 83.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.72 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -83.36 -38.25 22.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 111.564 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.7 t0 -62.03 -46.16 90.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.462 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.679 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.3 mt-10 -64.2 -42.94 96.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 301' ' ' TYR . 91.7 mt -60.45 -21.43 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.643 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -66.17 -13.93 61.02 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.256 0.551 . . . . 0.0 109.665 178.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.73 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.9 mt-30 -103.47 -0.73 29.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.469 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.01 28.18 17.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.2 p -67.64 -11.48 58.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.38 51.48 55.94 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.423 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.5 mttt -126.13 35.65 4.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.933 ' CE2' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -159.84 162.96 34.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.536 0.208 . . . . 0.0 111.267 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.5 164.69 30.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 53.0 p90 -138.02 149.03 45.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 90.1 155.56 31.17 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.083 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.55 -61.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -47.33 -52.31 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.43 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.3 m-20 -63.35 -55.77 21.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.398 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 35.7 m -57.82 -36.24 71.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.962 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.966 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.63 -43.12 77.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 52.3 mtmt -60.01 -45.43 92.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.556 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.06 66.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.813 0.339 . . . . 0.0 110.643 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.835 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -72.09 -26.92 62.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.25 -27.84 47.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 92.8 mmm -80.9 -8.5 59.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.585 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.9 16.89 49.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.275 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.95 -8.44 55.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.342 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.74 104.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.774 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.4 tt0 -59.64 -49.96 75.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.325 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.8 mm -136.7 124.05 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 322' ' ' VAL . 46.2 tp -87.92 126.05 34.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.201 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -111.53 104.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -122.4 162.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.435 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.627 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -106.88 144.34 33.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.729 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.51 -36.48 83.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.38 45.7 1.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.555 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 35.9 tp -79.11 122.58 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.47 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.652 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.2 m-20 -90.25 29.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.071 HG22 HD12 ' A' ' 374' ' ' LEU . 26.1 mm -126.92 133.18 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 111.567 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.701 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.7 mtt -140.19 162.08 36.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.877 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.512 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 17.1 tpt180 -86.6 111.47 20.66 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 38.8 m-85 -123.77 123.76 41.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -101.85 120.2 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.688 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 357' ' ' PHE . 0.9 OUTLIER -107.95 133.74 51.86 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.552 ' CD2' HD13 ' A' ' 369' ' ' ILE . 13.4 m-70 -140.01 158.5 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.75 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 8.5 t -105.29 160.03 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.053 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.02 130.04 44.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.652 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 89.72 9.96 65.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.781 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 50.95 37.43 17.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.902 0.351 . . . . 0.0 111.295 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.01 6.69 43.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.303 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -167.14 111.62 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.759 0.314 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -122.8 129.05 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.253 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.774 ' C ' HD13 ' A' ' 343' ' ' ILE . 31.1 tttp -137.54 123.68 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.939 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.774 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.1 mm -110.22 118.67 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.891 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 29.3 tp -143.37 156.81 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 112.684 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.12 127.34 37.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.896 178.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.542 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -122.09 165.09 16.62 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.9 p -101.6 169.88 7.16 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.306 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 5.3 Cg_endo -47.13 -49.88 12.01 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.024 1.816 . . . . 0.0 111.749 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -54.96 -53.59 53.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.38 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 26.6 mm100 -65.25 -46.09 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.64 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 87.7 mt-10 -60.01 -34.77 73.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.124 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 38.6 mmtt -57.58 -29.63 64.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.349 0.595 . . . . 0.0 109.653 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -96.49 31.63 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.092 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.913 ' HB2' HD22 ' A' ' 368' ' ' LEU . 5.0 pttt -71.08 -21.89 62.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.442 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.194 0.521 . . . . 0.0 109.945 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 358' ' ' THR . 97.8 m-70 -101.15 -49.77 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.282 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.3 OUTLIER 57.11 8.87 0.58 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 110.349 -178.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 359' ' ' ASP . 6.3 m -105.28 178.64 4.5 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.082 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.827 ' HB2' HG22 ' A' ' 362' ' ' THR . 73.7 m-20 -130.72 132.9 45.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -69.41 -2.57 11.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.687 0.279 . . . . 0.0 111.734 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -102.63 -20.26 14.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 359' ' ' ASP . 14.2 t -116.08 -38.71 3.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.919 0.39 . . . . 0.0 110.531 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 79.78 40.27 15.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.82 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.441 ' H ' HG23 ' A' ' 362' ' ' THR . 12.9 mt-30 -52.85 -172.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.988 0.423 . . . . 0.0 111.033 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -145.93 87.55 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 96.4 m-70 -144.86 148.08 33.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.017 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 334' ' ' HIS . 5.8 mm-40 -140.89 114.47 8.83 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.913 HD22 ' HB2' ' A' ' 354' ' ' LYS . 16.7 tp -62.71 138.42 58.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.539 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 334' ' ' HIS . 3.3 mp -117.28 -40.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.002 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -143.99 149.81 37.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.497 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.71 ' OG ' HD21 ' A' ' 368' ' ' LEU . 0.8 OUTLIER -146.51 116.07 7.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.805 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 3.9 tpt -119.07 130.26 24.94 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.672 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.6 Cg_exo -56.77 118.35 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.836 1.69 . . . . 0.0 110.835 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.071 HD12 HG22 ' A' ' 328' ' ' ILE . 32.4 mt -59.89 -41.23 91.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.935 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 391' ' ' ILE . 63.2 tp -60.01 -54.37 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.749 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 48.7 mt-10 -59.62 -40.03 86.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 109.564 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -60.24 -39.85 88.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.988 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -74.88 -27.37 60.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.588 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.61 -12.58 42.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.986 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -106.34 -13.7 15.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 76.4 m-20 -129.96 20.06 5.46 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.7 p90 -63.09 -16.1 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.584 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -83.31 -38.05 22.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -60.95 -38.02 84.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.766 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 381' ' ' ASN . 48.7 m-85 -85.95 -9.15 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.52 60.81 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.444 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.842 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.16 165.54 15.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.885 ' HB ' HG23 ' A' ' 319' ' ' ILE . 53.4 m -108.92 101.75 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.434 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -70.78 102.6 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.629 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.8 mm-40 -111.38 131.98 54.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.834 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 375' ' ' LEU . 38.0 mm -98.76 103.83 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 112.182 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.627 HG23 ' CE1' ' A' ' 323' ' ' TYR . 5.8 m -100.73 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.823 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 392' ' ' VAL . 1.3 p -157.94 154.0 27.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.07 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.462 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.5 p-10 -73.22 20.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -66.91 -40.03 87.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.635 0.255 . . . . 0.0 111.301 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 m -93.08 173.7 7.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.559 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.9 -50.11 75.08 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.9 -40.44 97.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.322 0.582 . . . . 0.0 109.648 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.462 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -61.93 -23.01 63.08 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 53.6 m -83.7 -23.11 31.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.092 -0.554 . . . . 0.0 110.483 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.23 -41.44 49.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.781 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.3 m-85 -60.0 -50.07 75.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.548 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 70.1 t -60.31 -39.96 82.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.563 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 400' ' ' SER . 1.4 mmpt? -71.14 -46.02 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.808 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -73.97 -31.02 60.41 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.595 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER -156.7 -83.36 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 99.39 148.63 23.31 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.995 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.527 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -47.09 2.97 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.607 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.36 134.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 118.336 1.068 . . . . 0.0 112.737 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.12 148.2 18.23 Favored Glycine 0 CA--C 1.511 -0.173 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.43 150.08 19.6 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.872 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.1 mt -109.5 126.8 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 42.3 mt -90.83 157.42 17.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.675 0.75 . . . . 0.0 112.776 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 415' ' ' TYR . 63.0 mtm180 -74.36 -40.03 62.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.531 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 417' ' ' VAL . 85.1 m-85 -160.79 172.97 16.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -56.88 124.42 18.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.682 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.0 m -129.99 160.02 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.396 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.61 136.44 45.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.0 -40.0 75.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.852 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -139.61 139.97 36.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -107.71 109.46 2.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.403 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 30.9 mtt -139.99 169.91 16.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.03 -40.02 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -72.97 -16.11 61.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.363 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 137.54 37.93 0.15 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 152.94 123.21 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.588 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.95 -33.05 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.67 22.2 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.507 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.97 -39.92 87.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.27 37.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.547 ' O ' ' HG ' ' A' ' 434' ' ' LEU . 19.5 p90 -59.62 -50.05 75.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 40.72 31.06 0.11 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.109 0.48 . . . . 0.0 111.38 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 432' ' ' PHE . 54.9 mt -99.53 -1.41 38.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.275 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.04 -41.24 91.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.0 110.71 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.97 -33.16 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.496 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.0 -31.8 70.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.618 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.02 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.002 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.71 130.03 49.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.898 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.754 0.312 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -68.76 -28.25 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.29 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -53.33 -40.03 64.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.642 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.03 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.455 ' HB ' ' HE3' ' A' ' 285' ' ' LYS . 44.4 pt -82.7 -23.06 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.777 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.675 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 110.221 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.8 pt-20 -85.24 -34.33 22.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -72.0 -39.97 68.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.455 ' HE3' ' HB ' ' A' ' 281' ' ' ILE . 21.2 mttt -86.6 -58.23 2.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.548 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 29.7 tp -57.69 -55.88 29.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 112.03 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.71 HG23 ' CE1' ' A' ' 402' ' ' PHE . 42.3 mt -58.0 -48.41 84.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.725 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.488 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.39 -37.54 82.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.716 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 23.4 ttt85 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.657 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.2 t80 -56.98 -46.76 81.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -79.12 -40.01 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.756 0.312 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.0 t0 -61.65 -45.48 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.671 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 6.7 mt-10 -64.53 -41.76 96.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -60.33 -21.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.474 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -66.76 -12.67 59.65 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.373 0.606 . . . . 0.0 109.458 178.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.533 ' HB2' HG23 ' A' ' 298' ' ' THR . 39.4 mt-30 -103.5 0.06 30.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.577 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.53 20.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.628 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.7 p -68.03 -14.7 63.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.57 31.32 70.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.911 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.528 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 43.9 mtmt -110.38 37.07 2.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.452 0.168 . . . . 0.0 110.642 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.949 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.8 m-85 -158.97 159.98 35.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.866 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.445 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -139.36 157.74 45.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 111.09 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.409 ' HD1' ' H ' ' A' ' 303' ' ' PHE . 0.2 OUTLIER -136.5 124.55 22.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 110.665 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 109.8 147.34 11.71 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.75 -58.91 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 0.0 110.744 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.1 pt-20 -47.41 -54.72 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.34 -57.02 9.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.63 HG21 HG22 ' A' ' 409' ' ' ILE . 18.7 m -52.1 -33.29 38.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.045 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.759 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.3 mp -75.66 -40.07 56.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.701 0.286 . . . . 0.0 111.517 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 10.4 mtmt -57.49 -50.02 74.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.52 -28.01 63.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.648 0.261 . . . . 0.0 110.922 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.39 -30.76 66.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.054 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.407 ' OE2' ' CZ ' ' A' ' 385' ' ' PHE . 78.3 mm-40 -73.75 -25.22 60.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 420' ' ' GLN . 29.6 mmt -83.04 -7.61 59.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.43 17.03 46.02 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.265 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.77 6.08 43.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.904 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.1 m -107.46 106.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.781 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.05 -49.97 75.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.629 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.78 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.7 tp -91.16 127.93 36.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.23 105.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.649 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -123.18 161.75 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.433 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.885 ' CE1' HG23 ' A' ' 392' ' ' VAL . 93.2 m-85 -109.67 146.04 35.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.915 0.388 . . . . 0.0 111.307 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.9 pt-20 -64.97 -30.03 71.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.334 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.17 48.5 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.456 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.3 tp -83.68 125.52 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.1 32.22 1.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.054 HG22 HD12 ' A' ' 374' ' ' LEU . 27.3 mm -129.5 137.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.0 162.08 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.373 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.635 ' HE ' HG21 ' A' ' 343' ' ' ILE . 22.1 ttt180 -94.12 124.62 38.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.09 0.471 . . . . 0.0 111.053 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 6.6 m-85 -121.08 158.12 28.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.43 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.94 HG12 ' CD1' ' A' ' 343' ' ' ILE . 10.0 m -122.27 113.52 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.761 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.5 OUTLIER -104.76 156.75 17.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.261 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.411 ' NE2' ' HA ' ' A' ' 366' ' ' HIS . 0.7 OUTLIER -71.14 161.74 30.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.455 ' HB2' ' C ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -141.92 110.99 6.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 49.94 37.12 13.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.348 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 338' ' ' THR . . . 129.77 -86.75 0.31 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 119.892 -1.147 . . . . 0.0 114.003 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.8 OUTLIER -170.51 -29.02 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.92 14.9 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.255 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 338' ' ' THR . 20.6 tp10 -166.39 137.36 3.47 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -130.32 140.12 50.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.009 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -94.42 144.38 25.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.266 179.498 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.94 ' CD1' HG12 ' A' ' 332' ' ' VAL . 20.6 mm -117.11 119.39 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.939 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.404 ' O ' HD22 ' A' ' 346' ' ' LEU . 55.9 tp -135.07 149.0 50.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.241 0.543 . . . . 0.0 112.063 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.527 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -88.47 117.05 27.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.06 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.536 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -118.83 156.4 29.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 22.0 p -100.59 169.4 7.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.8 Cg_endo -44.1 -45.57 11.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.87 -52.98 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -65.18 -50.02 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.7 mt-10 -59.97 -33.9 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.509 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -57.39 -29.93 64.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.338 0.59 . . . . 0.0 109.488 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.38 24.75 7.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.048 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.571 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 5.1 ptpt -62.45 -24.9 67.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.046 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 35.8 t -57.31 -40.03 77.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 110.007 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.463 ' C ' ' H ' ' A' ' 358' ' ' THR . 78.5 m80 -102.52 -42.4 5.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.761 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 55.38 6.92 0.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.999 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.3 m -107.29 -170.75 1.75 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.897 ' HB2' HG22 ' A' ' 362' ' ' THR . 88.4 m-20 -131.14 134.55 46.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -71.14 -1.33 12.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 111.441 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.01 -18.08 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.897 HG22 ' HB2' ' A' ' 359' ' ' ASP . 13.3 t -117.31 -37.86 3.45 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 74.31 27.95 64.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.892 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.731 ' H ' HG23 ' A' ' 362' ' ' THR . 54.4 mt-30 -58.32 -153.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.626 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.456 ' H ' ' HB3' ' A' ' 364' ' ' GLN . 56.3 mm-40 -139.84 122.81 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.702 0.287 . . . . 0.0 110.808 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 357' ' ' PHE . 91.4 m-70 -158.82 139.64 12.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.23 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 119.93 7.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 369' ' ' ILE . 54.7 tp -80.66 143.61 32.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.754 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 368' ' ' LEU . 1.9 mm -112.33 -36.75 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.848 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.716 ' O ' HD11 ' A' ' 368' ' ' LEU . 42.2 tt0 -158.2 166.65 31.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.585 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 3.1 p -145.88 118.5 8.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.178 0.513 . . . . 0.0 111.381 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.712 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -119.12 126.88 26.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.105 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.712 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 11.2 Cg_endo -55.49 125.81 20.37 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.064 1.842 . . . . 0.0 110.69 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -65.43 -41.33 93.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 391' ' ' ILE . 61.6 tp -60.06 -53.81 53.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.1 mt-10 -56.88 -40.01 75.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.893 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.24 -35.25 75.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.267 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 6.6 m-85 -64.16 -32.14 73.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.696 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.67 -10.01 47.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.71 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -103.19 -0.09 30.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -138.97 16.14 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -67.45 -19.16 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.689 0.281 . . . . 0.0 111.112 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -78.58 -47.44 17.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.94 -45.9 91.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 110.702 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -73.73 -15.21 61.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.787 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.14 2.49 66.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.27 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.904 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.2 162.18 17.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.811 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.4 m -107.14 100.32 9.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.548 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.8 102.77 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.675 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 67.2 mm-40 -110.45 128.95 55.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.845 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.967 HD12 HD11 ' A' ' 375' ' ' LEU . 33.2 mm -95.2 104.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.203 0.525 . . . . 0.0 112.146 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.885 HG23 ' CE1' ' A' ' 323' ' ' TYR . 15.0 m -101.2 -169.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.923 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.502 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.97 156.6 27.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 111.823 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 400' ' ' SER . 9.7 t70 -64.44 -7.34 9.58 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.209 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -53.21 -41.65 65.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.7 m -87.51 167.44 13.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.689 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 27.2 tt0 -60.03 -53.32 59.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.601 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 41.1 mp0 -60.07 -35.43 75.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.495 0.664 . . . . 0.0 109.316 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -56.24 -58.13 15.78 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.704 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 3.4 m -59.44 -22.0 60.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.815 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 84.5 mt-30 -68.93 -40.05 79.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.82 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.6 m-85 -65.9 -50.8 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.461 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 80.6 t -55.8 -35.11 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 400' ' ' SER . 6.0 mmtt -77.12 -50.6 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.468 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -75.45 -27.28 63.81 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.816 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -157.86 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 99.6 153.3 27.59 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.753 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 82.32 -50.63 4.36 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.934 -0.65 . . . . 0.0 114.699 178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -149.06 133.23 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 117.837 0.819 . . . . 0.0 112.482 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 139.13 7.14 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -123.93 144.61 15.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.805 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.949 HG23 ' CE2' ' A' ' 301' ' ' TYR . 26.4 mt -106.63 128.73 61.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.1 mt -89.55 152.8 21.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.751 0.786 . . . . 0.0 112.82 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.03 -34.96 73.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.729 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.43 ' O ' HG13 ' A' ' 417' ' ' VAL . 88.3 m-85 -156.84 164.68 37.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.4 mtm180 -59.15 122.83 14.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.258 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 415' ' ' TYR . 8.4 m -123.87 142.86 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.409 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.31 -39.96 77.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -145.5 161.63 39.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 314' ' ' MET . 2.6 mp0 -50.31 -63.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.771 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -46.4 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.151 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.7 ttt -137.13 160.68 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.03 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -59.97 -41.03 91.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.25 122.61 46.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.734 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 81.6 mt-30 -120.96 148.06 44.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.99 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -116.28 -5.36 17.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 116.02 -105.24 1.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.224 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.697 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.92 39.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.337 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.4 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 36.9 tt0 -64.01 -40.06 95.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 110.452 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -111.61 98.78 7.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.539 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.56 124.97 44.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.467 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.12 6.61 11.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.16 -3.85 6.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.963 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.23 -39.88 84.14 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.721 0.296 . . . . 0.0 110.772 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.61 -33.91 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.01 -34.55 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.251 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.98 -46.62 88.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.966 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.07 -39.92 87.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.878 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 33.2 m120 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.764 0.316 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.775 HG22 ' HB3' ' A' ' 282' ' ' GLN . 8.6 p -69.48 -27.63 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.202 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -54.34 -39.97 67.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.75 -50.03 75.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.208 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 3.4 pt -79.04 -43.48 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.806 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.775 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.1 OUTLIER -57.59 -35.82 70.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 -179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.525 ' O ' HD12 ' A' ' 287' ' ' ILE . 41.8 mt-10 -72.12 -31.43 66.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 398' ' ' GLU . 0.9 OUTLIER -83.79 -56.27 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.32 -179.262 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -57.66 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 22.0 tp -55.23 -58.21 8.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.784 HG23 ' CD2' ' A' ' 402' ' ' PHE . 82.5 mt -60.07 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.282 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.467 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.15 -39.02 57.37 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.269 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -60.05 -34.16 73.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.126 0.489 . . . . 0.0 110.279 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 19.0 t80 -59.92 -49.29 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.12 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -83.45 -38.31 22.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.53 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 295' ' ' SER . 43.3 t0 -64.18 -49.94 70.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.58 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 46.2 tp10 -61.26 -40.03 92.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 301' ' ' TYR . 88.2 mt -62.58 -26.33 40.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.841 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.77 -13.7 16.79 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.279 0.561 . . . . 0.0 109.944 178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -100.07 0.89 41.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.389 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.6 30.04 19.31 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 10.0 p -69.84 -10.04 56.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.21 51.14 57.79 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.43 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.1 mttt -130.25 40.67 3.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.877 -0.19 . . . . 0.0 110.6 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.854 ' CE1' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -161.69 163.57 29.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.38 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 p -145.15 160.38 41.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.43 126.76 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.649 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.554 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 109.38 153.25 14.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.331 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -55.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.861 0.362 . . . . 0.0 110.673 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.4 pt-20 -50.35 -51.03 49.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.19 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.38 -55.24 12.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.883 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.558 HG21 HG22 ' A' ' 409' ' ' ILE . 20.7 m -55.49 -37.56 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.225 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.95 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -69.61 -44.47 70.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.326 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.0 mttm -56.14 -50.03 72.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.24 65.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.936 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -70.72 -29.63 65.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.807 0.337 . . . . 0.0 110.616 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.54 -25.91 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 6.7 mmm -81.68 -8.6 59.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.853 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.12 11.57 32.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.343 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.47 59.77 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.4 0.28 . . . . 0.0 110.811 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.3 m -92.73 104.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.898 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.2 tp10 -59.55 -49.13 78.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 318' ' ' GLU . 31.3 mm -136.22 129.12 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' HG23 ' A' ' 322' ' ' VAL . 42.8 tp -94.08 127.85 40.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.222 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.571 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -114.48 108.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.09 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.646 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -124.45 161.97 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.435 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.81 ' CE1' HG23 ' A' ' 392' ' ' VAL . 89.4 m-85 -108.18 146.22 33.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.835 0.35 . . . . 0.0 111.312 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.9 pt-20 -63.62 -31.96 73.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.129 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -95.98 52.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.541 HD13 ' CA ' ' A' ' 408' ' ' GLY . 45.6 tp -85.65 123.91 31.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.21 27.72 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.963 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 374' ' ' LEU . 28.0 mm -127.15 134.83 65.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.104 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.8 mtm -139.99 161.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.669 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.604 HH11 HG22 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -90.61 120.37 31.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.1 0.476 . . . . 0.0 111.218 -179.171 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 371' ' ' SER . 3.9 m-85 -118.3 157.23 27.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.172 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.053 HG12 HD12 ' A' ' 343' ' ' ILE . 11.0 m -120.01 110.72 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.269 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.732 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.7 mm? -102.15 150.38 23.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.565 ' CD2' HD11 ' A' ' 369' ' ' ILE . 9.1 m170 -86.66 177.69 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.114 0.483 . . . . 0.0 111.425 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 3.4 m -115.14 161.67 18.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.686 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -45.92 -39.08 8.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 338' ' ' THR . . . -87.85 -119.57 1.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.907 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.6 OUTLIER -165.86 17.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -130.76 33.25 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 110.5 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 16.0 tp10 -158.29 122.97 4.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.996 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -113.1 136.7 52.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.981 0.419 . . . . 0.0 111.175 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.677 ' O ' HD13 ' A' ' 343' ' ' ILE . 8.7 tttp -111.01 139.67 46.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.736 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.053 HD12 HG12 ' A' ' 332' ' ' VAL . 10.6 mm -121.03 120.77 63.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.416 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 57.3 tp -135.32 163.05 30.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.383 0.611 . . . . 0.0 112.147 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.514 ' HD2' HD12 ' A' ' 328' ' ' ILE . 5.9 p90 -100.67 118.28 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -123.52 163.8 20.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 20.0 p -101.09 168.68 8.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.789 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.6 Cg_endo -45.55 -43.61 17.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.409 2.072 . . . . 0.0 111.949 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.02 -57.09 14.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 18.6 mm100 -62.95 -49.64 73.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.9 mt-10 -60.09 -31.29 69.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.404 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -39.59 77.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.418 0.628 . . . . 0.0 109.418 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 64.2 t0 -85.75 53.74 2.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.611 ' HB2' HD23 ' A' ' 368' ' ' LEU . 14.1 pttm -69.98 -34.68 73.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.4 m -63.13 -51.49 66.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.003 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.538 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 90.5 m-70 -88.71 -52.2 5.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.255 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 54.6 12.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.5 m -109.1 -170.61 1.69 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.062 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.79 ' HB2' HG22 ' A' ' 362' ' ' THR . 88.7 m-20 -132.27 139.33 48.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -74.25 0.39 14.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.617 0.246 . . . . 0.0 111.638 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -103.9 -20.91 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.585 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.79 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.5 t -117.88 -38.35 3.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.259 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 76.36 30.3 56.99 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.057 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.561 ' H ' HG23 ' A' ' 362' ' ' THR . 11.8 mm100 -56.78 -156.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.621 -0.289 . . . . 0.0 110.913 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 49.0 mt-10 -144.86 121.79 11.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.86 0.362 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.647 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 77.2 m80 -160.09 142.09 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.33 116.29 7.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 354' ' ' LYS . 39.4 tp -83.02 138.72 33.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.47 . . . . 0.0 111.878 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.0 mp -110.74 -43.52 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.838 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.607 ' O ' HD11 ' A' ' 368' ' ' LEU . 12.5 tp10 -145.26 167.12 23.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.177 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -148.33 117.62 6.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.957 0.408 . . . . 0.0 110.98 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 4.2 tpt -112.62 127.25 27.08 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 13.6 Cg_endo -57.73 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.071 1.847 . . . . 0.0 110.971 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.057 HD12 HG22 ' A' ' 328' ' ' ILE . 19.4 mt -64.38 -40.07 95.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.866 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 59.5 tp -59.84 -53.59 56.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -58.6 -39.93 81.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.873 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.409 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 74.0 t-105 -64.88 -39.74 94.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.57 ' CD1' HD21 ' A' ' 320' ' ' LEU . 6.4 m-85 -64.1 -30.75 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.22 -12.31 38.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.779 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -102.35 -13.83 17.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 69.0 m-80 -129.71 17.07 5.81 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -64.82 -19.59 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.243 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -79.0 -44.24 22.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.32 -43.45 96.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.179 0.514 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.716 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.8 m-85 -76.02 -12.27 60.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.17 2.41 58.73 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.17 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.785 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.71 161.49 18.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.174 0.511 . . . . 0.0 110.556 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.858 ' HB ' HG23 ' A' ' 319' ' ' ILE . 73.5 m -106.59 100.72 10.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.261 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.9 tm? -71.81 104.75 3.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.373 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -113.78 129.92 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.738 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 34.2 mm -94.75 103.61 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.016 0.436 . . . . 0.0 111.968 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.81 HG23 ' CE1' ' A' ' 323' ' ' TYR . 26.5 m -100.86 -172.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.901 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -157.97 154.42 27.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.639 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.38 3.29 1.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.89 -40.01 87.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.589 0.233 . . . . 0.0 111.208 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -94.36 162.47 13.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.96 -55.26 28.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 60.0 mp0 -59.97 -40.0 87.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.27 -24.36 68.94 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -84.0 -25.45 29.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.543 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.36 -40.01 77.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.586 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.784 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -59.59 -49.54 77.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.449 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 90.9 t -57.71 -37.76 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.3 OUTLIER -69.97 -54.13 14.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.223 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.5 66.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.565 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.554 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 27.4 t80 179.93 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.83 164.59 29.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.774 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.541 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.56 -49.48 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.009 -0.615 . . . . 0.0 114.328 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.67 131.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 117.529 0.664 . . . . 0.0 111.924 -177.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.32 135.89 5.7 Favored Glycine 0 CA--C 1.51 -0.237 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -119.88 138.62 13.28 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.516 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.854 HG23 ' CE1' ' A' ' 301' ' ' TYR . 21.4 mt -100.87 129.0 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 31.4 mt -90.57 153.71 20.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.684 0.754 . . . . 0.0 112.527 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 65.3 mtt180 -70.02 -38.05 75.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.707 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 50.9 p90 -163.79 175.77 10.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.692 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.2 mtm105 -57.96 126.58 28.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.068 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.34 128.86 34.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.522 ' HE2' HE22 ' A' ' 425' ' ' GLN . 27.7 p90 -85.06 -43.14 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.243 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -162.05 133.5 5.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.073 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 430' ' ' GLU . . . 43.24 -157.27 0.11 Allowed Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.401 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 5.3 ttm -118.79 -179.75 3.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -42.61 149.97 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 62.75 46.11 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 41.1 mt-30 -59.98 -46.78 88.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.024 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.79 -2.53 54.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.98 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 163.28 -156.23 27.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.45 24.0 13.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.603 0.24 . . . . 0.0 111.341 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -112.74 30.58 7.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.45 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.626 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 14.0 mm-40 -60.07 -42.72 95.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -103.76 5.31 36.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.23 110.53 23.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 111.389 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -87.39 12.49 11.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.042 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 45.0 mt -70.82 -5.4 30.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.971 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -40.06 87.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -73.75 -23.88 59.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.99 -36.36 77.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.437 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.03 -47.87 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.665 0.269 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 281' ' ' ILE . 12.5 p -67.2 -29.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.453 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -48.46 79.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.253 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.82 -48.7 79.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' A' ' 278' ' ' VAL . 40.7 pt -72.03 -23.9 22.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.31 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -53.83 -42.09 68.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.8 pt-20 -86.09 -25.08 26.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.553 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -84.1 -43.19 15.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.02 -58.45 2.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 27.1 tp -56.82 -56.45 21.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.678 -178.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.852 HG23 ' CE1' ' A' ' 402' ' ' PHE . 63.9 mt -60.03 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.537 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.469 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.32 -38.87 57.97 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.041 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -60.05 -32.2 70.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.03 0.443 . . . . 0.0 110.268 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 14.9 t80 -59.86 -46.0 90.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.094 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 291' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 41.3 m-85 -87.38 -40.14 14.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 71.4 m-20 -60.0 -44.25 94.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.475 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.667 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.8 tp10 -69.95 -39.74 75.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 301' ' ' TYR . 76.4 mt -63.82 -24.45 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.92 178.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -57.73 -17.52 15.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.096 0.474 . . . . 0.0 110.186 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.622 ' HB2' HG23 ' A' ' 298' ' ' THR . 11.2 mt-30 -100.48 2.99 42.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.737 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 30.0 18.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.011 0.434 . . . . 0.0 110.362 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.8 p -66.84 -11.79 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.32 52.3 54.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.65 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 40.1 mttt -131.12 39.78 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.804 -0.233 . . . . 0.0 111.214 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.852 ' CE2' HG23 ' A' ' 412' ' ' ILE . 76.6 m-85 -161.12 162.85 31.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 0.0 111.726 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.47 164.51 33.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 49.3 p90 -134.99 150.01 50.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.531 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 87.06 154.71 26.63 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.327 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.019 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -60.58 -62.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.983 -179.788 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -43.31 -52.13 5.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.619 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.6 m-20 -64.83 -54.8 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.498 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.582 HG22 HD13 ' A' ' 312' ' ' LEU . 36.3 m -57.58 -37.18 72.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.907 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 1.019 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.1 -45.0 74.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mttm -58.12 -49.6 76.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.65 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.474 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.747 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -70.77 -30.1 66.5 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.891 0.377 . . . . 0.0 110.267 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.8 -27.57 58.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 12.8 mmt -80.0 -7.24 58.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.82 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 18.69 47.41 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.06 -1.066 . . . . 0.0 110.942 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -91.27 0.0 57.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.481 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.939 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.8 m -100.39 105.68 18.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 412' ' ' ILE . 12.0 tp10 -59.6 -50.04 75.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.39 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 388' ' ' THR . 24.4 mm -135.91 123.97 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.334 0.112 . . . . 0.0 111.214 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.4 tp -85.41 122.97 30.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 111.204 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -107.11 102.21 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.824 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 320' ' ' LEU . 25.4 t -114.08 162.01 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.326 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.632 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 37.9 m-85 -114.0 148.72 36.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.927 ' OE2' HG21 ' A' ' 391' ' ' ILE . 22.0 mm-40 -65.3 155.73 34.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.06 178.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 57.8 t30 56.95 28.94 15.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.265 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -57.16 126.63 28.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.3 m-20 -89.93 27.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.614 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.062 HG22 HD12 ' A' ' 374' ' ' LEU . 31.0 mm -126.43 137.68 57.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.629 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -139.52 161.13 38.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.743 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 11.0 ttt-85 -86.94 105.66 17.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 346' ' ' LEU . 5.9 m-85 -118.58 122.59 42.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.905 HG12 HD12 ' A' ' 343' ' ' ILE . 19.4 m -92.3 122.9 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.095 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.764 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.8 mm? -116.59 159.16 22.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.081 0.467 . . . . 0.0 111.009 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.975 ' CD2' HD11 ' A' ' 369' ' ' ILE . 34.6 m170 -83.54 172.45 12.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.13 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -109.37 162.12 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.503 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -41.91 -32.04 0.39 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.087 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -93.93 -138.09 8.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.854 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.45 12.6 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.832 0.316 . . . . 0.0 111.543 179.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -131.24 39.77 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.029 0.442 . . . . 0.0 110.307 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 9.8 tp10 -164.26 132.45 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -115.94 139.23 50.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.068 0.461 . . . . 0.0 111.193 -178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.709 ' C ' HD13 ' A' ' 343' ' ' ILE . 18.6 tttp -122.8 138.16 54.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.112 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.905 HD12 HG12 ' A' ' 332' ' ' VAL . 2.1 mm -106.67 128.2 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.213 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 39.4 tp -137.04 148.09 46.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.319 0.581 . . . . 0.0 111.982 -179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.632 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -94.41 128.35 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.986 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.2 mm? -119.07 148.16 43.34 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.7 p -100.86 173.74 3.45 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.868 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -48.29 -48.13 17.81 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 121.905 1.737 . . . . 0.0 113.16 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 349' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 352' ' ' LYS . 25.1 pm0 -71.75 -30.96 66.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -87.07 -49.3 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.068 0.461 . . . . 0.0 111.719 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.411 ' CD ' ' CZ ' ' A' ' 331' ' ' TYR . 1.3 tm-20 -62.28 -32.94 73.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.918 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 349' ' ' GLU . 18.4 pttp -57.03 -24.32 52.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.082 0.468 . . . . 0.0 110.285 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -90.02 43.44 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.025 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.535 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 0.0 OUTLIER -69.97 -28.66 65.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.238 -179.028 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.3 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 110.681 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 358' ' ' THR . 96.9 m-70 -101.73 -53.32 2.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.713 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.764 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 60.79 2.17 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 -179.366 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 359' ' ' ASP . 6.1 m -92.7 -174.76 3.73 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.766 ' H ' HG22 ' A' ' 358' ' ' THR . 81.8 m-20 -136.56 130.59 32.62 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -70.04 -2.01 11.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.856 0.36 . . . . 0.0 110.795 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.36 -21.5 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 0.5 OUTLIER -131.09 -37.83 1.25 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.476 -179.884 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.01 -3.51 80.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.709 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.642 ' O ' HG23 ' A' ' 358' ' ' THR . 11.9 pt20 -48.3 98.75 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.907 0.384 . . . . 0.0 110.787 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -64.67 132.67 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.258 0.551 . . . . 0.0 111.327 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.668 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 81.9 m-70 -135.46 150.22 49.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.259 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.448 ' H ' ' H ' ' A' ' 334' ' ' HIS . 0.8 OUTLIER -138.89 118.27 12.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.495 HD13 ' C ' ' A' ' 368' ' ' LEU . 2.5 tm? -77.5 96.25 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.462 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.975 HD11 ' CD2' ' A' ' 334' ' ' HIS . 4.2 mp -72.28 -40.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -149.75 157.09 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.263 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.516 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.4 OUTLIER -148.7 116.49 6.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.624 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.468 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 6.1 tpt -117.82 132.08 23.82 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.627 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.631 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.4 Cg_exo -58.05 129.06 31.25 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.707 1.604 . . . . 0.0 110.133 178.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.062 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -69.14 -44.04 73.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 391' ' ' ILE . 33.0 tp -59.98 -53.43 57.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 44.0 mt-10 -58.04 -40.09 80.05 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.064 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.468 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 73.5 t-105 -67.21 -36.38 81.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.611 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.602 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 10.3 m-85 -70.04 -33.49 72.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.279 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.09 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.751 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.23 -12.95 14.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 377' ' ' TRP . 68.5 m-80 -134.11 19.94 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.602 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 53.1 p90 -64.47 -14.54 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -83.5 -35.04 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.72 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -39.81 87.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 312' ' ' LEU . 59.1 m-85 -82.37 -10.07 59.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.045 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.97 64.1 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.796 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.939 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.32 163.67 17.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.776 ' HB ' HG23 ' A' ' 319' ' ' ILE . 49.4 m -106.86 104.76 14.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.498 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 391' ' ' ILE . 1.2 tm? -65.16 102.41 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.116 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -115.92 107.79 15.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.933 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.927 HG21 ' OE2' ' A' ' 324' ' ' GLU . 27.6 mm -84.14 104.59 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.209 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.65 ' CB ' HD11 ' A' ' 287' ' ' ILE . 11.3 m -102.49 -172.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.078 -178.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 392' ' ' VAL . 0.7 OUTLIER -160.97 157.34 26.22 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.329 179.152 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 11.3 p-10 -69.98 19.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 393' ' ' THR . 23.7 mtpp -68.12 -40.04 82.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.652 0.263 . . . . 0.0 111.126 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 93.6 p -94.51 170.06 9.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 111.556 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.04 -45.51 92.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.687 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.469 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 33.6 mp0 -68.01 -40.54 82.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.382 0.61 . . . . 0.0 109.827 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.528 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.35 -19.67 60.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.293 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' A' ' 404' ' ' LYS . 65.6 m -84.02 -23.16 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.752 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 94.6 mt-30 -70.88 -41.47 71.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.807 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.0 m-85 -60.32 -46.33 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.082 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 394' ' ' ASP . 54.0 t -59.98 -37.84 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 400' ' ' SER . 22.1 mttm -66.94 -57.88 6.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.08 -52.56 42.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.834 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.531 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 50.4 t80 -151.91 -66.97 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.03 166.48 31.59 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.235 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.2 -49.2 2.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.041 -0.6 . . . . 0.0 114.404 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -143.97 134.4 21.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 117.697 0.748 . . . . 0.0 112.632 -177.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 145.22 12.18 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.97 144.26 15.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.287 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.8 mt -105.66 127.6 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 51.0 mt -87.85 153.49 21.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.64 0.733 . . . . 0.0 112.735 -177.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 58.8 mtp85 -69.83 -35.2 74.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.419 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.435 ' O ' HG13 ' A' ' 417' ' ' VAL . 50.9 p90 -171.3 179.63 2.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.683 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER -57.11 128.23 35.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 110.954 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -129.93 160.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.235 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.49 139.64 58.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.94 129.39 55.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.175 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -60.28 -39.94 88.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.493 ' HA2' ' HG2' ' A' ' 425' ' ' GLN . . . 134.32 90.79 0.38 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mtt -150.16 162.55 40.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 60.15 70.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.633 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 57.28 31.0 19.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.078 179.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.493 ' HG2' ' HA2' ' A' ' 421' ' ' GLY . 17.7 tp60 -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.957 0.408 . . . . 0.0 110.657 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.4 -23.73 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.566 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 116.12 -154.62 16.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.169 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -36.75 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.033 0.444 . . . . 0.0 110.519 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 432' ' ' PHE . 90.6 m-20 -103.43 68.34 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.751 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -59.98 -46.68 88.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.126 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -123.17 18.27 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.4 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.467 ' HB2' ' CB ' ' A' ' 429' ' ' ASP . 81.6 m-85 -98.84 119.69 38.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.69 -9.89 56.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.516 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.6 mt -53.49 -13.24 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.389 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 429' ' ' ASP . 81.0 m-20 -57.04 -40.04 75.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.837 0.351 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -68.56 -35.19 77.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.02 -31.66 70.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.14 -46.71 88.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -59.99 -39.96 87.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.994 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.902 179.991 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.719 0.295 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -60.04 -30.02 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -51.58 -39.93 58.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.771 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.06 -50.0 75.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.24 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -82.96 -23.47 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.864 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.679 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -60.02 -39.48 85.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.512 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.501 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.69 -22.67 29.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.35 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -50.09 8.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.21 -58.33 3.35 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.502 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.74 -55.61 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.054 0.454 . . . . 0.0 111.975 -178.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.77 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.6 mt -59.55 -49.18 84.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.623 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.86 -37.0 75.49 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.9 ttt85 -60.01 -39.08 84.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.606 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.8 t80 -57.51 -45.19 85.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.669 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -79.45 -40.0 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.01 -47.44 85.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.697 -179.025 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.85 -43.3 99.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.067 0.46 . . . . 0.0 109.864 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -59.98 -24.6 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.648 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 178.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.599 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.4 mt-30 -107.27 1.59 23.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.443 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 57.95 31.13 20.19 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.998 0.428 . . . . 0.0 110.341 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -67.71 -11.93 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.858 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.08 48.56 78.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.511 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.1 36.3 4.33 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.32 160.06 34.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.95 164.99 33.99 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.35 164.86 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 0.0 110.928 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.21 167.84 34.37 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.226 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.792 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.91 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.213 -179.583 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.26 -52.43 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.872 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.6 m-20 -65.78 -57.44 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.13 -36.39 68.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.591 0.234 . . . . 0.0 110.974 -179.222 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.69 64.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.64 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.44 -50.01 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.609 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.84 -28.32 68.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.68 0.276 . . . . 0.0 111.027 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.37 -28.24 61.03 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -77.51 -26.93 51.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.28 -7.3 58.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.789 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.42 42.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.519 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.14 -2.27 58.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.313 0.245 . . . . 0.0 111.073 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.2 m -100.95 107.11 20.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.84 -50.03 75.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.327 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.7 mm -135.51 125.1 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.82 128.23 36.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.903 0.382 . . . . 0.0 111.305 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.74 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.636 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.63 162.21 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.405 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.859 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.1 m-85 -110.63 149.86 29.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.043 0.449 . . . . 0.0 111.687 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.53 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.83 -27.98 67.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.31 34.98 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.681 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.33 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.526 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.53 23.28 5.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.268 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.977 HG22 HD12 ' A' ' 374' ' ' LEU . 14.9 mm -120.89 135.5 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.401 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.54 161.47 36.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.336 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.19 120.04 31.03 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.488 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.11 155.26 29.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.723 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.048 HG12 HD12 ' A' ' 343' ' ' ILE . 9.6 m -117.8 110.97 32.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.04 0.448 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.766 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.4 mp -97.49 142.28 29.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.941 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.574 ' CE1' HG12 ' A' ' 369' ' ' ILE . 1.0 OUTLIER -82.28 176.47 9.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.058 179.941 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 340' ' ' GLU . 21.5 p -103.36 162.39 13.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -47.65 -28.86 2.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.958 0.409 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.63 -119.6 4.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.726 179.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.54 22.26 0.28 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.788 0.294 . . . . 0.0 111.74 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.91 43.37 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.433 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.406 ' HB3' ' SG ' ' A' ' 335' ' ' CYS . 14.1 tt0 -169.15 130.01 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 110.214 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -115.49 140.41 49.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.099 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 343' ' ' ILE . 8.4 ttpt -121.48 145.48 47.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.048 HD12 HG12 ' A' ' 332' ' ' VAL . 6.6 mm -123.18 119.65 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.052 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.1 tp -128.14 161.85 28.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.177 0.513 . . . . 0.0 111.731 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.4 p90 -101.0 120.1 39.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.645 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 1.079 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.48 156.37 37.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.83 168.12 9.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.34 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.89 -49.58 8.12 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.525 2.15 . . . . 0.0 112.303 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.0 -55.51 33.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.397 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 1.079 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.97 -53.19 60.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.376 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.619 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.6 mt-10 -49.55 -33.22 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.85 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.1 mmmm -60.08 -28.28 67.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.153 0.501 . . . . 0.0 110.425 179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.627 ' HB2' ' CE1' ' A' ' 356' ' ' HIS . 0.0 OUTLIER -81.94 16.48 1.87 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.75 179.291 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.718 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 8.5 ptmm? -55.56 -23.26 25.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 85.8 p -60.05 -44.85 94.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.664 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.627 ' CE1' ' HB2' ' A' ' 353' ' ' ASP . 23.9 p-80 -107.84 -41.85 4.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.234 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.766 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.35 5.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.6 m -86.87 178.11 7.08 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.026 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.657 ' HB2' HG22 ' A' ' 362' ' ' THR . 93.1 m-20 -133.0 135.64 45.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -72.43 -0.19 11.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.096 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -104.37 -15.33 15.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.602 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.657 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.5 t -133.52 -37.76 0.94 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.718 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 84.87 41.52 7.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.716 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.808 ' C ' HG23 ' A' ' 358' ' ' THR . 14.1 pt20 -86.46 88.15 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.151 0.5 . . . . 0.0 110.686 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.29 129.91 41.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.174 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.663 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 86.7 m-70 -143.86 167.49 22.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -145.33 113.93 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.303 179.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.664 HD11 ' O ' ' A' ' 370' ' ' GLU . 58.6 tp -70.23 133.13 46.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.019 0.438 . . . . 0.0 111.055 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.7 mp -106.56 -40.02 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.664 ' O ' HD11 ' A' ' 368' ' ' LEU . 38.8 tt0 -152.17 166.12 32.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.535 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -145.34 117.14 8.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 179.515 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.99 124.16 30.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.44 120.92 9.16 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.945 1.763 . . . . 0.0 110.984 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 0.977 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.616 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.06 -51.44 69.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.77 -40.22 87.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.704 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.0 -40.03 94.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.809 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.1 -29.45 60.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.19 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.42 47.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.617 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -111.02 -9.31 14.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.74 19.84 5.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.5 p90 -69.99 -11.89 61.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.63 -38.3 21.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.99 -38.33 82.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.295 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.556 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -83.97 -10.43 57.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.63 1.26 52.7 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.644 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.75 165.15 17.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.74 100.23 9.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.338 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.93 102.22 2.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.648 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.7 mm-40 -107.82 128.01 54.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.928 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.6 mm -94.85 102.09 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 112.208 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.859 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.43 -169.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.817 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.7 p -154.89 151.55 28.7 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.021 0.439 . . . . 0.0 111.557 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.0 p-10 -71.08 1.43 5.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.319 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -60.03 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.283 . . . . 0.0 111.017 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.4 p -81.88 168.15 18.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.6 mt-30 -60.03 -54.79 41.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.8 -39.5 94.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.266 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.63 -59.7 9.34 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.593 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.92 -19.55 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.0 mt-30 -69.96 -40.03 75.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.914 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.47 -44.81 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.767 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.2 t -59.99 -45.23 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.423 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.79 -38.19 56.79 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -178.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.709 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.75 -94.52 0.48 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.192 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.06 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.818 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.53 -20.04 7.91 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.562 -1.304 . . . . 0.0 115.504 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.637 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.6 130.32 66.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.562 1.181 . . . . 0.0 111.765 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.67 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.48 151.05 19.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.735 -1.221 . . . . 0.0 114.105 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.0 mt -109.35 127.48 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.6 mt -88.23 153.33 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.52 0.676 . . . . 0.0 112.302 -178.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.528 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.2 mtt-85 -70.06 -36.75 75.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.605 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 417' ' ' VAL . 8.6 m-85 -160.92 170.59 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -58.09 128.03 35.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.693 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.98 159.91 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.886 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -87.16 132.24 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -70.04 136.89 50.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.0 130.7 48.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.767 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -66.15 147.23 49.94 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.704 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -150.02 170.1 19.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.464 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.01 -40.94 90.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.982 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.79 -40.03 91.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.794 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.64 140.03 58.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.125 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.94 0.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.539 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -141.57 130.09 4.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.395 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.28 -40.04 88.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.106 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -115.44 24.15 11.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.13 -39.92 87.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.926 0.394 . . . . 0.0 110.337 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.37 91.29 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.208 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.5 -137.68 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.88 40.02 16.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 109.194 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -89.03 -0.25 57.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.338 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.02 87.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -68.0 -35.17 77.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.478 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.93 -34.14 71.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.079 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.09 -42.4 94.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -60.06 -40.01 88.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.845 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.851 0.358 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.776 HG22 ' HB3' ' A' ' 282' ' ' GLN . 11.9 p -66.21 -29.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.257 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -52.28 -40.38 61.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.694 0.283 . . . . 0.0 111.434 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.55 -44.2 78.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.615 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 5.6 pt -81.47 -45.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.332 . . . . 0.0 111.802 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.776 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -57.17 -37.34 71.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.533 . . . . 0.0 110.085 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.576 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 93.3 mt-10 -77.77 -28.58 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.899 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -83.99 -57.52 3.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -70.0 -58.23 4.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 319' ' ' ILE . 19.2 tp -57.26 -58.35 8.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.702 0.287 . . . . 0.0 111.509 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.716 HG23 ' CE1' ' A' ' 402' ' ' PHE . 30.4 mt -59.97 -49.65 83.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.152 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.28 -37.19 79.6 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.633 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -60.03 -35.79 75.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 110.282 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.578 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.6 t80 -60.0 -46.58 89.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.699 0.285 . . . . 0.0 111.614 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 295' ' ' SER . 38.0 t0 -63.67 -46.85 83.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.463 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 33.4 tp10 -64.74 -40.0 94.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 301' ' ' TYR . 81.8 mt -62.27 -26.1 39.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.29 -14.06 16.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.273 0.559 . . . . 0.0 109.865 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.807 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.2 mt-30 -98.36 -0.02 44.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.422 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.23 28.89 17.21 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.196 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.5 p -69.98 -10.03 57.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.067 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.29 52.62 46.2 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.525 178.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 11.8 mtpt -130.33 40.57 3.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.864 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.2 m-85 -162.54 165.25 26.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.106 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 2.0 p -149.7 164.31 35.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.716 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 52.7 p90 -136.98 151.89 49.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.082 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 88.3 155.45 29.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.445 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.949 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -61.55 -56.49 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.283 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -47.68 -56.9 6.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.591 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.2 m-20 -60.7 -54.98 38.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.667 0.27 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 409' ' ' ILE . 18.9 m -58.68 -40.04 82.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.932 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -67.69 -48.07 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -54.99 -56.53 18.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.144 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.23 -30.14 70.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.07 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.865 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.04 -28.44 62.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.796 179.39 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -76.93 -26.21 53.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 45.4 mmm -82.08 -8.53 59.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.851 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.75 14.22 42.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.263 -178.307 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.79 -5.96 59.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.394 0.278 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.2 m -99.1 105.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.611 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.3 tt0 -59.93 -49.97 75.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.3 mm -133.78 126.34 50.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.563 0.221 . . . . 0.0 111.185 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.9 tp -93.52 129.43 39.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 111.058 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 412' ' ' ILE . 1.1 mt -116.14 109.32 27.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 110.142 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.61 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.8 t -125.43 161.84 29.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 31.5 m-85 -108.14 146.94 31.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 111.168 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.644 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.62 -32.76 74.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -94.1 51.53 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -83.9 125.87 32.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.7 23.03 4.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.036 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -122.43 133.47 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.596 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.599 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.7 mtt -139.53 161.54 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 31.9 ttt180 -92.39 122.26 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 111.645 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.53 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 6.6 m-85 -120.7 159.02 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.22 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 343' ' ' ILE . 5.3 m -121.87 111.87 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.362 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.739 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.0 mm? -103.13 149.39 24.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.752 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 3.7 m-70 -88.38 -179.3 6.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 335' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 17.9 t -110.57 161.25 15.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -45.7 -38.02 6.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.08 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 338' ' ' THR . . . -84.96 -113.22 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.391 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.4 OUTLIER -169.49 29.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.476 179.846 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 42.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.001 0.429 . . . . 0.0 110.753 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 340' ' ' GLU . . . . . 0.444 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 7.5 tp10 -164.37 124.62 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.98 142.37 45.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.977 0.418 . . . . 0.0 111.298 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.717 ' C ' HD13 ' A' ' 343' ' ' ILE . 49.8 tttp -121.24 141.52 50.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 1.011 HD12 HG12 ' A' ' 332' ' ' VAL . 5.5 mm -121.44 118.63 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.258 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.693 HD23 HD11 ' A' ' 346' ' ' LEU . 32.4 tp -132.55 157.8 43.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.609 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -92.09 116.67 29.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.629 179.461 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.693 HD11 HD23 ' A' ' 344' ' ' LEU . 1.4 mm? -120.59 153.64 36.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 112.711 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.6 p -101.0 168.98 8.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.542 178.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.9 Cg_endo -41.24 -46.14 5.54 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.062 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.05 -54.92 41.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 350' ' ' GLN . . . . . 0.547 ' OE1' HD12 ' A' ' 346' ' ' LEU . 62.8 mt-30 -66.77 -48.35 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.523 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.1 mt-10 -60.07 -32.42 70.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.535 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -57.28 -32.26 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.158 0.504 . . . . 0.0 110.174 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 353' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.0 t0 -91.46 61.46 4.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.612 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 24.3 mttt -70.01 -41.45 74.3 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.8 m -59.83 -55.39 34.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.425 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 36.7 m170 -85.47 -49.44 8.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.319 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.739 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 54.23 10.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.925 0.393 . . . . 0.0 110.403 -178.183 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.4 m -108.65 -165.6 1.04 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 358' ' ' THR . 74.3 m-20 -132.0 134.54 45.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -72.14 1.33 7.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.659 0.266 . . . . 0.0 111.587 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.86 -23.18 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.2 t -118.63 -36.42 3.49 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.405 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 76.91 33.87 44.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 365' ' ' GLU . 74.5 mm-40 -57.37 -157.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.544 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 0.4 OUTLIER -140.28 126.02 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.291 -179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.485 ' CB ' ' HB3' ' A' ' 357' ' ' PHE . 95.6 m-70 -161.51 142.82 11.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 57.0 mt-10 -145.91 105.26 3.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.421 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 370' ' ' GLU . 62.0 tp -75.22 137.38 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.024 0.44 . . . . 0.0 111.951 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.6 mp -116.54 -45.42 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.59 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.644 ' O ' HD11 ' A' ' 368' ' ' LEU . 52.9 tt0 -140.94 165.36 27.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.7 p -147.42 118.59 7.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.868 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.8 tpt -114.22 129.86 24.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.599 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -59.1 118.35 5.22 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.204 1.936 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.07 -39.46 86.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.674 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -60.07 -54.08 50.24 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.958 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.537 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.0 mt-10 -58.12 -40.06 80.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.928 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -62.51 -39.89 94.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.376 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.684 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.66 -28.69 62.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.085 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.48 -9.74 48.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.33 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -104.86 -14.06 15.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.62 20.22 5.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -64.88 -18.94 65.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.739 0.304 . . . . 0.0 111.019 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -81.05 -39.96 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -64.77 -39.96 94.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.621 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.581 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.7 m-85 -80.02 -11.33 59.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.976 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.34 57.52 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.488 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.22 163.66 16.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.189 0.519 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 50.2 m -106.95 100.4 9.9 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.08 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.744 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -76.28 107.18 8.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.504 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 43.3 mm-40 -113.71 135.17 54.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.909 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -98.97 105.2 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 0.0 112.146 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.561 HG13 ' NE2' ' A' ' 282' ' ' GLN . 5.8 m -102.1 -169.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.239 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -158.25 153.37 25.49 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.175 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 394' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.0 t0 -77.91 69.97 4.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.295 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -114.56 -34.94 5.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.937 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.5 m -102.93 179.36 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 25.3 mm100 -60.01 -40.65 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 34.4 mp0 -69.49 -40.66 76.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.46 -21.06 61.97 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.271 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 52.3 m -84.2 -21.43 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.027 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 85.5 mt-30 -77.48 -41.69 38.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.779 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.716 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -67.31 -49.62 63.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.555 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 394' ' ' ASP . 72.3 t -60.03 -40.04 82.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.871 0.367 . . . . 0.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -79.86 -41.32 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.325 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.26 95.29 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -134.06 -84.74 0.43 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.018 -0.591 . . . . 0.0 109.713 178.928 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 148.32 41.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.563 -1.303 . . . . 0.0 115.138 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 126.61 -28.49 4.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 119.556 -1.307 . . . . 0.0 115.218 177.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.563 HG22 HG21 ' A' ' 308' ' ' THR . 0.8 OUTLIER -125.02 127.83 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.056 0.928 . . . . 0.0 111.913 -178.51 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.43 139.77 7.67 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.34 140.62 13.59 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.595 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.864 HG23 ' CE1' ' A' ' 301' ' ' TYR . 48.4 mt -101.9 127.29 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.164 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 53.9 mt -87.42 151.55 22.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 112.798 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 34.9 mtp-105 -78.77 -27.68 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.734 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.413 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 95.5 m-85 -151.99 170.06 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.958 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -71.2 123.78 22.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.861 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 413' ' ' LEU . 24.3 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 418' ' ' ASP . . . . . 0.409 ' O ' ' CD2' ' A' ' 419' ' ' PHE . 96.4 m-20 -89.92 -79.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.704 0.288 . . . . 0.0 111.052 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 418' ' ' ASP . 54.0 m-85 -159.15 159.94 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.969 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 420' ' ' GLN . 10.0 mm-40 -60.78 -39.96 90.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.511 ' HA2' ' NE2' ' A' ' 425' ' ' GLN . . . -167.7 120.26 0.89 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.767 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 73.4 mtm -78.85 174.09 11.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.661 0.267 . . . . 0.0 110.647 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.97 -50.01 75.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -69.97 -39.99 75.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 110.245 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.511 ' NE2' ' HA2' ' A' ' 421' ' ' GLY . 49.2 tt0 -60.01 -40.08 88.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -54.57 122.81 26.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.575 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.33 -140.63 5.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.33 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.91 -39.95 96.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 111.195 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 429' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 -133.79 63.69 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.438 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 47.9 tt0 -59.99 -42.67 94.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.678 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 431' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 31.3 p90 -144.64 114.32 7.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 432' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 26.2 p90 -130.98 106.73 8.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 0.0 111.376 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.03 14.2 12.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.035 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.71 -3.86 27.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.774 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 110.641 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -69.8 -32.49 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -60.06 -33.2 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.03 -41.59 92.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.012 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.869 179.875 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.5 p -66.05 -29.95 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -51.65 -40.54 60.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.841 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -50.05 75.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.0 111.056 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -82.76 -20.91 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.697 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.679 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.63 -39.99 86.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.592 -179.433 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.4 mt-10 -77.16 -29.91 54.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.228 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.7 -58.1 3.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.75 -54.7 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.0 mt -59.98 -48.47 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.572 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.474 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.33 -37.88 66.9 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.041 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 43.8 ttt180 -60.0 -39.2 84.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.166 0.508 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.8 t80 -55.63 -45.77 77.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.772 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.32 -39.24 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.737 0.303 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.9 t0 -59.97 -43.25 95.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.381 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 293' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.17 -42.32 84.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.2 -23.88 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.57 178.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.02 -15.47 56.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.203 0.525 . . . . 0.0 110.048 178.847 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.86 2.12 29.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.596 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.25 29.73 18.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.962 0.41 . . . . 0.0 110.57 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.8 p -66.75 -13.02 60.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.9 49.18 73.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.402 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.635 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.4 36.8 4.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 159.99 34.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.337 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -140.95 161.2 38.4 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.11 144.85 47.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.29 157.0 29.1 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.908 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.06 -55.82 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 0.0 111.166 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -47.31 -57.24 5.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.943 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.12 -54.85 39.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.712 0.291 . . . . 0.0 111.452 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.0 m -56.56 -40.02 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.832 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.86 -45.23 78.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.566 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.3 mtmt -56.66 -50.04 73.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.998 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.85 -27.32 61.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.53 74.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.886 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.56 -24.35 61.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.8 -7.96 59.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.092 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.07 10.94 36.02 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.561 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 1.01 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -79.96 -6.19 57.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.441 0.296 . . . . 0.0 110.79 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.9 m -95.79 105.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.64 -50.0 75.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.9 mm -136.64 126.5 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.534 0.206 . . . . 0.0 111.41 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.9 tp -89.72 126.48 35.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.972 0.415 . . . . 0.0 111.467 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 321' ' ' ILE . . . . . 0.777 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.56 103.6 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.286 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.4 t -122.33 152.66 26.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.476 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.5 m-85 -98.42 142.95 29.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.411 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 324' ' ' GLU . . . . . 0.642 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.36 -24.05 67.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.835 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.28 33.35 1.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.492 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -71.2 123.91 23.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.699 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -96.57 28.7 3.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.724 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.58 133.19 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 329' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.3 mtt -140.62 162.53 35.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.161 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.58 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.17 29.72 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.244 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.74 28.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.496 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -131.79 112.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.788 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.9 mm? -101.54 129.6 47.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.24 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 334' ' ' HIS . . . . . 0.572 ' HB2' HD11 ' A' ' 369' ' ' ILE . 5.5 m-70 -137.05 150.81 48.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.179 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -111.56 152.74 27.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.92 129.92 44.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.755 0.312 . . . . 0.0 110.588 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.21 -1.2 35.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.701 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.48 23.55 2.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.775 0.287 . . . . 0.0 111.626 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.21 10.31 39.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.223 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -159.97 119.99 2.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.33 . . . . 0.0 111.155 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -136.6 129.97 31.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.165 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.772 ' C ' HD13 ' A' ' 343' ' ' ILE . 6.2 tttp -136.0 121.22 19.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.935 0.398 . . . . 0.0 111.435 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.772 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.4 mm -113.18 112.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.662 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp -144.08 156.5 44.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.414 -178.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 345' ' ' TYR . . . . . 0.901 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -84.96 137.09 33.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.183 178.861 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.68 164.1 22.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.635 0.731 . . . . 0.0 112.475 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.56 172.05 4.79 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.283 178.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 74.0 Cg_exo -48.94 -47.52 21.2 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 121.755 1.637 . . . . 0.0 111.768 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.17 -58.46 8.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.04 -48.95 79.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 -59.96 -35.69 75.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -57.97 -34.06 69.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.094 0.473 . . . . 0.0 109.807 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.68 40.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 354' ' ' LYS . . . . . 0.603 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 4.1 pttt -70.43 -19.09 63.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.55 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.6 t -66.83 -40.02 87.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 358' ' ' THR . 90.5 m-70 -98.03 -56.46 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.142 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 357' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.04 4.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.087 -179.108 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.807 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.3 m -91.74 174.44 7.34 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.749 ' HB2' HG22 ' A' ' 362' ' ' THR . 96.4 m-20 -130.09 138.54 50.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -72.89 -2.02 19.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.362 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -104.48 -13.83 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 362' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.6 t -131.85 -36.32 1.21 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.565 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 89.57 2.18 76.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.634 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 364' ' ' GLN . . . . . 0.807 ' C ' HG23 ' A' ' 358' ' ' THR . 37.5 mt-30 -50.01 94.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -82.37 133.0 35.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.371 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 366' ' ' HIS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 90.5 m-70 -147.1 164.41 33.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.159 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.25 108.1 7.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.93 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 370' ' ' GLU . 45.6 tp -63.46 140.02 58.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.114 0.483 . . . . 0.0 111.483 -179.335 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 334' ' ' HIS . 2.2 mp -111.74 -45.62 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.568 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.6 tt0 -143.12 156.25 44.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.177 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -143.87 116.16 8.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.403 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.56 121.92 32.5 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.72 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.57 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.57 120.84 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.782 1.655 . . . . 0.0 110.784 178.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 374' ' ' LEU . . . . . 1.008 HD12 HG22 ' A' ' 328' ' ' ILE . 20.9 mt -59.94 -44.16 94.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.259 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 68.9 tp -60.06 -50.79 72.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.97 85.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.673 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 377' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.26 -43.77 95.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.6 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.7 m-85 -73.68 -30.68 63.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.19 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.36 -25.09 60.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.539 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.69 -6.56 14.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.33 20.25 5.75 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.565 0.221 . . . . 0.0 111.349 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.35 -40.43 30.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.919 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.16 -36.37 77.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.49 -4.18 59.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.399 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.71 3.06 32.3 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.519 -179.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.72 166.31 13.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 388' ' ' THR . . . . . 0.801 ' HB ' HG23 ' A' ' 319' ' ' ILE . 58.1 m -109.13 100.57 9.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.003 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.756 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.35 102.36 1.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.679 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.77 130.03 55.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.4 mm -95.91 103.87 15.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.057 -178.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 392' ' ' VAL . . . . . 0.615 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.47 -171.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.173 -178.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.519 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.59 155.33 26.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.198 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.49 11.37 0.63 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.208 -179.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.02 94.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.676 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.4 m -92.06 170.91 9.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.844 0.354 . . . . 0.0 111.389 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.8 mt-30 -60.12 -54.35 46.93 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.545 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 398' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -59.99 -40.02 87.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.496 0.665 . . . . 0.0 109.467 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.11 -57.64 15.89 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.776 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.9 -19.44 51.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 401' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.42 -40.04 77.53 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.915 0.388 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 402' ' ' PHE . . . . . 0.749 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.97 -46.56 89.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.497 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.2 t -59.91 -34.08 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.017 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.24 -54.11 19.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.271 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.72 -20.56 70.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.939 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.2 t80 174.95 -75.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.41 167.86 28.88 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.705 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.73 -51.53 3.76 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.846 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.56 131.78 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.293 0.547 . . . . 0.0 112.234 -178.199 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.75 141.06 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.514 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.73 145.86 15.93 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.867 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.16 128.5 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 1.026 HD13 HG13 ' A' ' 417' ' ' VAL . 38.9 mt -90.66 153.15 20.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.72 0.771 . . . . 0.0 112.807 -177.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.0 -37.91 75.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.597 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 415' ' ' TYR . . . . . 0.692 ' O ' HG12 ' A' ' 417' ' ' VAL . 82.3 m-85 -158.24 -177.89 6.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.77 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.01 100.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 110.846 -179.712 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.026 HG13 HD13 ' A' ' 413' ' ' LEU . 2.3 p -143.43 137.74 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.073 -179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -146.27 100.24 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.09 -49.36 77.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.275 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.2 126.66 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.281 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -154.47 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.541 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.8 mtp 57.16 23.15 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.675 0.274 . . . . 0.0 111.056 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 424' ' ' TYR . 12.3 pt-20 -151.55 -53.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.385 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 424' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 423' ' ' GLU . 98.0 m-85 -160.85 88.66 0.77 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.705 0.288 . . . . 0.0 111.332 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 425' ' ' GLN . . . . . 0.689 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 32.0 mm-40 -70.05 -40.09 75.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.817 0.342 . . . . 0.0 110.803 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 156.12 -24.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.712 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -154.26 33.16 0.71 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.771 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.83 34.27 24.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 0.0 111.026 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -118.39 37.52 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.689 ' HA ' ' HG3' ' A' ' 425' ' ' GLN . 1.7 tm-20 -60.0 -41.09 91.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.4 99.12 5.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -116.71 117.07 28.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.83 -0.69 24.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.9 mt -50.96 -19.38 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.927 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -59.69 -40.02 86.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.396 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -74.88 -24.2 58.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.61 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.07 -38.43 82.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.003 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.06 -46.35 89.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.919 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.02 -39.95 87.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.869 -179.895 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 42.7 pt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.98 -41.17 91.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.376 0.607 . . . . 0.0 109.857 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.678 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 2.1 mp0 -80.29 -42.08 23.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.33 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -70.01 -39.99 75.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -58.41 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 18.0 tp -58.93 -55.94 28.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.891 0.377 . . . . 0.0 111.318 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 47.1 mt -60.99 -49.91 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.806 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.47 -38.78 58.56 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 20.6 ttt85 -60.03 -37.64 80.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 110.277 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.5 t80 -55.79 -47.46 77.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.938 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 34.8 m-85 -83.63 -38.73 21.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.9 t0 -60.33 -42.75 96.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.522 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.674 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.0 mt-10 -69.47 -43.3 73.48 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 301' ' ' TYR . 89.9 mt -59.55 -23.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.85 -12.88 53.32 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.22 0.534 . . . . 0.0 109.911 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 69.5 mt-30 -103.72 -0.01 29.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.466 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.24 30.29 20.01 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.6 HG23 ' HB2' ' A' ' 296' ' ' GLN . 6.5 p -67.21 -14.15 62.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.022 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.0 48.9 83.63 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.783 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.52 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 7.0 ttpt -130.22 37.1 3.92 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.4 m-85 -161.09 161.48 31.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.42 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 160.25 42.53 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.459 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 52.5 p90 -135.52 130.63 34.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 406' ' ' PHE . . . 106.83 150.9 17.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.982 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -54.61 -60.8 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.33 . . . . 0.0 111.028 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.9 pt-20 -47.4 -54.69 10.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.388 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.55 -54.57 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.518 HG21 HG22 ' A' ' 409' ' ' ILE . 22.1 m -56.21 -37.92 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.098 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.851 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.8 mp -69.93 -41.57 74.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.323 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 20.3 mtmt -58.88 -49.91 75.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.36 -26.16 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.289 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.883 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.32 -25.96 58.26 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 77.3 mm-40 -77.52 -28.08 51.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 78.5 mmm -79.99 -7.33 58.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.403 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.29 20.68 44.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.138 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.68 7.69 44.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.598 -0.301 . . . . 0.0 111.457 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 387' ' ' ALA . 31.0 m -107.27 107.2 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 121.038 0.446 . . . . 0.0 112.002 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.84 ' O ' HD13 ' A' ' 319' ' ' ILE . 11.2 tp10 -59.95 -50.76 72.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.3 mm -135.74 125.75 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.653 0.263 . . . . 0.0 111.425 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.2 tp -92.52 128.65 38.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.968 0.413 . . . . 0.0 111.219 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -115.1 107.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.089 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.603 HG23 ' HG ' ' A' ' 320' ' ' LEU . 7.6 t -123.51 163.19 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.935 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.908 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -110.9 149.23 30.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.764 ' CD ' HG21 ' A' ' 391' ' ' ILE . 49.1 mm-40 -59.37 -50.06 75.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.2 53.22 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.381 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 409' ' ' ILE . 31.4 tp -78.88 123.29 27.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -89.61 23.84 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 305' ' ' VAL . 15.8 mm -127.43 134.59 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.687 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.583 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 53.5 mtt -140.36 161.73 36.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.9 ttt180 -89.23 121.06 31.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.049 0.452 . . . . 0.0 111.303 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 4.6 m-85 -121.43 157.11 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.965 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.607 HD23 HD11 ' A' ' 346' ' ' LEU . 49.9 tp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.368 0.604 . . . . 0.0 111.957 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.557 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -94.04 118.86 32.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.601 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 344' ' ' LEU . 1.5 mm? -121.18 159.75 25.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 14.4 p -101.77 171.33 5.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.381 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.6 Cg_exo -47.38 -43.58 26.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.737 1.624 . . . . 0.0 111.89 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.88 -54.96 41.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.191 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 83.1 mt-30 -67.61 -46.29 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 94.5 mt-10 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.515 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.7 p . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.252 0.549 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 19.2 tpp -115.46 128.81 25.64 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.623 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.583 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 36.5 Cg_exo -59.77 120.0 7.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.011 1.807 . . . . 0.0 111.108 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.982 HD13 HG11 ' A' ' 305' ' ' VAL . 14.3 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.749 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 391' ' ' ILE . 63.1 tp -60.07 -51.96 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.4 mt-10 -60.02 -39.92 87.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.031 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -62.58 -40.02 95.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -71.07 -25.84 62.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.49 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.91 -9.99 49.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.761 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -108.75 -9.18 15.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.23 18.0 5.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.36 -18.72 65.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.665 0.269 . . . . 0.0 111.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -83.02 -42.23 17.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.758 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.85 -40.1 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 312' ' ' LEU . 38.0 m-85 -82.75 -10.25 58.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.28 2.41 53.92 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.498 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.48 162.49 18.92 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 319' ' ' ILE . 98.3 m -106.64 100.56 10.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.98 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.971 HD11 HD11 ' A' ' 391' ' ' ILE . 2.0 tm? -72.33 101.95 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.577 ' HG2' HG22 ' A' ' 388' ' ' THR . 19.7 mm-40 -111.36 118.17 35.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 375' ' ' LEU . 20.5 mm -88.66 108.96 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.042 0.448 . . . . 0.0 111.889 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.908 HG23 ' CE2' ' A' ' 323' ' ' TYR . 15.6 m -101.75 -170.68 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.25 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -154.53 151.59 29.07 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -70.73 12.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 395' ' ' LYS . 0.3 OUTLIER -64.7 -39.99 94.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.633 0.254 . . . . 0.0 111.644 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.9 m -92.05 170.6 9.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.386 . . . . 0.0 111.78 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -60.02 -48.83 80.1 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 44.3 mp0 -63.95 -39.99 95.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.372 0.606 . . . . 0.0 109.517 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.42 60.38 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.15 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.6 m -84.23 -22.24 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.631 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.533 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 79.6 mt-30 -73.87 -43.36 58.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.8 m-85 -60.01 -41.98 93.31 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.924 0.392 . . . . 0.0 110.357 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.77 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 54.6 t -60.0 -39.98 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -72.55 -42.8 64.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.953 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.62 98.74 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.374 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CD1' ' HA2' ' A' ' 304' ' ' GLY . 59.9 t80 -148.79 -67.14 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 125.03 57.88 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 119.842 -1.171 . . . . 0.0 115.095 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.75 -35.41 2.0 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.399 -1.382 . . . . 0.0 115.277 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.758 HD11 HD11 ' A' ' 326' ' ' LEU . 0.6 OUTLIER -136.13 134.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.883 0.841 . . . . 0.0 112.904 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -154.53 148.14 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.48 147.15 17.74 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.694 -1.241 . . . . 0.0 114.031 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 46.6 mt -108.72 126.39 65.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 50.4 mt -86.42 151.69 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 112.303 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.4 mtm180 -67.5 -38.69 84.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.446 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 96.6 m-85 -160.57 170.02 21.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.522 ' O ' ' HD1' ' A' ' 432' ' ' PHE . 95.9 m-20 . . . . . 0 C--O 1.226 -0.182 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -59.99 -40.05 87.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 110.345 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 26.7 p90 -96.92 67.68 2.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.522 ' HD1' ' O ' ' A' ' 429' ' ' ASP . 37.1 p90 -90.03 110.47 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.69 -2.61 30.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.719 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.65 -18.65 4.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.857 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.96 -39.97 87.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 0.0 110.587 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.68 -23.83 60.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.704 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.9 -37.56 79.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.251 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.03 -45.36 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.889 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.011 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 75.5 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.884 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 N--CA 1.461 0.103 0 CA-C-O 120.77 0.319 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.677 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -59.94 -39.54 85.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.555 -179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.67 -22.69 29.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.324 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -50.01 8.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.27 -58.33 3.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.501 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.72 -55.66 31.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.942 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.7 mt -59.48 -49.22 84.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.436 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.89 -37.03 75.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.084 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.8 ttt85 -59.93 -39.09 84.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.309 0.576 . . . . 0.0 110.049 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.607 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.9 t80 -57.56 -45.18 85.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.63 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -79.47 -39.94 31.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.07 -47.48 85.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.602 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.82 -43.29 99.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.039 0.447 . . . . 0.0 109.872 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -60.04 -24.54 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.664 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.16 0.505 . . . . 0.0 109.911 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.5 mt-30 -107.27 1.55 23.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.465 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 57.95 31.13 20.18 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.341 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.4 p -67.64 -11.97 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.845 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.6 78.09 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.535 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.12 36.3 4.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.33 160.02 34.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.087 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.91 165.07 33.7 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.821 0.344 . . . . 0.0 111.231 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.47 164.82 28.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.18 167.82 34.28 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.234 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.88 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.214 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.25 -52.49 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.843 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.8 m-20 -65.73 -57.42 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.15 -36.42 68.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.951 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.67 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.601 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.43 -50.07 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.8 -28.28 68.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 111.037 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.51 -28.13 60.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.84 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -77.51 -26.99 51.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.21 -7.33 58.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.776 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.44 42.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.467 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.12 -2.24 58.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.287 0.235 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.0 m -100.98 107.1 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.86 -50.01 75.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.33 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -135.5 125.12 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.77 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.8 128.25 36.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.275 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.76 105.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.742 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.635 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.64 162.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.371 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.857 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.2 m-85 -110.67 149.93 29.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.471 . . . . 0.0 111.674 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.92 -27.96 67.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.3 35.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.32 19.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.53 23.35 5.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.236 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.978 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -120.93 135.48 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.41 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.5 161.45 37.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.44 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.618 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.14 120.08 31.01 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.169 0.509 . . . . 0.0 111.468 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.14 155.22 29.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.734 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.99 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.9 tp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.162 0.506 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.5 p90 -100.96 120.05 39.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.651 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 1.077 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.43 156.33 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.8 168.11 9.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.368 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.85 -49.63 8.01 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.313 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.95 -55.56 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.392 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 1.077 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.94 -53.17 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.5 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.827 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.921 0.391 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.91 124.13 30.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.656 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.41 120.95 9.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.0 1.8 . . . . 0.0 110.982 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.978 HD12 HG22 ' A' ' 328' ' ' ILE . 14.3 mt -60.23 -42.3 94.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.595 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.04 -51.39 69.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.665 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.91 -40.17 87.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.685 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.01 -39.96 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.837 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.2 -29.4 60.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.125 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.39 47.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.598 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.11 -9.33 14.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.67 19.84 5.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -70.0 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.61 -38.35 21.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -59.93 -38.33 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.301 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.555 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -84.01 -10.43 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.62 1.28 52.7 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.654 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.76 165.12 17.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.428 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.72 100.27 9.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.3 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.92 102.2 2.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.854 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.649 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.8 mm-40 -107.86 128.01 54.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.873 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.5 mm -94.85 102.11 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 112.182 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.857 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.47 -169.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.769 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.6 p -154.86 151.54 28.72 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.055 0.455 . . . . 0.0 111.506 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.1 p-10 -71.04 1.43 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.303 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -59.94 -40.1 87.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 111.035 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.3 p -81.83 168.13 18.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.7 mt-30 -60.0 -54.81 41.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.84 -39.43 94.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.66 -59.74 9.3 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.6 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.58 12.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.1 mt-30 -69.97 -40.05 75.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 110.909 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.39 -44.9 93.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.764 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.4 t -59.99 -45.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.708 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.422 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.74 -38.19 56.96 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.707 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.7 -94.56 0.48 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.09 0.02 OUTLIER Glycine 0 CA--C 1.522 0.523 0 C-N-CA 119.642 -1.265 . . . . 0.0 114.853 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.51 -20.07 7.92 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.522 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.636 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.59 130.38 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 118.574 1.187 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.69 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.54 151.11 19.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.031 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.4 127.47 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -88.22 153.32 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 112.286 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.4 mtt-85 -70.04 -36.81 75.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.565 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -160.91 170.54 20.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.963 0.411 . . . . 0.0 110.721 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.654 0.264 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.09 -39.92 87.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.356 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.43 91.18 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.191 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.4 -137.62 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.87 39.95 16.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.96 -0.28 57.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.391 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.07 -39.94 87.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 110.518 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -68.07 -35.19 77.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.418 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.96 -34.06 71.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.082 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.13 -42.43 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.01 -40.01 87.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.889 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.3 pt . . . . . 0 CA--C 1.524 -0.051 0 CA-C-O 120.824 0.345 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.707 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 2.0 tm0? -58.85 -39.97 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.831 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 50.4 mt-10 -78.96 -30.0 44.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -53.46 5.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -72.63 -58.38 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.885 ' HG ' HD13 ' A' ' 321' ' ' ILE . 46.7 tp -55.13 -60.86 2.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 111.55 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.824 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.7 mt -59.94 -50.05 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.26 -38.92 57.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.25 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.1 ttt-85 -60.05 -39.95 87.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.281 0.563 . . . . 0.0 110.272 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.602 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 10.2 t80 -57.12 -48.55 78.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.749 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -80.01 -38.49 31.96 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -60.63 -47.89 84.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.7 mt-10 -62.91 -44.49 95.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 301' ' ' TYR . 96.5 mt -59.62 -24.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.463 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.47 -13.8 59.58 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.648 ' HB2' HG23 ' A' ' 298' ' ' THR . 58.4 mt-30 -103.37 -0.16 30.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.54 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.59 30.99 20.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.5 p -69.43 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.864 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.24 49.2 74.26 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.342 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 41.2 mttt -128.61 36.3 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 88.0 m-85 -159.75 160.74 34.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.309 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 19.3 m -140.5 160.03 40.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.14 0.495 . . . . 0.0 111.391 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.411 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -137.79 127.13 24.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.914 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 107.76 152.83 17.58 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.022 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -58.94 -55.48 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 0.0 111.174 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -49.35 -56.46 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.42 -52.37 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 409' ' ' ILE . 18.5 m -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.09 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.988 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.7 mp -67.25 -43.79 81.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.701 0.286 . . . . 0.0 111.28 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 314' ' ' MET . 20.7 mtmt -60.01 -47.62 85.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.4 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -27.81 65.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.431 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.77 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.7 -26.59 59.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 78.3 mm-40 -77.92 -28.9 49.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 94.3 mmm -80.84 -7.3 59.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.726 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.52 14.28 27.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.701 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.8 -9.76 59.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.617 0.246 . . . . 0.0 110.9 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.27 105.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.665 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.2 tt0 -60.01 -50.01 75.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.563 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.6 mm -135.58 125.99 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.746 ' HG ' HG23 ' A' ' 322' ' ' VAL . 56.4 tp -90.96 126.14 35.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.885 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -113.13 105.95 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.814 179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.746 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.3 t -124.29 151.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.4 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 392' ' ' VAL . 92.6 m-85 -95.57 145.01 25.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.53 -34.52 77.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -92.24 45.19 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.575 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 23.8 tp -75.85 125.81 29.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.678 ' O ' ' HA ' ' A' ' 347' ' ' THR . 83.0 m-20 -92.06 24.43 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.032 HG22 HD12 ' A' ' 374' ' ' LEU . 31.7 mm -125.87 136.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.939 0.399 . . . . 0.0 111.595 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.7 mtt -139.84 161.8 36.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.323 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.664 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.1 ttt85 -89.22 115.8 26.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 111.671 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 8.3 m-85 -116.53 156.91 26.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.145 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 110.942 179.634 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 346' ' ' LEU . 49.4 tp . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.373 0.606 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.732 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.8 p90 -100.02 123.19 43.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.189 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 1.048 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -124.84 157.88 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 69.8 p -101.16 170.28 6.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.672 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.6 Cg_exo -44.7 -48.38 10.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.837 1.691 . . . . 0.0 112.012 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -49.92 75.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.51 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 1.048 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.5 tp60 -69.59 -47.87 62.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 92.6 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.586 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.59 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.269 0.557 . . . . 0.0 111.448 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.4 tpt -117.04 131.46 23.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.8 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.588 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.1 Cg_exo -60.16 120.56 8.4 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.87 1.713 . . . . 0.0 110.782 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 328' ' ' ILE . 12.8 mt -62.21 -40.45 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.773 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 391' ' ' ILE . 60.8 tp -60.06 -51.68 68.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.7 mt-10 -60.23 -42.42 95.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.964 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.403 ' CD1' ' ND2' ' A' ' 381' ' ' ASN . 82.5 t90 -62.26 -39.93 94.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.421 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.65 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -70.0 -25.89 63.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.97 46.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.3 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.67 -12.75 15.8 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.5 20.34 5.67 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -68.76 -17.52 64.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.577 0.227 . . . . 0.0 111.446 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -77.14 -47.13 21.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.125 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -61.43 -44.43 97.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.322 0.582 . . . . 0.0 110.622 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.1 m-85 -69.95 -17.72 63.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.885 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.21 1.96 65.45 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.324 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.76 164.76 16.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.162 0.506 . . . . 0.0 110.796 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.842 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.6 m -107.14 100.27 9.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.049 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.55 HD23 HD23 ' A' ' 320' ' ' LEU . 1.7 tm? -71.74 102.34 2.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.97 0.414 . . . . 0.0 110.858 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -110.31 140.84 44.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.111 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 375' ' ' LEU . 36.3 mm -106.48 103.66 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.644 HG12 ' OE1' ' A' ' 282' ' ' GLN . 7.8 m -101.07 -175.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 3.0 p -157.95 152.29 24.58 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.686 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.3 t0 -76.85 76.15 3.46 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -117.57 -29.98 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.313 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 35.1 m -113.55 -174.93 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.771 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 401' ' ' GLN . 31.0 mt-30 -59.98 -47.75 84.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.01 0.434 . . . . 0.0 110.341 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 22.1 mp0 -61.62 -41.93 98.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.47 -22.45 67.67 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.546 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.4 m -83.08 -21.56 33.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.791 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 397' ' ' GLN . 9.5 mm100 -75.79 -46.67 29.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.013 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.824 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -59.96 -49.97 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.085 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 394' ' ' ASP . 96.9 t -59.98 -39.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -68.58 -42.9 77.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.399 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.1 -22.92 74.54 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.256 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.447 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 28.8 t80 -176.45 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.657 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 91.68 101.1 1.32 Allowed Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.564 -0.827 . . . . 0.0 115.101 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 130.42 -34.22 2.73 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.178 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -150.8 127.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 111.939 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -150.74 138.12 6.47 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.77 142.24 14.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.601 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.5 mt -104.66 126.71 59.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 59.2 mt -90.78 157.14 17.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.643 0.735 . . . . 0.0 112.466 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -70.04 -39.99 75.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.358 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 53.9 p90 -167.07 178.7 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.508 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.6 mtm180 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.899 0.38 . . . . 0.0 110.7 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 93.7 m-20 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.873 0.368 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -59.91 -40.07 87.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.018 0.437 . . . . 0.0 110.12 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.67 100.11 7.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.325 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 429' ' ' ASP . 1.3 p90 -117.34 130.94 56.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -86.1 6.84 27.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.81 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.97 -4.25 23.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.905 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.96 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.698 0.285 . . . . 0.0 111.068 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.95 -33.24 75.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.473 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.49 -34.26 72.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.268 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . 0.565 ' C ' HD13 ' A' ' 438' ' ' LEU . 3.0 tm? -60.02 -43.7 95.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -70.05 140.08 52.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.881 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.89 0.376 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.68 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.59 -39.99 85.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.606 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.5 mt-10 -77.08 -29.97 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.269 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.65 -58.16 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.76 -54.66 44.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.3 mt -60.03 -48.43 87.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.555 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.36 -37.88 67.19 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 44.0 ttt180 -60.0 -39.22 85.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.9 t80 -55.65 -45.73 77.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.755 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.4 -39.15 21.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.0 t0 -59.99 -43.2 95.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.402 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.18 -42.29 84.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 109.743 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.24 -23.81 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.6 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.04 -15.45 56.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.175 0.512 . . . . 0.0 110.006 178.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.84 2.08 29.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.622 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.25 29.72 18.43 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.966 0.413 . . . . 0.0 110.571 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.9 p -66.74 -12.98 60.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.915 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 49.12 73.39 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.443 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.38 36.84 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.947 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 160.05 34.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.323 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -141.0 161.19 38.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.445 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.15 144.84 47.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.31 156.89 28.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.871 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -59.94 -55.89 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.195 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.4 pt-20 -47.27 -57.23 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 96.0 m-20 -61.13 -54.9 38.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.676 0.274 . . . . 0.0 111.386 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.1 m -56.51 -40.09 74.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.86 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.88 -45.26 78.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.2 mtmt -56.63 -50.03 73.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.993 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.682 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.827 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.5 74.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.914 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.52 -24.41 61.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.78 -7.96 59.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.098 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.1 10.96 36.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.123 -1.036 . . . . 0.0 111.544 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.02 -6.16 57.09 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.399 0.28 . . . . 0.0 110.766 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.856 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.7 m -95.83 105.5 17.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.59 -49.98 75.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.306 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -136.7 126.56 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.579 0.228 . . . . 0.0 111.375 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 45.0 tp -89.73 126.49 35.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.94 0.4 . . . . 0.0 111.5 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.57 103.61 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.313 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.2 t -122.29 152.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -98.48 142.94 29.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.37 -24.0 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.833 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.32 33.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.762 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.6 tp -71.17 123.81 23.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -96.55 28.76 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.61 133.19 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.042 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.1 mtt -140.6 162.47 35.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.22 29.76 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.092 0.472 . . . . 0.0 111.222 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.76 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 111.411 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.923 0.392 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.9 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -85.02 137.15 33.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.104 178.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.71 164.05 22.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.596 0.713 . . . . 0.0 112.525 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.5 172.08 4.78 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.31 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 72.9 Cg_exo -48.95 -47.47 21.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 121.789 1.659 . . . . 0.0 111.815 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.15 -58.52 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -59.98 -48.99 79.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.111 0.482 . . . . 0.0 110.469 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.61 121.97 32.37 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.761 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.63 120.91 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.77 1.647 . . . . 0.0 110.712 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.007 HD12 HG22 ' A' ' 328' ' ' ILE . 20.7 mt -60.03 -44.09 94.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.265 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 69.1 tp -60.01 -50.87 72.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.99 85.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.638 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.28 -43.77 95.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.641 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.827 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.8 m-85 -73.59 -30.7 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.2 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.38 -25.09 60.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.495 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.71 -6.62 14.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.27 20.18 5.79 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.95 -14.48 63.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.615 0.245 . . . . 0.0 111.374 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.36 -40.41 30.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.923 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.1 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.52 -4.21 59.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.401 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.74 2.96 31.99 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.532 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.856 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.64 166.28 13.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 111.103 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.802 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.0 m -109.15 100.54 9.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.936 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.757 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.32 102.39 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.68 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.8 130.02 55.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.757 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.5 mm -95.86 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.173 0.511 . . . . 0.0 112.094 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.616 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.51 -171.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.155 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.52 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.55 155.33 26.16 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.274 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.48 11.31 0.63 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.15 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.04 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 111.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -92.06 170.83 9.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.838 0.352 . . . . 0.0 111.406 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.9 mt-30 -60.02 -54.38 46.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -60.02 -39.98 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 0.0 109.502 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.09 -57.64 15.85 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.805 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.87 -19.53 51.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.36 -40.04 77.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.751 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.99 -46.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.92 -34.06 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.014 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.25 -54.08 20.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.309 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.73 -20.62 70.41 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.938 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.4 t80 174.97 -75.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.33 167.95 28.99 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -51.47 3.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.835 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.55 131.79 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.294 0.547 . . . . 0.0 112.227 -178.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 141.05 8.33 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.68 145.87 15.95 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.866 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.947 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.11 128.55 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.71 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.8 mt -90.68 153.17 20.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.766 0.793 . . . . 0.0 112.815 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.01 -37.92 75.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.542 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.424 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 82.3 m-85 -158.25 -177.91 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.869 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.02 -41.04 91.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.43 99.1 5.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.397 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -116.68 117.07 28.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.84 -0.65 24.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.8 mt -50.94 -19.4 1.0 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.939 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -59.7 -40.01 86.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -74.9 -24.29 58.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.541 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.96 -38.42 82.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.452 . . . . 0.0 110.007 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.01 -46.44 89.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.887 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.04 -39.91 87.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.133 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.913 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.852 0.358 . . . . 0.0 111.445 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -55.64 -41.8 74.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.614 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 55.1 mt-10 -69.96 -33.43 72.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -57.2 3.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -70.0 -58.08 4.25 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.893 ' HG ' HD13 ' A' ' 321' ' ' ILE . 31.4 tp -57.51 -57.44 12.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 13.6 mt -61.48 -49.79 82.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.535 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.73 -34.36 81.85 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.415 -0.897 . . . . 0.0 112.651 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 4.8 ttt85 -59.95 -37.78 80.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 9.4 t80 -60.13 -41.29 92.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.754 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -84.66 -39.44 18.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.49 -50.05 75.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.667 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.1 OUTLIER -64.31 -40.95 96.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.524 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.0 mt -60.04 -23.26 26.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -15.39 46.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.331 0.586 . . . . 0.0 109.685 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.866 ' HB2' HG23 ' A' ' 298' ' ' THR . 68.3 mt-30 -100.7 1.92 40.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.649 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 56.09 29.85 15.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.106 0.479 . . . . 0.0 110.035 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.866 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.9 p -69.97 -10.34 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.773 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.79 50.69 59.68 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.091 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 18.6 mtpt -127.96 38.76 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.874 ' CE1' HG23 ' A' ' 412' ' ' ILE . 81.7 m-85 -161.99 163.37 28.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.417 ' O ' ' HE2' ' A' ' 290' ' ' TYR . 1.8 p -146.43 162.39 38.35 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.424 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.1 p90 -138.68 133.06 31.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.323 . . . . 0.0 110.33 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 103.58 147.76 18.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.955 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.981 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -52.82 -60.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -44.54 -58.09 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.345 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.93 -54.49 41.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 111.235 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.597 HG21 HG22 ' A' ' 409' ' ' ILE . 10.6 m -55.73 -40.01 71.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.027 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.981 HD13 HG12 ' A' ' 305' ' ' VAL . 2.5 mp -70.01 -41.21 74.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.697 0.284 . . . . 0.0 111.211 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mtmm -58.55 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.156 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.96 64.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.69 -28.6 63.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.744 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.2 -26.48 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 93.2 mmm -82.5 -9.1 59.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.648 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.42 42.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.324 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.92 59.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.386 0.274 . . . . 0.0 110.975 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.6 m -93.54 104.83 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.914 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.1 tt0 -59.91 -49.88 75.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.434 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 318' ' ' GLU . 23.4 mm -133.96 126.15 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.65 0.262 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.693 ' HG ' HG23 ' A' ' 322' ' ' VAL . 43.6 tp -91.55 127.33 36.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.942 0.401 . . . . 0.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.893 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.3 mt -112.71 106.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.693 HG23 ' HG ' ' A' ' 320' ' ' LEU . 29.8 t -122.61 155.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.488 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.591 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.9 m-85 -102.65 143.92 31.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.518 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.7 pt-20 -61.78 -35.68 78.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.68 48.31 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.053 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -78.19 125.43 29.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.804 0.335 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -92.94 26.39 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.57 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.003 HG22 HD12 ' A' ' 374' ' ' LEU . 23.2 mm -128.36 136.31 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.561 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 59.8 mtt -139.97 161.93 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.811 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.659 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 46.8 ttm-85 -89.17 115.48 26.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.803 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.51 ' CE2' ' HG2' ' A' ' 351' ' ' GLU . 3.2 m-85 -115.48 154.74 28.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 33.1 tp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.276 0.56 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.506 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.2 OUTLIER -97.67 120.03 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.4 mm? -124.46 167.48 14.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.554 0.692 . . . . 0.0 112.596 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.3 p -101.59 169.25 7.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.778 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 75.2 Cg_exo -49.46 -42.56 41.3 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.843 1.696 . . . . 0.0 111.745 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.26 -51.57 69.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.101 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 76.8 mt-30 -70.43 -46.61 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.996 0.426 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 97.2 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.852 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.188 0.518 . . . . 0.0 111.494 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.0 tpt -111.66 126.93 27.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.229 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.3 Cg_exo -57.56 118.67 5.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.877 1.718 . . . . 0.0 111.003 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.003 HD12 HG22 ' A' ' 328' ' ' ILE . 15.2 mt -60.89 -39.95 91.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.887 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.769 HD11 HD12 ' A' ' 391' ' ' ILE . 57.1 tp -59.5 -52.8 64.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.2 mt-10 -58.87 -40.01 83.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.059 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -67.35 -34.0 76.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.316 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 11.3 m-85 -69.78 -31.51 69.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.433 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -9.24 50.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.655 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -101.08 -15.44 17.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.423 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.68 18.11 5.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.35 -20.94 64.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 0.0 111.019 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -79.84 -43.37 22.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.98 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 110.637 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.635 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.3 m-85 -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.64 71.25 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.127 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.38 162.78 16.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.172 0.511 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.866 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.7 m -107.32 100.61 10.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.025 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.746 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.69 102.74 2.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.449 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -108.42 134.99 50.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.884 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.769 HD12 HD11 ' A' ' 375' ' ' LEU . 33.9 mm -99.93 102.09 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 5.7 m -101.6 -168.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.928 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -157.14 153.9 28.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.498 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 403' ' ' VAL . 35.4 p-10 -71.2 -1.86 14.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.532 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -41.36 92.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.534 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 283' ' ' GLU . 3.2 t -75.0 167.27 22.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 111.154 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 48.8 tp60 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 35.8 mp0 -67.72 -34.26 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 109.776 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -51.62 -57.9 11.27 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.921 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.7 m -62.74 -19.47 63.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 67.8 mt-30 -72.99 -40.08 65.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.996 0.427 . . . . 0.0 110.579 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 410' ' ' GLY . 0.2 OUTLIER -65.86 -41.53 91.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.802 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.774 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 71.8 t -60.45 -37.91 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -62.38 -45.03 95.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 0.0 110.417 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -74.95 -20.66 79.34 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.05 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 12.5 t80 -174.98 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.774 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 94.3 96.69 1.6 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.264 -0.969 . . . . 0.0 114.853 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.537 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 135.85 -31.68 2.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.764 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER -152.86 127.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 117.493 0.646 . . . . 0.0 111.895 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.07 136.04 5.65 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.42 134.69 11.33 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.139 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.874 HG23 ' CE1' ' A' ' 301' ' ' TYR . 63.0 mt -99.13 129.99 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 47.0 mt -88.58 149.39 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.728 0.775 . . . . 0.0 113.005 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.6 mtt180 -71.24 -29.92 65.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.239 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 63.7 t80 -169.81 165.01 9.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.983 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 N--CA 1.458 -0.03 0 CA-C-O 120.677 0.275 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.57 -39.94 88.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.569 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -109.12 62.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 40.4 p90 -79.94 99.82 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.314 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.21 13.42 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.051 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.46 -6.41 30.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.742 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -59.96 -40.03 87.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.769 0.318 . . . . 0.0 110.504 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.07 -32.35 71.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.91 -35.26 72.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.06 -44.64 94.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.874 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -60.06 -40.11 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.813 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 2.6 pt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.091 0.472 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.677 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -55.32 -36.85 66.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.7 pt-20 -69.93 -29.97 67.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -57.82 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.96 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -54.86 11.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 21.0 tp -58.55 -57.11 14.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 111.698 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.682 HG23 ' CE1' ' A' ' 402' ' ' PHE . 43.9 mt -59.95 -49.15 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -58.67 -38.17 91.09 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.217 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 8.3 ttt180 -60.02 -38.07 81.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 109.923 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.635 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 3.0 t80 -55.85 -48.62 75.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.93 -39.95 29.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.99 0.424 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 295' ' ' SER . 74.6 m-20 -60.01 -41.96 93.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.808 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.7 mt-10 -70.03 -41.15 74.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.58 -22.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.04 -14.28 53.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 109.65 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.769 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.2 mt-30 -103.17 0.04 31.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.418 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 7.3 t70 56.34 33.4 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 109.977 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.797 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 31.4 p -73.46 -10.8 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.126 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.41 ' HA3' ' HE ' ' A' ' 416' ' ' ARG . . . 56.89 53.94 40.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.665 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.537 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 9.0 mtpt -130.24 36.23 4.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.934 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -158.87 159.61 35.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.468 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 31.2 m -134.49 155.46 50.32 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.026 0.441 . . . . 0.0 111.378 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -134.87 118.32 16.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.82 155.41 10.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.978 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -60.03 -56.22 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.824 0.345 . . . . 0.0 111.113 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 9.0 pt-20 -51.91 -51.23 58.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.733 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -63.13 -54.15 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.443 HG21 HG22 ' A' ' 409' ' ' ILE . 31.9 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.978 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -65.61 -50.3 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 111.522 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -55.61 -52.38 63.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 -179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.56 71.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.27 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.962 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.34 -27.42 61.5 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.839 0.352 . . . . 0.0 110.463 179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -77.55 -27.6 51.62 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 30.9 mmt -80.86 -7.46 59.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.832 -1.531 . . . . 0.0 111.593 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.4 18.63 44.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.3 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.36 -2.97 58.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.601 -0.3 . . . . 0.0 111.377 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 312' ' ' LEU . 29.9 m -99.43 104.47 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.6 tp10 -57.12 -49.99 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.185 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.5 mm -135.49 126.01 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.562 0.22 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.66 ' HG ' HG23 ' A' ' 322' ' ' VAL . 37.3 tp -90.91 123.41 34.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 111.699 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -109.68 103.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.66 HG23 ' HG ' ' A' ' 320' ' ' LEU . 36.3 t -111.38 155.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.241 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 7.6 m-85 -103.61 142.45 34.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.174 0.511 . . . . 0.0 112.278 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 393' ' ' THR . 36.4 tt0 -68.07 156.78 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.017 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 28.27 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.92 0.391 . . . . 0.0 110.296 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.499 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.1 tp -59.96 125.5 23.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.409 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.08 30.31 1.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.7 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.957 HG22 HD12 ' A' ' 374' ' ' LEU . 26.5 mm -130.35 133.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.511 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.709 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 33.3 mtt -140.6 163.01 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.636 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.4 OUTLIER -88.19 118.79 28.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.832 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 59.9 m-85 -126.9 124.71 40.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.536 -179.167 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 34.4 tp . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.399 0.619 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.798 ' HD2' HD12 ' A' ' 328' ' ' ILE . 2.5 p90 -100.93 125.7 47.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.658 ' HB2' ' HG2' ' A' ' 351' ' ' GLU . 2.7 mm? -122.3 157.71 31.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.544 0.688 . . . . 0.0 112.773 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.626 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.3 p -99.35 168.13 10.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.311 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 4.7 Cg_endo -46.43 -46.62 16.87 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.27 1.98 . . . . 0.0 112.297 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -72.65 -44.89 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 349' ' ' GLU . 33.3 mt-30 -69.94 -46.64 64.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.832 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.373 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.546 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 121.182 0.515 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.66 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -121.31 137.27 26.62 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.186 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.709 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 28.1 Cg_endo -64.31 122.97 11.09 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.117 1.878 . . . . 0.0 110.626 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.957 HD12 HG22 ' A' ' 328' ' ' ILE . 19.6 mt -65.3 -41.06 94.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 38.4 tp -60.08 -53.66 55.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.644 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 48.0 mt-10 -59.98 -40.38 88.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.024 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -62.49 -40.03 95.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.083 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.578 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -70.54 -28.25 64.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.276 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -10.48 48.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.828 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.07 -9.49 14.72 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.5 m120 -129.2 19.45 5.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.604 0.24 . . . . 0.0 111.61 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -68.57 -17.41 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.597 0.237 . . . . 0.0 111.347 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -79.85 -46.97 15.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.02 -44.19 94.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.318 0.58 . . . . 0.0 109.96 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.553 ' CD2' HD23 ' A' ' 312' ' ' LEU . 26.7 m-85 -73.49 -19.97 60.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.039 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . 0.49 ' HA3' HH22 ' A' ' 414' ' ' ARG . . . 74.87 2.14 64.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.22 165.37 18.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.073 0.463 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.851 ' HB ' HG23 ' A' ' 319' ' ' ILE . 24.2 m -107.68 100.67 10.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 389' ' ' LEU . 0.9 OUTLIER -73.54 107.34 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.628 -178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.677 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -115.39 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.593 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 27.2 mm -98.5 102.34 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.114 0.483 . . . . 0.0 112.26 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.7 m -114.06 133.62 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.607 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 3.2 p -112.74 166.21 11.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.657 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.4 t0 -73.48 70.06 1.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.846 0.355 . . . . 0.0 111.352 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' A' ' 283' ' ' GLU . 4.9 ptmt -119.83 12.02 12.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 47.5 t -155.17 179.57 9.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -59.38 -53.32 59.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 50.9 mp0 -63.65 -39.98 95.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.411 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.87 -25.4 67.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.521 -0.847 . . . . 0.0 110.992 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.5 m -83.74 -23.38 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.554 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.78 -43.44 65.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.376 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.682 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.2 m-85 -65.3 -48.39 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.21 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.657 HG21 ' HB2' ' A' ' 394' ' ' ASP . 75.4 t -59.95 -40.08 81.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -48.17 33.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -73.22 -28.29 66.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -157.68 -84.72 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 100.09 151.73 26.04 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.461 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.99 -47.49 3.13 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.67 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -148.94 134.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 118.232 1.016 . . . . 0.0 112.985 -177.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.39 145.49 12.96 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.72 147.6 18.96 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.712 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.934 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.0 mt -106.5 126.72 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.3 mt -87.85 156.15 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 0.0 112.195 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.49 HH22 ' HA3' ' A' ' 386' ' ' GLY . 16.3 mtt-85 -77.77 -33.07 52.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.685 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.428 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 93.5 m-85 -156.39 170.01 23.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.753 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.833 0.349 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -59.94 -40.03 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.551 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.404 ' CZ ' ' OD2' ' A' ' 433' ' ' ASP . 64.8 t80 -120.56 102.35 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.297 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -130.97 80.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . 0.404 ' OD2' ' CZ ' ' A' ' 431' ' ' PHE . 96.6 m-20 -95.19 18.65 11.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.13 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.28 -15.42 47.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.86 -40.02 87.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -80.62 -20.22 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -59.97 -38.46 82.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.313 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.92 -49.18 78.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.951 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -67.84 139.97 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.914 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.693 0.283 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.55 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -57.48 -40.01 77.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.212 0.53 . . . . 0.0 110.019 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.603 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 1.9 mp0 -75.69 -51.34 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.407 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -40.05 87.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -84.55 -58.69 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.843 ' HG ' HD13 ' A' ' 321' ' ' ILE . 29.9 tp -60.01 -55.84 29.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.909 0.385 . . . . 0.0 111.834 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.878 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.3 mt -59.95 -47.88 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.572 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.425 ' HA2' ' OE1' ' A' ' 398' ' ' GLU . . . -57.81 -37.79 85.69 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.444 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt180 -60.02 -42.41 94.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.513 ' CE1' ' CE1' ' A' ' 402' ' ' PHE . 5.5 t80 -59.99 -41.71 92.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.516 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.688 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.7 t80 -84.27 -40.98 17.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -60.57 -43.37 97.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.663 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 75.4 mt-10 -60.06 -40.03 88.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.947 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 291' ' ' PHE . 64.1 mt -56.4 -30.26 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 t -53.03 -29.87 32.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.552 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 21.8 mt-30 -94.77 1.46 55.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.26 32.03 17.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.978 0.418 . . . . 0.0 110.085 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 1.5 p -64.26 -13.14 47.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.541 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.85 47.57 87.9 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.699 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 413' ' ' LEU . 36.3 mttp -129.48 48.05 2.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.585 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -170.51 168.08 7.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 111.348 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.6 p -153.1 169.0 24.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.42 135.64 33.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.047 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 104.17 146.52 15.98 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.815 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.47 -57.82 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.909 0.385 . . . . 0.0 110.982 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -49.02 -53.48 19.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.397 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.77 -53.04 53.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.312 . . . . 0.0 111.29 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.595 HG21 HG22 ' A' ' 409' ' ' ILE . 7.4 m -57.88 -38.58 76.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.871 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -69.07 -43.64 74.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.371 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.3 mtmm -57.37 -49.99 74.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.1 -26.08 62.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.389 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.797 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.07 -27.28 60.83 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.923 0.392 . . . . 0.0 110.586 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -77.51 -28.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.1 mmt -80.54 -7.01 59.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.979 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.91 14.48 23.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.677 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.29 -6.59 59.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.395 0.278 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.821 HG23 ' HB2' ' A' ' 387' ' ' ALA . 20.8 m -93.16 105.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.798 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.3 tt0 -59.98 -50.0 75.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 32.9 mm -135.22 126.34 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.529 0.204 . . . . 0.0 111.483 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.683 ' HG ' HG23 ' A' ' 322' ' ' VAL . 50.2 tp -92.0 125.52 36.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.022 0.439 . . . . 0.0 110.914 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.843 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -112.41 106.95 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.975 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.683 HG23 ' HG ' ' A' ' 320' ' ' LEU . 18.9 t -124.24 158.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.282 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.724 ' CE1' HG23 ' A' ' 392' ' ' VAL . 90.3 m-85 -104.58 146.48 28.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.42 . . . . 0.0 111.345 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.555 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.9 pt-20 -64.97 -30.9 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -97.25 49.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 20.3 tp -80.19 126.16 30.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 347' ' ' THR . 35.8 p-10 -92.67 21.42 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.468 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 305' ' ' VAL . 14.8 mm -124.7 136.78 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.569 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 40.2 mtt -140.52 161.6 37.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.868 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.571 HH21 HD22 ' A' ' 309' ' ' LEU . 11.1 mmt-85 -89.3 120.52 30.72 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.072 0.463 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.4 m-85 -118.08 152.34 35.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.739 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 332' ' ' VAL . 15.4 m . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 346' ' ' LEU . 48.7 tp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.308 0.575 . . . . 0.0 112.256 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.641 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.21 119.01 36.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.773 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.777 HD11 HD23 ' A' ' 344' ' ' LEU . 0.9 OUTLIER -121.36 154.23 36.73 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.679 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.3 p -101.27 171.44 5.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.087 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.679 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.9 Cg_exo -44.02 -47.39 10.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.858 1.705 . . . . 0.0 112.106 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.0 pt-20 -59.98 -49.04 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 97.5 mt-30 -70.22 -46.52 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 90.2 mt-10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.303 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.598 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.3 p . . . . . 0 CA--C 1.523 -0.084 0 CA-C-O 121.132 0.491 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 20.3 tpp -112.9 128.22 25.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.669 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.508 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 34.1 Cg_exo -59.95 116.96 3.67 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 121.925 1.75 . . . . 0.0 110.618 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.789 HD13 HG11 ' A' ' 305' ' ' VAL . 6.5 mt -60.06 -39.47 86.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.851 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.897 HD11 HD12 ' A' ' 391' ' ' ILE . 59.4 tp -60.03 -50.69 72.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.7 mt-10 -60.02 -39.95 87.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -66.31 -36.66 83.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.618 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.425 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -68.64 -26.38 65.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.76 -18.64 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.785 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -105.76 4.89 30.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 384' ' ' LYS . 39.4 t-20 -139.79 13.85 2.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -69.98 -17.58 63.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -77.16 -48.37 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . 0.445 ' HB2' ' OD1' ' A' ' 381' ' ' ASN . 34.1 mttt -60.11 -44.6 94.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.5 m-85 -69.89 -16.4 63.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.894 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.4 62.7 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.177 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.821 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.52 162.01 19.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 72.8 m -105.71 100.05 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.823 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.1 tm? -74.47 103.13 4.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.2 mm-40 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.694 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.897 HD12 HD11 ' A' ' 375' ' ' LEU . 22.4 mm -96.08 104.34 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.814 ' HB ' HD11 ' A' ' 287' ' ' ILE . 14.7 m -100.87 -172.57 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.235 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.556 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -158.57 154.15 26.14 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.098 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.448 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.6 p-10 -67.91 5.6 0.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -59.96 -39.97 87.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.8 m -91.1 169.76 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.9 0.381 . . . . 0.0 111.525 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.94 -49.34 78.07 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.621 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.653 ' O ' HG21 ' A' ' 287' ' ' ILE . 60.8 mm-40 -63.49 -35.94 82.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.642 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.675 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -24.02 66.28 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.004 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 59.8 m -83.94 -23.15 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.614 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.09 -41.59 63.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.602 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.878 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -65.0 -44.0 90.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.837 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 92.3 t -58.77 -32.84 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.486 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.07 -54.23 14.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.225 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -55.65 -53.79 39.2 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.887 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -137.09 -66.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 102.7 81.13 1.52 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.517 -0.849 . . . . 0.0 115.163 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.464 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 138.02 -29.4 2.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.991 -1.1 . . . . 0.0 114.15 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.98 130.64 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.689 0.744 . . . . 0.0 112.229 -178.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.99 135.12 5.13 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.95 142.15 14.37 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.461 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 318' ' ' GLU . 81.4 mt -109.96 130.0 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.8 mt -88.59 155.24 19.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 74.4 mtm180 -70.03 -39.96 75.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.581 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.572 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 54.4 p90 -158.42 169.92 23.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.7 mmm180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.733 0.302 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.12 -40.01 90.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.163 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -101.4 49.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 36.5 p90 -65.38 89.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 111.201 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.07 13.59 14.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.462 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.79 -18.13 41.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.606 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.379 . . . . 0.0 110.313 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -79.48 -19.96 48.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.83 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.74 -38.61 82.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.91 -41.21 91.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.933 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.86 152.24 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.762 0.315 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.657 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.3 tm0? -55.28 -43.99 75.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 0.0 109.993 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.714 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 64.5 mt-10 -77.59 -41.53 38.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -70.76 -40.07 72.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -87.03 -58.83 2.44 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 21.5 tp -59.94 -56.43 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 402' ' ' PHE . 30.6 mt -60.72 -48.71 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.333 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.13 -38.83 78.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.444 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.472 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 29.7 ttt180 -60.02 -39.61 86.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.328 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 5.7 t80 -55.59 -49.85 71.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.506 ' CE2' ' CB ' ' A' ' 401' ' ' GLN . 63.6 m-85 -79.41 -38.37 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.042 0.449 . . . . 0.0 111.006 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.93 -49.79 76.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.331 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.9 mt-10 -63.76 -45.43 89.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.877 0.37 . . . . 0.0 110.03 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 301' ' ' TYR . 93.6 mt -58.02 -23.6 21.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.42 -15.18 47.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.49 0.662 . . . . 0.0 109.549 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.799 ' HB2' HG23 ' A' ' 298' ' ' THR . 34.9 mt-30 -103.25 2.38 34.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.09 31.57 18.41 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.177 0.513 . . . . 0.0 110.25 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 296' ' ' GLN . 25.2 p -70.02 -9.99 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.766 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.52 48.03 73.0 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 119.926 -1.13 . . . . 0.0 113.655 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 33.5 mtmt -128.4 36.97 4.2 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.925 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.6 m-85 -160.0 160.04 32.84 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.35 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.13 159.42 43.32 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.748 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.8 p90 -131.9 125.35 31.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 114.94 169.13 15.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.765 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.45 -56.81 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 13.2 pt-20 -48.78 -50.35 34.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.463 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.32 -53.6 28.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.754 0.311 . . . . 0.0 111.368 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 409' ' ' ILE . 60.2 m -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.244 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.971 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -65.81 -45.04 83.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.9 mttm -58.95 -48.08 82.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.439 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.9 65.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.233 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.55 -27.87 61.56 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.804 0.335 . . . . 0.0 110.762 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 75.4 mm-40 -76.47 -26.82 55.77 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.2 mmt -81.82 -7.05 59.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.75 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.16 35.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.544 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.9 -2.11 58.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.289 0.236 . . . . 0.0 111.143 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.948 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.7 m -99.54 104.79 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.9 tt0 -56.8 -50.07 73.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.279 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.873 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -136.42 127.56 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.668 0.27 . . . . 0.0 111.466 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 312' ' ' LEU . 41.9 tp -95.34 128.62 42.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.026 0.441 . . . . 0.0 111.342 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 412' ' ' ILE . 0.9 OUTLIER -117.18 110.13 30.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 110.172 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.589 HG23 ' HG ' ' A' ' 320' ' ' LEU . 12.2 t -125.47 162.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.136 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 392' ' ' VAL . 90.4 m-85 -107.29 145.39 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -63.61 -41.43 98.3 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -86.36 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 409' ' ' ILE . 34.6 tp -89.24 120.6 30.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.604 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -90.06 26.64 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.017 HG21 HG21 ' A' ' 305' ' ' VAL . 23.9 mm -123.45 136.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.135 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 73.7 mtp -140.05 162.36 35.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.236 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.7 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.9 ttt-85 -84.7 106.27 16.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.991 0.424 . . . . 0.0 111.897 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.534 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 7.6 m-85 -120.57 123.54 43.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.259 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 0.0 111.517 -179.584 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.1 tp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.579 0.704 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.747 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.08 134.43 41.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.579 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.2 mm? -128.12 161.17 29.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.615 0.721 . . . . 0.0 112.87 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.2 p -101.56 168.76 8.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.372 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.5 Cg_endo -45.66 -47.42 13.59 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.283 1.989 . . . . 0.0 111.982 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.8 -50.07 74.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.743 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.638 ' NE2' HD12 ' A' ' 346' ' ' LEU . 43.4 mt-30 -69.05 -46.09 68.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 76.4 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.869 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 7.7 tpt -122.22 141.2 33.98 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.556 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.729 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.2 Cg_exo -62.96 124.4 13.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.232 1.955 . . . . 0.0 110.399 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.989 HD12 HG22 ' A' ' 328' ' ' ILE . 20.5 mt -68.42 -40.55 81.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.859 HD11 HD12 ' A' ' 391' ' ' ILE . 63.8 tp -59.95 -51.9 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 47.2 mt-10 -59.92 -39.96 87.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -62.21 -39.94 94.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.579 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.548 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.61 -27.09 61.95 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.477 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.81 -8.83 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.894 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.09 -9.93 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 18.94 5.9 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.71 -20.13 65.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.558 0.218 . . . . 0.0 111.202 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -79.13 -47.43 16.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -60.59 -45.24 94.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 312' ' ' LEU . 25.9 m-85 -71.38 -19.13 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.635 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.03 73.91 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.044 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.948 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.6 160.99 20.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.124 0.488 . . . . 0.0 110.338 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.873 ' HB ' HG23 ' A' ' 319' ' ' ILE . 64.5 m -106.47 99.87 9.42 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.7 tm? -75.43 102.7 5.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.388 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.657 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.2 mm-40 -109.17 135.64 49.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.756 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.859 HD12 HD11 ' A' ' 375' ' ' LEU . 43.4 mm -99.98 104.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.673 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.0 m -101.38 -170.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.148 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -157.55 151.47 24.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.056 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.548 ' HB2' HG21 ' A' ' 403' ' ' VAL . 60.1 t0 -76.58 69.97 3.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.851 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -43.47 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.5 m -90.03 176.71 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.743 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 398' ' ' GLU . 4.7 pt20 -60.02 -44.29 94.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 63.7 mm-40 -69.99 -41.51 74.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.727 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -19.23 60.84 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.545 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.0 m -83.9 -21.82 31.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.397 -0.401 . . . . 0.0 110.72 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.506 ' CB ' ' CE2' ' A' ' 291' ' ' PHE . 81.2 mt-30 -75.84 -41.37 52.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.784 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.834 ' CE2' HG23 ' A' ' 287' ' ' ILE . 7.3 m-30 -59.94 -44.99 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.889 0.376 . . . . 0.0 110.769 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 394' ' ' ASP . 55.6 t -60.01 -40.09 82.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.07 -40.03 47.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.042 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -67.41 -38.42 91.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.924 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 2.2 p90 -142.56 -78.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.756 0.312 . . . . 0.0 110.334 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 135.65 47.93 0.08 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.832 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.63 -37.04 1.96 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.393 -1.384 . . . . 0.0 115.416 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.781 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -126.47 128.88 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.751 0.775 . . . . 0.0 112.977 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.64 136.76 6.38 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.49 140.15 13.66 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.744 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.925 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.7 mt -103.4 127.18 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.7 mt -91.55 158.58 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 112.732 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.55 -39.89 67.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.435 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.2 p90 -165.1 176.05 8.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.93 -40.02 87.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -117.13 101.19 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -133.27 121.72 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.253 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -79.48 0.05 31.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 109.7 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.95 -9.85 54.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -60.03 -40.3 88.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.795 0.331 . . . . 0.0 110.629 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.0 -29.78 66.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -60.05 -34.86 73.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.314 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.91 -49.99 75.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.253 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -107.01 121.63 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.926 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.993 0.425 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.732 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.449 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.6 pt-20 -77.61 -24.61 49.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.548 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -83.94 -51.47 7.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -75.37 -57.11 4.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 24.2 tp -59.1 -53.76 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.841 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.793 HD11 ' HB ' ' A' ' 392' ' ' VAL . 29.5 mt -58.93 -49.96 81.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.7 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.32 -37.02 71.59 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -60.01 -37.51 79.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.5 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.3 t80 -58.86 -45.51 89.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.612 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.91 -39.16 17.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.717 0.294 . . . . 0.0 111.444 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.6 t0 -62.29 -45.2 94.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 111.336 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.772 ' OE2' HG21 ' A' ' 298' ' ' THR . 18.4 tp10 -67.64 -39.98 84.59 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 301' ' ' TYR . 80.4 mt -62.07 -26.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.43 -14.73 13.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.074 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.751 ' HB2' HG23 ' A' ' 298' ' ' THR . 23.5 mt-30 -99.24 1.23 44.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.603 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.92 27.43 16.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.317 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.772 HG21 ' OE2' ' A' ' 293' ' ' GLU . 17.2 p -64.88 -13.38 56.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.941 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 58.38 45.06 94.81 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.23 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.629 ' HA ' HD12 ' A' ' 413' ' ' LEU . 4.7 ptpt -130.89 46.6 2.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.041 0.421 . . . . 0.0 110.782 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.891 ' CE1' HG23 ' A' ' 412' ' ' ILE . 98.6 m-85 -160.49 160.96 32.66 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.954 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 27.6 m -141.56 159.38 42.35 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.812 0.339 . . . . 0.0 111.234 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.447 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.2 p90 -135.4 124.68 24.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.621 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.534 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 107.68 156.09 19.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.311 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.954 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -59.97 -53.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 20.5 pt-20 -51.8 -51.93 52.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.47 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 87.5 m-20 -67.02 -53.17 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 0.0 111.095 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 42.0 m -58.05 -40.01 79.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.017 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.954 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.4 mp -67.81 -46.59 71.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 41.3 mtmt -54.45 -50.03 68.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.941 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.82 59.44 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.321 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.878 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.63 -33.28 68.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.004 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -72.77 -25.52 61.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 4.3 mmt -82.46 -7.72 59.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.956 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.54 13.54 45.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.172 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.93 -6.99 59.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.549 0.34 . . . . 0.0 111.094 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 387' ' ' ALA . 35.6 m -99.79 106.68 19.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.649 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.4 tt0 -60.0 -52.7 64.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.696 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.7 mm -130.31 125.55 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.401 0.144 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.2 tp -91.15 127.4 36.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.959 0.409 . . . . 0.0 111.081 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.87 106.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.352 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.653 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -120.94 147.5 24.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.314 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.7 m-85 -90.17 143.19 26.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.0 112.252 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 12.2 tp10 -60.07 -43.06 95.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -91.6 53.57 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.541 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.4 tp -84.34 124.9 31.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -95.47 29.2 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.047 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.05 HG22 HD12 ' A' ' 374' ' ' LEU . 18.8 mm -123.84 131.45 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.926 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.635 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.8 mtt -140.58 162.54 35.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.516 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.0 ttt-85 -90.91 120.19 31.72 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.109 0.481 . . . . 0.0 111.606 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 18.3 m-85 -130.91 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.013 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 111.359 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 26.1 tp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.019 0.438 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -90.41 135.49 33.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.315 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.3 mm? -126.85 158.46 36.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.693 0.759 . . . . 0.0 112.63 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.6 p -101.09 169.22 8.07 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.741 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 2.2 Cg_endo -44.64 -48.83 9.96 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.055 1.836 . . . . 0.0 111.92 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.559 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.97 -46.07 66.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.767 0.317 . . . . 0.0 111.647 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 57.1 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.651 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.148 0.499 . . . . 0.0 110.617 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.0 128.46 25.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.635 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.5 Cg_exo -59.3 121.2 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.69 1.593 . . . . 0.0 110.5 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.05 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -60.12 -39.9 87.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.811 HD11 HD12 ' A' ' 391' ' ' ILE . 56.1 tp -59.98 -56.29 23.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.5 mt-10 -60.0 -40.05 87.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.008 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.78 -39.93 95.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.395 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.613 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -67.54 -25.17 65.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.014 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.65 -10.48 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -102.57 -14.7 16.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.8 19.88 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.19 -20.06 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.56 0.219 . . . . 0.0 111.265 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -80.37 -42.16 23.36 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.171 0.51 . . . . 0.0 110.493 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.68 ' CD2' HD23 ' A' ' 312' ' ' LEU . 20.9 m-85 -81.81 -10.01 59.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.35 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.79 54.52 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.0 m -107.64 100.99 10.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.486 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 391' ' ' ILE . 2.1 tm? -71.12 103.69 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.209 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.732 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.0 mm-40 -111.31 131.19 55.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 375' ' ' LEU . 32.0 mm -95.24 100.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.793 ' HB ' HD11 ' A' ' 287' ' ' ILE . 17.6 m -112.73 139.34 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 395' ' ' LYS . 5.7 p -111.45 164.47 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.881 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.411 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.3 p-10 -69.5 15.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 393' ' ' THR . 38.8 tttp -59.95 -45.25 93.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 5.0 m -90.76 173.77 7.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.978 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.84 -50.39 73.98 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.785 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 74.1 mm-40 -62.94 -36.89 84.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.506 0.67 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.411 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.11 -26.37 67.45 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.436 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.2 m -83.34 -26.62 30.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.242 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.8 -43.7 68.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.797 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.589 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.0 m-85 -60.02 -48.22 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 72.8 t -57.59 -33.57 45.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 400' ' ' SER . 2.9 mmpt? -74.65 -52.16 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.524 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.75 -25.57 69.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.279 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.534 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 21.7 t80 179.35 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.71 167.11 30.82 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.498 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.494 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.39 -47.83 3.03 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.594 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.77 130.58 5.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 117.742 0.771 . . . . 0.0 112.159 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.49 134.63 5.11 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.97 138.88 14.29 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.577 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.891 HG23 ' CE1' ' A' ' 301' ' ' TYR . 26.6 mt -102.48 127.2 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 69.8 mt -87.91 152.54 21.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 112.345 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.3 mtt-85 -68.99 -35.55 76.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.94 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.439 ' CG ' ' O ' ' A' ' 414' ' ' ARG . 97.0 m-85 -159.84 -171.83 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.56 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.94 0.4 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.7 mp0 -61.04 -39.96 91.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.454 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 53.7 p90 -140.59 114.99 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.293 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -135.62 116.41 14.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.335 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.99 11.3 9.76 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.062 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.6 mt -70.05 -2.25 12.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.937 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.38 -39.3 69.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -60.01 -39.53 86.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.316 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.61 -32.18 62.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.741 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.94 -45.81 91.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 N--CA 1.46 0.043 0 CA-C-O 120.732 0.301 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.665 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.32 -41.01 88.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.287 0.565 . . . . 0.0 109.917 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.74 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 79.8 mt-10 -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.896 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -39.95 94.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -86.8 -59.16 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -60.76 -55.22 35.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.838 0.352 . . . . 0.0 111.455 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 54.1 mt -59.91 -48.89 86.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.531 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -55.11 -38.34 66.32 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.532 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.421 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 43.3 ttt-85 -59.97 -36.59 77.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 0.0 110.046 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.621 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 11.6 t80 -60.09 -47.77 84.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.635 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -81.87 -36.65 27.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.89 -52.11 61.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.769 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -60.85 -44.63 96.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.397 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 301' ' ' TYR . 97.5 mt -56.38 -24.95 19.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -15.25 33.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 121.471 0.653 . . . . 0.0 109.621 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.817 ' HB2' HG23 ' A' ' 298' ' ' THR . 76.4 mt-30 -100.41 1.36 41.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.443 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.39 32.45 18.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.182 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 296' ' ' GLN . 24.3 p -74.13 -5.65 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 45.51 75.21 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.948 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 37.0 mtmt -122.26 37.9 4.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.883 ' CE1' HG23 ' A' ' 412' ' ' ILE . 73.8 m-85 -162.31 164.26 27.58 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.1 p -149.43 163.55 37.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.2 p90 -137.43 131.13 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 112.39 149.69 10.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.898 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.24 -58.23 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.6 pt-20 -49.33 -55.62 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.0 -52.42 63.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.701 0.286 . . . . 0.0 111.535 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 49.7 m -59.32 -39.96 84.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.091 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.823 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.1 mp -66.26 -42.08 89.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 314' ' ' MET . 24.4 mtmt -59.95 -45.42 92.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.129 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -70.03 -28.61 65.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.899 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.27 -24.97 59.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.985 0.422 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -78.94 -28.91 43.82 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 14.3 mmt -81.2 -8.04 59.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.676 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.67 28.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.742 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.78 -11.22 58.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.835 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.819 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.9 m -90.44 105.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.91 -49.42 77.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.418 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.887 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.3 mm -135.76 127.1 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.611 0.243 . . . . 0.0 111.434 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.674 ' HG ' HG23 ' A' ' 322' ' ' VAL . 55.4 tp -93.69 128.15 39.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.252 0.548 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -115.43 107.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.975 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.674 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.8 t -125.78 161.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.902 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -112.25 132.59 54.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 111.396 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.732 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.3 pt-20 -56.23 -25.92 49.32 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.847 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -90.05 45.28 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.291 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 25.3 tp -89.14 124.2 34.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 110.948 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.16 30.04 2.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.521 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.031 HG22 HD12 ' A' ' 374' ' ' LEU . 20.0 mm -124.52 135.18 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.129 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.645 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 60.5 mtp -140.11 162.32 35.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.623 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.615 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 15.6 ttt85 -88.08 117.12 26.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.029 0.442 . . . . 0.0 111.588 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 6.8 m-85 -125.42 123.39 39.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.347 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 111.436 -179.191 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 46.6 tp . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.277 0.561 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.633 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.5 p90 -100.07 119.48 38.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.554 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.592 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -124.33 163.58 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 112.534 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -101.32 170.79 6.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.669 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -49.36 -42.0 41.86 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.836 1.69 . . . . 0.0 111.862 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.2 -50.02 75.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.052 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 48.9 mt-30 -69.38 -50.12 49.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 84.2 mt-10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.999 0.428 . . . . 0.0 110.775 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.7 tpt -120.83 134.93 24.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.276 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.4 Cg_exo -61.01 130.36 32.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.926 1.75 . . . . 0.0 110.412 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.031 HD12 HG22 ' A' ' 328' ' ' ILE . 14.7 mt -69.63 -40.6 76.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.669 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 391' ' ' ILE . 60.1 tp -60.19 -56.1 25.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.902 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.0 mt-10 -57.58 -40.05 78.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.69 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.97 -40.02 91.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.458 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.2 OUTLIER -70.56 -26.87 63.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.43 -8.84 52.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.397 . . . . 0.0 112.005 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -108.23 -9.5 15.51 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.26 18.03 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.35 -21.02 66.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.595 0.236 . . . . 0.0 111.317 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -77.19 -46.36 23.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -62.87 -41.71 99.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 0.0 110.679 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -74.07 -17.89 60.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.35 69.25 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.209 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.819 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.2 163.07 18.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.887 ' HB ' HG23 ' A' ' 319' ' ' ILE . 90.0 m -106.66 99.84 9.39 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.3 tm? -76.12 102.6 5.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.923 0.392 . . . . 0.0 111.235 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.665 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.4 mm-40 -111.92 132.09 54.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.157 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.732 HG21 ' HB3' ' A' ' 324' ' ' GLU . 37.8 mm -94.97 105.63 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 111.886 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.902 HG23 ' CE2' ' A' ' 323' ' ' TYR . 6.5 m -101.91 -169.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.813 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.582 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.8 p -158.03 154.04 27.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.331 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.47 0.96 3.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.202 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -59.8 -40.87 89.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.618 0.247 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 283' ' ' GLU . 53.5 p -85.51 168.59 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -60.05 -55.16 37.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 69.6 mm-40 -63.21 -36.07 82.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 109.852 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.527 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -52.72 -59.04 9.75 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.323 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 m -59.59 -19.7 50.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 32.7 mt-30 -69.69 -40.04 76.57 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.069 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.561 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.9 m-85 -62.04 -36.5 81.8 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.03 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.883 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.8 t -60.09 -38.8 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -71.36 -45.63 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.991 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -58.75 -44.83 95.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.99 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 303' ' ' PHE . 60.3 t80 -146.44 -66.26 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.71 57.26 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.808 -1.187 . . . . 0.0 115.165 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 139.78 -36.1 1.86 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.258 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.656 HG12 HG13 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -132.24 133.38 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 117.964 0.882 . . . . 0.0 112.815 -177.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -150.83 136.67 5.69 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.73 143.64 15.95 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.441 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.883 HG23 ' CE1' ' A' ' 301' ' ' TYR . 30.9 mt -104.47 125.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.3 mt -94.98 163.16 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 0.0 112.799 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 74.6 mtt180 -78.48 -38.36 41.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.764 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 89.9 m-85 -158.48 -179.94 8.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.793 ' HG2' ' O ' ' A' ' 298' ' ' THR . 45.8 mtm180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.721 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.436 ' O ' ' CD1' ' A' ' 432' ' ' PHE . 41.5 tt0 -60.06 -49.4 77.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 432' ' ' PHE . 87.1 m-85 -76.28 -40.09 52.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 35.1 p90 45.14 69.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.221 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -77.92 6.1 8.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.931 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.28 -3.49 14.1 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.579 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.52 -40.07 81.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 110.47 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.91 -32.27 70.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.335 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.64 -35.8 75.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.02 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.01 -48.01 83.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.936 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--O 1.231 0.125 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.608 HE22 HG13 ' A' ' 392' ' ' VAL . 0.4 OUTLIER -59.07 -39.96 83.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.262 0.553 . . . . 0.0 110.054 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.736 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.6 mt-10 -81.13 -44.0 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -67.44 -40.06 85.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -86.03 -58.65 2.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -61.2 -56.59 18.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.634 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 58.1 mt -59.97 -45.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.69 -37.67 77.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.264 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 -59.96 -36.84 77.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.407 0.622 . . . . 0.0 110.056 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.647 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 8.9 t80 -59.96 -46.07 90.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.683 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -83.68 -37.33 22.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 295' ' ' SER . 53.4 t0 -62.02 -47.39 84.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.829 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.5 mp0 -66.71 -40.0 88.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.72 -22.35 26.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.17 -13.54 58.42 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.347 0.594 . . . . 0.0 109.528 178.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.66 ' HB2' HG23 ' A' ' 298' ' ' THR . 67.9 mt-30 -102.96 -0.71 30.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.541 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.19 30.66 20.47 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 11.3 p -69.73 -12.36 61.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.871 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.17 48.57 85.28 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.123 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.577 ' HA ' HD12 ' A' ' 413' ' ' LEU . 3.2 mtpm? -125.94 37.45 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.89 ' CE1' HG23 ' A' ' 412' ' ' ILE . 82.1 m-85 -160.61 161.54 32.55 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.142 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.7 159.71 41.67 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -135.91 124.84 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.82 153.06 13.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.27 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -57.33 -58.45 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.764 0.316 . . . . 0.0 110.794 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.8 pt-20 -50.41 -53.53 28.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.98 -55.2 27.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 409' ' ' ILE . 21.4 m -57.01 -39.35 74.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.931 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.3 mp -67.54 -42.21 83.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 25.2 mtmt -60.0 -49.94 75.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.792 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.84 -29.27 67.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.63 0.252 . . . . 0.0 110.934 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.752 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -71.76 -26.84 62.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.919 0.39 . . . . 0.0 110.448 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 33.6 mm-40 -79.04 -27.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.2 mmt -80.28 -7.42 59.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.849 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.33 18.15 48.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.258 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.59 11.76 29.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.364 0.266 . . . . 0.0 111.04 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.83 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.0 m -111.33 105.53 18.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 319' ' ' ILE . 59.9 tt0 -59.95 -49.99 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.85 HG23 ' HB ' ' A' ' 388' ' ' THR . 43.5 mm -137.65 126.02 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.618 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.6 tp -90.95 128.79 36.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 111.314 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.775 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -113.5 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.766 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.618 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.9 t -122.68 150.56 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.332 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -98.16 146.06 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 111.144 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.549 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.8 pt-20 -65.95 -33.28 75.45 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.074 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -90.06 41.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 29.3 tp -74.05 122.17 22.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 110.869 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -90.57 24.17 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.074 HG21 HG21 ' A' ' 305' ' ' VAL . 18.5 mm -125.95 131.34 71.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.676 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.743 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 66.7 mtp -140.27 161.76 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.593 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.639 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.6 ttt180 -85.1 116.09 23.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.937 0.398 . . . . 0.0 111.555 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 15.0 m-85 -119.07 119.0 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.528 0.11 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.317 -179.714 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 346' ' ' LEU . 47.0 tp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.329 0.585 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.91 121.21 40.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.923 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -121.09 161.39 21.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 4.4 p -101.66 169.14 8.06 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.115 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 86.5 Cg_exo -43.67 -53.02 4.75 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.812 1.675 . . . . 0.0 112.162 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.96 -58.8 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.79 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.13 -44.99 95.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.944 0.402 . . . . 0.0 111.36 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.8 mt-10 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.074 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 90.9 p . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.49 0.662 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -117.83 133.49 23.34 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.204 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 37.7 Cg_exo -58.39 114.29 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.824 1.682 . . . . 0.0 111.108 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.042 HD12 HG22 ' A' ' 328' ' ' ILE . 23.5 mt -60.01 -39.29 85.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.147 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 391' ' ' ILE . 63.3 tp -60.01 -52.27 66.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.61 -39.94 90.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.205 0.526 . . . . 0.0 109.822 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -61.28 -40.02 92.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.569 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -73.54 -24.19 60.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -9.13 53.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.75 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -110.04 -10.02 14.71 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.29 14.02 6.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -64.4 -18.5 64.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.584 0.23 . . . . 0.0 111.394 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -75.38 -39.97 58.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -67.21 -40.88 86.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.1 m-85 -72.67 -16.36 61.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.52 70.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.894 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.83 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.96 164.45 15.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.271 0.558 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.85 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.7 m -107.19 100.59 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.11 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -71.99 102.87 3.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.384 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.555 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -111.02 138.88 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.877 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 375' ' ' LEU . 36.7 mm -101.92 103.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.623 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.4 m -101.6 -171.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.225 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -156.24 153.75 29.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.473 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.5 p-10 -70.89 2.94 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -60.05 -40.0 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.567 0.222 . . . . 0.0 111.399 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.5 p -84.65 169.86 13.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.358 . . . . 0.0 111.416 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.04 -52.51 65.07 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 65.1 mm-40 -61.64 -38.08 86.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.473 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -63.22 -25.04 67.88 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.792 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.3 m -82.88 -25.7 32.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.529 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.14 -45.21 58.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 287' ' ' ILE . 1.6 m-85 -56.29 -49.6 73.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.522 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 85.2 t -59.86 -35.21 59.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.762 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 400' ' ' SER . 24.3 mmtt -69.9 -49.96 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.203 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.86 -23.84 75.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 11.1 t80 178.76 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 97.87 167.07 31.93 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.674 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.89 -49.2 2.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.025 -0.607 . . . . 0.0 114.191 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -145.15 132.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 117.492 0.646 . . . . 0.0 112.205 -177.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.572 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -152.5 143.33 10.22 Favored Glycine 0 CA--C 1.509 -0.301 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.9 142.07 13.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.57 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.89 HG23 ' CE1' ' A' ' 301' ' ' TYR . 57.2 mt -104.66 128.65 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.805 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.5 mt -87.38 150.16 24.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.784 0.802 . . . . 0.0 112.821 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.715 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 72.7 mtt-85 -69.95 -36.19 75.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 96.2 m-85 -159.38 167.04 29.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.772 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mtm180 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.874 0.369 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.97 -40.64 89.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -126.61 104.68 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -124.6 103.84 8.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 11.71 19.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.055 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 64.1 mt -73.4 -3.92 30.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.646 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -40.02 87.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 110.632 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.84 -30.6 68.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.0 -33.72 72.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.432 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.97 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.09 124.31 47.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.948 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.729 0.3 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.612 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -59.92 -40.47 88.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.957 0.408 . . . . 0.0 110.382 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.623 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 24.8 pt-20 -85.62 -38.54 18.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.904 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -70.03 -39.92 75.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -86.22 -57.23 3.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.917 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.0 tp -58.26 -56.31 23.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.079 0.466 . . . . 0.0 111.719 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 392' ' ' VAL . 52.4 mt -59.36 -49.97 81.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.466 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.98 -39.79 89.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.591 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -60.06 -36.49 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.471 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 4.9 t80 -59.08 -45.98 89.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -83.48 -42.32 17.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.864 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 295' ' ' SER . 45.1 t0 -60.72 -47.48 86.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.567 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.685 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 22.9 tp10 -63.06 -39.94 96.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 301' ' ' TYR . 87.7 mt -62.75 -26.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.599 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -60.34 -12.53 9.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 109.957 178.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.805 ' HB2' HG23 ' A' ' 298' ' ' THR . 83.7 mt-30 -98.97 0.04 43.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.466 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.99 29.65 19.25 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.346 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.805 HG23 ' HB2' ' A' ' 296' ' ' GLN . 19.0 p -73.35 -7.75 52.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.958 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.65 53.47 29.02 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.938 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 22.0 mttt -130.2 41.95 3.33 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.6 m-85 -161.78 163.02 29.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.775 0.321 . . . . 0.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.0 p -149.12 161.82 41.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.74 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.837 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 53.0 p90 -141.44 149.99 41.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 96.67 142.19 12.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.171 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.742 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -49.37 -64.12 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.765 0.317 . . . . 0.0 111.238 -179.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.1 pt-20 -47.15 -52.89 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.831 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.0 m-20 -64.35 -56.75 12.32 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 26.0 m -58.03 -37.38 74.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.742 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -69.94 -44.0 70.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.603 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.9 mtmm -59.9 -46.44 89.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.585 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.021 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.978 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.81 -24.92 55.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.895 0.378 . . . . 0.0 110.618 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -77.96 -28.32 49.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 89.8 mmm -81.1 -7.37 59.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.731 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.55 16.34 36.38 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.358 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.51 -9.65 58.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.411 0.284 . . . . 0.0 111.207 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.978 HG21 ' CD1' ' A' ' 312' ' ' LEU . 28.0 m -94.94 105.49 17.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.679 ' O ' HD13 ' A' ' 319' ' ' ILE . 43.0 tt0 -58.78 -50.9 72.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.275 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.88 HG23 ' HB ' ' A' ' 388' ' ' THR . 33.0 mm -134.05 127.0 50.96 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.061 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.737 ' HG ' HG23 ' A' ' 322' ' ' VAL . 31.6 tp -92.38 125.6 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.81 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.917 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -106.67 103.85 16.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.244 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.737 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.6 t -124.23 162.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 392' ' ' VAL . 75.9 m-85 -112.67 149.78 32.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 111.905 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.632 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.6 pt-20 -65.91 -40.41 91.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.149 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -89.77 56.49 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.752 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 26.5 tp -89.09 121.75 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -89.15 23.77 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.769 HG22 HD12 ' A' ' 374' ' ' LEU . 4.8 mm -121.62 131.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.6 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.3 mtt -139.48 162.97 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.622 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.5 ttt180 -88.85 116.04 26.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 112.012 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.6 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 9.1 m-85 -123.46 123.77 41.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.097 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.144 0.497 . . . . 0.0 111.662 -178.905 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.483 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 55.8 tp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.342 0.591 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.596 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 10.3 p90 -97.32 120.04 36.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.625 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.2 mm? -125.33 160.56 29.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.1 p -101.64 172.2 4.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.466 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.0 Cg_exo -46.6 -42.8 23.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.882 1.721 . . . . 0.0 111.92 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -59.22 5.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 88.9 mt-30 -60.37 -49.69 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 89.2 mt-10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.207 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.4 p . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.228 0.537 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.477 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -115.69 130.87 24.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.961 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.579 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.7 Cg_exo -60.72 120.15 7.71 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.03 1.82 . . . . 0.0 110.752 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 328' ' ' ILE . 20.2 mt -61.89 -39.56 92.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.021 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -59.99 -51.88 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.82 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.05 -40.15 88.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.718 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -63.0 -40.01 96.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.651 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.484 ' CZ ' ' HG ' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -70.01 -24.92 63.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.31 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.03 -7.62 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.072 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -105.47 -11.9 16.22 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.65 16.02 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -62.11 -20.49 64.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.93 -44.77 17.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -61.34 -40.57 94.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.704 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.661 ' CD2' HD23 ' A' ' 312' ' ' LEU . 23.5 m-85 -79.96 -12.7 59.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.15 55.44 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.873 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.87 161.54 19.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.103 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.88 ' HB ' HG23 ' A' ' 319' ' ' ILE . 47.2 m -105.64 99.66 9.25 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.5 tm? -74.6 103.55 4.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.115 0.483 . . . . 0.0 111.082 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.612 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.2 mm-40 -110.66 140.47 44.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.911 HD12 HD11 ' A' ' 375' ' ' LEU . 18.2 mm -105.43 104.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.834 HG23 ' CE2' ' A' ' 323' ' ' TYR . 9.3 m -101.09 -170.06 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.879 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.618 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.5 p -154.59 152.51 30.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.42 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.4 p-10 -68.58 3.28 1.91 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.548 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -59.99 -40.1 88.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.645 0.259 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -89.17 167.72 12.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.8 0.334 . . . . 0.0 111.516 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.07 -49.89 75.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 45.6 mp0 -63.47 -39.98 95.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.37 0.605 . . . . 0.0 109.756 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.3 -19.16 63.89 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.664 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.1 m -83.89 -22.46 31.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.017 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -74.23 -39.99 62.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.028 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.558 ' CD2' ' HE2' ' A' ' 406' ' ' PHE . 2.7 m-85 -63.26 -49.62 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.0 -45.92 94.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -73.97 -43.98 56.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.742 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.405 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -66.37 -41.51 94.44 Favored Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.837 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -129.29 -86.91 0.54 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.793 -0.704 . . . . 0.0 109.582 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 160.77 40.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.35 -1.405 . . . . 0.0 115.117 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.573 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 102.9 7.36 44.5 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.035 -1.078 . . . . 0.0 115.424 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.568 ' CD1' HG22 ' A' ' 305' ' ' VAL . 0.4 OUTLIER -144.97 125.34 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.207 1.003 . . . . 0.0 110.449 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.432 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -153.31 145.32 12.63 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -126.35 140.46 12.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.548 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.809 HG23 ' CE1' ' A' ' 301' ' ' TYR . 56.6 mt -99.11 127.52 51.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 34.9 mt -92.08 165.66 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.476 0.655 . . . . 0.0 112.345 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -91.6 -27.19 18.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 64.7 t80 -164.49 162.96 22.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 298' ' ' THR . 6.0 mmm180 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.0 -49.95 75.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.556 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.03 -31.52 69.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -81.41 107.9 14.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -82.82 7.51 14.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.339 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.69 -9.76 39.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.775 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -39.97 87.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.01 -31.37 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.355 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.405 ' O ' ' CE1' ' A' ' 440' ' ' HIS . 64.1 t80 -59.91 -31.88 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.745 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.06 -49.91 75.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.266 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -109.09 130.17 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 437' ' ' TYR . 59.1 m80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 285' ' ' LYS . 46.8 pt . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 120.904 0.383 . . . . 0.0 111.687 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.626 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 23.0 tm0? -59.45 -39.57 84.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.587 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 59.7 mt-10 -78.97 -30.27 44.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -52.17 6.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 281' ' ' ILE . 15.0 mtpt -70.01 -56.98 5.56 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 321' ' ' ILE . 23.7 tp -57.83 -54.93 41.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.317 0.579 . . . . 0.0 110.804 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 398' ' ' GLU . 11.0 mt -63.46 -45.34 98.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.248 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.31 -39.48 82.55 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.604 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -59.98 -37.77 80.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 21.7 t80 -60.05 -47.18 86.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.524 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -86.27 -35.92 19.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 295' ' ' SER . 26.2 t0 -66.22 -46.26 77.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 111.306 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.692 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 10.5 tp10 -65.7 -39.93 91.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 301' ' ' TYR . 86.3 mt -62.22 -25.41 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.63 -14.72 14.82 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.28 0.562 . . . . 0.0 109.806 178.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.649 ' HB2' HG23 ' A' ' 298' ' ' THR . 51.4 mt-30 -98.2 -0.06 44.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.748 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.69 29.97 19.31 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.974 0.416 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 296' ' ' GLN . 32.0 p -70.66 -12.05 61.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.949 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.26 47.78 89.17 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.72 -1.229 . . . . 0.0 114.442 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.751 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 16.8 ptpt -130.46 45.04 2.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.13 0.465 . . . . 0.0 110.783 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.841 ' CE1' HG23 ' A' ' 412' ' ' ILE . 87.3 m-85 -160.94 161.09 31.54 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.911 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 3.6 p -144.61 160.62 40.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.405 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 48.7 p90 -134.51 124.16 25.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.849 0.357 . . . . 0.0 110.819 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.509 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 113.79 155.1 11.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -59.91 -56.76 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.843 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.503 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -49.57 -57.46 7.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.482 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 88.0 m-20 -60.06 -52.2 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 33.5 m -59.99 -40.03 87.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.138 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.976 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.0 mp -66.01 -46.72 76.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -57.64 -50.46 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.027 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -65.18 -31.28 72.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.354 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.932 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.71 -24.29 59.9 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -79.73 -27.41 40.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.1 mmt -80.89 -8.83 59.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.313 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.55 15.16 38.61 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.518 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.52 -8.8 57.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.134 . . . . 0.0 111.322 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.7 m -92.03 103.91 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.844 0.354 . . . . 0.0 111.708 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.672 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.3 tt0 -58.68 -49.96 75.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.552 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.5 mm -133.75 126.6 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.545 0.212 . . . . 0.0 111.171 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.68 ' HG ' HG23 ' A' ' 322' ' ' VAL . 47.5 tp -92.03 124.04 35.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 1.031 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -111.41 105.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.584 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.68 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.4 t -116.51 159.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.833 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 70.2 m-85 -107.14 144.82 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -71.28 160.87 32.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.526 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.0 22.98 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.803 0.335 . . . . 0.0 110.445 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 24.4 tp -54.78 125.26 19.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.74 26.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.001 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.982 HG21 HG21 ' A' ' 305' ' ' VAL . 12.3 mm -130.76 130.57 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.537 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.633 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 9.9 mtt -139.68 162.66 34.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.582 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt180 -85.28 118.08 24.6 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 120.728 0.299 . . . . 0.0 111.662 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.816 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 43.8 m-85 -124.92 122.07 36.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.424 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 332' ' ' VAL . 23.7 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 0.0 111.161 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.183 0.516 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.546 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.62 116.95 29.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.54 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.9 mm? -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.456 0.645 . . . . 0.0 112.58 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.5 p -100.41 169.7 7.59 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.96 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.5 Cg_exo -47.71 -46.07 22.11 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 121.943 1.762 . . . . 0.0 112.953 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 350' ' ' GLN . 23.9 pm0 -64.4 -41.72 96.48 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 349' ' ' GLU . 40.3 mt-30 -84.62 -48.18 9.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.816 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 3.5 tm-20 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.946 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.566 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 1.4 m . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 121.187 0.518 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.1 tpt -113.6 129.11 24.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.2 Cg_exo -56.0 120.51 8.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.805 1.67 . . . . 0.0 110.981 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 305' ' ' VAL . 32.6 mt -62.03 -40.06 94.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.956 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 391' ' ' ILE . 50.4 tp -60.8 -55.65 30.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.3 mt-10 -59.79 -40.05 86.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.874 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -60.93 -39.92 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.982 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.559 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.1 m-85 -72.82 -27.12 61.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.214 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.54 -10.81 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.42 -9.75 15.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 20.69 5.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.567 0.222 . . . . 0.0 111.47 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -69.0 -17.65 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.09 -43.45 17.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.84 -41.47 99.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.466 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.6 m-85 -78.5 -15.84 58.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.805 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.34 2.21 66.97 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.52 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.62 162.66 18.73 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.164 0.507 . . . . 0.0 110.601 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 71.5 m -107.13 100.57 10.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.371 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.0 OUTLIER -72.19 105.53 4.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.389 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.626 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 14.3 mm-40 -111.39 143.5 42.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.774 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 375' ' ' LEU . 18.6 mm -107.37 100.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 287' ' ' ILE . 18.6 m -100.54 -170.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.267 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.553 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.6 OUTLIER -160.35 157.1 27.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.945 0.403 . . . . 0.0 111.748 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.43 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.0 p-10 -71.5 -0.12 9.74 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.496 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.25 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 54.3 p -78.88 168.07 20.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.778 0.323 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.97 -51.0 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 110.725 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.794 ' HG3' HG22 ' A' ' 287' ' ' ILE . 13.1 tp10 -70.07 -34.72 73.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -51.84 -57.21 13.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.8 m -60.7 -19.65 59.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.536 . . . . 0.0 112.073 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 36.6 mt-30 -70.3 -40.06 74.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.967 0.413 . . . . 0.0 110.467 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.608 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -59.6 -46.43 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.376 179.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.546 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 76.3 t -58.97 -33.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -69.14 -51.06 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.033 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -71.13 -22.1 78.47 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.637 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.509 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.0 t80 176.65 -77.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.48 168.33 31.33 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.52 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.32 -48.59 2.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.277 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.61 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -144.22 132.33 17.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 117.495 0.648 . . . . 0.0 112.383 -177.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.59 137.51 6.29 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.55 139.39 12.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.392 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 321' ' ' ILE . 56.2 mt -101.32 127.72 54.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 66.6 mt -91.6 168.77 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.719 . . . . 0.0 112.645 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -67.29 -40.05 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.742 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.652 ' O ' ' HB3' ' A' ' 300' ' ' LYS . 58.1 t80 -172.09 -60.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.724 0.297 . . . . 0.0 111.574 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 120.846 0.355 . . . . 0.0 110.643 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.798 0.333 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.85 -43.74 97.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.396 . . . . 0.0 110.918 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -128.43 106.25 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 24.8 p90 -122.5 98.55 5.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.371 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 9.4 27.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.395 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.97 -18.16 43.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.63 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -81.1 -20.07 42.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.656 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.98 -38.45 82.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.028 0.442 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.98 -46.86 88.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -72.2 146.75 47.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.78 0.324 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.573 HE22 HG13 ' A' ' 392' ' ' VAL . 0.8 OUTLIER -58.5 -40.23 82.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.127 0.489 . . . . 0.0 110.491 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.429 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.0 tt0 -71.39 -38.28 71.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -78.98 -55.36 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -67.76 -58.58 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.931 ' HG ' HD13 ' A' ' 321' ' ' ILE . 17.6 tp -52.62 -57.6 9.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 111.371 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.564 HG23 ' CD1' ' A' ' 402' ' ' PHE . 25.7 mt -61.69 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.878 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.9 -38.67 60.51 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 36.6 ttt180 -60.08 -39.95 87.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.204 0.526 . . . . 0.0 110.286 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.598 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.7 t80 -55.82 -47.85 76.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.685 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 33.6 m-85 -83.59 -37.83 22.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -61.22 -42.23 98.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.429 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.709 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.2 mt-10 -69.89 -42.14 73.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.999 0.428 . . . . 0.0 109.882 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.4 mt -60.16 -24.6 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -62.9 -15.95 57.14 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.244 0.545 . . . . 0.0 109.871 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.678 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -101.9 0.76 35.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.521 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.3 29.86 19.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 110.157 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.751 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.4 p -67.02 -10.15 46.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.997 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.55 49.57 60.46 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.841 -1.171 . . . . 0.0 113.374 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.7 mtmt -130.36 38.93 3.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.916 ' CE2' HG23 ' A' ' 412' ' ' ILE . 84.5 m-85 -160.88 161.42 31.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.252 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.66 163.25 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.6 p90 -137.65 130.88 30.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.69 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.463 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 109.35 142.46 9.68 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.361 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -50.17 -60.31 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 111.208 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 9.9 pt-20 -47.31 -54.04 12.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.629 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.08 -53.93 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 111.521 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 409' ' ' ILE . 40.6 m -58.36 -39.08 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.096 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.891 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.5 mp -65.93 -42.79 89.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.0 mtmm -59.96 -49.99 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.38 -29.35 69.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.29 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.958 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.07 -24.81 58.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.77 0.319 . . . . 0.0 110.733 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 76.8 mm-40 -79.39 -27.96 41.87 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 34.1 mmt -80.51 -7.57 59.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.759 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.97 18.33 47.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.409 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.63 -1.3 57.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.388 0.275 . . . . 0.0 111.371 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.958 HG21 ' CD1' ' A' ' 312' ' ' LEU . 30.3 m -100.3 104.3 15.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 319' ' ' ILE . 9.4 tp10 -57.71 -50.89 71.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.321 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.4 mm -135.4 126.85 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.643 0.259 . . . . 0.0 111.221 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.662 ' HG ' HG23 ' A' ' 322' ' ' VAL . 48.6 tp -92.74 126.43 37.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 111.634 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.931 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -112.67 106.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.662 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.8 t -124.8 161.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.155 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.4 m-85 -108.19 146.1 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 11.4 pt-20 -65.02 -34.11 77.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.9 47.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.585 HD11 HD11 ' A' ' 409' ' ' ILE . 31.1 tp -81.01 123.15 28.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.577 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -93.07 25.67 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 24.3 mm -123.18 132.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.666 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.5 mtm -140.35 162.09 36.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.4 ttt85 -89.7 119.99 30.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.105 0.479 . . . . 0.0 111.572 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 9.9 m-85 -127.11 123.09 36.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.485 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 332' ' ' VAL . 14.2 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.214 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.745 HD23 HD11 ' A' ' 346' ' ' LEU . 54.9 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.445 0.64 . . . . 0.0 112.153 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.739 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.8 p90 -99.97 121.15 40.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.047 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.921 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -127.42 160.61 30.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.625 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.2 p -101.5 172.49 4.39 Favored Pre-proline 0 N--CA 1.455 -0.177 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.588 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.6 Cg_exo -49.5 -43.22 39.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.035 1.823 . . . . 0.0 112.414 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -61.57 -49.27 77.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.921 ' HG2' HD12 ' A' ' 346' ' ' LEU . 10.9 tp60 -70.03 -48.1 59.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 75.3 mt-10 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.583 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.2 p . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.084 0.468 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.402 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.9 tpt -117.17 130.04 24.91 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.875 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.8 Cg_exo -60.02 125.17 16.9 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.832 1.688 . . . . 0.0 110.922 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.028 HD12 HG22 ' A' ' 328' ' ' ILE . 27.4 mt -66.49 -39.86 88.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.91 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 391' ' ' ILE . 65.0 tp -60.05 -52.16 66.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.6 mt-10 -58.89 -39.99 83.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.887 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.84 -40.83 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.618 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.55 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -70.31 -27.76 64.64 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -10.01 47.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.177 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -104.18 -12.78 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.976 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 30.6 m120 -129.64 19.93 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -65.51 -19.71 66.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.568 0.223 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.77 -44.93 17.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.05 -39.93 91.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.655 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -79.92 -13.14 59.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.84 2.26 56.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.305 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.918 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.02 163.16 18.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 110.649 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.884 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.5 m -107.82 100.41 9.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.3 tm? -75.35 102.3 5.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.111 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -108.43 139.46 43.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.827 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 375' ' ' LEU . 40.0 mm -103.49 104.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.388 0.613 . . . . 0.0 112.432 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CE1' ' A' ' 323' ' ' TYR . 6.0 m -101.65 -169.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.917 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.55 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -156.16 153.08 28.71 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.958 0.409 . . . . 0.0 111.511 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 403' ' ' VAL . 11.8 p-10 -72.87 17.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -70.03 -39.92 75.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.78 0.324 . . . . 0.0 111.235 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.5 t -89.26 170.04 10.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.678 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.0 -50.03 75.34 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.478 ' C ' HG21 ' A' ' 287' ' ' ILE . 66.8 mm-40 -64.51 -40.38 95.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.163 0.506 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.541 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.31 -18.53 63.13 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.442 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.1 m -83.98 -21.74 31.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.848 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.52 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 84.4 mt-30 -75.14 -41.35 58.49 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.835 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.617 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 3.3 m-85 -59.73 -42.75 93.82 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.792 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 57.7 t -60.01 -39.99 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.665 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -40.04 64.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.78 96.87 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.117 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.463 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 62.5 t80 -151.6 -68.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.792 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.14 58.29 0.18 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 119.965 -1.112 . . . . 0.0 114.916 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 140.78 -34.13 1.98 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 119.387 -1.387 . . . . 0.0 115.214 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -137.98 134.9 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.944 0.872 . . . . 0.0 112.997 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -151.86 142.92 9.85 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -125.72 145.95 15.97 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 119.781 -1.199 . . . . 0.0 113.887 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.916 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.5 mt -107.03 127.09 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 24.6 mt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.735 0.779 . . . . 0.0 112.753 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.428 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 64.8 mtm180 -70.15 -39.97 75.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.55 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.3 p90 -159.86 175.48 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 298' ' ' THR . 15.5 mtm180 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.39 . . . . 0.0 111.197 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 N--CA 1.458 -0.028 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.94 -44.4 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.646 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 20.7 p90 -106.38 83.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.769 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -106.28 22.18 16.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.71 45.16 0.67 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.489 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.8 mt -78.26 -3.81 44.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.467 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -39.95 87.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 110.434 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.0 -32.74 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.331 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.57 -33.6 71.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.363 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.97 -47.44 85.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.922 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -59.92 -40.04 87.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.957 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.468 ' HB ' ' HE2' ' A' ' 285' ' ' LYS . 41.9 pt . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.915 0.388 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -51.91 -45.89 64.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.725 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 58.9 mt-10 -73.82 -39.65 63.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.782 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -73.4 -43.85 59.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.468 ' HE2' ' HB ' ' A' ' 281' ' ' ILE . 38.1 mttm -87.07 -58.44 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 319' ' ' ILE . 25.6 tp -57.41 -57.09 14.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.454 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 60.6 mt -60.12 -50.11 81.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.846 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.433 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.82 -36.13 78.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.716 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.402 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 10.2 ttt180 -60.08 -38.14 81.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.306 0.574 . . . . 0.0 110.291 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 5.6 t80 -59.93 -45.52 92.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.972 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -83.13 -35.14 25.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.3 t0 -65.39 -45.31 84.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -68.95 -40.08 79.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 85.8 mt -60.63 -24.05 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.09 -13.69 49.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.321 0.582 . . . . 0.0 109.642 178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -102.63 -0.02 32.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.583 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 58.54 30.63 20.04 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.062 0.458 . . . . 0.0 110.229 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 296' ' ' GLN . 14.1 p -70.04 -9.71 56.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.47 42.96 94.15 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.839 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.4 mtmt -121.25 38.03 4.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.92 ' CE1' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -161.81 164.19 28.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.7 p -147.01 163.79 35.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.403 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 47.6 p90 -137.72 128.52 27.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.838 0.351 . . . . 0.0 110.816 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.553 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.76 151.69 12.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -58.91 -56.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.598 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.2 pt-20 -51.11 -53.74 31.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.18 -52.24 59.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.735 0.302 . . . . 0.0 111.307 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 409' ' ' ILE . 33.6 m -59.42 -39.76 84.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.91 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -67.51 -43.8 80.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.436 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -59.23 -49.36 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.778 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.7 64.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.31 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.801 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.95 -26.32 59.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.783 0.325 . . . . 0.0 110.691 179.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 73.9 mm-40 -76.83 -28.1 55.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.4 mmt -81.43 -7.38 59.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.899 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.03 13.51 27.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.72 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.13 -4.77 57.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.486 0.184 . . . . 0.0 110.914 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.8 m -98.93 107.11 19.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.668 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.9 tt0 -59.9 -50.03 75.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.779 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.857 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.7 mm -135.8 127.28 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 111.53 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.678 ' HG ' HG23 ' A' ' 322' ' ' VAL . 49.6 tp -93.23 128.22 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.482 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.774 HD11 HD11 ' A' ' 412' ' ' ILE . 1.3 mt -114.07 107.87 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.678 HG23 ' HG ' ' A' ' 320' ' ' LEU . 19.0 t -125.3 149.15 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.327 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.625 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.6 m-85 -99.89 132.61 45.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.596 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 13.6 pt-20 -53.58 -29.6 38.24 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.4 45.33 1.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 38.9 tp -83.71 121.54 27.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.376 . . . . 0.0 110.645 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -91.26 23.54 3.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.953 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 19.6 mm -119.97 136.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.563 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.723 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.5 mtt -139.05 161.94 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpm_? -90.05 114.27 26.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 371' ' ' SER . 33.3 m-85 -109.29 145.63 35.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.311 0.577 . . . . 0.0 111.361 179.735 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 346' ' ' LEU . 53.0 tp . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 112.13 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.565 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.2 p90 -103.78 119.78 39.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.076 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -123.29 158.24 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.5 p -101.86 173.34 3.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.4 Cg_exo -45.45 -46.7 14.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.997 1.798 . . . . 0.0 112.27 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.39 -58.55 8.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.365 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 46.3 mt-30 -60.93 -47.31 87.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.644 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 76.9 mt-10 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.443 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.91 ' HB2' ' CD2' ' A' ' 331' ' ' TYR . 17.5 t . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.449 ' HA ' ' HE3' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.87 128.82 25.67 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.152 179.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.723 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 71.7 Cg_exo -50.23 112.8 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.78 1.653 . . . . 0.0 111.153 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.984 HD13 HG11 ' A' ' 305' ' ' VAL . 14.5 mt -58.82 -40.04 82.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.388 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.625 HD11 HD12 ' A' ' 391' ' ' ILE . 65.6 tp -60.08 -52.49 65.11 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.305 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.4 mt-10 -60.94 -39.94 91.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 110.125 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -61.11 -40.01 92.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.596 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.5 OUTLIER -71.48 -23.45 61.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.571 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -8.77 53.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.994 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -108.34 -10.3 15.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.03 20.35 5.41 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -67.42 -20.16 65.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -79.88 -43.61 21.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -60.82 -40.03 91.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.675 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -80.15 -11.38 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.4 2.46 54.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.302 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.836 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.73 163.37 17.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.194 0.521 . . . . 0.0 110.62 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.857 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.0 m -107.8 100.37 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.0 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.1 tm? -73.76 102.63 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.552 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.9 mm-40 -108.84 139.44 43.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.408 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.625 HD12 HD11 ' A' ' 375' ' ' LEU . 16.4 mm -102.94 101.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.625 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.5 m -102.75 -172.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.587 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.607 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 14.6 p -156.99 152.41 26.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.337 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.9 t0 -78.91 76.96 5.39 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -119.22 -49.66 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.0 m -88.05 -176.78 5.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 11.7 mm-40 -59.43 -46.01 89.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.693 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.518 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 52.3 mp0 -64.5 -40.48 95.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -61.34 -27.69 68.11 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 72.9 m -83.87 -22.97 31.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.677 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 27.3 mt-30 -72.45 -40.62 66.88 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.501 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.637 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.1 m-85 -67.38 -49.96 61.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.443 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 394' ' ' ASP . 69.7 t -59.22 -38.14 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.467 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 400' ' ' SER . 8.6 mmpt? -69.96 -51.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.143 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.45 -26.2 69.35 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.543 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.553 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 17.0 t80 179.09 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 96.85 167.11 33.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.499 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.427 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.06 -48.69 2.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.031 -0.604 . . . . 0.0 114.28 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -147.44 131.43 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.383 0.592 . . . . 0.0 111.985 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.33 135.03 5.17 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.21 140.48 15.47 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.316 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.92 HG23 ' CE1' ' A' ' 301' ' ' TYR . 44.5 mt -103.5 125.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.849 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.1 mt -87.58 151.37 23.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.484 0.659 . . . . 0.0 112.264 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.571 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 63.4 mtt-85 -71.62 -33.9 69.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.632 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.434 ' CD2' ' N ' ' A' ' 416' ' ' ARG . 51.8 t80 -169.0 166.06 11.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 111.148 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.79 -41.14 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.708 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.438 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 51.3 p90 -144.32 114.74 7.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.357 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 19.0 p90 -133.59 85.7 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.273 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -90.08 15.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.459 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 53.5 mt -65.87 -9.46 29.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.804 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.481 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -78.41 -21.18 49.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -59.92 -38.33 82.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.04 0.448 . . . . 0.0 110.284 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.99 -44.99 94.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.954 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.06 -40.03 88.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.887 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 48.5 pt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.418 HE22 HG13 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -51.05 -39.58 56.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.815 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 mp0 -69.98 -46.73 64.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -49.16 78.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -74.55 -58.83 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.737 ' HG ' HD13 ' A' ' 321' ' ' ILE . 40.6 tp -61.32 -58.84 6.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.957 0.408 . . . . 0.0 112.079 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.638 HD13 ' HA2' ' A' ' 399' ' ' GLY . 41.3 mt -59.99 -41.24 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.154 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 398' ' ' GLU . . . -57.1 -38.92 88.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.358 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 53.9 ttt-85 -60.02 -38.7 83.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.283 0.563 . . . . 0.0 109.767 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.637 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 8.3 t80 -60.01 -46.14 90.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -80.79 -35.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.3 t0 -60.01 -49.86 76.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.576 0.227 . . . . 0.0 111.572 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.623 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.1 mt-10 -61.75 -43.11 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 94.5 mt -57.76 -27.9 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.448 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -63.69 -14.61 53.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.283 0.563 . . . . 0.0 109.56 178.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.623 ' HB2' HG23 ' A' ' 298' ' ' THR . 56.8 mt-30 -105.96 -2.46 22.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.653 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.85 32.44 21.27 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.033 0.444 . . . . 0.0 110.405 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.9 p -69.82 -14.31 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.841 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.73 46.36 94.64 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 119.869 -1.157 . . . . 0.0 113.363 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.545 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 49.2 mttp -122.68 33.97 5.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.4 m-85 -159.87 161.06 34.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.618 0.247 . . . . 0.0 111.544 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 55.7 m -140.99 159.94 41.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.09 0.472 . . . . 0.0 111.456 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.7 p90 -131.96 149.36 52.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 84.77 167.21 42.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.832 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.034 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -71.59 -55.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.0 111.065 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.7 pt-20 -47.31 -53.71 12.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.798 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 85.3 m-20 -64.27 -53.87 42.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.477 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.481 HG22 HD13 ' A' ' 312' ' ' LEU . 23.8 m -58.21 -40.03 80.57 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.668 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 1.034 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.9 mp -66.02 -47.52 74.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.834 0.35 . . . . 0.0 111.223 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 314' ' ' MET . 14.7 mttm -56.42 -49.98 72.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.19 68.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.737 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.2 OUTLIER -71.24 -27.64 63.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.57 -26.77 41.26 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.5 mmt -80.47 -9.06 59.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.771 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.23 45.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.458 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.61 -5.45 58.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.142 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.5 m -92.74 102.48 13.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.74 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.0 tt0 -59.4 -48.79 80.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.204 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.43 125.06 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.51 0.195 . . . . 0.0 111.362 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.606 ' HG ' HG23 ' A' ' 322' ' ' VAL . 23.6 tp -88.69 123.66 33.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -109.53 103.66 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.606 HG23 ' HG ' ' A' ' 320' ' ' LEU . 10.6 t -114.39 153.64 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.663 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 77.2 m-85 -99.94 142.18 31.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.474 . . . . 0.0 112.135 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.411 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 12.6 pt-20 -67.13 154.91 40.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.73 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.05 25.39 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 0.0 110.301 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 49.2 tp -52.41 128.89 27.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.719 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -91.02 22.23 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.481 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 374' ' ' LEU . 19.3 mm -124.41 135.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.62 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.02 161.97 36.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.642 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 47.3 ttt180 -91.5 118.78 30.88 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 110.892 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.1 m-85 -116.21 153.13 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 332' ' ' VAL . 16.1 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.145 0.498 . . . . 0.0 111.556 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.67 HD23 HD11 ' A' ' 346' ' ' LEU . 50.5 tp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.29 0.566 . . . . 0.0 111.998 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -95.38 116.53 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.258 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.67 HD11 HD23 ' A' ' 344' ' ' LEU . 1.3 mm? -118.83 152.0 37.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.409 0.623 . . . . 0.0 112.156 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 40.7 p -100.44 173.82 3.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.337 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -45.61 -45.07 16.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.786 1.657 . . . . 0.0 112.01 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -59.95 -57.33 13.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.26 -49.91 73.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.5 mt-10 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.43 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 9.1 tpp -118.51 134.36 23.48 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.473 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.5 Cg_endo -59.84 123.02 12.38 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 110.846 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.044 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -65.98 -44.08 85.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.845 HD11 ' CD1' ' A' ' 391' ' ' ILE . 56.3 tp -59.98 -50.0 75.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 47.3 mt-10 -60.57 -40.0 90.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.001 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.43 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 68.8 t-105 -67.51 -38.77 84.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.277 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.717 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.7 m-85 -73.47 -27.82 61.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.29 53.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.144 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -107.87 -16.61 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.819 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -129.82 21.4 5.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.5 p90 -61.83 -16.62 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.566 0.222 . . . . 0.0 111.572 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -83.46 -36.39 24.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.667 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -60.02 -39.92 87.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.633 ' CD2' HD23 ' A' ' 312' ' ' LEU . 42.9 m-85 -87.04 -5.95 58.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.179 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.73 2.71 46.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.188 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.66 162.27 18.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.871 ' HB ' HG23 ' A' ' 319' ' ' ILE . 76.0 m -107.11 100.91 10.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.29 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -66.85 102.33 0.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.596 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.71 134.2 52.26 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.845 ' CD1' HD11 ' A' ' 375' ' ' LEU . 30.9 mm -99.97 99.93 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 13.1 m -100.99 -171.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.776 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.663 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -160.04 156.44 26.98 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.008 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.491 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.4 p-10 -74.04 16.64 0.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.01 -29.56 66.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.714 0.292 . . . . 0.0 111.411 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 17.2 m -97.3 169.66 9.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 111.385 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -59.93 -50.0 75.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.096 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.445 ' HG3' ' CA ' ' A' ' 288' ' ' GLY . 75.0 mm-40 -67.84 -40.43 83.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 110.121 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.99 -19.08 65.36 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.038 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.4 m -83.92 -23.47 31.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.754 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -70.53 -40.01 73.71 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.704 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.618 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.5 m-85 -60.03 -50.71 72.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.297 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 394' ' ' ASP . 73.8 t -56.51 -35.57 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.088 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -70.62 -49.86 43.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 110.35 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -73.5 -18.58 79.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.041 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.483 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.4 t80 174.47 -78.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.22 169.61 30.6 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.306 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.473 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.5 -49.04 2.97 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.244 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.4 OUTLIER -140.49 133.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 117.527 0.663 . . . . 0.0 112.624 -177.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -152.38 142.18 9.13 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.2 143.47 14.34 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.556 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.5 mt -104.26 128.87 57.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 30.0 mt -89.94 151.4 21.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.677 0.751 . . . . 0.0 112.494 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 415' ' ' TYR . 11.0 mtt180 -69.97 -38.47 76.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.866 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 97.8 m-85 -160.71 178.47 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.371 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.894 0.378 . . . . 0.0 110.282 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.729 0.299 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -66.45 -37.66 85.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.492 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -125.83 105.95 9.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -132.41 128.4 37.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -88.57 13.32 12.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.471 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.01 -3.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.043 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -58.84 -40.07 83.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.302 . . . . 0.0 110.555 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.43 -24.94 60.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.93 -35.56 75.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.511 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.91 -41.05 90.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.924 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -69.09 127.28 32.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.001 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.737 HD12 ' HD2' ' A' ' 285' ' ' LYS . 49.4 pt . . . . . 0 N--CA 1.462 0.162 0 CA-C-O 120.875 0.369 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.674 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -48.15 -44.73 32.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.258 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.504 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 4.1 mp0 -71.66 -32.06 67.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.467 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -54.49 4.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.737 ' HD2' HD12 ' A' ' 281' ' ' ILE . 57.7 mttt -73.42 -57.99 3.62 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -54.88 41.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.767 0.318 . . . . 0.0 111.659 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' A' ' 402' ' ' PHE . 20.7 mt -59.96 -51.31 74.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.519 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.55 -36.23 88.64 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.012 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -59.98 -33.0 71.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.604 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.4 t80 -60.08 -45.58 92.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.63 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 32.3 m-85 -85.83 -36.85 19.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -60.04 -49.96 75.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.839 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.7 mp0 -66.29 -40.73 90.26 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.697 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.5 mt -60.0 -22.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -18.77 52.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.493 0.663 . . . . 0.0 109.62 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.6 mt-30 -101.41 0.21 36.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.828 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 57.73 29.89 18.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.965 0.412 . . . . 0.0 110.333 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.0 p -67.43 -11.53 58.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.828 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.25 53.4 45.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.402 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.0 mttt -130.34 36.66 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.878 ' CE1' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -160.86 162.39 32.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.695 0.284 . . . . 0.0 111.743 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.1 p -148.99 165.98 30.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.963 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.2 p90 -138.45 148.6 44.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.29 157.57 33.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.049 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.98 -58.68 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 110.662 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.0 -54.24 10.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.706 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 73.9 m-20 -63.67 -54.56 33.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.351 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.537 HG22 HD13 ' A' ' 312' ' ' LEU . 27.9 m -56.38 -37.91 70.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.897 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.972 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -69.7 -43.97 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.1 mttm -56.2 -52.62 63.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.67 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -26.2 63.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.79 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -69.18 -36.81 77.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 110.685 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -70.77 -25.36 62.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.6 mmt -82.58 -7.87 59.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.889 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.11 13.61 42.74 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.253 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -81.43 -7.13 59.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.941 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.866 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.2 m -97.86 106.73 19.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.857 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.1 tt0 -59.93 -50.26 74.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.748 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.5 mm -136.6 122.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.528 0.204 . . . . 0.0 110.776 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.9 tp -84.76 125.87 32.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.67 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -109.65 103.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.284 179.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.5 t -111.45 158.45 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.903 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 392' ' ' VAL . 9.8 m-85 -109.96 148.33 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.12 0.486 . . . . 0.0 112.196 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 391' ' ' ILE . 90.1 mt-10 -67.48 158.92 30.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.183 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.39 29.42 13.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.8 tp -57.87 127.23 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 109.999 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 347' ' ' THR . 34.3 p-10 -90.02 26.94 1.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 305' ' ' VAL . 29.8 mm -128.25 132.96 67.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.939 0.399 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 57.0 mtt -140.43 161.93 36.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.6 ttm180 -86.11 106.76 17.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.087 0.47 . . . . 0.0 110.757 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.537 ' CD2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -116.01 119.75 36.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.032 0.444 . . . . 0.0 111.662 -179.099 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 56.7 tp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.281 0.562 . . . . 0.0 111.738 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.576 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.4 p90 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.685 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.0 mm? -124.82 164.61 19.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.736 0.779 . . . . 0.0 113.009 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 p -101.83 171.26 5.5 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.803 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.1 Cg_exo -49.29 -42.39 40.52 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.98 1.787 . . . . 0.0 112.051 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.56 -50.22 72.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 21.6 mm100 -68.07 -48.81 64.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.591 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 94.2 mt-10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.301 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.863 0.363 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -115.17 120.09 37.42 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.783 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.662 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 7.5 Cg_endo -50.27 120.45 6.27 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.094 1.863 . . . . 0.0 111.107 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 328' ' ' ILE . 18.4 mt -61.9 -41.42 97.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.669 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.826 HD11 HD12 ' A' ' 391' ' ' ILE . 45.5 tp -60.0 -53.3 59.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 61.6 mt-10 -59.93 -40.01 87.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.039 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -66.92 -35.72 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.462 ' HE1' HD22 ' A' ' 312' ' ' LEU . 1.2 m-85 -69.5 -27.5 65.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.965 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -11.65 43.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.223 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.21 -9.74 15.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 14.7 m120 -130.0 18.24 5.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.7 p90 -67.89 -19.25 64.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 382' ' ' TYR . 33.1 mmtt -81.37 -40.93 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -61.49 -39.97 92.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.21 0.529 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 312' ' ' LEU . 17.3 m-85 -81.55 -8.18 59.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.287 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.0 2.79 48.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.363 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.866 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.23 164.55 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 111.15 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.882 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.6 m -107.56 102.7 11.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.15 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 391' ' ' ILE . 0.9 OUTLIER -65.15 103.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.115 0.483 . . . . 0.0 111.124 -178.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.674 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.1 mm-40 -109.43 127.57 54.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.953 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.826 HD12 HD11 ' A' ' 375' ' ' LEU . 42.0 mm -99.91 100.01 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 112.03 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 321' ' ' ILE . 21.9 m -113.71 141.36 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.447 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 13.1 p -121.09 164.44 16.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.832 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.65 80.66 0.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -112.87 -30.13 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.305 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 8.3 t -126.76 -172.95 2.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 67.9 mt-30 -59.97 -49.51 77.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 52.8 mp0 -59.96 -44.12 94.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.181 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.95 66.52 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 404' ' ' LYS . 68.9 m -84.01 -23.47 30.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.44 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 73.4 mt-30 -70.99 -43.95 66.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.529 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.578 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.5 m-85 -62.89 -48.03 80.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.09 -39.58 80.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.001 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 400' ' ' SER . 25.4 mtmt -70.37 -52.83 19.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.77 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -62.39 -22.35 63.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.931 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 18.0 t80 176.77 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.11 168.47 31.86 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.156 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.488 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.55 -47.69 2.76 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.39 133.38 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 117.847 0.824 . . . . 0.0 112.609 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.476 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -156.97 149.8 20.7 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -133.72 149.19 19.65 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.677 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 301' ' ' TYR . 20.1 mt -110.25 127.75 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.753 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 78.3 mt -84.84 150.62 24.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.646 0.736 . . . . 0.0 112.76 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.684 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 20.7 mtm180 -70.01 -32.18 70.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.363 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.543 ' HA ' ' HE2' ' A' ' 300' ' ' LYS . 53.2 p90 -159.45 179.51 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 298' ' ' THR . 1.2 tmm_? . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.264 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.6 0.238 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.41 -39.98 92.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.604 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.65 99.04 6.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -118.29 109.61 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.044 0.45 . . . . 0.0 111.179 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.57 -5.38 36.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.63 -13.52 0.67 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.207 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -55.17 -40.02 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -70.01 -32.56 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.374 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -59.98 -32.22 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.514 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.101 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.849 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 N--CA 1.461 0.09 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.629 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -57.67 -40.74 80.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 -179.23 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 21.3 pt-20 -73.22 -29.9 63.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.303 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -84.69 -56.67 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.92 -57.81 4.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.58 HD23 ' OE1' ' A' ' 282' ' ' GLN . 28.9 tp -57.45 -57.31 13.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.781 HG23 ' CE1' ' A' ' 402' ' ' PHE . 31.2 mt -59.94 -48.71 86.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.42 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.25 60.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.083 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.5 ttt180 -59.94 -40.11 87.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.614 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 6.6 t80 -57.39 -45.93 83.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.72 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -83.36 -38.25 22.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 111.564 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.7 t0 -62.03 -46.16 90.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.462 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.679 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.3 mt-10 -64.2 -42.94 96.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 301' ' ' TYR . 91.7 mt -60.45 -21.43 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.643 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -66.17 -13.93 61.02 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.256 0.551 . . . . 0.0 109.665 178.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.73 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.9 mt-30 -103.47 -0.73 29.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.469 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.01 28.18 17.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.2 p -67.64 -11.48 58.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.38 51.48 55.94 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.423 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.5 mttt -126.13 35.65 4.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.933 ' CE2' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -159.84 162.96 34.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.536 0.208 . . . . 0.0 111.267 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.5 164.69 30.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 53.0 p90 -138.02 149.03 45.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 90.1 155.56 31.17 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.083 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.55 -61.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -47.33 -52.31 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.43 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.3 m-20 -63.35 -55.77 21.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.398 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 35.7 m -57.82 -36.24 71.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.962 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.966 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.63 -43.12 77.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 52.3 mtmt -60.01 -45.43 92.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.556 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.06 66.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.813 0.339 . . . . 0.0 110.643 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.835 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -72.09 -26.92 62.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.25 -27.84 47.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 92.8 mmm -80.9 -8.5 59.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.585 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.9 16.89 49.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.275 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.95 -8.44 55.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.342 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.74 104.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.774 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.4 tt0 -59.64 -49.96 75.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.325 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.8 mm -136.7 124.05 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 322' ' ' VAL . 46.2 tp -87.92 126.05 34.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.201 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -111.53 104.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -122.4 162.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.435 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.627 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -106.88 144.34 33.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.729 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.51 -36.48 83.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.38 45.7 1.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.555 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 35.9 tp -79.11 122.58 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.47 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.652 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.2 m-20 -90.25 29.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.071 HG22 HD12 ' A' ' 374' ' ' LEU . 26.1 mm -126.92 133.18 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 111.567 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.701 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.7 mtt -140.19 162.08 36.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.877 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.512 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 17.1 tpt180 -86.6 111.47 20.66 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 38.8 m-85 -123.77 123.76 41.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.339 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.688 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 29.3 tp . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.604 0.716 . . . . 0.0 112.684 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.12 127.34 37.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.896 178.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.538 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -122.09 165.09 16.62 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.9 p -101.6 169.88 7.16 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.306 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 5.3 Cg_endo -47.13 -49.88 12.01 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.024 1.816 . . . . 0.0 111.749 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -54.96 -53.59 53.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.38 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 26.6 mm100 -65.25 -46.09 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.64 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 87.7 mt-10 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.124 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.947 0.403 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 3.9 tpt -119.07 130.26 24.94 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.672 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.6 Cg_exo -56.77 118.35 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.836 1.69 . . . . 0.0 110.835 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.071 HD12 HG22 ' A' ' 328' ' ' ILE . 32.4 mt -59.89 -41.23 91.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.935 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 391' ' ' ILE . 63.2 tp -60.01 -54.37 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.749 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 48.7 mt-10 -59.62 -40.03 86.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 109.564 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -60.24 -39.85 88.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.988 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -74.88 -27.37 60.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.588 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.61 -12.58 42.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.986 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -106.34 -13.7 15.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.8 m120 -129.96 20.06 5.46 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.7 p90 -63.09 -16.1 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.584 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -83.31 -38.05 22.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -60.95 -38.02 84.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.766 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 381' ' ' ASN . 48.7 m-85 -85.95 -9.15 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.52 60.81 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.444 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.842 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.16 165.54 15.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.885 ' HB ' HG23 ' A' ' 319' ' ' ILE . 53.4 m -108.92 101.75 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.434 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -70.78 102.6 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.629 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.8 mm-40 -111.38 131.98 54.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.834 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 375' ' ' LEU . 38.0 mm -98.76 103.83 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 112.182 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.627 HG23 ' CE1' ' A' ' 323' ' ' TYR . 5.8 m -100.73 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.823 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 392' ' ' VAL . 1.3 p -157.94 154.0 27.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.07 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.462 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.5 p-10 -73.22 20.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -66.91 -40.03 87.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.635 0.255 . . . . 0.0 111.301 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 m -93.08 173.7 7.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.559 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.9 -50.11 75.08 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.9 -40.44 97.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.322 0.582 . . . . 0.0 109.648 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.462 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -61.93 -23.01 63.08 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 53.6 m -83.7 -23.11 31.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.092 -0.554 . . . . 0.0 110.483 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.23 -41.44 49.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.781 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.3 m-85 -60.0 -50.07 75.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.548 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 70.1 t -60.31 -39.96 82.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.563 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 400' ' ' SER . 1.4 mmpt? -71.14 -46.02 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.808 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -73.97 -31.02 60.41 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.595 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER -156.7 -83.36 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 99.39 148.63 23.31 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.995 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.527 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -47.09 2.97 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.607 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.36 134.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 118.336 1.068 . . . . 0.0 112.737 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.12 148.2 18.23 Favored Glycine 0 CA--C 1.511 -0.173 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.43 150.08 19.6 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.872 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.1 mt -109.5 126.8 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 42.3 mt -90.83 157.42 17.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.675 0.75 . . . . 0.0 112.776 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 415' ' ' TYR . 63.0 mtm180 -74.36 -40.03 62.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.531 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.481 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 85.1 m-85 -160.79 172.97 16.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.682 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.535 0.207 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.97 -39.92 87.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.27 37.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.547 ' O ' ' HG ' ' A' ' 434' ' ' LEU . 19.5 p90 -59.62 -50.05 75.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 40.72 31.06 0.11 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.109 0.48 . . . . 0.0 111.38 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 432' ' ' PHE . 54.9 mt -99.53 -1.41 38.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.275 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.04 -41.24 91.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.0 110.71 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.97 -33.16 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.496 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.0 -31.8 70.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.618 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.02 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.002 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.71 130.03 49.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.898 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.455 ' HB ' ' HE3' ' A' ' 285' ' ' LYS . 44.4 pt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.675 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 110.221 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.8 pt-20 -85.24 -34.33 22.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -72.0 -39.97 68.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.455 ' HE3' ' HB ' ' A' ' 281' ' ' ILE . 21.2 mttt -86.6 -58.23 2.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.548 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 29.7 tp -57.69 -55.88 29.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 112.03 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.71 HG23 ' CE1' ' A' ' 402' ' ' PHE . 42.3 mt -58.0 -48.41 84.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.725 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.488 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.39 -37.54 82.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.716 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 23.4 ttt85 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.657 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.2 t80 -56.98 -46.76 81.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -79.12 -40.01 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.756 0.312 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.0 t0 -61.65 -45.48 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.671 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 6.7 mt-10 -64.53 -41.76 96.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -60.33 -21.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.474 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -66.76 -12.67 59.65 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.373 0.606 . . . . 0.0 109.458 178.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.533 ' HB2' HG23 ' A' ' 298' ' ' THR . 39.4 mt-30 -103.5 0.06 30.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.577 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.53 20.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.628 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.7 p -68.03 -14.7 63.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.57 31.32 70.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.911 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.528 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 43.9 mtmt -110.38 37.07 2.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.452 0.168 . . . . 0.0 110.642 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.949 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.8 m-85 -158.97 159.98 35.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.866 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.445 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -139.36 157.74 45.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 111.09 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.409 ' HD1' ' H ' ' A' ' 303' ' ' PHE . 0.2 OUTLIER -136.5 124.55 22.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 110.665 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 109.8 147.34 11.71 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.75 -58.91 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 0.0 110.744 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.1 pt-20 -47.41 -54.72 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.34 -57.02 9.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.63 HG21 HG22 ' A' ' 409' ' ' ILE . 18.7 m -52.1 -33.29 38.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.045 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.759 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.3 mp -75.66 -40.07 56.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.701 0.286 . . . . 0.0 111.517 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 10.4 mtmt -57.49 -50.02 74.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.52 -28.01 63.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.648 0.261 . . . . 0.0 110.922 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.39 -30.76 66.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.054 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.407 ' OE2' ' CZ ' ' A' ' 385' ' ' PHE . 78.3 mm-40 -73.75 -25.22 60.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 29.6 mmt -83.04 -7.61 59.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.43 17.03 46.02 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.265 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.77 6.08 43.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.904 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.1 m -107.46 106.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.781 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.05 -49.97 75.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.629 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.78 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.7 tp -91.16 127.93 36.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.23 105.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.649 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -123.18 161.75 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.433 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.885 ' CE1' HG23 ' A' ' 392' ' ' VAL . 93.2 m-85 -109.67 146.04 35.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.915 0.388 . . . . 0.0 111.307 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.9 pt-20 -64.97 -30.03 71.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.334 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.17 48.5 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.456 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.3 tp -83.68 125.52 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.1 32.22 1.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.054 HG22 HD12 ' A' ' 374' ' ' LEU . 27.3 mm -129.5 137.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.0 162.08 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.373 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.555 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 22.1 ttt180 -94.12 124.62 38.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.09 0.471 . . . . 0.0 111.053 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 6.6 m-85 -121.08 158.12 28.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.43 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.542 -179.643 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.404 ' O ' HD22 ' A' ' 346' ' ' LEU . 55.9 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 112.063 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.527 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -88.47 117.05 27.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.06 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.536 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -118.83 156.4 29.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 22.0 p -100.59 169.4 7.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.8 Cg_endo -44.1 -45.57 11.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.87 -52.98 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -65.18 -50.02 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.7 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.509 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.585 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 3.1 p . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 121.178 0.513 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.712 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -119.12 126.88 26.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.105 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.712 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 11.2 Cg_endo -55.49 125.81 20.37 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.064 1.842 . . . . 0.0 110.69 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -65.43 -41.33 93.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 391' ' ' ILE . 61.6 tp -60.06 -53.81 53.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.1 mt-10 -56.88 -40.01 75.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.893 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.24 -35.25 75.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.267 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 6.6 m-85 -64.16 -32.14 73.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.696 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.67 -10.01 47.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.71 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -103.19 -0.09 30.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -138.97 16.14 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -67.45 -19.16 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.689 0.281 . . . . 0.0 111.112 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -78.58 -47.44 17.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.94 -45.9 91.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 110.702 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -73.73 -15.21 61.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.787 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.14 2.49 66.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.27 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.904 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.2 162.18 17.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.811 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.4 m -107.14 100.32 9.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.548 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.8 102.77 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.675 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 67.2 mm-40 -110.45 128.95 55.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.845 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.967 HD12 HD11 ' A' ' 375' ' ' LEU . 33.2 mm -95.2 104.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.203 0.525 . . . . 0.0 112.146 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.885 HG23 ' CE1' ' A' ' 323' ' ' TYR . 15.0 m -101.2 -169.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.923 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.502 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.97 156.6 27.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 111.823 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 400' ' ' SER . 9.7 t70 -64.44 -7.34 9.58 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.209 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -53.21 -41.65 65.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.7 m -87.51 167.44 13.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.689 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 27.2 tt0 -60.03 -53.32 59.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.601 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 41.1 mp0 -60.07 -35.43 75.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.495 0.664 . . . . 0.0 109.316 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -56.24 -58.13 15.78 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.704 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 3.4 m -59.44 -22.0 60.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.815 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 84.5 mt-30 -68.93 -40.05 79.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.82 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.6 m-85 -65.9 -50.8 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.461 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 80.6 t -55.8 -35.11 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 400' ' ' SER . 6.0 mmtt -77.12 -50.6 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.468 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -75.45 -27.28 63.81 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.816 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -157.86 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 99.6 153.3 27.59 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.753 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 82.32 -50.63 4.36 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.934 -0.65 . . . . 0.0 114.699 178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -149.06 133.23 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 117.837 0.819 . . . . 0.0 112.482 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 139.13 7.14 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -123.93 144.61 15.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.805 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.949 HG23 ' CE2' ' A' ' 301' ' ' TYR . 26.4 mt -106.63 128.73 61.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.1 mt -89.55 152.8 21.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.751 0.786 . . . . 0.0 112.82 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.03 -34.96 73.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.729 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 88.3 m-85 -156.84 164.68 37.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.4 mtm180 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.258 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.712 0.291 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.01 -40.06 95.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 110.452 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -111.61 98.78 7.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.539 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.56 124.97 44.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.467 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.12 6.61 11.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.16 -3.85 6.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.963 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.23 -39.88 84.14 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.721 0.296 . . . . 0.0 110.772 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.61 -33.91 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.01 -34.55 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.251 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.98 -46.62 88.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.966 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.07 -39.92 87.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.878 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 3.4 pt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.828 0.347 . . . . 0.0 111.806 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.1 OUTLIER -57.59 -35.82 70.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 -179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.525 ' O ' HD12 ' A' ' 287' ' ' ILE . 41.8 mt-10 -72.12 -31.43 66.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 398' ' ' GLU . 0.9 OUTLIER -83.79 -56.27 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.32 -179.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -57.66 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 22.0 tp -55.23 -58.21 8.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.784 HG23 ' CD2' ' A' ' 402' ' ' PHE . 82.5 mt -60.07 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.282 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.467 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.15 -39.02 57.37 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.269 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -60.05 -34.16 73.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.126 0.489 . . . . 0.0 110.279 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 19.0 t80 -59.92 -49.29 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.12 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -83.45 -38.31 22.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.53 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 295' ' ' SER . 43.3 t0 -64.18 -49.94 70.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.58 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 46.2 tp10 -61.26 -40.03 92.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 301' ' ' TYR . 88.2 mt -62.58 -26.33 40.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.841 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.77 -13.7 16.79 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.279 0.561 . . . . 0.0 109.944 178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -100.07 0.89 41.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.389 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.6 30.04 19.31 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 10.0 p -69.84 -10.04 56.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.21 51.14 57.79 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.43 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.1 mttt -130.25 40.67 3.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.877 -0.19 . . . . 0.0 110.6 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.854 ' CE1' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -161.69 163.57 29.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.38 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 p -145.15 160.38 41.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.43 126.76 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.649 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.554 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 109.38 153.25 14.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.331 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -55.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.861 0.362 . . . . 0.0 110.673 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.4 pt-20 -50.35 -51.03 49.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.19 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.38 -55.24 12.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.883 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.558 HG21 HG22 ' A' ' 409' ' ' ILE . 20.7 m -55.49 -37.56 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.225 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.95 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -69.61 -44.47 70.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.326 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.0 mttm -56.14 -50.03 72.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.24 65.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.936 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -70.72 -29.63 65.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.807 0.337 . . . . 0.0 110.616 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.54 -25.91 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 6.7 mmm -81.68 -8.6 59.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.853 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.12 11.57 32.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.343 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.47 59.77 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.4 0.28 . . . . 0.0 110.811 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.3 m -92.73 104.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.898 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.2 tp10 -59.55 -49.13 78.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 318' ' ' GLU . 31.3 mm -136.22 129.12 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' HG23 ' A' ' 322' ' ' VAL . 42.8 tp -94.08 127.85 40.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.222 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.571 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -114.48 108.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.09 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.646 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -124.45 161.97 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.435 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.81 ' CE1' HG23 ' A' ' 392' ' ' VAL . 89.4 m-85 -108.18 146.22 33.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.835 0.35 . . . . 0.0 111.312 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.9 pt-20 -63.62 -31.96 73.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.129 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -95.98 52.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.541 HD13 ' CA ' ' A' ' 408' ' ' GLY . 45.6 tp -85.65 123.91 31.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.21 27.72 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.963 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 374' ' ' LEU . 28.0 mm -127.15 134.83 65.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.104 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.8 mtm -139.99 161.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.669 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.0 OUTLIER -90.61 120.37 31.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.1 0.476 . . . . 0.0 111.218 -179.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 371' ' ' SER . 3.9 m-85 -118.3 157.23 27.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.172 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 332' ' ' VAL . 11.0 m . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.269 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 57.3 tp . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.383 0.611 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.514 ' HD2' HD12 ' A' ' 328' ' ' ILE . 5.9 p90 -100.67 118.28 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -123.52 163.8 20.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 20.0 p -101.09 168.68 8.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.789 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.6 Cg_endo -45.55 -43.61 17.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.409 2.072 . . . . 0.0 111.949 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.02 -57.09 14.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 18.6 mm100 -62.95 -49.64 73.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.9 mt-10 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.957 0.408 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 4.2 tpt -112.62 127.25 27.08 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 13.6 Cg_endo -57.73 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.071 1.847 . . . . 0.0 110.971 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.057 HD12 HG22 ' A' ' 328' ' ' ILE . 19.4 mt -64.38 -40.07 95.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.866 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 59.5 tp -59.84 -53.59 56.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -58.6 -39.93 81.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.873 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.409 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 74.0 t-105 -64.88 -39.74 94.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.57 ' CD1' HD21 ' A' ' 320' ' ' LEU . 6.4 m-85 -64.1 -30.75 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.22 -12.31 38.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.779 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -102.35 -13.83 17.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 69.0 m-80 -129.71 17.07 5.81 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -64.82 -19.59 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.243 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -79.0 -44.24 22.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.32 -43.45 96.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.179 0.514 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.716 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.8 m-85 -76.02 -12.27 60.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.17 2.41 58.73 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.17 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.785 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.71 161.49 18.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.174 0.511 . . . . 0.0 110.556 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.858 ' HB ' HG23 ' A' ' 319' ' ' ILE . 73.5 m -106.59 100.72 10.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.261 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.9 tm? -71.81 104.75 3.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.373 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -113.78 129.92 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.738 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 34.2 mm -94.75 103.61 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.016 0.436 . . . . 0.0 111.968 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.81 HG23 ' CE1' ' A' ' 323' ' ' TYR . 26.5 m -100.86 -172.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.901 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -157.97 154.42 27.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.639 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.38 3.29 1.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.89 -40.01 87.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.589 0.233 . . . . 0.0 111.208 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -94.36 162.47 13.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.96 -55.26 28.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 60.0 mp0 -59.97 -40.0 87.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.27 -24.36 68.94 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -84.0 -25.45 29.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.543 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.36 -40.01 77.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.586 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.784 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -59.59 -49.54 77.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.449 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 90.9 t -57.71 -37.76 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.3 OUTLIER -69.97 -54.13 14.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.223 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.5 66.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.565 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.554 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 27.4 t80 179.93 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.83 164.59 29.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.774 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.541 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.56 -49.48 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.009 -0.615 . . . . 0.0 114.328 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.67 131.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 117.529 0.664 . . . . 0.0 111.924 -177.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.32 135.89 5.7 Favored Glycine 0 CA--C 1.51 -0.237 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -119.88 138.62 13.28 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.516 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.854 HG23 ' CE1' ' A' ' 301' ' ' TYR . 21.4 mt -100.87 129.0 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 31.4 mt -90.57 153.71 20.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.684 0.754 . . . . 0.0 112.527 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 65.3 mtt180 -70.02 -38.05 75.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.707 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 50.9 p90 -163.79 175.77 10.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.692 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.2 mtm105 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.576 0.227 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.07 -42.72 95.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 111.082 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -103.76 5.31 36.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.23 110.53 23.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 111.389 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -87.39 12.49 11.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.042 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 45.0 mt -70.82 -5.4 30.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.971 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -40.06 87.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -73.75 -23.88 59.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.99 -36.36 77.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.437 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.03 -47.87 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 40.7 pt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.944 0.402 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -53.83 -42.09 68.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.8 pt-20 -86.09 -25.08 26.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.553 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -84.1 -43.19 15.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.02 -58.45 2.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 27.1 tp -56.82 -56.45 21.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.678 -178.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.852 HG23 ' CE1' ' A' ' 402' ' ' PHE . 63.9 mt -60.03 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.537 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.469 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.32 -38.87 57.97 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.041 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -60.05 -32.2 70.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.03 0.443 . . . . 0.0 110.268 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 14.9 t80 -59.86 -46.0 90.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.094 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 41.3 m-85 -87.38 -40.14 14.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 71.4 m-20 -60.0 -44.25 94.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.475 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.667 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.8 tp10 -69.95 -39.74 75.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 301' ' ' TYR . 76.4 mt -63.82 -24.45 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.92 178.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -57.73 -17.52 15.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.096 0.474 . . . . 0.0 110.186 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.622 ' HB2' HG23 ' A' ' 298' ' ' THR . 11.2 mt-30 -100.48 2.99 42.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.737 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 30.0 18.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.011 0.434 . . . . 0.0 110.362 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.8 p -66.84 -11.79 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.32 52.3 54.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.65 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 40.1 mttt -131.12 39.78 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.804 -0.233 . . . . 0.0 111.214 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.852 ' CE2' HG23 ' A' ' 412' ' ' ILE . 76.6 m-85 -161.12 162.85 31.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 0.0 111.726 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.47 164.51 33.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 49.3 p90 -134.99 150.01 50.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.531 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 87.06 154.71 26.63 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.327 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.019 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -60.58 -62.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.983 -179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -43.31 -52.13 5.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.619 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.6 m-20 -64.83 -54.8 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.498 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.582 HG22 HD13 ' A' ' 312' ' ' LEU . 36.3 m -57.58 -37.18 72.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.907 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 1.019 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.1 -45.0 74.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mttm -58.12 -49.6 76.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.65 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.474 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.747 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -70.77 -30.1 66.5 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.891 0.377 . . . . 0.0 110.267 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.8 -27.57 58.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 12.8 mmt -80.0 -7.24 58.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.82 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 18.69 47.41 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.06 -1.066 . . . . 0.0 110.942 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -91.27 0.0 57.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.481 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.939 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.8 m -100.39 105.68 18.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 412' ' ' ILE . 12.0 tp10 -59.6 -50.04 75.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.39 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 388' ' ' THR . 24.4 mm -135.91 123.97 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.334 0.112 . . . . 0.0 111.214 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.4 tp -85.41 122.97 30.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 111.204 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -107.11 102.21 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.824 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 320' ' ' LEU . 25.4 t -114.08 162.01 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.326 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.632 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 37.9 m-85 -114.0 148.72 36.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.927 ' OE2' HG21 ' A' ' 391' ' ' ILE . 22.0 mm-40 -65.3 155.73 34.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.06 178.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 57.8 t30 56.95 28.94 15.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.265 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -57.16 126.63 28.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.3 m-20 -89.93 27.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.614 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.062 HG22 HD12 ' A' ' 374' ' ' LEU . 31.0 mm -126.43 137.68 57.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.629 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -139.52 161.13 38.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.743 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 11.0 ttt-85 -86.94 105.66 17.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 346' ' ' LEU . 5.9 m-85 -118.58 122.59 42.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.095 -179.372 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 39.4 tp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.319 0.581 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.632 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -94.41 128.35 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.986 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.2 mm? -119.07 148.16 43.34 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.7 p -100.86 173.74 3.45 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.868 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -48.29 -48.13 17.81 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 121.905 1.737 . . . . 0.0 113.16 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -71.75 -30.96 66.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -87.07 -49.3 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.068 0.461 . . . . 0.0 111.719 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.411 ' CD ' ' CZ ' ' A' ' 331' ' ' TYR . 1.3 tm-20 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.918 -179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.516 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 121.113 0.482 . . . . 0.0 111.624 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.468 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 6.1 tpt -117.82 132.08 23.82 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.627 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.631 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.4 Cg_exo -58.05 129.06 31.25 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.707 1.604 . . . . 0.0 110.133 178.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.062 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -69.14 -44.04 73.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 391' ' ' ILE . 33.0 tp -59.98 -53.43 57.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 44.0 mt-10 -58.04 -40.09 80.05 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.064 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.468 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 73.5 t-105 -67.21 -36.38 81.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.611 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.602 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 10.3 m-85 -70.04 -33.49 72.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.279 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.09 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.751 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -110.23 -12.95 14.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 377' ' ' TRP . 68.5 m-80 -134.11 19.94 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.602 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 53.1 p90 -64.47 -14.54 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -83.5 -35.04 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.72 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -39.81 87.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 312' ' ' LEU . 59.1 m-85 -82.37 -10.07 59.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.045 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.97 64.1 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.796 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.939 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.32 163.67 17.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.776 ' HB ' HG23 ' A' ' 319' ' ' ILE . 49.4 m -106.86 104.76 14.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.498 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 391' ' ' ILE . 1.2 tm? -65.16 102.41 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.116 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -115.92 107.79 15.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.933 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.927 HG21 ' OE2' ' A' ' 324' ' ' GLU . 27.6 mm -84.14 104.59 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.209 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.65 ' CB ' HD11 ' A' ' 287' ' ' ILE . 11.3 m -102.49 -172.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.078 -178.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 392' ' ' VAL . 0.7 OUTLIER -160.97 157.34 26.22 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.329 179.152 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 11.3 p-10 -69.98 19.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 393' ' ' THR . 23.7 mtpp -68.12 -40.04 82.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.652 0.263 . . . . 0.0 111.126 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 93.6 p -94.51 170.06 9.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 111.556 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.04 -45.51 92.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.687 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.469 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 33.6 mp0 -68.01 -40.54 82.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.382 0.61 . . . . 0.0 109.827 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.528 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.35 -19.67 60.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.293 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' A' ' 404' ' ' LYS . 65.6 m -84.02 -23.16 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.752 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 30.8 mt-30 -70.88 -41.47 71.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.807 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.0 m-85 -60.32 -46.33 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.082 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 394' ' ' ASP . 54.0 t -59.98 -37.84 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 400' ' ' SER . 22.1 mttm -66.94 -57.88 6.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.08 -52.56 42.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.834 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.531 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 50.4 t80 -151.91 -66.97 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.03 166.48 31.59 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.235 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.2 -49.2 2.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.041 -0.6 . . . . 0.0 114.404 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -143.97 134.4 21.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 117.697 0.748 . . . . 0.0 112.632 -177.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 145.22 12.18 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.97 144.26 15.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.287 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.8 mt -105.66 127.6 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 51.0 mt -87.85 153.49 21.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.64 0.733 . . . . 0.0 112.735 -177.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 58.8 mtp85 -69.83 -35.2 74.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.419 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 416' ' ' ARG . 50.9 p90 -171.3 179.63 2.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.683 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 110.954 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 432' ' ' PHE . 90.6 m-20 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -59.98 -46.68 88.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.126 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -123.17 18.27 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.4 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.467 ' HB2' ' CB ' ' A' ' 429' ' ' ASP . 81.6 m-85 -98.84 119.69 38.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.69 -9.89 56.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.516 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.6 mt -53.49 -13.24 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.389 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 429' ' ' ASP . 81.0 m-20 -57.04 -40.04 75.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.837 0.351 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -68.56 -35.19 77.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.02 -31.66 70.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.14 -46.71 88.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -59.99 -39.96 87.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.994 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.902 179.991 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 120.788 0.327 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.679 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -60.02 -39.48 85.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.512 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.501 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.69 -22.67 29.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.35 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -50.09 8.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.21 -58.33 3.35 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.502 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.74 -55.61 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.054 0.454 . . . . 0.0 111.975 -178.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.77 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.6 mt -59.55 -49.18 84.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.623 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.86 -37.0 75.49 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.9 ttt85 -60.01 -39.08 84.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.606 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.8 t80 -57.51 -45.19 85.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.669 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -79.45 -40.0 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.01 -47.44 85.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.697 -179.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.85 -43.3 99.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.067 0.46 . . . . 0.0 109.864 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -59.98 -24.6 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.648 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 178.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.599 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.4 mt-30 -107.27 1.59 23.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.443 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 57.95 31.13 20.19 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.998 0.428 . . . . 0.0 110.341 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -67.71 -11.93 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.858 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.08 48.56 78.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.511 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.1 36.3 4.33 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.32 160.06 34.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.95 164.99 33.99 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.35 164.86 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 0.0 110.928 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.21 167.84 34.37 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.226 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.792 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.91 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.213 -179.583 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.26 -52.43 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.872 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.6 m-20 -65.78 -57.44 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.13 -36.39 68.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.591 0.234 . . . . 0.0 110.974 -179.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.69 64.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.64 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.44 -50.01 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.609 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.84 -28.32 68.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.68 0.276 . . . . 0.0 111.027 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.37 -28.24 61.03 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -77.51 -26.93 51.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.28 -7.3 58.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.789 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.42 42.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.519 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.14 -2.27 58.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.313 0.245 . . . . 0.0 111.073 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.2 m -100.95 107.11 20.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.84 -50.03 75.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.327 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.7 mm -135.51 125.1 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.82 128.23 36.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.903 0.382 . . . . 0.0 111.305 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.74 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.636 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.63 162.21 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.405 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.859 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.1 m-85 -110.63 149.86 29.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.043 0.449 . . . . 0.0 111.687 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.53 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.83 -27.98 67.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.31 34.98 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.681 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.33 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.526 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.53 23.28 5.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.268 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.977 HG22 HD12 ' A' ' 374' ' ' LEU . 14.9 mm -120.89 135.5 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.401 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.54 161.47 36.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.336 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.19 120.04 31.03 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.488 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.11 155.26 29.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.723 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.04 0.448 . . . . 0.0 111.033 179.863 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.1 tp . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 121.177 0.513 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.4 p90 -101.0 120.1 39.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.645 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 1.079 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.48 156.37 37.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.83 168.12 9.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.34 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.89 -49.58 8.12 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.525 2.15 . . . . 0.0 112.303 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.0 -55.51 33.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.397 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 1.079 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.97 -53.19 60.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.376 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.619 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.6 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.85 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.945 0.403 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.99 124.16 30.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.44 120.92 9.16 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.945 1.763 . . . . 0.0 110.984 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 0.977 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.616 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.06 -51.44 69.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.77 -40.22 87.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.704 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.0 -40.03 94.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.809 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.1 -29.45 60.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.19 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.42 47.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.617 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -111.02 -9.31 14.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.74 19.84 5.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.5 p90 -69.99 -11.89 61.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.63 -38.3 21.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.99 -38.33 82.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.295 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.556 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -83.97 -10.43 57.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.63 1.26 52.7 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.644 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.75 165.15 17.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.74 100.23 9.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.338 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.93 102.22 2.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.648 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.7 mm-40 -107.82 128.01 54.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.928 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.6 mm -94.85 102.09 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 112.208 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.859 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.43 -169.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.817 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.7 p -154.89 151.55 28.7 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.021 0.439 . . . . 0.0 111.557 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.0 p-10 -71.08 1.43 5.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.319 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -60.03 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.283 . . . . 0.0 111.017 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.4 p -81.88 168.15 18.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.6 mt-30 -60.03 -54.79 41.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.8 -39.5 94.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.266 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.63 -59.7 9.34 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.593 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.92 -19.55 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.0 mt-30 -69.96 -40.03 75.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.914 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.47 -44.81 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.767 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.2 t -59.99 -45.23 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.423 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.79 -38.19 56.79 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -178.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.709 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.75 -94.52 0.48 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.192 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.06 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.818 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.53 -20.04 7.91 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.562 -1.304 . . . . 0.0 115.504 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.637 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.6 130.32 66.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.562 1.181 . . . . 0.0 111.765 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.67 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.48 151.05 19.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.735 -1.221 . . . . 0.0 114.105 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.0 mt -109.35 127.48 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.6 mt -88.23 153.33 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.52 0.676 . . . . 0.0 112.302 -178.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.528 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.2 mtt-85 -70.06 -36.75 75.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.605 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -160.92 170.59 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.693 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.611 0.243 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.13 -39.92 87.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.926 0.394 . . . . 0.0 110.337 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.37 91.29 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.208 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.5 -137.68 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.88 40.02 16.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 109.194 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -89.03 -0.25 57.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.338 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.02 87.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -68.0 -35.17 77.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.478 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.93 -34.14 71.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.079 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.09 -42.4 94.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -60.06 -40.01 88.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.845 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 5.6 pt . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.796 0.332 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.561 ' NE2' HG13 ' A' ' 392' ' ' VAL . 0.0 OUTLIER -57.17 -37.34 71.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.533 . . . . 0.0 110.085 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.576 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 93.3 mt-10 -77.77 -28.58 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.899 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -83.99 -57.52 3.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -70.0 -58.23 4.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 319' ' ' ILE . 19.2 tp -57.26 -58.35 8.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.702 0.287 . . . . 0.0 111.509 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.716 HG23 ' CE1' ' A' ' 402' ' ' PHE . 30.4 mt -59.97 -49.65 83.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.152 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.28 -37.19 79.6 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.633 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -60.03 -35.79 75.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 110.282 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.578 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.6 t80 -60.0 -46.58 89.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.699 0.285 . . . . 0.0 111.614 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 295' ' ' SER . 38.0 t0 -63.67 -46.85 83.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.463 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 33.4 tp10 -64.74 -40.0 94.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 301' ' ' TYR . 81.8 mt -62.27 -26.1 39.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.29 -14.06 16.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.273 0.559 . . . . 0.0 109.865 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.807 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.2 mt-30 -98.36 -0.02 44.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.422 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.23 28.89 17.21 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.196 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.5 p -69.98 -10.03 57.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.067 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.29 52.62 46.2 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.525 178.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 11.8 mtpt -130.33 40.57 3.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.864 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.2 m-85 -162.54 165.25 26.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.106 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 2.0 p -149.7 164.31 35.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.716 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 52.7 p90 -136.98 151.89 49.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.082 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 88.3 155.45 29.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.445 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.949 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -61.55 -56.49 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.283 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -47.68 -56.9 6.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.591 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.2 m-20 -60.7 -54.98 38.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.667 0.27 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 409' ' ' ILE . 18.9 m -58.68 -40.04 82.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.932 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -67.69 -48.07 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -54.99 -56.53 18.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.144 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.23 -30.14 70.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.07 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.865 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.04 -28.44 62.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.796 179.39 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -76.93 -26.21 53.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 45.4 mmm -82.08 -8.53 59.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.851 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.75 14.22 42.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.263 -178.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.79 -5.96 59.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.394 0.278 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.2 m -99.1 105.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.611 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.3 tt0 -59.93 -49.97 75.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.3 mm -133.78 126.34 50.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.563 0.221 . . . . 0.0 111.185 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.9 tp -93.52 129.43 39.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 111.058 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 412' ' ' ILE . 1.1 mt -116.14 109.32 27.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 110.142 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.61 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.8 t -125.43 161.84 29.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 31.5 m-85 -108.14 146.94 31.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 111.168 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.644 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.62 -32.76 74.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -94.1 51.53 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -83.9 125.87 32.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.7 23.03 4.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.036 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -122.43 133.47 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.596 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.599 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.7 mtt -139.53 161.54 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 31.9 ttt180 -92.39 122.26 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 111.645 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.53 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 6.6 m-85 -120.7 159.02 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.22 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.362 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.693 HD23 HD11 ' A' ' 346' ' ' LEU . 32.4 tp . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.609 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -92.09 116.67 29.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.629 179.461 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.693 HD11 HD23 ' A' ' 344' ' ' LEU . 1.4 mm? -120.59 153.64 36.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 112.711 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.6 p -101.0 168.98 8.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.542 178.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.9 Cg_endo -41.24 -46.14 5.54 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.062 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.05 -54.92 41.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . 0.547 ' OE1' HD12 ' A' ' 346' ' ' LEU . 62.8 mt-30 -66.77 -48.35 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.523 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.1 mt-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.535 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.7 p . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 121.137 0.494 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.8 tpt -114.22 129.86 24.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.599 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -59.1 118.35 5.22 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.204 1.936 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.07 -39.46 86.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.674 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -60.07 -54.08 50.24 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.958 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.537 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.0 mt-10 -58.12 -40.06 80.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.928 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -62.51 -39.89 94.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.376 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.684 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.66 -28.69 62.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.085 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.48 -9.74 48.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.33 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -104.86 -14.06 15.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.62 20.22 5.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -64.88 -18.94 65.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.739 0.304 . . . . 0.0 111.019 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -81.05 -39.96 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -64.77 -39.96 94.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.621 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.581 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.7 m-85 -80.02 -11.33 59.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.976 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.34 57.52 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.488 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.22 163.66 16.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.189 0.519 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 50.2 m -106.95 100.4 9.9 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.08 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.744 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -76.28 107.18 8.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.504 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 43.3 mm-40 -113.71 135.17 54.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.909 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -98.97 105.2 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 0.0 112.146 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.561 HG13 ' NE2' ' A' ' 282' ' ' GLN . 5.8 m -102.1 -169.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.239 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -158.25 153.37 25.49 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.175 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.0 t0 -77.91 69.97 4.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.295 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -114.56 -34.94 5.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.937 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.5 m -102.93 179.36 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 25.3 mm100 -60.01 -40.65 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 34.4 mp0 -69.49 -40.66 76.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.46 -21.06 61.97 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.271 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 52.3 m -84.2 -21.43 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.027 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 85.5 mt-30 -77.48 -41.69 38.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.779 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.716 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -67.31 -49.62 63.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.555 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 394' ' ' ASP . 72.3 t -60.03 -40.04 82.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.871 0.367 . . . . 0.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -79.86 -41.32 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.325 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.26 95.29 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -134.06 -84.74 0.43 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.018 -0.591 . . . . 0.0 109.713 178.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 148.32 41.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.563 -1.303 . . . . 0.0 115.138 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 126.61 -28.49 4.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 119.556 -1.307 . . . . 0.0 115.218 177.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.563 HG22 HG21 ' A' ' 308' ' ' THR . 0.8 OUTLIER -125.02 127.83 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.056 0.928 . . . . 0.0 111.913 -178.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.43 139.77 7.67 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.34 140.62 13.59 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.595 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.864 HG23 ' CE1' ' A' ' 301' ' ' TYR . 48.4 mt -101.9 127.29 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 53.9 mt -87.42 151.55 22.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 112.798 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 34.9 mtp-105 -78.77 -27.68 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.734 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.413 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 95.5 m-85 -151.99 170.06 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.958 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.99 -42.67 94.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.678 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 31.3 p90 -144.64 114.32 7.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 26.2 p90 -130.98 106.73 8.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 0.0 111.376 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.03 14.2 12.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.035 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.71 -3.86 27.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.774 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 110.641 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -69.8 -32.49 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -60.06 -33.2 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.03 -41.59 92.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.012 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.869 179.875 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.92 0.391 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.679 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.63 -39.99 86.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.592 -179.433 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.4 mt-10 -77.16 -29.91 54.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.228 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.7 -58.1 3.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.75 -54.7 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.0 mt -59.98 -48.47 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.572 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.474 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.33 -37.88 66.9 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.041 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 43.8 ttt180 -60.0 -39.2 84.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.166 0.508 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.8 t80 -55.63 -45.77 77.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.772 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.32 -39.24 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.737 0.303 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.9 t0 -59.97 -43.25 95.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.381 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.17 -42.32 84.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.2 -23.88 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.57 178.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.02 -15.47 56.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.203 0.525 . . . . 0.0 110.048 178.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.86 2.12 29.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.596 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.25 29.73 18.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.962 0.41 . . . . 0.0 110.57 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.8 p -66.75 -13.02 60.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.9 49.18 73.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.402 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.635 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.4 36.8 4.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 159.99 34.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.337 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -140.95 161.2 38.4 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.11 144.85 47.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.29 157.0 29.1 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.908 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.06 -55.82 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 0.0 111.166 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -47.31 -57.24 5.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.943 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.12 -54.85 39.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.712 0.291 . . . . 0.0 111.452 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.0 m -56.56 -40.02 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.832 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.86 -45.23 78.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.566 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.3 mtmt -56.66 -50.04 73.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.998 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.85 -27.32 61.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.53 74.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.886 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.56 -24.35 61.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.8 -7.96 59.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.092 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.07 10.94 36.02 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.561 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -79.96 -6.19 57.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.441 0.296 . . . . 0.0 110.79 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.9 m -95.79 105.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.64 -50.0 75.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.9 mm -136.64 126.5 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.534 0.206 . . . . 0.0 111.41 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.9 tp -89.72 126.48 35.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.972 0.415 . . . . 0.0 111.467 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 321' ' ' ILE . . . . . 0.777 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.56 103.6 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.286 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.4 t -122.33 152.66 26.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.476 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.5 m-85 -98.42 142.95 29.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.411 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 324' ' ' GLU . . . . . 0.642 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.36 -24.05 67.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.835 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.28 33.35 1.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 326' ' ' LEU . . . . . 0.492 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -71.2 123.91 23.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.699 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -96.57 28.7 3.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.724 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.58 133.19 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 329' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.3 mtt -140.62 162.53 35.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.161 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.58 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.17 29.72 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.244 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.74 28.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.496 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.872 0.368 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 345' ' ' TYR . . . . . 0.901 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -84.96 137.09 33.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.183 178.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.68 164.1 22.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.635 0.731 . . . . 0.0 112.475 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.56 172.05 4.79 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.283 178.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 74.0 Cg_exo -48.94 -47.52 21.2 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 121.755 1.637 . . . . 0.0 111.768 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.17 -58.46 8.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.04 -48.95 79.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.112 0.482 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.56 121.92 32.5 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.72 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.57 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.57 120.84 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.782 1.655 . . . . 0.0 110.784 178.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 374' ' ' LEU . . . . . 1.008 HD12 HG22 ' A' ' 328' ' ' ILE . 20.9 mt -59.94 -44.16 94.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.259 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 68.9 tp -60.06 -50.79 72.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.97 85.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.673 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 377' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.26 -43.77 95.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.6 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.7 m-85 -73.68 -30.68 63.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.19 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.36 -25.09 60.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.539 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.69 -6.56 14.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.33 20.25 5.75 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.565 0.221 . . . . 0.0 111.349 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.35 -40.43 30.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.919 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.16 -36.37 77.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.49 -4.18 59.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.399 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.71 3.06 32.3 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.519 -179.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.72 166.31 13.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 388' ' ' THR . . . . . 0.801 ' HB ' HG23 ' A' ' 319' ' ' ILE . 58.1 m -109.13 100.57 9.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.003 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.756 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.35 102.36 1.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.679 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.77 130.03 55.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.4 mm -95.91 103.87 15.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.057 -178.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 392' ' ' VAL . . . . . 0.615 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.47 -171.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.173 -178.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.519 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.59 155.33 26.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.198 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.49 11.37 0.63 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.208 -179.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.02 94.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.676 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.4 m -92.06 170.91 9.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.844 0.354 . . . . 0.0 111.389 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.8 mt-30 -60.12 -54.35 46.93 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.545 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 398' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -59.99 -40.02 87.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.496 0.665 . . . . 0.0 109.467 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.11 -57.64 15.89 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.776 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.9 -19.44 51.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 401' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.42 -40.04 77.53 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.915 0.388 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 402' ' ' PHE . . . . . 0.749 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.97 -46.56 89.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.497 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.2 t -59.91 -34.08 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.017 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.24 -54.11 19.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.271 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.72 -20.56 70.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.939 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.2 t80 174.95 -75.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.41 167.86 28.88 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.705 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.73 -51.53 3.76 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.846 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.56 131.78 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.293 0.547 . . . . 0.0 112.234 -178.199 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 410' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.75 141.06 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.73 145.86 15.93 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.867 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.16 128.5 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.9 mt -90.66 153.15 20.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.72 0.771 . . . . 0.0 112.807 -177.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.0 -37.91 75.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.597 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 415' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 414' ' ' ARG . 82.3 m-85 -158.24 -177.89 6.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.77 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 110.846 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.0 -41.09 91.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.4 99.12 5.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -116.71 117.07 28.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.83 -0.69 24.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.9 mt -50.96 -19.38 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.927 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -59.69 -40.02 86.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.396 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -74.88 -24.2 58.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.61 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.07 -38.43 82.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.003 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.06 -46.35 89.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.919 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.02 -39.95 87.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.869 -179.895 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 39.0 p-10 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.781 0.324 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -65.75 -29.23 46.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.359 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -53.22 -40.56 64.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.521 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -62.71 -47.27 84.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.753 0.311 . . . . 0.0 111.19 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 42.7 pt -81.98 -23.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.533 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.525 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.98 -41.17 91.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.376 0.607 . . . . 0.0 109.857 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.678 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 2.1 mp0 -80.29 -42.08 23.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.33 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -70.01 -39.99 75.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -58.41 2.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 18.0 tp -58.93 -55.94 28.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.891 0.377 . . . . 0.0 111.318 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.678 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 47.1 mt -60.99 -49.91 82.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.806 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.47 -38.78 58.56 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 20.6 ttt85 -60.03 -37.64 80.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 110.277 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.5 t80 -55.79 -47.46 77.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.938 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 34.8 m-85 -83.63 -38.73 21.17 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.9 t0 -60.33 -42.75 96.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.522 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.674 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.0 mt-10 -69.47 -43.3 73.48 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.485 HD11 ' HB2' ' A' ' 301' ' ' TYR . 89.9 mt -59.55 -23.03 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.85 -12.88 53.32 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.22 0.534 . . . . 0.0 109.911 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 69.5 mt-30 -103.72 -0.01 29.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.466 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.24 30.29 20.01 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 110.387 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.6 HG23 ' HB2' ' A' ' 296' ' ' GLN . 6.5 p -67.21 -14.15 62.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.022 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.0 48.9 83.63 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.783 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.52 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 7.0 ttpt -130.22 37.1 3.92 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.926 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.4 m-85 -161.09 161.48 31.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.42 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 160.25 42.53 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.459 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 52.5 p90 -135.52 130.63 34.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.877 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 406' ' ' PHE . . . 106.83 150.9 17.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.326 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.982 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -54.61 -60.8 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.33 . . . . 0.0 111.028 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.9 pt-20 -47.4 -54.69 10.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.388 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.55 -54.57 30.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 0.0 111.15 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.518 HG21 HG22 ' A' ' 409' ' ' ILE . 22.1 m -56.21 -37.92 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.098 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.851 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.8 mp -69.93 -41.57 74.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 0.0 111.323 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 20.3 mtmt -58.88 -49.91 75.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.628 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.36 -26.16 63.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.289 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.883 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.32 -25.96 58.26 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 77.3 mm-40 -77.52 -28.08 51.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 78.5 mmm -79.99 -7.33 58.75 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.403 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.29 20.68 44.97 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.138 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.68 7.69 44.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.598 -0.301 . . . . 0.0 111.457 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 387' ' ' ALA . 31.0 m -107.27 107.2 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 121.038 0.446 . . . . 0.0 112.002 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.84 ' O ' HD13 ' A' ' 319' ' ' ILE . 11.2 tp10 -59.95 -50.76 72.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 318' ' ' GLU . 33.3 mm -135.74 125.75 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.653 0.263 . . . . 0.0 111.425 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.2 tp -92.52 128.65 38.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.968 0.413 . . . . 0.0 111.219 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -115.1 107.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.089 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.603 HG23 ' HG ' ' A' ' 320' ' ' LEU . 7.6 t -123.51 163.19 23.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.935 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.908 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -110.9 149.23 30.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.764 ' CD ' HG21 ' A' ' 391' ' ' ILE . 49.1 mm-40 -59.37 -50.06 75.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.338 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -85.2 53.22 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.381 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 409' ' ' ILE . 31.4 tp -78.88 123.29 27.1 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -89.61 23.84 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.128 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.972 HG21 HG21 ' A' ' 305' ' ' VAL . 15.8 mm -127.43 134.59 65.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.687 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.583 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 53.5 mtt -140.36 161.73 36.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 26.9 ttt180 -89.23 121.06 31.16 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.049 0.452 . . . . 0.0 111.303 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 4.6 m-85 -121.43 157.11 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.965 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.988 HG12 HD12 ' A' ' 343' ' ' ILE . 3.9 m -120.84 108.37 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.744 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.7 mm? -99.15 145.57 27.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.678 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 17.3 m170 -91.17 -177.04 4.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 9.1 t -113.55 160.74 18.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -60.1 -40.01 88.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.56 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -97.85 -5.05 57.68 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.734 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.9 p 75.17 -171.13 0.1 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 122.62 0.368 . . . . 0.0 110.769 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 60.54 24.71 14.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.659 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -160.11 122.3 3.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.958 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.86 138.34 49.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.644 ' C ' HD13 ' A' ' 343' ' ' ILE . 4.9 tmtm? -120.06 140.3 51.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.988 HD12 HG12 ' A' ' 332' ' ' VAL . 6.7 mm -119.02 116.27 50.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.159 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.607 HD23 HD11 ' A' ' 346' ' ' LEU . 49.9 tp -131.88 156.56 45.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.368 0.604 . . . . 0.0 111.957 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.557 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -94.04 118.86 32.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.601 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 344' ' ' LEU . 1.5 mm? -121.18 159.75 25.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 14.4 p -101.77 171.33 5.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.381 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.634 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.6 Cg_exo -47.38 -43.58 26.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 121.737 1.624 . . . . 0.0 111.89 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.88 -54.96 41.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.191 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 83.1 mt-30 -67.61 -46.29 72.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 0.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 94.5 mt-10 -61.21 -31.44 71.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.472 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -57.65 -34.82 69.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.286 0.565 . . . . 0.0 109.946 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.7 t0 -87.17 62.76 7.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.256 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.547 ' HG3' HD23 ' A' ' 368' ' ' LEU . 28.8 tttt -68.78 -45.11 72.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 94.1 p -59.97 -53.56 56.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.719 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 84.4 m-70 -86.32 -48.63 8.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.627 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.744 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.4 OUTLIER 53.41 11.54 0.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.863 0.364 . . . . 0.0 110.336 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.642 HG22 ' H ' ' A' ' 359' ' ' ASP . 0.7 OUTLIER -106.68 -169.85 1.62 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.202 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.642 ' H ' HG22 ' A' ' 358' ' ' THR . 87.3 m-20 -130.66 133.2 45.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -69.96 -2.44 12.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.301 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -101.33 -28.26 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.4 t -117.46 -36.46 3.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.154 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 77.37 39.94 25.0 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.711 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.42 ' C ' HG23 ' A' ' 358' ' ' THR . 23.7 mt-30 -52.66 -169.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -131.07 83.48 2.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.817 0.341 . . . . 0.0 110.83 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -130.02 137.36 50.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.412 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 43.6 mt-10 -140.97 102.63 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.78 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.74 HD11 ' O ' ' A' ' 370' ' ' GLU . 51.9 tp -72.33 132.1 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.174 0.511 . . . . 0.0 112.146 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.682 HD13 ' C ' ' A' ' 368' ' ' LEU . 3.4 mm -113.5 -44.12 4.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.56 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.74 ' O ' HD11 ' A' ' 368' ' ' LEU . 36.8 tt0 -139.99 163.04 33.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.125 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.515 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.7 p -147.42 119.74 8.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.252 0.549 . . . . 0.0 111.536 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 19.2 tpp -115.46 128.81 25.64 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.623 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.583 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 36.5 Cg_exo -59.77 120.0 7.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.011 1.807 . . . . 0.0 111.108 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.982 HD13 HG11 ' A' ' 305' ' ' VAL . 14.3 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.749 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 391' ' ' ILE . 63.1 tp -60.07 -51.96 67.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.4 mt-10 -60.02 -39.92 87.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.031 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -62.58 -40.02 95.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.63 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.562 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -71.07 -25.84 62.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.49 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.91 -9.99 49.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.761 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -108.75 -9.18 15.25 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.23 18.0 5.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.36 -18.72 65.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.665 0.269 . . . . 0.0 111.194 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -83.02 -42.23 17.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.925 0.393 . . . . 0.0 110.758 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -60.85 -40.1 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 312' ' ' LEU . 38.0 m-85 -82.75 -10.25 58.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.28 2.41 53.92 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.498 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.964 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.48 162.49 18.92 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 110.848 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.709 ' HB ' HG23 ' A' ' 319' ' ' ILE . 98.3 m -106.64 100.56 10.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 108.98 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.971 HD11 HD11 ' A' ' 391' ' ' ILE . 2.0 tm? -72.33 101.95 3.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 0.0 110.925 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.577 ' HG2' HG22 ' A' ' 388' ' ' THR . 19.7 mm-40 -111.36 118.17 35.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 1.021 HD12 HD11 ' A' ' 375' ' ' LEU . 20.5 mm -88.66 108.96 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.042 0.448 . . . . 0.0 111.889 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.908 HG23 ' CE2' ' A' ' 323' ' ' TYR . 15.6 m -101.75 -170.68 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.25 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -154.53 151.59 29.07 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -70.73 12.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 0.3 OUTLIER -64.7 -39.99 94.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.633 0.254 . . . . 0.0 111.644 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.9 m -92.05 170.6 9.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.386 . . . . 0.0 111.78 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -60.02 -48.83 80.1 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 44.3 mp0 -63.95 -39.99 95.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.372 0.606 . . . . 0.0 109.517 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.1 -20.42 60.38 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.15 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 71.6 m -84.23 -22.24 30.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.631 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.533 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 79.6 mt-30 -73.87 -43.36 58.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.675 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.8 m-85 -60.01 -41.98 93.31 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.924 0.392 . . . . 0.0 110.357 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.77 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 54.6 t -60.0 -39.98 81.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.655 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -72.55 -42.8 64.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.953 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.62 98.74 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.374 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CD1' ' HA2' ' A' ' 304' ' ' GLY . 59.9 t80 -148.79 -67.14 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 125.03 57.88 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 119.842 -1.171 . . . . 0.0 115.095 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 138.75 -35.41 2.0 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.399 -1.382 . . . . 0.0 115.277 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.758 HD11 HD11 ' A' ' 326' ' ' LEU . 0.6 OUTLIER -136.13 134.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 117.883 0.841 . . . . 0.0 112.904 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -154.53 148.14 18.23 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -129.48 147.15 17.74 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.694 -1.241 . . . . 0.0 114.031 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.926 HG23 ' CE2' ' A' ' 301' ' ' TYR . 46.6 mt -108.72 126.39 65.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 50.4 mt -86.42 151.69 23.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.588 0.709 . . . . 0.0 112.303 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.703 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.4 mtm180 -67.5 -38.69 84.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 417' ' ' VAL . 96.6 m-85 -160.57 170.02 21.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.304 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -57.22 124.18 17.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 110.447 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 415' ' ' TYR . 32.9 m -126.97 153.97 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.84 -0.37 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 58.91 170.07 0.06 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.684 0.278 . . . . 0.0 110.692 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.449 ' HA ' ' H ' ' A' ' 427' ' ' GLY . 30.2 mt-30 -118.79 142.46 47.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.938 0.399 . . . . 0.0 111.139 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.682 ' HA3' ' HG2' ' A' ' 425' ' ' GLN . . . 160.0 -139.13 5.94 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.611 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' HB3' ' A' ' 425' ' ' GLN . 9.8 mmt -76.25 -168.62 0.98 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 110.775 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 424' ' ' TYR . 15.2 pt-20 -60.02 -49.21 78.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.522 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.444 ' N ' ' HG3' ' A' ' 423' ' ' GLU . 64.8 t80 -77.9 -35.0 51.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.017 0.437 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.682 ' HG2' ' HA3' ' A' ' 421' ' ' GLY . 11.9 tp60 -60.0 -39.94 87.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.589 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 150.19 -98.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.968 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 421' ' ' GLY . . . -75.15 -144.96 1.16 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.972 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 421' ' ' GLY . 95.3 m-20 -141.27 22.9 2.2 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 120.755 0.312 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.522 ' O ' ' HD1' ' A' ' 432' ' ' PHE . 95.9 m-20 -107.9 24.46 12.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.62 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.625 ' HB2' ' HA2' ' A' ' 421' ' ' GLY . 6.9 tm-20 -59.99 -40.05 87.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.914 0.388 . . . . 0.0 110.345 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.424 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 26.7 p90 -96.92 67.68 2.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.522 ' HD1' ' O ' ' A' ' 429' ' ' ASP . 37.1 p90 -90.03 110.47 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.69 -2.61 30.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.719 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 10.7 mt -54.65 -18.65 4.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.857 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.96 -39.97 87.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 0.0 110.587 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.68 -23.83 60.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.704 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -59.9 -37.56 79.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.108 0.48 . . . . 0.0 110.251 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.03 -45.36 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.889 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.011 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 75.5 m80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.884 179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.737 0.303 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -60.07 -29.94 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.3 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -51.54 -40.02 58.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.01 -50.04 75.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.667 0.27 . . . . 0.0 111.241 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt -82.91 -23.51 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.849 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.677 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -59.94 -39.54 85.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.992 0.425 . . . . 0.0 110.555 -179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.67 -22.69 29.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.324 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -50.01 8.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.27 -58.33 3.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.501 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.72 -55.66 31.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.015 0.436 . . . . 0.0 111.942 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.7 mt -59.48 -49.22 84.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.616 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.436 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.89 -37.03 75.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.084 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.8 ttt85 -59.93 -39.09 84.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.309 0.576 . . . . 0.0 110.049 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.607 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.9 t80 -57.56 -45.18 85.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.63 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -79.47 -39.94 31.0 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.07 -47.48 85.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.602 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.82 -43.29 99.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.039 0.447 . . . . 0.0 109.872 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -60.04 -24.54 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.664 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.39 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.16 0.505 . . . . 0.0 109.911 178.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.6 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.5 mt-30 -107.27 1.55 23.97 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.465 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 57.95 31.13 20.18 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.341 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.4 p -67.64 -11.97 59.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.845 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.6 78.09 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.535 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.12 36.3 4.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.33 160.02 34.59 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.087 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.91 165.07 33.7 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.821 0.344 . . . . 0.0 111.231 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.47 164.82 28.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.884 0.373 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.18 167.82 34.28 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.234 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.88 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.214 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.25 -52.49 15.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.843 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.8 m-20 -65.73 -57.42 8.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.15 -36.42 68.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.951 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.67 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.601 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.43 -50.07 72.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.604 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.8 -28.28 68.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.671 0.272 . . . . 0.0 111.037 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.51 -28.13 60.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.84 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -77.51 -26.99 51.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.21 -7.33 58.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.776 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.44 42.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.467 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.12 -2.24 58.45 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.287 0.235 . . . . 0.0 111.023 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.0 m -100.98 107.1 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.86 -50.01 75.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.33 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -135.5 125.12 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.77 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.8 128.25 36.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.275 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.76 105.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.742 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.635 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.64 162.22 26.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.371 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.857 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.2 m-85 -110.67 149.93 29.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.09 0.471 . . . . 0.0 111.674 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.92 -27.96 67.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.039 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.3 35.05 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.32 19.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.53 23.35 5.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.236 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.978 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -120.93 135.48 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.41 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.5 161.45 37.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.44 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.618 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.14 120.08 31.01 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.169 0.509 . . . . 0.0 111.468 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.14 155.22 29.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.734 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.049 HG12 HD12 ' A' ' 343' ' ' ILE . 9.6 m -117.77 110.96 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.766 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.4 mp -97.52 142.33 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.927 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.446 ' CE1' HG12 ' A' ' 369' ' ' ILE . 2.5 m170 -82.32 176.43 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 111.049 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 340' ' ' GLU . 21.6 p -103.36 162.4 13.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.584 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -47.58 -28.94 2.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.037 0.446 . . . . 0.0 110.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.58 -119.62 4.54 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.743 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.56 22.29 0.28 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.827 0.313 . . . . 0.0 111.756 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.9 43.34 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.768 0.318 . . . . 0.0 111.451 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.405 ' HB3' ' SG ' ' A' ' 335' ' ' CYS . 14.2 tt0 -169.15 130.0 1.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.929 0.395 . . . . 0.0 110.274 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -115.4 140.42 49.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.168 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 343' ' ' ILE . 8.4 ttpt -121.54 145.48 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.049 HD12 HG12 ' A' ' 332' ' ' VAL . 6.6 mm -123.17 119.66 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.058 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 53.9 tp -128.15 161.76 28.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.162 0.506 . . . . 0.0 111.744 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.5 p90 -100.96 120.05 39.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.651 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 1.077 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.43 156.33 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.8 168.11 9.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.368 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.85 -49.63 8.01 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.481 2.121 . . . . 0.0 112.313 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.95 -55.56 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.392 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 1.077 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.94 -53.17 60.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.5 mt-10 -49.67 -33.14 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.827 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.1 mmmm -59.98 -28.3 67.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.179 0.514 . . . . 0.0 110.486 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.428 ' HB2' ' NE2' ' A' ' 356' ' ' HIS . 0.0 OUTLIER -82.07 16.56 1.89 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.654 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.719 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 8.5 ptmm? -55.58 -23.29 26.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 85.6 p -59.96 -44.94 94.11 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.67 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 358' ' ' THR . 6.3 p80 -107.79 -41.97 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.228 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.766 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.42 5.1 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.866 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.806 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.6 m -86.89 178.09 7.08 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.99 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.656 ' HB2' HG22 ' A' ' 362' ' ' THR . 93.2 m-20 -132.97 135.64 45.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -72.44 -0.16 11.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.073 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -104.35 -15.37 15.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.643 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.656 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.5 t -133.47 -37.76 0.94 Allowed 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.767 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 84.8 41.55 7.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.77 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.806 ' C ' HG23 ' A' ' 358' ' ' THR . 13.0 pt20 -86.53 88.15 7.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.151 0.501 . . . . 0.0 110.624 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -64.27 129.91 41.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.664 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 60.7 m80 -143.85 167.55 22.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.205 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -145.33 113.93 6.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.323 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.664 HD11 ' O ' ' A' ' 370' ' ' GLU . 58.5 tp -70.29 133.17 46.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 111.021 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.7 mp -106.53 -40.12 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.664 ' O ' HD11 ' A' ' 368' ' ' LEU . 38.7 tt0 -152.12 166.16 32.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.568 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -145.35 117.04 8.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.845 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.91 124.13 30.86 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.656 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.41 120.95 9.21 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.0 1.8 . . . . 0.0 110.982 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.978 HD12 HG22 ' A' ' 328' ' ' ILE . 14.3 mt -60.23 -42.3 94.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.595 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.04 -51.39 69.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.665 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.91 -40.17 87.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.685 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.01 -39.96 94.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.837 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.625 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.2 -29.4 60.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.125 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.22 -19.39 47.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.598 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.11 -9.33 14.37 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.67 19.84 5.62 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -70.0 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.61 -38.35 21.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -59.93 -38.33 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.301 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.555 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -84.01 -10.43 57.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.62 1.28 52.7 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.654 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.76 165.12 17.16 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.428 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.72 100.27 9.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.3 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.92 102.2 2.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.854 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.649 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.8 mm-40 -107.86 128.01 54.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.873 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.5 mm -94.85 102.11 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.066 0.46 . . . . 0.0 112.182 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.857 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.47 -169.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.769 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.6 p -154.86 151.54 28.72 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.055 0.455 . . . . 0.0 111.506 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.1 p-10 -71.04 1.43 5.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.303 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -59.94 -40.1 87.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 111.035 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.3 p -81.83 168.13 18.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.7 mt-30 -60.0 -54.81 41.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.84 -39.43 94.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.66 -59.74 9.3 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.6 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.58 12.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.1 mt-30 -69.97 -40.05 75.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.034 0.445 . . . . 0.0 110.909 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.39 -44.9 93.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.764 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.4 t -59.99 -45.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.708 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.74 -38.19 56.96 Favored Glycine 0 CA--C 1.495 -1.17 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.707 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.7 -94.56 0.48 Allowed 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.09 0.02 OUTLIER Glycine 0 CA--C 1.522 0.523 0 C-N-CA 119.642 -1.265 . . . . 0.0 114.853 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.51 -20.07 7.92 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 119.545 -1.312 . . . . 0.0 115.522 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.636 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.59 130.38 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 118.574 1.187 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.69 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.54 151.11 19.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.716 -1.231 . . . . 0.0 114.031 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.4 127.47 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.8 mt -88.22 153.32 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.568 0.699 . . . . 0.0 112.286 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.4 mtt-85 -70.04 -36.81 75.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.565 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.431 ' O ' HG13 ' A' ' 417' ' ' VAL . 8.7 m-85 -160.91 170.54 20.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.458 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -58.01 127.99 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.963 0.411 . . . . 0.0 110.721 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.97 159.87 41.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.908 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -87.16 132.25 33.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.0 136.91 50.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -59.96 130.65 47.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -66.18 147.18 49.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.7 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -149.9 170.11 19.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.695 0.283 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.01 -40.98 91.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.96 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.84 -39.97 91.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.807 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.65 140.01 58.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.97 0.48 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.524 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -141.55 130.16 4.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.391 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.37 -39.97 89.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.701 0.286 . . . . 0.0 111.079 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -115.47 24.16 11.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.137 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.09 -39.92 87.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.356 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.43 91.18 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.191 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -115.4 -137.62 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.764 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.87 39.95 16.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.555 0.693 . . . . 0.0 109.258 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.96 -0.28 57.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.391 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.07 -39.94 87.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.791 0.329 . . . . 0.0 110.518 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -68.07 -35.19 77.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.418 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -58.96 -34.06 71.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.082 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.13 -42.43 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.01 -40.01 87.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.889 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.651 0.262 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.1 p -76.62 -29.98 18.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.153 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -48.19 -47.88 35.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.768 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.92 75.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 46.3 pt -80.08 -20.75 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.92 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.707 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 2.0 tm0? -58.85 -39.97 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.831 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.535 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 50.4 mt-10 -78.96 -30.0 44.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.046 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -53.46 5.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -72.63 -58.38 3.4 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.885 ' HG ' HD13 ' A' ' 321' ' ' ILE . 46.7 tp -55.13 -60.86 2.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.971 0.415 . . . . 0.0 111.55 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.824 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.7 mt -59.94 -50.05 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.414 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.26 -38.92 57.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.25 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 19.1 ttt-85 -60.05 -39.95 87.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.281 0.563 . . . . 0.0 110.272 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.602 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 10.2 t80 -57.12 -48.55 78.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.749 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -80.01 -38.49 31.96 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -60.63 -47.89 84.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.682 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.7 mt-10 -62.91 -44.49 95.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 301' ' ' TYR . 96.5 mt -59.62 -24.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.463 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.47 -13.8 59.58 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.648 ' HB2' HG23 ' A' ' 298' ' ' THR . 58.4 mt-30 -103.37 -0.16 30.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.54 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.59 30.99 20.59 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.676 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.5 p -69.43 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.864 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.24 49.2 74.26 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.93 -1.129 . . . . 0.0 113.342 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.549 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 41.2 mttt -128.61 36.3 4.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 88.0 m-85 -159.75 160.74 34.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.309 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 19.3 m -140.5 160.03 40.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.14 0.495 . . . . 0.0 111.391 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.411 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -137.79 127.13 24.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.914 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 107.76 152.83 17.58 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.022 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -58.94 -55.48 23.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.77 0.319 . . . . 0.0 111.174 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.5 pt-20 -49.35 -56.46 9.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.42 -52.37 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.713 0.292 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.51 HG21 HG22 ' A' ' 409' ' ' ILE . 18.5 m -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.09 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.988 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.7 mp -67.25 -43.79 81.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.701 0.286 . . . . 0.0 111.28 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 314' ' ' MET . 20.7 mtmt -60.01 -47.62 85.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.4 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -27.81 65.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.431 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.77 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.7 -26.59 59.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 78.3 mm-40 -77.92 -28.9 49.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 94.3 mmm -80.84 -7.3 59.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.847 -1.524 . . . . 0.0 111.726 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.52 14.28 27.26 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.701 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.8 -9.76 59.19 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.617 0.246 . . . . 0.0 110.9 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.27 105.8 17.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.665 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.2 tt0 -60.01 -50.01 75.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.563 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.842 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.6 mm -135.58 125.99 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.622 0.249 . . . . 0.0 111.224 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.746 ' HG ' HG23 ' A' ' 322' ' ' VAL . 56.4 tp -90.96 126.14 35.99 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.885 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.5 OUTLIER -113.13 105.95 19.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.814 179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.746 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.3 t -124.29 151.64 29.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.4 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.512 ' CE1' HG23 ' A' ' 392' ' ' VAL . 92.6 m-85 -95.57 145.01 25.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.966 0.412 . . . . 0.0 111.08 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 14.5 pt-20 -63.53 -34.52 77.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -92.24 45.19 1.19 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.575 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 23.8 tp -75.85 125.81 29.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.678 ' O ' ' HA ' ' A' ' 347' ' ' THR . 83.0 m-20 -92.06 24.43 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.032 HG22 HD12 ' A' ' 374' ' ' LEU . 31.7 mm -125.87 136.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.939 0.399 . . . . 0.0 111.595 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.7 mtt -139.84 161.8 36.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.323 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.664 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.1 ttt85 -89.22 115.8 26.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.024 0.44 . . . . 0.0 111.671 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 8.3 m-85 -116.53 156.91 26.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.145 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.065 HG12 HD12 ' A' ' 343' ' ' ILE . 4.0 m -121.27 110.56 28.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.923 0.392 . . . . 0.0 110.942 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.7 HD22 ' N ' ' A' ' 333' ' ' LEU . 1.2 mm? -106.07 149.81 26.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.8 ' CD2' HD11 ' A' ' 369' ' ' ILE . 41.0 m170 -80.63 170.69 16.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.781 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -114.84 161.92 17.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.606 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -46.83 -29.66 2.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.043 0.449 . . . . 0.0 110.32 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 339' ' ' GLU . . . -113.5 96.04 0.78 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.14 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 337' ' ' GLY . 0.8 OUTLIER -20.34 -44.95 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.537 0.735 . . . . 0.0 112.979 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 337' ' ' GLY . 44.8 mt-10 -73.44 42.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 110.964 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 60.3 tt0 -166.17 134.06 2.85 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.618 ' O ' HD13 ' A' ' 343' ' ' ILE . 33.5 tttp -122.3 144.61 48.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.065 HD12 HG12 ' A' ' 332' ' ' VAL . 8.4 mm -120.0 122.16 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.289 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 346' ' ' LEU . 49.4 tp -132.17 160.67 35.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.373 0.606 . . . . 0.0 112.424 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.732 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.8 p90 -100.02 123.19 43.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.189 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 1.048 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -124.84 157.88 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 69.8 p -101.16 170.28 6.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.672 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.6 Cg_exo -44.7 -48.38 10.53 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.837 1.691 . . . . 0.0 112.012 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -49.92 75.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.51 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 1.048 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.5 tp60 -69.59 -47.87 62.06 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.072 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 92.6 mt-10 -59.74 -35.72 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.586 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -58.03 -28.33 64.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.125 0.488 . . . . 0.0 110.305 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -84.36 21.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.0 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 357' ' ' PHE . 2.9 ptmm? -55.76 -11.35 0.94 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 94.2 p -61.12 -56.21 23.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.763 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.757 ' HB3' HG22 ' A' ' 358' ' ' THR . 75.8 m80 -108.03 -50.21 3.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.744 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 63.27 0.86 0.84 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.877 -178.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.757 HG22 ' HB3' ' A' ' 356' ' ' HIS . 15.3 t -88.18 -164.36 1.1 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.515 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.46 151.42 22.56 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.013 0.435 . . . . 0.0 111.076 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -74.03 0.37 13.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.565 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -84.86 -50.16 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.212 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 1.2 t -106.55 -36.19 6.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.058 0.456 . . . . 0.0 110.313 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.699 ' C ' HG21 ' A' ' 358' ' ' THR . . . 73.21 22.79 78.59 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.496 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.638 ' N ' HG21 ' A' ' 358' ' ' THR . 14.7 pt20 -166.81 94.5 0.49 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.996 0.427 . . . . 0.0 112.097 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.467 ' CG ' ' CD2' ' A' ' 366' ' ' HIS . 4.2 pt-20 -159.08 -42.25 0.06 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 111.17 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.467 ' CD2' ' CG ' ' A' ' 365' ' ' GLU . 97.4 m-70 -110.0 160.91 16.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -151.0 119.71 6.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 354' ' ' LYS . 53.2 tp -70.01 137.22 51.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.8 HD11 ' CD2' ' A' ' 334' ' ' HIS . 2.1 mp -106.61 -41.03 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.801 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 371' ' ' SER . 42.2 tt0 -155.63 167.7 29.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.455 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.59 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p -147.93 117.0 6.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.448 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 1.4 tpt -117.04 131.46 23.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.8 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.588 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.1 Cg_exo -60.16 120.56 8.4 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.87 1.713 . . . . 0.0 110.782 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 328' ' ' ILE . 12.8 mt -62.21 -40.45 96.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.773 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 391' ' ' ILE . 60.8 tp -60.06 -51.68 68.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.7 mt-10 -60.23 -42.42 95.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.964 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.403 ' CD1' ' ND2' ' A' ' 381' ' ' ASN . 82.5 t90 -62.26 -39.93 94.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.421 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.65 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -70.0 -25.89 63.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.26 -9.97 46.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.3 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.67 -12.75 15.8 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.5 20.34 5.67 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -68.76 -17.52 64.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.577 0.227 . . . . 0.0 111.446 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -77.14 -47.13 21.2 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 111.125 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -61.43 -44.43 97.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.322 0.582 . . . . 0.0 110.622 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 312' ' ' LEU . 27.1 m-85 -69.95 -17.72 63.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.885 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.21 1.96 65.45 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.324 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.76 164.76 16.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.162 0.506 . . . . 0.0 110.796 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.842 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.6 m -107.14 100.27 9.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.049 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.55 HD23 HD23 ' A' ' 320' ' ' LEU . 1.7 tm? -71.74 102.34 2.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.97 0.414 . . . . 0.0 110.858 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.707 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.5 mm-40 -110.31 140.84 44.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.111 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 375' ' ' LEU . 36.3 mm -106.48 103.66 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.644 HG12 ' OE1' ' A' ' 282' ' ' GLN . 7.8 m -101.07 -175.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 323' ' ' TYR . 3.0 p -157.95 152.29 24.58 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.686 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.3 t0 -76.85 76.15 3.46 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -117.57 -29.98 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.313 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 35.1 m -113.55 -174.93 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.771 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 401' ' ' GLN . 31.0 mt-30 -59.98 -47.75 84.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.01 0.434 . . . . 0.0 110.341 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 22.1 mp0 -61.62 -41.93 98.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -64.47 -22.45 67.67 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.546 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 58.4 m -83.08 -21.56 33.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.791 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 397' ' ' GLN . 9.5 mm100 -75.79 -46.67 29.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.013 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.824 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.2 OUTLIER -59.96 -49.97 75.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.085 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 394' ' ' ASP . 96.9 t -59.98 -39.93 81.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.139 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -68.58 -42.9 77.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.937 0.399 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.1 -22.92 74.54 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.256 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.447 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 28.8 t80 -176.45 -69.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.657 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 91.68 101.1 1.32 Allowed Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.564 -0.827 . . . . 0.0 115.101 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.426 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 130.42 -34.22 2.73 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.178 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -150.8 127.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 111.939 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -150.74 138.12 6.47 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.77 142.24 14.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.601 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 23.5 mt -104.66 126.71 59.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 59.2 mt -90.78 157.14 17.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.643 0.735 . . . . 0.0 112.466 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -70.04 -39.99 75.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.358 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 417' ' ' VAL . 53.9 p90 -167.07 178.7 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.508 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.6 mtm180 -56.47 124.29 17.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.899 0.38 . . . . 0.0 110.7 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.04 159.98 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.401 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -65.21 130.93 45.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.773 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -100.0 15.75 26.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.42 ' HA ' ' NE2' ' A' ' 425' ' ' GLN . 63.8 mt-30 -67.97 140.09 56.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 92.73 83.8 1.52 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.987 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.6 ttt -148.49 163.56 36.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.764 0.316 . . . . 0.0 110.76 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -60.0 -39.96 87.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.07 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.26 17.28 23.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.541 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 4.6 tp60 -59.99 -47.94 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.053 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 51.16 57.18 11.83 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.847 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -125.26 141.57 13.14 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.53 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.86 -40.04 87.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 93.7 m-20 -105.84 36.83 2.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.541 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 49.8 tt0 -59.91 -40.07 87.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.018 0.437 . . . . 0.0 110.12 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -117.67 100.11 7.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.325 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 429' ' ' ASP . 1.3 p90 -117.34 130.94 56.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -86.1 6.84 27.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.81 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.97 -4.25 23.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.905 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.05 -39.96 87.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.698 0.285 . . . . 0.0 111.068 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -66.95 -33.24 75.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.919 0.39 . . . . 0.0 110.473 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.49 -34.26 72.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.268 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . 0.565 ' C ' HD13 ' A' ' 438' ' ' LEU . 3.0 tm? -60.02 -43.7 95.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -70.05 140.08 52.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.881 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.81 0.338 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.5 p -66.11 -29.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.313 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -51.58 -40.56 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.98 -50.06 75.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.5 pt -82.75 -20.94 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.653 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.68 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.59 -39.99 85.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.606 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.5 mt-10 -77.08 -29.97 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.269 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.65 -58.16 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.76 -54.66 44.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.751 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.3 mt -60.03 -48.43 87.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.555 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.36 -37.88 67.19 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 44.0 ttt180 -60.0 -39.22 85.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.168 0.508 . . . . 0.0 110.041 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.9 t80 -55.65 -45.73 77.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.755 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.4 -39.15 21.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.0 t0 -59.99 -43.2 95.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.402 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.18 -42.29 84.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.136 0.493 . . . . 0.0 109.743 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.24 -23.81 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.6 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.04 -15.45 56.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.175 0.512 . . . . 0.0 110.006 178.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.84 2.08 29.69 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.622 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.25 29.72 18.43 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.966 0.413 . . . . 0.0 110.571 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.9 p -66.74 -12.98 60.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.915 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.89 49.12 73.39 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.443 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.637 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.38 36.84 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.947 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 160.05 34.57 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.323 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -141.0 161.19 38.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.06 0.457 . . . . 0.0 111.445 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.15 144.84 47.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.31 156.89 28.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.871 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -59.94 -55.89 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.822 0.344 . . . . 0.0 111.195 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.4 pt-20 -47.27 -57.23 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 96.0 m-20 -61.13 -54.9 38.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.676 0.274 . . . . 0.0 111.386 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.1 m -56.51 -40.09 74.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.86 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.88 -45.26 78.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.2 mtmt -56.63 -50.03 73.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.993 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.29 61.0 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.682 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.827 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.5 74.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.914 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.52 -24.41 61.95 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.78 -7.96 59.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.098 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.1 10.96 36.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.123 -1.036 . . . . 0.0 111.544 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 1.012 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -80.02 -6.16 57.09 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.399 0.28 . . . . 0.0 110.766 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.856 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.7 m -95.83 105.5 17.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.59 -49.98 75.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.306 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 28.0 mm -136.7 126.56 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.579 0.228 . . . . 0.0 111.375 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 45.0 tp -89.73 126.49 35.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.94 0.4 . . . . 0.0 111.5 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.776 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.57 103.61 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.313 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.2 t -122.29 152.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.4 m-85 -98.48 142.94 29.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.37 -24.0 67.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.833 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.32 33.35 1.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.762 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.6 tp -71.17 123.81 23.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.731 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -96.55 28.76 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.715 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.61 133.19 69.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.042 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.572 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.1 mtt -140.6 162.47 35.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.193 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.22 29.76 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.092 0.472 . . . . 0.0 111.222 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.76 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.526 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -131.8 112.23 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 111.411 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.787 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.9 mm? -101.56 129.61 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.571 ' HB2' HD11 ' A' ' 369' ' ' ILE . 57.1 m170 -137.11 150.74 48.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -111.55 152.75 27.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.693 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.92 129.94 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.596 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.19 -1.16 35.18 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.768 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.43 23.6 2.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.658 0.266 . . . . 0.0 111.656 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -102.22 10.25 39.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.174 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -159.96 119.97 2.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.78 0.324 . . . . 0.0 111.178 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.402 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 17.5 mt-10 -136.63 130.0 31.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.154 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.771 ' C ' HD13 ' A' ' 343' ' ' ILE . 6.2 tttp -136.03 121.22 19.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.771 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.4 mm -113.14 112.39 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.672 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp -144.03 156.52 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.446 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.9 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -85.02 137.15 33.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.104 178.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.71 164.05 22.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.596 0.713 . . . . 0.0 112.525 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.5 172.08 4.78 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.31 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 72.9 Cg_exo -48.95 -47.47 21.38 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 121.789 1.659 . . . . 0.0 111.815 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.15 -58.52 7.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -59.98 -48.99 79.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 -59.96 -35.71 75.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -58.02 -34.05 69.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.096 0.474 . . . . 0.0 109.756 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.66 40.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.856 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.605 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 4.1 pttt -70.46 -19.04 62.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.551 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.5 t -66.8 -40.03 87.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.107 0.48 . . . . 0.0 110.111 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 358' ' ' THR . 90.4 m-70 -98.08 -56.44 2.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.089 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.787 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.06 4.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.086 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.3 m -91.67 174.41 7.37 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.749 ' HB2' HG22 ' A' ' 362' ' ' THR . 96.4 m-20 -130.06 138.59 50.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -72.96 -1.98 19.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.368 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -104.54 -13.73 15.91 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.7 t -131.88 -36.33 1.2 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.576 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.28 76.45 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.635 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.808 ' C ' HG23 ' A' ' 358' ' ' THR . 37.5 mt-30 -50.04 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -82.33 133.03 35.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.362 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 73.5 m80 -147.11 164.43 33.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.141 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.27 108.1 7.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.912 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 370' ' ' GLU . 45.6 tp -63.52 139.96 58.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.157 0.503 . . . . 0.0 111.482 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 334' ' ' HIS . 2.2 mp -111.7 -45.56 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.511 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.568 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.7 tt0 -143.12 156.26 44.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.183 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -143.87 116.19 8.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.469 179.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.61 121.97 32.37 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.761 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.63 120.91 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.77 1.647 . . . . 0.0 110.712 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.007 HD12 HG22 ' A' ' 328' ' ' ILE . 20.7 mt -60.03 -44.09 94.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.265 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 69.1 tp -60.01 -50.87 72.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.99 85.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.638 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.28 -43.77 95.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.641 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.827 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.8 m-85 -73.59 -30.7 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.2 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.38 -25.09 60.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.495 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.71 -6.62 14.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.27 20.18 5.79 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.586 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.95 -14.48 63.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.615 0.245 . . . . 0.0 111.374 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.36 -40.41 30.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 120.954 0.407 . . . . 0.0 110.923 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.1 -36.38 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.52 -4.21 59.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.401 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.74 2.96 31.99 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.532 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.856 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.64 166.28 13.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 111.103 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.802 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.0 m -109.15 100.54 9.68 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.936 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.757 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.32 102.39 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.68 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.8 130.02 55.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.757 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.5 mm -95.86 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.173 0.511 . . . . 0.0 112.094 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.616 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.51 -171.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.155 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.52 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.55 155.33 26.16 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.274 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.48 11.31 0.63 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.15 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.04 94.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 0.0 111.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -92.06 170.83 9.52 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.838 0.352 . . . . 0.0 111.406 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.494 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.9 mt-30 -60.02 -54.38 46.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.56 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -60.02 -39.98 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 0.0 109.502 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.09 -57.64 15.85 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.805 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.87 -19.53 51.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.36 -40.04 77.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.751 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.99 -46.54 89.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.7 t -59.92 -34.06 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.014 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.25 -54.08 20.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 110.309 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.73 -20.62 70.41 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.938 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.4 t80 174.97 -75.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.33 167.95 28.99 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -51.47 3.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.835 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.55 131.79 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 117.294 0.547 . . . . 0.0 112.227 -178.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.82 141.05 8.33 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.68 145.87 15.95 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 119.877 -1.154 . . . . 0.0 113.866 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.947 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.11 128.55 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.025 HD13 HG13 ' A' ' 417' ' ' VAL . 38.8 mt -90.68 153.17 20.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.766 0.793 . . . . 0.0 112.815 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.01 -37.92 75.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.542 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.691 ' O ' HG12 ' A' ' 417' ' ' VAL . 82.3 m-85 -158.25 -177.91 6.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.0 99.97 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.869 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.025 HG13 HD13 ' A' ' 413' ' ' LEU . 2.3 p -143.42 137.73 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.161 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -146.32 100.25 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.632 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.07 -49.4 77.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.252 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.13 126.63 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.309 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -154.46 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.8 mtp 57.16 23.14 8.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.675 0.274 . . . . 0.0 111.079 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 424' ' ' TYR . 12.3 pt-20 -151.61 -53.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.397 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 423' ' ' GLU . 98.0 m-85 -160.88 88.61 0.77 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.69 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 32.0 mm-40 -69.99 -40.04 75.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.857 0.361 . . . . 0.0 110.88 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 156.11 -24.16 0.53 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.738 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -154.29 33.21 0.71 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.73 34.36 24.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 111.057 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -118.42 37.53 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.69 ' HA ' ' HG3' ' A' ' 425' ' ' GLN . 1.7 tm-20 -60.02 -41.04 91.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.998 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.43 99.1 5.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.397 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -116.68 117.07 28.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.178 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.84 -0.65 24.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.8 mt -50.94 -19.4 1.0 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.939 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -59.7 -40.01 86.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -74.9 -24.29 58.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.541 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.96 -38.42 82.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.452 . . . . 0.0 110.007 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.01 -46.44 89.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.887 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.04 -39.91 87.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.133 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.913 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.729 0.3 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.7 p -66.87 -29.43 46.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -56.53 -44.83 81.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.57 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.17 -47.54 82.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.766 0.317 . . . . 0.0 111.205 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 278' ' ' VAL . 46.8 pt -75.64 -29.91 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.445 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -55.64 -41.8 74.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.614 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 55.1 mt-10 -69.96 -33.43 72.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.235 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -57.2 3.26 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -70.0 -58.08 4.25 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.893 ' HG ' HD13 ' A' ' 321' ' ' ILE . 31.4 tp -57.51 -57.44 12.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.229 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.692 HD11 ' HB ' ' A' ' 392' ' ' VAL . 13.6 mt -61.48 -49.79 82.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.711 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.535 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.73 -34.36 81.85 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.415 -0.897 . . . . 0.0 112.651 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 4.8 ttt85 -59.95 -37.78 80.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.673 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 9.4 t80 -60.13 -41.29 92.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.754 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -84.66 -39.44 18.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.49 -50.05 75.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.667 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.1 OUTLIER -64.31 -40.95 96.97 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.524 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 301' ' ' TYR . 82.0 mt -60.04 -23.26 26.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -15.39 46.45 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.331 0.586 . . . . 0.0 109.685 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.866 ' HB2' HG23 ' A' ' 298' ' ' THR . 68.3 mt-30 -100.7 1.92 40.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.649 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 56.09 29.85 15.28 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.106 0.479 . . . . 0.0 110.035 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.866 HG23 ' HB2' ' A' ' 296' ' ' GLN . 34.9 p -69.97 -10.34 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.773 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.79 50.69 59.68 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.873 -1.156 . . . . 0.0 113.091 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 18.6 mtpt -127.96 38.76 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.874 ' CE1' HG23 ' A' ' 412' ' ' ILE . 81.7 m-85 -161.99 163.37 28.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.417 ' O ' ' HE2' ' A' ' 290' ' ' TYR . 1.8 p -146.43 162.39 38.35 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.9 0.381 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.424 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.1 p90 -138.68 133.06 31.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.323 . . . . 0.0 110.33 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 406' ' ' PHE . . . 103.58 147.76 18.53 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.955 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.981 HG12 HD13 ' A' ' 309' ' ' LEU . 0.2 OUTLIER -52.82 -60.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.7 pt-20 -44.54 -58.09 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.345 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.93 -54.49 41.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.66 0.266 . . . . 0.0 111.235 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.597 HG21 HG22 ' A' ' 409' ' ' ILE . 10.6 m -55.73 -40.01 71.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.027 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.981 HD13 HG12 ' A' ' 305' ' ' VAL . 2.5 mp -70.01 -41.21 74.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.697 0.284 . . . . 0.0 111.211 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 9.9 mtmm -58.55 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.156 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.95 -27.96 64.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.69 -28.6 63.83 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.715 0.293 . . . . 0.0 110.744 179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.2 -26.48 52.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 93.2 mmm -82.5 -9.1 59.56 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.648 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.42 42.06 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.324 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.92 59.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.386 0.274 . . . . 0.0 110.975 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.6 m -93.54 104.83 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.914 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.1 tt0 -59.91 -49.88 75.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.434 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.914 HD13 ' O ' ' A' ' 318' ' ' GLU . 23.4 mm -133.96 126.15 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.65 0.262 . . . . 0.0 111.409 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.693 ' HG ' HG23 ' A' ' 322' ' ' VAL . 43.6 tp -91.55 127.33 36.96 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.942 0.401 . . . . 0.0 110.789 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.893 HD13 ' HG ' ' A' ' 286' ' ' LEU . 2.3 mt -112.71 106.79 21.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.172 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.693 HG23 ' HG ' ' A' ' 320' ' ' LEU . 29.8 t -122.61 155.85 27.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.488 -178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.591 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 96.9 m-85 -102.65 143.92 31.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.518 ' HA ' HD21 ' A' ' 375' ' ' LEU . 12.7 pt-20 -61.78 -35.68 78.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.084 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.68 48.31 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.053 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -78.19 125.43 29.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.804 0.335 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -92.94 26.39 2.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.57 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.003 HG22 HD12 ' A' ' 374' ' ' LEU . 23.2 mm -128.36 136.31 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.561 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.611 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 59.8 mtt -139.97 161.93 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.811 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.659 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 46.8 ttm-85 -89.17 115.48 26.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.803 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.618 ' HB3' HD13 ' A' ' 368' ' ' LEU . 3.2 m-85 -115.48 154.74 28.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.023 HG12 HD12 ' A' ' 343' ' ' ILE . 9.4 m -118.85 111.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.253 0.549 . . . . 0.0 111.478 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.7 OUTLIER -99.08 155.42 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.757 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.408 ' CD2' ' OE1' ' A' ' 341' ' ' GLU . 1.8 m170 -98.12 179.61 4.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.893 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 1.8 m -116.95 161.36 19.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -45.11 -30.3 1.09 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 338' ' ' THR . . . -95.03 -121.4 3.61 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.751 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.6 OUTLIER -163.46 13.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.25 30.26 5.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.075 0.464 . . . . 0.0 110.434 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 20.6 tp10 -155.01 121.05 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.259 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.408 ' OE1' ' CD2' ' A' ' 334' ' ' HIS . 2.6 mt-10 -116.05 141.16 48.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.6 ' O ' HD13 ' A' ' 343' ' ' ILE . 6.0 tttp -115.36 143.15 45.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.023 HD12 HG12 ' A' ' 332' ' ' VAL . 11.1 mm -119.69 119.99 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.043 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.445 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 33.1 tp -132.67 158.96 40.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 112.064 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.506 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.2 OUTLIER -97.67 120.03 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.4 mm? -124.46 167.48 14.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.554 0.692 . . . . 0.0 112.596 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 11.3 p -101.59 169.25 7.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.778 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 75.2 Cg_exo -49.46 -42.56 41.3 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.843 1.696 . . . . 0.0 111.745 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.26 -51.57 69.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.101 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 76.8 mt-30 -70.43 -46.61 63.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.996 0.426 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 97.2 mt-10 -63.1 -28.42 70.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.852 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -56.25 -30.2 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.272 0.558 . . . . 0.0 109.754 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.0 t0 -90.12 63.07 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.998 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 25.8 mtmt -70.08 -41.34 74.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -63.79 -57.93 8.39 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.405 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.509 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 36.3 m170 -80.96 -46.02 15.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.809 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.966 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.7 OUTLIER 49.92 15.2 0.16 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 110.175 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.8 m -107.17 -178.56 3.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.729 ' HB2' HG23 ' A' ' 362' ' ' THR . 94.1 m-20 -128.79 134.67 48.46 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -69.44 -7.0 33.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.694 0.283 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -100.89 -29.51 12.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.851 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.729 HG23 ' HB2' ' A' ' 359' ' ' ASP . 0.1 OUTLIER -109.01 -39.06 5.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.15 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.11 40.84 19.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.061 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.469 ' HB2' HG23 ' A' ' 358' ' ' THR . 14.1 mm-40 -41.47 166.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.148 -0.526 . . . . 0.0 111.676 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.22 17.19 14.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.735 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.638 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 72.7 m80 -87.81 157.03 19.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.271 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 333' ' ' LEU . 54.5 mt-10 -147.75 115.19 6.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.802 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.797 HD11 ' O ' ' A' ' 370' ' ' GLU . 56.1 tp -76.35 142.79 41.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 111.564 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.713 HD12 ' O ' ' A' ' 332' ' ' VAL . 1.7 mp -117.44 -41.13 2.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.247 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.797 ' O ' HD11 ' A' ' 368' ' ' LEU . 59.5 tt0 -144.78 167.85 21.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.368 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 1.0 OUTLIER -149.66 116.81 6.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.188 0.518 . . . . 0.0 111.494 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 10.0 tpt -111.66 126.93 27.64 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.229 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.3 Cg_exo -57.56 118.67 5.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.877 1.718 . . . . 0.0 111.003 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.003 HD12 HG22 ' A' ' 328' ' ' ILE . 15.2 mt -60.89 -39.95 91.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.887 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.769 HD11 HD12 ' A' ' 391' ' ' ILE . 57.1 tp -59.5 -52.8 64.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.2 mt-10 -58.87 -40.01 83.08 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.059 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -67.35 -34.0 76.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.316 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 11.3 m-85 -69.78 -31.51 69.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.433 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -9.24 50.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.655 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -101.08 -15.44 17.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.423 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.68 18.11 5.74 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -62.35 -20.94 64.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.665 0.269 . . . . 0.0 111.019 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -79.84 -43.37 22.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.98 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.138 0.494 . . . . 0.0 110.637 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.635 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.3 m-85 -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.78 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.64 71.25 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.127 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.38 162.78 16.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.172 0.511 . . . . 0.0 110.938 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.866 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.7 m -107.32 100.61 10.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.025 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.746 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.69 102.74 2.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.161 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.449 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -108.42 134.99 50.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.884 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.769 HD12 HD11 ' A' ' 375' ' ' LEU . 33.9 mm -99.93 102.09 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 287' ' ' ILE . 5.7 m -101.6 -168.03 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.928 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.2 p -157.14 153.9 28.49 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.498 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.517 ' HB3' HG21 ' A' ' 403' ' ' VAL . 35.4 p-10 -71.2 -1.86 14.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.532 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -41.36 92.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.631 0.253 . . . . 0.0 111.534 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 283' ' ' GLU . 3.2 t -75.0 167.27 22.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 0.0 111.154 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 48.8 tp60 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.668 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.535 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 35.8 mp0 -67.72 -34.26 76.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 109.776 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -51.62 -57.9 11.27 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.921 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.7 m -62.74 -19.47 63.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 398' ' ' GLU . 67.8 mt-30 -72.99 -40.08 65.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.996 0.427 . . . . 0.0 110.579 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 410' ' ' GLY . 0.2 OUTLIER -65.86 -41.53 91.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.802 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.774 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 71.8 t -60.45 -37.91 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -62.38 -45.03 95.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 0.0 110.417 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -74.95 -20.66 79.34 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.05 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.485 ' CZ ' ' HA2' ' A' ' 304' ' ' GLY . 12.5 t80 -174.98 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.774 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 94.3 96.69 1.6 Allowed Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.264 -0.969 . . . . 0.0 114.853 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.537 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 135.85 -31.68 2.61 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.764 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.636 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER -152.86 127.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 117.493 0.646 . . . . 0.0 111.895 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.07 136.04 5.65 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.42 134.69 11.33 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.139 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.874 HG23 ' CE1' ' A' ' 301' ' ' TYR . 63.0 mt -99.13 129.99 48.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 47.0 mt -88.58 149.39 23.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.728 0.775 . . . . 0.0 113.005 -177.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 40.6 mtt180 -71.24 -29.92 65.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.239 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.635 ' O ' HG13 ' A' ' 417' ' ' VAL . 63.7 t80 -169.81 165.01 9.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.983 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -49.98 121.05 4.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.292 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 415' ' ' TYR . 32.8 m -130.02 159.99 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.718 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 138.39 57.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.043 0.449 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -76.91 145.33 38.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.793 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -119.36 140.01 51.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.418 ' HA2' ' CG ' ' A' ' 430' ' ' GLU . . . 62.78 108.59 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.4 mmm -142.24 169.05 18.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.833 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -59.92 -28.63 67.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -70.1 -30.93 68.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.942 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.49 149.01 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.067 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -58.37 -79.52 0.1 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.743 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -178.85 -90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.685 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.06 -33.46 72.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.446 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.15 20.16 10.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.01 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.418 ' CG ' ' HA2' ' A' ' 421' ' ' GLY . 39.7 tt0 -66.57 -39.94 88.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.999 0.428 . . . . 0.0 110.569 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -109.12 62.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 40.4 p90 -79.94 99.82 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.314 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.21 13.42 15.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.051 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.46 -6.41 30.21 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.742 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -59.96 -40.03 87.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.769 0.318 . . . . 0.0 110.504 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.07 -32.35 71.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.91 -35.26 72.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.201 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.06 -44.64 94.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.874 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -60.06 -40.11 88.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.813 -179.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 282' ' ' GLN . 9.8 p -65.8 -28.46 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' A' ' 282' ' ' GLN . 3.0 pttm -53.13 -38.15 62.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.382 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 64.3 t80 -62.69 -47.04 85.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.547 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 2.6 pt -83.44 -41.89 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.091 0.472 . . . . 0.0 111.838 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.789 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.2 OUTLIER -55.32 -36.85 66.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 -178.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.7 pt-20 -69.93 -29.97 67.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.07 -57.82 3.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.96 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -54.86 11.55 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 21.0 tp -58.55 -57.11 14.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 111.698 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.682 HG23 ' CE1' ' A' ' 402' ' ' PHE . 43.9 mt -59.95 -49.15 85.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -58.67 -38.17 91.09 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.217 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 8.3 ttt180 -60.02 -38.07 81.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.242 0.544 . . . . 0.0 109.923 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.635 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 3.0 t80 -55.85 -48.62 75.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.262 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.93 -39.95 29.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.99 0.424 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.545 ' O ' ' HB2' ' A' ' 295' ' ' SER . 74.6 m-20 -60.01 -41.96 93.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.808 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.661 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 5.7 mt-10 -70.03 -41.15 74.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.58 -22.7 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.264 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.04 -14.28 53.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.259 0.552 . . . . 0.0 109.65 178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.769 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.2 mt-30 -103.17 0.04 31.19 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.418 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 7.3 t70 56.34 33.4 22.26 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 109.977 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.797 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 31.4 p -73.46 -10.8 60.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.126 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.41 ' HA3' ' HE ' ' A' ' 416' ' ' ARG . . . 56.89 53.94 40.53 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.665 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.537 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 9.0 mtpt -130.24 36.23 4.01 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.934 ' CE2' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -158.87 159.61 35.21 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.468 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 31.2 m -134.49 155.46 50.32 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.026 0.441 . . . . 0.0 111.378 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 0.2 OUTLIER -134.87 118.32 16.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 115.82 155.41 10.65 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.978 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -60.03 -56.22 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.824 0.345 . . . . 0.0 111.113 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 9.0 pt-20 -51.91 -51.23 58.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.733 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -63.13 -54.15 42.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.443 HG21 HG22 ' A' ' 409' ' ' ILE . 31.9 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.978 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -65.61 -50.3 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.769 0.318 . . . . 0.0 111.522 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -55.61 -52.38 63.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.416 . . . . 0.0 111.094 -179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.56 71.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.27 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.962 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.34 -27.42 61.5 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 120.839 0.352 . . . . 0.0 110.463 179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -77.55 -27.6 51.62 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 30.9 mmt -80.86 -7.46 59.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.832 -1.531 . . . . 0.0 111.593 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.4 18.63 44.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.3 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.36 -2.97 58.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.601 -0.3 . . . . 0.0 111.377 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.962 HG21 ' CD1' ' A' ' 312' ' ' LEU . 29.9 m -99.43 104.47 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.666 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.6 tp10 -57.12 -49.99 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.185 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.5 mm -135.49 126.01 43.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.562 0.22 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.66 ' HG ' HG23 ' A' ' 322' ' ' VAL . 37.3 tp -90.91 123.41 34.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.967 0.413 . . . . 0.0 111.699 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -109.68 103.29 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.66 HG23 ' HG ' ' A' ' 320' ' ' LEU . 36.3 t -111.38 155.67 12.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.241 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 7.6 m-85 -103.61 142.45 34.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.174 0.511 . . . . 0.0 112.278 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 393' ' ' THR . 36.4 tt0 -68.07 156.78 36.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.017 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 28.27 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.92 0.391 . . . . 0.0 110.296 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.499 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.1 tp -59.96 125.5 23.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.409 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.08 30.31 1.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.7 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.957 HG22 HD12 ' A' ' 374' ' ' LEU . 26.5 mm -130.35 133.29 64.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.511 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.709 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 33.3 mtt -140.6 163.01 34.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.636 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 0.4 OUTLIER -88.19 118.79 28.02 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.874 0.369 . . . . 0.0 110.779 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.832 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 59.9 m-85 -126.9 124.71 40.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.685 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.025 HG12 HD12 ' A' ' 343' ' ' ILE . 4.7 m -92.15 117.48 35.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.536 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.835 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.2 mm? -100.94 164.4 11.84 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.153 0.502 . . . . 0.0 111.38 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.45 ' CG ' HD11 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -108.5 -173.77 2.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.779 179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 40.9 t -116.06 160.24 20.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.681 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -56.96 -39.98 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -89.11 -6.08 72.17 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.717 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.6 p 66.86 27.97 8.88 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.908 0.385 . . . . 0.0 111.075 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -125.04 25.2 7.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.674 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 21.7 tp10 -165.74 130.21 2.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -113.76 129.69 56.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.07 0.462 . . . . 0.0 111.176 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.652 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -117.72 141.52 48.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.727 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.025 HD12 HG12 ' A' ' 332' ' ' VAL . 3.0 mm -113.97 127.08 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.185 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.488 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 34.4 tp -140.7 160.62 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.399 0.619 . . . . 0.0 111.776 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.798 ' HD2' HD12 ' A' ' 328' ' ' ILE . 2.5 p90 -100.93 125.7 47.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.769 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.658 ' HB2' ' HG2' ' A' ' 351' ' ' GLU . 2.7 mm? -122.3 157.71 31.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.544 0.688 . . . . 0.0 112.773 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.626 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 8.3 p -99.35 168.13 10.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.311 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 4.7 Cg_endo -46.43 -46.62 16.87 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.27 1.98 . . . . 0.0 112.297 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -72.65 -44.89 61.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 349' ' ' GLU . 33.3 mt-30 -69.94 -46.64 64.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.832 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 0.0 OUTLIER -68.73 -24.2 64.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.373 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 348' ' ' PRO . 32.9 ttpt -58.13 -25.12 61.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.307 0.575 . . . . 0.0 109.765 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.92 19.0 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.817 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.894 ' HD2' HD23 ' A' ' 368' ' ' LEU . 30.4 tttt -48.18 -26.0 1.73 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.7 p -64.3 -39.95 94.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 0.0 110.446 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.41 ' C ' ' H ' ' A' ' 358' ' ' THR . 94.6 m-70 -106.66 -53.6 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.297 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.835 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 62.7 3.6 1.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.617 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.4 m -89.04 178.43 6.39 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.522 ' H ' HG22 ' A' ' 358' ' ' THR . 76.1 m-20 -130.33 130.47 44.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -68.4 -4.15 13.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.448 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -101.97 -19.04 15.39 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 364' ' ' GLN . 4.4 t -131.86 -37.32 1.16 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.555 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 365' ' ' GLU . . . 91.09 5.25 68.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.917 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.601 ' H ' HG23 ' A' ' 362' ' ' THR . 61.1 mm-40 -52.83 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.901 0.381 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.487 ' OE2' HG21 ' A' ' 358' ' ' THR . 72.5 mm-40 -65.7 128.65 36.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.476 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 96.5 m-70 -140.08 153.48 46.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.506 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 53.7 mt-10 -139.51 113.2 8.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.327 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.894 HD23 ' HD2' ' A' ' 354' ' ' LYS . 49.9 tp -75.58 138.29 41.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.045 0.45 . . . . 0.0 111.55 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.45 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.3 mp -113.68 -35.19 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.191 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.853 ' O ' HD11 ' A' ' 368' ' ' LEU . 33.9 mt-10 -140.05 150.2 44.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.015 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.546 ' HB3' ' HD1' ' A' ' 331' ' ' TYR . 2.8 p -141.13 115.08 9.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.182 0.515 . . . . 0.0 111.575 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.66 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -121.31 137.27 26.62 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.186 -179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.709 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 28.1 Cg_endo -64.31 122.97 11.09 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.117 1.878 . . . . 0.0 110.626 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.957 HD12 HG22 ' A' ' 328' ' ' ILE . 19.6 mt -65.3 -41.06 94.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 38.4 tp -60.08 -53.66 55.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.644 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 48.0 mt-10 -59.98 -40.38 88.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.024 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -62.49 -40.03 95.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.083 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.578 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -70.54 -28.25 64.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.276 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -10.48 48.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.828 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.07 -9.49 14.72 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.5 m120 -129.2 19.45 5.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.604 0.24 . . . . 0.0 111.61 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -68.57 -17.41 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.597 0.237 . . . . 0.0 111.347 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -79.85 -46.97 15.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.729 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -60.02 -44.19 94.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.318 0.58 . . . . 0.0 109.96 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.553 ' CD2' HD23 ' A' ' 312' ' ' LEU . 26.7 m-85 -73.49 -19.97 60.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.039 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . 0.49 ' HA3' HH22 ' A' ' 414' ' ' ARG . . . 74.87 2.14 64.26 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.662 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.22 165.37 18.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.073 0.463 . . . . 0.0 110.32 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.851 ' HB ' HG23 ' A' ' 319' ' ' ILE . 24.2 m -107.68 100.67 10.04 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 389' ' ' LEU . 0.9 OUTLIER -73.54 107.34 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.628 -178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.677 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.8 mm-40 -115.39 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.593 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 27.2 mm -98.5 102.34 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.114 0.483 . . . . 0.0 112.26 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.644 ' HB ' HD11 ' A' ' 287' ' ' ILE . 27.7 m -114.06 133.62 59.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.607 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 324' ' ' GLU . 3.2 p -112.74 166.21 11.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.371 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.657 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.4 t0 -73.48 70.06 1.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.846 0.355 . . . . 0.0 111.352 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.41 ' HE2' ' OE2' ' A' ' 283' ' ' GLU . 4.9 ptmt -119.83 12.02 12.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.14 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 47.5 t -155.17 179.57 9.02 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -59.38 -53.32 59.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.032 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 50.9 mp0 -63.65 -39.98 95.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.411 ' HA2' ' OH ' ' A' ' 323' ' ' TYR . . . -62.87 -25.4 67.7 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.521 -0.847 . . . . 0.0 110.992 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 67.5 m -83.74 -23.38 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.554 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -71.78 -43.44 65.72 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.376 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.682 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.2 m-85 -65.3 -48.39 73.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.21 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.657 HG21 ' HB2' ' A' ' 394' ' ' ASP . 75.4 t -59.95 -40.08 81.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.8 -48.17 33.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.872 0.368 . . . . 0.0 111.132 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.407 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -73.22 -28.29 66.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.508 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -157.68 -84.72 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 100.09 151.73 26.04 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.461 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 78.99 -47.49 3.13 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.67 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -148.94 134.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 118.232 1.016 . . . . 0.0 112.985 -177.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -153.39 145.49 12.96 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.72 147.6 18.96 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.712 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.934 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.0 mt -106.5 126.72 62.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 38.3 mt -87.85 156.15 19.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.566 0.698 . . . . 0.0 112.195 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.49 HH22 ' HA3' ' A' ' 386' ' ' GLY . 16.3 mtt-85 -77.77 -33.07 52.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.685 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.428 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 93.5 m-85 -156.39 170.01 23.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.753 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.797 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -64.21 120.78 12.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.544 HG22 HD13 ' A' ' 413' ' ' LEU . 17.0 m -130.04 159.95 41.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.997 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -80.36 170.03 16.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.798 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -99.65 137.74 37.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -59.98 -40.01 87.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.001 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.468 ' HA3' ' HG3' ' A' ' 430' ' ' GLU . . . 89.47 163.87 39.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 52.6 mtp -143.08 160.28 40.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.1 -39.94 87.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.032 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.436 ' O ' ' CD2' ' A' ' 424' ' ' TYR . 53.5 t80 -98.38 11.91 36.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 130.56 -51.82 0.85 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.619 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -59.46 126.88 43.43 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.527 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.05 -40.02 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.814 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -115.91 31.07 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.468 ' HG3' ' HA3' ' A' ' 421' ' ' GLY . 8.2 tp10 -59.94 -40.03 87.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.551 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.404 ' CZ ' ' OD2' ' A' ' 433' ' ' ASP . 64.8 t80 -120.56 102.35 8.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.297 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -130.97 80.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.41 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . 0.404 ' OD2' ' CZ ' ' A' ' 431' ' ' PHE . 96.6 m-20 -95.19 18.65 11.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.13 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.28 -15.42 47.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.776 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.86 -40.02 87.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 110.396 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -80.62 -20.22 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -59.97 -38.46 82.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.313 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.92 -49.18 78.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.951 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -67.84 139.97 56.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.914 179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.1 m120 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.733 0.302 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.6 p -58.88 -27.21 34.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.109 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -41.26 76.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.039 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -59.97 -47.77 84.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.798 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -80.01 -22.83 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.432 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.55 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.2 OUTLIER -57.48 -40.01 77.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.212 0.53 . . . . 0.0 110.019 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.603 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 1.9 mp0 -75.69 -51.34 12.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.407 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -40.05 87.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -84.55 -58.69 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.843 ' HG ' HD13 ' A' ' 321' ' ' ILE . 29.9 tp -60.01 -55.84 29.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.909 0.385 . . . . 0.0 111.834 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.878 HG23 ' CD2' ' A' ' 402' ' ' PHE . 67.3 mt -59.95 -47.88 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.572 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.425 ' HA2' ' OE1' ' A' ' 398' ' ' GLU . . . -57.81 -37.79 85.69 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.444 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 15.7 ttt180 -60.02 -42.41 94.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.513 ' CE1' ' CE1' ' A' ' 402' ' ' PHE . 5.5 t80 -59.99 -41.71 92.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.516 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.688 ' HA ' HD12 ' A' ' 294' ' ' ILE . 64.7 t80 -84.27 -40.98 17.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.848 0.356 . . . . 0.0 111.209 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -60.57 -43.37 97.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.663 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 75.4 mt-10 -60.06 -40.03 88.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.947 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 291' ' ' PHE . 64.1 mt -56.4 -30.26 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 t -53.03 -29.87 32.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.552 ' HB2' ' CG2' ' A' ' 298' ' ' THR . 21.8 mt-30 -94.77 1.46 55.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.26 32.03 17.77 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.978 0.418 . . . . 0.0 110.085 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 1.5 p -64.26 -13.14 47.6 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.541 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.85 47.57 87.9 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.699 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.585 ' HA ' ' HB2' ' A' ' 413' ' ' LEU . 36.3 mttp -129.48 48.05 2.42 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.585 ' HE2' ' HB3' ' A' ' 293' ' ' GLU . 0.1 OUTLIER -170.51 168.08 7.86 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.865 0.364 . . . . 0.0 111.348 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.6 p -153.1 169.0 24.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.42 135.64 33.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.047 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 104.17 146.52 15.98 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.815 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.896 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.47 -57.82 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.909 0.385 . . . . 0.0 110.982 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -49.02 -53.48 19.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.397 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.77 -53.04 53.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.756 0.312 . . . . 0.0 111.29 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.595 HG21 HG22 ' A' ' 409' ' ' ILE . 7.4 m -57.88 -38.58 76.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.871 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -69.07 -43.64 74.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.371 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.3 mtmm -57.37 -49.99 74.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.1 -26.08 62.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.389 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.797 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.07 -27.28 60.83 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.923 0.392 . . . . 0.0 110.586 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -77.51 -28.26 52.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.1 mmt -80.54 -7.01 59.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.979 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.91 14.48 23.85 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.677 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.29 -6.59 59.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.395 0.278 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.821 HG23 ' HB2' ' A' ' 387' ' ' ALA . 20.8 m -93.16 105.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.798 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.3 tt0 -59.98 -50.0 75.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.839 HG23 ' HB ' ' A' ' 388' ' ' THR . 32.9 mm -135.22 126.34 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 120.529 0.204 . . . . 0.0 111.483 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.683 ' HG ' HG23 ' A' ' 322' ' ' VAL . 50.2 tp -92.0 125.52 36.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.022 0.439 . . . . 0.0 110.914 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.843 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.9 OUTLIER -112.41 106.95 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.975 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.683 HG23 ' HG ' ' A' ' 320' ' ' LEU . 18.9 t -124.24 158.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.282 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.724 ' CE1' HG23 ' A' ' 392' ' ' VAL . 90.3 m-85 -104.58 146.48 28.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.42 . . . . 0.0 111.345 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.555 ' HA ' HD21 ' A' ' 375' ' ' LEU . 15.9 pt-20 -64.97 -30.9 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -97.25 49.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.509 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 20.3 tp -80.19 126.16 30.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 347' ' ' THR . 35.8 p-10 -92.67 21.42 5.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.468 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.896 HG21 HG21 ' A' ' 305' ' ' VAL . 14.8 mm -124.7 136.78 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.569 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 40.2 mtt -140.52 161.6 37.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.868 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.571 HH21 HD22 ' A' ' 309' ' ' LEU . 11.1 mmt-85 -89.3 120.52 30.72 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.072 0.463 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.4 m-85 -118.08 152.34 35.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.739 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.008 HG12 HD12 ' A' ' 343' ' ' ILE . 15.4 m -116.44 108.03 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.976 HD11 ' CD2' ' A' ' 357' ' ' PHE . 1.6 mm? -96.36 150.02 21.04 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.432 ' CE1' HG12 ' A' ' 369' ' ' ILE . 3.7 m170 -91.58 179.75 5.57 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.962 0.411 . . . . 0.0 111.102 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.57 161.44 20.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.692 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -45.19 -30.06 1.1 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.636 ' O ' HG23 ' A' ' 338' ' ' THR . . . -92.75 -118.17 2.56 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.058 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.5 OUTLIER -168.85 25.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.691 0.281 . . . . 0.0 111.722 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.49 38.37 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 110.047 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -157.04 120.04 4.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.16 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -114.18 139.16 49.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.113 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.679 ' O ' HD13 ' A' ' 343' ' ' ILE . 1.7 ttpt -117.57 142.57 47.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.638 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.008 HD12 HG12 ' A' ' 332' ' ' VAL . 8.3 mm -120.75 116.67 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.491 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 346' ' ' LEU . 48.7 tp -128.49 157.85 39.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.308 0.575 . . . . 0.0 112.256 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.641 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.21 119.01 36.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.773 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.777 HD11 HD23 ' A' ' 344' ' ' LEU . 0.9 OUTLIER -121.36 154.23 36.73 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.679 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 18.3 p -101.27 171.44 5.4 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.087 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.679 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 90.9 Cg_exo -44.02 -47.39 10.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.858 1.705 . . . . 0.0 112.106 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.0 pt-20 -59.98 -49.04 79.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 97.5 mt-30 -70.22 -46.52 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 90.2 mt-10 -60.74 -33.59 73.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.303 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.95 -36.16 72.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 66.0 t0 -84.53 58.45 4.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.724 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.512 ' HG3' HD23 ' A' ' 368' ' ' LEU . 21.5 ttpt -67.1 -39.95 86.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 54.1 m -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.469 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 35.1 m80 -102.49 -55.87 2.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.756 0.312 . . . . 0.0 111.08 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.976 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 60.56 3.22 0.56 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.206 -179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.835 HG22 ' H ' ' A' ' 359' ' ' ASP . 6.4 m -88.18 -174.56 4.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.958 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.835 ' H ' HG22 ' A' ' 358' ' ' THR . 95.9 m-20 -81.24 162.53 23.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.586 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -73.08 -3.96 29.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -82.15 -44.39 16.51 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.907 0.384 . . . . 0.0 111.035 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.92 -35.5 3.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.874 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 63.29 18.92 61.32 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.117 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.531 ' N ' HG21 ' A' ' 358' ' ' THR . 60.3 mt-30 -155.59 84.93 1.04 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.72 ' HB2' HG23 ' A' ' 358' ' ' THR . 53.4 mm-40 -144.17 -39.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.364 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -128.23 171.37 12.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.735 0.302 . . . . 0.0 111.093 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -145.36 118.89 9.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.464 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.747 HD11 ' O ' ' A' ' 370' ' ' GLU . 55.5 tp -70.02 134.31 48.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 332' ' ' VAL . 4.0 mp -112.5 -45.1 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.187 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.747 ' O ' HD11 ' A' ' 368' ' ' LEU . 54.0 mm-40 -137.64 162.98 32.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.598 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.3 p -148.86 117.35 6.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.132 0.491 . . . . 0.0 111.401 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 20.3 tpp -112.9 128.22 25.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.669 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.508 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 34.1 Cg_exo -59.95 116.96 3.67 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 121.925 1.75 . . . . 0.0 110.618 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.789 HD13 HG11 ' A' ' 305' ' ' VAL . 6.5 mt -60.06 -39.47 86.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.851 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.897 HD11 HD12 ' A' ' 391' ' ' ILE . 59.4 tp -60.03 -50.69 72.72 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 52.7 mt-10 -60.02 -39.95 87.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.953 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -66.31 -36.66 83.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.618 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.425 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -68.64 -26.38 65.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.259 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.76 -18.64 27.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.785 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -105.76 4.89 30.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 384' ' ' LYS . 39.4 t-20 -139.79 13.85 2.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -69.98 -17.58 63.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -77.16 -48.37 17.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 111.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . 0.445 ' HB2' ' OD1' ' A' ' 381' ' ' ASN . 34.1 mttt -60.11 -44.6 94.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.226 0.536 . . . . 0.0 110.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.5 m-85 -69.89 -16.4 63.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.894 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.4 62.7 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.177 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.821 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.52 162.01 19.1 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.839 ' HB ' HG23 ' A' ' 319' ' ' ILE . 72.8 m -105.71 100.05 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.823 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.1 tm? -74.47 103.13 4.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.52 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 20.2 mm-40 -111.57 132.37 54.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.694 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.897 HD12 HD11 ' A' ' 375' ' ' LEU . 22.4 mm -96.08 104.34 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.814 ' HB ' HD11 ' A' ' 287' ' ' ILE . 14.7 m -100.87 -172.57 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.235 -178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.556 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.9 OUTLIER -158.57 154.15 26.14 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.098 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.448 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.6 p-10 -67.91 5.6 0.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -59.96 -39.97 87.45 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.8 m -91.1 169.76 10.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.9 0.381 . . . . 0.0 111.525 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.94 -49.34 78.07 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.621 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.653 ' O ' HG21 ' A' ' 287' ' ' ILE . 60.8 mm-40 -63.49 -35.94 82.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.642 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.675 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -24.02 66.28 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.004 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 59.8 m -83.94 -23.15 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.614 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -73.09 -41.59 63.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.602 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.878 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -65.0 -44.0 90.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.793 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.837 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 92.3 t -58.77 -32.84 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.486 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.07 -54.23 14.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.225 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -55.65 -53.79 39.2 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.887 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -137.09 -66.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.837 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 102.7 81.13 1.52 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.517 -0.849 . . . . 0.0 115.163 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.464 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 138.02 -29.4 2.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.991 -1.1 . . . . 0.0 114.15 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.98 130.64 4.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.689 0.744 . . . . 0.0 112.229 -178.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -149.99 135.12 5.13 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -122.95 142.15 14.37 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.461 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 318' ' ' GLU . 81.4 mt -109.96 130.0 63.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.794 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.8 mt -88.59 155.24 19.74 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.605 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 74.4 mtm180 -70.03 -39.96 75.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.581 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.572 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 54.4 p90 -158.42 169.92 23.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.75 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.7 mmm180 -56.15 128.2 34.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.907 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.0 159.99 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.042 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -94.67 127.39 40.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.19 134.21 47.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -133.64 156.4 47.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.711 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 72.58 96.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.394 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.3 mtt -146.19 161.81 39.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.755 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.99 -40.04 87.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.947 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.27 21.25 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.495 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 6.1 tp-100 -60.09 -39.92 87.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.094 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 146.25 -100.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.823 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -170.84 100.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.653 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 60.35 10.37 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.563 0.22 . . . . 0.0 111.379 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.5 23.05 14.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.733 0.302 . . . . 0.0 110.47 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 69.1 mt-10 -66.12 -40.01 90.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.163 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -101.4 49.72 0.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.467 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 36.5 p90 -65.38 89.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 111.201 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.07 13.59 14.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.462 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.79 -18.13 41.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.606 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.379 . . . . 0.0 110.313 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -79.48 -19.96 48.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.83 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.74 -38.61 82.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.935 0.398 . . . . 0.0 110.294 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.9 tp -59.91 -41.21 91.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.933 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.86 152.24 35.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.884 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 34.8 t30 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.67 0.271 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -60.03 -29.94 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.284 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -52.27 -47.28 65.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.609 0.242 . . . . 0.0 111.526 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -49.92 75.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 278' ' ' VAL . 45.7 pt -75.75 -26.73 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.799 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.657 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 1.3 tm0? -55.28 -43.99 75.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 0.0 109.993 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.714 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 64.5 mt-10 -77.59 -41.53 38.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.617 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -70.76 -40.07 72.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -87.03 -58.83 2.44 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.613 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 21.5 tp -59.94 -56.43 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.834 HG23 ' CE2' ' A' ' 402' ' ' PHE . 30.6 mt -60.72 -48.71 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.333 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.13 -38.83 78.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.444 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.472 ' HG2' ' HG3' ' A' ' 293' ' ' GLU . 29.7 ttt180 -60.02 -39.61 86.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.328 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 5.7 t80 -55.59 -49.85 71.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.506 ' CE2' ' CB ' ' A' ' 401' ' ' GLN . 63.6 m-85 -79.41 -38.37 34.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.042 0.449 . . . . 0.0 111.006 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.93 -49.79 76.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.331 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.664 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.9 mt-10 -63.76 -45.43 89.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.877 0.37 . . . . 0.0 110.03 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 301' ' ' TYR . 93.6 mt -58.02 -23.6 21.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.42 -15.18 47.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.49 0.662 . . . . 0.0 109.549 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.799 ' HB2' HG23 ' A' ' 298' ' ' THR . 34.9 mt-30 -103.25 2.38 34.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.09 31.57 18.41 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.177 0.513 . . . . 0.0 110.25 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 296' ' ' GLN . 25.2 p -70.02 -9.99 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.766 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.52 48.03 73.0 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 119.926 -1.13 . . . . 0.0 113.655 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 33.5 mtmt -128.4 36.97 4.2 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.925 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.6 m-85 -160.0 160.04 32.84 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.35 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 p -146.13 159.42 43.32 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.748 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 54.8 p90 -131.9 125.35 31.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 114.94 169.13 15.93 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.765 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -75.45 -56.81 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 111.14 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 13.2 pt-20 -48.78 -50.35 34.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.463 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -67.32 -53.6 28.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.754 0.311 . . . . 0.0 111.368 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 409' ' ' ILE . 60.2 m -59.41 -40.03 85.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.244 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.971 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.0 mp -65.81 -45.04 83.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 314' ' ' MET . 15.9 mttm -58.95 -48.08 82.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.439 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.9 65.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.233 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.55 -27.87 61.56 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 120.804 0.335 . . . . 0.0 110.762 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 75.4 mm-40 -76.47 -26.82 55.77 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 21.2 mmt -81.82 -7.05 59.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.75 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.07 17.16 35.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.544 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -86.9 -2.11 58.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.289 0.236 . . . . 0.0 111.143 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.948 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.7 m -99.54 104.79 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.816 ' O ' HD13 ' A' ' 319' ' ' ILE . 34.9 tt0 -56.8 -50.07 73.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.279 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.873 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.8 mm -136.42 127.56 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.668 0.27 . . . . 0.0 111.466 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 312' ' ' LEU . 41.9 tp -95.34 128.62 42.33 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.026 0.441 . . . . 0.0 111.342 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 412' ' ' ILE . 0.9 OUTLIER -117.18 110.13 30.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 110.172 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.589 HG23 ' HG ' ' A' ' 320' ' ' LEU . 12.2 t -125.47 162.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.136 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 392' ' ' VAL . 90.4 m-85 -107.29 145.39 32.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.593 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -63.61 -41.43 98.3 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.297 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -86.36 55.39 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.664 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.595 HD11 HD11 ' A' ' 409' ' ' ILE . 34.6 tp -89.24 120.6 30.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.604 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -90.06 26.64 1.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.017 HG21 HG21 ' A' ' 305' ' ' VAL . 23.9 mm -123.45 136.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.135 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 73.7 mtp -140.05 162.36 35.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.236 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.7 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.9 ttt-85 -84.7 106.27 16.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.991 0.424 . . . . 0.0 111.897 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.534 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 7.6 m-85 -120.57 123.54 43.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.259 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.608 HG12 HD12 ' A' ' 343' ' ' ILE . 3.0 m -97.58 124.82 50.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.817 0.341 . . . . 0.0 111.517 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.775 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.1 mm? -117.35 139.98 50.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.687 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.554 ' CE1' HG13 ' A' ' 369' ' ' ILE . 48.8 m170 -117.75 136.21 53.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.04 0.447 . . . . 0.0 110.557 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.409 ' CB ' ' HG2' ' A' ' 365' ' ' GLU . 58.5 m -110.08 150.5 28.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.11 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 339' ' ' GLU . 89.1 mt-30 60.02 25.63 14.88 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.398 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.619 ' O ' HG23 ' A' ' 338' ' ' THR . . . 84.02 -39.09 2.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.593 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.1 OUTLIER 177.87 -5.8 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 336' ' ' GLN . 54.8 tt0 -59.98 -38.24 82.0 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.733 0.301 . . . . 0.0 111.062 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -143.92 119.08 10.1 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 3.8 mt-10 -120.04 128.94 53.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.767 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.787 ' C ' HD13 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -129.56 150.95 50.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.585 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.787 HD13 ' C ' ' A' ' 342' ' ' LYS . 1.4 mm -109.29 136.34 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 47.1 tp -143.99 159.48 42.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 112.54 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.747 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.08 134.43 41.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.579 179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.2 mm? -128.12 161.17 29.87 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.615 0.721 . . . . 0.0 112.87 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.2 p -101.56 168.76 8.62 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.372 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.57 ' O ' ' HG2' ' A' ' 352' ' ' LYS . 3.5 Cg_endo -45.66 -47.42 13.59 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.283 1.989 . . . . 0.0 111.982 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.8 -50.07 74.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.743 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.638 ' NE2' HD12 ' A' ' 346' ' ' LEU . 43.4 mt-30 -69.05 -46.09 68.76 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 76.4 mt-10 -58.76 -33.43 70.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.869 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 49.4 mmtt -57.92 -32.93 68.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.349 0.595 . . . . 0.0 109.597 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -92.63 36.74 1.01 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.95 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.743 ' HB2' HD13 ' A' ' 368' ' ' LEU . 5.3 pttt -70.05 -28.62 65.6 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 87.1 p -59.97 -40.03 87.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.051 0.453 . . . . 0.0 110.436 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -98.76 -51.63 3.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.244 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.775 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 56.9 10.72 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.98 0.419 . . . . 0.0 110.25 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 359' ' ' ASP . 2.0 m -101.79 -179.96 4.16 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 362' ' ' THR . 76.5 m-20 -129.08 130.96 47.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -67.16 -4.06 9.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.746 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -101.31 -22.02 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 359' ' ' ASP . 10.3 t -119.44 -35.36 3.59 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.076 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.04 42.63 15.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.794 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.432 ' C ' HG23 ' A' ' 358' ' ' THR . 58.5 mt-30 -52.05 -172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.038 0.447 . . . . 0.0 111.206 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 335' ' ' CYS . 1.7 pm0 -135.49 29.31 3.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.362 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -70.31 153.42 43.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.386 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 333' ' ' LEU . 43.5 mt-10 -151.85 123.09 7.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.166 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.743 HD13 ' HB2' ' A' ' 354' ' ' LYS . 6.9 tt -78.79 129.06 34.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 111.706 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.648 ' N ' HD13 ' A' ' 369' ' ' ILE . 1.5 mm -102.47 -46.49 10.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.656 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.008 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.534 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.2 OUTLIER -144.93 115.85 7.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.083 0.468 . . . . 0.0 110.603 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 7.7 tpt -122.22 141.2 33.98 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.556 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.729 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 23.2 Cg_exo -62.96 124.4 13.93 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.232 1.955 . . . . 0.0 110.399 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.989 HD12 HG22 ' A' ' 328' ' ' ILE . 20.5 mt -68.42 -40.55 81.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.859 HD11 HD12 ' A' ' 391' ' ' ILE . 63.8 tp -59.95 -51.9 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 47.2 mt-10 -59.92 -39.96 87.26 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.81 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -62.21 -39.94 94.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.579 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.548 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.61 -27.09 61.95 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.477 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.81 -8.83 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.894 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.09 -9.93 15.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 18.94 5.9 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -66.71 -20.13 65.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.558 0.218 . . . . 0.0 111.202 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -79.13 -47.43 16.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.871 0.367 . . . . 0.0 111.011 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -60.59 -45.24 94.7 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.213 0.53 . . . . 0.0 110.554 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.6 ' CD2' HD23 ' A' ' 312' ' ' LEU . 25.9 m-85 -71.38 -19.13 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.635 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.03 73.91 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.044 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.948 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.6 160.99 20.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.124 0.488 . . . . 0.0 110.338 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.873 ' HB ' HG23 ' A' ' 319' ' ' ILE . 64.5 m -106.47 99.87 9.42 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.705 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.7 tm? -75.43 102.7 5.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.388 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.657 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.2 mm-40 -109.17 135.64 49.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.756 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.859 HD12 HD11 ' A' ' 375' ' ' LEU . 43.4 mm -99.98 104.17 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.673 HG23 ' CE2' ' A' ' 323' ' ' TYR . 5.0 m -101.38 -170.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.148 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -157.55 151.47 24.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.056 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.548 ' HB2' HG21 ' A' ' 403' ' ' VAL . 60.1 t0 -76.58 69.97 3.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.851 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 -43.47 2.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 53.5 m -90.03 176.71 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.743 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 398' ' ' GLU . 4.7 pt20 -60.02 -44.29 94.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 63.7 mm-40 -69.99 -41.51 74.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.727 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.91 -19.23 60.84 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.545 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 53.0 m -83.9 -21.82 31.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.397 -0.401 . . . . 0.0 110.72 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.506 ' CB ' ' CE2' ' A' ' 291' ' ' PHE . 81.2 mt-30 -75.84 -41.37 52.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.784 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.834 ' CE2' HG23 ' A' ' 287' ' ' ILE . 7.3 m-30 -59.94 -44.99 94.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.889 0.376 . . . . 0.0 110.769 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 394' ' ' ASP . 55.6 t -60.01 -40.09 82.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -77.07 -40.03 47.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.042 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -67.41 -38.42 91.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.924 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 2.2 p90 -142.56 -78.86 0.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.756 0.312 . . . . 0.0 110.334 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 135.65 47.93 0.08 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.284 -0.96 . . . . 0.0 114.832 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.63 -37.04 1.96 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.393 -1.384 . . . . 0.0 115.416 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.781 HD13 HG22 ' A' ' 305' ' ' VAL . 1.1 mp -126.47 128.88 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.751 0.775 . . . . 0.0 112.977 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -146.64 136.76 6.38 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.49 140.15 13.66 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.744 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.925 HG23 ' CE2' ' A' ' 301' ' ' TYR . 18.7 mt -103.4 127.18 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.7 mt -91.55 158.58 16.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 112.732 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 54.3 mtp85 -72.55 -39.89 67.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.435 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.2 p90 -165.1 176.05 8.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.692 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.577 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -57.78 130.57 47.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.966 0.412 . . . . 0.0 110.935 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 33.1 m -126.85 160.0 35.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.108 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -105.55 49.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.203 0.525 . . . . 0.0 111.231 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -49.99 75.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -139.81 139.07 36.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.906 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -65.87 120.02 15.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.475 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.401 ' H ' ' HB2' ' A' ' 425' ' ' GLN . 61.4 mtt -130.9 162.26 30.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.888 0.375 . . . . 0.0 110.932 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -59.95 -40.0 87.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -82.05 5.67 18.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.535 ' HG2' ' HG2' ' A' ' 430' ' ' GLU . 5.1 tp-100 -59.97 -39.99 87.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.788 0.327 . . . . 0.0 111.043 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 105.01 -32.28 7.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -92.93 110.15 3.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.436 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -60.06 -39.95 87.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -100.91 33.05 2.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.682 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 425' ' ' GLN . 16.1 tp10 -59.93 -40.02 87.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -117.13 101.19 8.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -133.27 121.72 22.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.253 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -79.48 0.05 31.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 109.7 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 22.5 mt -68.95 -9.85 54.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.889 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -60.03 -40.3 88.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.795 0.331 . . . . 0.0 110.629 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.0 -29.78 66.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -60.05 -34.86 73.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.314 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.91 -49.99 75.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.253 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -107.01 121.63 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.032 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 83.9 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.926 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.676 0.274 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.81 -29.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.29 -41.27 37.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.917 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -50.02 75.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.667 0.27 . . . . 0.0 111.544 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -82.95 -27.26 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 0.0 111.766 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.732 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.449 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.6 pt-20 -77.61 -24.61 49.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.548 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -83.94 -51.47 7.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -75.37 -57.11 4.09 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.568 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 24.2 tp -59.1 -53.76 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.841 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.793 HD11 ' HB ' ' A' ' 392' ' ' VAL . 29.5 mt -58.93 -49.96 81.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.7 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.32 -37.02 71.59 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.611 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -60.01 -37.51 79.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.197 0.522 . . . . 0.0 110.5 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.585 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.3 t80 -58.86 -45.51 89.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.612 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.91 -39.16 17.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.717 0.294 . . . . 0.0 111.444 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.6 t0 -62.29 -45.2 94.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 111.336 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.772 ' OE2' HG21 ' A' ' 298' ' ' THR . 18.4 tp10 -67.64 -39.98 84.59 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 301' ' ' TYR . 80.4 mt -62.07 -26.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -59.43 -14.73 13.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.074 178.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.751 ' HB2' HG23 ' A' ' 298' ' ' THR . 23.5 mt-30 -99.24 1.23 44.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.603 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.92 27.43 16.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.317 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.772 HG21 ' OE2' ' A' ' 293' ' ' GLU . 17.2 p -64.88 -13.38 56.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.941 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 58.38 45.06 94.81 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.23 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.629 ' HA ' HD12 ' A' ' 413' ' ' LEU . 4.7 ptpt -130.89 46.6 2.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.041 0.421 . . . . 0.0 110.782 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.891 ' CE1' HG23 ' A' ' 412' ' ' ILE . 98.6 m-85 -160.49 160.96 32.66 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.954 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 27.6 m -141.56 159.38 42.35 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.812 0.339 . . . . 0.0 111.234 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.447 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 53.2 p90 -135.4 124.68 24.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.381 . . . . 0.0 110.621 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.534 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 107.68 156.09 19.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.311 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.954 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -59.97 -53.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 20.5 pt-20 -51.8 -51.93 52.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.47 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 87.5 m-20 -67.02 -53.17 33.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 0.0 111.095 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 42.0 m -58.05 -40.01 79.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.017 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.954 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.4 mp -67.81 -46.59 71.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.77 0.319 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 41.3 mtmt -54.45 -50.03 68.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.941 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.82 59.44 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.321 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.878 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.63 -33.28 68.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.004 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -72.77 -25.52 61.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 4.3 mmt -82.46 -7.72 59.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.956 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.54 13.54 45.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.172 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.853 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -80.93 -6.99 59.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.549 0.34 . . . . 0.0 111.094 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.916 HG23 ' HB2' ' A' ' 387' ' ' ALA . 35.6 m -99.79 106.68 19.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.649 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.4 tt0 -60.0 -52.7 64.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.696 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.7 mm -130.31 125.55 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.401 0.144 . . . . 0.0 111.05 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.653 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.2 tp -91.15 127.4 36.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.959 0.409 . . . . 0.0 111.081 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.7 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.87 106.28 20.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.352 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.653 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -120.94 147.5 24.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.314 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 11.7 m-85 -90.17 143.19 26.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.0 112.252 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 391' ' ' ILE . 12.2 tp10 -60.07 -43.06 95.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.037 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -91.6 53.57 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.998 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.541 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.4 tp -84.34 124.9 31.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.608 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -95.47 29.2 2.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.047 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.05 HG22 HD12 ' A' ' 374' ' ' LEU . 18.8 mm -123.84 131.45 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.926 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.635 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.8 mtt -140.58 162.54 35.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.594 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.516 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.0 ttt-85 -90.91 120.19 31.72 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.109 0.481 . . . . 0.0 111.606 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 18.3 m-85 -130.91 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.013 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.745 HG12 HD12 ' A' ' 343' ' ' ILE . 2.4 m -98.31 119.18 45.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 111.359 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.685 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.3 mm? -104.57 119.94 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.514 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.934 ' CG ' HD11 ' A' ' 369' ' ' ILE . 47.7 m170 -129.44 152.63 48.78 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.225 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 18.2 m -103.27 160.95 14.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.607 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.06 130.03 44.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 89.59 12.92 62.02 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.91 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 4.6 p 48.84 39.93 15.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.711 0.291 . . . . 0.0 111.44 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -103.28 8.64 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 9.9 tp10 -163.84 122.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 0.0 110.803 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -129.78 128.17 41.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.525 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.811 ' C ' HD13 ' A' ' 343' ' ' ILE . 24.4 tttp -140.36 121.33 14.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.951 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.811 HD13 ' C ' ' A' ' 342' ' ' LYS . 1.9 mm -113.8 115.51 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.541 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 26.1 tp -143.07 160.95 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.019 0.438 . . . . 0.0 111.508 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.906 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -90.41 135.49 33.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.315 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 345' ' ' TYR . 2.3 mm? -126.85 158.46 36.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.693 0.759 . . . . 0.0 112.63 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.6 p -101.09 169.22 8.07 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.741 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 2.2 Cg_endo -44.64 -48.83 9.96 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.055 1.836 . . . . 0.0 111.92 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.559 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -69.97 -46.07 66.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.767 0.317 . . . . 0.0 111.647 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.577 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 57.1 mt-10 -59.96 -38.44 82.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.651 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 13.9 mmtm -58.29 -32.68 68.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.134 0.492 . . . . 0.0 110.108 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.24 37.88 0.95 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.36 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.62 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 0.2 OUTLIER -73.11 -12.72 61.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.979 -179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 70.0 m -59.99 -39.98 87.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.718 0.294 . . . . 0.0 110.975 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' A' ' 358' ' ' THR . 58.8 m80 -104.0 -56.91 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.224 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.66 -0.74 0.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 364' ' ' GLN . 1.3 m -86.85 -169.69 2.74 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.623 0.249 . . . . 0.0 111.182 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.761 ' H ' HG22 ' A' ' 358' ' ' THR . 93.6 m-20 -90.73 158.12 17.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.107 0.479 . . . . 0.0 111.266 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -75.17 -3.53 33.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.981 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -78.09 -49.29 14.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.301 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.485 HG21 HE21 ' A' ' 364' ' ' GLN . 1.3 t -110.17 -35.21 6.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.173 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 71.11 22.43 78.49 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.138 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.854 ' HB2' HG21 ' A' ' 358' ' ' THR . 75.7 mt-30 -49.32 178.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.728 0.299 . . . . 0.0 110.748 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -119.92 106.09 11.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.919 0.39 . . . . 0.0 111.631 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -81.29 171.99 14.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.348 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -127.62 103.94 7.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 332' ' ' VAL . 25.4 tp -67.0 124.76 23.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.78 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.934 HD11 ' CG ' ' A' ' 334' ' ' HIS . 3.1 mp -84.65 -47.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.88 161.62 34.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.733 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.577 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.6 OUTLIER -141.33 115.81 9.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.617 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.0 128.46 25.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.853 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.635 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.5 Cg_exo -59.3 121.2 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.69 1.593 . . . . 0.0 110.5 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.05 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -60.12 -39.9 87.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.811 HD11 HD12 ' A' ' 391' ' ' ILE . 56.1 tp -59.98 -56.29 23.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.5 mt-10 -60.0 -40.05 87.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.008 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -62.78 -39.93 95.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.395 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.613 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -67.54 -25.17 65.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.014 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.65 -10.48 45.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.077 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -102.57 -14.7 16.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.5 m-20 -129.8 19.88 5.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.19 -20.06 66.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.56 0.219 . . . . 0.0 111.265 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -80.37 -42.16 23.36 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -59.95 -40.07 87.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.171 0.51 . . . . 0.0 110.493 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.68 ' CD2' HD23 ' A' ' 312' ' ' LEU . 20.9 m-85 -81.81 -10.01 59.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.35 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.79 54.52 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.303 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.916 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.48 164.68 15.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.217 0.532 . . . . 0.0 110.952 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.0 m -107.64 100.99 10.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.486 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 391' ' ' ILE . 2.1 tm? -71.12 103.69 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.209 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.732 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.0 mm-40 -111.31 131.19 55.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 375' ' ' LEU . 32.0 mm -95.24 100.83 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.793 ' HB ' HD11 ' A' ' 287' ' ' ILE . 17.6 m -112.73 139.34 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 395' ' ' LYS . 5.7 p -111.45 164.47 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.881 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.411 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.3 p-10 -69.5 15.32 0.08 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 393' ' ' THR . 38.8 tttp -59.95 -45.25 93.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 5.0 m -90.76 173.77 7.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 111.978 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -59.84 -50.39 73.98 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.785 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 74.1 mm-40 -62.94 -36.89 84.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.506 0.67 . . . . 0.0 109.286 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.411 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -62.11 -26.37 67.45 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.436 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.2 m -83.34 -26.62 30.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.242 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.8 -43.7 68.13 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.797 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.589 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.0 m-85 -60.02 -48.22 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.975 0.417 . . . . 0.0 110.836 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 72.8 t -57.59 -33.57 45.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.924 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 400' ' ' SER . 2.9 mmpt? -74.65 -52.16 12.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.524 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.75 -25.57 69.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.279 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.534 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 21.7 t80 179.35 -76.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.71 167.11 30.82 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.498 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.494 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.39 -47.83 3.03 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.594 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.77 130.58 5.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 117.742 0.771 . . . . 0.0 112.159 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -148.49 134.63 5.11 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -117.97 138.88 14.29 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.577 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.891 HG23 ' CE1' ' A' ' 301' ' ' TYR . 26.6 mt -102.48 127.2 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 417' ' ' VAL . 69.8 mt -87.91 152.54 21.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.566 0.698 . . . . 0.0 112.345 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 5.3 mtt-85 -68.99 -35.55 76.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.94 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 417' ' ' VAL . 97.0 m-85 -159.84 -171.83 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.506 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -66.69 99.3 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.964 0.412 . . . . 0.0 110.56 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 413' ' ' LEU . 1.5 p -136.57 139.43 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.147 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -104.77 160.95 14.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -69.97 149.86 47.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.993 0.425 . . . . 0.0 110.587 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -60.08 -39.97 87.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.985 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -133.89 -140.21 4.29 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.563 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 72.3 mtm -111.04 179.93 3.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.914 0.388 . . . . 0.0 110.816 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -62.57 -39.99 95.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.642 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -108.83 61.06 0.6 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.011 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.498 ' HB3' ' HG3' ' A' ' 430' ' ' GLU . 27.6 mt-30 -60.05 -40.06 88.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.3 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.54 -93.64 1.85 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.615 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -121.11 -154.58 9.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.764 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.0 -20.06 63.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.669 0.271 . . . . 0.0 111.462 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.38 60.19 3.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.94 0.4 . . . . 0.0 110.929 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 425' ' ' GLN . 47.7 mp0 -61.04 -39.96 91.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.454 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 53.7 p90 -140.59 114.99 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.293 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -135.62 116.41 14.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.335 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.99 11.3 9.76 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.062 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 35.6 mt -70.05 -2.25 12.22 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.937 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.38 -39.3 69.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 110.91 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -60.01 -39.53 86.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.316 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -55.61 -32.18 62.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.741 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.94 -45.81 91.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.01 -39.99 87.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 29.0 m120 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.815 0.34 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.24 -30.04 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -52.02 -44.83 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.645 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.98 -49.92 75.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.302 . . . . 0.0 111.084 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -77.76 -26.93 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.697 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.665 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -59.32 -41.01 88.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.287 0.565 . . . . 0.0 109.917 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.74 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 79.8 mt-10 -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.896 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -39.95 94.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -86.8 -59.16 2.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -60.76 -55.22 35.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.838 0.352 . . . . 0.0 111.455 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.74 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 54.1 mt -59.91 -48.89 86.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.531 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -55.11 -38.34 66.32 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.532 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.421 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 43.3 ttt-85 -59.97 -36.59 77.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.267 0.556 . . . . 0.0 110.046 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.621 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 11.6 t80 -60.09 -47.77 84.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.635 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -81.87 -36.65 27.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.855 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -63.89 -52.11 61.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.769 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -60.85 -44.63 96.74 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.397 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 301' ' ' TYR . 97.5 mt -56.38 -24.95 19.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.27 -15.25 33.08 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 121.471 0.653 . . . . 0.0 109.621 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.817 ' HB2' HG23 ' A' ' 298' ' ' THR . 76.4 mt-30 -100.41 1.36 41.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.443 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 55.39 32.45 18.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.182 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.817 HG23 ' HB2' ' A' ' 296' ' ' GLN . 24.3 p -74.13 -5.65 43.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.38 45.51 75.21 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.941 -1.123 . . . . 0.0 113.948 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 37.0 mtmt -122.26 37.9 4.27 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.883 ' CE1' HG23 ' A' ' 412' ' ' ILE . 73.8 m-85 -162.31 164.26 27.58 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.1 p -149.43 163.55 37.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.2 p90 -137.43 131.13 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 112.39 149.69 10.96 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.898 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.007 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.24 -58.23 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 110.934 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.6 pt-20 -49.33 -55.62 12.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.0 -52.42 63.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.701 0.286 . . . . 0.0 111.535 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 49.7 m -59.32 -39.96 84.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.091 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.823 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.1 mp -66.26 -42.08 89.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 314' ' ' MET . 24.4 mtmt -59.95 -45.42 92.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.129 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -70.03 -28.61 65.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.899 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.27 -24.97 59.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.985 0.422 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -78.94 -28.91 43.82 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 14.3 mmt -81.2 -8.04 59.68 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.676 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.05 13.67 28.24 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.742 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.78 -11.22 58.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.74 0.305 . . . . 0.0 110.835 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.819 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.9 m -90.44 105.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.83 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.91 -49.42 77.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.418 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.887 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.3 mm -135.76 127.1 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 120.611 0.243 . . . . 0.0 111.434 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.674 ' HG ' HG23 ' A' ' 322' ' ' VAL . 55.4 tp -93.69 128.15 39.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.252 0.548 . . . . 0.0 111.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -115.43 107.26 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.975 179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.674 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.8 t -125.78 161.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.659 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.902 ' CE2' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -112.25 132.59 54.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 111.396 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.732 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.3 pt-20 -56.23 -25.92 49.32 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.847 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -90.05 45.28 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.291 . . . . 0.0 110.921 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 25.3 tp -89.14 124.2 34.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 110.948 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.16 30.04 2.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.521 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.031 HG22 HD12 ' A' ' 374' ' ' LEU . 20.0 mm -124.52 135.18 64.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.129 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.645 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 60.5 mtp -140.11 162.32 35.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.623 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.692 ' CZ ' HG21 ' A' ' 343' ' ' ILE . 15.6 ttt85 -88.08 117.12 26.74 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.029 0.442 . . . . 0.0 111.588 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.511 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 6.8 m-85 -125.42 123.39 39.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.347 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.981 HG12 HG13 ' A' ' 343' ' ' ILE . 17.6 m -92.21 121.83 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 111.436 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.845 HD11 ' CD2' ' A' ' 357' ' ' PHE . 1.1 mp -109.26 148.09 31.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.502 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.544 ' CD2' HD11 ' A' ' 369' ' ' ILE . 11.2 m170 -81.35 179.6 7.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.396 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 340' ' ' GLU . 0.1 OUTLIER -142.08 105.63 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 111.208 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 52.27 33.36 12.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.6 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.15 88.14 0.99 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.184 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 339' ' ' GLU . 1.1 p 45.51 -169.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.631 0.253 . . . . 0.0 111.667 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 338' ' ' THR . 5.5 mm-40 77.08 -15.27 0.76 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.941 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 335' ' ' CYS . 6.0 tp10 -158.68 118.22 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.427 ' OE2' ' CD2' ' A' ' 334' ' ' HIS . 3.2 mm-40 -109.23 137.98 46.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.008 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.775 ' C ' HD12 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -128.27 146.62 50.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.17 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.981 HG13 HG12 ' A' ' 332' ' ' VAL . 1.3 mp -117.91 126.94 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.6 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 46.6 tp -134.8 159.78 40.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.277 0.561 . . . . 0.0 111.279 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.633 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 3.5 p90 -100.07 119.48 38.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.554 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.592 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.2 mm? -124.33 163.58 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 112.534 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 3.0 p -101.32 170.79 6.07 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.669 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.1 Cg_exo -49.36 -42.0 41.86 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 121.836 1.69 . . . . 0.0 111.862 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.2 -50.02 75.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.052 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 48.9 mt-30 -69.38 -50.12 49.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.97 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 84.2 mt-10 -59.96 -35.06 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -57.74 -33.18 68.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -95.37 36.22 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.635 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.69 ' HB2' HD13 ' A' ' 368' ' ' LEU . 5.6 ptpt -70.03 -23.65 63.14 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.239 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.4 m -60.48 -39.99 89.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 110.461 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 366' ' ' HIS . 99.3 m-70 -99.05 -50.59 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.845 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 53.2 7.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.713 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.807 HG21 ' HB2' ' A' ' 364' ' ' GLN . 0.2 OUTLIER -92.2 -176.87 4.49 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 110.997 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.572 ' H ' HG22 ' A' ' 358' ' ' THR . 96.0 m-20 -82.19 156.89 24.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.978 0.418 . . . . 0.0 110.949 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -75.07 -0.83 20.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.968 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -83.0 -45.89 13.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.673 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.452 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 1.0 OUTLIER -113.83 -37.11 4.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.922 0.391 . . . . 0.0 110.454 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 364' ' ' GLN . . . 67.31 27.52 73.52 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.162 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.807 ' HB2' HG21 ' A' ' 358' ' ' THR . 85.7 mt-30 -46.18 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -113.88 107.04 15.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 356' ' ' HIS . 68.1 m-70 -91.73 -174.68 3.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -140.72 113.5 8.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.358 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.69 HD13 ' HB2' ' A' ' 354' ' ' LYS . 6.2 tt -90.54 123.01 33.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.559 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.564 ' HB ' ' CG2' ' A' ' 332' ' ' VAL . 2.4 mp -76.05 -42.42 38.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.486 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -169.56 167.22 9.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.059 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.511 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -142.82 116.38 9.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.999 0.428 . . . . 0.0 110.775 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 8.7 tpt -120.83 134.93 24.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.276 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 25.4 Cg_exo -61.01 130.36 32.35 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.926 1.75 . . . . 0.0 110.412 178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.031 HD12 HG22 ' A' ' 328' ' ' ILE . 14.7 mt -69.63 -40.6 76.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.669 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 391' ' ' ILE . 60.1 tp -60.19 -56.1 25.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.902 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.0 mt-10 -57.58 -40.05 78.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.69 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.97 -40.02 91.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.458 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.2 OUTLIER -70.56 -26.87 63.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.43 -8.84 52.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.397 . . . . 0.0 112.005 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -108.23 -9.5 15.51 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.26 18.03 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -66.35 -21.02 66.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.595 0.236 . . . . 0.0 111.317 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -77.19 -46.36 23.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.834 0.349 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -62.87 -41.71 99.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 0.0 110.679 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -74.07 -17.89 60.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.65 2.35 69.25 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.209 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.819 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.2 163.07 18.01 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.056 0.455 . . . . 0.0 110.526 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.887 ' HB ' HG23 ' A' ' 319' ' ' ILE . 90.0 m -106.66 99.84 9.39 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.597 ' O ' HD13 ' A' ' 389' ' ' LEU . 2.3 tm? -76.12 102.6 5.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.923 0.392 . . . . 0.0 111.235 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.665 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.4 mm-40 -111.92 132.09 54.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.157 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.732 HG21 ' HB3' ' A' ' 324' ' ' GLU . 37.8 mm -94.97 105.63 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.046 0.451 . . . . 0.0 111.886 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.902 HG23 ' CE2' ' A' ' 323' ' ' TYR . 6.5 m -101.91 -169.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.813 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.582 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.8 p -158.03 154.04 27.0 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.331 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.47 0.96 3.41 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.202 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -59.8 -40.87 89.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.618 0.247 . . . . 0.0 111.394 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 283' ' ' GLU . 53.5 p -85.51 168.59 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -60.05 -55.16 37.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.887 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 69.6 mm-40 -63.21 -36.07 82.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 109.852 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.527 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -52.72 -59.04 9.75 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.323 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.4 m -59.59 -19.7 50.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 32.7 mt-30 -69.69 -40.04 76.57 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.696 0.284 . . . . 0.0 111.069 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.561 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.9 m-85 -62.04 -36.5 81.8 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.013 0.435 . . . . 0.0 110.03 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.883 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 55.8 t -60.09 -38.8 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.602 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -71.36 -45.63 62.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.991 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -58.75 -44.83 95.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.99 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 303' ' ' PHE . 60.3 t80 -146.44 -66.26 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.71 57.26 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.808 -1.187 . . . . 0.0 115.165 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 139.78 -36.1 1.86 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.258 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.656 HG12 HG13 ' A' ' 305' ' ' VAL . 0.8 OUTLIER -132.24 133.38 60.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 117.964 0.882 . . . . 0.0 112.815 -177.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -150.83 136.67 5.69 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -121.73 143.64 15.95 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.441 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.883 HG23 ' CE1' ' A' ' 301' ' ' TYR . 30.9 mt -104.47 125.49 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 30.3 mt -94.98 163.16 13.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 0.0 112.799 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 415' ' ' TYR . 74.6 mtt180 -78.48 -38.36 41.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.764 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 414' ' ' ARG . 89.9 m-85 -158.48 -179.94 8.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.793 ' HG2' ' O ' ' A' ' 298' ' ' THR . 45.8 mtm180 -61.99 124.16 20.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.721 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.422 ' CG2' HD13 ' A' ' 413' ' ' LEU . 33.2 m -130.03 159.98 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.201 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -74.24 129.98 38.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.704 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.95 -39.99 75.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.221 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 58.24 40.06 25.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.389 . . . . 0.0 110.763 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 134.14 140.15 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.362 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 20.9 ptp -159.15 179.91 8.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.749 0.309 . . . . 0.0 110.957 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.56 -33.09 67.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.957 0.408 . . . . 0.0 110.561 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -107.04 107.16 18.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.516 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 2.1 tp-100 -162.59 160.36 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.942 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -54.14 -70.97 0.79 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.844 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 165.99 -96.95 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -36.13 76.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.992 0.425 . . . . 0.0 110.495 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.34 24.58 3.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.837 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.516 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 41.5 tt0 -60.06 -49.4 77.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.03 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 432' ' ' PHE . 87.1 m-85 -76.28 -40.09 52.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.443 ' CD2' ' O ' ' A' ' 432' ' ' PHE . 35.1 p90 45.14 69.51 0.43 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.221 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -77.92 6.1 8.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.931 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.28 -3.49 14.1 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.579 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.52 -40.07 81.87 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 110.47 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.91 -32.27 70.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.335 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.64 -35.8 75.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.02 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.01 -48.01 83.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.021 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.936 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 33.8 m120 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.75 0.31 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.546 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -66.3 -30.05 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.182 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -52.19 -45.92 65.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.639 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -59.96 -49.7 76.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.23 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -77.09 -27.48 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.758 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.608 HE22 HG13 ' A' ' 392' ' ' VAL . 0.4 OUTLIER -59.07 -39.96 83.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.262 0.553 . . . . 0.0 110.054 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.736 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.6 mt-10 -81.13 -44.0 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -67.44 -40.06 85.45 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -86.03 -58.65 2.56 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 319' ' ' ILE . 22.0 tp -61.2 -56.59 18.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.634 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 58.1 mt -59.97 -45.57 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -56.69 -37.67 77.96 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.264 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 41.4 ttt-85 -59.96 -36.84 77.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.407 0.622 . . . . 0.0 110.056 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.647 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 8.9 t80 -59.96 -46.07 90.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.683 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -83.68 -37.33 22.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 295' ' ' SER . 53.4 t0 -62.02 -47.39 84.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.829 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.5 mp0 -66.71 -40.0 88.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.887 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 301' ' ' TYR . 79.4 mt -60.72 -22.35 26.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -65.17 -13.54 58.42 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.347 0.594 . . . . 0.0 109.528 178.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.66 ' HB2' HG23 ' A' ' 298' ' ' THR . 67.9 mt-30 -102.96 -0.71 30.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.541 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.19 30.66 20.47 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.58 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.665 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 11.3 p -69.73 -12.36 61.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.871 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.17 48.57 85.28 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.123 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.577 ' HA ' HD12 ' A' ' 413' ' ' LEU . 3.2 mtpm? -125.94 37.45 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.89 ' CE1' HG23 ' A' ' 412' ' ' ILE . 82.1 m-85 -160.61 161.54 32.55 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.142 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.7 159.71 41.67 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -135.91 124.84 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.82 153.06 13.03 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.27 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.074 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -57.33 -58.45 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.764 0.316 . . . . 0.0 110.794 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.8 pt-20 -50.41 -53.53 28.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.98 -55.2 27.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 409' ' ' ILE . 21.4 m -57.01 -39.35 74.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.931 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.3 mp -67.54 -42.21 83.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 25.2 mtmt -60.0 -49.94 75.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.792 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.84 -29.27 67.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.63 0.252 . . . . 0.0 110.934 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.752 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -71.76 -26.84 62.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.919 0.39 . . . . 0.0 110.448 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 33.6 mm-40 -79.04 -27.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.2 mmt -80.28 -7.42 59.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.849 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.33 18.15 48.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.258 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -94.59 11.76 29.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.364 0.266 . . . . 0.0 111.04 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.83 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.0 m -111.33 105.53 18.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.792 ' O ' HD13 ' A' ' 319' ' ' ILE . 59.9 tt0 -59.95 -49.99 75.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.85 HG23 ' HB ' ' A' ' 388' ' ' THR . 43.5 mm -137.65 126.02 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.618 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.6 tp -90.95 128.79 36.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 111.314 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.775 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -113.5 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.766 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.618 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.9 t -122.68 150.56 26.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.332 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.7 m-85 -98.16 146.06 25.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 111.144 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.549 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.8 pt-20 -65.95 -33.28 75.45 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.074 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -90.06 41.91 1.07 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.623 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 29.3 tp -74.05 122.17 22.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 110.869 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -90.57 24.17 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.074 HG21 HG21 ' A' ' 305' ' ' VAL . 18.5 mm -125.95 131.34 71.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.676 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.743 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 66.7 mtp -140.27 161.76 36.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.593 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.639 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 72.6 ttt180 -85.1 116.09 23.27 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.937 0.398 . . . . 0.0 111.555 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.757 ' CD2' ' HB3' ' A' ' 371' ' ' SER . 15.0 m-85 -119.07 119.0 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.042 HG12 HD12 ' A' ' 343' ' ' ILE . 6.2 m -91.05 112.1 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.317 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.874 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.6 OUTLIER -91.99 174.83 7.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.672 -179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.565 ' CD2' HD11 ' A' ' 369' ' ' ILE . 1.7 m170 -120.38 -179.67 4.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.145 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 34.5 t -126.13 160.99 28.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.719 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -59.47 -39.9 85.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.909 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.11 -16.16 79.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.699 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.7 m 72.59 3.61 4.74 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -111.08 30.59 6.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.43 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -161.08 124.04 3.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.991 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -111.43 135.44 52.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.603 ' C ' HD13 ' A' ' 343' ' ' ILE . 22.2 ttpt -117.87 140.47 49.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.257 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.042 HD12 HG12 ' A' ' 332' ' ' VAL . 7.3 mm -118.12 117.52 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.97 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 346' ' ' LEU . 47.0 tp -131.18 157.68 42.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 112.139 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -98.91 121.21 40.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.923 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -121.09 161.39 21.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 4.4 p -101.66 169.14 8.06 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.115 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 86.5 Cg_exo -43.67 -53.02 4.75 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.812 1.675 . . . . 0.0 112.162 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.96 -58.8 5.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.79 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.13 -44.99 95.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.944 0.402 . . . . 0.0 111.36 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.8 mt-10 -60.03 -29.93 68.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.074 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 0.0 OUTLIER -57.6 -38.67 75.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.382 0.61 . . . . 0.0 109.755 179.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 61.3 t0 -78.3 61.98 2.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.211 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.728 ' HG3' HD23 ' A' ' 368' ' ' LEU . 18.2 ttpt -65.3 -50.25 66.39 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 66.3 m -55.87 -58.24 8.68 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.513 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 90.9 m-70 -80.48 -49.76 10.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.874 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.6 OUTLIER 53.13 10.35 0.17 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -178.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.809 HG21 ' H ' ' A' ' 365' ' ' GLU . 0.4 OUTLIER -98.32 -169.02 1.74 Allowed 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.08 0.467 . . . . 0.0 111.706 -179.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 358' ' ' THR . 95.9 m-20 -81.09 162.58 23.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.573 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -74.92 0.89 14.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -85.5 -47.3 10.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.692 0.282 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.459 HG21 ' CG ' ' A' ' 365' ' ' GLU . 1.6 t -115.68 -37.27 3.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.805 0.336 . . . . 0.0 110.517 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 57.4 24.66 52.82 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.773 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -151.7 36.03 0.56 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.809 ' H ' HG21 ' A' ' 358' ' ' THR . 70.9 mm-40 -125.58 13.05 8.08 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.66 ' CD2' HG23 ' A' ' 358' ' ' THR . 85.2 m-70 -145.96 160.0 42.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.713 0.292 . . . . 0.0 110.831 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -152.24 123.42 7.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.728 HD23 ' HG3' ' A' ' 354' ' ' LYS . 42.4 tp -95.16 133.56 38.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.058 0.456 . . . . 0.0 111.606 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.932 HD12 ' O ' ' A' ' 332' ' ' VAL . 1.8 mt -95.72 -57.8 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.615 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.553 ' O ' HG22 ' A' ' 332' ' ' VAL . 9.2 tt0 -160.47 140.22 11.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.085 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.757 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 90.9 p -116.19 139.05 50.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.49 0.662 . . . . 0.0 112.041 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -117.83 133.49 23.34 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.204 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 37.7 Cg_exo -58.39 114.29 1.92 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.824 1.682 . . . . 0.0 111.108 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.042 HD12 HG22 ' A' ' 328' ' ' ILE . 23.5 mt -60.01 -39.29 85.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.147 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.743 HD11 HD12 ' A' ' 391' ' ' ILE . 63.3 tp -60.01 -52.27 66.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 54.0 mt-10 -60.61 -39.94 90.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.205 0.526 . . . . 0.0 109.822 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -61.28 -40.02 92.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.569 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.708 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.4 OUTLIER -73.54 -24.19 60.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.48 -9.13 53.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.75 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -110.04 -10.02 14.71 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 80.7 m-20 -129.29 14.02 6.12 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -64.4 -18.5 64.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.584 0.23 . . . . 0.0 111.394 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -75.38 -39.97 58.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.865 0.364 . . . . 0.0 110.983 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -67.21 -40.88 86.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.672 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.585 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.1 m-85 -72.67 -16.36 61.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.978 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.7 2.52 70.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.894 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.83 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.96 164.45 15.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.271 0.558 . . . . 0.0 110.934 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.85 ' HB ' HG23 ' A' ' 319' ' ' ILE . 57.7 m -107.19 100.59 10.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.11 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.572 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -71.99 102.87 3.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.384 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.555 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.6 mm-40 -111.02 138.88 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.877 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 375' ' ' LEU . 36.7 mm -101.92 103.56 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.623 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.4 m -101.6 -171.28 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.225 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 1.0 OUTLIER -156.24 153.75 29.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.369 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.473 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 36.5 p-10 -70.89 2.94 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -60.05 -40.0 87.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.567 0.222 . . . . 0.0 111.399 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 52.5 p -84.65 169.86 13.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.853 0.358 . . . . 0.0 111.416 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -60.04 -52.51 65.07 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 65.1 mm-40 -61.64 -38.08 86.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.372 0.606 . . . . 0.0 109.574 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.473 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -63.22 -25.04 67.88 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.792 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 68.3 m -82.88 -25.7 32.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.529 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -73.14 -45.21 58.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 287' ' ' ILE . 1.6 m-85 -56.29 -49.6 73.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.522 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 85.2 t -59.86 -35.21 59.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.762 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 400' ' ' SER . 24.3 mmtt -69.9 -49.96 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.203 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -68.86 -23.84 75.74 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.58 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 11.1 t80 178.76 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 97.87 167.07 31.93 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.674 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.89 -49.2 2.81 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.025 -0.607 . . . . 0.0 114.191 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.6 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -145.15 132.76 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 117.492 0.646 . . . . 0.0 112.205 -177.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.572 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -152.5 143.33 10.22 Favored Glycine 0 CA--C 1.509 -0.301 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -125.9 142.07 13.4 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.57 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.89 HG23 ' CE1' ' A' ' 301' ' ' TYR . 57.2 mt -104.66 128.65 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.805 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.5 mt -87.38 150.16 24.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.784 0.802 . . . . 0.0 112.821 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.715 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 72.7 mtt-85 -69.95 -36.19 75.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.825 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.573 ' O ' HG13 ' A' ' 417' ' ' VAL . 96.2 m-85 -159.38 167.04 29.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.772 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 298' ' ' THR . 2.2 mtm180 -55.12 121.91 9.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 415' ' ' TYR . 27.6 m -130.04 158.23 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -110.36 13.94 22.76 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.328 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 60.06 31.42 20.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.35 . . . . 0.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -70.01 156.12 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.076 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 431' ' ' PHE . . . 87.65 121.21 1.55 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.062 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 23.1 mmt 60.02 29.04 18.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 0.0 111.535 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.432 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 59.0 tt0 -152.2 103.84 2.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 61.89 30.1 18.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.476 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 421' ' ' GLY . 2.6 mp0 -98.99 139.98 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.78 -29.98 49.82 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.612 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -83.27 123.25 6.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.513 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.755 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -110.76 38.23 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.704 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -59.97 -40.64 89.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 110.379 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.503 ' CD1' ' HA2' ' A' ' 421' ' ' GLY . 24.9 m-85 -126.61 104.68 8.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.445 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -124.6 103.84 8.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 11.71 19.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.055 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 64.1 mt -73.4 -3.92 30.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.646 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -40.02 87.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 110.632 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -69.84 -30.6 68.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.569 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -60.0 -33.72 72.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.432 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.97 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.09 124.31 47.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.948 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 34.5 m120 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.771 0.319 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 10.6 p -67.61 -27.44 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.307 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -54.65 -39.97 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.575 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -68.67 -42.33 78.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.904 0.383 . . . . 0.0 111.534 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 278' ' ' VAL . 27.8 pt -82.72 -21.36 9.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.689 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.612 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.1 OUTLIER -59.92 -40.47 88.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.957 0.408 . . . . 0.0 110.382 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.623 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 24.8 pt-20 -85.62 -38.54 18.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.904 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -70.03 -39.92 75.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -86.22 -57.23 3.1 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.917 ' HG ' HD12 ' A' ' 321' ' ' ILE . 36.0 tp -58.26 -56.31 23.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.079 0.466 . . . . 0.0 111.719 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 392' ' ' VAL . 52.4 mt -59.36 -49.97 81.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.346 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.466 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.98 -39.79 89.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.591 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -60.06 -36.49 77.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.088 0.471 . . . . 0.0 110.136 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.586 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 4.9 t80 -59.08 -45.98 89.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.893 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -83.48 -42.32 17.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.864 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 295' ' ' SER . 45.1 t0 -60.72 -47.48 86.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.567 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.685 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 22.9 tp10 -63.06 -39.94 96.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 301' ' ' TYR . 87.7 mt -62.75 -26.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.599 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -60.34 -12.53 9.44 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.203 0.525 . . . . 0.0 109.957 178.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.805 ' HB2' HG23 ' A' ' 298' ' ' THR . 83.7 mt-30 -98.97 0.04 43.12 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.466 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.99 29.65 19.25 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.346 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.805 HG23 ' HB2' ' A' ' 296' ' ' GLN . 19.0 p -73.35 -7.75 52.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.958 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 51.65 53.47 29.02 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.938 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 22.0 mttt -130.2 41.95 3.33 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.6 m-85 -161.78 163.02 29.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.775 0.321 . . . . 0.0 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.0 p -149.12 161.82 41.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.74 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.837 ' HB2' ' CG ' ' A' ' 406' ' ' PHE . 53.0 p90 -141.44 149.99 41.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 96.67 142.19 12.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.171 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.742 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -49.37 -64.12 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.765 0.317 . . . . 0.0 111.238 -179.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.1 pt-20 -47.15 -52.89 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.831 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.0 m-20 -64.35 -56.75 12.32 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 26.0 m -58.03 -37.38 74.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.686 0.279 . . . . 0.0 110.925 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.742 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -69.94 -44.0 70.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.603 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 314' ' ' MET . 11.9 mtmm -59.9 -46.44 89.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.585 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.97 67.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.021 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.978 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.81 -24.92 55.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.895 0.378 . . . . 0.0 110.618 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -77.96 -28.32 49.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 89.8 mmm -81.1 -7.37 59.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.731 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.55 16.34 36.38 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.358 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -84.51 -9.65 58.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.411 0.284 . . . . 0.0 111.207 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.978 HG21 ' CD1' ' A' ' 312' ' ' LEU . 28.0 m -94.94 105.49 17.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.679 ' O ' HD13 ' A' ' 319' ' ' ILE . 43.0 tt0 -58.78 -50.9 72.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.275 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.88 HG23 ' HB ' ' A' ' 388' ' ' THR . 33.0 mm -134.05 127.0 50.96 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.061 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.737 ' HG ' HG23 ' A' ' 322' ' ' VAL . 31.6 tp -92.38 125.6 37.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.81 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.917 HD12 ' HG ' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -106.67 103.85 16.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.244 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.737 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.6 t -124.23 162.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.834 ' CE2' HG23 ' A' ' 392' ' ' VAL . 75.9 m-85 -112.67 149.78 32.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 111.905 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.632 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.6 pt-20 -65.91 -40.41 91.45 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.149 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -89.77 56.49 3.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.752 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 26.5 tp -89.09 121.75 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.472 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.1 m-20 -89.15 23.77 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.769 HG22 HD12 ' A' ' 374' ' ' LEU . 4.8 mm -121.62 131.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.6 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.3 mtt -139.48 162.97 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.455 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.622 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.5 ttt180 -88.85 116.04 26.83 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 112.012 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.6 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 9.1 m-85 -123.46 123.77 41.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.097 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.996 HG12 HG13 ' A' ' 343' ' ' ILE . 16.2 m -91.43 117.57 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.144 0.497 . . . . 0.0 111.662 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.924 HD21 ' CD1' ' A' ' 357' ' ' PHE . 5.3 mp -102.76 154.88 18.74 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.528 ' CD2' HD11 ' A' ' 369' ' ' ILE . 9.8 m170 -90.66 176.05 6.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.145 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.423 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 7.9 t -112.77 161.85 16.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -44.0 -39.32 4.03 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.847 0.356 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 338' ' ' THR . . . -85.51 -118.43 0.93 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.983 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.2 OUTLIER -164.84 19.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.1 40.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.497 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.423 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 7.4 tp10 -156.9 119.97 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.023 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -112.93 141.51 46.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.791 ' C ' HD12 ' A' ' 343' ' ' ILE . 5.5 tmmm? -128.54 146.88 50.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.394 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.996 HG13 HG12 ' A' ' 332' ' ' VAL . 1.7 mp -123.14 122.89 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.483 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 55.8 tp -130.69 161.65 31.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.342 0.591 . . . . 0.0 111.704 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.596 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 10.3 p90 -97.32 120.04 36.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.48 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.627 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -125.33 160.56 29.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.623 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.1 p -101.64 172.2 4.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.466 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 82.0 Cg_exo -46.6 -42.8 23.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.882 1.721 . . . . 0.0 111.92 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -59.22 5.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 88.9 mt-30 -60.37 -49.69 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.204 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 89.2 mt-10 -59.97 -31.5 69.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.207 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.55 -39.9 77.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.352 0.596 . . . . 0.0 109.414 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 63.2 t0 -82.76 60.77 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.129 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.641 ' HB2' HD23 ' A' ' 368' ' ' LEU . 9.0 pttp -69.95 -38.77 76.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.12 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 41.3 t -59.48 -58.06 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.616 0.246 . . . . 0.0 111.336 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 55.6 m80 -80.23 -56.98 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.704 0.288 . . . . 0.0 110.769 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.924 ' CD1' HD21 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.58 5.45 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.627 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.817 HG22 ' H ' ' A' ' 359' ' ' ASP . 4.4 m -91.32 -173.22 3.53 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.417 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.817 ' H ' HG22 ' A' ' 358' ' ' THR . 96.0 m-20 -78.69 162.27 26.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.774 0.321 . . . . 0.0 110.451 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -71.93 -3.87 25.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -84.56 -46.39 11.61 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.47 HG21 ' CD ' ' A' ' 365' ' ' GLU . 1.3 t -113.35 -37.33 4.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.976 0.417 . . . . 0.0 110.355 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.515 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 62.74 22.46 64.23 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.85 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.43 ' H ' HG21 ' A' ' 358' ' ' THR . 29.2 mt-30 -156.6 83.65 0.97 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.817 ' HB2' HG23 ' A' ' 358' ' ' THR . 81.7 mt-10 -151.03 -28.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.494 ' CB ' HD23 ' A' ' 333' ' ' LEU . 42.7 m170 -123.05 163.09 21.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 46.5 mt-10 -145.08 116.77 8.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 354' ' ' LYS . 56.6 tp -71.42 139.0 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.827 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.821 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.9 mp -109.44 -49.29 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.505 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.628 ' O ' HD11 ' A' ' 368' ' ' LEU . 9.1 tp10 -143.03 166.82 23.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.373 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.4 p -145.15 116.58 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.228 0.537 . . . . 0.0 111.611 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.477 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -115.69 130.87 24.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.961 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.579 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 30.7 Cg_exo -60.72 120.15 7.71 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.03 1.82 . . . . 0.0 110.752 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.769 HD12 HG22 ' A' ' 328' ' ' ILE . 20.2 mt -61.89 -39.56 92.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.021 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -59.99 -51.88 67.78 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.82 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.05 -40.15 88.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.718 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -63.0 -40.01 96.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.651 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.484 ' CZ ' ' HG ' ' A' ' 309' ' ' LEU . 0.4 OUTLIER -70.01 -24.92 63.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.31 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.03 -7.62 53.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.072 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -105.47 -11.9 16.22 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.65 16.02 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -62.11 -20.49 64.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.694 0.283 . . . . 0.0 110.942 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.93 -44.77 17.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -61.34 -40.57 94.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.704 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.661 ' CD2' HD23 ' A' ' 312' ' ' LEU . 23.5 m-85 -79.96 -12.7 59.7 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.15 55.44 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.873 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -84.87 161.54 19.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.979 0.418 . . . . 0.0 110.103 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.88 ' HB ' HG23 ' A' ' 319' ' ' ILE . 47.2 m -105.64 99.66 9.25 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.674 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.5 tm? -74.6 103.55 4.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.115 0.483 . . . . 0.0 111.082 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.612 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 7.2 mm-40 -110.66 140.47 44.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.911 HD12 HD11 ' A' ' 375' ' ' LEU . 18.2 mm -105.43 104.45 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.834 HG23 ' CE2' ' A' ' 323' ' ' TYR . 9.3 m -101.09 -170.06 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.879 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.618 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 1.5 p -154.59 152.51 30.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 111.756 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.42 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.4 p-10 -68.58 3.28 1.91 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.548 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -59.99 -40.1 88.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.645 0.259 . . . . 0.0 111.139 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 43.2 t -89.17 167.72 12.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.8 0.334 . . . . 0.0 111.516 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -60.07 -49.89 75.87 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.228 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 45.6 mp0 -63.47 -39.98 95.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.37 0.605 . . . . 0.0 109.756 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.502 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.3 -19.16 63.89 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.664 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.1 m -83.89 -22.46 31.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.017 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -74.23 -39.99 62.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.028 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.558 ' CD2' ' HE2' ' A' ' 406' ' ' PHE . 2.7 m-85 -63.26 -49.62 73.37 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.0 -45.92 94.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.824 0.345 . . . . 0.0 110.894 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -73.97 -43.98 56.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.742 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.405 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -66.37 -41.51 94.44 Favored Glycine 0 CA--C 1.495 -1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.837 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -129.29 -86.91 0.54 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.793 -0.704 . . . . 0.0 109.582 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 160.77 40.94 0.02 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.35 -1.405 . . . . 0.0 115.117 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.573 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 102.9 7.36 44.5 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.035 -1.078 . . . . 0.0 115.424 177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.568 ' CD1' HG22 ' A' ' 305' ' ' VAL . 0.4 OUTLIER -144.97 125.34 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.207 1.003 . . . . 0.0 110.449 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.432 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -153.31 145.32 12.63 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -126.35 140.46 12.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.548 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.809 HG23 ' CE1' ' A' ' 301' ' ' TYR . 56.6 mt -99.11 127.52 51.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 34.9 mt -92.08 165.66 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.476 0.655 . . . . 0.0 112.345 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -91.6 -27.19 18.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.162 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.522 ' O ' HG13 ' A' ' 417' ' ' VAL . 64.7 t80 -164.49 162.96 22.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 298' ' ' THR . 6.0 mmm180 -56.8 120.36 7.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -130.0 159.94 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.501 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -63.67 130.01 42.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.982 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -70.64 -52.49 20.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.649 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.416 ' O ' ' NE2' ' A' ' 425' ' ' GLN . 28.1 pt20 -159.92 163.71 34.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.135 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -51.06 123.46 17.48 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.845 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 39.9 mtt -128.43 168.08 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.8 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.11 -39.97 88.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.655 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -92.86 -4.29 53.15 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 420' ' ' GLN . 1.7 tp-100 -59.99 -41.36 91.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 111.307 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 70.99 79.09 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.564 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -167.46 105.09 0.23 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.44 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.97 -39.98 87.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.84 0.353 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.65 16.42 24.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.188 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.0 -49.95 75.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.556 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.03 -31.52 69.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.588 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -81.41 107.9 14.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -82.82 7.51 14.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.339 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.69 -9.76 39.55 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.775 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.03 -39.97 87.75 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -70.01 -31.37 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.355 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.405 ' O ' ' CE1' ' A' ' 440' ' ' HIS . 64.1 t80 -59.91 -31.88 70.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.745 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.06 -49.91 75.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.266 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -109.09 130.17 55.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.405 ' CE1' ' O ' ' A' ' 437' ' ' TYR . 59.1 m80 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.764 0.316 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 282' ' ' GLN . 7.1 p -67.09 -30.24 48.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.105 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -48.9 -44.29 40.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.97 -49.94 75.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.332 . . . . 0.0 111.216 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.412 ' HB ' ' HD2' ' A' ' 285' ' ' LYS . 46.8 pt -83.06 -20.99 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.687 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.626 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 23.0 tm0? -59.45 -39.57 84.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.587 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 59.7 mt-10 -78.97 -30.27 44.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.211 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -52.17 6.1 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 281' ' ' ILE . 15.0 mtpt -70.01 -56.98 5.56 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 1.031 ' HG ' HD13 ' A' ' 321' ' ' ILE . 23.7 tp -57.83 -54.93 41.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.317 0.579 . . . . 0.0 110.804 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.794 HG22 ' HG3' ' A' ' 398' ' ' GLU . 11.0 mt -63.46 -45.34 98.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.248 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.31 -39.48 82.55 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.604 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -59.98 -37.77 80.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.491 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 301' ' ' TYR . 21.7 t80 -60.05 -47.18 86.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.524 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -86.27 -35.92 19.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 295' ' ' SER . 26.2 t0 -66.22 -46.26 77.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.055 0.455 . . . . 0.0 111.306 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.692 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 10.5 tp10 -65.7 -39.93 91.75 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 301' ' ' TYR . 86.3 mt -62.22 -25.41 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -59.63 -14.72 14.82 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.28 0.562 . . . . 0.0 109.806 178.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.649 ' HB2' HG23 ' A' ' 298' ' ' THR . 51.4 mt-30 -98.2 -0.06 44.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.748 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.69 29.97 19.31 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.974 0.416 . . . . 0.0 110.582 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 296' ' ' GLN . 32.0 p -70.66 -12.05 61.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.949 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.26 47.78 89.17 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.72 -1.229 . . . . 0.0 114.442 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.751 ' HG3' ' CE2' ' A' ' 301' ' ' TYR . 16.8 ptpt -130.46 45.04 2.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.13 0.465 . . . . 0.0 110.783 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.841 ' CE1' HG23 ' A' ' 412' ' ' ILE . 87.3 m-85 -160.94 161.09 31.54 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.911 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 3.6 p -144.61 160.62 40.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.405 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 48.7 p90 -134.51 124.16 25.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.849 0.357 . . . . 0.0 110.819 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.509 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 113.79 155.1 11.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.369 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 374' ' ' LEU . 0.1 OUTLIER -59.91 -56.76 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.843 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.503 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -49.57 -57.46 7.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.482 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 302' ' ' CYS . 88.0 m-20 -60.06 -52.2 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 111.308 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.512 HG21 HG22 ' A' ' 409' ' ' ILE . 33.5 m -59.99 -40.03 87.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.138 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.976 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.0 mp -66.01 -46.72 76.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 111.253 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -57.64 -50.46 73.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.027 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 317' ' ' VAL . . . -65.18 -31.28 72.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.354 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.932 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.71 -24.29 59.9 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -79.73 -27.41 40.59 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.1 mmt -80.89 -8.83 59.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.313 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.55 15.16 38.61 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.518 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.723 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -86.52 -8.8 57.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.932 -0.134 . . . . 0.0 111.322 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.932 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.7 m -92.03 103.91 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 120.844 0.354 . . . . 0.0 111.708 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.672 ' O ' HD13 ' A' ' 319' ' ' ILE . 35.3 tt0 -58.68 -49.96 75.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.552 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.5 mm -133.75 126.6 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.545 0.212 . . . . 0.0 111.171 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.68 ' HG ' HG23 ' A' ' 322' ' ' VAL . 47.5 tp -92.03 124.04 35.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 111.342 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 1.031 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -111.41 105.1 18.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.584 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.68 HG23 ' HG ' ' A' ' 320' ' ' LEU . 23.4 t -116.51 159.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.833 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 70.2 m-85 -107.14 144.82 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -71.28 160.87 32.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.526 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.0 22.98 12.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.803 0.335 . . . . 0.0 110.445 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 24.4 tp -54.78 125.26 19.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.336 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -86.74 26.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.001 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.982 HG21 HG21 ' A' ' 305' ' ' VAL . 12.3 mm -130.76 130.57 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.537 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.633 ' HB2' ' CE1' ' A' ' 331' ' ' TYR . 9.9 mtt -139.68 162.66 34.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.582 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 3.0 ttt180 -85.28 118.08 24.6 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 120.728 0.299 . . . . 0.0 111.662 -178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.816 ' CZ ' ' HG3' ' A' ' 351' ' ' GLU . 43.8 m-85 -124.92 122.07 36.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.424 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.907 HG12 HG13 ' A' ' 343' ' ' ILE . 23.7 m -93.0 117.54 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 0.0 111.161 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.784 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.2 mm? -100.27 149.61 23.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.062 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.563 ' CG ' HD11 ' A' ' 369' ' ' ILE . 0.0 OUTLIER -88.85 -176.0 5.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.209 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 28.9 t -126.39 158.91 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -60.0 -39.94 87.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.997 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.43 -19.41 60.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.953 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 339' ' ' GLU . 0.3 OUTLIER 78.33 179.29 0.13 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.535 ' H ' HG22 ' A' ' 338' ' ' THR . 65.1 mt-10 61.82 35.77 16.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 0.0 110.426 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -163.69 121.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.949 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -112.19 138.11 49.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 0.0 111.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.803 ' C ' HD12 ' A' ' 343' ' ' ILE . 17.4 tttp -124.79 146.71 49.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.483 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.907 HG13 HG12 ' A' ' 332' ' ' VAL . 1.1 mp -119.46 120.03 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.283 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 59.9 tp -130.91 151.17 51.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.183 0.516 . . . . 0.0 111.626 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.546 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.62 116.95 29.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.54 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 357' ' ' PHE . 1.9 mm? -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.456 0.645 . . . . 0.0 112.58 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.5 p -100.41 169.7 7.59 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.96 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 85.5 Cg_exo -47.71 -46.07 22.11 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 121.943 1.762 . . . . 0.0 112.953 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 350' ' ' GLN . 23.9 pm0 -64.4 -41.72 96.48 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.424 ' N ' ' HG2' ' A' ' 349' ' ' GLU . 40.3 mt-30 -84.62 -48.18 9.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.816 ' HG3' ' CZ ' ' A' ' 331' ' ' TYR . 3.5 tm-20 -60.96 -27.8 68.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.946 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 348' ' ' PRO . 1.3 ttmp? -56.46 -30.02 62.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 109.807 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.559 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 58.6 t0 -88.34 63.52 7.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.1 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.641 ' HG2' HD13 ' A' ' 368' ' ' LEU . 20.2 mtmt -69.97 -40.48 75.35 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.8 t -60.2 -57.96 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.051 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.559 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 80.1 m80 -82.16 -45.27 15.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.387 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.784 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 52.59 12.56 0.26 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.974 0.416 . . . . 0.0 110.23 -178.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.4 m -104.77 -175.35 2.77 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.339 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.647 ' H ' HG22 ' A' ' 358' ' ' THR . 82.0 m-20 -130.05 138.76 50.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -72.84 -3.48 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.28 -26.41 13.32 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.604 HG22 ' HB2' ' A' ' 359' ' ' ASP . 7.2 t -120.4 -36.9 3.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.469 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 78.22 39.73 22.2 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.752 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.582 ' O ' HG23 ' A' ' 358' ' ' THR . 60.2 mm-40 -54.48 -167.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.848 0.356 . . . . 0.0 111.111 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 52.1 mt-10 -138.74 116.52 11.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 93.5 m-70 -159.3 147.09 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 68.3 mt-10 -141.94 105.36 4.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.288 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 331' ' ' TYR . 2.9 tt -64.66 119.84 11.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 0.0 111.804 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.563 HD11 ' CG ' ' A' ' 334' ' ' HIS . 2.5 mt -108.37 -50.02 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.491 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 39.1 mt-10 -137.97 155.4 48.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.333 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.566 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 1.4 m -148.26 116.66 6.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.187 0.518 . . . . 0.0 111.767 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.416 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.1 tpt -113.6 129.11 24.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.242 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 35.2 Cg_exo -56.0 120.51 8.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.805 1.67 . . . . 0.0 110.981 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.997 HD13 HG11 ' A' ' 305' ' ' VAL . 32.6 mt -62.03 -40.06 94.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.956 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.731 HD11 HD12 ' A' ' 391' ' ' ILE . 50.4 tp -60.8 -55.65 30.59 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 50.3 mt-10 -59.79 -40.05 86.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.874 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -60.93 -39.92 91.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.982 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.559 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.1 m-85 -72.82 -27.12 61.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.214 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.54 -10.81 47.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -108.42 -9.75 15.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.25 20.69 5.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.567 0.222 . . . . 0.0 111.47 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -69.0 -17.65 63.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.179 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.09 -43.45 17.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.876 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -62.84 -41.47 99.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.053 0.454 . . . . 0.0 110.466 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.515 ' CD2' HD23 ' A' ' 312' ' ' LEU . 28.6 m-85 -78.5 -15.84 58.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.805 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.34 2.21 66.97 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.52 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.837 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.62 162.66 18.73 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.164 0.507 . . . . 0.0 110.601 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 71.5 m -107.13 100.57 10.04 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.371 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.0 OUTLIER -72.19 105.53 4.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.389 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.626 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 14.3 mm-40 -111.39 143.5 42.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.774 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 375' ' ' LEU . 18.6 mm -107.37 100.69 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.79 ' HB ' HD11 ' A' ' 287' ' ' ILE . 18.6 m -100.54 -170.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.267 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.553 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.6 OUTLIER -160.35 157.1 27.32 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.945 0.403 . . . . 0.0 111.748 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.43 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 35.0 p-10 -71.5 -0.12 9.74 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.496 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -60.12 -39.93 87.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.641 0.258 . . . . 0.0 111.25 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 54.3 p -78.88 168.07 20.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.778 0.323 . . . . 0.0 111.213 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.97 -51.0 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 110.725 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.794 ' HG3' HG22 ' A' ' 287' ' ' ILE . 13.1 tp10 -70.07 -34.72 73.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.492 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -51.84 -57.21 13.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.8 m -60.7 -19.65 59.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.536 . . . . 0.0 112.073 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 36.6 mt-30 -70.3 -40.06 74.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.967 0.413 . . . . 0.0 110.467 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.608 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -59.6 -46.43 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.376 179.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.546 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 76.3 t -58.97 -33.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.378 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -69.14 -51.06 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.033 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -71.13 -22.1 78.47 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.637 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.509 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.0 t80 176.65 -77.4 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 98.48 168.33 31.33 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.52 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 76.32 -48.59 2.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.277 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.61 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.3 OUTLIER -144.22 132.33 17.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 117.495 0.648 . . . . 0.0 112.383 -177.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.59 137.51 6.29 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.55 139.39 12.54 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.392 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.913 HD11 HD11 ' A' ' 321' ' ' ILE . 56.2 mt -101.32 127.72 54.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 66.6 mt -91.6 168.77 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.719 . . . . 0.0 112.645 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -67.29 -40.05 86.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.742 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.652 ' O ' ' HB3' ' A' ' 300' ' ' LYS . 58.1 t80 -172.09 -60.17 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.724 0.297 . . . . 0.0 111.574 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -164.81 128.2 2.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.846 0.355 . . . . 0.0 110.643 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.723 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -130.03 159.99 41.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.538 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.49 134.65 57.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.32 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.426 ' O ' ' CD1' ' A' ' 419' ' ' PHE . 58.1 t80 -80.78 -5.76 57.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.385 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 65.9 29.63 10.26 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.844 0.354 . . . . 0.0 111.257 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 430' ' ' GLU . . . 69.26 -176.86 30.07 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.509 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.42 ' H ' ' HB2' ' A' ' 425' ' ' GLN . 27.9 mtt -135.12 169.15 17.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.938 0.399 . . . . 0.0 111.039 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -60.01 -40.04 87.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.311 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -99.15 7.52 45.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.42 ' HB2' ' H ' ' A' ' 422' ' ' MET . 7.1 tp-100 -59.98 -39.98 87.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.747 0.308 . . . . 0.0 111.263 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 155.95 -77.68 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.609 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 430' ' ' GLU . . . -141.42 -161.04 8.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.539 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.96 -40.0 75.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.63 54.6 1.22 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.25 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 427' ' ' GLY . 2.4 mt-10 -62.85 -43.74 97.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.396 . . . . 0.0 110.918 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -128.43 106.25 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 432' ' ' PHE . 24.8 p90 -122.5 98.55 5.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.371 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.96 9.4 27.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.395 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.97 -18.16 43.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.63 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -81.1 -20.07 42.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.656 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.98 -38.45 82.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.028 0.442 . . . . 0.0 110.343 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.98 -46.86 88.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.826 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -72.2 146.75 47.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 50.7 t30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.803 0.335 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.932 HG22 ' HB2' ' A' ' 282' ' ' GLN . 11.3 p -69.95 -30.62 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -42.48 -30.01 0.31 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.94 -60.0 2.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.747 0.308 . . . . 0.0 111.473 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.7 pt -82.31 -21.13 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.767 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.932 ' HB2' HG22 ' A' ' 278' ' ' VAL . 0.8 OUTLIER -58.5 -40.23 82.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.127 0.489 . . . . 0.0 110.491 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.429 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 34.0 tt0 -71.39 -38.28 71.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -78.98 -55.36 5.2 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -67.76 -58.58 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.931 ' HG ' HD13 ' A' ' 321' ' ' ILE . 17.6 tp -52.62 -57.6 9.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.986 0.422 . . . . 0.0 111.371 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.564 HG23 ' CD1' ' A' ' 402' ' ' PHE . 25.7 mt -61.69 -49.95 82.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.878 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -53.9 -38.67 60.51 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.439 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 36.6 ttt180 -60.08 -39.95 87.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.204 0.526 . . . . 0.0 110.286 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.598 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 15.7 t80 -55.82 -47.85 76.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.685 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 33.6 m-85 -83.59 -37.83 22.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 295' ' ' SER . 55.3 t0 -61.22 -42.23 98.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.429 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.709 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 3.2 mt-10 -69.89 -42.14 73.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.999 0.428 . . . . 0.0 109.882 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.4 mt -60.16 -24.6 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -62.9 -15.95 57.14 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.244 0.545 . . . . 0.0 109.871 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.678 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -101.9 0.76 35.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.521 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.3 29.86 19.49 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.99 0.424 . . . . 0.0 110.157 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.751 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 15.4 p -67.02 -10.15 46.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.997 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 54.55 49.57 60.46 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 119.841 -1.171 . . . . 0.0 113.374 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.7 mtmt -130.36 38.93 3.7 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.916 ' CE2' HG23 ' A' ' 412' ' ' ILE . 84.5 m-85 -160.88 161.42 31.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.252 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.4 p -148.66 163.25 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 406' ' ' PHE . 53.6 p90 -137.65 130.88 30.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.349 . . . . 0.0 110.69 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.463 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 109.35 142.46 9.68 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.361 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -50.17 -60.31 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 111.208 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 9.9 pt-20 -47.31 -54.04 12.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.629 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.08 -53.93 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 111.521 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 409' ' ' ILE . 40.6 m -58.36 -39.08 78.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.096 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.891 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.5 mp -65.93 -42.79 89.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 314' ' ' MET . 12.0 mtmm -59.96 -49.99 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.38 -29.35 69.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.29 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.958 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -75.07 -24.81 58.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 120.77 0.319 . . . . 0.0 110.733 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 76.8 mm-40 -79.39 -27.96 41.87 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 34.1 mmt -80.51 -7.57 59.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.759 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.97 18.33 47.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.409 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -90.63 -1.3 57.88 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.388 0.275 . . . . 0.0 111.371 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.958 HG21 ' CD1' ' A' ' 312' ' ' LEU . 30.3 m -100.3 104.3 15.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.924 ' O ' HD13 ' A' ' 319' ' ' ILE . 9.4 tp10 -57.71 -50.89 71.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.321 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 318' ' ' GLU . 26.4 mm -135.4 126.85 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 120.643 0.259 . . . . 0.0 111.221 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.662 ' HG ' HG23 ' A' ' 322' ' ' VAL . 48.6 tp -92.74 126.43 37.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 111.634 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.931 HD13 ' HG ' ' A' ' 286' ' ' LEU . 0.4 OUTLIER -112.67 106.69 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.302 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.662 HG23 ' HG ' ' A' ' 320' ' ' LEU . 11.8 t -124.8 161.95 27.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.155 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.738 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.4 m-85 -108.19 146.1 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.391 . . . . 0.0 111.217 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.641 ' HB3' HG21 ' A' ' 391' ' ' ILE . 11.4 pt-20 -65.02 -34.11 77.65 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.9 47.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.585 HD11 HD11 ' A' ' 409' ' ' ILE . 31.1 tp -81.01 123.15 28.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.577 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 347' ' ' THR . 95.9 m-20 -93.07 25.67 3.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 24.3 mm -123.18 132.6 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.666 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.5 mtm -140.35 162.09 36.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 9.4 ttt85 -89.7 119.99 30.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.105 0.479 . . . . 0.0 111.572 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.533 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 9.9 m-85 -127.11 123.09 36.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.485 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.998 HG12 HD12 ' A' ' 343' ' ' ILE . 14.2 m -92.8 114.29 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.942 0.401 . . . . 0.0 111.214 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 333' ' ' LEU . 1.7 mm? -93.58 160.5 14.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.004 0.431 . . . . 0.0 111.654 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.534 ' CD2' HD11 ' A' ' 369' ' ' ILE . 0.1 OUTLIER -108.69 -170.34 1.65 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.942 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 340' ' ' GLU . 48.8 t -121.48 160.77 23.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.714 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -57.07 -40.03 76.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -87.05 -11.93 69.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.631 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 2.9 m 74.1 30.0 1.28 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -129.01 25.56 5.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.004 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 335' ' ' CYS . 6.9 tp10 -160.87 125.37 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.139 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -118.72 140.78 49.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.01 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.837 ' C ' HD13 ' A' ' 343' ' ' ILE . 13.0 pttt -129.98 150.01 51.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.788 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.998 HD12 HG12 ' A' ' 332' ' ' VAL . 2.8 mm -120.05 119.31 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.525 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.745 HD23 HD11 ' A' ' 346' ' ' LEU . 54.9 tp -131.19 161.83 31.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.445 0.64 . . . . 0.0 112.153 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.739 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.8 p90 -99.97 121.15 40.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.047 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.921 HD12 ' HG2' ' A' ' 350' ' ' GLN . 1.6 mm? -127.42 160.61 30.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.625 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 15.2 p -101.5 172.49 4.39 Favored Pre-proline 0 N--CA 1.455 -0.177 0 CA-C-N 113.994 -1.457 . . . . 0.0 109.588 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 81.6 Cg_exo -49.5 -43.22 39.76 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.035 1.823 . . . . 0.0 112.414 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 350' ' ' GLN . 13.1 pt-20 -61.57 -49.27 77.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.921 ' HG2' HD12 ' A' ' 346' ' ' LEU . 10.9 tp60 -70.03 -48.1 59.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.781 0.324 . . . . 0.0 111.033 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 75.3 mt-10 -57.52 -33.6 68.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.583 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.78 -39.44 84.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.889 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -79.72 67.68 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.217 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.622 ' HE2' HD23 ' A' ' 368' ' ' LEU . 1.7 mtpm? -70.05 -37.43 75.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.71 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 93.2 p -56.23 -52.09 65.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.916 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.471 ' C ' ' H ' ' A' ' 358' ' ' THR . 79.1 m80 -88.29 -58.04 2.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 111.309 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.57 ' CE1' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 57.51 -3.28 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.84 HG21 ' N ' ' A' ' 364' ' ' GLN . 13.4 t -88.34 -162.71 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 0.0 111.472 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 363' ' ' GLY . 55.2 m-20 -95.63 161.57 13.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.453 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -75.78 -6.42 50.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.991 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -73.41 -41.76 62.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.0 110.307 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.681 ' OG1' ' HG3' ' A' ' 364' ' ' GLN . 2.4 t -116.61 -34.95 4.36 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.752 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 358' ' ' THR . . . 63.45 21.67 64.83 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-N 115.767 -0.652 . . . . 0.0 113.122 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.84 ' N ' HG21 ' A' ' 358' ' ' THR . 84.3 mt-30 -54.99 -172.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.04 0.448 . . . . 0.0 111.717 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -117.28 134.86 54.31 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.437 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.546 ' CD2' ' HB ' ' A' ' 358' ' ' THR . 82.9 m-70 -127.0 176.85 7.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -137.21 109.8 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.622 HD23 ' HE2' ' A' ' 354' ' ' LYS . 34.1 tp -72.93 132.79 43.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.812 0.339 . . . . 0.0 111.103 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.831 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.1 mp -89.03 -53.77 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.159 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 371' ' ' SER . 33.7 tt0 -147.51 166.54 26.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.711 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.2 p -143.62 116.99 9.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.084 0.468 . . . . 0.0 110.97 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.402 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.9 tpt -117.17 130.04 24.91 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.875 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 29.8 Cg_exo -60.02 125.17 16.9 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.832 1.688 . . . . 0.0 110.922 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.028 HD12 HG22 ' A' ' 328' ' ' ILE . 27.4 mt -66.49 -39.86 88.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.91 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 391' ' ' ILE . 65.0 tp -60.05 -52.16 66.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 55.6 mt-10 -58.89 -39.99 83.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.887 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -62.84 -40.83 98.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.618 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.55 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.6 OUTLIER -70.31 -27.76 64.64 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.59 -10.01 47.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.177 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -104.18 -12.78 16.49 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.976 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 30.6 m120 -129.64 19.93 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -65.51 -19.71 66.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.568 0.223 . . . . 0.0 111.253 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.77 -44.93 17.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.737 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -61.05 -39.93 91.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.655 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.623 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.6 m-85 -79.92 -13.14 59.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.84 2.26 56.84 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.305 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.918 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.02 163.16 18.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.0 110.649 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.884 ' HB ' HG23 ' A' ' 319' ' ' ILE . 48.5 m -107.82 100.41 9.79 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 389' ' ' LEU . 2.3 tm? -75.35 102.3 5.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.111 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.574 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -108.43 139.46 43.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.827 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.709 HD12 HD11 ' A' ' 375' ' ' LEU . 40.0 mm -103.49 104.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.388 0.613 . . . . 0.0 112.432 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.738 HG23 ' CE1' ' A' ' 323' ' ' TYR . 6.0 m -101.65 -169.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.917 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.55 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -156.16 153.08 28.71 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.958 0.409 . . . . 0.0 111.511 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 403' ' ' VAL . 11.8 p-10 -72.87 17.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.3 mmtt -70.03 -39.92 75.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.78 0.324 . . . . 0.0 111.235 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 22.5 t -89.26 170.04 10.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.678 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.0 -50.03 75.34 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.478 ' C ' HG21 ' A' ' 287' ' ' ILE . 66.8 mm-40 -64.51 -40.38 95.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.163 0.506 . . . . 0.0 109.803 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.541 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.31 -18.53 63.13 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.442 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 73.1 m -83.98 -21.74 31.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.848 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.52 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 84.4 mt-30 -75.14 -41.35 58.49 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.835 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.617 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 3.3 m-85 -59.73 -42.75 93.82 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.963 0.411 . . . . 0.0 110.295 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.792 ' HA ' ' HA2' ' A' ' 407' ' ' GLY . 57.7 t -60.01 -39.99 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.665 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -40.04 64.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.636 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.49 -38.78 96.87 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.117 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.463 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 62.5 t80 -151.6 -68.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.792 ' HA2' ' HA ' ' A' ' 403' ' ' VAL . . . 124.14 58.29 0.18 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 119.965 -1.112 . . . . 0.0 114.916 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 140.78 -34.13 1.98 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 119.387 -1.387 . . . . 0.0 115.214 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 305' ' ' VAL . 0.7 OUTLIER -137.98 134.9 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.944 0.872 . . . . 0.0 112.997 -177.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 402' ' ' PHE . . . -151.86 142.92 9.85 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -125.72 145.95 15.97 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 119.781 -1.199 . . . . 0.0 113.887 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.916 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.5 mt -107.03 127.09 62.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 24.6 mt -90.85 155.2 18.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.735 0.779 . . . . 0.0 112.753 -178.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.428 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 64.8 mtm180 -70.15 -39.97 75.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.418 -1.264 . . . . 0.0 110.55 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 54.3 p90 -159.86 175.48 13.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.738 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.751 ' HG2' ' O ' ' A' ' 298' ' ' THR . 15.5 mtm180 -57.66 123.89 17.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.918 0.39 . . . . 0.0 111.197 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.471 ' CG2' HD13 ' A' ' 413' ' ' LEU . 33.2 m -130.05 160.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 128.5 36.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.592 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -111.13 149.82 30.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -80.01 159.93 26.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.711 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -60.7 134.74 49.6 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.911 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.499 ' H ' ' HB3' ' A' ' 425' ' ' GLN . 45.8 mtt -118.89 169.65 9.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.672 0.272 . . . . 0.0 110.684 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.01 -42.58 94.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.728 0.299 . . . . 0.0 111.076 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -69.89 -34.79 74.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.008 0.432 . . . . 0.0 110.567 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.499 ' HB3' ' H ' ' A' ' 422' ' ' MET . 48.6 tt0 -65.64 128.77 37.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.982 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 45.88 -105.17 0.08 OUTLIER Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 155.08 -100.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.53 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -38.94 84.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -106.18 23.93 13.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 422' ' ' MET . 1.2 tt0 -59.94 -44.4 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.038 0.447 . . . . 0.0 110.646 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.443 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 20.7 p90 -106.38 83.73 1.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.769 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -106.28 22.18 16.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -79.71 45.16 0.67 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.489 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 26.8 mt -78.26 -3.81 44.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.467 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.94 -39.95 87.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 110.434 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.0 -32.74 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.331 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.57 -33.6 71.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.363 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.97 -47.44 85.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.922 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -59.92 -40.04 87.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.957 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.847 0.356 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 9.0 p -67.46 -26.81 36.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -40.23 74.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.664 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -50.07 75.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.468 ' HB ' ' HE2' ' A' ' 285' ' ' LYS . 41.9 pt -78.33 -27.65 14.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.191 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.54 ' O ' ' HB3' ' A' ' 286' ' ' LEU . 0.0 OUTLIER -51.91 -45.89 64.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.725 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 58.9 mt-10 -73.82 -39.65 63.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.782 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -73.4 -43.85 59.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.468 ' HE2' ' HB ' ' A' ' 281' ' ' ILE . 38.1 mttm -87.07 -58.44 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 319' ' ' ILE . 25.6 tp -57.41 -57.09 14.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.898 0.38 . . . . 0.0 111.454 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 283' ' ' GLU . 60.6 mt -60.12 -50.11 81.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.846 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.433 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.82 -36.13 78.28 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.716 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.402 ' HG3' ' OE2' ' A' ' 293' ' ' GLU . 10.2 ttt180 -60.08 -38.14 81.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.306 0.574 . . . . 0.0 110.291 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.632 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 5.6 t80 -59.93 -45.52 92.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.972 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -83.13 -35.14 25.83 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 49.3 t0 -65.39 -45.31 84.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.506 ' HB3' ' HE2' ' A' ' 301' ' ' TYR . 0.0 OUTLIER -68.95 -40.08 79.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.872 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 301' ' ' TYR . 85.8 mt -60.63 -24.05 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -64.09 -13.69 49.38 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.321 0.582 . . . . 0.0 109.642 178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 298' ' ' THR . 31.0 mt-30 -102.63 -0.02 32.56 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.583 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 58.54 30.63 20.04 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.062 0.458 . . . . 0.0 110.229 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.756 HG23 ' HB2' ' A' ' 296' ' ' GLN . 14.1 p -70.04 -9.71 56.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.47 42.96 94.15 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.839 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.566 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.4 mtmt -121.25 38.03 4.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.92 ' CE1' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -161.81 164.19 28.96 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.7 p -147.01 163.79 35.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.859 0.361 . . . . 0.0 110.887 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.403 ' HB3' ' OH ' ' A' ' 290' ' ' TYR . 47.6 p90 -137.72 128.52 27.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.838 0.351 . . . . 0.0 110.816 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.553 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 110.76 151.69 12.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.068 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -58.91 -56.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.598 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 8.2 pt-20 -51.11 -53.74 31.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.18 -52.24 59.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.735 0.302 . . . . 0.0 111.307 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 409' ' ' ILE . 33.6 m -59.42 -39.76 84.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.91 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.9 mp -67.51 -43.8 80.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.436 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.7 mttm -59.23 -49.36 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.778 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.7 64.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.31 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.801 ' HG ' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.95 -26.32 59.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.783 0.325 . . . . 0.0 110.691 179.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 73.9 mm-40 -76.83 -28.1 55.38 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.4 mmt -81.43 -7.38 59.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.899 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.03 13.51 27.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.72 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.13 -4.77 57.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.486 0.184 . . . . 0.0 110.914 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 413' ' ' LEU . 27.8 m -98.93 107.11 19.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.668 ' O ' HD13 ' A' ' 319' ' ' ILE . 33.9 tt0 -59.9 -50.03 75.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.779 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.857 HG23 ' HB ' ' A' ' 388' ' ' THR . 44.7 mm -135.8 127.28 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.677 0.275 . . . . 0.0 111.53 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.678 ' HG ' HG23 ' A' ' 322' ' ' VAL . 49.6 tp -93.23 128.22 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.03 0.443 . . . . 0.0 111.482 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.774 HD11 HD11 ' A' ' 412' ' ' ILE . 1.3 mt -114.07 107.87 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.678 HG23 ' HG ' ' A' ' 320' ' ' LEU . 19.0 t -125.3 149.15 29.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.327 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.625 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.6 m-85 -99.89 132.61 45.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.899 0.38 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.596 ' HA ' ' CD2' ' A' ' 375' ' ' LEU . 13.6 pt-20 -53.58 -29.6 38.24 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.426 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -91.4 45.33 1.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 38.9 tp -83.71 121.54 27.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.891 0.376 . . . . 0.0 110.645 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -91.26 23.54 3.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.953 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.068 HG21 HG21 ' A' ' 305' ' ' VAL . 19.6 mm -119.97 136.82 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.563 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.723 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 11.5 mtt -139.05 161.94 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 1.3 tpm_? -90.05 114.27 26.12 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.253 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 371' ' ' SER . 33.3 m-85 -109.29 145.63 35.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.737 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.88 HG12 HD12 ' A' ' 343' ' ' ILE . 2.7 m -109.7 109.34 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.311 0.577 . . . . 0.0 111.361 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.932 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.5 OUTLIER -97.14 175.07 6.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.411 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.83 ' CD2' HD11 ' A' ' 369' ' ' ILE . 32.6 m170 -113.27 170.01 8.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.804 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 49.4 t -105.65 160.55 15.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.56 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.14 -38.77 40.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.832 0.349 . . . . 0.0 110.883 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 338' ' ' THR . . . -82.47 -108.35 0.44 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.234 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.2 OUTLIER -178.54 36.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.07 0.462 . . . . 0.0 111.108 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -156.37 46.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.997 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 4.4 tp10 -170.84 113.64 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.699 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -99.13 139.06 35.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.058 0.456 . . . . 0.0 111.005 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.649 ' O ' HD13 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -115.02 141.43 48.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.984 -179.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.88 HD12 HG12 ' A' ' 332' ' ' VAL . 8.8 mm -120.72 121.46 65.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.02 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 346' ' ' LEU . 53.0 tp -130.09 161.02 31.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 0.0 112.13 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.565 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.2 p90 -103.78 119.78 39.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.076 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 346' ' ' LEU . 1.8 mm? -123.29 158.24 31.4 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 2.5 p -101.86 173.34 3.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 84.4 Cg_exo -45.45 -46.7 14.09 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.997 1.798 . . . . 0.0 112.27 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -60.39 -58.55 8.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.365 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.405 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 46.3 mt-30 -60.93 -47.31 87.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.644 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 76.9 mt-10 -59.76 -34.98 73.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.443 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -57.46 -29.77 64.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -92.31 40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.956 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.665 ' HA ' ' CD1' ' A' ' 357' ' ' PHE . 15.9 pttt -64.13 -28.66 69.92 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 55.1 m -60.04 -39.99 87.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.748 0.309 . . . . 0.0 110.776 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -106.81 -54.31 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.668 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.932 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 61.19 5.12 1.0 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.701 -178.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.724 HG21 ' N ' ' A' ' 364' ' ' GLN . 13.5 m -87.59 -178.9 6.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.458 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.718 ' H ' HG22 ' A' ' 358' ' ' THR . 96.0 m-20 -79.07 161.83 26.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.825 0.345 . . . . 0.0 110.315 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -74.64 -2.07 24.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.572 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -84.16 -46.07 12.3 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.09 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.82 -36.3 4.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.91 0.386 . . . . 0.0 110.844 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 358' ' ' THR . . . 62.78 21.7 63.43 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.881 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.724 ' N ' HG21 ' A' ' 358' ' ' THR . 23.0 mt-30 -156.07 83.14 1.0 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 111.821 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.638 ' HB2' HG23 ' A' ' 358' ' ' THR . 61.7 mm-40 -151.51 -47.59 0.11 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -101.73 169.92 8.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -148.59 119.33 7.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.347 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.727 ' HA ' HD12 ' A' ' 333' ' ' LEU . 2.4 tm? -83.82 127.88 34.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.213 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.83 HD11 ' CD2' ' A' ' 334' ' ' HIS . 3.5 mt -93.2 -49.29 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.547 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.795 ' O ' HG22 ' A' ' 332' ' ' VAL . 22.5 tt0 -179.36 153.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.028 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.91 ' HB2' ' CD2' ' A' ' 331' ' ' TYR . 17.5 t -125.42 148.09 48.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.449 ' HE3' ' HA ' ' A' ' 372' ' ' MET . 0.0 OUTLIER -119.87 128.82 25.67 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.152 179.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.723 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 71.7 Cg_exo -50.23 112.8 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.78 1.653 . . . . 0.0 111.153 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.984 HD13 HG11 ' A' ' 305' ' ' VAL . 14.5 mt -58.82 -40.04 82.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.388 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.625 HD11 HD12 ' A' ' 391' ' ' ILE . 65.6 tp -60.08 -52.49 65.11 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.305 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 51.4 mt-10 -60.94 -39.94 91.4 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.186 0.517 . . . . 0.0 110.125 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -61.11 -40.01 92.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.596 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.529 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.5 OUTLIER -71.48 -23.45 61.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.571 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -8.77 53.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.994 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -108.34 -10.3 15.35 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -130.03 20.35 5.41 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -67.42 -20.16 65.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -79.88 -43.61 21.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -60.82 -40.03 91.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.675 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -80.15 -11.38 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.1 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.4 2.46 54.8 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.302 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.836 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.73 163.37 17.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.194 0.521 . . . . 0.0 110.62 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.857 ' HB ' HG23 ' A' ' 319' ' ' ILE . 66.0 m -107.8 100.37 9.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.0 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 389' ' ' LEU . 2.1 tm? -73.76 102.63 4.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.552 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.9 mm-40 -108.84 139.44 43.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.408 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.625 HD12 HD11 ' A' ' 375' ' ' LEU . 16.4 mm -102.94 101.56 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.625 HG23 ' CE1' ' A' ' 323' ' ' TYR . 4.5 m -102.75 -172.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.587 -178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.607 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 14.6 p -156.99 152.41 26.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.337 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.9 t0 -78.91 76.96 5.39 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -119.22 -49.66 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 49.0 m -88.05 -176.78 5.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 11.7 mm-40 -59.43 -46.01 89.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.693 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.518 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 52.3 mp0 -64.5 -40.48 95.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.384 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -61.34 -27.69 68.11 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 72.9 m -83.87 -22.97 31.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.677 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 27.3 mt-30 -72.45 -40.62 66.88 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.501 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.637 ' CD1' HG23 ' A' ' 287' ' ' ILE . 2.1 m-85 -67.38 -49.96 61.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.443 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 394' ' ' ASP . 69.7 t -59.22 -38.14 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.467 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 400' ' ' SER . 8.6 mmpt? -69.96 -51.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.143 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -63.45 -26.2 69.35 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.543 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.553 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 17.0 t80 179.09 -73.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 96.85 167.11 33.3 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.499 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.427 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 76.06 -48.69 2.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.031 -0.604 . . . . 0.0 114.28 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -147.44 131.43 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.383 0.592 . . . . 0.0 111.985 -178.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.33 135.03 5.17 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -118.21 140.48 15.47 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.316 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.92 HG23 ' CE1' ' A' ' 301' ' ' TYR . 44.5 mt -103.5 125.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.849 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.1 mt -87.58 151.37 23.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.484 0.659 . . . . 0.0 112.264 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.571 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 63.4 mtt-85 -71.62 -33.9 69.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.632 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 417' ' ' VAL . 51.8 t80 -169.0 166.06 11.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -53.42 132.73 40.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 111.148 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.3 m -130.02 160.09 41.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -78.67 127.81 32.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.324 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -69.95 -40.02 75.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.074 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -104.2 142.8 33.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -81.8 -42.13 9.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.473 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 8.4 ptp -150.04 162.86 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.787 0.327 . . . . 0.0 110.838 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.21 -32.45 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.93 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -113.62 82.39 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.65 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.463 ' CB ' ' HG2' ' A' ' 430' ' ' GLU . 82.4 mt-30 -70.01 -39.99 75.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.416 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.84 68.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.781 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.08 -175.48 17.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.905 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.06 -40.1 88.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.441 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 -76.13 60.63 1.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.512 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.463 ' HG2' ' CB ' ' A' ' 425' ' ' GLN . 48.4 mt-10 -59.79 -41.14 90.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.708 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.438 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 51.3 p90 -144.32 114.74 7.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.357 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 19.0 p90 -133.59 85.7 2.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.273 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -90.08 15.79 9.56 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.459 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 53.5 mt -65.87 -9.46 29.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.804 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.481 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -78.41 -21.18 49.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.773 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -59.92 -38.33 82.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.04 0.448 . . . . 0.0 110.284 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.99 -44.99 94.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.954 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -60.06 -40.03 88.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.887 -179.878 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 32.4 m120 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.801 0.334 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.6 p -66.29 -27.58 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.204 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.67 -46.87 74.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.568 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.443 ' CD2' ' HE3' ' A' ' 395' ' ' LYS . 51.8 t80 -60.03 -49.09 79.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 0.0 111.091 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 278' ' ' VAL . 48.5 pt -76.45 -21.47 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' VAL . 0.0 OUTLIER -51.05 -39.58 56.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.815 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 20.5 mp0 -69.98 -46.73 64.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.98 -49.16 78.75 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -74.55 -58.83 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.737 ' HG ' HD13 ' A' ' 321' ' ' ILE . 40.6 tp -61.32 -58.84 6.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.957 0.408 . . . . 0.0 112.079 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.638 HD13 ' HA2' ' A' ' 399' ' ' GLY . 41.3 mt -59.99 -41.24 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.154 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 398' ' ' GLU . . . -57.1 -38.92 88.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 119.595 -1.288 . . . . 0.0 111.358 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 53.9 ttt-85 -60.02 -38.7 83.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.283 0.563 . . . . 0.0 109.767 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.637 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 8.3 t80 -60.01 -46.14 90.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -80.79 -35.01 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 295' ' ' SER . 66.3 t0 -60.01 -49.86 76.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.576 0.227 . . . . 0.0 111.572 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.623 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.1 mt-10 -61.75 -43.11 99.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 94.5 mt -57.76 -27.9 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.448 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.6 OUTLIER -63.69 -14.61 53.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.283 0.563 . . . . 0.0 109.56 178.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.623 ' HB2' HG23 ' A' ' 298' ' ' THR . 56.8 mt-30 -105.96 -2.46 22.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.653 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 59.85 32.44 21.27 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.033 0.444 . . . . 0.0 110.405 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 9.9 p -69.82 -14.31 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.841 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.73 46.36 94.64 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 119.869 -1.157 . . . . 0.0 113.363 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.545 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 49.2 mttp -122.68 33.97 5.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.4 m-85 -159.87 161.06 34.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.618 0.247 . . . . 0.0 111.544 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 55.7 m -140.99 159.94 41.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.09 0.472 . . . . 0.0 111.456 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.7 p90 -131.96 149.36 52.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 84.77 167.21 42.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.832 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.034 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.1 OUTLIER -71.59 -55.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.048 0.452 . . . . 0.0 111.065 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.7 pt-20 -47.31 -53.71 12.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.798 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 85.3 m-20 -64.27 -53.87 42.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.477 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.481 HG22 HD13 ' A' ' 312' ' ' LEU . 23.8 m -58.21 -40.03 80.57 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.668 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 1.034 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.9 mp -66.02 -47.52 74.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.834 0.35 . . . . 0.0 111.223 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 314' ' ' MET . 14.7 mttm -56.42 -49.98 72.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.98 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -67.42 -29.19 68.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.737 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.717 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.2 OUTLIER -71.24 -27.64 63.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.53 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.57 -26.77 41.26 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 5.5 mmt -80.47 -9.06 59.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.771 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.23 45.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.458 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.61 -5.45 58.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.142 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 387' ' ' ALA . 17.5 m -92.74 102.48 13.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.74 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.0 tt0 -59.4 -48.79 80.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.204 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.43 125.06 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 120.51 0.195 . . . . 0.0 111.362 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.606 ' HG ' HG23 ' A' ' 322' ' ' VAL . 23.6 tp -88.69 123.66 33.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.193 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.737 HD13 ' HG ' ' A' ' 286' ' ' LEU . 1.1 mt -109.53 103.66 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.505 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.606 HG23 ' HG ' ' A' ' 320' ' ' LEU . 10.6 t -114.39 153.64 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.663 ' HD2' ' HA ' ' A' ' 393' ' ' THR . 77.2 m-85 -99.94 142.18 31.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.474 . . . . 0.0 112.135 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.411 ' HB3' ' CG2' ' A' ' 391' ' ' ILE . 12.6 pt-20 -67.13 154.91 40.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.73 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 41.6 t30 60.05 25.39 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.967 0.413 . . . . 0.0 110.301 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.639 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 49.2 tp -52.41 128.89 27.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.719 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -91.02 22.23 3.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.481 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 374' ' ' LEU . 19.3 mm -124.41 135.88 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.62 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.654 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.02 161.97 36.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.642 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 47.3 ttt180 -91.5 118.78 30.88 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 110.892 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.536 ' CZ ' ' HG2' ' A' ' 351' ' ' GLU . 3.1 m-85 -116.21 153.13 32.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.894 HG12 ' CD1' ' A' ' 343' ' ' ILE . 16.1 m -114.59 114.04 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.145 0.498 . . . . 0.0 111.556 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.96 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.6 mm? -108.06 160.88 15.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.577 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.725 ' CD2' HD11 ' A' ' 369' ' ' ILE . 33.0 m170 -89.55 171.17 9.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.683 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 12.8 t -101.49 160.91 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.813 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . 0.42 ' HG2' ' HG3' ' A' ' 365' ' ' GLU . 78.6 mt-30 -44.83 -31.43 1.23 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -106.56 -116.09 4.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.799 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.74 172.43 18.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.664 0.269 . . . . 0.0 110.549 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 59.89 45.71 12.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.261 0.553 . . . . 0.0 110.107 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -172.23 128.5 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.175 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.16 139.01 52.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.008 0.432 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.62 ' O ' HD13 ' A' ' 343' ' ' ILE . 39.9 tttp -111.58 148.71 32.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.571 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.894 ' CD1' HG12 ' A' ' 332' ' ' VAL . 9.3 mm -119.0 123.86 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.611 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.67 HD23 HD11 ' A' ' 346' ' ' LEU . 50.5 tp -132.38 154.14 50.08 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.29 0.566 . . . . 0.0 111.998 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 345' ' ' TYR . 0.1 OUTLIER -95.38 116.53 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.258 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.67 HD11 HD23 ' A' ' 344' ' ' LEU . 1.3 mm? -118.83 152.0 37.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.409 0.623 . . . . 0.0 112.156 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.667 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 40.7 p -100.44 173.82 3.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.337 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.667 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -45.61 -45.07 16.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.786 1.657 . . . . 0.0 112.01 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -59.95 -57.33 13.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -62.26 -49.91 73.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.049 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.5 mt-10 -60.04 -32.75 71.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.471 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -57.39 -29.68 64.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 66.2 t0 -89.79 60.41 5.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.859 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 7.6 mtmp? -69.97 -39.04 76.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.848 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 74.1 m -57.88 -40.01 79.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.802 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 71.6 m80 -105.61 -53.12 2.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.846 0.355 . . . . 0.0 111.559 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.96 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.42 4.29 0.68 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -178.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 359' ' ' ASP . 0.2 OUTLIER -96.96 -166.24 1.37 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.57 ' H ' HG22 ' A' ' 358' ' ' THR . 85.8 m-20 -130.37 123.77 30.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -65.8 -2.39 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.755 0.312 . . . . 0.0 111.087 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -101.23 -23.69 14.38 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.457 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 359' ' ' ASP . 3.6 t -126.1 -36.28 2.36 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.441 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 364' ' ' GLN . . . 79.62 42.91 10.75 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.734 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.506 ' N ' HG22 ' A' ' 358' ' ' THR . 13.5 mm-40 -47.02 -177.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.312 0.577 . . . . 0.0 111.871 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 336' ' ' GLN . 76.0 mm-40 -119.34 28.97 7.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -88.2 139.99 29.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -140.26 112.51 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.019 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 333' ' ' LEU . 14.1 tp -65.08 127.31 31.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.252 0.549 . . . . 0.0 112.127 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.725 HD11 ' CD2' ' A' ' 334' ' ' HIS . 1.4 mt -115.48 -41.73 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.063 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.63 ' HB2' ' CG2' ' A' ' 332' ' ' VAL . 37.2 mt-10 -141.36 160.19 40.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.554 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 2.5 p -147.02 116.49 7.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.352 0.596 . . . . 0.0 111.125 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.43 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 9.1 tpp -118.51 134.36 23.48 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.473 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.5 Cg_endo -59.84 123.02 12.38 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.356 2.037 . . . . 0.0 110.846 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.044 HD12 HG22 ' A' ' 328' ' ' ILE . 12.2 mt -65.98 -44.08 85.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.845 HD11 ' CD1' ' A' ' 391' ' ' ILE . 56.3 tp -59.98 -50.0 75.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.576 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 47.3 mt-10 -60.57 -40.0 90.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.001 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.43 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 68.8 t-105 -67.51 -38.77 84.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.277 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.717 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.7 m-85 -73.47 -27.82 61.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.33 -9.29 53.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.144 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -107.87 -16.61 14.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.819 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -129.82 21.4 5.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.5 p90 -61.83 -16.62 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.566 0.222 . . . . 0.0 111.572 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -83.46 -36.39 24.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.667 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -60.02 -39.92 87.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.633 ' CD2' HD23 ' A' ' 312' ' ' LEU . 42.9 m-85 -87.04 -5.95 58.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.179 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 70.73 2.71 46.34 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.188 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.66 162.27 18.86 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.263 0.554 . . . . 0.0 110.944 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.871 ' HB ' HG23 ' A' ' 319' ' ' ILE . 76.0 m -107.11 100.91 10.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.29 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -66.85 102.33 0.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.596 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -109.71 134.2 52.26 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.845 ' CD1' HD11 ' A' ' 375' ' ' LEU . 30.9 mm -99.97 99.93 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 283' ' ' GLU . 13.1 m -100.99 -171.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.776 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.663 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 0.2 OUTLIER -160.04 156.44 26.98 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.008 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.491 ' HB3' HG21 ' A' ' 403' ' ' VAL . 36.4 p-10 -74.04 16.64 0.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.443 ' HE3' ' CD2' ' A' ' 280' ' ' PHE . 1.0 OUTLIER -70.01 -29.56 66.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.714 0.292 . . . . 0.0 111.411 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 17.2 m -97.3 169.66 9.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.946 0.403 . . . . 0.0 111.385 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -59.93 -50.0 75.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.096 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.445 ' HG3' ' CA ' ' A' ' 288' ' ' GLY . 75.0 mm-40 -67.84 -40.43 83.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.265 0.555 . . . . 0.0 110.121 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.638 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.99 -19.08 65.36 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.038 178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.4 m -83.92 -23.47 31.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.754 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -70.53 -40.01 73.71 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.704 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.618 ' HB2' ' OH ' ' A' ' 323' ' ' TYR . 1.5 m-85 -60.03 -50.71 72.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.297 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' A' ' 394' ' ' ASP . 73.8 t -56.51 -35.57 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.088 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -70.62 -49.86 43.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.869 0.366 . . . . 0.0 110.35 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -73.5 -18.58 79.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.041 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.483 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 10.4 t80 174.47 -78.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.22 169.61 30.6 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.306 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.473 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.5 -49.04 2.97 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.89 -0.672 . . . . 0.0 114.244 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.4 OUTLIER -140.49 133.72 33.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 117.527 0.663 . . . . 0.0 112.624 -177.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 402' ' ' PHE . . . -152.38 142.18 9.13 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.2 143.47 14.34 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.556 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.5 mt -104.26 128.87 57.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 30.0 mt -89.94 151.4 21.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.677 0.751 . . . . 0.0 112.494 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 415' ' ' TYR . 11.0 mtt180 -69.97 -38.47 76.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.866 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 300' ' ' LYS . 97.8 m-85 -160.71 178.47 9.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.371 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.13 136.76 58.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.894 0.378 . . . . 0.0 110.282 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.578 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -129.98 160.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -85.97 97.85 10.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.057 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -59.93 -50.11 75.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.769 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -145.39 -38.58 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.286 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -103.21 -118.32 4.45 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.491 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 83.1 mtp -114.03 160.04 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.641 0.258 . . . . 0.0 110.649 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 416' ' ' ARG . 36.9 tt0 -65.58 -43.5 89.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.203 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -59.98 -46.28 89.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.158 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 422' ' ' MET . 83.8 mt-30 57.41 51.77 9.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -63.15 100.37 0.34 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.619 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.47 -145.74 20.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.0 19.98 18.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.635 0.255 . . . . 0.0 111.015 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.9 52.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.153 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.47 ' CG ' ' HG2' ' A' ' 425' ' ' GLN . 51.1 mp0 -66.45 -37.66 85.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.492 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -125.83 105.95 9.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -132.41 128.4 37.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.623 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -88.57 13.32 12.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.471 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.01 -3.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.043 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -58.84 -40.07 83.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.735 0.302 . . . . 0.0 110.555 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.43 -24.94 60.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.737 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -59.93 -35.56 75.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.511 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.91 -41.05 90.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.924 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -69.09 127.28 32.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 13.5 m170 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.001 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.73 0.3 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.7 p -65.49 -29.96 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.333 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -50.12 -50.32 48.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.789 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.53 -50.03 74.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.571 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.737 HD12 ' HD2' ' A' ' 285' ' ' LYS . 49.4 pt -75.4 -21.06 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.717 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.674 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.8 OUTLIER -48.15 -44.73 32.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.258 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.504 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 4.1 mp0 -71.66 -32.06 67.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.467 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.65 -54.49 4.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.737 ' HD2' HD12 ' A' ' 281' ' ' ILE . 57.7 mttt -73.42 -57.99 3.62 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.9 tp -57.69 -54.88 41.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.767 0.318 . . . . 0.0 111.659 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.578 HG23 ' CE1' ' A' ' 402' ' ' PHE . 20.7 mt -59.96 -51.31 74.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.519 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.464 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -59.55 -36.23 88.64 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.012 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -59.98 -33.0 71.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.27 0.557 . . . . 0.0 110.075 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.604 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.4 t80 -60.08 -45.58 92.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.63 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 32.3 m-85 -85.83 -36.85 19.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 111.017 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -60.04 -49.96 75.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.839 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 301' ' ' TYR . 4.7 mp0 -66.29 -40.73 90.26 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.029 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.697 HD11 ' HB2' ' A' ' 301' ' ' TYR . 83.5 mt -60.0 -22.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -18.77 52.6 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.493 0.663 . . . . 0.0 109.62 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 298' ' ' THR . 41.6 mt-30 -101.41 0.21 36.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.828 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 57.73 29.89 18.08 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.965 0.412 . . . . 0.0 110.333 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.71 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.0 p -67.43 -11.53 58.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.828 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.25 53.4 45.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.402 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.56 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 43.0 mttt -130.34 36.66 3.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.878 ' CE1' HG23 ' A' ' 412' ' ' ILE . 86.6 m-85 -160.86 162.39 32.16 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.695 0.284 . . . . 0.0 111.743 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.1 p -148.99 165.98 30.01 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.963 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 52.2 p90 -138.45 148.6 44.57 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 91.29 157.57 33.83 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.049 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.064 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.98 -58.68 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.15 0.5 . . . . 0.0 110.662 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.0 -54.24 10.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.706 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 73.9 m-20 -63.67 -54.56 33.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.351 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.537 HG22 HD13 ' A' ' 312' ' ' LEU . 27.9 m -56.38 -37.91 70.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.897 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.972 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -69.7 -43.97 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.679 0.276 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.1 mttm -56.2 -52.62 63.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.67 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.98 -26.2 63.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.79 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.695 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -69.18 -36.81 77.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 110.685 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -70.77 -25.36 62.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 3.6 mmt -82.58 -7.87 59.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.889 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.11 13.61 42.74 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.253 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.971 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -81.43 -7.13 59.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.941 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.866 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.2 m -97.86 106.73 19.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.857 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.1 tt0 -59.93 -50.26 74.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.748 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.882 HG23 ' HB ' ' A' ' 388' ' ' THR . 26.5 mm -136.6 122.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.528 0.204 . . . . 0.0 110.776 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.9 tp -84.76 125.87 32.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.894 0.378 . . . . 0.0 111.006 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.67 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -109.65 103.58 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.284 179.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 320' ' ' LEU . 4.5 t -111.45 158.45 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.903 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 392' ' ' VAL . 9.8 m-85 -109.96 148.33 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.12 0.486 . . . . 0.0 112.196 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.539 ' HG3' HG22 ' A' ' 391' ' ' ILE . 90.1 mt-10 -67.48 158.92 30.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.183 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 55.39 29.42 13.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 33.8 tp -57.87 127.23 31.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.381 . . . . 0.0 109.999 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 347' ' ' THR . 34.3 p-10 -90.02 26.94 1.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.405 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.064 HG21 HG21 ' A' ' 305' ' ' VAL . 29.8 mm -128.25 132.96 67.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.939 0.399 . . . . 0.0 111.095 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 57.0 mtt -140.43 161.93 36.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.017 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 2.6 ttm180 -86.11 106.76 17.47 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.087 0.47 . . . . 0.0 110.757 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.537 ' CD2' ' HG2' ' A' ' 351' ' ' GLU . 3.9 m-85 -116.01 119.75 36.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.372 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.99 HG12 HD12 ' A' ' 343' ' ' ILE . 17.0 m -92.44 117.94 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.032 0.444 . . . . 0.0 111.662 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.688 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.6 mm? -105.25 153.39 21.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.91 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.68 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 0.6 OUTLIER -89.96 -177.87 5.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.731 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.432 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 44.7 t -104.06 157.66 16.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.997 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . 0.524 ' HG2' ' HB2' ' A' ' 365' ' ' GLU . 86.3 mt-30 -60.0 -40.02 87.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.242 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.39 10.29 57.88 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.112 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 339' ' ' GLU . 0.2 OUTLIER 67.09 -178.57 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.781 0.324 . . . . 0.0 110.93 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.49 ' H ' HG22 ' A' ' 338' ' ' THR . 76.2 mm-40 60.04 28.49 18.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 47.4 tp10 -165.65 126.42 1.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.878 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -117.26 136.02 53.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.413 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.703 ' C ' HD13 ' A' ' 343' ' ' ILE . 5.7 ttpt -117.4 144.64 44.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.405 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.99 HD12 HG12 ' A' ' 332' ' ' VAL . 5.4 mm -118.63 122.09 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.545 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 56.7 tp -136.2 161.02 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.281 0.562 . . . . 0.0 111.738 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.576 ' O ' HD13 ' A' ' 346' ' ' LEU . 2.4 p90 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.685 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.0 mm? -124.82 164.61 19.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.736 0.779 . . . . 0.0 113.009 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.1 p -101.83 171.26 5.5 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.803 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 83.1 Cg_exo -49.29 -42.39 40.52 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.98 1.787 . . . . 0.0 112.051 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -62.56 -50.22 72.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.327 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 21.6 mm100 -68.07 -48.81 64.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.591 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 94.2 mt-10 -60.01 -31.76 70.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.301 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -57.44 -32.31 66.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.152 0.501 . . . . 0.0 110.156 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 64.6 t0 -89.62 58.18 4.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.441 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 7.6 mtmp? -66.51 -40.02 88.96 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.6 t -62.47 -58.23 8.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.313 . . . . 0.0 111.585 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 91.4 m-70 -81.5 -51.83 7.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.369 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.86 ' HB3' ' HB2' ' A' ' 366' ' ' HIS . 0.5 OUTLIER 52.21 12.16 0.2 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.409 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.812 HG23 ' C ' ' A' ' 364' ' ' GLN . 6.3 m -97.43 -177.84 3.95 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.751 ' H ' HG22 ' A' ' 358' ' ' THR . 90.1 m-20 -132.62 135.55 45.94 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -72.84 1.38 8.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.673 0.273 . . . . 0.0 111.421 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -104.06 -22.38 13.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.812 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.642 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.7 t -122.92 -37.82 2.69 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.576 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 82.95 41.61 8.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.738 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.812 ' C ' HG23 ' A' ' 358' ' ' THR . 15.0 mm100 -92.86 98.33 11.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.463 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.524 ' HB2' ' HG2' ' A' ' 336' ' ' GLN . 17.3 mm-40 -69.34 132.87 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 111.181 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.86 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 64.2 m80 -139.56 159.99 40.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 70.4 mt-10 -142.99 115.16 8.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.93 0.395 . . . . 0.0 110.175 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 331' ' ' TYR . 14.1 tp -79.29 123.3 27.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.602 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.7 mp -93.8 -35.87 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.523 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 371' ' ' SER . 38.6 tt0 -158.12 165.4 35.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.564 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.406 ' N ' ' HG2' ' A' ' 370' ' ' GLU . 0.1 OUTLIER -147.2 115.84 6.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.571 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 2.7 tpt -115.17 120.09 37.42 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.783 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.662 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 7.5 Cg_endo -50.27 120.45 6.27 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.094 1.863 . . . . 0.0 111.107 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.985 HD12 HG22 ' A' ' 328' ' ' ILE . 18.4 mt -61.9 -41.42 97.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.669 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.826 HD11 HD12 ' A' ' 391' ' ' ILE . 45.5 tp -60.0 -53.3 59.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 61.6 mt-10 -59.93 -40.01 87.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.039 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -66.92 -35.72 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.462 ' HE1' HD22 ' A' ' 312' ' ' LEU . 1.2 m-85 -69.5 -27.5 65.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.965 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.13 -11.65 43.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.223 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -108.21 -9.74 15.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.925 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 14.7 m120 -130.0 18.24 5.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 52.7 p90 -67.89 -19.25 64.99 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 382' ' ' TYR . 33.1 mmtt -81.37 -40.93 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -61.49 -39.97 92.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.21 0.529 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.695 ' CD2' HD23 ' A' ' 312' ' ' LEU . 17.3 m-85 -81.55 -8.18 59.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.287 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.0 2.79 48.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.363 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.866 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.23 164.55 15.57 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 111.15 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.882 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.6 m -107.56 102.7 11.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.15 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 391' ' ' ILE . 0.9 OUTLIER -65.15 103.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.115 0.483 . . . . 0.0 111.124 -178.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.674 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 6.1 mm-40 -109.43 127.57 54.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.953 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.826 HD12 HD11 ' A' ' 375' ' ' LEU . 42.0 mm -99.91 100.01 9.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.429 . . . . 0.0 112.03 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.59 ' CG2' HG22 ' A' ' 321' ' ' ILE . 21.9 m -113.71 141.36 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.447 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 13.1 p -121.09 164.44 16.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.832 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -68.65 80.66 0.28 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -112.87 -30.13 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.305 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 8.3 t -126.76 -172.95 2.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 67.9 mt-30 -59.97 -49.51 77.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.524 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 52.8 mp0 -59.96 -44.12 94.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.181 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.95 66.52 Favored Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 404' ' ' LYS . 68.9 m -84.01 -23.47 30.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.44 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 73.4 mt-30 -70.99 -43.95 66.96 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.529 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.578 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.5 m-85 -62.89 -48.03 80.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 55.1 t -60.09 -39.58 80.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.001 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 400' ' ' SER . 25.4 mtmt -70.37 -52.83 19.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.77 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -62.39 -22.35 63.31 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.931 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 405' ' ' GLY . 18.0 t80 176.77 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.11 168.47 31.86 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.156 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.488 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 77.55 -47.69 2.76 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.39 133.38 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 117.847 0.824 . . . . 0.0 112.609 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.476 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -156.97 149.8 20.7 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -133.72 149.19 19.65 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.677 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.878 HG23 ' CE1' ' A' ' 301' ' ' TYR . 20.1 mt -110.25 127.75 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.125 HD13 HG13 ' A' ' 417' ' ' VAL . 78.3 mt -84.84 150.62 24.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.646 0.736 . . . . 0.0 112.76 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.684 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 20.7 mtm180 -70.01 -32.18 70.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.363 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.697 ' O ' HG12 ' A' ' 417' ' ' VAL . 53.2 p90 -159.45 179.51 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 298' ' ' THR . 1.2 tmm_? -61.96 94.64 0.05 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.264 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.125 HG13 HD13 ' A' ' 413' ' ' LEU . 1.3 p -130.05 130.02 65.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.176 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -112.71 159.78 18.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.599 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -69.47 -29.93 67.71 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.641 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -63.11 140.06 58.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.617 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -75.05 -84.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.811 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 93.6 mtp -92.36 176.81 6.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 111.064 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -59.96 -41.05 91.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.451 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.99 139.95 51.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.422 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.415 ' NE2' ' CG ' ' A' ' 430' ' ' GLU . 57.6 mt-30 -131.64 150.06 52.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 111.126 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 170.79 37.24 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.188 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -137.84 165.92 25.24 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.616 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -59.96 -40.06 87.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.698 0.285 . . . . 0.0 111.132 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -88.7 39.55 0.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.623 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.415 ' CG ' ' NE2' ' A' ' 425' ' ' GLN . 41.8 tt0 -61.41 -39.98 92.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.604 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.65 99.04 6.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -118.29 109.61 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.044 0.45 . . . . 0.0 111.179 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -72.57 -5.38 36.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.63 -13.52 0.67 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.207 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -55.17 -40.02 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -70.01 -32.56 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.374 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -59.98 -32.22 70.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.514 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.02 -40.03 87.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.101 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.849 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.802 0.334 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 282' ' ' GLN . 8.7 p -65.84 -29.73 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.294 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -51.32 -43.71 61.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.419 ' O ' ' HG2' ' A' ' 283' ' ' GLU . 63.8 t80 -66.76 -43.62 83.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.642 0.258 . . . . 0.0 111.519 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 278' ' ' VAL . 45.6 pt -82.77 -21.04 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.629 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.7 OUTLIER -57.67 -40.74 80.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.734 -179.23 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.512 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 21.3 pt-20 -73.22 -29.9 63.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.303 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -84.69 -56.67 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -69.92 -57.81 4.6 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.58 HD23 ' OE1' ' A' ' 282' ' ' GLN . 28.9 tp -57.45 -57.31 13.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.781 HG23 ' CE1' ' A' ' 402' ' ' PHE . 31.2 mt -59.94 -48.71 86.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.42 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.25 60.68 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.083 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 16.5 ttt180 -59.94 -40.11 87.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.614 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 6.6 t80 -57.39 -45.93 83.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.72 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -83.36 -38.25 22.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.734 0.302 . . . . 0.0 111.564 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.7 t0 -62.03 -46.16 90.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.462 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.679 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.3 mt-10 -64.2 -42.94 96.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 301' ' ' TYR . 91.7 mt -60.45 -21.43 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.643 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -66.17 -13.93 61.02 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.256 0.551 . . . . 0.0 109.665 178.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.73 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.9 mt-30 -103.47 -0.73 29.51 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.469 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.01 28.18 17.68 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 296' ' ' GLN . 15.2 p -67.64 -11.48 58.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.806 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.38 51.48 55.94 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.423 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.554 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.5 mttt -126.13 35.65 4.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.933 ' CE2' HG23 ' A' ' 412' ' ' ILE . 83.3 m-85 -159.84 162.96 34.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.536 0.208 . . . . 0.0 111.267 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.5 164.69 30.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 53.0 p90 -138.02 149.03 45.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.183 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 90.1 155.56 31.17 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.083 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.0 HG21 HG21 ' A' ' 328' ' ' ILE . 0.2 OUTLIER -63.55 -61.39 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.83 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.0 pt-20 -47.33 -52.31 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.43 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.3 m-20 -63.35 -55.77 21.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.398 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 35.7 m -57.82 -36.24 71.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.962 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.966 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.7 mp -68.63 -43.12 77.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 307' ' ' ASP . 52.3 mtmt -60.01 -45.43 92.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.556 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.06 66.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.813 0.339 . . . . 0.0 110.643 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.835 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.2 OUTLIER -72.09 -26.92 62.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.107 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.25 -27.84 47.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 92.8 mmm -80.9 -8.5 59.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.585 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.9 16.89 49.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.275 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -87.95 -8.44 55.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.342 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 387' ' ' ALA . 27.5 m -92.74 104.75 16.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.774 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.4 tt0 -59.64 -49.96 75.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.325 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 388' ' ' THR . 36.8 mm -136.7 124.05 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-O 120.617 0.246 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 322' ' ' VAL . 46.2 tp -87.92 126.05 34.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.956 0.408 . . . . 0.0 111.201 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -111.53 104.88 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 320' ' ' LEU . 21.7 t -122.4 162.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.435 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.627 ' CE1' HG23 ' A' ' 392' ' ' VAL . 96.1 m-85 -106.88 144.34 33.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.93 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.729 ' HB3' HG21 ' A' ' 391' ' ' ILE . 15.2 pt-20 -63.51 -36.48 83.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.38 45.7 1.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.555 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 35.9 tp -79.11 122.58 26.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.47 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.652 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.2 m-20 -90.25 29.56 1.23 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.811 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.071 HG22 HD12 ' A' ' 374' ' ' LEU . 26.1 mm -126.92 133.18 69.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.117 0.484 . . . . 0.0 111.567 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.701 ' HB2' ' HE1' ' A' ' 331' ' ' TYR . 8.7 mtt -140.19 162.08 36.11 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.877 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.512 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 17.1 tpt180 -86.6 111.47 20.66 Favored 'General case' 0 N--CA 1.461 0.097 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 38.8 m-85 -123.77 123.76 41.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.658 HG12 HD12 ' A' ' 343' ' ' ILE . 0.4 OUTLIER -101.85 120.2 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.688 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.742 HD11 ' CE2' ' A' ' 357' ' ' PHE . 0.9 OUTLIER -107.95 133.74 51.86 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.538 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.493 ' HB2' HD11 ' A' ' 369' ' ' ILE . 36.2 m170 -140.01 158.5 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.75 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 8.5 t -105.29 160.03 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.053 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -60.02 130.04 44.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.652 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 89.72 9.96 65.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.781 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 50.95 37.43 17.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.902 0.351 . . . . 0.0 111.295 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.01 6.69 43.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.303 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -167.14 111.62 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.759 0.314 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.456 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 12.0 mt-10 -122.8 129.05 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.253 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.774 ' C ' HD13 ' A' ' 343' ' ' ILE . 31.1 tttp -137.54 123.68 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.939 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.774 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.1 mm -110.22 118.67 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.891 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 29.3 tp -143.37 156.81 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.604 0.716 . . . . 0.0 112.684 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -92.12 127.34 37.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.896 178.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.542 ' HG ' ' CE1' ' A' ' 357' ' ' PHE . 2.2 mm? -122.09 165.09 16.62 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 327' ' ' ASP . 1.9 p -101.6 169.88 7.16 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.306 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 5.3 Cg_endo -47.13 -49.88 12.01 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.024 1.816 . . . . 0.0 111.749 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -54.96 -53.59 53.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.38 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 26.6 mm100 -65.25 -46.09 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.64 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 87.7 mt-10 -60.01 -34.77 73.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.124 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 38.6 mmtt -57.58 -29.63 64.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.349 0.595 . . . . 0.0 109.653 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -96.49 31.63 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.092 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.913 ' HB2' HD22 ' A' ' 368' ' ' LEU . 5.0 pttt -71.08 -21.89 62.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.442 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 47.5 t -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.194 0.521 . . . . 0.0 109.945 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' A' ' 358' ' ' THR . 97.8 m-70 -101.15 -49.77 3.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.282 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.742 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.3 OUTLIER 57.11 8.87 0.58 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.09 0.472 . . . . 0.0 110.349 -178.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.573 HG22 ' H ' ' A' ' 359' ' ' ASP . 6.3 m -105.28 178.64 4.5 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.082 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.827 ' HB2' HG22 ' A' ' 362' ' ' THR . 73.7 m-20 -130.72 132.9 45.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -69.41 -2.57 11.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.687 0.279 . . . . 0.0 111.734 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -102.63 -20.26 14.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 359' ' ' ASP . 14.2 t -116.08 -38.71 3.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.919 0.39 . . . . 0.0 110.531 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 79.78 40.27 15.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.82 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.441 ' H ' HG23 ' A' ' 362' ' ' THR . 12.9 mt-30 -52.85 -172.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.988 0.423 . . . . 0.0 111.033 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -145.93 87.55 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 96.4 m-70 -144.86 148.08 33.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.017 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 334' ' ' HIS . 5.8 mm-40 -140.89 114.47 8.83 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.913 HD22 ' HB2' ' A' ' 354' ' ' LYS . 16.7 tp -62.71 138.42 58.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.539 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 334' ' ' HIS . 3.3 mp -117.28 -40.98 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.002 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -143.99 149.81 37.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.497 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.71 ' OG ' HD21 ' A' ' 368' ' ' LEU . 0.8 OUTLIER -146.51 116.07 7.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.805 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 3.9 tpt -119.07 130.26 24.94 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.672 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.654 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.6 Cg_exo -56.77 118.35 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.836 1.69 . . . . 0.0 110.835 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.071 HD12 HG22 ' A' ' 328' ' ' ILE . 32.4 mt -59.89 -41.23 91.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.935 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.821 HD11 HD12 ' A' ' 391' ' ' ILE . 63.2 tp -60.01 -54.37 46.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.749 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 48.7 mt-10 -59.62 -40.03 86.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 109.564 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -60.24 -39.85 88.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.988 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.577 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.9 OUTLIER -74.88 -27.37 60.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.588 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.61 -12.58 42.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.986 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -106.34 -13.7 15.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 32.8 m120 -129.96 20.06 5.46 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.408 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 54.7 p90 -63.09 -16.1 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.584 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -83.31 -38.05 22.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 110.861 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -60.95 -38.02 84.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.766 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 381' ' ' ASN . 48.7 m-85 -85.95 -9.15 57.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.67 2.52 60.81 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.444 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.842 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -88.16 165.54 15.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.231 0.539 . . . . 0.0 111.05 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.885 ' HB ' HG23 ' A' ' 319' ' ' ILE . 53.4 m -108.92 101.75 10.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.434 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 391' ' ' ILE . 2.3 tm? -70.78 102.6 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.629 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 75.8 mm-40 -111.38 131.98 54.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.834 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.821 HD12 HD11 ' A' ' 375' ' ' LEU . 38.0 mm -98.76 103.83 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.119 0.485 . . . . 0.0 112.182 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.627 HG23 ' CE1' ' A' ' 323' ' ' TYR . 5.8 m -100.73 -172.99 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.823 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 392' ' ' VAL . 1.3 p -157.94 154.0 27.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.07 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.462 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 34.5 p-10 -73.22 20.0 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -66.91 -40.03 87.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.635 0.255 . . . . 0.0 111.301 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 20.8 m -93.08 173.7 7.6 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.559 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -59.9 -50.11 75.08 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.926 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.9 -40.44 97.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.322 0.582 . . . . 0.0 109.648 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.462 ' C ' ' HA ' ' A' ' 394' ' ' ASP . . . -61.93 -23.01 63.08 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 53.6 m -83.7 -23.11 31.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.092 -0.554 . . . . 0.0 110.483 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -76.23 -41.44 49.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.781 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.3 m-85 -60.0 -50.07 75.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.548 ' HA ' ' CA ' ' A' ' 407' ' ' GLY . 70.1 t -60.31 -39.96 82.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.563 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 400' ' ' SER . 1.4 mmpt? -71.14 -46.02 62.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.808 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -73.97 -31.02 60.41 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.595 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.3 OUTLIER -156.7 -83.36 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 403' ' ' VAL . . . 99.39 148.63 23.31 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.995 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.527 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.67 -47.09 2.97 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.614 -0.803 . . . . 0.0 114.607 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.36 134.44 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 118.336 1.068 . . . . 0.0 112.737 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -155.12 148.2 18.23 Favored Glycine 0 CA--C 1.511 -0.173 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.43 150.08 19.6 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.872 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.933 HG23 ' CE2' ' A' ' 301' ' ' TYR . 27.1 mt -109.5 126.8 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 42.3 mt -90.83 157.42 17.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.675 0.75 . . . . 0.0 112.776 -178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 415' ' ' TYR . 63.0 mtm180 -74.36 -40.03 62.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.531 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 417' ' ' VAL . 85.1 m-85 -160.79 172.97 16.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.642 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.1 OUTLIER -56.88 124.42 18.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.682 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.0 m -129.99 160.02 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.396 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.61 136.44 45.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.0 -40.0 75.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.852 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -139.61 139.97 36.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -107.71 109.46 2.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.403 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 30.9 mtt -139.99 169.91 16.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.03 -40.02 87.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -72.97 -16.11 61.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.363 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.908 0.385 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 137.54 37.93 0.15 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 152.94 123.21 0.96 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.588 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.95 -33.05 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.913 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -88.67 22.2 2.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.507 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.97 -39.92 87.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -97.27 37.76 1.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.547 ' O ' ' HG ' ' A' ' 434' ' ' LEU . 19.5 p90 -59.62 -50.05 75.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.581 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 40.72 31.06 0.11 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 121.109 0.48 . . . . 0.0 111.38 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 432' ' ' PHE . 54.9 mt -99.53 -1.41 38.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.275 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.04 -41.24 91.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.763 0.316 . . . . 0.0 110.71 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -69.97 -33.16 71.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.496 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -60.0 -31.8 70.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.618 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.02 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.002 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.71 130.03 49.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.898 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.754 0.312 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -68.76 -28.25 39.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.29 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -53.33 -40.03 64.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.642 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -60.03 -49.85 76.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.0 111.082 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.455 ' HB ' ' HE3' ' A' ' 285' ' ' LYS . 44.4 pt -82.7 -23.06 8.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.777 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.675 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.98 -40.03 87.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 110.221 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 15.8 pt-20 -85.24 -34.33 22.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.287 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -72.0 -39.97 68.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.455 ' HE3' ' HB ' ' A' ' 281' ' ' ILE . 21.2 mttt -86.6 -58.23 2.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.548 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 29.7 tp -57.69 -55.88 29.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 112.03 -178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.71 HG23 ' CE1' ' A' ' 402' ' ' PHE . 42.3 mt -58.0 -48.41 84.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.725 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.488 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.39 -37.54 82.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.716 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 23.4 ttt85 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.335 0.588 . . . . 0.0 110.192 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.657 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.2 t80 -56.98 -46.76 81.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -79.12 -40.01 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.756 0.312 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 295' ' ' SER . 54.0 t0 -61.65 -45.48 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.671 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 6.7 mt-10 -64.53 -41.76 96.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 85.9 mt -60.33 -21.85 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.474 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.562 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.4 OUTLIER -66.76 -12.67 59.65 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.373 0.606 . . . . 0.0 109.458 178.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.533 ' HB2' HG23 ' A' ' 298' ' ' THR . 39.4 mt-30 -103.5 0.06 30.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.577 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.97 30.53 20.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.628 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 3.7 p -68.03 -14.7 63.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.937 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.57 31.32 70.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.911 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.528 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 43.9 mtmt -110.38 37.07 2.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.452 0.168 . . . . 0.0 110.642 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.949 ' CE2' HG23 ' A' ' 412' ' ' ILE . 89.8 m-85 -158.97 159.98 35.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.866 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.445 ' O ' ' OH ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -139.36 157.74 45.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 111.09 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.409 ' HD1' ' H ' ' A' ' 303' ' ' PHE . 0.2 OUTLIER -136.5 124.55 22.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 110.665 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 109.8 147.34 11.71 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.943 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -54.75 -58.91 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.829 0.347 . . . . 0.0 110.744 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 6.1 pt-20 -47.41 -54.72 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.34 -57.02 9.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.761 0.315 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.63 HG21 HG22 ' A' ' 409' ' ' ILE . 18.7 m -52.1 -33.29 38.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.045 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.759 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.3 mp -75.66 -40.07 56.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.701 0.286 . . . . 0.0 111.517 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 306' ' ' GLU . 10.4 mtmt -57.49 -50.02 74.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.531 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -71.52 -28.01 63.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.648 0.261 . . . . 0.0 110.922 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.763 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -71.39 -30.76 66.5 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.054 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.407 ' OE2' ' CZ ' ' A' ' 385' ' ' PHE . 78.3 mm-40 -73.75 -25.22 60.06 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 420' ' ' GLN . 29.6 mmt -83.04 -7.61 59.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.946 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.43 17.03 46.02 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.265 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.77 6.08 43.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.904 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.1 m -107.46 106.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.781 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.1 tt0 -59.05 -49.97 75.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.629 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.8 mm -136.78 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.649 ' HG ' HG23 ' A' ' 322' ' ' VAL . 38.7 tp -91.16 127.93 36.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 412' ' ' ILE . 1.0 OUTLIER -112.23 105.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.939 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.649 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -123.18 161.75 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.433 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.885 ' CE1' HG23 ' A' ' 392' ' ' VAL . 93.2 m-85 -109.67 146.04 35.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.915 0.388 . . . . 0.0 111.307 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.574 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.9 pt-20 -64.97 -30.03 71.0 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.334 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.17 48.5 1.17 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.456 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.3 tp -83.68 125.52 31.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.1 32.22 1.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.054 HG22 HD12 ' A' ' 374' ' ' LEU . 27.3 mm -129.5 137.16 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.675 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 15.0 mtm -140.0 162.08 36.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.373 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.635 ' HE ' HG21 ' A' ' 343' ' ' ILE . 22.1 ttt180 -94.12 124.62 38.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.09 0.471 . . . . 0.0 111.053 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.585 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 6.6 m-85 -121.08 158.12 28.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.43 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.94 HG12 ' CD1' ' A' ' 343' ' ' ILE . 10.0 m -122.27 113.52 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.542 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.761 HD11 ' CD2' ' A' ' 357' ' ' PHE . 0.5 OUTLIER -104.76 156.75 17.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.261 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.411 ' NE2' ' HA ' ' A' ' 366' ' ' HIS . 0.7 OUTLIER -71.14 161.74 30.61 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.455 ' HB2' ' C ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -141.92 110.99 6.3 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 49.94 37.12 13.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.348 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.746 ' O ' HG23 ' A' ' 338' ' ' THR . . . 129.77 -86.75 0.31 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 119.892 -1.147 . . . . 0.0 114.003 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.8 OUTLIER -170.51 -29.02 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.92 14.9 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.255 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 338' ' ' THR . 20.6 tp10 -166.39 137.36 3.47 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -130.32 140.12 50.66 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.009 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -94.42 144.38 25.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.266 179.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.94 ' CD1' HG12 ' A' ' 332' ' ' VAL . 20.6 mm -117.11 119.39 61.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.939 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.404 ' O ' HD22 ' A' ' 346' ' ' LEU . 55.9 tp -135.07 149.0 50.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.241 0.543 . . . . 0.0 112.063 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.527 ' HB2' ' CG2' ' A' ' 328' ' ' ILE . 0.2 OUTLIER -88.47 117.05 27.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.06 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.536 ' CB ' ' HG3' ' A' ' 351' ' ' GLU . 2.1 mm? -118.83 156.4 29.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.673 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 22.0 p -100.59 169.4 7.95 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.322 178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.673 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.8 Cg_endo -44.1 -45.57 11.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -59.87 -52.98 63.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.21 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -65.18 -50.02 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 331' ' ' TYR . 88.7 mt-10 -59.97 -33.9 72.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.509 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -57.39 -29.93 64.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.338 0.59 . . . . 0.0 109.488 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -99.38 24.75 7.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.048 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.571 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 5.1 ptpt -62.45 -24.9 67.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.046 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 35.8 t -57.31 -40.03 77.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 110.007 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.463 ' C ' ' H ' ' A' ' 358' ' ' THR . 78.5 m80 -102.52 -42.4 5.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.525 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.761 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 55.38 6.92 0.19 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.999 -179.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.3 m -107.29 -170.75 1.75 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.897 ' HB2' HG22 ' A' ' 362' ' ' THR . 88.4 m-20 -131.14 134.55 46.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -71.14 -1.33 12.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.685 0.278 . . . . 0.0 111.441 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -104.01 -18.08 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.897 HG22 ' HB2' ' A' ' 359' ' ' ASP . 13.3 t -117.31 -37.86 3.45 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 74.31 27.95 64.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.892 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.731 ' H ' HG23 ' A' ' 362' ' ' THR . 54.4 mt-30 -58.32 -153.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.626 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.456 ' H ' ' HB3' ' A' ' 364' ' ' GLN . 56.3 mm-40 -139.84 122.81 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.702 0.287 . . . . 0.0 110.808 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.636 ' HB3' ' HB3' ' A' ' 357' ' ' PHE . 91.4 m-70 -158.82 139.64 12.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.23 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 119.93 7.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 369' ' ' ILE . 54.7 tp -80.66 143.61 32.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.754 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 368' ' ' LEU . 1.9 mm -112.33 -36.75 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.848 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.716 ' O ' HD11 ' A' ' 368' ' ' LEU . 42.2 tt0 -158.2 166.65 31.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.388 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.585 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 3.1 p -145.88 118.5 8.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.178 0.513 . . . . 0.0 111.381 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.712 ' HE2' ' HD2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -119.12 126.88 26.81 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.105 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.712 ' HD2' ' HE2' ' A' ' 372' ' ' MET . 11.2 Cg_endo -55.49 125.81 20.37 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.064 1.842 . . . . 0.0 110.69 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.054 HD12 HG22 ' A' ' 328' ' ' ILE . 12.3 mt -65.43 -41.33 93.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.967 HD11 HD12 ' A' ' 391' ' ' ILE . 61.6 tp -60.06 -53.81 53.38 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.469 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 51.1 mt-10 -56.88 -40.01 75.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.893 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -69.24 -35.25 75.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.267 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 309' ' ' LEU . 6.6 m-85 -64.16 -32.14 73.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.696 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.67 -10.01 47.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.71 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -103.19 -0.09 30.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -138.97 16.14 2.65 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -67.45 -19.16 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.689 0.281 . . . . 0.0 111.112 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -78.58 -47.44 17.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.896 0.379 . . . . 0.0 110.999 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.94 -45.9 91.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.182 0.515 . . . . 0.0 110.702 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.616 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.0 m-85 -73.73 -15.21 61.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.787 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 75.14 2.49 66.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.27 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.904 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.2 162.18 17.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.087 0.47 . . . . 0.0 110.406 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.811 ' HB ' HG23 ' A' ' 319' ' ' ILE . 84.4 m -107.14 100.32 9.8 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.548 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 391' ' ' ILE . 1.9 tm? -70.8 102.77 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.027 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.675 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 67.2 mm-40 -110.45 128.95 55.84 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.845 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.967 HD12 HD11 ' A' ' 375' ' ' LEU . 33.2 mm -95.2 104.04 15.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.203 0.525 . . . . 0.0 112.146 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.885 HG23 ' CE1' ' A' ' 323' ' ' TYR . 15.0 m -101.2 -169.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.923 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.502 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.97 156.6 27.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.142 0.496 . . . . 0.0 111.823 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 400' ' ' SER . 9.7 t70 -64.44 -7.34 9.58 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.209 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -53.21 -41.65 65.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 6.7 m -87.51 167.44 13.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.884 0.373 . . . . 0.0 111.689 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 27.2 tt0 -60.03 -53.32 59.21 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.601 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 41.1 mp0 -60.07 -35.43 75.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.495 0.664 . . . . 0.0 109.316 179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -56.24 -58.13 15.78 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.704 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 404' ' ' LYS . 3.4 m -59.44 -22.0 60.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.815 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 84.5 mt-30 -68.93 -40.05 79.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 0.0 110.82 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.71 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.6 m-85 -65.9 -50.8 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.0 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.461 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 80.6 t -55.8 -35.11 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 400' ' ' SER . 6.0 mmtt -77.12 -50.6 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 111.468 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -75.45 -27.28 63.81 Favored Glycine 0 CA--C 1.508 -0.406 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.816 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 402' ' ' PHE . 0.0 OUTLIER -157.86 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 99.6 153.3 27.59 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.753 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.455 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 82.32 -50.63 4.36 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.934 -0.65 . . . . 0.0 114.699 178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -149.06 133.23 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 117.837 0.819 . . . . 0.0 112.482 -177.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.14 139.13 7.14 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 301' ' ' TYR . . . -123.93 144.61 15.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.942 -1.123 . . . . 0.0 113.805 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.949 HG23 ' CE2' ' A' ' 301' ' ' TYR . 26.4 mt -106.63 128.73 61.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.868 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 32.1 mt -89.55 152.8 21.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.751 0.786 . . . . 0.0 112.82 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 26.9 mtp180 -70.03 -34.96 73.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.729 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.43 ' O ' HG13 ' A' ' 417' ' ' VAL . 88.3 m-85 -156.84 164.68 37.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.637 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 298' ' ' THR . 8.4 mtm180 -59.15 122.83 14.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.258 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 415' ' ' TYR . 8.4 m -123.87 142.86 39.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.409 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.31 -39.96 77.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.004 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -145.5 161.63 39.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 314' ' ' MET . 2.6 mp0 -50.31 -63.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.672 0.272 . . . . 0.0 110.771 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -46.4 -94.97 0.01 OUTLIER Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.151 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.7 ttt -137.13 160.68 38.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 111.03 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -59.97 -41.03 91.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.036 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -107.25 122.61 46.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.734 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 81.6 mt-30 -120.96 148.06 44.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.99 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -116.28 -5.36 17.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.456 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 116.02 -105.24 1.37 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.224 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.697 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.92 39.95 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.337 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.4 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 36.9 tt0 -64.01 -40.06 95.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 110.452 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -111.61 98.78 7.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.539 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.56 124.97 44.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.467 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.12 6.61 11.17 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.979 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.16 -3.85 6.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.963 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.23 -39.88 84.14 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.721 0.296 . . . . 0.0 110.772 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -66.61 -33.91 76.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.01 -34.55 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.251 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.98 -46.62 88.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.966 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.07 -39.92 87.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.878 179.974 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 33.2 m120 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.764 0.316 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.775 HG22 ' HB3' ' A' ' 282' ' ' GLN . 8.6 p -69.48 -27.63 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.202 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -54.34 -39.97 67.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 111.209 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.75 -50.03 75.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.208 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.463 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 3.4 pt -79.04 -43.48 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.806 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.775 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.1 OUTLIER -57.59 -35.82 70.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 -179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.525 ' O ' HD12 ' A' ' 287' ' ' ILE . 41.8 mt-10 -72.12 -31.43 66.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 398' ' ' GLU . 0.9 OUTLIER -83.79 -56.27 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.32 -179.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -57.66 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.543 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 22.0 tp -55.23 -58.21 8.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.784 HG23 ' CD2' ' A' ' 402' ' ' PHE . 82.5 mt -60.07 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.282 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.467 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.15 -39.02 57.37 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.269 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -60.05 -34.16 73.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.126 0.489 . . . . 0.0 110.279 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.595 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 19.0 t80 -59.92 -49.29 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.12 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -83.45 -38.31 22.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.53 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 295' ' ' SER . 43.3 t0 -64.18 -49.94 70.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.58 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 46.2 tp10 -61.26 -40.03 92.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.819 0.342 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 301' ' ' TYR . 88.2 mt -62.58 -26.33 40.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.841 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.77 -13.7 16.79 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 121.279 0.561 . . . . 0.0 109.944 178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 298' ' ' THR . 26.2 mt-30 -100.07 0.89 41.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.389 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.6 30.04 19.31 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.727 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 10.0 p -69.84 -10.04 56.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.005 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.21 51.14 57.79 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.43 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 17.1 mttt -130.25 40.67 3.5 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.877 -0.19 . . . . 0.0 110.6 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.854 ' CE1' HG23 ' A' ' 412' ' ' ILE . 77.8 m-85 -161.69 163.57 29.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.38 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 p -145.15 160.38 41.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -135.43 126.76 28.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.649 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.554 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 109.38 153.25 14.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.331 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -60.03 -55.51 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.861 0.362 . . . . 0.0 110.673 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 7.4 pt-20 -50.35 -51.03 49.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.19 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -68.38 -55.24 12.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.727 0.298 . . . . 0.0 110.883 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.558 HG21 HG22 ' A' ' 409' ' ' ILE . 20.7 m -55.49 -37.56 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.225 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.95 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -69.61 -44.47 70.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.326 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 314' ' ' MET . 10.0 mttm -56.14 -50.03 72.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -70.32 -28.24 65.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.936 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 385' ' ' PHE . 0.1 OUTLIER -70.72 -29.63 65.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 120.807 0.337 . . . . 0.0 110.616 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.54 -25.91 50.56 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 6.7 mmm -81.68 -8.6 59.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.853 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.12 11.57 32.97 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.343 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -80.54 -9.47 59.77 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.4 0.28 . . . . 0.0 110.811 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 387' ' ' ALA . 28.3 m -92.73 104.03 15.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.898 ' O ' HD13 ' A' ' 319' ' ' ILE . 6.2 tp10 -59.55 -49.13 78.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.107 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 318' ' ' GLU . 31.3 mm -136.22 129.12 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.646 ' HG ' HG23 ' A' ' 322' ' ' VAL . 42.8 tp -94.08 127.85 40.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.222 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.571 HD11 HD11 ' A' ' 412' ' ' ILE . 0.8 OUTLIER -114.48 108.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.137 0.494 . . . . 0.0 110.09 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.646 HG23 ' HG ' ' A' ' 320' ' ' LEU . 20.4 t -124.45 161.97 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.435 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.81 ' CE1' HG23 ' A' ' 392' ' ' VAL . 89.4 m-85 -108.18 146.22 33.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.835 0.35 . . . . 0.0 111.312 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.528 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.9 pt-20 -63.62 -31.96 73.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.129 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -95.98 52.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.035 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.541 HD13 ' CA ' ' A' ' 408' ' ' GLY . 45.6 tp -85.65 123.91 31.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.416 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.21 27.72 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.963 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 374' ' ' LEU . 28.0 mm -127.15 134.83 65.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.104 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 12.8 mtm -139.99 161.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.669 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.604 HH11 HG22 ' A' ' 343' ' ' ILE . 0.0 OUTLIER -90.61 120.37 31.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.1 0.476 . . . . 0.0 111.218 -179.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 371' ' ' SER . 3.9 m-85 -118.3 157.23 27.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.172 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.053 HG12 HD12 ' A' ' 343' ' ' ILE . 11.0 m -120.01 110.72 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.269 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.732 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.7 mm? -102.15 150.38 23.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.565 ' CD2' HD11 ' A' ' 369' ' ' ILE . 9.1 m170 -86.66 177.69 7.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.114 0.483 . . . . 0.0 111.425 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 3.4 m -115.14 161.67 18.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.686 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -45.92 -39.08 8.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.874 0.369 . . . . 0.0 110.746 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 338' ' ' THR . . . -87.85 -119.57 1.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.907 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.6 OUTLIER -165.86 17.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -130.76 33.25 4.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.015 0.436 . . . . 0.0 110.5 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 16.0 tp10 -158.29 122.97 4.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.996 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -113.1 136.7 52.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.981 0.419 . . . . 0.0 111.175 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.677 ' O ' HD13 ' A' ' 343' ' ' ILE . 8.7 tttp -111.01 139.67 46.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.736 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.053 HD12 HG12 ' A' ' 332' ' ' VAL . 10.6 mm -121.03 120.77 63.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.416 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 57.3 tp -135.32 163.05 30.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.383 0.611 . . . . 0.0 112.147 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.514 ' HD2' HD12 ' A' ' 328' ' ' ILE . 5.9 p90 -100.67 118.28 36.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.1 mm? -123.52 163.8 20.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.675 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 20.0 p -101.09 168.68 8.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.789 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 3.6 Cg_endo -45.55 -43.61 17.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.409 2.072 . . . . 0.0 111.949 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.02 -57.09 14.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 346' ' ' LEU . 18.6 mm100 -62.95 -49.64 73.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.9 mt-10 -60.09 -31.29 69.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.404 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -39.59 77.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.418 0.628 . . . . 0.0 109.418 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 64.2 t0 -85.75 53.74 2.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.611 ' HB2' HD23 ' A' ' 368' ' ' LEU . 14.1 pttm -69.98 -34.68 73.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.4 m -63.13 -51.49 66.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.838 0.351 . . . . 0.0 111.003 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.538 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 90.5 m-70 -88.71 -52.2 5.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.255 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 54.6 12.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.01 0.433 . . . . 0.0 110.06 -178.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.5 m -109.1 -170.61 1.69 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.062 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.79 ' HB2' HG22 ' A' ' 362' ' ' THR . 88.7 m-20 -132.27 139.33 48.2 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -74.25 0.39 14.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.617 0.246 . . . . 0.0 111.638 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -103.9 -20.91 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.585 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.79 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.5 t -117.88 -38.35 3.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.259 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 76.36 30.3 56.99 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.057 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.561 ' H ' HG23 ' A' ' 362' ' ' THR . 11.8 mm100 -56.78 -156.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.621 -0.289 . . . . 0.0 110.913 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 49.0 mt-10 -144.86 121.79 11.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.86 0.362 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.647 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 77.2 m80 -160.09 142.09 12.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.964 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.33 116.29 7.32 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 354' ' ' LYS . 39.4 tp -83.02 138.72 33.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.47 . . . . 0.0 111.878 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 332' ' ' VAL . 3.0 mp -110.74 -43.52 5.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.838 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.607 ' O ' HD11 ' A' ' 368' ' ' LEU . 12.5 tp10 -145.26 167.12 23.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.177 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -148.33 117.62 6.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.957 0.408 . . . . 0.0 110.98 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 4.2 tpt -112.62 127.25 27.08 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.605 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 13.6 Cg_endo -57.73 123.81 14.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.071 1.847 . . . . 0.0 110.971 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.057 HD12 HG22 ' A' ' 328' ' ' ILE . 19.4 mt -64.38 -40.07 95.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.866 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.977 HD11 HD12 ' A' ' 391' ' ' ILE . 59.5 tp -59.84 -53.59 56.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.3 mt-10 -58.6 -39.93 81.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.873 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.409 ' CE2' ' ND2' ' A' ' 381' ' ' ASN . 74.0 t-105 -64.88 -39.74 94.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.57 ' CD1' HD21 ' A' ' 320' ' ' LEU . 6.4 m-85 -64.1 -30.75 71.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.103 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -90.22 -12.31 38.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.779 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -102.35 -13.83 17.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 69.0 m-80 -129.71 17.07 5.81 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -64.82 -19.59 65.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.243 . . . . 0.0 111.238 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -79.0 -44.24 22.69 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.32 -43.45 96.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.179 0.514 . . . . 0.0 110.625 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.716 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.8 m-85 -76.02 -12.27 60.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.17 2.41 58.73 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.17 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.785 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.71 161.49 18.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.174 0.511 . . . . 0.0 110.556 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.858 ' HB ' HG23 ' A' ' 319' ' ' ILE . 73.5 m -106.59 100.72 10.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.261 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.636 HD13 ' O ' ' A' ' 389' ' ' LEU . 1.9 tm? -71.81 104.75 3.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.373 -178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 388' ' ' THR . 5.7 mm-40 -113.78 129.92 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.738 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.977 HD12 HD11 ' A' ' 375' ' ' LEU . 34.2 mm -94.75 103.61 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.016 0.436 . . . . 0.0 111.968 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.81 HG23 ' CE1' ' A' ' 323' ' ' TYR . 26.5 m -100.86 -172.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.901 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.496 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -157.97 154.42 27.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.639 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.38 3.29 1.33 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.89 -40.01 87.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.589 0.233 . . . . 0.0 111.208 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 1.2 t -94.36 162.47 13.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.96 -55.26 28.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 60.0 mp0 -59.97 -40.0 87.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.365 0.603 . . . . 0.0 109.723 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -64.27 -24.36 68.94 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -84.0 -25.45 29.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.543 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.36 -40.01 77.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.586 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.784 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -59.59 -49.54 77.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.028 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.449 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 90.9 t -57.71 -37.76 61.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.3 OUTLIER -69.97 -54.13 14.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.223 179.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.5 66.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.565 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.554 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 27.4 t80 179.93 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 99.83 164.59 29.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.774 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.541 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.56 -49.48 3.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.009 -0.615 . . . . 0.0 114.328 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -148.67 131.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 117.529 0.664 . . . . 0.0 111.924 -177.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -148.32 135.89 5.7 Favored Glycine 0 CA--C 1.51 -0.237 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -119.88 138.62 13.28 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.516 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.854 HG23 ' CE1' ' A' ' 301' ' ' TYR . 21.4 mt -100.87 129.0 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 31.4 mt -90.57 153.71 20.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.684 0.754 . . . . 0.0 112.527 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 65.3 mtt180 -70.02 -38.05 75.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.707 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 300' ' ' LYS . 50.9 p90 -163.79 175.77 10.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.692 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.727 ' HG2' ' O ' ' A' ' 298' ' ' THR . 14.2 mtm105 -57.96 126.58 28.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.913 0.387 . . . . 0.0 111.026 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.97 160.01 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.068 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.34 128.86 34.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -85.06 -43.14 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.243 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.431 ' HB3' HE22 ' A' ' 425' ' ' GLN . 55.9 tt0 -162.05 133.5 5.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.073 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 430' ' ' GLU . . . 43.24 -157.27 0.11 Allowed Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.401 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 425' ' ' GLN . 5.3 ttm -118.79 -179.75 3.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -42.61 149.97 0.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 62.75 46.11 5.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 430' ' ' GLU . 40.1 mt-30 -59.98 -46.78 88.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.024 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 75.79 -2.53 54.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.98 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 163.28 -156.23 27.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -110.45 24.0 13.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.603 0.24 . . . . 0.0 111.341 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -112.74 30.58 7.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.45 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.626 ' HG3' ' HG2' ' A' ' 425' ' ' GLN . 14.0 mm-40 -60.07 -42.72 95.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 111.082 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -103.76 5.31 36.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -99.23 110.53 23.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.02 0.438 . . . . 0.0 111.389 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -87.39 12.49 11.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.042 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 45.0 mt -70.82 -5.4 30.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.971 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.02 -40.06 87.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -73.75 -23.88 59.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -59.99 -36.36 77.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.437 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.03 -47.87 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.871 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 9.1 m120 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.665 0.269 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 281' ' ' ILE . 12.5 p -67.2 -29.14 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.453 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -48.46 79.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.253 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.82 -48.7 79.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' A' ' 278' ' ' VAL . 40.7 pt -72.03 -23.9 22.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.31 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.0 OUTLIER -53.83 -42.09 68.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 -179.402 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 17.8 pt-20 -86.09 -25.08 26.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.553 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -84.1 -43.19 15.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -87.02 -58.45 2.59 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' ' 282' ' ' GLN . 27.1 tp -56.82 -56.45 21.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.678 -178.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.852 HG23 ' CE1' ' A' ' 402' ' ' PHE . 63.9 mt -60.03 -49.99 81.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.537 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.469 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -53.32 -38.87 57.97 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.041 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -60.05 -32.2 70.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.03 0.443 . . . . 0.0 110.268 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 14.9 t80 -59.86 -46.0 90.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.094 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 401' ' ' GLN . 41.3 m-85 -87.38 -40.14 14.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 0.0 110.826 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 295' ' ' SER . 71.4 m-20 -60.0 -44.25 94.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.475 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.667 ' HB3' ' CE1' ' A' ' 301' ' ' TYR . 8.8 tp10 -69.95 -39.74 75.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' A' ' 301' ' ' TYR . 76.4 mt -63.82 -24.45 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.92 178.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.546 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -57.73 -17.52 15.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.096 0.474 . . . . 0.0 110.186 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.622 ' HB2' HG23 ' A' ' 298' ' ' THR . 11.2 mt-30 -100.48 2.99 42.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.737 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 57.93 30.0 18.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.011 0.434 . . . . 0.0 110.362 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 16.8 p -66.84 -11.79 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 59.32 52.3 54.06 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.65 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.571 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 40.1 mttt -131.12 39.78 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.804 -0.233 . . . . 0.0 111.214 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.852 ' CE2' HG23 ' A' ' 412' ' ' ILE . 76.6 m-85 -161.12 162.85 31.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 0.0 111.726 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 2.7 p -147.47 164.51 33.13 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 49.3 p90 -134.99 150.01 50.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.531 ' HA2' ' CE2' ' A' ' 406' ' ' PHE . . . 87.06 154.71 26.63 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.327 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.019 HG12 ' CD1' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -60.58 -62.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.002 0.429 . . . . 0.0 110.983 -179.788 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 4.0 pt-20 -43.31 -52.13 5.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.619 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 74.6 m-20 -64.83 -54.8 25.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.498 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.582 HG22 HD13 ' A' ' 312' ' ' LEU . 36.3 m -57.58 -37.18 72.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.907 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 1.019 ' CD1' HG12 ' A' ' 305' ' ' VAL . 1.8 mp -68.1 -45.0 74.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.9 mttm -58.12 -49.6 76.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -68.95 -28.65 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.474 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.747 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.3 OUTLIER -70.77 -30.1 66.5 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.891 0.377 . . . . 0.0 110.267 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -75.8 -27.57 58.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 12.8 mmt -80.0 -7.24 58.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.82 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 18.69 47.41 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.06 -1.066 . . . . 0.0 110.942 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -91.27 0.0 57.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.437 -0.381 . . . . 0.0 111.481 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.939 HG23 ' HB2' ' A' ' 387' ' ' ALA . 30.8 m -100.39 105.68 18.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 412' ' ' ILE . 12.0 tp10 -59.6 -50.04 75.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.39 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.776 HG23 ' HB ' ' A' ' 388' ' ' THR . 24.4 mm -135.91 123.97 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.334 0.112 . . . . 0.0 111.214 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 322' ' ' VAL . 21.4 tp -85.41 122.97 30.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 111.204 179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -107.11 102.21 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.824 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 320' ' ' LEU . 25.4 t -114.08 162.01 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.326 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.632 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 37.9 m-85 -114.0 148.72 36.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.927 ' OE2' HG21 ' A' ' 391' ' ' ILE . 22.0 mm-40 -65.3 155.73 34.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.06 178.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 57.8 t30 56.95 28.94 15.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.265 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -57.16 126.63 28.08 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 348' ' ' PRO . 96.3 m-20 -89.93 27.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.614 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.062 HG22 HD12 ' A' ' 374' ' ' LEU . 31.0 mm -126.43 137.68 57.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.629 -179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 6.3 mtt -139.52 161.13 38.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.743 179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 11.0 ttt-85 -86.94 105.66 17.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.084 -179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 346' ' ' LEU . 5.9 m-85 -118.58 122.59 42.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.712 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.905 HG12 HD12 ' A' ' 343' ' ' ILE . 19.4 m -92.3 122.9 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.095 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.764 HD11 ' CE2' ' A' ' 357' ' ' PHE . 2.8 mm? -116.59 159.16 22.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.081 0.467 . . . . 0.0 111.009 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.975 ' CD2' HD11 ' A' ' 369' ' ' ILE . 34.6 m170 -83.54 172.45 12.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.13 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 340' ' ' GLU . 0.0 OUTLIER -109.37 162.12 14.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.503 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -41.91 -32.04 0.39 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.087 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -93.93 -138.09 8.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.854 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.45 12.6 0.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.832 0.316 . . . . 0.0 111.543 179.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -131.24 39.77 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.029 0.442 . . . . 0.0 110.307 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 335' ' ' CYS . 9.8 tp10 -164.26 132.45 3.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -115.94 139.23 50.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.068 0.461 . . . . 0.0 111.193 -178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.709 ' C ' HD13 ' A' ' 343' ' ' ILE . 18.6 tttp -122.8 138.16 54.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.112 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.905 HD12 HG12 ' A' ' 332' ' ' VAL . 2.1 mm -106.67 128.2 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.213 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 39.4 tp -137.04 148.09 46.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.319 0.581 . . . . 0.0 111.982 -179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.632 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.1 OUTLIER -94.41 128.35 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.986 179.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 346' ' ' LEU . 2.2 mm? -119.07 148.16 43.34 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 12.7 p -100.86 173.74 3.45 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.868 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 89.2 Cg_exo -48.29 -48.13 17.81 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 121.905 1.737 . . . . 0.0 113.16 -179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 352' ' ' LYS . 25.1 pm0 -71.75 -30.96 66.16 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -87.07 -49.3 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.068 0.461 . . . . 0.0 111.719 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.411 ' CD ' ' CZ ' ' A' ' 331' ' ' TYR . 1.3 tm-20 -62.28 -32.94 73.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.918 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 349' ' ' GLU . 18.4 pttp -57.03 -24.32 52.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.082 0.468 . . . . 0.0 110.285 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -90.02 43.44 1.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.025 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.535 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 0.0 OUTLIER -69.97 -28.66 65.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.238 -179.028 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 65.3 m -60.06 -39.96 87.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.343 . . . . 0.0 110.681 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.415 ' C ' ' H ' ' A' ' 358' ' ' THR . 96.9 m-70 -101.73 -53.32 2.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.713 179.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.764 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.1 OUTLIER 60.79 2.17 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 -179.366 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 359' ' ' ASP . 6.1 m -92.7 -174.76 3.73 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.766 ' H ' HG22 ' A' ' 358' ' ' THR . 81.8 m-20 -136.56 130.59 32.62 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -70.04 -2.01 11.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.856 0.36 . . . . 0.0 110.795 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -96.36 -21.5 17.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.428 ' CG2' ' HB2' ' A' ' 359' ' ' ASP . 0.5 OUTLIER -131.09 -37.83 1.25 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.476 -179.884 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 91.01 -3.51 80.76 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.709 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.642 ' O ' HG23 ' A' ' 358' ' ' THR . 11.9 pt20 -48.3 98.75 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.907 0.384 . . . . 0.0 110.787 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -64.67 132.67 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.258 0.551 . . . . 0.0 111.327 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.668 ' HB2' ' HB3' ' A' ' 357' ' ' PHE . 46.8 m80 -135.46 150.22 49.76 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.259 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.448 ' H ' ' H ' ' A' ' 334' ' ' HIS . 0.8 OUTLIER -138.89 118.27 12.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.495 HD13 ' C ' ' A' ' 368' ' ' LEU . 2.5 tm? -77.5 96.25 4.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.462 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.975 HD11 ' CD2' ' A' ' 334' ' ' HIS . 4.2 mp -72.28 -40.08 64.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -149.75 157.09 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.263 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.516 ' HB3' ' CD2' ' A' ' 331' ' ' TYR . 0.4 OUTLIER -148.7 116.49 6.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.624 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.468 ' HG2' ' CE3' ' A' ' 377' ' ' TRP . 6.1 tpt -117.82 132.08 23.82 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.627 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.631 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 38.4 Cg_exo -58.05 129.06 31.25 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.707 1.604 . . . . 0.0 110.133 178.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.062 HD12 HG22 ' A' ' 328' ' ' ILE . 18.0 mt -69.14 -44.04 73.13 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 391' ' ' ILE . 33.0 tp -59.98 -53.43 57.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 44.0 mt-10 -58.04 -40.09 80.05 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.064 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.468 ' CE3' ' HG2' ' A' ' 372' ' ' MET . 73.5 t-105 -67.21 -36.38 81.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.611 178.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.602 ' O ' ' HB3' ' A' ' 382' ' ' TYR . 10.3 m-85 -70.04 -33.49 72.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.279 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.09 46.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.751 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -110.23 -12.95 14.41 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.443 ' ND2' ' CD2' ' A' ' 377' ' ' TRP . 68.5 m-80 -134.11 19.94 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.602 ' HB3' ' O ' ' A' ' 378' ' ' PHE . 53.1 p90 -64.47 -14.54 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -83.5 -35.04 25.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 0.0 110.72 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -39.81 87.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.508 ' CG ' HD23 ' A' ' 312' ' ' LEU . 59.1 m-85 -82.37 -10.07 59.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.045 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.97 64.1 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.796 -178.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.939 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -86.32 163.67 17.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.268 0.556 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.776 ' HB ' HG23 ' A' ' 319' ' ' ILE . 49.4 m -106.86 104.76 14.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.498 179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 391' ' ' ILE . 1.2 tm? -65.16 102.41 0.64 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 111.116 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' A' ' 388' ' ' THR . 6.2 mm-40 -115.92 107.79 15.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.933 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.927 HG21 ' OE2' ' A' ' 324' ' ' GLU . 27.6 mm -84.14 104.59 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.209 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.65 ' CB ' HD11 ' A' ' 287' ' ' ILE . 11.3 m -102.49 -172.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.078 -178.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 392' ' ' VAL . 0.7 OUTLIER -160.97 157.34 26.22 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.329 179.152 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HA ' ' C ' ' A' ' 399' ' ' GLY . 11.3 p-10 -69.98 19.99 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 393' ' ' THR . 23.7 mtpp -68.12 -40.04 82.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.652 0.263 . . . . 0.0 111.126 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 93.6 p -94.51 170.06 9.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 111.556 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.04 -45.51 92.59 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.687 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.469 ' HG2' ' CA ' ' A' ' 288' ' ' GLY . 33.6 mp0 -68.01 -40.54 82.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.382 0.61 . . . . 0.0 109.827 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.528 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -62.35 -19.67 60.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.293 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' A' ' 404' ' ' LYS . 65.6 m -84.02 -23.16 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.389 -0.406 . . . . 0.0 110.752 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 291' ' ' PHE . 30.8 mt-30 -70.88 -41.47 71.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.807 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 287' ' ' ILE . 4.0 m-85 -60.32 -46.33 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.868 0.366 . . . . 0.0 111.082 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 394' ' ' ASP . 54.0 t -59.98 -37.84 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.939 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 400' ' ' SER . 22.1 mttm -66.94 -57.88 6.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.349 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -54.08 -52.56 42.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.109 -1.043 . . . . 0.0 110.834 179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.531 ' CE2' ' HA2' ' A' ' 304' ' ' GLY . 50.4 t80 -151.91 -66.97 0.17 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 402' ' ' PHE . . . 98.03 166.48 31.59 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.235 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.2 -49.2 2.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.041 -0.6 . . . . 0.0 114.404 178.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.1 OUTLIER -143.97 134.4 21.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 117.697 0.748 . . . . 0.0 112.632 -177.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -154.69 145.22 12.18 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 178.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -127.97 144.26 15.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.287 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 301' ' ' TYR . 34.8 mt -105.66 127.6 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 316' ' ' ALA . 51.0 mt -87.85 153.49 21.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.64 0.733 . . . . 0.0 112.735 -177.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 58.8 mtp85 -69.83 -35.2 74.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.419 179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.435 ' O ' HG13 ' A' ' 417' ' ' VAL . 50.9 p90 -171.3 179.63 2.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.683 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.9 OUTLIER -57.11 128.23 35.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 110.954 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 316' ' ' ALA . 33.1 m -129.93 160.02 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.235 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.49 139.64 58.2 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.456 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -109.94 129.39 55.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.175 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -60.28 -39.94 88.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.493 ' HA2' ' HG2' ' A' ' 425' ' ' GLN . . . 134.32 90.79 0.38 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.417 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mtt -150.16 162.55 40.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.979 0.418 . . . . 0.0 111.156 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 60.15 70.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.633 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 57.28 31.0 19.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.078 179.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.493 ' HG2' ' HA2' ' A' ' 421' ' ' GLY . 17.7 tp60 -60.02 -39.97 87.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.957 0.408 . . . . 0.0 110.657 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 163.4 -23.73 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.566 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 116.12 -154.62 16.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.169 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -36.75 77.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.033 0.444 . . . . 0.0 110.519 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 432' ' ' PHE . 90.6 m-20 -103.43 68.34 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.751 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -59.98 -46.68 88.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.126 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -123.17 18.27 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.4 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.467 ' HB2' ' CB ' ' A' ' 429' ' ' ASP . 81.6 m-85 -98.84 119.69 38.01 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.899 0.381 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.69 -9.89 56.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.516 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 13.6 mt -53.49 -13.24 0.57 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.389 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 429' ' ' ASP . 81.0 m-20 -57.04 -40.04 75.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.837 0.351 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -68.56 -35.19 77.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.02 -31.66 70.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.513 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.14 -46.71 88.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.959 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -59.99 -39.96 87.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.994 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.902 179.991 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.719 0.295 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 8.7 p -60.04 -30.02 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -51.58 -39.93 58.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.771 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.06 -50.0 75.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.24 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -82.96 -23.47 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.864 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.679 HE22 HG13 ' A' ' 392' ' ' VAL . 0.3 OUTLIER -60.02 -39.48 85.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.512 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.501 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 16.8 pt-20 -84.69 -22.67 29.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.35 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -50.09 8.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -76.21 -58.33 3.35 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.502 ' HG ' ' CD1' ' A' ' 321' ' ' ILE . 26.4 tp -56.74 -55.61 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.054 0.454 . . . . 0.0 111.975 -178.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.77 HG23 ' CE1' ' A' ' 402' ' ' PHE . 23.6 mt -59.55 -49.18 84.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.623 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -56.86 -37.0 75.49 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 12.9 ttt85 -60.01 -39.08 84.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.282 0.563 . . . . 0.0 109.999 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.606 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 2.8 t80 -57.51 -45.19 85.26 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.669 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -79.45 -40.0 30.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.4 t0 -60.01 -47.44 85.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.697 -179.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.658 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.4 mt-10 -62.85 -43.3 99.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.067 0.46 . . . . 0.0 109.864 179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 290' ' ' TYR . 97.3 mt -59.98 -24.6 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.648 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.7 -12.44 34.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 178.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.599 ' HB2' HG23 ' A' ' 298' ' ' THR . 21.4 mt-30 -107.27 1.59 23.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.443 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 57.95 31.13 20.19 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.998 0.428 . . . . 0.0 110.341 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.878 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 24.3 p -67.71 -11.93 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.858 -179.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 57.08 48.56 78.68 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.005 -1.093 . . . . 0.0 113.511 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.532 ' C ' ' CD1' ' A' ' 301' ' ' TYR . 16.9 mttp -128.1 36.3 4.33 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.94 ' CE2' HG23 ' A' ' 412' ' ' ILE . 93.5 m-85 -159.32 160.06 34.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.9 p -149.95 164.99 33.99 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 1.0 OUTLIER -139.35 164.86 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 0.0 110.928 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 79.21 167.84 34.37 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.226 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.792 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -72.91 -59.86 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.213 -179.583 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 11.4 pt-20 -47.26 -52.43 16.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.872 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.737 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 83.6 m-20 -65.78 -57.44 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 312' ' ' LEU . 26.5 m -56.13 -36.39 68.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.591 0.234 . . . . 0.0 110.974 -179.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.757 ' CD1' HG12 ' A' ' 305' ' ' VAL . 5.4 mp -70.01 -46.69 64.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.64 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 314' ' ' MET . 9.7 mtmt -56.44 -50.01 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.609 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -66.84 -28.32 68.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.68 0.276 . . . . 0.0 111.027 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.904 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -74.37 -28.24 61.03 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 179.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -77.51 -26.93 51.56 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 17.9 mmt -80.28 -7.3 58.97 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 113.858 -1.519 . . . . 0.0 111.789 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 59.84 17.42 42.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.519 -178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -89.14 -2.27 58.45 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.313 0.245 . . . . 0.0 111.073 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.904 HG21 ' CD1' ' A' ' 312' ' ' LEU . 31.2 m -100.95 107.11 20.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.77 ' O ' HD13 ' A' ' 319' ' ' ILE . 36.8 tt0 -59.84 -50.03 75.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.327 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.84 HG23 ' HB ' ' A' ' 388' ' ' THR . 39.7 mm -135.51 125.1 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 120.547 0.213 . . . . 0.0 111.284 -179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 312' ' ' LEU . 29.7 tp -90.82 128.23 36.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.903 0.382 . . . . 0.0 111.305 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 412' ' ' ILE . 0.6 OUTLIER -111.74 105.91 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.746 179.722 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.636 HG23 ' HG ' ' A' ' 320' ' ' LEU . 8.2 t -124.63 162.21 26.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.405 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.859 ' CE2' HG23 ' A' ' 392' ' ' VAL . 94.1 m-85 -110.63 149.86 29.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.043 0.449 . . . . 0.0 111.687 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.53 ' HB3' HG21 ' A' ' 391' ' ' ILE . 12.6 pt-20 -66.83 -27.98 67.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -94.31 34.98 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.681 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.556 HD11 HD11 ' A' ' 409' ' ' ILE . 43.0 tp -70.31 122.33 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.526 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.53 23.28 5.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.268 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.977 HG22 HD12 ' A' ' 374' ' ' LEU . 14.9 mm -120.89 135.5 60.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.401 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 4.7 mtt -138.54 161.47 36.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.336 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 33.0 ttm180 -90.19 120.04 31.03 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.488 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 10.7 m-85 -117.11 155.26 29.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.723 179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.048 HG12 HD12 ' A' ' 343' ' ' ILE . 9.6 m -117.8 110.97 32.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.04 0.448 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.766 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.4 mp -97.49 142.28 29.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.941 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.446 ' CE1' HG12 ' A' ' 369' ' ' ILE . 2.5 m170 -82.28 176.47 9.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 340' ' ' GLU . 21.5 p -103.36 162.39 13.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -47.65 -28.86 2.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.958 0.409 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -101.63 -119.6 4.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.726 179.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.54 22.26 0.28 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.788 0.294 . . . . 0.0 111.74 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -134.91 43.37 2.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.769 0.319 . . . . 0.0 111.433 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.406 ' HB3' ' SG ' ' A' ' 335' ' ' CYS . 14.1 tt0 -169.15 130.01 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 110.214 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -115.49 140.41 49.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.099 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.739 ' O ' HD13 ' A' ' 343' ' ' ILE . 8.4 ttpt -121.48 145.48 47.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.862 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.048 HD12 HG12 ' A' ' 332' ' ' VAL . 6.6 mm -123.18 119.65 58.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.052 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 54.1 tp -128.14 161.85 28.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.177 0.513 . . . . 0.0 111.731 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.516 ' O ' HD13 ' A' ' 346' ' ' LEU . 3.4 p90 -101.0 120.1 39.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.645 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 1.079 HD12 ' HG2' ' A' ' 350' ' ' GLN . 2.3 mm? -124.48 156.37 37.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -178.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.622 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 6.8 p -100.83 168.12 9.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.34 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.4 Cg_endo -43.89 -49.58 8.12 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.525 2.15 . . . . 0.0 112.303 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.0 -55.51 33.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.397 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 1.079 ' HG2' HD12 ' A' ' 346' ' ' LEU . 4.7 tp60 -59.97 -53.19 60.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.376 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.619 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 77.6 mt-10 -49.55 -33.22 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.85 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 348' ' ' PRO . 2.1 mmmm -60.08 -28.28 67.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.153 0.501 . . . . 0.0 110.425 179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.427 ' HB2' ' NE2' ' A' ' 356' ' ' HIS . 0.0 OUTLIER -81.94 16.48 1.87 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.75 179.291 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.718 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 8.5 ptmm? -55.56 -23.26 25.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.056 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 85.8 p -60.05 -44.85 94.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.664 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 358' ' ' THR . 6.3 p80 -107.84 -41.85 4.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.234 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.766 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 57.35 5.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.6 m -86.87 178.11 7.08 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.026 179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.657 ' HB2' HG22 ' A' ' 362' ' ' THR . 93.1 m-20 -133.0 135.64 45.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -72.43 -0.19 11.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.096 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -104.37 -15.33 15.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.602 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.657 HG22 ' HB2' ' A' ' 359' ' ' ASP . 5.5 t -133.52 -37.76 0.94 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.718 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 84.87 41.52 7.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.716 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.808 ' C ' HG23 ' A' ' 358' ' ' THR . 13.0 pt20 -86.46 88.15 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.151 0.5 . . . . 0.0 110.686 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.29 129.91 41.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.174 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.663 ' HB3' ' HG ' ' A' ' 333' ' ' LEU . 61.1 m80 -143.86 167.49 22.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -145.33 113.93 6.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.303 179.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.664 HD11 ' O ' ' A' ' 370' ' ' GLU . 58.6 tp -70.23 133.13 46.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.019 0.438 . . . . 0.0 111.055 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.7 mp -106.56 -40.02 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.137 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.664 ' O ' HD11 ' A' ' 368' ' ' LEU . 38.8 tt0 -152.17 166.12 32.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.535 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.544 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -145.34 117.14 8.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 179.515 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 25.4 tpp -114.99 124.16 30.75 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.602 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.594 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 32.3 Cg_exo -57.44 120.92 9.16 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.945 1.763 . . . . 0.0 110.984 178.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 0.977 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.16 -42.31 94.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.616 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.866 HD11 HD12 ' A' ' 391' ' ' ILE . 63.7 tp -60.06 -51.44 69.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 68.1 mt-10 -59.77 -40.22 87.47 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.704 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -62.0 -40.03 94.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.809 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.626 ' CE1' HD22 ' A' ' 312' ' ' LEU . 1.6 m-85 -75.1 -29.45 60.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.19 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -80.18 -19.42 47.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.617 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -111.02 -9.31 14.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -129.74 19.84 5.58 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.5 p90 -69.99 -11.89 61.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -83.63 -38.3 21.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -59.99 -38.33 82.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.295 179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.556 ' CD2' HD23 ' A' ' 312' ' ' LEU . 24.4 m-85 -83.97 -10.43 57.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.394 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.63 1.26 52.7 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.644 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.822 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -85.75 165.15 17.15 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.428 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.84 ' HB ' HG23 ' A' ' 319' ' ' ILE . 97.9 m -106.74 100.23 9.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.338 179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.785 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -71.93 102.22 2.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.648 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 76.7 mm-40 -107.82 128.01 54.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.928 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.866 HD12 HD11 ' A' ' 375' ' ' LEU . 22.6 mm -94.85 102.09 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 112.208 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.859 HG23 ' CE2' ' A' ' 323' ' ' TYR . 4.1 m -100.43 -169.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.817 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.615 ' HA ' ' HD2' ' A' ' 323' ' ' TYR . 4.7 p -154.89 151.55 28.7 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.021 0.439 . . . . 0.0 111.557 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 403' ' ' VAL . 34.0 p-10 -71.08 1.43 5.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.319 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -60.03 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.283 . . . . 0.0 111.017 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 85.4 p -81.88 168.15 18.24 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 43.6 mt-30 -60.03 -54.79 41.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.845 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 401' ' ' GLN . 4.5 mp0 -62.8 -39.5 94.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.266 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -53.63 -59.7 9.34 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.593 179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.92 -19.55 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 398' ' ' GLU . 80.0 mt-30 -69.96 -40.03 75.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.914 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 287' ' ' ILE . 2.9 m-85 -63.47 -44.81 93.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.767 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 394' ' ' ASP . 88.2 t -59.99 -45.23 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -75.25 -42.5 55.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.423 ' C ' ' CD1' ' A' ' 406' ' ' PHE . . . -72.79 -38.19 56.79 Favored Glycine 0 CA--C 1.496 -1.116 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -178.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.709 ' CG ' ' HB2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -124.75 -94.52 0.48 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.192 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 406' ' ' PHE . . . 155.46 34.06 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.818 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 122.53 -20.04 7.91 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.562 -1.304 . . . . 0.0 115.504 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.637 HD13 HG22 ' A' ' 305' ' ' VAL . 1.2 mt -129.6 130.32 66.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.562 1.181 . . . . 0.0 111.765 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -154.67 148.69 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -132.48 151.05 19.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.735 -1.221 . . . . 0.0 114.105 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.94 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.0 mt -109.35 127.48 66.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 37.6 mt -88.23 153.33 21.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.52 0.676 . . . . 0.0 112.302 -178.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.528 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 44.2 mtt-85 -70.06 -36.75 75.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.605 179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 417' ' ' VAL . 8.6 m-85 -160.92 170.59 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.409 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.878 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -58.09 128.03 35.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.693 -179.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 415' ' ' TYR . 33.1 m -129.98 159.91 41.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.886 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -87.16 132.24 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -70.04 136.89 50.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.0 130.7 48.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.767 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -66.15 147.23 49.94 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.704 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -150.02 170.1 19.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.7 0.286 . . . . 0.0 110.464 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -60.01 -40.94 90.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.982 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -60.79 -40.03 91.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.794 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -65.64 140.03 58.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.125 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -118.51 89.94 0.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.539 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -141.57 130.09 4.26 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.395 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.28 -40.04 88.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.106 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -115.44 24.15 11.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -60.13 -39.92 87.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.926 0.394 . . . . 0.0 110.337 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.436 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 22.3 p90 -107.37 91.29 3.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.208 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -115.5 -137.68 0.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 65.7 t0 60.88 40.02 16.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 109.194 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 51.1 mt -89.03 -0.25 57.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.338 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.02 87.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -68.0 -35.17 77.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.478 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.93 -34.14 71.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.079 179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 63.8 tp -60.09 -42.4 94.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.859 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -60.06 -40.01 88.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.845 179.958 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.851 0.358 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.776 HG22 ' HB3' ' A' ' 282' ' ' GLN . 11.9 p -66.21 -29.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.257 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -52.28 -40.38 61.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.694 0.283 . . . . 0.0 111.434 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.55 -44.2 78.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.615 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.455 ' CG1' ' N ' ' A' ' 282' ' ' GLN . 5.6 pt -81.47 -45.7 20.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.796 0.332 . . . . 0.0 111.802 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.776 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.0 OUTLIER -57.17 -37.34 71.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.22 0.533 . . . . 0.0 110.085 -179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.576 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 93.3 mt-10 -77.77 -28.58 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.899 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -83.99 -57.52 3.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -70.0 -58.23 4.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 319' ' ' ILE . 19.2 tp -57.26 -58.35 8.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.702 0.287 . . . . 0.0 111.509 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.716 HG23 ' CE1' ' A' ' 402' ' ' PHE . 30.4 mt -59.97 -49.65 83.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.152 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -57.28 -37.19 79.6 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.633 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -60.03 -35.79 75.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.215 0.531 . . . . 0.0 110.282 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.578 ' HA ' ' CE1' ' A' ' 301' ' ' TYR . 12.6 t80 -60.0 -46.58 89.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.402 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.699 0.285 . . . . 0.0 111.614 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 295' ' ' SER . 38.0 t0 -63.67 -46.85 83.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 111.463 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 301' ' ' TYR . 33.4 tp10 -64.74 -40.0 94.57 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 301' ' ' TYR . 81.8 mt -62.27 -26.1 39.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -60.29 -14.06 16.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.273 0.559 . . . . 0.0 109.865 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.807 ' HB2' HG23 ' A' ' 298' ' ' THR . 27.2 mt-30 -98.36 -0.02 44.57 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.422 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.23 28.89 17.21 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.196 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.811 ' O ' ' HG2' ' A' ' 416' ' ' ARG . 30.5 p -69.98 -10.03 57.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.067 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 55.29 52.62 46.2 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.525 178.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 301' ' ' TYR . 11.8 mtpt -130.33 40.57 3.51 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.864 ' CE1' HG23 ' A' ' 412' ' ' ILE . 74.2 m-85 -162.54 165.25 26.26 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.855 0.359 . . . . 0.0 111.106 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 307' ' ' ASP . 2.0 p -149.7 164.31 35.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.966 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.716 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 52.7 p90 -136.98 151.89 49.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.082 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 88.3 155.45 29.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.445 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.949 HG11 HD13 ' A' ' 374' ' ' LEU . 0.0 OUTLIER -61.55 -56.49 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.283 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 310' ' ' LYS . 8.5 pt-20 -47.68 -56.9 6.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.591 -179.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 303' ' ' PHE . 96.2 m-20 -60.7 -54.98 38.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.667 0.27 . . . . 0.0 111.395 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 409' ' ' ILE . 18.9 m -58.68 -40.04 82.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.003 -179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.932 ' CD1' HG12 ' A' ' 305' ' ' VAL . 3.2 mp -67.69 -48.07 67.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 306' ' ' GLU . 0.1 OUTLIER -54.99 -56.53 18.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.144 -179.453 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -61.23 -30.14 70.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.07 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.865 ' CD1' HG21 ' A' ' 317' ' ' VAL . 0.1 OUTLIER -73.04 -28.44 62.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.796 179.39 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -76.93 -26.21 53.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 176.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 45.4 mmm -82.08 -8.53 59.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.851 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 61.75 14.22 42.97 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.263 -178.307 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 413' ' ' LEU . . . -82.79 -5.96 59.19 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.394 0.278 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 312' ' ' LEU . 27.2 m -99.1 105.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.611 ' O ' HD13 ' A' ' 319' ' ' ILE . 42.3 tt0 -59.93 -49.97 75.61 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.838 HG23 ' HB ' ' A' ' 388' ' ' THR . 42.3 mm -133.78 126.34 50.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.563 0.221 . . . . 0.0 111.185 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.61 ' HG ' HG23 ' A' ' 322' ' ' VAL . 40.9 tp -93.52 129.43 39.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.914 0.388 . . . . 0.0 111.058 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 412' ' ' ILE . 1.1 mt -116.14 109.32 27.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 110.142 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.61 HG23 ' HG ' ' A' ' 320' ' ' LEU . 14.8 t -125.43 161.84 29.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 -178.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.548 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 31.5 m-85 -108.14 146.94 31.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.75 0.31 . . . . 0.0 111.168 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.644 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.62 -32.76 74.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -94.1 51.53 1.51 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.766 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.57 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 28.4 tp -83.9 125.87 32.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.746 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -92.7 23.03 4.31 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.115 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.036 HG22 HD12 ' A' ' 374' ' ' LEU . 14.8 mm -122.43 133.47 68.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.596 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.599 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 13.7 mtt -139.53 161.54 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 31.9 ttt180 -92.39 122.26 34.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 111.645 -178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.53 ' HE1' ' HB2' ' A' ' 329' ' ' MET . 6.6 m-85 -120.7 159.02 26.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.22 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 343' ' ' ILE . 5.3 m -121.87 111.87 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 111.362 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.739 HD11 ' CD2' ' A' ' 357' ' ' PHE . 2.0 mm? -103.13 149.39 24.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.752 ' HB2' ' HB2' ' A' ' 367' ' ' GLU . 29.2 m170 -88.38 -179.3 6.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 340' ' ' GLU . 17.9 t -110.57 161.25 15.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.513 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 35.8 tp60 -45.7 -38.02 6.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.08 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 338' ' ' THR . . . -84.96 -113.22 0.7 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.391 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 337' ' ' GLY . 0.4 OUTLIER -169.49 29.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.476 179.846 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -148.16 42.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.001 0.429 . . . . 0.0 110.753 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . 0.444 ' HB3' ' CB ' ' A' ' 335' ' ' CYS . 7.5 tp10 -164.37 124.62 2.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.104 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.98 142.37 45.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.977 0.418 . . . . 0.0 111.298 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.717 ' C ' HD13 ' A' ' 343' ' ' ILE . 49.8 tttp -121.24 141.52 50.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.798 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 1.011 HD12 HG12 ' A' ' 332' ' ' VAL . 5.5 mm -121.44 118.63 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.258 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.693 HD23 HD11 ' A' ' 346' ' ' LEU . 32.4 tp -132.55 157.8 43.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.315 0.578 . . . . 0.0 112.294 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.609 ' O ' HD13 ' A' ' 346' ' ' LEU . 0.2 OUTLIER -92.09 116.67 29.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.629 179.461 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.693 HD11 HD23 ' A' ' 344' ' ' LEU . 1.4 mm? -120.59 153.64 36.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.444 0.64 . . . . 0.0 112.711 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.6 p -101.0 168.98 8.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.542 178.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 1.9 Cg_endo -41.24 -46.14 5.54 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.465 2.11 . . . . 0.0 112.062 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.05 -54.92 41.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . 0.547 ' OE1' HD12 ' A' ' 346' ' ' LEU . 62.8 mt-30 -66.77 -48.35 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.523 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 95.1 mt-10 -60.07 -32.42 70.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.535 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 21.3 ttpt -57.28 -32.26 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.158 0.504 . . . . 0.0 110.174 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 356' ' ' HIS . 62.0 t0 -91.46 61.46 4.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.612 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 351' ' ' GLU . 24.3 mttt -70.01 -41.45 74.3 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.8 m -59.83 -55.39 34.83 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.425 -178.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 353' ' ' ASP . 36.7 m170 -85.47 -49.44 8.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.319 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.739 ' CD2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 54.23 10.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.925 0.393 . . . . 0.0 110.403 -178.183 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.755 HG22 ' H ' ' A' ' 359' ' ' ASP . 1.4 m -108.65 -165.6 1.04 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.246 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 358' ' ' THR . 74.3 m-20 -132.0 134.54 45.7 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 6.0 mtpp -72.14 1.33 7.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.659 0.266 . . . . 0.0 111.587 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.86 -23.18 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 359' ' ' ASP . 2.2 t -118.63 -36.42 3.49 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.405 -179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 76.91 33.87 44.56 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 365' ' ' GLU . 74.5 mm-40 -57.37 -157.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.319 . . . . 0.0 110.544 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 366' ' ' HIS . 0.4 OUTLIER -140.28 126.02 19.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.291 -179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.485 ' CB ' ' HB3' ' A' ' 357' ' ' PHE . 95.6 m-70 -161.51 142.82 11.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.906 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 334' ' ' HIS . 57.0 mt-10 -145.91 105.26 3.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.421 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 370' ' ' GLU . 62.0 tp -75.22 137.38 41.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.024 0.44 . . . . 0.0 111.951 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 332' ' ' VAL . 2.6 mp -116.54 -45.42 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.59 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.644 ' O ' HD11 ' A' ' 368' ' ' LEU . 52.9 tt0 -140.94 165.36 27.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 1.7 p -147.42 118.59 7.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.868 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . . . . . . . . . 5.8 tpt -114.22 129.86 24.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.96 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.599 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 18.7 Cg_endo -59.1 118.35 5.22 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.204 1.936 . . . . 0.0 111.026 178.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.036 HD12 HG22 ' A' ' 328' ' ' ILE . 14.4 mt -60.07 -39.46 86.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.674 -179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 391' ' ' ILE . 63.9 tp -60.07 -54.08 50.24 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.672 -0.411 . . . . 0.0 109.958 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.537 ' HB2' ' HG2' ' A' ' 373' ' ' PRO . 52.0 mt-10 -58.12 -40.06 80.26 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.928 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -62.51 -39.89 94.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.376 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.684 ' CE1' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -72.66 -28.69 62.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.085 179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -89.48 -9.74 48.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.33 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -104.86 -14.06 15.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.425 ' O ' ' CD2' ' A' ' 385' ' ' PHE . 98.6 m-20 -129.62 20.22 5.62 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -64.88 -18.94 65.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.739 0.304 . . . . 0.0 111.019 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -81.05 -39.96 24.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -64.77 -39.96 94.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.621 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.581 ' CD2' HD23 ' A' ' 312' ' ' LEU . 39.7 m-85 -80.02 -11.33 59.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.976 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.93 2.34 57.52 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.488 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -87.22 163.66 16.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.189 0.519 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.838 ' HB ' HG23 ' A' ' 319' ' ' ILE . 50.2 m -106.95 100.4 9.9 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.08 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.744 HD11 HD11 ' A' ' 391' ' ' ILE . 2.4 tm? -76.28 107.18 8.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.558 -178.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.504 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 43.3 mm-40 -113.71 135.17 54.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.755 179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.909 HD12 HD11 ' A' ' 375' ' ' LEU . 36.2 mm -98.97 105.2 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.125 0.488 . . . . 0.0 112.146 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.561 HG13 ' NE2' ' A' ' 282' ' ' GLN . 5.8 m -102.1 -169.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.239 -178.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 323' ' ' TYR . 0.8 OUTLIER -158.25 153.37 25.49 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.175 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 403' ' ' VAL . 57.0 t0 -77.91 69.97 4.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.295 -179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -114.56 -34.94 5.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.937 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 75.5 m -102.93 179.36 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.934 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 25.3 mm100 -60.01 -40.65 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 287' ' ' ILE . 34.4 mp0 -69.49 -40.66 76.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . . . . . . . . . . . -62.46 -21.06 61.97 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.271 178.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 52.3 m -84.2 -21.43 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.178 -0.511 . . . . 0.0 111.027 178.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 85.5 mt-30 -77.48 -41.69 38.54 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.779 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.716 ' CE1' HG23 ' A' ' 287' ' ' ILE . 3.3 m-85 -67.31 -49.62 63.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.555 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 394' ' ' ASP . 72.3 t -60.03 -40.04 82.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.871 0.367 . . . . 0.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -79.86 -41.32 26.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.325 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.26 95.29 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.716 ' HB3' ' HB2' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -134.06 -84.74 0.43 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.018 -0.591 . . . . 0.0 109.713 178.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 148.32 41.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.563 -1.303 . . . . 0.0 115.138 179.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 323' ' ' TYR . . . 126.61 -28.49 4.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 119.556 -1.307 . . . . 0.0 115.218 177.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.563 HG22 HG21 ' A' ' 308' ' ' THR . 0.8 OUTLIER -125.02 127.83 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.056 0.928 . . . . 0.0 111.913 -178.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -149.43 139.77 7.67 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 178.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -122.34 140.62 13.59 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.595 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.864 HG23 ' CE1' ' A' ' 301' ' ' TYR . 48.4 mt -101.9 127.29 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 317' ' ' VAL . 53.9 mt -87.42 151.55 22.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.558 0.694 . . . . 0.0 112.798 -177.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 34.9 mtp-105 -78.77 -27.68 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.734 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.413 ' HA ' ' CE ' ' A' ' 300' ' ' LYS . 95.5 m-85 -151.99 170.06 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.958 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.811 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -71.2 123.78 22.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.861 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 413' ' ' LEU . 24.3 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . 0.409 ' O ' ' CD2' ' A' ' 419' ' ' PHE . 96.4 m-20 -89.92 -79.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.704 0.288 . . . . 0.0 111.052 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 418' ' ' ASP . 54.0 m-85 -159.15 159.94 34.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.969 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' A' ' 420' ' ' GLN . 10.0 mm-40 -60.78 -39.96 90.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -167.7 120.26 0.89 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.767 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 73.4 mtm -78.85 174.09 11.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.661 0.267 . . . . 0.0 110.647 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.97 -50.01 75.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -69.97 -39.99 75.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 110.245 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.01 -40.08 88.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.638 179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -54.57 122.81 26.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.575 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 176.33 -140.63 5.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.33 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.91 -39.95 96.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 0.0 111.195 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 432' ' ' PHE . 96.0 m-20 -133.79 63.69 1.62 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 110.984 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.99 -42.67 94.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.678 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 431' ' ' PHE . 31.3 p90 -144.64 114.32 7.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 429' ' ' ASP . 26.2 p90 -130.98 106.73 8.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.05 0.452 . . . . 0.0 111.376 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.03 14.2 12.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.035 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 44.2 mt -72.71 -3.86 27.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.774 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.81 0.338 . . . . 0.0 110.641 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -69.8 -32.49 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -60.06 -33.2 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.278 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.03 -41.59 92.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.012 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.95 -39.98 87.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 6.3 m80 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.869 179.875 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 7.5 p -66.05 -29.95 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -51.65 -40.54 60.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.841 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -50.05 75.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.0 111.056 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . . . . . . . . . 45.6 pt -82.76 -20.91 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.697 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.679 ' NE2' ' HB3' ' A' ' 390' ' ' GLU . 0.4 OUTLIER -59.63 -39.99 86.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.592 -179.433 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 287' ' ' ILE . 53.4 mt-10 -77.16 -29.91 54.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.228 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -83.88 -53.5 5.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -71.7 -58.1 3.78 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 319' ' ' ILE . 16.2 tp -58.75 -54.7 44.18 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.749 HG23 ' CD2' ' A' ' 402' ' ' PHE . 46.0 mt -59.98 -48.47 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.572 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.474 ' CA ' ' HG2' ' A' ' 398' ' ' GLU . . . -55.33 -37.88 66.9 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.041 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 293' ' ' GLU . 43.8 ttt180 -60.0 -39.2 84.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.166 0.508 . . . . 0.0 110.056 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.638 ' HA ' ' CE2' ' A' ' 301' ' ' TYR . 7.8 t80 -55.63 -45.77 77.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.772 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -83.32 -39.24 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.737 0.303 . . . . 0.0 111.749 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 295' ' ' SER . 65.9 t0 -59.97 -43.25 95.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.381 -179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 301' ' ' TYR . 4.0 mt-10 -67.17 -42.32 84.46 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.2 -23.88 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.57 178.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.591 ' HB2' ' O ' ' A' ' 292' ' ' ASP . 0.5 OUTLIER -63.02 -15.47 56.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.203 0.525 . . . . 0.0 110.048 178.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.609 ' HB2' HG23 ' A' ' 298' ' ' THR . 29.0 mt-30 -104.86 2.12 29.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.596 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 58.25 29.73 18.45 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.962 0.41 . . . . 0.0 110.57 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 296' ' ' GLN . 13.8 p -66.75 -13.02 60.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.939 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 56.9 49.18 73.0 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.402 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.635 ' HA ' HD12 ' A' ' 413' ' ' LEU . 17.5 mttp -126.4 36.8 4.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.946 ' CE2' HG23 ' A' ' 412' ' ' ILE . 95.3 m-85 -159.35 159.99 34.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.337 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 307' ' ' ASP . 44.7 m -140.95 161.2 38.4 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 307' ' ' ASP . 55.7 p90 -135.11 144.85 47.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 406' ' ' PHE . . . 86.29 157.0 29.1 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.908 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 328' ' ' ILE . 0.0 OUTLIER -60.06 -55.82 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 0.0 111.166 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 310' ' ' LYS . 5.5 pt-20 -47.31 -57.24 5.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.943 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 302' ' ' CYS . 95.9 m-20 -61.12 -54.85 39.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.712 0.291 . . . . 0.0 111.452 -179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.537 HG21 HG22 ' A' ' 409' ' ' ILE . 28.0 m -56.56 -40.02 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.882 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.832 ' CD1' HG12 ' A' ' 305' ' ' VAL . 2.2 mp -66.86 -45.23 78.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.566 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 314' ' ' MET . 13.3 mtmt -56.66 -50.04 73.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.998 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . -73.85 -27.32 61.03 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 378' ' ' PHE . 0.1 OUTLIER -69.66 -34.53 74.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.886 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 309' ' ' LEU . 81.3 mm-40 -71.56 -24.35 61.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 310' ' ' LYS . 15.4 mmt -83.8 -7.96 59.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.092 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.07 10.94 36.02 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.561 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 1.01 ' HB1' HG11 ' A' ' 417' ' ' VAL . . . -79.96 -6.19 57.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.441 0.296 . . . . 0.0 110.79 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 387' ' ' ALA . 34.9 m -95.79 105.59 17.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.938 ' O ' HD13 ' A' ' 319' ' ' ILE . 37.0 tt0 -59.64 -50.0 75.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.279 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.938 HD13 ' O ' ' A' ' 318' ' ' GLU . 27.9 mm -136.64 126.5 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 120.534 0.206 . . . . 0.0 111.41 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.725 ' HG ' HG23 ' A' ' 322' ' ' VAL . 44.9 tp -89.72 126.48 35.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.972 0.415 . . . . 0.0 111.467 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 321' ' ' ILE . . . . . 0.777 HD11 HD11 ' A' ' 412' ' ' ILE . 0.5 OUTLIER -111.56 103.6 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.286 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.725 HG23 ' HG ' ' A' ' 320' ' ' LEU . 17.4 t -122.33 152.66 26.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.476 -179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . 0.633 ' OH ' ' HB2' ' A' ' 402' ' ' PHE . 96.5 m-85 -98.42 142.95 29.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.037 0.446 . . . . 0.0 111.411 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 324' ' ' GLU . . . . . 0.642 ' HB3' HG21 ' A' ' 391' ' ' ILE . 16.8 pt-20 -65.36 -24.05 67.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.835 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -96.28 33.35 1.78 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.745 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.492 ' HG ' ' H ' ' A' ' 328' ' ' ILE . 21.5 tp -71.2 123.91 23.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.699 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 347' ' ' THR . 96.0 m-20 -96.57 28.7 3.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.724 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 1.056 HG21 HG21 ' A' ' 305' ' ' VAL . 20.0 mm -126.58 133.19 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.063 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 329' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 373' ' ' PRO . 56.3 mtt -140.62 162.53 35.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.161 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.58 ' N ' ' HG ' ' A' ' 374' ' ' LEU . 13.0 ttt180 -88.58 120.17 29.72 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.069 0.461 . . . . 0.0 111.244 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 331' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 371' ' ' SER . 7.4 m-85 -124.81 160.74 28.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.496 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.589 HG12 HD12 ' A' ' 343' ' ' ILE . 0.7 OUTLIER -131.79 112.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.021 0.439 . . . . 0.0 111.423 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.788 HD11 ' CE2' ' A' ' 357' ' ' PHE . 1.9 mm? -101.54 129.6 47.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.24 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 334' ' ' HIS . . . . . 0.572 ' HB2' HD11 ' A' ' 369' ' ' ILE . 57.2 m170 -137.05 150.81 48.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.179 179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 335' ' ' CYS . . . . . . . . . . . . . 1.2 t -111.56 152.74 27.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 336' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.92 129.92 44.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.755 0.312 . . . . 0.0 110.588 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 107.21 -1.2 35.13 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.701 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.48 23.55 2.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.775 0.287 . . . . 0.0 111.626 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -102.21 10.31 39.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.223 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 340' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -159.97 119.99 2.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.794 0.33 . . . . 0.0 111.155 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.4 ' HB3' ' CD2' ' A' ' 334' ' ' HIS . 17.5 mt-10 -136.6 129.97 31.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.165 179.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.772 ' C ' HD13 ' A' ' 343' ' ' ILE . 6.2 tttp -136.0 121.22 19.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.935 0.398 . . . . 0.0 111.435 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.772 HD13 ' C ' ' A' ' 342' ' ' LYS . 2.4 mm -113.18 112.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.662 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 345' ' ' TYR . 1.8 tp -144.08 156.5 44.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.872 0.368 . . . . 0.0 111.414 -178.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 345' ' ' TYR . . . . . 0.901 ' HB2' HG23 ' A' ' 328' ' ' ILE . 0.3 OUTLIER -84.96 137.09 33.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.183 178.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.583 ' HB2' ' HG3' ' A' ' 351' ' ' GLU . 2.7 mm? -127.68 164.1 22.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.635 0.731 . . . . 0.0 112.475 -179.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.587 ' HB ' ' HD2' ' A' ' 348' ' ' PRO . 1.7 p -101.56 172.05 4.79 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.283 178.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 348' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 347' ' ' THR . 74.0 Cg_exo -48.94 -47.52 21.2 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 121.755 1.637 . . . . 0.0 111.768 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 349' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.17 -58.46 8.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 350' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -60.04 -48.95 79.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 346' ' ' LEU . 91.1 mt-10 -59.96 -35.69 75.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -57.97 -34.06 69.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.094 0.473 . . . . 0.0 109.807 179.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 353' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.68 40.54 1.04 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.909 178.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 354' ' ' LYS . . . . . 0.603 ' HA ' ' CD2' ' A' ' 357' ' ' PHE . 4.1 pttt -70.43 -19.09 63.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.55 -178.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 46.6 t -66.83 -40.02 87.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.454 . . . . 0.0 110.068 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 358' ' ' THR . 90.5 m-70 -98.03 -56.46 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.142 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 333' ' ' LEU . 0.2 OUTLIER 60.04 4.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.087 -179.108 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.807 HG23 ' C ' ' A' ' 364' ' ' GLN . 3.3 m -91.74 174.44 7.34 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.749 ' HB2' HG22 ' A' ' 362' ' ' THR . 96.4 m-20 -130.09 138.54 50.76 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -72.89 -2.02 19.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.362 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -104.48 -13.83 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . 0.749 HG22 ' HB2' ' A' ' 359' ' ' ASP . 6.6 t -131.85 -36.32 1.21 Allowed 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.565 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 89.57 2.18 76.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.634 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 364' ' ' GLN . . . . . 0.807 ' C ' HG23 ' A' ' 358' ' ' THR . 37.5 mt-30 -50.01 94.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.951 0.405 . . . . 0.0 110.463 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -82.37 133.0 35.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.371 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 366' ' ' HIS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 333' ' ' LEU . 73.4 m80 -147.1 164.41 33.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.159 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -135.25 108.1 7.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.93 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 370' ' ' GLU . 45.6 tp -63.46 140.02 58.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.114 0.483 . . . . 0.0 111.483 -179.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 334' ' ' HIS . 2.2 mp -111.74 -45.62 5.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.568 ' O ' HD11 ' A' ' 368' ' ' LEU . 34.6 tt0 -143.12 156.25 44.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.177 -179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 331' ' ' TYR . 0.3 OUTLIER -143.87 116.16 8.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.403 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 372' ' ' MET . . . . . 0.422 ' CE ' ' HD2' ' A' ' 373' ' ' PRO . 3.7 tpt -116.56 121.92 32.5 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.72 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.57 ' HA ' ' HG2' ' A' ' 329' ' ' MET . 31.4 Cg_exo -57.57 120.84 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 121.782 1.655 . . . . 0.0 110.784 178.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 374' ' ' LEU . . . . . 1.008 HD12 HG22 ' A' ' 328' ' ' ILE . 20.9 mt -59.94 -44.16 94.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.259 -178.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.81 HD11 ' CD1' ' A' ' 391' ' ' ILE . 68.9 tp -60.06 -50.79 72.32 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 373' ' ' PRO . 53.9 mt-10 -59.45 -39.97 85.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.673 179.244 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 377' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 381' ' ' ASN . 76.7 t-105 -60.26 -43.77 95.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.6 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 312' ' ' LEU . 8.7 m-85 -73.68 -30.68 63.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.19 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -73.36 -25.09 60.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.539 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 380' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -110.69 -6.56 14.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 377' ' ' TRP . 72.7 m-80 -129.33 20.25 5.75 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.584 ' HB3' ' HB2' ' A' ' 389' ' ' LEU . 54.6 p90 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.565 0.221 . . . . 0.0 111.349 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 382' ' ' TYR . 26.4 mmtt -79.35 -40.43 30.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 110.919 179.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 384' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -60.16 -36.37 77.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.723 ' CD2' HD23 ' A' ' 312' ' ' LEU . 22.2 m-85 -85.49 -4.18 59.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.399 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.71 3.06 32.3 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.519 -179.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.855 ' HB2' HG23 ' A' ' 317' ' ' VAL . . . -89.72 166.31 13.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 111.121 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 388' ' ' THR . . . . . 0.801 ' HB ' HG23 ' A' ' 319' ' ' ILE . 58.1 m -109.13 100.57 9.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.003 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.756 HD11 HD11 ' A' ' 391' ' ' ILE . 3.2 tm? -69.35 102.36 1.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.679 ' HB3' ' NE2' ' A' ' 282' ' ' GLN . 5.7 mm-40 -109.77 130.03 55.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.734 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.81 ' CD1' HD11 ' A' ' 375' ' ' LEU . 32.4 mm -95.91 103.87 15.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.233 0.539 . . . . 0.0 112.057 -178.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 392' ' ' VAL . . . . . 0.615 HG23 ' CE1' ' A' ' 323' ' ' TYR . 13.6 m -101.47 -171.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.173 -178.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.519 ' HA ' ' HD1' ' A' ' 323' ' ' TYR . 0.7 OUTLIER -159.59 155.33 26.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.198 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 394' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -72.49 11.37 0.63 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.208 -179.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -62.16 -40.02 94.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.676 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 396' ' ' SER . . . . . . . . . . . . . 38.4 m -92.06 170.91 9.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.844 0.354 . . . . 0.0 111.389 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.493 ' O ' ' HG3' ' A' ' 401' ' ' GLN . 78.8 mt-30 -60.12 -54.35 46.93 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.545 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 398' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 287' ' ' ILE . 15.4 mp0 -59.99 -40.02 87.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.496 0.665 . . . . 0.0 109.467 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 399' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 287' ' ' ILE . . . -54.11 -57.64 15.89 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.776 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 5.8 m -59.9 -19.44 51.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 401' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 397' ' ' GLN . 92.0 mt-30 -69.42 -40.04 77.53 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.915 0.388 . . . . 0.0 110.961 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 402' ' ' PHE . . . . . 0.749 ' CD2' HG23 ' A' ' 287' ' ' ILE . 0.9 OUTLIER -59.97 -46.56 89.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.688 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.497 ' HA ' ' HA3' ' A' ' 407' ' ' GLY . 69.2 t -59.91 -34.08 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.017 -179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -68.24 -54.11 19.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 0.0 110.271 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 406' ' ' PHE . . . -66.72 -20.56 70.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.939 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 304' ' ' GLY . 24.2 t80 174.95 -75.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 403' ' ' VAL . . . 100.41 167.86 28.88 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.705 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . 0.415 ' CA ' HD13 ' A' ' 326' ' ' LEU . . . 78.73 -51.53 3.76 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.846 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 409' ' ' ILE . 0.2 OUTLIER -140.56 131.78 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 117.293 0.547 . . . . 0.0 112.234 -178.199 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 320' ' ' LEU . . . -150.75 141.06 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.73 145.86 15.93 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.867 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.946 HG23 ' CE2' ' A' ' 301' ' ' TYR . 19.1 mt -109.16 128.5 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 1.026 HD13 HG13 ' A' ' 417' ' ' VAL . 38.9 mt -90.66 153.15 20.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.72 0.771 . . . . 0.0 112.807 -177.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' A' ' 318' ' ' GLU . 17.7 mtt85 -70.0 -37.91 75.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.597 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 415' ' ' TYR . . . . . 0.692 ' O ' HG12 ' A' ' 417' ' ' VAL . 82.3 m-85 -158.24 -177.89 6.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.77 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 416' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 298' ' ' THR . 0.0 OUTLIER -60.01 100.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 110.846 -179.712 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.026 HG13 HD13 ' A' ' 413' ' ' LEU . 2.3 p -143.43 137.74 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.073 -179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 418' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -146.27 100.24 3.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 419' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.09 -49.36 77.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.275 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.2 126.66 34.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.281 -179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -154.47 -90.48 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.541 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 49.8 mtp 57.16 23.15 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.675 0.274 . . . . 0.0 111.056 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 424' ' ' TYR . 12.3 pt-20 -151.55 -53.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.385 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 424' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 423' ' ' GLU . 98.0 m-85 -160.85 88.66 0.77 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.705 0.288 . . . . 0.0 111.332 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 425' ' ' GLN . . . . . 0.689 ' HG3' ' HA ' ' A' ' 430' ' ' GLU . 32.0 mm-40 -70.05 -40.09 75.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.817 0.342 . . . . 0.0 110.803 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 156.12 -24.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.712 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . -154.26 33.16 0.71 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.771 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 56.83 34.27 24.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 0.0 111.026 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 429' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -118.39 37.52 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.689 ' HA ' ' HG3' ' A' ' 425' ' ' GLN . 1.7 tm-20 -60.0 -41.09 91.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 431' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -125.4 99.12 5.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.442 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 432' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -116.71 117.07 28.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.169 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 433' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -76.83 -0.69 24.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.322 179.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 434' ' ' LEU . 10.9 mt -50.96 -19.38 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.927 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -59.69 -40.02 86.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.396 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -74.88 -24.2 58.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.61 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.07 -38.43 82.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.052 0.453 . . . . 0.0 110.003 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 438' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.06 -46.35 89.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.919 179.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.02 -39.95 87.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.121 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.869 -179.895 . . . . . . . . 0 0 . 1 stop_ save_